Psyllid ID: psy17559

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-
Protein Sequence
LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYWHVSYPTTGC
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHHHHHHccccccccccccEEEcccccEEEEccccccHHHHHHHcccccccccccccccccccccccccHHHHHHHHHHHHHcccccccccHHHHHHHHcccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEccccccccccccccccccccHHHcHHHHHHccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHccccccccccccccc
Coil and Loop (DISEMBL)
lkqvpyssfqvlkgltylrekhaiihrdvkpsnilvnsggeikicdfgvsgqlidsmansfvgtrsymsperlqgthysvQSDIWSLGLSLVEMAIgmypipppdaktlaaifgpsrgdgywhvsypttgc
Flexible Loop (DISEMBL)
lkqvpyssfQVLKGLTYLREKHaiihrdvkpsnilvNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYWHVSYPTTGC
Low Complexity Region (SEG)
LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYWHVSYPTTGC
Disordered region (IsUnstruct)
******SSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYWHVSY*****
Disordered Region (DISOPRED)
*KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG*****************
Disordered Region (DISEMBL)
LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYWHVSYPTTGC
Disordered Region (DISPRO)
LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYWHVSYPT**C
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYWHVSYPTTGC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	131	2.2.26 [Sep-21-2011]
Q05116	395	Dual specificity mitogen-	N/A	N/A	0.832	0.275	0.880	2e-51
Q1HG70	400	Dual specificity mitogen-	yes	N/A	0.862	0.282	0.840	4e-51
Q91447	388	Dual specificity mitogen-	N/A	N/A	0.854	0.288	0.849	5e-51
Q24324	396	Dual specificity mitogen-	yes	N/A	0.816	0.270	0.878	5e-51
P29678	393	Dual specificity mitogen-	yes	N/A	0.816	0.272	0.869	6e-51
P36507	400	Dual specificity mitogen-	yes	N/A	0.862	0.282	0.831	6e-51
Q01986	393	Dual specificity mitogen-	yes	N/A	0.816	0.272	0.869	6e-51
P31938	393	Dual specificity mitogen-	yes	N/A	0.816	0.272	0.869	7e-51
Q02750	393	Dual specificity mitogen-	no	N/A	0.816	0.272	0.869	7e-51
Q63980	393	Dual specificity mitogen-	yes	N/A	0.816	0.272	0.869	8e-51

>sp|Q05116|MP2K1_XENLA Dual specificity mitogen-activated protein kinase kinase 1 OS=Xenopus laevis GN=map2k1 PE=1 SV=2

 Score =  200 bits (509), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 96/109 (88%), Positives = 100/109 (91%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 170 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 229

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPS 116
           MSPERLQGTHYSVQSDIWS+GLSLVEMAIG YPIPPPDAK L  IFG S
Sbjct: 230 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELIFGCS 278

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates the MAPK/ERK cascade, ultimately leading to phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements.
Xenopus laevis (taxid: 8355)
EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 2

>sp|Q1HG70|MP2K2_CANFA Dual specificity mitogen-activated protein kinase kinase 2 OS=Canis familiaris GN=MAP2K2 PE=2 SV=1

 Score =  199 bits (507), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 95/113 (84%), Positives = 101/113 (89%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  VL+GL YLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 174 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 233

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDG 120
           MSPERLQGTHYSVQSDIWS+GLSLVE++IG YPIPPPDAK L AIFG    DG
Sbjct: 234 MSPERLQGTHYSVQSDIWSMGLSLVELSIGRYPIPPPDAKELEAIFGRPMVDG 286

Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases.

Canis familiaris (taxid: 9615)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q91447|MP2K1_SERCA Dual specificity mitogen-activated protein kinase kinase 1 (Fragment) OS=Serinus canaria GN=MAP2K1 PE=2 SV=1

 Score =  199 bits (506), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 96/113 (84%), Positives = 102/113 (90%), Gaps = 1/113 (0%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 163 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 222

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG-PSRGD 119
           MSPERLQGTHYSVQSDIWS+GLSLVEMAIG YPIPPPD+K L  +FG P  GD
Sbjct: 223 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDSKELELMFGCPVEGD 275

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements.

Serinus canaria (taxid: 9135)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q24324|DSOR1_DROME Dual specificity mitogen-activated protein kinase kinase dSOR1 OS=Drosophila melanogaster GN=Dsor1 PE=2 SV=2

 Score =  199 bits (505), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 94/107 (87%), Positives = 99/107 (92%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +  VLKGL+YLR+ HAIIHRDVKPSNILVNS GEIKICDFGVSGQLIDSMANSFVGTRSY
Sbjct: 189 TLAVLKGLSYLRDNHAIIHRDVKPSNILVNSSGEIKICDFGVSGQLIDSMANSFVGTRSY 248

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP+  TL +IF 
Sbjct: 249 MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPNTATLESIFA 295

Required downstream of Raf in the sevenless (sev), torso (tor), and Drosophila EGF receptor homolog (DER) signal transduction pathways. Involved in both positive regulation (at the posterior terminus) and negative regulation (at the anterior domain) of tll, as in other terminal class gene products, maybe via the ERK-A kinase.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P29678|MP2K1_RABIT Dual specificity mitogen-activated protein kinase kinase 1 OS=Oryctolagus cuniculus GN=MAP2K1 PE=1 SV=2

 Score =  198 bits (504), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 93/107 (86%), Positives = 99/107 (92%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 170 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 229

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK L  +FG
Sbjct: 230 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 276

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P36507|MP2K2_HUMAN Dual specificity mitogen-activated protein kinase kinase 2 OS=Homo sapiens GN=MAP2K2 PE=1 SV=1

 Score =  198 bits (504), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 94/113 (83%), Positives = 101/113 (89%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  VL+GL YLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 174 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 233

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDG 120
           M+PERLQGTHYSVQSDIWS+GLSLVE+A+G YPIPPPDAK L AIFG    DG
Sbjct: 234 MAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDG 286

Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q01986|MP2K1_RAT Dual specificity mitogen-activated protein kinase kinase 1 OS=Rattus norvegicus GN=Map2k1 PE=1 SV=2

 Score =  198 bits (504), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 93/107 (86%), Positives = 99/107 (92%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 170 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 229

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK L  +FG
Sbjct: 230 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELLFG 276

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P31938|MP2K1_MOUSE Dual specificity mitogen-activated protein kinase kinase 1 OS=Mus musculus GN=Map2k1 PE=1 SV=2

 Score =  198 bits (504), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 93/107 (86%), Positives = 99/107 (92%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 170 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 229

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK L  +FG
Sbjct: 230 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELLFG 276

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q02750|MP2K1_HUMAN Dual specificity mitogen-activated protein kinase kinase 1 OS=Homo sapiens GN=MAP2K1 PE=1 SV=2

 Score =  198 bits (504), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 93/107 (86%), Positives = 99/107 (92%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 170 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 229

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK L  +FG
Sbjct: 230 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 276

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q63980|MP2K1_CRIGR Dual specificity mitogen-activated protein kinase kinase 1 OS=Cricetulus griseus GN=MAP2K1 PE=1 SV=1

 Score =  198 bits (504), Expect = 8e-51,   Method: Compositional matrix adjust.
 Identities = 93/107 (86%), Positives = 99/107 (92%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 170 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 229

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK L  +FG
Sbjct: 230 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELLFG 276

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Cricetulus griseus (taxid: 10029)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	131
242017000	400	mitogen-activated protein kinase ERK-A,	0.832	0.272	0.935	4e-54
112982906	404	MAP kinse-ERK kinase [Bombyx mori] gi|77	0.832	0.269	0.926	1e-52
289742647	395	mitogen-activated protein kinase kinase	0.916	0.303	0.841	1e-52
357627030	400	MAP kinse-ERK kinase [Danaus plexippus]	0.832	0.272	0.926	1e-52
195129968	235	GI15238 [Drosophila mojavensis] gi|19390	0.916	0.510	0.841	2e-51
195448050	397	GK25111 [Drosophila willistoni] gi|19416	0.916	0.302	0.842	2e-51
340720584	415	PREDICTED: dual specificity mitogen-acti	0.908	0.286	0.824	2e-51
350401186	415	PREDICTED: dual specificity mitogen-acti	0.908	0.286	0.824	2e-51
332374632	388	unknown [Dendroctonus ponderosae]	0.816	0.275	0.915	4e-51
125983818	396	GA13960 [Drosophila pseudoobscura pseudo	0.916	0.303	0.816	1e-50

>gi|242017000|ref|XP_002428982.1| mitogen-activated protein kinase ERK-A, putative [Pediculus humanus corporis] gi|212513815|gb|EEB16244.1| mitogen-activated protein kinase ERK-A, putative [Pediculus humanus corporis]

 Score =  215 bits (548), Expect = 4e-54,   Method: Compositional matrix adjust.
 Identities = 102/109 (93%), Positives = 107/109 (98%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSP 70
           VLKGL+YLR+KHAI+HRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSP
Sbjct: 194 VLKGLSYLRDKHAIMHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSP 253

Query: 71  ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGD 119
           ERLQGT+YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP + D
Sbjct: 254 ERLQGTYYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPKKND 302

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|112982906|ref|NP_001036922.1| MAP kinse-ERK kinase [Bombyx mori] gi|77799294|dbj|BAE46742.1| MAP kinse-ERK kinase [Bombyx mori]

 Score =  211 bits (536), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 101/109 (92%), Positives = 104/109 (95%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSP 70
           VLKGL+YLR+KHAI+HRDVKPSNILVNS GEIKICDFGVSGQLIDSMANSFVGTRSYMSP
Sbjct: 196 VLKGLSYLRDKHAIMHRDVKPSNILVNSNGEIKICDFGVSGQLIDSMANSFVGTRSYMSP 255

Query: 71  ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGD 119
           ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG    D
Sbjct: 256 ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGGQNED 304

Source: Bombyx mori

Species: Bombyx mori

Genus: Bombyx

Family: Bombycidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|289742647|gb|ADD20071.1| mitogen-activated protein kinase kinase [Glossina morsitans morsitans]

 Score =  211 bits (536), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 101/120 (84%), Positives = 106/120 (88%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +  VLKGL+YLR+KHAI+HRDVKPSNILVNS GEIKICDFGVSGQLIDSMANSFVGTRSY
Sbjct: 187 TLAVLKGLSYLRDKHAIMHRDVKPSNILVNSSGEIKICDFGVSGQLIDSMANSFVGTRSY 246

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYWHVSYP 127
           MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT+ AIF     DG   V  P
Sbjct: 247 MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTIEAIFDERNEDGTQTVLEP 306

Source: Glossina morsitans morsitans

Species: Glossina morsitans

Genus: Glossina

Family: Glossinidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|357627030|gb|EHJ76872.1| MAP kinse-ERK kinase [Danaus plexippus]

 Score =  210 bits (535), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 101/109 (92%), Positives = 104/109 (95%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSP 70
           VLKGL+YLR+KHAI+HRDVKPSNILVNS GEIKICDFGVSGQLIDSMANSFVGTRSYMSP
Sbjct: 192 VLKGLSYLRDKHAIMHRDVKPSNILVNSNGEIKICDFGVSGQLIDSMANSFVGTRSYMSP 251

Query: 71  ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGD 119
           ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG    D
Sbjct: 252 ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGGQNED 300

Source: Danaus plexippus

Species: Danaus plexippus

Genus: Danaus

Family: Nymphalidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195129968|ref|XP_002009426.1| GI15238 [Drosophila mojavensis] gi|193907876|gb|EDW06743.1| GI15238 [Drosophila mojavensis]

 Score =  207 bits (526), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 101/120 (84%), Positives = 106/120 (88%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +  VLKGL+YLR+KHAIIHRDVKPSNILVNS GEIKICDFGVSGQLIDSMANSFVGTRSY
Sbjct: 28  TLAVLKGLSYLRDKHAIIHRDVKPSNILVNSSGEIKICDFGVSGQLIDSMANSFVGTRSY 87

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYWHVSYP 127
           MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD+ TL AIF  +  DG   V  P
Sbjct: 88  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDSATLEAIFADNADDGNPTVIEP 147

Source: Drosophila mojavensis

Species: Drosophila mojavensis

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195448050|ref|XP_002071487.1| GK25111 [Drosophila willistoni] gi|194167572|gb|EDW82473.1| GK25111 [Drosophila willistoni]

 Score =  207 bits (526), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 102/121 (84%), Positives = 106/121 (87%), Gaps = 1/121 (0%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +  VLKGL+YLR+KHAIIHRDVKPSNILVNS GEIKICDFGVSGQLIDSMANSFVGTRSY
Sbjct: 189 TLAVLKGLSYLRDKHAIIHRDVKPSNILVNSSGEIKICDFGVSGQLIDSMANSFVGTRSY 248

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP-SRGDGYWHVSY 126
           MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD  T+ AIF   S GDG   V  
Sbjct: 249 MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDTVTMEAIFAENSDGDGNQTVLE 308

Query: 127 P 127
           P
Sbjct: 309 P 309

Source: Drosophila willistoni

Species: Drosophila willistoni

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340720584|ref|XP_003398714.1| PREDICTED: dual specificity mitogen-activated protein kinase kinase dSOR1-like [Bombus terrestris]

 Score =  206 bits (525), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 103/125 (82%), Positives = 107/125 (85%), Gaps = 6/125 (4%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSP 70
           VLKGL+YLR+KHAI+HRDVKPSNILVNS GEIKICDFGVSGQLIDSMANSFVGTRSYMSP
Sbjct: 192 VLKGLSYLRDKHAIMHRDVKPSNILVNSAGEIKICDFGVSGQLIDSMANSFVGTRSYMSP 251

Query: 71  ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG------PSRGDGYWHV 124
           ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD KTLAAIF       P       + 
Sbjct: 252 ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDEKTLAAIFNSPPGQPPVENVATNNA 311

Query: 125 SYPTT 129
           S PTT
Sbjct: 312 STPTT 316

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|350401186|ref|XP_003486077.1| PREDICTED: dual specificity mitogen-activated protein kinase kinase dSOR1-like [Bombus impatiens]

 Score =  206 bits (525), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 103/125 (82%), Positives = 107/125 (85%), Gaps = 6/125 (4%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSP 70
           VLKGL+YLR+KHAI+HRDVKPSNILVNS GEIKICDFGVSGQLIDSMANSFVGTRSYMSP
Sbjct: 192 VLKGLSYLRDKHAIMHRDVKPSNILVNSAGEIKICDFGVSGQLIDSMANSFVGTRSYMSP 251

Query: 71  ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG------PSRGDGYWHV 124
           ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD KTLAAIF       P       + 
Sbjct: 252 ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDEKTLAAIFSSPPGQPPVENVATNNA 311

Query: 125 SYPTT 129
           S PTT
Sbjct: 312 STPTT 316

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332374632|gb|AEE62457.1| unknown [Dendroctonus ponderosae]

 Score =  205 bits (522), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 98/107 (91%), Positives = 105/107 (98%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSP 70
           VLKGL+YLR+KHAI+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSYMSP
Sbjct: 189 VLKGLSYLRDKHAIMHRDVKPSNILVNSSGEIKMCDFGVSGQLIDSMANSFVGTRSYMSP 248

Query: 71  ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
           ERLQGTHYSVQSDI+SLGLSLVEMAIGMYPIPPPDAKTLAAIFG ++
Sbjct: 249 ERLQGTHYSVQSDIYSLGLSLVEMAIGMYPIPPPDAKTLAAIFGQTK 295

Source: Dendroctonus ponderosae

Species: Dendroctonus ponderosae

Genus: Dendroctonus

Family: Curculionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|125983818|ref|XP_001355674.1| GA13960 [Drosophila pseudoobscura pseudoobscura] gi|195164061|ref|XP_002022867.1| GL16493 [Drosophila persimilis] gi|54643990|gb|EAL32733.1| GA13960 [Drosophila pseudoobscura pseudoobscura] gi|194104929|gb|EDW26972.1| GL16493 [Drosophila persimilis]

 Score =  204 bits (519), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 98/120 (81%), Positives = 104/120 (86%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +  VLKGL+YLR+KHAIIHRDVKPSNILVNS GEIKICDFGVSGQLIDSMANSFVGTRSY
Sbjct: 189 TLAVLKGLSYLRDKHAIIHRDVKPSNILVNSSGEIKICDFGVSGQLIDSMANSFVGTRSY 248

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYWHVSYP 127
           MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP+  TLA++F     D    V  P
Sbjct: 249 MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPNTATLASMFADKVEDSNQPVDEP 308

Source: Drosophila pseudoobscura pseudoobscura

Species: Drosophila pseudoobscura

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	131
UNIPROTKB|Q5ZIF0	395	MAP2K1 "Uncharacterized protei	0.854	0.283	0.849	1.6e-47
ZFIN|ZDB-GENE-040426-2759	400	map2k1 "mitogen-activated prot	0.854	0.28	0.849	2.6e-47
UNIPROTKB|I3L5D4	400	MAP2K2 "Uncharacterized protei	0.916	0.3	0.804	3.3e-47
UNIPROTKB|Q17QH2	400	MAP2K2 "MAP2K2 protein" [Bos t	0.862	0.282	0.840	4.2e-47
UNIPROTKB|Q1HG70	400	MAP2K2 "Dual specificity mitog	0.862	0.282	0.840	4.2e-47
MGI|MGI:1346866	393	Map2k1 "mitogen-activated prot	0.816	0.272	0.869	5.4e-47
RGD|70495	393	Map2k1 "mitogen activated prot	0.816	0.272	0.869	5.4e-47
UNIPROTKB|Q0VD16	393	MAP2K1 "MAP2K1 protein" [Bos t	0.816	0.272	0.869	6.9e-47
UNIPROTKB|F1PJI7	380	MAP2K1 "Uncharacterized protei	0.816	0.281	0.869	6.9e-47
UNIPROTKB|J9P5W6	393	MAP2K1 "Uncharacterized protei	0.816	0.272	0.869	6.9e-47

UNIPROTKB|Q5ZIF0 MAP2K1 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 497 (180.0 bits), Expect = 1.6e-47, P = 1.6e-47
 Identities = 96/113 (84%), Positives = 102/113 (90%)

Query:     8 SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
             S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct:   170 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 229

Query:    68 MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG-PSRGD 119
             MSPERLQGTHYSVQSDIWS+GLSLVEMAIG YPIPPPD+K L  +FG P  GD
Sbjct:   230 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDSKELELMFGCPVEGD 282

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0007050 "cell cycle arrest" evidence=IEA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA

GO:0030182 "neuron differentiation" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0090398 "cellular senescence" evidence=IEA

ZFIN|ZDB-GENE-040426-2759 map2k1 "mitogen-activated protein kinase kinase 1" [Danio rerio (taxid:7955)]

 Score = 495 (179.3 bits), Expect = 2.6e-47, P = 2.6e-47
 Identities = 96/113 (84%), Positives = 102/113 (90%)

Query:     8 SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
             S  V+KGL+YLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct:   171 SIAVIKGLSYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 230

Query:    68 MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG-PSRGD 119
             MSPERLQGTHYSVQSDIWS+GLSLVEMAIG +PIPPPDAK L  IFG P  GD
Sbjct:   231 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRFPIPPPDAKELEQIFGQPLEGD 283

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

UNIPROTKB|I3L5D4 MAP2K2 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 494 (179.0 bits), Expect = 3.3e-47, P = 3.3e-47
 Identities = 99/123 (80%), Positives = 105/123 (85%)

Query:     8 SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
             S  VL+GL YLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct:   174 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 233

Query:    68 MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG-P--SRGDGYWHV 124
             MSPERLQGTHYSVQSDIWS+GLSLVE++IG YPIPPPDAK L AIFG P    GDG  H 
Sbjct:   234 MSPERLQGTHYSVQSDIWSMGLSLVELSIGRYPIPPPDAKELEAIFGRPMVDGGDGEPHS 293

Query:   125 SYP 127
               P
Sbjct:   294 ISP 296

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q17QH2 MAP2K2 "MAP2K2 protein" [Bos taurus (taxid:9913)]

 Score = 493 (178.6 bits), Expect = 4.2e-47, P = 4.2e-47
 Identities = 95/113 (84%), Positives = 101/113 (89%)

Query:     8 SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
             S  VL+GL YLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct:   174 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 233

Query:    68 MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDG 120
             MSPERLQGTHYSVQSDIWS+GLSLVE++IG YPIPPPDAK L AIFG    DG
Sbjct:   234 MSPERLQGTHYSVQSDIWSMGLSLVELSIGRYPIPPPDAKELEAIFGRPMVDG 286

GO:2000147 "positive regulation of cell motility" evidence=IEA

GO:0097110 "scaffold protein binding" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0036289 "peptidyl-serine autophosphorylation" evidence=IEA

GO:0032947 "protein complex scaffold" evidence=IEA

GO:0030165 "PDZ domain binding" evidence=IEA

GO:0009898 "internal side of plasma membrane" evidence=IEA

GO:0005911 "cell-cell junction" evidence=IEA

GO:0005874 "microtubule" evidence=IEA

GO:0005783 "endoplasmic reticulum" evidence=IEA

GO:0005778 "peroxisomal membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q1HG70 MAP2K2 "Dual specificity mitogen-activated protein kinase kinase 2" [Canis lupus familiaris (taxid:9615)]

 Score = 493 (178.6 bits), Expect = 4.2e-47, P = 4.2e-47
 Identities = 95/113 (84%), Positives = 101/113 (89%)

Query:     8 SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
             S  VL+GL YLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct:   174 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 233

Query:    68 MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDG 120
             MSPERLQGTHYSVQSDIWS+GLSLVE++IG YPIPPPDAK L AIFG    DG
Sbjct:   234 MSPERLQGTHYSVQSDIWSMGLSLVELSIGRYPIPPPDAKELEAIFGRPMVDG 286

GO:2000147 "positive regulation of cell motility" evidence=IEA

GO:0097110 "scaffold protein binding" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0036289 "peptidyl-serine autophosphorylation" evidence=IEA

GO:0032947 "protein complex scaffold" evidence=IEA

GO:0030165 "PDZ domain binding" evidence=IEA

GO:0009898 "internal side of plasma membrane" evidence=IEA

GO:0005911 "cell-cell junction" evidence=IEA

GO:0005874 "microtubule" evidence=IEA

GO:0005783 "endoplasmic reticulum" evidence=IEA

GO:0005778 "peroxisomal membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

MGI|MGI:1346866 Map2k1 "mitogen-activated protein kinase kinase 1" [Mus musculus (taxid:10090)]

 Score = 492 (178.3 bits), Expect = 5.4e-47, P = 5.4e-47
 Identities = 93/107 (86%), Positives = 99/107 (92%)

Query:     8 SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
             S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct:   170 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 229

Query:    68 MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
             MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK L  +FG
Sbjct:   230 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELLFG 276

GO:0000165 "MAPK cascade" evidence=ISO

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000187 "activation of MAPK activity" evidence=ISO;IMP;TAS

GO:0003056 "regulation of vascular smooth muscle contraction" evidence=ISO

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISO;IMP

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IMP

GO:0005524 "ATP binding" evidence=ISO

GO:0005634 "nucleus" evidence=TAS

GO:0005737 "cytoplasm" evidence=IEA

GO:0005739 "mitochondrion" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=ISO;TAS

GO:0005829 "cytosol" evidence=ISO;TAS

GO:0005856 "cytoskeleton" evidence=IEA

GO:0005874 "microtubule" evidence=ISO

GO:0005886 "plasma membrane" evidence=ISO

GO:0005925 "focal adhesion" evidence=TAS

GO:0005938 "cell cortex" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA;ISO;IMP

GO:0006979 "response to oxidative stress" evidence=ISO

GO:0007050 "cell cycle arrest" evidence=ISO

GO:0007067 "mitosis" evidence=ISO

GO:0008283 "cell proliferation" evidence=ISO

GO:0008285 "negative regulation of cell proliferation" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0017016 "Ras GTPase binding" evidence=ISO

GO:0019901 "protein kinase binding" evidence=ISO

GO:0030182 "neuron differentiation" evidence=ISO;IMP

GO:0030216 "keratinocyte differentiation" evidence=IMP

GO:0030335 "positive regulation of cell migration" evidence=ISO

GO:0030425 "dendrite" evidence=ISO

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=ISO

GO:0032320 "positive regulation of Ras GTPase activity" evidence=ISO

GO:0032402 "melanosome transport" evidence=ISO

GO:0032839 "dendrite cytoplasm" evidence=ISO

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0032968 "positive regulation of transcription elongation from RNA polymerase II promoter" evidence=ISO

GO:0033267 "axon part" evidence=ISO

GO:0034111 "negative regulation of homotypic cell-cell adhesion" evidence=ISO

GO:0043204 "perikaryon" evidence=ISO

GO:0043539 "protein serine/threonine kinase activator activity" evidence=ISO

GO:0045597 "positive regulation of cell differentiation" evidence=IDA

GO:0046579 "positive regulation of Ras protein signal transduction" evidence=ISO

GO:0047496 "vesicle transport along microtubule" evidence=ISO

GO:0048313 "Golgi inheritance" evidence=ISO

GO:0048471 "perinuclear region of cytoplasm" evidence=ISO

GO:0048678 "response to axon injury" evidence=ISO

GO:0048812 "neuron projection morphogenesis" evidence=ISO

GO:0048870 "cell motility" evidence=IMP

GO:0051291 "protein heterooligomerization" evidence=ISO

GO:0051384 "response to glucocorticoid stimulus" evidence=ISO

GO:0060674 "placenta blood vessel development" evidence=IMP

GO:0060711 "labyrinthine layer development" evidence=IMP

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=ISO

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0090398 "cellular senescence" evidence=ISO

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

RGD|70495 Map2k1 "mitogen activated protein kinase kinase 1" [Rattus norvegicus (taxid:10116)]

 Score = 492 (178.3 bits), Expect = 5.4e-47, P = 5.4e-47
 Identities = 93/107 (86%), Positives = 99/107 (92%)

Query:     8 SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
             S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct:   170 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 229

Query:    68 MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
             MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK L  +FG
Sbjct:   230 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELLFG 276

GO:0000165 "MAPK cascade" evidence=IMP

GO:0000187 "activation of MAPK activity" evidence=ISO;IDA;TAS

GO:0003056 "regulation of vascular smooth muscle contraction" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISO;IMP;IDA;TAS

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA;ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IDA

GO:0005634 "nucleus" evidence=TAS

GO:0005737 "cytoplasm" evidence=ISO

GO:0005739 "mitochondrion" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=IDA;TAS

GO:0005816 "spindle pole body" evidence=IEA

GO:0005829 "cytosol" evidence=IDA;TAS

GO:0005886 "plasma membrane" evidence=ISO;IDA

GO:0005925 "focal adhesion" evidence=TAS

GO:0005938 "cell cortex" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=ISO;IDA;TAS

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0007050 "cell cycle arrest" evidence=IEA;ISO

GO:0007067 "mitosis" evidence=IDA

GO:0007243 "intracellular protein kinase cascade" evidence=TAS

GO:0008283 "cell proliferation" evidence=IDA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA;ISO

GO:0017016 "Ras GTPase binding" evidence=IPI

GO:0019901 "protein kinase binding" evidence=IPI

GO:0030182 "neuron differentiation" evidence=ISO;IMP

GO:0030216 "keratinocyte differentiation" evidence=IEA;ISO

GO:0030335 "positive regulation of cell migration" evidence=IMP

GO:0030425 "dendrite" evidence=IDA

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=IDA;IPI

GO:0032320 "positive regulation of Ras GTPase activity" evidence=IMP

GO:0032402 "melanosome transport" evidence=IDA

GO:0032839 "dendrite cytoplasm" evidence=IDA

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0032968 "positive regulation of transcription elongation from RNA polymerase II promoter" evidence=IMP

GO:0033267 "axon part" evidence=IDA

GO:0034111 "negative regulation of homotypic cell-cell adhesion" evidence=IMP

GO:0043204 "perikaryon" evidence=IDA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA;ISO

GO:0045597 "positive regulation of cell differentiation" evidence=IEA;ISO

GO:0046579 "positive regulation of Ras protein signal transduction" evidence=IMP

GO:0047496 "vesicle transport along microtubule" evidence=IDA

GO:0048313 "Golgi inheritance" evidence=IMP

GO:0048471 "perinuclear region of cytoplasm" evidence=IDA

GO:0048678 "response to axon injury" evidence=IMP

GO:0048812 "neuron projection morphogenesis" evidence=IMP

GO:0048870 "cell motility" evidence=IEA;ISO

GO:0051291 "protein heterooligomerization" evidence=IPI

GO:0051384 "response to glucocorticoid stimulus" evidence=IDA

GO:0060674 "placenta blood vessel development" evidence=IEA;ISO

GO:0060711 "labyrinthine layer development" evidence=IEA;ISO

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=ISO

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0090398 "cellular senescence" evidence=IEA;ISO

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

GO:0005874 "microtubule" evidence=IDA

UNIPROTKB|Q0VD16 MAP2K1 "MAP2K1 protein" [Bos taurus (taxid:9913)]

 Score = 491 (177.9 bits), Expect = 6.9e-47, P = 6.9e-47
 Identities = 93/107 (86%), Positives = 99/107 (92%)

Query:     8 SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
             S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct:   170 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 229

Query:    68 MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
             MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK L  +FG
Sbjct:   230 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 276

GO:0090398 "cellular senescence" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0030182 "neuron differentiation" evidence=IEA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA

GO:0007050 "cell cycle arrest" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F1PJI7 MAP2K1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 491 (177.9 bits), Expect = 6.9e-47, P = 6.9e-47
 Identities = 93/107 (86%), Positives = 99/107 (92%)

Query:     8 SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
             S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct:   170 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 229

Query:    68 MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
             MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK L  +FG
Sbjct:   230 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 276

GO:0090398 "cellular senescence" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0030182 "neuron differentiation" evidence=IEA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA

GO:0007050 "cell cycle arrest" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|J9P5W6 MAP2K1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 491 (177.9 bits), Expect = 6.9e-47, P = 6.9e-47
 Identities = 93/107 (86%), Positives = 99/107 (92%)

Query:     8 SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
             S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct:   170 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 229

Query:    68 MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
             MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK L  +FG
Sbjct:   230 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 276

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P36507	MP2K2_HUMAN	2, ., 7, ., 1, 2, ., 2	0.8318	0.8625	0.2825	yes	N/A
Q10664	MEK2_CAEEL	2, ., 7, ., 1, 2, ., 2	0.6517	0.8549	0.2894	yes	N/A
Q94A06	M2K1_ARATH	2, ., 7, ., 1, 2, ., 2	0.59	0.7480	0.2768	yes	N/A
Q63980	MP2K1_CRIGR	2, ., 7, ., 1, 2, ., 2	0.8691	0.8167	0.2722	yes	N/A
Q55CL6	MP2K1_DICDI	2, ., 7, ., 1, 2, ., 2	0.6105	0.7099	0.1409	yes	N/A
P29678	MP2K1_RABIT	2, ., 7, ., 1, 2, ., 2	0.8691	0.8167	0.2722	yes	N/A
Q01986	MP2K1_RAT	2, ., 7, ., 1, 2, ., 2	0.8691	0.8167	0.2722	yes	N/A
P33886	WIS1_SCHPO	2, ., 7, ., 1, 2, ., 2	0.5192	0.7404	0.1603	yes	N/A
Q24324	DSOR1_DROME	2, ., 7, ., 1, 2, ., 2	0.8785	0.8167	0.2702	yes	N/A
Q1HG70	MP2K2_CANFA	2, ., 7, ., 1, 2, ., 2	0.8407	0.8625	0.2825	yes	N/A
P06784	STE7_YEAST	2, ., 7, ., 1, 2, ., 2	0.5638	0.7175	0.1825	yes	N/A
P31938	MP2K1_MOUSE	2, ., 7, ., 1, 2, ., 2	0.8691	0.8167	0.2722	yes	N/A
Q5QN75	M2K1_ORYSJ	2, ., 7, ., 1, 2, ., 2	0.55	0.7480	0.2760	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	131
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-81
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-66
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-66
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-64
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-51
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-50
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-46
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-45
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-44
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-40
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-40
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-40
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-39
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-39
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-35
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-34
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-31
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-31
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-30
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-30
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-29
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-27
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-27
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-26
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-26
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-26
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-25
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-25
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-24
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-24
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-24
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-23
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-23
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-23
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-22
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-22
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-22
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-22
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-21
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-21
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-21
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-21
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-21
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-21
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-21
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-21
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-21
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-20
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-20
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-20
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-20
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-20
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-20
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-19
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-19
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-19
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-19
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-19
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-19
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-19
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-18
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-18
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-18
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-18
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-18
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-18
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-18
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-18
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-18
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-18
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-18
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-18
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-17
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-17
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-17
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-17
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-17
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-17
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-17
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-17
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	9e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-16
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-16
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-16
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-16
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-16
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-16
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-16
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-16
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-16
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	9e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-16
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-15
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-15
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-15
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-15
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-15
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-15
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-15
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-14
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-14
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-14
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-14
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-14
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-14
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-14
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-14
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-14
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-14
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-14
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-14
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-14
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-14
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-14
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-13
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-13
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-13
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-13
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-13
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-13
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-13
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-12
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-12
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-12
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-12
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-12
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-12
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-12
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-12
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-12
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-12
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-11
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-11
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-11
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-10
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-10
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-10
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-09
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-09
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-08
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-08
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-08
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-08
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	9e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-07
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-05
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	9e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-04
COG0661	517	COG0661, AarF, Predicted unusual protein kinase [G	0.002
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.003

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  240 bits (615), Expect = 3e-81
 Identities = 95/108 (87%), Positives = 100/108 (92%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  VL+GLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 105 SIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 164

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
           MSPERLQGTHY+VQSDIWSLGLSLVEMAIG YPIPPPDAK L A+FG 
Sbjct: 165 MSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR 212

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score =  204 bits (520), Expect = 1e-66
 Identities = 97/113 (85%), Positives = 102/113 (90%), Gaps = 1/113 (0%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 109 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 168

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG-PSRGD 119
           MSPERLQGTHYSVQSDIWS+GLSLVEMAIG YPIPPPDAK L  +FG P  GD
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGD 221

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  202 bits (515), Expect = 6e-66
 Identities = 96/113 (84%), Positives = 101/113 (89%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  VL+GL YLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 109 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 168

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDG 120
           MSPERLQGTHYSVQSDIWS+GLSLVE+AIG YPIPPPDAK L AIFG    DG
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDG 221

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  196 bits (500), Expect = 2e-64
 Identities = 71/99 (71%), Positives = 85/99 (85%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +  VLKGLTYL EKH IIHRDVKPSNILVNS G+IK+CDFGVSGQL++S+A +FVGT SY
Sbjct: 106 AVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSY 165

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           M+PER+QG  YSV+SDIWSLGLSL+E+A G +P PP + 
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  163 bits (414), Expect = 3e-51
 Identities = 59/90 (65%), Positives = 81/90 (90%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSP 70
           V++GLTYL   H I+HRD+KPSNILVNS G+IK+CDFGVSG+LI+S+A++FVGT +YMSP
Sbjct: 112 VVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSP 171

Query: 71  ERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           ER+QG  Y+V+SD+WSLG+S++E+A+G +P
Sbjct: 172 ERIQGGKYTVKSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  161 bits (410), Expect = 1e-50
 Identities = 58/105 (55%), Positives = 77/105 (73%), Gaps = 2/105 (1%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           Q+LKGL YL  K  IIHRD+KPSN+L+NS GE+KI DFG+S  L +++   N+FVGT +Y
Sbjct: 107 QILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTY 166

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
           MSPER+QG  YS  +DIWSLGL+L+E A+G +P  PP   +   +
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  151 bits (382), Expect = 2e-46
 Identities = 57/102 (55%), Positives = 77/102 (75%), Gaps = 1/102 (0%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSP 70
           VLKGL+YL  +  IIHRD+KPSNIL+   G++K+CDFGVSG+L++S+A +F GT  YM+P
Sbjct: 114 VLKGLSYLHSRK-IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAP 172

Query: 71  ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
           ER+QG  YS+ SD+WSLGL+L+E+A   +P PP     L  I
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI 214

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  146 bits (370), Expect = 6e-45
 Identities = 54/118 (45%), Positives = 74/118 (62%), Gaps = 5/118 (4%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-NS 60
            Q+ Y   ++LKGL YL     IIHRD+K +NIL+ S GE+K+ DFG+S QL D+ A N+
Sbjct: 98  SQIAYVCKELLKGLEYLHSNG-IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT 156

Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI---PPPDAKTLAAIFGP 115
            VGT  +M+PE + G  Y  ++DIWSLG++ +E+A G  P    PP  A    A  GP
Sbjct: 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP 214

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  144 bits (365), Expect = 7e-44
 Identities = 61/112 (54%), Positives = 86/112 (76%), Gaps = 9/112 (8%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           ++ V+KGL +L+E+H IIHRDVKP+N+LVN  G++K+CDFGVSG L+ S+A + +G +SY
Sbjct: 108 TYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSY 167

Query: 68  MSPERLQGTH------YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           M+PER++         Y+VQSD+WSLGLS++EMA+G YP PP   +T A IF
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP---ETYANIF 216

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  135 bits (342), Expect = 2e-40
 Identities = 46/98 (46%), Positives = 71/98 (72%), Gaps = 5/98 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF-VGTRS 66
           +  ++K L YL  K ++IHRDVKPSN+L+N  G++K+CDFG+SG L+DS+A +   G + 
Sbjct: 109 AVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP 168

Query: 67  YMSPERLQG----THYSVQSDIWSLGLSLVEMAIGMYP 100
           YM+PER+        Y V+SD+WSLG++++E+A G +P
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  135 bits (341), Expect = 3e-40
 Identities = 52/96 (54%), Positives = 71/96 (73%), Gaps = 4/96 (4%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF-VGTRSYMS 69
            +K L YL+E+  IIHRDVKPSNIL++  G IK+CDFG+SGQL+DS+A +   G R YM+
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMA 175

Query: 70  PERLQGTH---YSVQSDIWSLGLSLVEMAIGMYPIP 102
           PER+  +    Y V+SD+WSLG++L E+A G +P P
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  134 bits (340), Expect = 5e-40
 Identities = 49/97 (50%), Positives = 72/97 (74%), Gaps = 5/97 (5%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS-FVGTRSYMS 69
           ++K L YL+EKH +IHRDVKPSNIL+++ G +K+CDFG+SG+L+DS A +   G  +YM+
Sbjct: 123 IVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMA 182

Query: 70  PERL----QGTHYSVQSDIWSLGLSLVEMAIGMYPIP 102
           PER+        Y +++D+WSLG+SLVE+A G +P  
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  133 bits (336), Expect = 1e-39
 Identities = 53/92 (57%), Positives = 75/92 (81%), Gaps = 1/92 (1%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSP 70
           V+KGLTYL     I+HRDVKPSN+LVN+ G++K+CDFGVS QL++S+A ++VGT +YM+P
Sbjct: 104 VVKGLTYLWSLK-ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAP 162

Query: 71  ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIP 102
           ER+ G  Y + SD+WSLG+S +E+A+G +P P
Sbjct: 163 ERISGEQYGIHSDVWSLGISFMELALGRFPYP 194

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  132 bits (334), Expect = 2e-39
 Identities = 46/105 (43%), Positives = 60/105 (57%), Gaps = 4/105 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRSYM 68
           Q+L  L YL  K  I+HRD+KP NIL++  G +K+ DFG++ QL       +FVGT  YM
Sbjct: 105 QILSALEYLHSKG-IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYM 163

Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           +PE L G  Y    DIWSLG+ L E+  G  P   P    L  +F
Sbjct: 164 APEVLLGKGYGKAVDIWSLGVILYELLTGKPPF--PGDDQLLELF 206

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  120 bits (304), Expect = 6e-35
 Identities = 50/99 (50%), Positives = 66/99 (66%), Gaps = 6/99 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           Q LKGL YL      IHRD+K  NIL+N  G+ K+ DFGVSGQL D+MA  N+ +GT  +
Sbjct: 107 QTLKGLEYLHSNK-KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFW 165

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP---IPP 103
           M+PE +Q   Y+ ++DIWSLG++ +EMA G  P   I P
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  119 bits (300), Expect = 3e-34
 Identities = 44/94 (46%), Positives = 61/94 (64%), Gaps = 4/94 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           Q+L+GL YL   + IIHRD+KP NIL++  G +KI DFG++ +L+   S   +FVGT  Y
Sbjct: 106 QILRGLEYLHS-NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWY 164

Query: 68  MSPERLQ-GTHYSVQSDIWSLGLSLVEMAIGMYP 100
           M+PE L  G  Y  + D+WSLG+ L E+  G  P
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  112 bits (282), Expect = 1e-31
 Identities = 41/107 (38%), Positives = 59/107 (55%), Gaps = 6/107 (5%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRS 66
            Q+   L YL  +  I+HRD+KP NI + S G +K+ DFG+S  L  +  +A + VGT  
Sbjct: 110 VQLCLALKYLHSRK-ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPY 168

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           Y+SPE  Q   Y+ +SDIWSLG  L E+        P + + L  + 
Sbjct: 169 YLSPELCQNKPYNYKSDIWSLGCVLYELCTLK---HPFEGENLLELA 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 3e-31
 Identities = 46/96 (47%), Positives = 69/96 (71%), Gaps = 6/96 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           +VL GL YL E+  I HRD+K +NIL++  G++K+ DFGVSGQL  +M+  N+FVGT  +
Sbjct: 106 EVLLGLEYLHEEGKI-HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFW 164

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
           M+PE ++ + Y  ++DIWSLG++ +E+A G    PP
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKG---EPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  108 bits (273), Expect = 3e-30
 Identities = 41/94 (43%), Positives = 60/94 (63%), Gaps = 5/94 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA----NSFVG 63
           + Q+L+GL YL     I+HRD+K +NILV+S G +K+ DFG + +L D        S  G
Sbjct: 107 TRQILEGLAYLHSNG-IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165

Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIG 97
           T  +M+PE ++G  Y   +DIWSLG +++EMA G
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATG 199

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  107 bits (269), Expect = 3e-30
 Identities = 45/90 (50%), Positives = 62/90 (68%), Gaps = 5/90 (5%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSG-GEIKICDFGVSGQL--IDSMANSFVGTR 65
            Q+L+GL YL     IIHRD+KP NIL++S  G++K+ DFG+S  L    S+  + VGT 
Sbjct: 99  LQILEGLEYLHSNG-IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157

Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEM 94
           +YM+PE L G  +YS +SDIWSLG+ L E+
Sbjct: 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 2e-29
 Identities = 43/103 (41%), Positives = 62/103 (60%), Gaps = 6/103 (5%)

Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NS 60
           Q+ Y   + LKGL YL E    IHRD+K +NIL+   G++K+ DFGVS QL  ++A   S
Sbjct: 102 QIAYVCRETLKGLAYLHETG-KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160

Query: 61  FVGTRSYMSPERLQ---GTHYSVQSDIWSLGLSLVEMAIGMYP 100
           F+GT  +M+PE         Y  + DIW+LG++ +E+A    P
Sbjct: 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  105 bits (263), Expect = 3e-28
 Identities = 48/102 (47%), Positives = 66/102 (64%), Gaps = 8/102 (7%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVGTR 65
           + Q+L G+ YL  +H I+HRD+KPSN+L+NS   +KI DFGVS  L  +M   NS VGT 
Sbjct: 174 ARQILSGIAYLHRRH-IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTI 232

Query: 66  SYMSPERL-----QGTHYSVQSDIWSLGLSLVEMAIGMYPIP 102
           +YMSPER+      G +     DIWSLG+S++E  +G +P  
Sbjct: 233 AYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274

Length = 353

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 2e-27
 Identities = 42/106 (39%), Positives = 60/106 (56%), Gaps = 6/106 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVGTRSY 67
           +++  L YL     II+RD+KP NIL+++ G IK+ DFG++ +L       N+F GT  Y
Sbjct: 101 EIVLALEYLHSLG-IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           ++PE L G  Y    D WSLG+ L EM  G    PP  A+    I+
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTG---KPPFYAEDRKEIY 202

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  101 bits (254), Expect = 3e-27
 Identities = 43/97 (44%), Positives = 62/97 (63%), Gaps = 3/97 (3%)

Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMANS 60
           Q+ Y   +VL+GL YL  ++ +IHRD+K  NIL++  G +K+ DFG + QL    S  NS
Sbjct: 117 QIAYVCREVLQGLEYLHSQN-VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175

Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIG 97
            VGT  +M+PE ++   Y  + DIWSLG+  +EMA G
Sbjct: 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  100 bits (250), Expect = 6e-27
 Identities = 45/104 (43%), Positives = 60/104 (57%), Gaps = 11/104 (10%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS------FVG 63
           +VLKGL YL   +  IHRD+K  NIL+   G +KI DFGVS  L D    +      FVG
Sbjct: 110 EVLKGLEYL-HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVG 168

Query: 64  TRSYMSPERL-QGTHYSVQSDIWSLGLSLVEMAIGMYP---IPP 103
           T  +M+PE + Q   Y  ++DIWS G++ +E+A G  P    PP
Sbjct: 169 TPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 99.8 bits (249), Expect = 8e-27
 Identities = 43/106 (40%), Positives = 71/106 (66%), Gaps = 5/106 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYM 68
           Q+L GL YL +++  +HRD+K +NILV++ G +K+ DFG++ Q+++ S A SF G+  +M
Sbjct: 110 QILLGLEYLHDRN-TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWM 168

Query: 69  SPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           +PE +     Y + +DIWSLG +++EMA G    P    + +AA+F
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMATG--KPPWSQLEGVAAVF 212

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 3e-26
 Identities = 47/109 (43%), Positives = 68/109 (62%), Gaps = 9/109 (8%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRS 66
           +QVL+GL YL E+  +IHRD+K +NIL    G +K+ DFGV+ +L D      S VGT  
Sbjct: 106 YQVLQGLAYLHEQ-GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPY 164

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP--DAKTLAAIF 113
           +M+PE ++ +  S  SDIWSLG +++E+  G     PP  D   +AA+F
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGN----PPYYDLNPMAALF 209

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 98.1 bits (245), Expect = 5e-26
 Identities = 45/117 (38%), Positives = 67/117 (57%), Gaps = 23/117 (19%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           + L+GL YL E   +IHRD+K  NIL+    E+K+ DFGVS QL  ++   N+F+GT  +
Sbjct: 121 ETLRGLAYLHENK-VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYW 179

Query: 68  MSPERLQ-----GTHYSVQSDIWSLGLSLVEMAIG------MYPI---------PPP 104
           M+PE +         Y  +SD+WSLG++ +E+A G      M+P+         PPP
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP 236

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 97.1 bits (242), Expect = 8e-26
 Identities = 44/101 (43%), Positives = 64/101 (63%), Gaps = 4/101 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           Q+L+GL  L E+  I+HRD+K +NIL+ +   +KI D G+S  L  +MA + +GT  YM+
Sbjct: 111 QLLRGLQALHEQK-ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMA 169

Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLA 110
           PE  +G  YS +SDIWSLG  L EMA    P    +A+++ 
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF---EARSMQ 207

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 96.8 bits (241), Expect = 1e-25
 Identities = 51/112 (45%), Positives = 69/112 (61%), Gaps = 11/112 (9%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL---IDSMAN-----SF 61
           Q+LKGL YL  +  IIHRD+K +NILV++ G IKI DFG+S +L     S        S 
Sbjct: 114 QILKGLNYLHNR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172

Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
            G+  +M+PE ++ T Y+ ++DIWSLG  +VEM  G +P   PD   L AIF
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF--PDCTQLQAIF 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 96.7 bits (240), Expect = 2e-25
 Identities = 53/137 (38%), Positives = 80/137 (58%), Gaps = 22/137 (16%)

Query: 1   LKQVPYSSFQV-------LKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL 53
           L+  P+  FQ+       LKGL YL  +  I HRD+K +N+L++  G++K+ DFGV+GQL
Sbjct: 93  LRAGPFDEFQIATMLKEILKGLDYLHSEKKI-HRDIKAANVLLSEQGDVKLADFGVAGQL 151

Query: 54  IDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIG------MYP----- 100
            D+    N+FVGT  +M+PE +Q + Y  ++DIWSLG++ +E+A G      M+P     
Sbjct: 152 TDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF 211

Query: 101 -IPPPDAKTLAAIFGPS 116
            IP  +  TL   F   
Sbjct: 212 LIPKNNPPTLTGEFSKP 228

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 92.7 bits (231), Expect = 5e-24
 Identities = 43/114 (37%), Positives = 60/114 (52%), Gaps = 14/114 (12%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---------GQLIDSMANS 60
           +++  L YL   + IIHRD+KP NIL++S G +K+ DFG+S             D   + 
Sbjct: 101 EIVLALEYLH-SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159

Query: 61  -FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
             VGT  Y++PE + G  +S   D WSLG  L E  +G   IPP   +T   IF
Sbjct: 160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG---IPPFHGETPEEIF 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 92.5 bits (230), Expect = 6e-24
 Identities = 40/113 (35%), Positives = 67/113 (59%), Gaps = 12/113 (10%)

Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NS 60
           Q+ Y   Q+L+ L +L   H +IHRD+K  NIL+   G++K+ DFGVS +   ++   ++
Sbjct: 104 QIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162

Query: 61  FVGTRSYMSP-----ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT 108
           F+GT  +M+P     E  +   Y  ++DIWSLG++L+E+A     + PP  + 
Sbjct: 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELA----QMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 92.4 bits (229), Expect = 9e-24
 Identities = 42/93 (45%), Positives = 67/93 (72%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           ++LKGL YL  +  I HRD+K +N+L++  G++K+ DFGV+GQL D+    N+FVGT  +
Sbjct: 109 EILKGLDYLHSERKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFW 167

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           M+PE ++ + Y  ++DIWSLG++ +E+A G  P
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 92.1 bits (229), Expect = 1e-23
 Identities = 49/120 (40%), Positives = 71/120 (59%), Gaps = 9/120 (7%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           +VL  L Y+  K  +IHRD+K +NILV + G +K+CDFGV+  L    S  ++FVGT  +
Sbjct: 109 EVLVALKYI-HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYW 167

Query: 68  MSPERLQ-GTHYSVQSDIWSLGLSLVEMAIGMYP---IPPPDAKTLAAIFGPSR--GDGY 121
           M+PE +  G +Y  ++DIWSLG+++ EMA G  P   +    A  L     P R   +GY
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGY 227

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 91.7 bits (227), Expect = 1e-23
 Identities = 43/93 (46%), Positives = 67/93 (72%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           ++LKGL YL  +  I HRD+K +N+L++  GE+K+ DFGV+GQL D+    N+FVGT  +
Sbjct: 109 EILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 167

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           M+PE ++ + Y  ++DIWSLG++ +E+A G  P
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 91.5 bits (227), Expect = 2e-23
 Identities = 39/98 (39%), Positives = 60/98 (61%), Gaps = 8/98 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE-IKICDFGVSGQL------IDSMANSFV 62
           Q+L+GL+YL E   IIHRDVK +N+L++S G+ ++I DFG + +L              +
Sbjct: 111 QLLRGLSYLHENQ-IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL 169

Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           GT ++M+PE L+G  Y    D+WS+G  ++EMA    P
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 90.5 bits (225), Expect = 3e-23
 Identities = 38/88 (43%), Positives = 51/88 (57%), Gaps = 2/88 (2%)

Query: 14  GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-DSMANSFVGTRSYMSPER 72
            L YL  K  IIHRD+KP NIL++  G + I DF ++ ++  D++  S  GT  YM+PE 
Sbjct: 112 ALEYLHSKG-IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEV 170

Query: 73  LQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           L    YSV  D WSLG++  E   G  P
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.3 bits (224), Expect = 3e-23
 Identities = 43/112 (38%), Positives = 67/112 (59%), Gaps = 10/112 (8%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-----IDSMANSFV 62
           + Q+L+G+ YL     I+HRD+K +NIL +S G +K+ DFG S +L       +   S  
Sbjct: 110 TRQILEGVEYLHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT 168

Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP-PDAKTLAAIF 113
           GT  +MSPE + G  Y  ++D+WS+G ++VEM   +   PP  + + +AAIF
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEM---LTEKPPWAEFEAMAAIF 217

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 92.1 bits (227), Expect = 4e-23
 Identities = 44/117 (37%), Positives = 63/117 (53%), Gaps = 13/117 (11%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLIDS--- 56
             +  +   Q+L  L YL  K  IIHRD+KP NIL++  G  +K+ DFG++  L D    
Sbjct: 100 ESEALFILAQILSALEYLHSKG-IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158

Query: 57  -----MANSFVGTRSYMSPERLQGT---HYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
                + ++ VGT  YM+PE L G    + S  SDIWSLG++L E+  G+ P     
Sbjct: 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215

Length = 384

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 90.1 bits (224), Expect = 8e-23
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)

Query: 7   SSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN---SFVG 63
             +Q+L+ + Y    H IIHRD+KP NILV+  G +K+CDFG +  L    A+    +V 
Sbjct: 105 YIWQLLQAIAYC-HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA 163

Query: 64  TRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
           TR Y +PE L G T+Y    D+W++G  + E+  G
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 89.6 bits (223), Expect = 8e-23
 Identities = 33/82 (40%), Positives = 51/82 (62%), Gaps = 2/82 (2%)

Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHY 78
            + ++HRD+KP+NI +++   +K+ DFG++  L    S A ++VGT  YMSPE+L    Y
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSY 187

Query: 79  SVQSDIWSLGLSLVEMAIGMYP 100
             +SDIWSLG  + E+     P
Sbjct: 188 DEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 88.2 bits (219), Expect = 2e-22
 Identities = 40/100 (40%), Positives = 57/100 (57%), Gaps = 10/100 (10%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS------GQLIDSMANSFVG 63
           Q+L+GL YL   H I+HRD+KP+NI ++  G IK+ DFG +         +     S  G
Sbjct: 107 QLLEGLAYLHS-HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165

Query: 64  TRSYMSPERLQGT---HYSVQSDIWSLGLSLVEMAIGMYP 100
           T +YM+PE + G     +   +DIWSLG  ++EMA G  P
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 88.3 bits (219), Expect = 2e-22
 Identities = 39/89 (43%), Positives = 56/89 (62%), Gaps = 5/89 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRS 66
           Q+   L ++  K  I+HRD+KP+N+ + + G +K+ D G+ G+   S    A+S VGT  
Sbjct: 114 QLCSALEHMHSKR-IMHRDIKPANVFITATGVVKLGDLGL-GRFFSSKTTAAHSLVGTPY 171

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           YMSPER+    Y+ +SDIWSLG  L EMA
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 88.4 bits (219), Expect = 2e-22
 Identities = 45/100 (45%), Positives = 64/100 (64%), Gaps = 6/100 (6%)

Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQL--IDSMANSFV 62
           + + Q+L+GL YL +   I+HRD+K  N+LVN+  G +KI DFG S +L  I+    +F 
Sbjct: 112 FYTKQILEGLKYLHDNQ-IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT 170

Query: 63  GTRSYMSPERL-QGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
           GT  YM+PE + +G   Y   +DIWSLG ++VEMA G  P
Sbjct: 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 89.0 bits (221), Expect = 4e-22
 Identities = 38/90 (42%), Positives = 51/90 (56%), Gaps = 4/90 (4%)

Query: 24  IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 83
            IHRD+KP N L+++ G IK+ DFG+S  ++ + ANS VG+  YM+PE L+G  Y    D
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIV-TYANSVVGSPDYMAPEVLRGKGYDFTVD 180

Query: 84  IWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
            WSLG  L E   G    PP    T    +
Sbjct: 181 YWSLGCMLYEFLCG---FPPFSGSTPNETW 207

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 87.5 bits (218), Expect = 5e-22
 Identities = 41/108 (37%), Positives = 54/108 (50%), Gaps = 20/108 (18%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
              +    +Q+L+GL Y    H I+HRD+KP NIL+N  G +K+ DFG        +A +
Sbjct: 97  PNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINRDGVLKLADFG--------LARA 147

Query: 61  F----------VGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
           F          V T  Y +PE L G  HYS   DIWS+G    EM  G
Sbjct: 148 FGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 87.6 bits (218), Expect = 8e-22
 Identities = 43/94 (45%), Positives = 58/94 (61%), Gaps = 11/94 (11%)

Query: 9   FQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVS-GQLIDSMANSF---- 61
           +Q+L+GL YL   H+  +IHRD+KPSNILVNS  ++KICDFG++ G   D     F    
Sbjct: 110 YQILRGLKYL---HSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166

Query: 62  VGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEM 94
           V TR Y +PE  L  + Y+   DIWS+G    E+
Sbjct: 167 VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL 200

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 87.6 bits (218), Expect = 9e-22
 Identities = 49/133 (36%), Positives = 74/133 (55%), Gaps = 29/133 (21%)

Query: 6   YSSFQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANS 60
           Y  +Q+LK L Y+   H+  +IHRD+KPSNIL+NS   +K+ DFG++    +L ++  N 
Sbjct: 111 YIMYQLLKALKYI---HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167

Query: 61  ----FVGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG--MYP------------- 100
               +V TR Y +PE L G T Y+   D+WS+G  L EM +G  ++P             
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE 227

Query: 101 -IPPPDAKTLAAI 112
            I PP A+ + +I
Sbjct: 228 VIGPPSAEDIESI 240

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 1e-21
 Identities = 36/100 (36%), Positives = 53/100 (53%), Gaps = 6/100 (6%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MA 58
             +    +Q+L+GL +    H I+HRD+KP N+L+N+ G +K+ DFG   +   S     
Sbjct: 98  SLIKSYLYQLLQGLAFC-HSHGILHRDLKPENLLINTEGVLKLADFG-LARSFGSPVRPY 155

Query: 59  NSFVGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
             +V TR Y +PE L G   YS   DIWS+G    E+   
Sbjct: 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR 195

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 86.6 bits (214), Expect = 1e-21
 Identities = 47/127 (37%), Positives = 72/127 (56%), Gaps = 23/127 (18%)

Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSF 61
           + Y   ++L+GL +L   H +IHRD+K  N+L+    E+K+ DFGVS QL  ++   N+F
Sbjct: 123 IAYICREILRGLAHL-HAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 181

Query: 62  VGTRSYMSPERLQ-----GTHYSVQSDIWSLGLSLVEMAIG------MYPI--------- 101
           +GT  +M+PE +         Y  +SDIWSLG++ +EMA G      M+P+         
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 241

Query: 102 PPPDAKT 108
           PPP  K+
Sbjct: 242 PPPKLKS 248

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 86.5 bits (215), Expect = 2e-21
 Identities = 41/113 (36%), Positives = 53/113 (46%), Gaps = 23/113 (20%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL---------------- 53
           ++L  L YL  K  IIHRD+KP NIL++    IKI DFG +  L                
Sbjct: 110 EILLALEYLHSK-GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168

Query: 54  ---IDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
              I+       SFVGT  Y+SPE L        SD+W+LG  + +M  G  P
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 86.4 bits (215), Expect = 2e-21
 Identities = 37/92 (40%), Positives = 54/92 (58%), Gaps = 5/92 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF---VGTRS 66
           Q+L+GL YL     I+HRD+K SNIL+N+ G +K+ DFG++       +  +   V T  
Sbjct: 108 QLLEGLQYLHSNG-ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW 166

Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
           Y  PE L G T Y  + D+WS+G  L E+ +G
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 87.0 bits (216), Expect = 2e-21
 Identities = 41/96 (42%), Positives = 57/96 (59%), Gaps = 3/96 (3%)

Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            + +  +Q+L+GL Y+     IIHRD+KPSNI VN   E+KI DFG++    D M   +V
Sbjct: 119 HIQFLVYQILRGLKYIHSAG-IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM-TGYV 176

Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIG 97
            TR Y +PE  L   HY+   DIWS+G  + E+  G
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 86.8 bits (215), Expect = 2e-21
 Identities = 40/95 (42%), Positives = 58/95 (61%), Gaps = 3/95 (3%)

Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVG 63
           + Y  +Q+L+GL Y+     ++HRD+KPSNIL+N   ++KICDFG++ ++ D     +V 
Sbjct: 110 IQYFLYQILRGLKYVHSA-GVVHRDLKPSNILINENCDLKICDFGLA-RIQDPQMTGYVS 167

Query: 64  TRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIG 97
           TR Y +PE  L    Y V+ DIWS G    EM  G
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 85.2 bits (211), Expect = 3e-21
 Identities = 41/88 (46%), Positives = 56/88 (63%), Gaps = 3/88 (3%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRS 66
           FQ++  ++Y+  K  I+HRD+K  NI +   G IK+ DFG+S  L    SMA + VGT  
Sbjct: 108 FQIVSAVSYI-HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY 166

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
           YMSPE  QG  Y+ +SDIW+LG  L E+
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 85.2 bits (211), Expect = 4e-21
 Identities = 38/100 (38%), Positives = 56/100 (56%), Gaps = 3/100 (3%)

Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NS 60
           Q+      VLK L++L     +IHRD+K  +IL+ S G +K+ DFG   Q+   +    S
Sbjct: 116 QIATVCLAVLKALSFL-HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174

Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            VGT  +M+PE +    Y  + DIWSLG+ ++EM  G  P
Sbjct: 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 84.8 bits (209), Expect = 6e-21
 Identities = 44/117 (37%), Positives = 72/117 (61%), Gaps = 10/117 (8%)

Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSF 61
           + Y   ++L+GL++L + H +IHRD+K  N+L+    E+K+ DFGVS QL  ++   N+F
Sbjct: 113 IAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 171

Query: 62  VGTRSYMSPERLQ-----GTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           +GT  +M+PE +         Y  +SD+WSLG++ +EMA G  P+   D   + A+F
Sbjct: 172 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL--CDMHPMRALF 226

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 84.7 bits (209), Expect = 7e-21
 Identities = 43/102 (42%), Positives = 65/102 (63%), Gaps = 12/102 (11%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           Q+L+ L YL     IIHRD+K  N+L+   G+IK+ DFGVS + + ++   +SF+GT  +
Sbjct: 118 QMLEALQYLHSMK-IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYW 176

Query: 68  MSP-----ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP 104
           M+P     E ++ T Y  ++DIWSLG++L+EMA     I PP
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMA----QIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 85.2 bits (211), Expect = 7e-21
 Identities = 38/93 (40%), Positives = 59/93 (63%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           +++ GL +L +K  II+RD+K  N+L++  G IKI DFG+  + +  +  A++F GT  Y
Sbjct: 104 EIICGLQFLHKK-GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDY 162

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           ++PE L+G  Y+   D WS G+ L EM IG  P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 84.4 bits (209), Expect = 8e-21
 Identities = 43/101 (42%), Positives = 60/101 (59%), Gaps = 5/101 (4%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRS 66
           FQ+L+G+ +    H IIHRD+KP NILV+  G +K+CDFG +  L     +   +V TR 
Sbjct: 107 FQILRGIEFC-HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRW 165

Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE L G T Y    DIW++G  + EM  G  P+ P D+
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE-PLFPGDS 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 83.3 bits (206), Expect = 2e-20
 Identities = 38/93 (40%), Positives = 58/93 (62%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSY 67
           Q+L GL +L  K  I+HRD+K  N+ +++   +KI D GV+  L D+   AN+ VGT  Y
Sbjct: 109 QILLGLAHLHSKK-ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYY 167

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           +SPE  +   Y+ +SD+W+LG+ L E   G +P
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 83.3 bits (206), Expect = 2e-20
 Identities = 40/104 (38%), Positives = 57/104 (54%), Gaps = 6/104 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           +V+ G+  L  +  IIHRD+KP N+L++  G +K+ DFG+S          FVGT  Y++
Sbjct: 105 EVVLGVEDL-HQRGIIHRDIKPENLLIDQTGHLKLTDFGLSR--NGLENKKFVGTPDYLA 161

Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE + G      SD WSLG  + E   G    PP  A+T  A+F
Sbjct: 162 PETILGVGDDKMSDWWSLGCVIFEFLFGY---PPFHAETPDAVF 202

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 83.2 bits (206), Expect = 3e-20
 Identities = 37/92 (40%), Positives = 51/92 (55%), Gaps = 4/92 (4%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRS 66
           +Q L+ + +   KH  IHRDVKP NIL+   G+IK+CDFG +  L         +V TR 
Sbjct: 107 WQTLQAVNFC-HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW 165

Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
           Y +PE L G T Y    D+W++G    E+  G
Sbjct: 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 82.5 bits (204), Expect = 4e-20
 Identities = 45/110 (40%), Positives = 63/110 (57%), Gaps = 9/110 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTR 65
           QVL+GL YL  K  I+HRD+K  N+LV++ G  KI DFG+S +  D        S  G+ 
Sbjct: 116 QVLEGLAYLHSK-GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174

Query: 66  SYMSPERLQGTH--YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
            +M+PE +      YS + DIWSLG  ++EM  G  P    D + +AA+F
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW--SDEEAIAAMF 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 82.8 bits (205), Expect = 5e-20
 Identities = 40/102 (39%), Positives = 56/102 (54%), Gaps = 3/102 (2%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS--GQLIDSMANSFVGTRSY 67
           +++ GL +L E   II+RD+K  N+L++S G IKI DFG+   G L     ++F GT  Y
Sbjct: 104 EIVLGLQFLHE-RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDY 162

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           ++PE L    Y    D W+LG+ L EM  G  P    D   L
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL 204

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 82.3 bits (204), Expect = 5e-20
 Identities = 37/88 (42%), Positives = 53/88 (60%), Gaps = 2/88 (2%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-NSFVGTRS 66
             Q+L+G+ +L   H I+HRD+KP NILV S G++KI DFG++      MA  S V T  
Sbjct: 113 MRQLLRGVDFL-HSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLW 171

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
           Y +PE L  + Y+   D+WS+G    E+
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 6e-20
 Identities = 38/107 (35%), Positives = 53/107 (49%), Gaps = 31/107 (28%)

Query: 25  IHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---------------------------- 56
           IHRD+KP NIL+++ G IK+ DFG+  ++  +                            
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182

Query: 57  ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
               ANS VGT  Y++PE L+GT Y ++ D WSLG+ L EM  G  P
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 81.1 bits (201), Expect = 1e-19
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 2/92 (2%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYM 68
            V+    YL  +  II+RD+KP N+L++S G +K+ DFG + +L       +F GT  Y+
Sbjct: 101 CVVLAFEYLHNRG-IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV 159

Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           +PE +    Y    D WSLG+ L E+  G  P
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 81.9 bits (202), Expect = 2e-19
 Identities = 44/98 (44%), Positives = 60/98 (61%), Gaps = 7/98 (7%)

Query: 3   QVPYSSFQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           ++ +  +Q+LKGL Y+   HA  IIHRD+KP N+ VN   E+KI DFG++ Q  DS    
Sbjct: 119 RIQFLVYQMLKGLKYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-TDSEMTG 174

Query: 61  FVGTRSYMSPER-LQGTHYSVQSDIWSLGLSLVEMAIG 97
           +V TR Y +PE  L   HY+   DIWS+G  + EM  G
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 81.2 bits (200), Expect = 2e-19
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)

Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 121 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-TGYV 178

Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 80.8 bits (199), Expect = 3e-19
 Identities = 42/111 (37%), Positives = 65/111 (58%), Gaps = 3/111 (2%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMA 58
           L +  + + +++ GL +L  K  II+RD+K  N++++  G IKI DFG+  + +  D+ A
Sbjct: 95  LYRATFYAAEIVCGLQFLHSK-GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153

Query: 59  NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           ++F GT  Y++PE LQG  Y+   D WS G+ L EM IG  P    D   L
Sbjct: 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 80.6 bits (199), Expect = 3e-19
 Identities = 39/89 (43%), Positives = 54/89 (60%), Gaps = 6/89 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
             L+GL YL   H  IHRD+K  NIL+   G +K+ DFG S  L+   ANSFVGT  +M+
Sbjct: 123 GALQGLAYL-HSHERIHRDIKAGNILLTEPGTVKLADFG-SASLVSP-ANSFVGTPYWMA 179

Query: 70  PE---RLQGTHYSVQSDIWSLGLSLVEMA 95
           PE    +    Y  + D+WSLG++ +E+A
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELA 208

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 80.9 bits (200), Expect = 4e-19
 Identities = 40/91 (43%), Positives = 56/91 (61%), Gaps = 7/91 (7%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS--GQLIDS--MANSFVGT 64
           +Q+L+GL YL     I+HRD+KP N+LVNS   +KICDFG++   +  +S  M    V T
Sbjct: 110 YQILRGLKYLHSAG-ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-T 167

Query: 65  RSYMSPERLQG-THYSVQSDIWSLGLSLVEM 94
           + Y +PE L G  HY+   DIWS+G    E+
Sbjct: 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAEL 198

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 80.8 bits (199), Expect = 4e-19
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 3/92 (3%)

Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPE-RLQGTH 77
           K+ I++RD+KP NIL+++ G I +CDFG+S   +  +   N+F GT  Y++PE  L    
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173

Query: 78  YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           Y+   D WSLG+ + EM  G  P    D + +
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM 205

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 6e-19
 Identities = 39/98 (39%), Positives = 60/98 (61%), Gaps = 13/98 (13%)

Query: 6   YSSFQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS------M 57
           Y  +Q+L+GL Y+   H+  ++HRD+KPSN+L+N+  ++KICDFG++ ++ D        
Sbjct: 110 YFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTNCDLKICDFGLA-RIADPEHDHTGF 165

Query: 58  ANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEM 94
              +V TR Y +PE  L    Y+   DIWS+G  L EM
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 79.6 bits (197), Expect = 6e-19
 Identities = 31/89 (34%), Positives = 51/89 (57%), Gaps = 5/89 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF---VGTRS 66
            +LKG+ Y+     I+HRD+KP+N+L+++ G +KI DFG++    +     +   V TR 
Sbjct: 107 MLLKGVAYMHAN-GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRW 165

Query: 67  YMSPERLQGT-HYSVQSDIWSLGLSLVEM 94
           Y +PE L G   Y    D+W++G    E+
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVGCIFAEL 194

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 78.9 bits (194), Expect = 1e-18
 Identities = 43/102 (42%), Positives = 63/102 (61%), Gaps = 12/102 (11%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           Q L+ L YL E + IIHRD+K  NIL    G+IK+ DFGVS +   ++   +SF+GT  +
Sbjct: 111 QTLEALNYLHE-NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW 169

Query: 68  MSPERL-----QGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP 104
           M+PE +     +   Y  ++D+WSLG++L+EMA     I PP
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMA----QIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 78.7 bits (195), Expect = 1e-18
 Identities = 37/90 (41%), Positives = 55/90 (61%), Gaps = 5/90 (5%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRS 66
           +Q+L+GL ++  KH   HRD+KP N+LV+    +KI DFG++ + I S      +V TR 
Sbjct: 106 YQILQGLAHI-HKHGFFHRDLKPENLLVSGPEVVKIADFGLARE-IRSRPPYTDYVSTRW 163

Query: 67  YMSPE-RLQGTHYSVQSDIWSLGLSLVEMA 95
           Y +PE  L+ T YS   DIW+LG  + E+ 
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELY 193

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 79.2 bits (195), Expect = 1e-18
 Identities = 43/111 (38%), Positives = 65/111 (58%), Gaps = 6/111 (5%)

Query: 4   VPYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ--LIDSMA 58
           +P ++F   +++ GL +L  K  I++RD+K  NIL+++ G IKI DFG+  +  L D+  
Sbjct: 95  LPRATFYAAEIICGLQFLHSK-GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153

Query: 59  NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
            +F GT  Y++PE L G  Y+   D WS G+ L EM IG  P    D + L
Sbjct: 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 78.1 bits (192), Expect = 2e-18
 Identities = 36/80 (45%), Positives = 51/80 (63%), Gaps = 4/80 (5%)

Query: 24  IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSV 80
           ++HRD+KP+N+ + + G +K+ D G+ G+   S    A+S VGT  YMSPER+    Y+ 
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGL-GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 185

Query: 81  QSDIWSLGLSLVEMAIGMYP 100
           +SDIWSLG  L EMA    P
Sbjct: 186 KSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 78.9 bits (194), Expect = 2e-18
 Identities = 43/104 (41%), Positives = 60/104 (57%), Gaps = 3/104 (2%)

Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E++I DFG++ Q  D M   +V
Sbjct: 119 HVQFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT-GYV 176

Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 78.4 bits (194), Expect = 2e-18
 Identities = 35/87 (40%), Positives = 49/87 (56%), Gaps = 4/87 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN--SFVGTRSY 67
             L+GL YL   + I+HRD+KP+N+L+ S G +K+ DFG++             V TR Y
Sbjct: 110 MTLRGLEYL-HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWY 168

Query: 68  MSPERLQG-THYSVQSDIWSLGLSLVE 93
            +PE L G  HY V  D+WS+G    E
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 77.3 bits (190), Expect = 4e-18
 Identities = 41/87 (47%), Positives = 56/87 (64%), Gaps = 4/87 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSY 67
           Q+L G+ Y+ ++  I+HRD+K  NI + +   +KI DFGVS  L+ S  +A +F GT  Y
Sbjct: 114 QLLLGVHYMHQRR-ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYY 171

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM 94
           MSPE L+   Y  +SDIWSLG  L EM
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 77.4 bits (190), Expect = 4e-18
 Identities = 44/110 (40%), Positives = 68/110 (61%), Gaps = 10/110 (9%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-----IDSMANSFVGT 64
           Q+L+G++YL   + I+HRD+K +NIL +S G +K+ DFG S +L       +   S  GT
Sbjct: 114 QILEGMSYL-HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP-PDAKTLAAIF 113
             +MSPE + G  Y  ++D+WSLG ++VEM   +   PP  + + +AAIF
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEM---LTEKPPWAEYEAMAAIF 219

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 76.8 bits (190), Expect = 4e-18
 Identities = 33/109 (30%), Positives = 53/109 (48%), Gaps = 6/109 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           + Q+ +G+ YL  K+  IHRD+   N LV     +KI DFG+S  L D       G +  
Sbjct: 108 ALQIARGMEYLESKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLP 166

Query: 67  --YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
             +M+PE L+   ++ +SD+WS G+ L E+        P    +   + 
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIF--TLGEQPYPGMSNEEVL 213

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 77.6 bits (192), Expect = 4e-18
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 6/98 (6%)

Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y++ QV+  L YL     I++RD+KP N+L++S G IKI DFG + + +     +  GT 
Sbjct: 106 YAA-QVVLALEYLHSLD-IVYRDLKPENLLLDSDGYIKITDFGFA-KRVKGRTYTLCGTP 162

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
            Y++PE +    Y    D W+LG+ + EM  G    PP
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEMLAG---YPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 77.5 bits (191), Expect = 4e-18
 Identities = 43/119 (36%), Positives = 69/119 (57%), Gaps = 9/119 (7%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSM 57
              V   ++Q+LKG+ +  E + ++HRD+KP N+L+N  GE+K+ DFG++   G  +++ 
Sbjct: 99  PNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157

Query: 58  ANSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPIPP--PDAKTLAAIF 113
           +N  V T  Y +P+ L G+  YS   DIWS+G  + EM  G  P+ P   +   L  IF
Sbjct: 158 SNEVV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLLKIF 214

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 76.8 bits (190), Expect = 4e-18
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 7/92 (7%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           + Q+ KG+ YL  K+  +HRD+   N LV     +KI DFG+S + I             
Sbjct: 108 ALQIAKGMEYLESKN-FVHRDLAARNCLVTENLVVKISDFGLS-RDIYEDDYYRKRGGGK 165

Query: 68  -----MSPERLQGTHYSVQSDIWSLGLSLVEM 94
                M+PE L+   ++ +SD+WS G+ L E+
Sbjct: 166 LPIKWMAPESLKDGKFTSKSDVWSFGVLLWEI 197

Length = 258

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 78.0 bits (192), Expect = 4e-18
 Identities = 41/96 (42%), Positives = 57/96 (59%), Gaps = 3/96 (3%)

Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
           +V Y  +Q+L GL Y+     IIHRD+KP N+ VN   E+KI DFG++ +  D+    +V
Sbjct: 118 KVQYLVYQMLCGLKYI-HSAGIIHRDLKPGNLAVNEDCELKILDFGLA-RHADAEMTGYV 175

Query: 63  GTRSYMSPER-LQGTHYSVQSDIWSLGLSLVEMAIG 97
            TR Y +PE  L   HY+   DIWS+G  + EM  G
Sbjct: 176 VTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 77.5 bits (191), Expect = 5e-18
 Identities = 39/92 (42%), Positives = 54/92 (58%), Gaps = 3/92 (3%)

Query: 24  IIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSVQ 81
           II+RD+KP NIL++  G IK+ DFG+S + ID    A SF GT  YM+PE +    ++  
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178

Query: 82  SDIWSLGLSLVEMAIGMYPIPPPDAK-TLAAI 112
           +D WS G+ + EM  G  P    D K T+  I
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 77.4 bits (191), Expect = 5e-18
 Identities = 41/105 (39%), Positives = 63/105 (60%), Gaps = 11/105 (10%)

Query: 6   YSSF--QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS-GQLIDSMANS-- 60
           + SF  Q+L GL Y+   + ++HRD+KP N+LVN+  E+KICDFG++ G   +   N+  
Sbjct: 107 FQSFIYQILCGLKYIHSAN-VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165

Query: 61  ---FVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
              +V TR Y +PE  L    Y+   D+WS+G  L E+ +G  P+
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL-LGRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 77.4 bits (190), Expect = 6e-18
 Identities = 38/87 (43%), Positives = 55/87 (63%), Gaps = 6/87 (6%)

Query: 12  LKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPE 71
           L+GL YL   H +IHRD+K  NIL+   G++K+ DFG +     S ANSFVGT  +M+PE
Sbjct: 131 LQGLAYL-HSHNMIHRDIKAGNILLTEPGQVKLADFGSAS--KSSPANSFVGTPYWMAPE 187

Query: 72  ---RLQGTHYSVQSDIWSLGLSLVEMA 95
               +    Y  + D+WSLG++ +E+A
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELA 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 77.4 bits (191), Expect = 7e-18
 Identities = 41/109 (37%), Positives = 61/109 (55%), Gaps = 13/109 (11%)

Query: 4   VPYSSFQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN-- 59
           + Y  +Q+L+GL Y+   H+  +IHRD+KPSN+LVN   E++I DFG++  L  S     
Sbjct: 109 IRYFLYQLLRGLKYI---HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK 165

Query: 60  ----SFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPIPP 103
                +V TR Y +PE L     Y+   D+WS+G    EM +G   + P
Sbjct: 166 YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM-LGRRQLFP 213

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 76.0 bits (188), Expect = 7e-18
 Identities = 34/109 (31%), Positives = 54/109 (49%), Gaps = 6/109 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           + Q+ +G+ YL  K+  IHRD+   N LV     +KI DFG+S  L D       G +  
Sbjct: 109 ALQIARGMEYLESKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP 167

Query: 67  --YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
             +M+PE L+   ++ +SD+WS G+ L E+        P    + A + 
Sbjct: 168 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIF--TLGEEPYPGMSNAEVL 214

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 76.1 bits (187), Expect = 9e-18
 Identities = 44/119 (36%), Positives = 68/119 (57%), Gaps = 13/119 (10%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--------DSMANSF 61
           Q+L G+ YL   + ++HRD+K +N+++   G IK+ DFG + +L          +M  S 
Sbjct: 110 QILDGVAYLHN-NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168

Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF--GPSRG 118
            GT  +M+PE +  + Y  +SDIWS+G ++ EMA G  P+   D   LAA+F  G  RG
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD--RLAAMFYIGAHRG 225

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 77.1 bits (190), Expect = 9e-18
 Identities = 42/100 (42%), Positives = 59/100 (59%), Gaps = 8/100 (8%)

Query: 6   YSSFQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFV 62
           Y  +Q+L G+ +L   H+  IIHRD+KPSNI+V S   +KI DFG++     S M   +V
Sbjct: 122 YLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 178

Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIG--MYP 100
            TR Y +PE + G  Y    DIWS+G  + EM  G  ++P
Sbjct: 179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 75.8 bits (186), Expect = 1e-17
 Identities = 44/110 (40%), Positives = 68/110 (61%), Gaps = 10/110 (9%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-----IDSMANSFVGT 64
           Q+L+G++YL   + I+HRD+K +NIL +S G +K+ DFG S +L       +   S  GT
Sbjct: 114 QILEGVSYL-HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172

Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP-PDAKTLAAIF 113
             +MSPE + G  Y  ++DIWS+G ++VEM   +   PP  + + +AAIF
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEM---LTEKPPWAEFEAMAAIF 219

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 75.8 bits (186), Expect = 1e-17
 Identities = 39/115 (33%), Positives = 66/115 (57%), Gaps = 10/115 (8%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL---IDSMANSFVGTR 65
           +Q++K + +   K+ I+HRD+KP N+L++    +K+CDFG +  L    ++    +V TR
Sbjct: 107 YQLIKAIHWC-HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATR 165

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK-----TLAAIFGP 115
            Y SPE L G  Y    D+WS+G  L E++ G  P+ P +++     T+  + GP
Sbjct: 166 WYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ-PLFPGESEIDQLFTIQKVLGP 219

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 75.3 bits (185), Expect = 2e-17
 Identities = 39/88 (44%), Positives = 55/88 (62%), Gaps = 3/88 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLID-SMANSFVGTRSY 67
           Q+L  L ++  K  I+HRD+K  NIL++    + KI DFG+S  L   S A + VGT  Y
Sbjct: 109 QILLALHHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCY 167

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           +SPE  +G  Y+ +SDIW+LG  L E+A
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELA 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 76.3 bits (188), Expect = 2e-17
 Identities = 40/104 (38%), Positives = 64/104 (61%), Gaps = 11/104 (10%)

Query: 6   YSSFQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFG---VSGQLIDSMANS 60
           Y  +Q+L+GL Y+   H+  ++HRD+KPSN+L+N+  ++KICDFG    + +  D M   
Sbjct: 112 YFLYQLLRGLKYI---HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMT-E 167

Query: 61  FVGTRSYMSPER-LQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
           +V TR Y +PE  L  + Y+   D+WS+G    E+ +G  P+ P
Sbjct: 168 YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL-LGRKPLFP 210

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 75.9 bits (186), Expect = 2e-17
 Identities = 39/87 (44%), Positives = 56/87 (64%), Gaps = 6/87 (6%)

Query: 12  LKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPE 71
           L+GL YL   H +IHRD+K  NIL+   G++K+ DFG +   I S ANSFVGT  +M+PE
Sbjct: 135 LQGLAYL-HSHNMIHRDIKAGNILLTEPGQVKLADFGSAS--IASPANSFVGTPYWMAPE 191

Query: 72  ---RLQGTHYSVQSDIWSLGLSLVEMA 95
               +    Y  + D+WSLG++ +E+A
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELA 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 75.1 bits (184), Expect = 2e-17
 Identities = 46/120 (38%), Positives = 71/120 (59%), Gaps = 16/120 (13%)

Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NS 60
           Q+ Y S + L+GL YL  K   +HRD+K +NIL+   G +K+ DFGVS Q+  ++A   S
Sbjct: 107 QIAYVSRETLQGLYYLHSK-GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS 165

Query: 61  FVGTRSYMSP-----ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP--DAKTLAAIF 113
           F+GT  +M+P     ER  G  Y+   DIW++G++ +E+A     + PP  D   + A+F
Sbjct: 166 FIGTPYWMAPEVAAVERKGG--YNQLCDIWAVGITAIELA----ELQPPMFDLHPMRALF 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 75.1 bits (184), Expect = 2e-17
 Identities = 38/94 (40%), Positives = 57/94 (60%), Gaps = 5/94 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRS 66
           Q+   L ++  +  ++HRD+KP+N+ + + G +K+ D G+ G+   S    A+S VGT  
Sbjct: 114 QLCSALEHMHSRR-VMHRDIKPANVFITATGVVKLGDLGL-GRFFSSKTTAAHSLVGTPY 171

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           YMSPER+    Y+ +SDIWSLG  L EMA    P
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 75.5 bits (185), Expect = 2e-17
 Identities = 42/110 (38%), Positives = 61/110 (55%), Gaps = 6/110 (5%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN-- 59
           +Q+      VL+ L+YL  +  +IHRD+K  +IL+ S G IK+ DFG   Q+   +    
Sbjct: 118 EQIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176

Query: 60  SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI---PPPDA 106
           S VGT  +M+PE +    Y  + DIWSLG+ ++EM  G  P    PP  A
Sbjct: 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 75.0 bits (185), Expect = 4e-17
 Identities = 34/83 (40%), Positives = 51/83 (61%), Gaps = 6/83 (7%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTRS 66
           Q+L G+ +L + + I+HRD+K SN+L+N+ G +KICDFG++   G  +       V T  
Sbjct: 114 QLLSGVAHLHD-NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT-QLVVTLW 171

Query: 67  YMSPERLQGT-HYSVQSDIWSLG 88
           Y +PE L G   YS   D+WS+G
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVG 194

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 74.5 bits (184), Expect = 4e-17
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 7/92 (7%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           + Q+ KG+ YL  K   +HRD+   N LV     +KI DFG+S + +         T   
Sbjct: 111 AIQIAKGMEYLASKK-FVHRDLAARNCLVGEDLVVKISDFGLS-RDVYDDDYYRKKTGGK 168

Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
               +M+PE L+   ++ +SD+WS G+ L E+
Sbjct: 169 LPIRWMAPESLKDGIFTSKSDVWSFGVLLWEI 200

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 74.7 bits (184), Expect = 4e-17
 Identities = 37/93 (39%), Positives = 56/93 (60%), Gaps = 4/93 (4%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS-GQLIDSMANSF-VGTRS 66
           FQ+L+GL Y  ++  ++HRD+KP N+L++  GE+K+ DFG++  + + S   S  V T  
Sbjct: 110 FQLLRGLAYCHQRR-VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLW 168

Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGM 98
           Y  P+ L G T YS   D+W +G    EMA G 
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 73.9 bits (181), Expect = 6e-17
 Identities = 42/124 (33%), Positives = 73/124 (58%), Gaps = 12/124 (9%)

Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NS 60
           Q+ Y   + L+GL YL  K   +HRD+K +NIL+   G++K+ DFGV+ ++  ++A   S
Sbjct: 107 QIAYVCRETLQGLAYLHSK-GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS 165

Query: 61  FVGTRSYMSPERL---QGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP--DAKTLAAIFGP 115
           F+GT  +M+PE     +   Y+   DIW++G++ +E+A     + PP  D   + A+F  
Sbjct: 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELA----ELQPPMFDLHPMRALFLM 221

Query: 116 SRGD 119
           S+ +
Sbjct: 222 SKSN 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 74.1 bits (182), Expect = 7e-17
 Identities = 34/91 (37%), Positives = 58/91 (63%), Gaps = 3/91 (3%)

Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVG 63
           + + Q++ GL +L +   II+RD+KP N+L+++ G ++I D G++ +L D  S    + G
Sbjct: 101 FYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG 159

Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
           T  +M+PE LQG  Y    D ++LG++L EM
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEM 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 73.5 bits (180), Expect = 9e-17
 Identities = 36/88 (40%), Positives = 53/88 (60%), Gaps = 3/88 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSY 67
           Q+   L YL EKH I+HRD+K  N+ +     IK+ D G++  L +   MA++ +GT  Y
Sbjct: 110 QIAMALQYLHEKH-ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYY 168

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           MSPE      Y+ +SD+W+LG  + EMA
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMA 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.5 bits (180), Expect = 9e-17
 Identities = 41/110 (37%), Positives = 67/110 (60%), Gaps = 10/110 (9%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ-----LIDSMANSFVGT 64
           Q+L+G++YL   + I+HRD+K +NIL +S G +K+ DFG S +     +  +   S  GT
Sbjct: 114 QILQGVSYL-HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172

Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP-PDAKTLAAIF 113
             +MSPE + G  Y  ++D+WS+  ++VEM   +   PP  + + +AAIF
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEM---LTEKPPWAEYEAMAAIF 219

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 73.9 bits (181), Expect = 1e-16
 Identities = 41/114 (35%), Positives = 58/114 (50%), Gaps = 18/114 (15%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN--SFVGTRSYM 68
           VL+ L YL  +  +IHRD+K  +IL+   G +K+ DFG   Q+   +    S VGT  +M
Sbjct: 126 VLQALCYLHSQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWM 184

Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI---------------PPPDAK 107
           +PE +  T Y  + DIWSLG+ ++EM  G  P                PPP  K
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK 238

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 73.9 bits (181), Expect = 1e-16
 Identities = 38/87 (43%), Positives = 55/87 (63%), Gaps = 6/87 (6%)

Query: 12  LKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPE 71
           L+GL YL   H +IHRDVK  NIL++  G +K+ DFG +   I + AN FVGT  +M+PE
Sbjct: 125 LQGLAYL-HSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS--IMAPANXFVGTPYWMAPE 181

Query: 72  ---RLQGTHYSVQSDIWSLGLSLVEMA 95
               +    Y  + D+WSLG++ +E+A
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELA 208

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 73.6 bits (181), Expect = 1e-16
 Identities = 37/97 (38%), Positives = 57/97 (58%), Gaps = 3/97 (3%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGV--SGQLIDSMANSFVGTRSYM 68
           V+ GL YL E + I++RD+K  N+L+++ G +KI DFG+   G       ++F GT  ++
Sbjct: 110 VVLGLQYLHE-NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFL 168

Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           +PE L  T Y+   D W LG+ + EM +G  P P  D
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 73.3 bits (180), Expect = 1e-16
 Identities = 38/90 (42%), Positives = 55/90 (61%), Gaps = 6/90 (6%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 107 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 164

Query: 66  SYMSPERLQGT-HYSVQSDIWSLGLSLVEM 94
            Y +PE L G  +YS   DIWSLG    EM
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 73.9 bits (181), Expect = 2e-16
 Identities = 38/97 (39%), Positives = 61/97 (62%), Gaps = 5/97 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE-IKICDFGVSGQLIDSMAN-SFVGTR 65
           S+Q+ + L Y+  K  I HRD+KP N+L++     +K+CDFG +  L+    + S++ +R
Sbjct: 176 SYQLCRALAYIHSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234

Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y +PE + G T+Y+   D+WSLG  + EM +G YPI
Sbjct: 235 FYRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YPI 270

Length = 440

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 73.1 bits (179), Expect = 2e-16
 Identities = 43/121 (35%), Positives = 67/121 (55%), Gaps = 10/121 (8%)

Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSF 61
           + Y   + L GL +L   +  IHRDVK +NIL+ + G +K+ DFGVS QL  +    N+ 
Sbjct: 126 IAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 184

Query: 62  VGTRSYMSPERLQ-----GTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPS 116
           VGT  +M+PE +       + Y  + D+WSLG++ +E+  G  P+   D   + A+F   
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL--ADLHPMRALFKIP 242

Query: 117 R 117
           R
Sbjct: 243 R 243

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 2e-16
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 20/98 (20%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF------- 61
           +Q+L+G+ Y    H ++HRD+KP N+L++  G +K+ DFG        +A +F       
Sbjct: 106 YQLLQGIAYC-HSHRVLHRDLKPQNLLIDREGALKLADFG--------LARAFGVPVRTY 156

Query: 62  ---VGTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEMA 95
              V T  Y +PE L G+  YS   DIWS+G    EM 
Sbjct: 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMV 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 72.5 bits (178), Expect = 2e-16
 Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 2/92 (2%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYM 68
           Q++ GL +L ++  I++RD+KP N+L++  G ++I D G++ +L          GT  YM
Sbjct: 103 QIICGLEHLHQRR-IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYM 161

Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           +PE LQG  Y    D ++LG +L EM  G  P
Sbjct: 162 APEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 72.4 bits (177), Expect = 3e-16
 Identities = 39/87 (44%), Positives = 54/87 (62%), Gaps = 2/87 (2%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-NSFVGTRSY 67
           FQ+L+GL +L   H ++HRD+KP NILV S G+IK+ DFG++      MA  S V T  Y
Sbjct: 117 FQLLRGLDFL-HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 175

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM 94
            +PE L  + Y+   D+WS+G    EM
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 3e-16
 Identities = 38/108 (35%), Positives = 61/108 (56%), Gaps = 6/108 (5%)

Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y+S +++  L YL  K  I++RD+KP NIL++  G IK+ DFG + +L D    +  GT 
Sbjct: 106 YAS-EIVCALEYLHSKE-IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW-TLCGTP 162

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
            Y++PE +Q   ++   D W+LG+ + EM +G    PP        I+
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVG---YPPFFDDNPFGIY 207

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 72.0 bits (176), Expect = 4e-16
 Identities = 41/98 (41%), Positives = 60/98 (61%), Gaps = 8/98 (8%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL+Y  ++  I+HRD+KP N+L+N  GE+K+ DFG++        + +N  V T 
Sbjct: 110 FQLLRGLSYCHKRK-ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TL 167

Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG--MYP 100
            Y  P+ L G T YS   D+W +G  L EMA G  M+P
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFP 205

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 72.1 bits (177), Expect = 4e-16
 Identities = 44/112 (39%), Positives = 62/112 (55%), Gaps = 10/112 (8%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQL---IDSMANSFVGT 64
           +Q+LKG+ +   KH ++HRD+KP N+LV+   G +KI D G+       + S  +  V T
Sbjct: 117 YQLLKGVAHC-HKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-T 174

Query: 65  RSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA--KTLAAIF 113
             Y +PE L G THYS   DIWS+G    EM     P+ P D+  + L  IF
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEM-SRKQPLFPGDSELQQLLHIF 225

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 71.7 bits (176), Expect = 4e-16
 Identities = 38/99 (38%), Positives = 55/99 (55%), Gaps = 6/99 (6%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+LKGL +    H ++HRD+KP N+L+N  GE+K+ DFG++   G  +   +   V T 
Sbjct: 106 FQLLKGLAFCHS-HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TL 163

Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPP 103
            Y  P+ L G   YS   D+WS G    E+A    P+ P
Sbjct: 164 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 72.0 bits (177), Expect = 5e-16
 Identities = 40/96 (41%), Positives = 55/96 (57%), Gaps = 6/96 (6%)

Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMAN 59
           QV     Q+L+GL YL E + IIHRD+K SN+L+   G +KI DFG++   G     M  
Sbjct: 109 QVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTP 167

Query: 60  SFVGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEM 94
             V T  Y +PE L G T Y+   D+W++G  L E+
Sbjct: 168 KVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAEL 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 71.1 bits (174), Expect = 5e-16
 Identities = 39/94 (41%), Positives = 59/94 (62%), Gaps = 4/94 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSM--ANSFVGTRS 66
           Q+  GL ++ ++  I+HRD+K  NI ++  G + K+ DFG++ QL DSM  A + VGT  
Sbjct: 109 QISLGLKHIHDRK-ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPY 167

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           Y+SPE  Q   Y+ ++DIWSLG  L E+    +P
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 71.6 bits (175), Expect = 6e-16
 Identities = 44/123 (35%), Positives = 65/123 (52%), Gaps = 23/123 (18%)

Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSF 61
           + Y  +  L GL +L     IIHRDVK +NIL+ + G +K+ DFGVS QL  +    N+ 
Sbjct: 130 ISYILYGALLGLQHLHNNR-IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188

Query: 62  VGTRSYMSPERLQ-----GTHYSVQSDIWSLGLSLVEMAIG------MYPI--------- 101
           VGT  +M+PE +         Y  + D+WSLG++ +E+  G      M+P+         
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN 248

Query: 102 PPP 104
           PPP
Sbjct: 249 PPP 251

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 71.4 bits (175), Expect = 9e-16
 Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 6/99 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGV--SGQLIDSMANSFVGTRSY 67
           +V   L +L  +H +I+RD+K  NIL+++ G  K+ DFG+   G L      +F GT  Y
Sbjct: 104 EVTLALMFL-HRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDY 162

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           ++PE LQ   Y    D W+LG+ + EM  G    PP +A
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQ---PPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 71.5 bits (175), Expect = 9e-16
 Identities = 37/97 (38%), Positives = 58/97 (59%), Gaps = 3/97 (3%)

Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVG 63
           + + ++L  L  L + + +I+RD+KP NIL++  G I +CDFG+    +  D   N+F G
Sbjct: 97  FYTAELLCALENLHKFN-VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG 155

Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           T  Y++PE L G  Y+   D W+LG+ L EM  G+ P
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 71.1 bits (174), Expect = 9e-16
 Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           + L+ L +L     +IHRD+K  NIL+   G +K+ DFG   Q+    S  ++ VGT  +
Sbjct: 123 ECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           M+PE +    Y  + DIWSLG+  +EM  G  P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 71.4 bits (175), Expect = 1e-15
 Identities = 38/101 (37%), Positives = 60/101 (59%), Gaps = 8/101 (7%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           S QV +G+ +L  K+ I HRDV   N+L+  G   KICDFG++  +++  +N  V   + 
Sbjct: 218 SSQVAQGMDFLASKNCI-HRDVAARNVLLTDGRVAKICDFGLARDIMND-SNYVVKGNAR 275

Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
               +M+PE +    Y+VQSD+WS G+ L E+ ++G  P P
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYP 316

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 70.2 bits (172), Expect = 2e-15
 Identities = 38/108 (35%), Positives = 65/108 (60%), Gaps = 10/108 (9%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-----SMANSFV 62
           S+QV KG+ +L  K+ I HRD+   N+L+  G  +KICDFG++  +++        N+ +
Sbjct: 147 SYQVAKGMAFLASKNCI-HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205

Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP--PPDAK 107
             + +M+PE +    Y+ +SD+WS G+ L E+ ++G  P P  P D+K
Sbjct: 206 PVK-WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK 252

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 70.9 bits (174), Expect = 2e-15
 Identities = 36/120 (30%), Positives = 54/120 (45%), Gaps = 41/120 (34%)

Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGV------------------------------- 49
           K   IHRD+KP N+L+++ G IK+ DFG+                               
Sbjct: 119 KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178

Query: 50  --SGQLIDS-------MANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
             S +  ++       +A S VGT  Y++PE    T Y+ + D WSLG+ + EM +G YP
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG-YP 237

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 69.9 bits (171), Expect = 2e-15
 Identities = 37/101 (36%), Positives = 55/101 (54%), Gaps = 8/101 (7%)

Query: 2   KQVPYSSFQVLKGLTY--LREKHA----IIHRDVKPSNILVNSGGEIKICDFGVSGQLID 55
           + V +   Q+L       L  KH     I+HRD+K  NI +   G IK+ DFG++  L  
Sbjct: 94  RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153

Query: 56  SM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
           ++  A + +GT  Y+SPE  +   Y+ +SDIW+LG  L EM
Sbjct: 154 TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 70.4 bits (172), Expect = 2e-15
 Identities = 38/97 (39%), Positives = 57/97 (58%), Gaps = 2/97 (2%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS-GQLIDSMANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     + M   
Sbjct: 123 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP 181

Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIG 97
           +V TR Y +PE + G  Y    DIWS+G  + E+  G
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 70.2 bits (172), Expect = 2e-15
 Identities = 35/85 (41%), Positives = 49/85 (57%), Gaps = 9/85 (10%)

Query: 25  IHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSF--VGTRSYMSPERLQGTH---- 77
           +HRD+KP N+L++  G IK+ DFG + +L  + M NS   VGT  Y++PE L   +    
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183

Query: 78  --YSVQSDIWSLGLSLVEMAIGMYP 100
             Y V+ D WSLG+   EM  G  P
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 69.4 bits (170), Expect = 3e-15
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           QV  G+ YL E    IHRD+   N+LV      K+ DFG++  + + +  +  G +    
Sbjct: 111 QVASGMAYL-EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK 169

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
           + +PE      +S++SD+WS G+ L E +  G  P P
Sbjct: 170 WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYP 206

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 69.6 bits (170), Expect = 3e-15
 Identities = 38/92 (41%), Positives = 55/92 (59%), Gaps = 4/92 (4%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGV--SGQLIDSMANSFVGTRS 66
           FQ+L+GL Y+  +H I+HRD+KP N+L++  GE+K+ DFG+  +  +     +S V T  
Sbjct: 110 FQLLRGLAYIHGQH-ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLW 168

Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
           Y  P+ L G T YS   DIW  G   +EM  G
Sbjct: 169 YRPPDVLLGATDYSSALDIWGAGCIFIEMLQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 70.1 bits (171), Expect = 3e-15
 Identities = 42/105 (40%), Positives = 59/105 (56%), Gaps = 2/105 (1%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 126 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 184

Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           +V TR Y +PE + G  Y    DIWS+G  + EM  G    P  D
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 69.6 bits (170), Expect = 3e-15
 Identities = 37/86 (43%), Positives = 52/86 (60%), Gaps = 2/86 (2%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-NSFVGTRSYM 68
           Q L+GL +L   + I+HRD+KP NILV SGG++K+ DFG++      MA    V T  Y 
Sbjct: 116 QFLRGLDFL-HANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYR 174

Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEM 94
           +PE L  + Y+   D+WS+G    EM
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 69.8 bits (171), Expect = 3e-15
 Identities = 31/82 (37%), Positives = 50/82 (60%), Gaps = 2/82 (2%)

Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHY 78
           +  II+RD+KP NIL+++ G +K+ DFG+  + I   ++ ++F GT  YM+PE L  + +
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH 177

Query: 79  SVQSDIWSLGLSLVEMAIGMYP 100
               D WSLG  + +M  G  P
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 5e-15
 Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 14/104 (13%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNS----GGEIKICDFGVSGQLIDSMANSF--- 61
           +Q+L G+ YL     ++HRD+KP+NILV       G +KI D G++ +L ++        
Sbjct: 115 WQILNGVHYLHSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLA-RLFNAPLKPLADL 172

Query: 62  ---VGTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPI 101
              V T  Y +PE L G  HY+   DIW++G    E+ + + PI
Sbjct: 173 DPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAEL-LTLEPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 69.4 bits (170), Expect = 6e-15
 Identities = 35/97 (36%), Positives = 55/97 (56%), Gaps = 10/97 (10%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS-----FVG 63
           +Q+L+ L Y+   + + HRD+KP NIL N+  ++KICDFG++    +    +     +V 
Sbjct: 110 YQLLRALKYIHTAN-VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168

Query: 64  TRSYMSPERLQG---THYSVQSDIWSLGLSLVEMAIG 97
           TR Y +PE L G   + Y+   DIWS+G    E+  G
Sbjct: 169 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 68.5 bits (167), Expect = 8e-15
 Identities = 37/97 (38%), Positives = 58/97 (59%), Gaps = 6/97 (6%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGV--SGQLIDSMANSFVGTRS 66
           FQ+L+GL Y   +  ++HRD+KP N+L+N  GE+K+ DFG+  +  +     ++ V T  
Sbjct: 111 FQLLRGLNYC-HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLW 169

Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIG--MYP 100
           Y  P+ L G T YS Q D+W +G    EM+ G  ++P
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 68.1 bits (166), Expect = 1e-14
 Identities = 40/110 (36%), Positives = 59/110 (53%), Gaps = 6/110 (5%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--N 59
           +Q+      VLK L+ L  +  +IHRD+K  +IL+   G +K+ DFG   Q+   +    
Sbjct: 116 EQIAAVCLAVLKALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174

Query: 60  SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI---PPPDA 106
           S VGT  +M+PE +    Y  + DIWSLG+ ++EM  G  P    PP  A
Sbjct: 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 224

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 68.3 bits (167), Expect = 1e-14
 Identities = 39/116 (33%), Positives = 64/116 (55%), Gaps = 10/116 (8%)

Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVG 63
           YS+ ++   L +L E+  II+RD+K  N+L+++ G IK+ D+G+  + I      ++F G
Sbjct: 101 YSA-EISLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG 158

Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI------PPPDAKTLAAIF 113
           T +Y++PE L+G  Y    D W+LG+ + EM  G  P         PD  T   +F
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF 214

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 68.5 bits (167), Expect = 1e-14
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF---VGTRSY 67
           VL+ + YL E + IIHRD+K  NI +N  G++ + DFG +   +D  AN +    GT + 
Sbjct: 191 VLRAIQYLHE-NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIG 97
            +PE L    Y    DIWS G+ L EMA  
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 68.2 bits (166), Expect = 1e-14
 Identities = 39/94 (41%), Positives = 56/94 (59%), Gaps = 2/94 (2%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 119 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 177

Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
           +V TR Y +PE + G  Y    DIWS+G  + EM
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 68.3 bits (167), Expect = 1e-14
 Identities = 36/96 (37%), Positives = 55/96 (57%), Gaps = 6/96 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSY 67
           ++   L YL   + II+RD+KP NIL++S G + + DFG+  + I+     ++F GT  Y
Sbjct: 104 EIASALGYLHSLN-IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEY 162

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
           ++PE L+   Y    D W LG  L EM   +Y +PP
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEM---LYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 68.1 bits (166), Expect = 1e-14
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 2/102 (1%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN--SFVGTRSY 67
           +++  L YL  +  +++RD+K  N++++  G IKI DFG+  + I   A   +F GT  Y
Sbjct: 103 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEY 162

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           ++PE L+   Y    D W LG+ + EM  G  P    D + L
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 204

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 67.5 bits (165), Expect = 1e-14
 Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 4/88 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
            V + + YL E +  IHRD+   N LV     +K+ DFG++  ++D    S  GT+    
Sbjct: 108 DVCEAMEYL-ESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK 166

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
           +  PE    + +S +SD+WS G+ + E+
Sbjct: 167 WAPPEVFDYSRFSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 68.2 bits (166), Expect = 1e-14
 Identities = 36/97 (37%), Positives = 57/97 (58%), Gaps = 3/97 (3%)

Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGV--SGQLIDSMANSFVG 63
           + S ++   L YL E+  II+RD+K  N+L++S G IK+ D+G+   G       ++F G
Sbjct: 100 FYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158

Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           T +Y++PE L+G  Y    D W+LG+ + EM  G  P
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 68.3 bits (167), Expect = 1e-14
 Identities = 35/100 (35%), Positives = 50/100 (50%), Gaps = 5/100 (5%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN- 59
           L+Q      ++L+ L YL  +  IIHRDVK  NI ++      + DFG + +L       
Sbjct: 184 LEQAITIQRRLLEALAYLHGR-GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242

Query: 60  ---SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAI 96
               + GT    SPE L    Y  ++DIWS GL L EM++
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV 282

Length = 392

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 68.5 bits (167), Expect = 1e-14
 Identities = 42/120 (35%), Positives = 67/120 (55%), Gaps = 14/120 (11%)

Query: 2   KQVPYSSFQVLKGLTY------LREKHA--IIHRDVKPSNILVNSGGEIKICDFGVSGQL 53
           + +P+  ++V  GL +      L E H+  ++HRD+K +NI +   G IK+ DFG S Q 
Sbjct: 162 EHLPFQEYEV--GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219

Query: 54  IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
            DS+    A+SF GT  Y++PE  +   YS ++D+WSLG+ L E+     P   P  + +
Sbjct: 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI 279

Length = 478

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 67.8 bits (165), Expect = 2e-14
 Identities = 39/97 (40%), Positives = 61/97 (62%), Gaps = 4/97 (4%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS-GQLIDSMANSF-VGTRS 66
           FQ+L+GL+Y+ +++ I+HRD+KP N+L++  GE+K+ DFG++  + + S   S  V T  
Sbjct: 110 FQLLRGLSYIHQRY-ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLW 168

Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIP 102
           Y  P+ L G T YS   D+W +G   VEM  G+   P
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 67.9 bits (166), Expect = 2e-14
 Identities = 33/84 (39%), Positives = 47/84 (55%), Gaps = 8/84 (9%)

Query: 25  IHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT----- 76
           +HRD+KP N+L++  G I++ DFG   +L+      +N  VGT  Y+SPE LQ       
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 77  HYSVQSDIWSLGLSLVEMAIGMYP 100
            Y  + D WSLG+ + EM  G  P
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 67.7 bits (165), Expect = 2e-14
 Identities = 37/98 (37%), Positives = 58/98 (59%), Gaps = 8/98 (8%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           +Q+L+GL Y   +  ++HRD+KP N+L+N  GE+K+ DFG++        + +N  V T 
Sbjct: 111 YQILRGLAYC-HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TL 168

Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG--MYP 100
            Y  P+ L G + YS Q D+W +G    EMA G  ++P
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 68.0 bits (166), Expect = 2e-14
 Identities = 41/115 (35%), Positives = 64/115 (55%), Gaps = 10/115 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS----GQLIDSMANSFVGTR 65
           QVL  + ++  KH +IHRD+K +NIL+ S G +K+ DFG S      + D +  +F GT 
Sbjct: 151 QVLLAVHHVHSKH-MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDA-----KTLAAIFGP 115
            Y++PE  +   YS ++D++SLG+ L E+     P    +      KTLA  + P
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264

Length = 496

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 67.3 bits (164), Expect = 2e-14
 Identities = 33/101 (32%), Positives = 57/101 (56%), Gaps = 2/101 (1%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-N 59
           +++V + S Q+  G+ +L     I++RD+KP N+L++  G  ++ D G++ +L D     
Sbjct: 94  MERVIHYSAQITCGILHLHSM-DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTIT 152

Query: 60  SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
              GT  YM+PE L+   YS   D +++G S+ EM  G  P
Sbjct: 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 68.0 bits (166), Expect = 2e-14
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           S+QV KG+++L  K+ I HRD+   NIL+  G   KICDFG++   I + +N  V   + 
Sbjct: 220 SYQVAKGMSFLASKNCI-HRDLAARNILLTHGRITKICDFGLARD-IRNDSNYVVKGNAR 277

Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP--PPDAK 107
               +M+PE +    Y+ +SD+WS G+ L E+ ++G  P P  P D+K
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK 325

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 67.1 bits (164), Expect = 2e-14
 Identities = 30/87 (34%), Positives = 51/87 (58%), Gaps = 1/87 (1%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRSYM 68
           Q++  L YL ++  I+HRD+ P+NI++    ++ I DFG++ Q   +S   S VGT  Y 
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180

Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEMA 95
            PE ++   Y  ++D+W+ G  L +M 
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMC 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 67.4 bits (164), Expect = 2e-14
 Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           + L+ L +L     +IHRD+K  NIL+   G +K+ DFG   Q+    S  ++ VGT  +
Sbjct: 123 ECLQALDFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           M+PE +    Y  + DIWSLG+  +EM  G  P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 67.1 bits (164), Expect = 3e-14
 Identities = 36/100 (36%), Positives = 53/100 (53%), Gaps = 6/100 (6%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMANSFVGTR 65
           ++QV +G+ +L  K   IHRD+   N+LV     +KI DFG++  +  ID    +  G  
Sbjct: 138 AYQVARGMEFLASKK-CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196

Query: 66  SY--MSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
               M+PE L    Y+ QSD+WS G+ L E   +G  P P
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 67.0 bits (164), Expect = 3e-14
 Identities = 37/99 (37%), Positives = 52/99 (52%), Gaps = 15/99 (15%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN---------- 59
           Q+L+G+ YL E H I+HRD+K +NIL+++ G +KI DFG++        N          
Sbjct: 123 QLLEGINYLHENH-ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181

Query: 60  ---SFVGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEM 94
              + V TR Y  PE L G   Y+   DIW +G    EM
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEM 220

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 67.0 bits (163), Expect = 3e-14
 Identities = 36/110 (32%), Positives = 61/110 (55%), Gaps = 7/110 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           ++   L +L E+  II+RD+K  N+L+++ G IK+ D+G+  + +      ++F GT +Y
Sbjct: 104 EICIALNFLHER-GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNY 162

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI----PPPDAKTLAAIF 113
           ++PE L+G  Y    D W+LG+ + EM  G  P       PD  T   +F
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF 212

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 66.7 bits (162), Expect = 4e-14
 Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           + L+ L +L     +IHRD+K  NIL+   G +K+ DFG   Q+    S  ++ VGT  +
Sbjct: 124 ECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           M+PE +    Y  + DIWSLG+  +EM  G  P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 67.1 bits (164), Expect = 4e-14
 Identities = 36/86 (41%), Positives = 48/86 (55%), Gaps = 13/86 (15%)

Query: 25  IHRDVKPSNILVNSGGEIKICDFGV------SGQLIDSMANSFVGTRSYMSPERL--QGT 76
           IHRDVKP N+L++  G +K+ DFG       +G +    A   VGT  Y+SPE L  QG 
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA---VGTPDYISPEVLKSQGG 220

Query: 77  H--YSVQSDIWSLGLSLVEMAIGMYP 100
              Y  + D WS+G+ L EM +G  P
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 66.7 bits (162), Expect = 4e-14
 Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           + L+ L +L     +IHRD+K  N+L+   G +K+ DFG   Q+    S  ++ VGT  +
Sbjct: 123 ECLQALEFLHANQ-VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           M+PE +    Y  + DIWSLG+  +EM  G  P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 5e-14
 Identities = 35/111 (31%), Positives = 59/111 (53%), Gaps = 11/111 (9%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
             Q+ KG++YL EK  ++HRD+   N+LV +   +KI DFG++ +L+D     +      
Sbjct: 115 CVQIAKGMSYLEEKR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLDVDEKEYHAEGGK 172

Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP---IPPPDAKTL 109
               +M+ E +    Y+ +SD+WS G+++ E M  G  P   IP  +   L
Sbjct: 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL 223

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 66.5 bits (162), Expect = 5e-14
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 3/97 (3%)

Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVG 63
           + + ++   L +L +K  II+RD+K  N+L++  G  K+ DFG+  + I +    ++F G
Sbjct: 100 FYAAEITSALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158

Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           T  Y++PE LQ   Y    D W++G+ L EM  G  P
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 66.6 bits (162), Expect = 5e-14
 Identities = 37/106 (34%), Positives = 59/106 (55%), Gaps = 6/106 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSY 67
           ++   L YL   + I++RD+KP NIL++S G I + DFG+  + I+     ++F GT  Y
Sbjct: 104 EIASALGYLHSLN-IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEY 162

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           ++PE L    Y    D W LG  L EM   +Y +PP  ++  A ++
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEM---LYGLPPFYSRNTAEMY 205

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 65.9 bits (161), Expect = 6e-14
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 20/98 (20%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF------- 61
           +Q+L+G+ +      ++HRD+KP N+L+++ G IK+ DFG        +A +F       
Sbjct: 108 YQILQGILFC-HSRRVLHRDLKPQNLLIDNKGVIKLADFG--------LARAFGIPVRVY 158

Query: 62  ---VGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
              V T  Y +PE L G   YS   DIWS+G    EMA
Sbjct: 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 65.6 bits (160), Expect = 8e-14
 Identities = 36/105 (34%), Positives = 57/105 (54%), Gaps = 12/105 (11%)

Query: 2   KQVPYSSFQVLKGLTYL-REKHAIIHRDVKPSNILVNSGGEIKICDFGVS-----GQLID 55
           ++  + + ++  GL  L RE+  I++RD+KP NIL++  G I+I D G++     G+ I 
Sbjct: 102 ERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR 159

Query: 56  SMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
                 VGT  YM+PE ++   Y+   D W LG  + EM  G  P
Sbjct: 160 GR----VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 65.8 bits (160), Expect = 8e-14
 Identities = 30/82 (36%), Positives = 46/82 (56%), Gaps = 1/82 (1%)

Query: 20  EKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHY 78
           ++  I++RD+KP NIL++  G I+I D G++ Q+ +       VGT  YM+PE +    Y
Sbjct: 119 QRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178

Query: 79  SVQSDIWSLGLSLVEMAIGMYP 100
           +   D W LG  + EM  G  P
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 66.0 bits (161), Expect = 9e-14
 Identities = 42/129 (32%), Positives = 64/129 (49%), Gaps = 14/129 (10%)

Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMAN 59
           P++ F   ++  GL +L  K  II+RD+K  N+++++ G IKI DFG+  + I       
Sbjct: 101 PHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159

Query: 60  SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL-AAIFGPSRG 118
           +F GT  Y++PE +    Y    D W+ G+ L EM  G  P    D   L  +I   +  
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-- 217

Query: 119 DGYWHVSYP 127
                VSYP
Sbjct: 218 -----VSYP 221

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 65.8 bits (160), Expect = 9e-14
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 3/102 (2%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN--SFVGTRSY 67
           +++  L YL  +  +++RD+K  N++++  G IKI DFG+  + I   A   +F GT  Y
Sbjct: 103 EIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 161

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           ++PE L+   Y    D W LG+ + EM  G  P    D + L
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 203

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 66.1 bits (161), Expect = 1e-13
 Identities = 33/86 (38%), Positives = 46/86 (53%), Gaps = 2/86 (2%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSG-QLIDSMANSFVGTRSYM 68
           Q+L+GL YL     IIHRDVK  NI +N   ++ I D G +   ++        GT    
Sbjct: 165 QILEGLRYLHA-QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETN 223

Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEM 94
           +PE L    Y+ ++DIWS G+ L EM
Sbjct: 224 APEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 65.4 bits (159), Expect = 1e-13
 Identities = 33/100 (33%), Positives = 56/100 (56%), Gaps = 2/100 (2%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANS 60
           ++  + + ++L GL  L  ++  ++RD+KP NIL++  G I+I D G++ ++ +      
Sbjct: 102 ERALFYAAEILCGLEDLHREN-TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160

Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            VGT  YM+PE L    Y++  D W LG  + EM  G  P
Sbjct: 161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 65.0 bits (158), Expect = 1e-13
 Identities = 33/100 (33%), Positives = 61/100 (61%), Gaps = 2/100 (2%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           K++ + + +++ GL ++  +  +++RD+KP+NIL++  G ++I D G++        ++ 
Sbjct: 97  KEMRFYATEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 155

Query: 62  VGTRSYMSPERLQ-GTHYSVQSDIWSLGLSLVEMAIGMYP 100
           VGT  YM+PE LQ GT Y   +D +SLG  L ++  G  P
Sbjct: 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.8 bits (158), Expect = 2e-13
 Identities = 32/89 (35%), Positives = 49/89 (55%), Gaps = 5/89 (5%)

Query: 24  IIHRDVKPSNILVNSGGEIKICDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTH--Y 78
           II+RD+K  NIL++S G + + DFG+S + +   +  A SF GT  YM+PE ++G    +
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185

Query: 79  SVQSDIWSLGLSLVEMAIGMYPIPPPDAK 107
               D WSLG+   E+  G  P      +
Sbjct: 186 DKAVDWWSLGVLTFELLTGASPFTVDGEQ 214

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 65.0 bits (158), Expect = 2e-13
 Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 10/92 (10%)

Query: 14  GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS-----GQLIDSMANSFVGTRSYM 68
           GL  L ++  I++RD+KP NIL++  G I+I D G++     GQ I       VGT  YM
Sbjct: 114 GLEDLHQER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYM 168

Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           +PE ++   Y+   D W+LG  L EM  G  P
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 64.7 bits (158), Expect = 2e-13
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFV 62
           + Q+  G+ YL  K   IHRD+   NIL+ S  ++KI DFG+   L  +     M     
Sbjct: 103 AVQIANGMRYLESKR-FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLK 161

Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
              ++ +PE L+   +S  SD+W  G++L EM
Sbjct: 162 VPFAWCAPESLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 64.8 bits (158), Expect = 2e-13
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 3/91 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           +++    YL  K  II+RD+KP N+L+++ G +K+ DFG + ++ D    +  GT  Y++
Sbjct: 126 ELVLAFEYLHSK-DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-TFTLCGTPEYLA 183

Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           PE +Q   +    D W++G+ L E   G YP
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAG-YP 213

Length = 329

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 64.8 bits (158), Expect = 2e-13
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           +++  L YL     +++RD+K  N++++  G IKI DFG+  + I   A   +F GT  Y
Sbjct: 103 EIVSALGYLHSCD-VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 161

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           ++PE L+   Y    D W LG+ + EM  G  P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 64.6 bits (157), Expect = 2e-13
 Identities = 36/109 (33%), Positives = 59/109 (54%), Gaps = 3/109 (2%)

Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ-LIDSMAN-S 60
           Q  + + ++  GL +L  +  II+RD+K  N++++S G IKI DFG+  + ++D +   +
Sbjct: 102 QAVFYAAEISVGLFFLHRR-GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160

Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           F GT  Y++PE +    Y    D W+ G+ L EM  G  P    D   L
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 64.8 bits (158), Expect = 3e-13
 Identities = 40/125 (32%), Positives = 53/125 (42%), Gaps = 45/125 (36%)

Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGV--------------SGQLI--DSM------- 57
           K   IHRD+KP NIL++  G IK+ DFG+               G     DSM       
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 58  ----------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
                                 A+S VGT +Y++PE L  T Y+   D WS+G+ L EM 
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238

Query: 96  IGMYP 100
           +G  P
Sbjct: 239 VGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 64.4 bits (157), Expect = 3e-13
 Identities = 35/89 (39%), Positives = 51/89 (57%), Gaps = 5/89 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF---VGTRS 66
           Q+L+GL Y  +K+  +HRD+K SNIL+N+ G+IK+ DFG++       +  +   V T  
Sbjct: 124 QLLEGLNYCHKKN-FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182

Query: 67  YMSPERLQGTH-YSVQSDIWSLGLSLVEM 94
           Y  PE L G   Y    D+WS G  L E+
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 63.8 bits (155), Expect = 3e-13
 Identities = 36/102 (35%), Positives = 56/102 (54%), Gaps = 3/102 (2%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVGTRSY 67
           Q+  G+ ++ EK  ++HRD+K  NI +   G++K+ DFG +  L      A ++VGT  Y
Sbjct: 108 QMCLGVQHIHEKR-VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYY 166

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           + PE  +   Y+ +SDIWSLG  L E+    +P      K L
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 63.4 bits (154), Expect = 4e-13
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 5/94 (5%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---SY 67
           V +G+ YL E    IHRD+   N LV+  G +K+ DFG+S  ++D    S VG++    +
Sbjct: 109 VCEGMAYL-ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 167

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYP 100
             PE L  + +S +SD+W+ G+ + E+ ++G  P
Sbjct: 168 SPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMP 201

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 63.9 bits (155), Expect = 4e-13
 Identities = 35/102 (34%), Positives = 54/102 (52%), Gaps = 3/102 (2%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN--SFVGTRSY 67
           +++  L YL     I++RD+K  N++++  G IKI DFG+  + I   A   +F GT  Y
Sbjct: 103 EIVSALDYLHSGK-IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEY 161

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           ++PE L+   Y    D W LG+ + EM  G  P    D + L
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 63.6 bits (155), Expect = 4e-13
 Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 8/93 (8%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           S Q+ KG+ YL  +   IHRD+   NILV S   +KI DFG++ +++    + +      
Sbjct: 115 SSQICKGMDYLGSQR-YIHRDLAARNILVESEDLVKISDFGLA-KVLPEDKDYYYVKEPG 172

Query: 67  -----YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
                + +PE L+ + +S  SD+WS G++L E+
Sbjct: 173 ESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 63.9 bits (155), Expect = 5e-13
 Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 6/100 (6%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           SFQV KG+ +L  +  I HRD+   NIL++    +KICDFG++  +         G    
Sbjct: 185 SFQVAKGMEFLASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    Y++QSD+WS G+ L E+ ++G  P P
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 283

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 63.5 bits (154), Expect = 5e-13
 Identities = 36/98 (36%), Positives = 54/98 (55%), Gaps = 11/98 (11%)

Query: 25  IHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTH---- 77
           +HRD+KP NIL++  G I++ DFG   +L++     ++  VGT  Y+SPE LQ       
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183

Query: 78  -YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
            Y  + D WSLG+ + EM  G  P     A++L   +G
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYG 218

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 64.0 bits (156), Expect = 6e-13
 Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 21/105 (20%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS-------GQLIDSMANS-- 60
           ++   + Y+  K  ++HRD+KP NIL+   GE+ I D+G +         L+D   +   
Sbjct: 121 KICATIEYVHSK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179

Query: 61  -----------FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
                       VGT  YM+PERL G   S  +DI++LG+ L +M
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224

Length = 932

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 62.8 bits (153), Expect = 6e-13
 Identities = 29/88 (32%), Positives = 50/88 (56%), Gaps = 5/88 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRS 66
           QV +G+ YL E++  IHRD+   NILV      K+ DFG++  + + +   ++  +  + 
Sbjct: 112 QVAEGMAYLEEQN-SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK- 169

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
           + +PE      +S +SD+WS G+ L EM
Sbjct: 170 WTAPEAASHGTFSTKSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 63.5 bits (154), Expect = 7e-13
 Identities = 36/96 (37%), Positives = 54/96 (56%), Gaps = 6/96 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGV--SGQLIDSMANSFVGTRSY 67
           +V   + YL   + II+RD+KP NIL++S G + + DFG+   G   +   ++F GT  Y
Sbjct: 104 EVASAIGYLHSLN-IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEY 162

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
           ++PE L+   Y    D W LG  L EM   +Y +PP
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEM---LYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 63.1 bits (153), Expect = 7e-13
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 6/96 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGV--SGQLIDSMANSFVGTRSY 67
           ++   L YL   + I++RD+KP NIL++S G + + DFG+   G        +F GT  Y
Sbjct: 104 EIASALGYLHSIN-IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEY 162

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
           ++PE ++   Y    D W LG  L EM   +Y +PP
Sbjct: 163 LAPEVIRKQPYDNTVDWWCLGAVLYEM---LYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 8e-13
 Identities = 35/100 (35%), Positives = 56/100 (56%), Gaps = 6/100 (6%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           SFQV +G+ +L  +  I HRD+   NIL++    +KICDFG++  +         G+   
Sbjct: 180 SFQVARGMEFLASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    Y+ QSD+WS G+ L E+ ++G  P P
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 278

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 63.1 bits (153), Expect = 9e-13
 Identities = 32/85 (37%), Positives = 51/85 (60%), Gaps = 7/85 (8%)

Query: 23  AIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT--- 76
            +IHRDVKP N+L++  G +K+ DFG   ++ ++     ++ VGT  Y+SPE L+     
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 77  -HYSVQSDIWSLGLSLVEMAIGMYP 100
            +Y  + D WS+G+ L EM +G  P
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 63.1 bits (153), Expect = 1e-12
 Identities = 33/83 (39%), Positives = 50/83 (60%), Gaps = 7/83 (8%)

Query: 25  IHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMA--NSFVGTRSYMSPERLQGT----H 77
           IHRDVKP N+L++  G +K+ DFG   ++  + M   ++ VGT  Y+SPE L+      +
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223

Query: 78  YSVQSDIWSLGLSLVEMAIGMYP 100
           Y  + D WS+G+ L EM +G  P
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 62.0 bits (150), Expect = 1e-12
 Identities = 35/94 (37%), Positives = 49/94 (52%), Gaps = 6/94 (6%)

Query: 14  GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS----YMS 69
           G+ YL  KH I HRD+   N LV     +KI DFG+S +  D +  S  G +     + +
Sbjct: 106 GMEYLESKHCI-HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTA 164

Query: 70  PERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
           PE L    YS +SD+WS G+ L E  ++G  P  
Sbjct: 165 PEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA 198

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 62.3 bits (151), Expect = 1e-12
 Identities = 38/110 (34%), Positives = 59/110 (53%), Gaps = 6/110 (5%)

Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ-LIDSMAN- 59
           P++ F   ++  GL +L  K  II+RD+K  N++++S G IKI DFG+  + + D +   
Sbjct: 101 PHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK 159

Query: 60  SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           +F GT  Y++PE +    Y    D W+ G+ L EM  G  P    D   L
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 62.7 bits (152), Expect = 1e-12
 Identities = 30/91 (32%), Positives = 56/91 (61%), Gaps = 2/91 (2%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           Q++    YL+  + I++RD+KP N+L++  G IK+ DFG + +++D+   +  GT  Y++
Sbjct: 139 QIVLIFEYLQSLN-IVYRDLKPENLLLDKDGFIKMTDFGFA-KVVDTRTYTLCGTPEYIA 196

Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           PE L    +   +D W+LG+ + E+ +G  P
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 62.3 bits (151), Expect = 1e-12
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 11/98 (11%)

Query: 25  IHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTH---- 77
           +HRD+KP N+L++  G I++ DFG   ++       ++  VGT  Y+SPE LQ       
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183

Query: 78  -YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
            Y  + D WSLG+ + EM  G  P     A++L   +G
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYG 218

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 61.9 bits (151), Expect = 2e-12
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 7/98 (7%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRS 66
           +Q+LK L ++  ++ I HRD+KP NIL+     +K+ DFG S + I S      ++ TR 
Sbjct: 107 YQLLKSLDHM-HRNGIFHRDIKPENILIK-DDILKLADFG-SCRGIYSKPPYTEYISTRW 163

Query: 67  YMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
           Y +PE  L   +Y  + DIW++G    E+ + ++P+ P
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEI-LSLFPLFP 200

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 62.1 bits (151), Expect = 2e-12
 Identities = 37/104 (35%), Positives = 61/104 (58%), Gaps = 8/104 (7%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVS---GQLIDSMANSFVGT 64
           +Q+L+G+ Y    H ++HRD+KP N+L++     +K+ DFG++   G  + +  +  V T
Sbjct: 109 YQILRGIAYC-HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-T 166

Query: 65  RSYMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK 107
             Y +PE L G+ HYS   DIWS+G    EM +   P+ P D++
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEM-VNQKPLFPGDSE 209

Length = 294

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 62.2 bits (151), Expect = 2e-12
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 6/100 (6%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           SFQV +G+ +L  +  I HRD+   NIL++    +KICDFG++  +         G    
Sbjct: 179 SFQVARGMEFLASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237

Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    Y+ QSD+WS G+ L E+ ++G  P P
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 61.8 bits (150), Expect = 2e-12
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 5/104 (4%)

Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL +K+  IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 108 YMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 166

Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 167 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 61.7 bits (150), Expect = 2e-12
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 8/99 (8%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFV 62
           + Q+  G+ YL   H  +HRD+   N LV  G  +KI DFG+S  +  +      + S +
Sbjct: 130 AIQIAAGMEYLSSHH-FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188

Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYP 100
             R +M PE +    ++ +SDIWS G+ L E+ + G+ P
Sbjct: 189 PVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 62.1 bits (151), Expect = 2e-12
 Identities = 31/101 (30%), Positives = 53/101 (52%), Gaps = 18/101 (17%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVS----------GQLIDSM 57
           +Q+L+GL Y+   + ++HRD+KP+N+ +N+   + KI DFG++          G L + +
Sbjct: 121 YQLLRGLKYIHSAN-VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179

Query: 58  ANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIG 97
                 T+ Y SP   L   +Y+   D+W+ G    EM  G
Sbjct: 180 V-----TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 61.5 bits (149), Expect = 2e-12
 Identities = 31/100 (31%), Positives = 59/100 (59%), Gaps = 2/100 (2%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
            ++ + + +++ GL ++  +  +++RD+KP+NIL++  G ++I D G++        ++ 
Sbjct: 97  AEMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 155

Query: 62  VGTRSYMSPERLQ-GTHYSVQSDIWSLGLSLVEMAIGMYP 100
           VGT  YM+PE LQ G  Y   +D +SLG  L ++  G  P
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 62.0 bits (150), Expect = 3e-12
 Identities = 34/101 (33%), Positives = 59/101 (58%), Gaps = 8/101 (7%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-----SMANSFV 62
           S+QV  G+ +L  K+ + HRD+   N+L+  G  +KICDFG++  ++      S  ++F+
Sbjct: 245 SYQVANGMEFLASKNCV-HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
             + +M+PE +    Y+  SD+WS G+ L E+  +G  P P
Sbjct: 304 PLK-WMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 61.4 bits (149), Expect = 3e-12
 Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 8/99 (8%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFV 62
           + QV  G+ YL E+   +HRD+   N LV     +KI DFG+S  +  +       N  +
Sbjct: 136 AKQVAAGMAYLSERK-FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAI 194

Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYP 100
             R +M PE +    Y+ +SD+W+ G+ L E+ + GM P
Sbjct: 195 PIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 61.1 bits (148), Expect = 3e-12
 Identities = 31/87 (35%), Positives = 49/87 (56%), Gaps = 4/87 (4%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---SY 67
           V +G+ YL E   +IHRD+   N LV     +K+ DFG++  ++D    S  GT+    +
Sbjct: 109 VCEGMAYL-ESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKW 167

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM 94
            SPE    + YS +SD+WS G+ + E+
Sbjct: 168 SSPEVFSFSKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 61.5 bits (149), Expect = 3e-12
 Identities = 35/109 (32%), Positives = 58/109 (53%), Gaps = 6/109 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTR--- 65
           Q+ KG+ YL E+  ++HRD+   N+LV +   +KI DFG++  L  D       G +   
Sbjct: 117 QIAKGMNYLEERR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
            +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 224

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 60.6 bits (147), Expect = 4e-12
 Identities = 31/87 (35%), Positives = 52/87 (59%), Gaps = 4/87 (4%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---SY 67
           V +G+ YL E+++ IHRD+   N LV+S G +K+ DFG++  ++D    S  G +    +
Sbjct: 109 VCEGMEYL-ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW 167

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM 94
             PE    + YS +SD+WS G+ + E+
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 60.4 bits (146), Expect = 5e-12
 Identities = 38/107 (35%), Positives = 56/107 (52%), Gaps = 7/107 (6%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
            KQ+   +     G+ YL  K+ I HRD+   N LV     +KI DFG+S Q  D + +S
Sbjct: 92  TKQLVKFALDAAAGMAYLESKNCI-HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS 150

Query: 61  FVGTRS----YMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
             G +     + +PE L    YS +SD+WS G+ L E  ++G+ P P
Sbjct: 151 -SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYP 196

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 60.8 bits (148), Expect = 5e-12
 Identities = 28/90 (31%), Positives = 48/90 (53%), Gaps = 5/90 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---- 65
           ++  G+ YL  K   +HRD+   N +V     +KI DFG++  + ++      G      
Sbjct: 127 EIADGMAYLAAKK-FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
            +M+PE L+   ++ +SD+WS G+ L EMA
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 61.0 bits (148), Expect = 5e-12
 Identities = 39/129 (30%), Positives = 49/129 (37%), Gaps = 49/129 (37%)

Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVS-----------------------------G 51
           K   IHRD+KP NIL++ GG IK+ DFG+S                              
Sbjct: 119 KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178

Query: 52  QLIDS--------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSL 91
             +DS                    MA S VGT  Y++PE      Y  + D WSLG  +
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238

Query: 92  VEMAIGMYP 100
            E  IG  P
Sbjct: 239 FECLIGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 60.9 bits (148), Expect = 5e-12
 Identities = 35/105 (33%), Positives = 47/105 (44%), Gaps = 18/105 (17%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA----------- 58
           Q+L GL  L  K   +HRD+ P+NI +NS G  KI DFG++ +                 
Sbjct: 127 QILNGLNVL-HKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185

Query: 59  -----NSFVGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
                 S V T  Y +PE L G   Y    D+WS+G    E+  G
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230

Length = 335

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 60.7 bits (147), Expect = 6e-12
 Identities = 38/108 (35%), Positives = 62/108 (57%), Gaps = 14/108 (12%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           ++Q+ +G+ YL E   ++HRD+   N+LV  G ++KI DFG+S  + +   +S+V  RS 
Sbjct: 133 AWQISRGMQYLAEM-KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE--DSYV-KRSK 188

Query: 67  ------YMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP--PPD 105
                 +M+ E L    Y+ QSD+WS G+ L E+  +G  P P   P+
Sbjct: 189 GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 61.3 bits (148), Expect = 6e-12
 Identities = 38/97 (39%), Positives = 55/97 (56%), Gaps = 20/97 (20%)

Query: 24  IIHRDVKPSNILVNSG----GEI-------------KICDFGVSGQL-IDSMANSFVGTR 65
           ++HRD+KP NI +++G    G+I             KI DFG+S  + I+SMA+S VGT 
Sbjct: 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTP 205

Query: 66  SYMSPERL--QGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            Y SPE L  +   Y  +SD+W+LG  + E+  G  P
Sbjct: 206 YYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 60.3 bits (147), Expect = 6e-12
 Identities = 32/93 (34%), Positives = 55/93 (59%), Gaps = 4/93 (4%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSG-GEIKICDFGVSGQLIDSMANSFVGTRSY 67
            Q+++ L  L  KH IIH D+K  N+L +     I +CD+G+  ++I +  + + GT  Y
Sbjct: 116 RQLVEALNDL-HKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC-KIIGT-PSCYDGTLDY 172

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            SPE+++G +Y V  D W++G+   E+  G +P
Sbjct: 173 FSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 60.6 bits (147), Expect = 7e-12
 Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 18/103 (17%)

Query: 15  LTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS--GQL----------IDSMANSFV 62
           L YL   + I+HRD+KP N+L+ S G IK+ DFG+S  G +          I+     F+
Sbjct: 114 LEYL-HNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172

Query: 63  -----GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
                GT  Y++PE +    Y    D W++G+ L E  +G  P
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.4 bits (146), Expect = 7e-12
 Identities = 35/102 (34%), Positives = 58/102 (56%), Gaps = 5/102 (4%)

Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN--- 59
           +V + S +++  L +L  K  I++RD+K  NIL++S G + + DFG+S + +        
Sbjct: 106 EVRFYSGEIILALEHL-HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY 164

Query: 60  SFVGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYP 100
           SF GT  YM+PE ++G   +    D WSLG+ + E+  G  P
Sbjct: 165 SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 60.4 bits (146), Expect = 9e-12
 Identities = 33/101 (32%), Positives = 61/101 (60%), Gaps = 8/101 (7%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-----SMANSFV 62
           ++QV +G+ +L  K+ + HRD+   N+L+  G  +KICDFG++  ++      S  ++F+
Sbjct: 243 TYQVARGMEFLASKNCV-HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301

Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
             + +M+PE +    Y+  SD+WS G+ L E+ ++G  P P
Sbjct: 302 PVK-WMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP 341

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.4 bits (144), Expect = 1e-11
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 9/99 (9%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           K + Y+S Q+ KG+ YL  K   +HRD+   NILV S   +KI DFG++ +++      +
Sbjct: 109 KLLLYAS-QICKGMEYLGSKR-YVHRDLATRNILVESENRVKIGDFGLT-KVLPQDKEYY 165

Query: 62  VGTRS------YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
                      + +PE L  + +SV SD+WS G+ L E+
Sbjct: 166 KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 1e-11
 Identities = 38/124 (30%), Positives = 53/124 (42%), Gaps = 36/124 (29%)

Query: 10  QVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDF------GVSGQLI------- 54
           +VL  L YL   H   I++RD+KP NIL++  G I + DF       V    +       
Sbjct: 111 EVLLALEYL---HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167

Query: 55  ------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAI 96
                                +NSFVGT  Y++PE + G  +    D W+LG+ L EM  
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227

Query: 97  GMYP 100
           G  P
Sbjct: 228 GTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 59.2 bits (143), Expect = 2e-11
 Identities = 31/85 (36%), Positives = 49/85 (57%), Gaps = 5/85 (5%)

Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQG-- 75
           K  II+RD+K  NIL++S G + + DFG+S +  +     A SF GT  YM+P+ ++G  
Sbjct: 123 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGD 182

Query: 76  THYSVQSDIWSLGLSLVEMAIGMYP 100
             +    D WS+G+ + E+  G  P
Sbjct: 183 GGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 58.9 bits (142), Expect = 2e-11
 Identities = 31/99 (31%), Positives = 59/99 (59%), Gaps = 5/99 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           S Q+ +G+ ++ E+   IHRD++ +NILV++    KI DFG++  + D+   +  G +  
Sbjct: 108 SAQIAEGMAFI-EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 166

Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
             + +PE +    ++++SD+WS G+ L+E+   G  P P
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 205

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 58.9 bits (143), Expect = 2e-11
 Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 5/97 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           Q+ +G+ YL  ++  IHRD+   NILV      KI DFG++  + D    +  G +    
Sbjct: 111 QIAEGMAYLESRN-YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK 169

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
           + +PE      ++++SD+WS G+ L E +  G  P P
Sbjct: 170 WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYP 206

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 58.9 bits (142), Expect = 2e-11
 Identities = 37/100 (37%), Positives = 55/100 (55%), Gaps = 6/100 (6%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMANSFVGTR 65
           ++QV +G+ YL  K  I HRD+   N+LV     +KI DFG++  +  ID    +  G  
Sbjct: 146 AYQVARGMEYLASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 204

Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE L    Y+ QSD+WS G+ L E+  +G  P P
Sbjct: 205 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 58.6 bits (142), Expect = 2e-11
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 6/94 (6%)

Query: 14  GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS----YMS 69
           G+ YL  K+ I HRD+   N LV     +KI DFG+S +    +     G +     + +
Sbjct: 105 GMEYLESKNCI-HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTA 163

Query: 70  PERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
           PE L    Y+ +SD+WS G+ L E  ++G  P P
Sbjct: 164 PEALNYGRYTSESDVWSYGILLWETFSLGDTPYP 197

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 59.5 bits (144), Expect = 2e-11
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 13/100 (13%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVN-SGGE--IKICDFGVSGQLID---------SM 57
           QVL  L     +  I+HRD+KP NI+V+ +G     K+ DFG+   L           + 
Sbjct: 87  QVLDALACAHNQ-GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTR 145

Query: 58  ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIG 97
               +GT +Y +PE+L+G   +  SD+++ GL  +E   G
Sbjct: 146 TTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 58.9 bits (142), Expect = 3e-11
 Identities = 41/129 (31%), Positives = 55/129 (42%), Gaps = 49/129 (37%)

Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGV--------------SGQLI--DSM------- 57
           K   IHRD+KP NIL++  G IK+ DFG+              SG  +  DSM       
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 58  --------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSL 91
                                     A+S VGT +Y++PE L  T Y+   D WS+G+ L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238

Query: 92  VEMAIGMYP 100
            EM +G  P
Sbjct: 239 YEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 58.4 bits (141), Expect = 4e-11
 Identities = 43/123 (34%), Positives = 60/123 (48%), Gaps = 16/123 (13%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L QV   + Q+L  + Y+  +  IIHRD+K  N+LVN   +I + DFG +     S +  
Sbjct: 259 LAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317

Query: 61  F----VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPS 116
           F     GT    +PE L G  Y+   DIWS GL + E A+             A++F  S
Sbjct: 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHT-----------ASLFSAS 366

Query: 117 RGD 119
           RGD
Sbjct: 367 RGD 369

Length = 461

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 57.7 bits (139), Expect = 5e-11
 Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 3/96 (3%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V +G+ YL  K  ++HRD+   NILV+  G  K+ DFG++      + NS +  + +
Sbjct: 106 SLDVAEGMEYLESKK-LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-W 163

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +PE L+   +S +SD+WS G+ L E+ + G  P P
Sbjct: 164 TAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYP 199

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 57.6 bits (139), Expect = 6e-11
 Identities = 30/97 (30%), Positives = 56/97 (57%), Gaps = 5/97 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           Q+ +G+ ++  K+ I HRD++ +NILV+     KI DFG++  + D+   +  G +    
Sbjct: 110 QIAEGMAFIERKNYI-HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK 168

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
           + +PE +    ++++SD+WS G+ L E+   G  P P
Sbjct: 169 WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYP 205

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 57.7 bits (139), Expect = 6e-11
 Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 5/97 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           QV  G+ Y+ E+   IHRD++ +NILV  G   KI DFG++  + D+   +  G +    
Sbjct: 110 QVAAGMAYI-ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK 168

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
           + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP 205

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 57.8 bits (140), Expect = 6e-11
 Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 7/91 (7%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY-- 67
           Q+  G++YL  K  +IH+D+   N +++   ++KI D  +S  L     +  +G      
Sbjct: 125 QIACGMSYL-HKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC-LGDNENRP 182

Query: 68  ---MSPERLQGTHYSVQSDIWSLGLSLVEMA 95
              M+ E L    YS  SD+WS G+ L E+ 
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 57.7 bits (139), Expect = 7e-11
 Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 6/96 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTR--- 65
           Q+ KG++YL E   ++HRD+   N+LV S   +KI DFG++  L ID       G +   
Sbjct: 117 QIAKGMSYLEEVR-LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 175

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
            +M+ E +    ++ QSD+WS G+++ E M  G  P
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 57.7 bits (139), Expect = 7e-11
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 6/100 (6%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMANSFVGTR 65
           ++QV +G+ YL  +  I HRD+   N+LV     +KI DFG++  +  ID    +  G  
Sbjct: 140 AYQVARGMEYLESRRCI-HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL 198

Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE L    Y+ QSD+WS G+ + E+  +G  P P
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 57.3 bits (138), Expect = 1e-10
 Identities = 36/107 (33%), Positives = 57/107 (53%), Gaps = 6/107 (5%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMA 58
            K +   ++QV +G+ YL  +  I HRD+   N+LV     +KI DFG++  +  ID   
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYK 194

Query: 59  NSFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +  G     +M+PE L    Y+ QSD+WS G+ + E+  +G  P P
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 57.0 bits (137), Expect = 1e-10
 Identities = 31/99 (31%), Positives = 57/99 (57%), Gaps = 5/99 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           S Q+ +G+ Y+ E+   IHRD++ +N+LV+     KI DFG++  + D+   +  G +  
Sbjct: 109 SAQIAEGMAYI-ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 167

Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
             + +PE +    ++++SD+WS G+ L E+   G  P P
Sbjct: 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYP 206

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 57.3 bits (138), Expect = 1e-10
 Identities = 36/113 (31%), Positives = 52/113 (46%), Gaps = 37/113 (32%)

Query: 25  IHRDVKPSNILVNSGGEIKICDFGV------------------------SGQLIDS---- 56
           IHRD+KP N+L+++ G +K+ DFG+                        S Q ++S    
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 57  ---------MANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
                    +A S VGT  Y++PE    T Y+   D WSLG+ + EM IG  P
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 56.9 bits (137), Expect = 1e-10
 Identities = 44/143 (30%), Positives = 57/143 (39%), Gaps = 51/143 (35%)

Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGV--------------SGQLI--DSM------- 57
           K   IHRD+KP NIL++  G IK+ DFG+               G  I  DSM       
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 58  --------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSL 91
                                     A+S VGT +Y++PE L    Y+   D WS+G+ L
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238

Query: 92  VEMAIGMYPI--PPPDAKTLAAI 112
            EM +G  P   P P    L  I
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVI 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 56.6 bits (137), Expect = 2e-10
 Identities = 36/100 (36%), Positives = 50/100 (50%), Gaps = 11/100 (11%)

Query: 10  QVLKGLTYL-REKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSF---V 62
            +L GL Y+ R K  I+HRD+K +NIL+   G +K+ DFG++       +S  N +   V
Sbjct: 127 MLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184

Query: 63  GTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPI 101
            T  Y  PE L G   Y    D+W  G  + EM     PI
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 56.6 bits (136), Expect = 2e-10
 Identities = 36/100 (36%), Positives = 55/100 (55%), Gaps = 6/100 (6%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMANSFVGTR 65
           ++QV +G+ YL  +  I HRD+   N+LV     +KI DFG++  +  ID    +  G  
Sbjct: 140 AYQVARGMEYLASQKCI-HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL 198

Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE L    Y+ QSD+WS G+ L E+  +G  P P
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.5 bits (136), Expect = 2e-10
 Identities = 36/123 (29%), Positives = 61/123 (49%), Gaps = 7/123 (5%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----- 55
           LKQ    + Q+ KG+ YL  +   +HRD+   N+LV S  ++KI DFG++  +       
Sbjct: 108 LKQQLKYAVQICKGMDYLGSRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY 166

Query: 56  SMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
           ++ +       + +PE L  + + + SD+WS G++L E+         P    L  I GP
Sbjct: 167 TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMI-GP 225

Query: 116 SRG 118
           + G
Sbjct: 226 THG 228

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 56.2 bits (135), Expect = 2e-10
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 5/106 (4%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +
Sbjct: 101 LPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159

Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 205

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 56.2 bits (135), Expect = 2e-10
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 4/97 (4%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID---SM 57
           LKQ      Q+L  + Y+ +K  +IHRD+K  NI +N  G+I + DFG +        + 
Sbjct: 266 LKQTRAIMKQLLCAVEYIHDK-KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324

Query: 58  ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
              +VGT +  SPE L G  Y   +DIWS GL L++M
Sbjct: 325 DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361

Length = 501

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 55.8 bits (134), Expect = 3e-10
 Identities = 35/113 (30%), Positives = 49/113 (43%), Gaps = 37/113 (32%)

Query: 25  IHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---------------------------- 56
           IHRD+KP N+L++S G +K+ DFG+   L  +                            
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 57  ---------MANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
                    +A S VGT  Y++PE    T Y+   D WSLG+ + EM IG  P
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 55.4 bits (133), Expect = 3e-10
 Identities = 29/96 (30%), Positives = 52/96 (54%), Gaps = 3/96 (3%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V + + YL E +  +HRD+   N+LV+     K+ DFG++ +   +     +  + +
Sbjct: 108 SLDVCEAMEYL-EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-W 165

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +PE L+   +S +SD+WS G+ L E+ + G  P P
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 55.0 bits (133), Expect = 5e-10
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 12/103 (11%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDF---------GVSGQLIDSMAN 59
             VL  L Y+  K   IHR VK S+IL++  G++ +            G   +++     
Sbjct: 108 KDVLNALDYIHSKG-FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166

Query: 60  SFVGTRSYMSPERL-QGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
           S V    ++SPE L Q    Y+ +SDI+S+G++  E+A G  P
Sbjct: 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 55.0 bits (132), Expect = 6e-10
 Identities = 30/99 (30%), Positives = 54/99 (54%), Gaps = 7/99 (7%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---- 56
           L Q+ + + Q+  G+ YL  +H  +HRD+   N LV +   +KI DFG+S  +  +    
Sbjct: 122 LSQMLHIASQIASGMVYLASQH-FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 180

Query: 57  -MANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
              ++ +  R +M PE +    ++ +SD+WS G+ L E+
Sbjct: 181 VGGHTMLPIR-WMPPESIMYRKFTTESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 55.0 bits (132), Expect = 6e-10
 Identities = 35/107 (32%), Positives = 55/107 (51%), Gaps = 12/107 (11%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTR 65
           Q+ KG+ YL E+H ++HR++   NIL+ S   ++I DFGV+  L         +      
Sbjct: 117 QIAKGMYYL-EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-------GMYPIPPPD 105
            +M+ E +    Y+ QSD+WS G+++ EM         GM P   PD
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 54.6 bits (131), Expect = 7e-10
 Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 8/99 (8%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFV 62
           + Q+  G+ YL   H  +H+D+   NIL+     +KI D G+S ++  +        S +
Sbjct: 130 AIQIAAGMEYL-SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYP 100
             R +M PE +    +S  SDIWS G+ L E+ + G+ P
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 54.7 bits (131), Expect = 7e-10
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 8/97 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGV-----SGQLIDSMANSFVGT 64
           Q+  G+ +L   H ++H+D+   N+LV     +KI D G+     +      M NS +  
Sbjct: 132 QIAAGMEFLSSHH-VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190

Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYP 100
           R +MSPE +    +S+ SDIWS G+ L E+ + G+ P
Sbjct: 191 R-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 54.7 bits (132), Expect = 7e-10
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 10/97 (10%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS---- 66
           +  G+ YL E    +HRD+   NILVNS    K+ DFG+S +L DS   +   T+     
Sbjct: 115 IASGMKYLSE-MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS--EATYTTKGGKIP 171

Query: 67  --YMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             + +PE +    ++  SD+WS G+ + E M+ G  P
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 54.6 bits (131), Expect = 8e-10
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 7/99 (7%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ YL   H  +HRD+   N LV  G  +KI DFG+S   I S    
Sbjct: 121 LGQMLAIASQIASGMVYLASLH-FVHRDLATRNCLVGQGLVVKIGDFGMSRD-IYSTDYY 178

Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
            VG R+     +M PE +    ++ +SDIWS G+ L E+
Sbjct: 179 RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 53.9 bits (129), Expect = 1e-09
 Identities = 33/106 (31%), Positives = 57/106 (53%), Gaps = 5/106 (4%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   IHRD++ +NILV      KI DFG++  + D+   +
Sbjct: 101 LPQLVDMAAQIADGMAYI-ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159

Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP 205

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.7 bits (129), Expect = 2e-09
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 7/123 (5%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS-----GQLID 55
           L Q+   + Q+ +G+ YL  +H  IHRD+   N+L+++   +KI DFG++     G    
Sbjct: 106 LAQLLLFAQQICEGMAYLHSQH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 164

Query: 56  SMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
            +         + + E L+   +S  SD+WS G++L E+         P  K    I GP
Sbjct: 165 RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-GP 223

Query: 116 SRG 118
            +G
Sbjct: 224 KQG 226

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 53.5 bits (128), Expect = 2e-09
 Identities = 32/96 (33%), Positives = 53/96 (55%), Gaps = 6/96 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS----GQLIDSMANSFVGTR 65
           Q+ KG+ YL E+  ++HRD+   N+LV S   +KI DFG++    G   +  A+      
Sbjct: 117 QIAKGMMYLEERR-LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 175

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
            +M+ E +    ++ QSD+WS G+++ E M  G  P
Sbjct: 176 KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 52.7 bits (126), Expect = 4e-09
 Identities = 34/108 (31%), Positives = 57/108 (52%), Gaps = 14/108 (12%)

Query: 6   YSSFQVL-------KGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA 58
           +SS+Q++        G+ YL + +  +HRD+   NILVNS  E K+ DFG+S  L D   
Sbjct: 104 FSSYQLVGMLRGIAAGMKYLSDMN-YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162

Query: 59  NSFVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
            ++  +       + +PE +    ++  SD+WS G+ + E M+ G  P
Sbjct: 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 52.6 bits (126), Expect = 4e-09
 Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 11/102 (10%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGE-----IKICDFGVSGQLIDSMANSFVGTR 65
           V KG  YL + H  IHRD+   N LV+  G      +KI DFG++  +  S      G  
Sbjct: 115 VAKGCVYLEQMH-FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173

Query: 66  ----SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
                +M+PE L    ++ QSD+WS G+ + E + +G  P P
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 52.4 bits (126), Expect = 5e-09
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 7/98 (7%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           +  V +G+ YL EK+  +HRD+   N+LV+     K+ DFG++    ++      G    
Sbjct: 108 ALDVCEGMEYLEEKN-FVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLPV 163

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            + +PE L+   +S +SD+WS G+ L E+ + G  P P
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 52.1 bits (125), Expect = 7e-09
 Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 5/91 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           + Q+  G+ YL  +H  +HRD+   N LV     +KI DFG+S  +  +      G    
Sbjct: 128 AVQIASGMVYLASQH-FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
              +M PE +    ++ +SD+WS G+ L E+
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 51.7 bits (124), Expect = 7e-09
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 8/104 (7%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF---VGTR- 65
           QV KG+ YL  K   +HRD+   N +++    +K+ DFG++  + D    S     G + 
Sbjct: 106 QVAKGMEYLASKK-FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164

Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDA 106
              +M+ E LQ   ++ +SD+WS G+ L E M  G  P P  D+
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS 208

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 51.9 bits (124), Expect = 8e-09
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 3/101 (2%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS-GQLIDSMANS 60
           +Q+ + +  V +G+ YL +K   IHRD+   NILV      KI DFG+S GQ +      
Sbjct: 124 QQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182

Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYP 100
                 +M+ E L  + Y+  SD+WS G+ L E+ ++G  P
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 51.6 bits (124), Expect = 9e-09
 Identities = 31/106 (29%), Positives = 54/106 (50%), Gaps = 16/106 (15%)

Query: 1   LKQVPYSSF-----QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID 55
            K + +S+      Q+  G+ YL E    +HRD+   N LV     IKI DFG+S  L  
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYL-ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL-- 180

Query: 56  SMANSF--VGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
             ++ +  V  R+     +M+ E +    ++ +SD+W+ G++L E+
Sbjct: 181 -YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 51.6 bits (123), Expect = 1e-08
 Identities = 37/99 (37%), Positives = 54/99 (54%), Gaps = 17/99 (17%)

Query: 9   FQVLKGLTYLREKHA--IIHRDVKPSNILV----NSGGEIKICDFGVSGQLIDSM----- 57
           +Q+L G+ YL   HA  ++HRD+KP+NILV       G +KI D G + +L +S      
Sbjct: 115 YQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSPLKPLA 170

Query: 58  -ANSFVGTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEM 94
             +  V T  Y +PE L G  HY+   DIW++G    E+
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 51.2 bits (122), Expect = 1e-08
 Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 7/97 (7%)

Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----M 57
           Q+ + + Q+  G+ YL  +H  +HRD+   N LV     +KI DFG+S  +  +      
Sbjct: 121 QMLHIAQQIAAGMVYLASQH-FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG 179

Query: 58  ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
            ++ +  R +M PE +    ++ +SD+WSLG+ L E+
Sbjct: 180 GHTMLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 51.2 bits (122), Expect = 1e-08
 Identities = 37/99 (37%), Positives = 54/99 (54%), Gaps = 17/99 (17%)

Query: 9   FQVLKGLTYLREKHA--IIHRDVKPSNILV----NSGGEIKICDFGVSGQLIDSM----- 57
           +Q+L G+ YL   HA  ++HRD+KP+NILV       G +KI D G + +L +S      
Sbjct: 115 YQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSPLKPLA 170

Query: 58  -ANSFVGTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEM 94
             +  V T  Y +PE L G  HY+   DIW++G    E+
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 50.9 bits (122), Expect = 1e-08
 Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 6/99 (6%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           S+Q+   L YL  K   +HRD+   N+LV+S   +K+ DFG+S  L D         +  
Sbjct: 113 SYQLSTALAYLESKR-FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP 171

Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
             +M+PE +    ++  SD+W  G+ + E  I M  + P
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWE--ILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 50.4 bits (121), Expect = 2e-08
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 10/92 (10%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS--- 66
           QV  G+ YL  KH  +HRD+   N+L+ +  + KI DFG+S  L     + +    +   
Sbjct: 103 QVAMGMAYLESKH-FVHRDLAARNVLLVNRHQAKISDFGMSRAL--GAGSDYYRATTAGR 159

Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
               + +PE +    +S +SD+WS G++L E 
Sbjct: 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEA 191

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 50.6 bits (121), Expect = 2e-08
 Identities = 21/41 (51%), Positives = 30/41 (73%), Gaps = 1/41 (2%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS 50
           +V   L YL  +H IIHRD+KP N+L+++ G IK+ DFG+S
Sbjct: 112 EVALALDYL-HRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 50.3 bits (120), Expect = 3e-08
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 9/95 (9%)

Query: 14  GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN----SFVGTR---S 66
           G+ YL E +  +HRD+   NILVNS    K+ DFG+S  L D  ++    S +G +    
Sbjct: 118 GMKYLSEMN-YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
           + +PE +    ++  SD+WS G+ + E M+ G  P
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 49.9 bits (119), Expect = 4e-08
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 7/93 (7%)

Query: 14  GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS-----YM 68
           G+ YL +    +HRD+   NILVNS    K+ DFG+S  L D    ++          + 
Sbjct: 118 GMKYLSDM-GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 176

Query: 69  SPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
           +PE +    ++  SD+WS G+ + E M+ G  P
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 49.2 bits (117), Expect = 7e-08
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 10/91 (10%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS--- 66
           QV  G+ YL  K+  +HRD+   N+L+ +    KI DFG+S  L     +S+   RS   
Sbjct: 103 QVSMGMKYLEGKN-FVHRDLAARNVLLVNQHYAKISDFGLSKAL--GADDSYYKARSAGK 159

Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVE 93
               + +PE +    +S +SD+WS G+++ E
Sbjct: 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 48.9 bits (116), Expect = 8e-08
 Identities = 37/103 (35%), Positives = 52/103 (50%), Gaps = 10/103 (9%)

Query: 7   SSFQVLK-------GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS-GQLIDSMA 58
           SS Q+L        G+ YL +K   IHRD+   NILV      KI DFG+S GQ +    
Sbjct: 110 SSQQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 168

Query: 59  NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYP 100
                   +M+ E L  + Y+  SD+WS G+ L E+ ++G  P
Sbjct: 169 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 48.8 bits (116), Expect = 9e-08
 Identities = 30/105 (28%), Positives = 46/105 (43%), Gaps = 17/105 (16%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGG----------------EIKICDFGVSGQ 52
           FQ    L Y   +  ++H D+KP NIL+ +                   ++ICD G    
Sbjct: 238 FQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD 297

Query: 53  LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIG 97
              S   + V TR Y SPE + G  +   +D+WS+G  + E+  G
Sbjct: 298 ERHSRT-AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341

Length = 467

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 48.5 bits (115), Expect = 1e-07
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 9/95 (9%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS-GQLI---DSMANSFVGTRS 66
           V  G+ YL EK   IHRD+   N+LV      KI DFG+S G+ +    +M    V    
Sbjct: 128 VATGMQYLSEKQ-FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPV---R 183

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYP 100
           +M+ E L  + Y+ +SD+WS G+ L E+ ++G  P
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 48.5 bits (115), Expect = 1e-07
 Identities = 29/100 (29%), Positives = 53/100 (53%), Gaps = 7/100 (7%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---- 56
           LK++   + ++  G+ YL   +  +HRD+   N +V     +KI DFG++  + ++    
Sbjct: 118 LKKMIQMAGEIADGMAYL-NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 176

Query: 57  -MANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
                 +  R +MSPE L+   ++  SD+WS G+ L E+A
Sbjct: 177 KGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIA 215

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 48.2 bits (115), Expect = 1e-07
 Identities = 34/110 (30%), Positives = 44/110 (40%), Gaps = 25/110 (22%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDSMANSFVGTR 65
             V KG  YL E H  IHRD+   N L+   G     KI DFG        MA       
Sbjct: 123 RDVAKGCKYLEENH-FIHRDIAARNCLLTCKGPGRVAKIADFG--------MARDIYRAS 173

Query: 66  SY------------MSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
            Y            M PE      ++ ++D+WS G+ L E  ++G  P P
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP 223

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 47.3 bits (112), Expect = 3e-07
 Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 5/93 (5%)

Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSF 61
           Y + Q+  G+ YL   +  +HRD+   N LV +   IKI DFG+S  L       +    
Sbjct: 133 YMAVQIASGMKYLASLN-FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRA 191

Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
           V    +M+ E +    ++  SD+W+ G++L EM
Sbjct: 192 VLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 47.1 bits (112), Expect = 4e-07
 Identities = 26/89 (29%), Positives = 50/89 (56%), Gaps = 6/89 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTR 65
           Q+  G+ +L      +HRD+   N LV+S  E+K+    +S  + +S    + N+ +  R
Sbjct: 125 QIALGMDHL-SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR 183

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
            +++PE +Q   +S +SD+WS G+ + E+
Sbjct: 184 -WLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 46.6 bits (110), Expect = 5e-07
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 10/99 (10%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR----- 65
           +  G+ YL  K   IHRD+   N ++N    + + DFG+S ++ +   + +   R     
Sbjct: 121 IASGMEYLSSKS-FIHRDLAARNCMLNENMNVCVADFGLSKKIYN--GDYYRQGRIAKMP 177

Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             +++ E L    Y+ +SD+WS G+++ E+A  G  P P
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP 216

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 46.5 bits (110), Expect = 6e-07
 Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 5/99 (5%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L+++   + ++  G+ YL  K   +HRD+   N +V     +KI DFG++  + ++    
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 176

Query: 61  FVGTR----SYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
             G       +M+PE L+   ++  SD+WS G+ L E+ 
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.7 bits (108), Expect = 1e-06
 Identities = 31/103 (30%), Positives = 54/103 (52%), Gaps = 12/103 (11%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDF---------GVSGQLIDSMAN 59
           F  L+GL YL + +  IHR++K S+IL++  G + +            G   +++     
Sbjct: 108 FGALRGLNYLHQ-NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQ 166

Query: 60  SFVGTRSYMSPERL-QGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
                  ++SPE L Q  + Y+V+SDI+S+G++  E+A G  P
Sbjct: 167 FSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 45.3 bits (107), Expect = 1e-06
 Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 8/98 (8%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS---- 66
           +  G+ YL  K+  IHRD+   N ++N    + + DFG+S + I S      G  S    
Sbjct: 122 IASGMEYLSSKN-FIHRDLAARNCMLNENMTVCVADFGLSKK-IYSGDYYRQGCASKLPV 179

Query: 67  -YMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
            +++ E L    Y+  SD+W+ G+++ E M  G  P  
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA 217

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 45.3 bits (107), Expect = 1e-06
 Identities = 27/91 (29%), Positives = 47/91 (51%), Gaps = 10/91 (10%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS--- 66
           QV  G+ YL E+   +HRD+   N+L+ +    KI DFG+S  L      ++   ++   
Sbjct: 103 QVSMGMKYL-EETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL--GADENYYKAKTHGK 159

Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVE 93
               + +PE +    +S +SD+WS G+ + E
Sbjct: 160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 44.7 bits (105), Expect = 3e-06
 Identities = 21/41 (51%), Positives = 28/41 (68%), Gaps = 1/41 (2%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS 50
           QVL GL  L  +  I+HRD+KP N+LV   G++KI DFG +
Sbjct: 317 QVLTGLRKL-HRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 44.1 bits (104), Expect = 4e-06
 Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 5/93 (5%)

Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSF 61
           + + Q+  G+ YL   +  +HRD+   N LV     IKI DFG+S  L       +    
Sbjct: 134 FMATQIASGMKYLSSLN-FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRA 192

Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
           V    +MS E +    ++  SD+W+ G++L E+
Sbjct: 193 VLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 43.0 bits (101), Expect = 8e-06
 Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 5/94 (5%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS---Y 67
           +  G+ YL E    +H+ +    +LVNS    KI  F    +       + +  +S   +
Sbjct: 116 LASGMKYLSEM-GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLW 174

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
            +PE +Q  H+S  SD+WS G+ + E M+ G  P
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 42.6 bits (100), Expect = 1e-05
 Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 12/101 (11%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEI---------KICDFGVSGQLIDSMANSF 61
           VLK L Y+      +HR VK S+IL++  G++          + + G   +++       
Sbjct: 110 VLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYS 168

Query: 62  VGTRSYMSPERLQGT--HYSVQSDIWSLGLSLVEMAIGMYP 100
           V    ++SPE LQ     Y  +SDI+S+G++  E+A G  P
Sbjct: 169 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 42.5 bits (100), Expect = 1e-05
 Identities = 25/99 (25%), Positives = 50/99 (50%), Gaps = 10/99 (10%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR----- 65
           +  G+ YL  ++  IHRD+   N ++     + + DFG+S ++     + +   R     
Sbjct: 122 IALGMEYLSNRN-FIHRDLAARNCMLREDMTVCVADFGLSKKIYS--GDYYRQGRIAKMP 178

Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             +++ E L    Y+ +SD+W+ G+++ E+A  G  P P
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP 217

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 42.1 bits (99), Expect = 2e-05
 Identities = 24/78 (30%), Positives = 38/78 (48%), Gaps = 1/78 (1%)

Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 80
           +  I+ RD+ P+NIL++  G I++  F    ++ DS     V    Y +PE    +  + 
Sbjct: 103 REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV-ENMYCAPEVGGISEETE 161

Query: 81  QSDIWSLGLSLVEMAIGM 98
             D WSLG  L E+  G 
Sbjct: 162 ACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 41.8 bits (98), Expect = 2e-05
 Identities = 27/89 (30%), Positives = 44/89 (49%), Gaps = 5/89 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTR 65
           Q+  G+ YL   +  +HRD+   N LV     IKI DFG+S  L       +    V   
Sbjct: 146 QIASGMKYLSSLN-FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPI 204

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
            +M+ E +    ++  SD+W+ G++L E+
Sbjct: 205 RWMAWECILMGKFTTASDVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.2 bits (94), Expect = 9e-05
 Identities = 36/119 (30%), Positives = 51/119 (42%), Gaps = 41/119 (34%)

Query: 10  QVLKGLTYLREKHA--IIHRDVKPSNILVNSG-GEIKICDFGVSGQL---IDSMANSFVG 63
           Q+L  L  L   H+  I+HRDVKP NI+ + G G  KI D G +  L   I+ +   F+ 
Sbjct: 263 QILFALDGL---HSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLL 319

Query: 64  TRSYMSPERLQGTHY--SVQS-------------------------DIWSLGLSLVEMA 95
              Y +PE+     Y  S Q+                         DI+S GL  ++MA
Sbjct: 320 DPRYAAPEQ-----YIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA 373

Length = 566

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 38.9 bits (91), Expect = 2e-04
 Identities = 24/87 (27%), Positives = 36/87 (41%), Gaps = 12/87 (13%)

Query: 9  FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYM 68
           Q L  L  L       HR  K  NIL     +  +   G         +        +M
Sbjct: 24 LQCLGALREL-------HRQAKSGNIL--LTWDGLLKLDGSVAFKTPEQSR---PDPYFM 71

Query: 69 SPERLQGTHYSVQSDIWSLGLSLVEMA 95
          +PE +QG  Y+ ++DI+SLG++L E  
Sbjct: 72 APEVIQGQSYTEKADIYSLGITLYEAL 98

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 38.8 bits (90), Expect = 3e-04
 Identities = 26/94 (27%), Positives = 42/94 (44%), Gaps = 10/94 (10%)

Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI---------DSMANSF 61
           +L  L Y+ E H I H D+KP NI+V+      I D+G++   I             +  
Sbjct: 135 MLTTLEYIHE-HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLH 193

Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
            GT  Y   +   G   + + D+ SLG  +++ A
Sbjct: 194 RGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA 227

Length = 294

>gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only]

 Score = 36.5 bits (85), Expect = 0.002
 Identities = 16/46 (34%), Positives = 21/46 (45%), Gaps = 4/46 (8%)

Query: 22  HAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVG 63
               H D  P NILV S G I + DFG+ G+L       +A   + 
Sbjct: 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKFRRYLAELLLA 329

Length = 517

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 35.3 bits (82), Expect = 0.003
 Identities = 13/31 (41%), Positives = 21/31 (67%), Gaps = 1/31 (3%)

Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSG 51
              IIH D+  SN+++ SGG+I + DFG++ 
Sbjct: 113 SAGIIHGDLTTSNMIL-SGGKIYLIDFGLAE 142

Length = 211

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	131
KOG0598|consensus	357		99.96
KOG0591|consensus	375		99.96
KOG0616|consensus	355		99.96
KOG0694|consensus	694		99.95
KOG0575|consensus	592		99.95
KOG0581|consensus	364		99.95
KOG0595|consensus	429		99.94
KOG0592|consensus	604		99.94
KOG0192|consensus	362		99.94
KOG0583|consensus	370		99.94
KOG0594|consensus	323		99.93
KOG0197|consensus	468		99.93
KOG0600|consensus	560		99.93
KOG0986|consensus	591		99.93
KOG0615|consensus	475		99.93
KOG0614|consensus	732		99.93
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.93
KOG0578|consensus	550		99.92
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.92
KOG0193|consensus	678		99.92
KOG0696|consensus	683		99.92
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.92
KOG0658|consensus	364		99.92
KOG0597|consensus	808		99.92
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.92
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.92
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.92
KOG0198|consensus	313		99.92
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.92
KOG0593|consensus	396		99.92
KOG0611|consensus	668		99.92
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.92
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.92
KOG0663|consensus	419		99.92
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.92
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.92
KOG0667|consensus	586		99.92
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.91
KOG0588|consensus	786		99.91
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.91
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.91
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.91
KOG0661|consensus	538		99.91
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.91
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.91
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.91
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.91
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.91
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.91
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.91
PHA02882	294	putative serine/threonine kinase; Provisional	99.91
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.91
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.91
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.91
PTZ00284	467	protein kinase; Provisional	99.91
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.91
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.91
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.91
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.91
KOG0033|consensus	355		99.91
KOG0585|consensus	576		99.91
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.91
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.91
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.91
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.91
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.91
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.91
KOG0983|consensus	391		99.91
KOG0660|consensus	359		99.91
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.91
KOG0659|consensus	318		99.91
KOG0605|consensus	550		99.91
PTZ00283	496	serine/threonine protein kinase; Provisional	99.91
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.91
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.91
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.9
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.9
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.9
KOG4721|consensus	904		99.9
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.9
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.9
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.9
PTZ00267	478	NIMA-related protein kinase; Provisional	99.9
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.9
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.9
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.9
KOG0690|consensus	516		99.9
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.9
PTZ00036	440	glycogen synthase kinase; Provisional	99.9
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.9
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.9
KOG0599|consensus	411		99.9
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.9
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.9
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.9
PHA03212	391	serine/threonine kinase US3; Provisional	99.9
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.9
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.9
KOG0984|consensus	282		99.9
PHA02988	283	hypothetical protein; Provisional	99.9
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.89
KOG0603|consensus	612		99.89
KOG0582|consensus	516		99.89
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.89
PHA03207	392	serine/threonine kinase US3; Provisional	99.89
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.89
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.89
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.89
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.89
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.89
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.89
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.89
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.89
PHA03210	501	serine/threonine kinase US3; Provisional	99.89
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.89
KOG0589|consensus	426		99.89
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.89
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.89
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.89
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.89
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.89
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.89
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.89
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.89
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.89
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.88
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.88
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.88
KOG0695|consensus	593		99.88
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.88
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.88
KOG0610|consensus	459		99.88
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.88
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.88
KOG0201|consensus	467		99.88
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.88
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.88
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.88
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.88
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.88
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.88
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.88
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.88
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.88
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.88
KOG1095|consensus	1025		99.88
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.87
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.87
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.87
KOG1187|consensus	361		99.87
KOG0612|consensus	1317		99.87
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.87
KOG0580|consensus	281		99.87
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.87
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.87
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.87
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.87
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.87
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.87
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.87
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.87
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.87
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.87
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.87
PHA03211	461	serine/threonine kinase US3; Provisional	99.87
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.87
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.87
PHA03209	357	serine/threonine kinase US3; Provisional	99.87
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.87
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.87
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.87
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.87
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.87
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.87
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.87
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.87
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.87
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.87
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.87
KOG0584|consensus	632		99.87
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.87
KOG4717|consensus	864		99.87
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.87
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.87
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.87
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.86
KOG0604|consensus	400		99.86
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.86
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.86
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.86
KOG1026|consensus	774		99.86
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.86
KOG0666|consensus	438		99.86
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.86
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.86
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.86
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.86
KOG0671|consensus	415		99.86
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.86
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.86
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.86
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.86
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.86
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.86
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.86
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.86
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.86
KOG0665|consensus	369		99.86
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.86
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.86
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.86
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.86
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.86
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.86
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.86
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.86
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.86
KOG0032|consensus	382		99.86
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.86
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.86
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.86
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.86
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.86
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.86
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.86
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.86
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.86
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.85
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.85
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.85
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.85
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.85
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.85
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.85
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.85
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.85
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.85
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.85
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.85
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.85
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.85
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.85
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.85
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.85
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.85
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.85
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.85
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.85
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.85
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.85
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.85
PLN00181	793	protein SPA1-RELATED; Provisional	99.85
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.85
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.85
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.85
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.85
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.85
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.85
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.85
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.85
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.85
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.85
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.85
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.85
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.85
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.85
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.85
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.85
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.85
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.85
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.85
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.85
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.85
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.85
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.84
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.84
KOG0664|consensus	449		99.84
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.84
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.84
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.84
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.84
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.84
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.84
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.84
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.84
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.84
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.84
KOG2345|consensus	302		99.84
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.84
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.84
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.84
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.84
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.84
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.84
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.84
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.84
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.84
KOG4279|consensus	1226		99.84
KOG4278|consensus	1157		99.84
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.84
KOG1989|consensus	738		99.84
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.84
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.84
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.84
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.84
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.84
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.84
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.84
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.84
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.84
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.84
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.84
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.84
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.83
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.83
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.83
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.83
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.83
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.83
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.83
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.83
PLN00009	294	cyclin-dependent kinase A; Provisional	99.83
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.83
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.83
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.83
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.83
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.83
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.83
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.83
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.83
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.83
KOG1035|consensus	1351		99.83
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.83
KOG0579|consensus	1187		99.83
KOG0669|consensus	376		99.83
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.83
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.83
KOG1006|consensus	361		99.83
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.83
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.83
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.83
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.83
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.83
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.83
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.83
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.83
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.83
KOG0577|consensus	948		99.83
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.82
KOG1024|consensus	563		99.82
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.82
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.82
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.82
KOG4250|consensus	732		99.82
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.82
KOG0668|consensus	338		99.82
KOG4645|consensus	1509		99.82
KOG0596|consensus	677		99.82
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.82
KOG4236|consensus	888		99.82
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.82
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.82
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.82
KOG0608|consensus	1034		99.82
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.82
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.82
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.82
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.82
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.81
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.81
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.81
KOG0194|consensus	474		99.81
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.81
KOG0586|consensus	596		99.81
KOG0607|consensus	463		99.81
KOG0200|consensus	609		99.81
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.81
KOG0662|consensus	292		99.81
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.81
KOG0670|consensus	752		99.81
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.81
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.81
KOG0196|consensus	996		99.8
KOG0199|consensus	1039		99.79
KOG1152|consensus	772		99.79
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.79
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.79
KOG3653|consensus	534		99.77
KOG1025|consensus	1177		99.76
KOG0574|consensus	502		99.76
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.76
KOG1151|consensus	775		99.76
KOG4257|consensus	974		99.76
KOG1094|consensus	807		99.75
KOG1027|consensus	903		99.74
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.73
KOG2052|consensus	513		99.72
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.72
KOG1345|consensus	378		99.69
KOG0587|consensus	953		99.68
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.66
KOG1165|consensus	449		99.66
KOG1164|consensus	322		99.65
KOG1290|consensus	590		99.63
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.6
KOG1167|consensus	418		99.59
KOG1163|consensus	341		99.59
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.58
KOG0590|consensus	601		99.57
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.52
KOG0606|consensus	1205		99.5
KOG0603|consensus	612		99.48
KOG1033|consensus	516		99.39
KOG0576|consensus	829		99.37
KOG1240|consensus	1431		99.35
KOG4158|consensus	598		99.35
PRK09188	365	serine/threonine protein kinase; Provisional	99.24
PRK12274	218	serine/threonine protein kinase; Provisional	99.23
KOG1023|consensus	484		99.21
KOG0195|consensus	448		99.17
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.1
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.08
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.06
KOG1166|consensus	974		99.05
smart00090	237	RIO RIO-like kinase.	98.87
COG4248	637	Uncharacterized protein with protein kinase and he	98.85
KOG0590|consensus	601		98.83
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	98.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	98.8
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.74
PRK14879	211	serine/threonine protein kinase; Provisional	98.62
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	98.62
PRK09605	535	bifunctional UGMP family protein/serine/threonine	98.56
PRK10345	210	hypothetical protein; Provisional	98.55
KOG1243|consensus	690		98.45
KOG2137|consensus	700		98.41
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.26
KOG1266|consensus	458		98.2
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.15
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.07
KOG0606|consensus	1205		98.03
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.03
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.01
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.0
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	97.88
KOG0601|consensus	524		97.82
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	97.65
PRK09902	216	hypothetical protein; Provisional	97.57
KOG0601|consensus	524		97.52
KOG3087|consensus	229		97.44
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.24
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.24
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	97.18
KOG3741|consensus	655		95.93
COG0661	517	AarF Predicted unusual protein kinase [General fun	95.77
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	95.7
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	95.34
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.15
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	95.1
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.97
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	94.87
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.75
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	94.67
PRK05231	319	homoserine kinase; Provisional	94.4
PF01636	239	APH: Phosphotransferase enzyme family This family	94.23
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	94.08
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	93.85
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	93.75
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	93.61
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	93.41
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	93.39
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	93.33
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	93.29
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	93.19
KOG2268|consensus	465		93.03
PRK10271	188	thiK thiamine kinase; Provisional	92.86
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	91.43
COG2334	331	Putative homoserine kinase type II (protein kinase	91.34
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	91.21
PLN02236	344	choline kinase	90.71
KOG1235|consensus	538		90.58
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	89.98
KOG1035|consensus	1351		89.39
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	87.37
PRK09550	401	mtnK methylthioribose kinase; Reviewed	86.44
KOG0576|consensus	829		86.35
PRK06148	1013	hypothetical protein; Provisional	86.34
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	86.23
PRK11768	325	serine/threonine protein kinase; Provisional	85.88
PRK12396	409	5-methylribose kinase; Reviewed	84.38
PHA03111	444	Ser/Thr kinase; Provisional	83.86
KOG1826|consensus	2724		83.42
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	83.11
PRK06149	972	hypothetical protein; Provisional	82.36
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	81.34

>KOG0598|consensus

Probab=99.96  E-value=8.8e-30  Score=174.96  Aligned_cols=114  Identities=36%  Similarity=0.610  Sum_probs=102.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      .++..+..|+.||.|||++ ||+||||+|+||+++..|.++++|||+++....  ..+.+..||+.|+|||++.+.+++.
T Consensus       126 ~arfYlaEi~lAL~~LH~~-gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~  204 (357)
T KOG0598|consen  126 RARFYLAEIVLALGYLHSK-GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDK  204 (357)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCc
Confidence            4778899999999999998 899999999999999999999999999986543  3566789999999999999999999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR  117 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  117 (131)
                      .+|+||+|+++|+|++|..||...+.....+.+.+..
T Consensus       205 ~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k  241 (357)
T KOG0598|consen  205 AVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK  241 (357)
T ss_pred             ccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc
Confidence            9999999999999999999999988777766655544

>KOG0591|consensus

Probab=99.96  E-value=4.5e-29  Score=167.30  Aligned_cols=121  Identities=34%  Similarity=0.482  Sum_probs=107.0

Q ss_pred             CchhHHHHHHHHHHHHHHh--c-CCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCC
Q psy17559          2 KQVPYSSFQVLKGLTYLRE--K-HAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT   76 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~--~-~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~   76 (131)
                      +++++++.|++.||..||+  . ..++||||+|.|||++.+|.+|++|||+++.....  ...+.+||+.|++||.+...
T Consensus       124 ~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~  203 (375)
T KOG0591|consen  124 KTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHES  203 (375)
T ss_pred             HHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcC
Confidence            3688999999999999999  3 23999999999999999999999999999776543  44567999999999999999


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCCCCCCCCc
Q psy17559         77 HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYW  122 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  122 (131)
                      +|+.++|+||+||++|||..-+.||.+++..++.+.+.+......+
T Consensus       204 ~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p  249 (375)
T KOG0591|consen  204 GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP  249 (375)
T ss_pred             CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc
Confidence            9999999999999999999999999999998888888777555444

>KOG0616|consensus

Probab=99.96  E-value=9.4e-29  Score=166.39  Aligned_cols=109  Identities=30%  Similarity=0.568  Sum_probs=99.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .++..+.|++.|++|||+. ++++|||+|+|+++|++|.+|+.|||.++..... +.+..|++.|+|||++...++..++
T Consensus       145 ~arFYAAeivlAleylH~~-~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-T~TlCGTPeYLAPEii~sk~ynkav  222 (355)
T KOG0616|consen  145 HARFYAAEIVLALEYLHSL-DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-TWTLCGTPEYLAPEIIQSKGYNKAV  222 (355)
T ss_pred             hHHHHHHHHHHHHHHHHhc-CeeeccCChHHeeeccCCcEEEEeccceEEecCc-EEEecCCccccChHHhhcCCCCcch
Confidence            4678899999999999998 7999999999999999999999999999887665 7788999999999999999999999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      |+||||+++|||+.|..||...+...+.+.+
T Consensus       223 DWWalGVLIYEMlaG~pPF~~~~~~~iY~KI  253 (355)
T KOG0616|consen  223 DWWALGVLIYEMLAGYPPFYDDNPIQIYEKI  253 (355)
T ss_pred             hHHHHHHHHHHHHcCCCCCcCCChHHHHHHH
Confidence            9999999999999999999988876555544

>KOG0694|consensus

Probab=99.95  E-value=3.5e-28  Score=177.61  Aligned_cols=110  Identities=33%  Similarity=0.634  Sum_probs=100.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++..++.++.||.|||++ ||+||||+.+||++|..|.+|++|||++++..  ...+.++.||+.|+|||++.+..|+.
T Consensus       469 rarfyaAev~l~L~fLH~~-~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~  547 (694)
T KOG0694|consen  469 RARFYAAEVVLGLQFLHEN-GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTR  547 (694)
T ss_pred             HHHHHHHHHHHHHHHHHhc-CceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccc
Confidence            4678899999999999997 89999999999999999999999999998653  45678899999999999999999999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+|+||+++|||+.|+.||.+.+.+++-.-+
T Consensus       548 aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI  580 (694)
T KOG0694|consen  548 AVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI  580 (694)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999988887665543

>KOG0575|consensus

Probab=99.95  E-value=5.7e-28  Score=174.54  Aligned_cols=112  Identities=33%  Similarity=0.544  Sum_probs=100.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.+.+||+.|+.|||+. +|+||||+..|+|++++.++|++|||++....  .....+..||+.|.|||++...+.+.
T Consensus       119 Eary~l~QIv~GlkYLH~~-~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsf  197 (592)
T KOG0575|consen  119 EARYFLRQIVEGLKYLHSL-GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSF  197 (592)
T ss_pred             HHHHHHHHHHHHHHHHHhc-CceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCC
Confidence            5789999999999999997 79999999999999999999999999997654  24567889999999999999999999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~  115 (131)
                      .+|+||+||++|.++.|+.||+..+.++....+..
T Consensus       198 EvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~  232 (592)
T KOG0575|consen  198 EVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL  232 (592)
T ss_pred             chhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh
Confidence            99999999999999999999998887766665543

>KOG0581|consensus

Probab=99.95  E-value=4.9e-28  Score=166.56  Aligned_cols=101  Identities=66%  Similarity=1.159  Sum_probs=94.3

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcch
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD   83 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~d   83 (131)
                      +-.++++++.||.|||+.+.|+||||||.|+++..+|.+|++|||++.....+...+++||..||+||.+.+..|+.++|
T Consensus       180 L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sD  259 (364)
T KOG0581|consen  180 LGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSD  259 (364)
T ss_pred             HHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccc
Confidence            45789999999999997457999999999999999999999999999888777788999999999999999999999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCC
Q psy17559         84 IWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        84 ~~slg~~l~~l~~g~~p~~~~  104 (131)
                      +||||+.++|+..|+.||...
T Consensus       260 IWSLGLsllE~a~GrfP~~~~  280 (364)
T KOG0581|consen  260 IWSLGLSLLELAIGRFPYPPP  280 (364)
T ss_pred             eecccHHHHHHhhCCCCCCCc
Confidence            999999999999999999764

>KOG0595|consensus

Probab=99.94  E-value=2.3e-27  Score=165.02  Aligned_cols=110  Identities=34%  Similarity=0.570  Sum_probs=97.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC------CcEEEeecccccccccc-cccCCCCccceeCcccccC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG------GEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQG   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~------~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~   75 (131)
                      +++.++.|++.||++||++ +|+||||+|.||+++.+      -.+|++|||+++..... ...+..|++-|||||++..
T Consensus       110 t~r~Fm~QLA~alq~L~~~-~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~  188 (429)
T KOG0595|consen  110 TARHFMQQLASALQFLHEN-NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMS  188 (429)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHh
Confidence            5788999999999999998 69999999999999864      34799999999887643 4567889999999999999


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ..|+.++|+||+|+++|++++|..||......++..-+
T Consensus       189 ~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~  226 (429)
T KOG0595|consen  189 QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI  226 (429)
T ss_pred             ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence            99999999999999999999999999988877666544

>KOG0592|consensus

Probab=99.94  E-value=4.3e-27  Score=168.47  Aligned_cols=103  Identities=41%  Similarity=0.680  Sum_probs=91.1

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---------------cccCCCCcccee
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---------------MANSFVGTRSYM   68 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---------------~~~~~~~~~~~~   68 (131)
                      ++..+.||+.|++|||+. |||||||+|+|||+|.++.++++|||.++...+.               ....++||..|.
T Consensus       176 aR~YAAeIldAleylH~~-GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYV  254 (604)
T KOG0592|consen  176 ARFYAAEILDALEYLHSN-GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYV  254 (604)
T ss_pred             HHHHHHHHHHHHHHHHhc-CceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeeccc
Confidence            577899999999999997 8999999999999999999999999988654321               114578999999


Q ss_pred             CcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         69 SPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        69 ~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +||++.....++++|+|+|||++|+|++|+.||.+.+.-
T Consensus       255 SPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney  293 (604)
T KOG0592|consen  255 SPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY  293 (604)
T ss_pred             CHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH
Confidence            999999999999999999999999999999999866644

>KOG0192|consensus

Probab=99.94  E-value=4.6e-27  Score=165.77  Aligned_cols=109  Identities=35%  Similarity=0.593  Sum_probs=94.1

Q ss_pred             CchhHHHHHHHHHHHHHHhcCC-cEecCCCCCcEEEecCC-cEEEeeccccccccc--ccccCCCCccceeCccccc--C
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHA-IIHRDVKPSNILVNSGG-EIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQ--G   75 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~-~~h~~l~~~~il~~~~~-~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~--~   75 (131)
                      ..+..++.|++.||.|||++ + |+||||++.|++++.+. .+||+|||+++....  .......||..|+|||++.  .
T Consensus       142 ~~~l~~aldiArGm~YLH~~-~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~  220 (362)
T KOG0192|consen  142 KVRLRIALDIARGMEYLHSE-GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEK  220 (362)
T ss_pred             HHHHHHHHHHHHHHHHHhcC-CCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCC
Confidence            35678999999999999997 7 99999999999999997 999999999976554  2233368899999999999  5


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      ..++.++|+||||+++||+++|..||.......+..
T Consensus       221 ~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~  256 (362)
T KOG0192|consen  221 SPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVAS  256 (362)
T ss_pred             CcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            689999999999999999999999998777643333

>KOG0583|consensus

Probab=99.94  E-value=6.5e-27  Score=165.85  Aligned_cols=110  Identities=33%  Similarity=0.629  Sum_probs=97.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC-CcEEEeeccccccc--ccccccCCCCccceeCcccccCCC-C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG-GEIKICDFGVSGQL--IDSMANSFVGTRSYMSPERLQGTH-Y   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~-~~~~l~d~g~~~~~--~~~~~~~~~~~~~~~~Pe~~~~~~-~   78 (131)
                      +++.+++|++.|++|||++ |++||||+++|++++.+ +++|++|||++...  ......+..|++.|+|||++.+.. |
T Consensus       121 ~ar~~F~Qlisav~y~H~~-gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y  199 (370)
T KOG0583|consen  121 EARKYFRQLISAVAYCHSR-GIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTY  199 (370)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCc
Confidence            5778999999999999997 89999999999999999 99999999999766  345677889999999999999876 7


Q ss_pred             C-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         79 S-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~-~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      + .++|+||+|+++|.|++|..||...+...+...+
T Consensus       200 ~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki  235 (370)
T KOG0583|consen  200 SGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI  235 (370)
T ss_pred             CCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            5 8899999999999999999999986665555543

>KOG0594|consensus

Probab=99.93  E-value=4.8e-26  Score=155.96  Aligned_cols=103  Identities=36%  Similarity=0.570  Sum_probs=91.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc-c-ccccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-D-SMANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~-~-~~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      .++.+++|++.|++|||++ +|+||||+|.|++++++|.+|++|||+++... + ....+.+.+..|+|||++.+. .|+
T Consensus       121 ~ik~~m~Qll~gl~~~H~~-~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys  199 (323)
T KOG0594|consen  121 LIKSFMRQLLRGLAFLHSH-GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYS  199 (323)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCC
Confidence            4789999999999999997 89999999999999999999999999997554 2 235566788899999999886 699


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      ..+|+||+||++.||++++.-|.+...
T Consensus       200 ~~vDiWs~GcIfaEm~~~~~LFpG~se  226 (323)
T KOG0594|consen  200 TSVDIWSLGCIFAEMFTRRPLFPGDSE  226 (323)
T ss_pred             CCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence            999999999999999999998975553

>KOG0197|consensus

Probab=99.93  E-value=1.6e-26  Score=164.70  Aligned_cols=114  Identities=30%  Similarity=0.462  Sum_probs=98.8

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCC---CccceeCcccccCCCC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHY   78 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~---~~~~~~~Pe~~~~~~~   78 (131)
                      .+.+.++.||++|++||.++ .+|||||.+.|||++++..+|++|||+++...+.......   -...|+|||.+....+
T Consensus       303 ~~Ll~~a~qIaeGM~YLes~-~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~F  381 (468)
T KOG0197|consen  303 PQLLDFAAQIAEGMAYLESK-NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKF  381 (468)
T ss_pred             HHHHHHHHHHHHHHHHHHhC-CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCc
Confidence            46788999999999999998 6999999999999999999999999999955443322222   2457999999999999


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  116 (131)
                      +.++|+||||+++||+++ |+.|+.+....++.+.+...
T Consensus       382 S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G  420 (468)
T KOG0197|consen  382 SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG  420 (468)
T ss_pred             ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc
Confidence            999999999999999987 99999999999999888544

>KOG0600|consensus

Probab=99.93  E-value=4.2e-26  Score=162.28  Aligned_cols=121  Identities=36%  Similarity=0.572  Sum_probs=100.4

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCC-C
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT-H   77 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~-~   77 (131)
                      .+++.++.|++.||.|||++ |++||||+..|||+|.+|.+|++|||+++.+...   .....+-|.+|++||++.+. .
T Consensus       218 ~qIKc~mkQLl~Gl~~cH~~-gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~  296 (560)
T KOG0600|consen  218 PQIKCYMKQLLEGLEYCHSR-GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATS  296 (560)
T ss_pred             HHHHHHHHHHHHHHHHHhhc-CeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcc
Confidence            46889999999999999998 8999999999999999999999999999855432   34556778999999999985 6


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhCC--CCCCCCcc
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPD-AKTLAAIFGP--SRGDGYWH  123 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~-~~~~~~~~~~--~~~~~~~~  123 (131)
                      |+..+|+||.||++.||+.|+.+|++.. .+++..++..  ...+.||+
T Consensus       297 Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~  345 (560)
T KOG0600|consen  297 YGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP  345 (560)
T ss_pred             cccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence            9999999999999999999999998665 3444444432  22444777

>KOG0986|consensus

Probab=99.93  E-value=2.9e-26  Score=161.87  Aligned_cols=104  Identities=33%  Similarity=0.572  Sum_probs=93.8

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++++..+.+|+.||++||.+ +|++||++|.||++|+.|.++++|+|++...... .....+||..|||||++....|+.
T Consensus       287 ~ra~FYAAEi~cGLehlH~~-~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~  365 (591)
T KOG0986|consen  287 QRARFYAAEIICGLEHLHRR-RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDF  365 (591)
T ss_pred             HHHHHHHHHHHhhHHHHHhc-ceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccC
Confidence            46788899999999999998 7999999999999999999999999999877654 344559999999999999989999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      ++|+|++||++|+|+.|+.||.....
T Consensus       366 s~Dwf~lGCllYemi~G~sPFr~~Ke  391 (591)
T KOG0986|consen  366 SPDWFSLGCLLYEMIAGHSPFRQRKE  391 (591)
T ss_pred             CccHHHHHhHHHHHHcccCchhhhhh
Confidence            99999999999999999999975543

>KOG0615|consensus

Probab=99.93  E-value=7.1e-27  Score=162.96  Aligned_cols=113  Identities=34%  Similarity=0.492  Sum_probs=94.3

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC---CcEEEeecccccccc-cccccCCCCccceeCcccccCCCC-
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG---GEIKICDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHY-   78 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~---~~~~l~d~g~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~-   78 (131)
                      -+.+++|++.|+.|||+. ||+||||+|+||++..+   ..+|++|||+++..+ .....+..||+.|.|||++.+..+ 
T Consensus       278 ~K~~f~Qll~avkYLH~~-GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~  356 (475)
T KOG0615|consen  278 GKLLFKQLLTAVKYLHSQ-GIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVE  356 (475)
T ss_pred             hHHHHHHHHHHHHHHHHc-CcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCee
Confidence            467899999999999997 99999999999999866   458999999998765 346778899999999999987543 


Q ss_pred             --CCcchHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhCCCC
Q psy17559         79 --SVQSDIWSLGLSLVEMAIGMYPIPPPDAKT-LAAIFGPSR  117 (131)
Q Consensus        79 --~~~~d~~slg~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~  117 (131)
                        ..++|+||+||++|-+++|..||+..-.+. +.+.+.+..
T Consensus       357 ~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~  398 (475)
T KOG0615|consen  357 YYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR  398 (475)
T ss_pred             cccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc
Confidence              357899999999999999999998655544 555555443

>KOG0614|consensus

Probab=99.93  E-value=1.4e-25  Score=160.39  Aligned_cols=115  Identities=28%  Similarity=0.482  Sum_probs=104.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc-cccccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      +.+.++..+++|++|||++ +|++|||+|.|.+++.+|.+|+.|||+++..+ ..+++++.|++.|.|||++...+.+.+
T Consensus       521 tarF~~acv~EAfeYLH~k-~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~a  599 (732)
T KOG0614|consen  521 TARFYVACVLEAFEYLHRK-GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRA  599 (732)
T ss_pred             hhhhhHHHHHHHHHHHHhc-CceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchh
Confidence            4667888899999999998 89999999999999999999999999998875 457889999999999999999999999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCCCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRG  118 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  118 (131)
                      +|.||||++++|+++|..||++.++-...+++.+...
T Consensus       600 vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid  636 (732)
T KOG0614|consen  600 VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID  636 (732)
T ss_pred             hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh
Confidence            9999999999999999999999998887777665543

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.93  E-value=3.6e-25  Score=156.84  Aligned_cols=110  Identities=32%  Similarity=0.556  Sum_probs=92.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--------------------------
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--------------------------   56 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--------------------------   56 (131)
                      +++.++.|++.||+|||++ |++||||+|.||+++.++.++++|||++......                          
T Consensus       102 ~~~~~~~qi~~aL~~lH~~-givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (363)
T cd05628         102 ETQFYIAETVLAIDSIHQL-GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR  180 (363)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccccccccccccccccccc
Confidence            4678899999999999997 8999999999999999999999999987543210                          


Q ss_pred             -----------cccCCCCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         57 -----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        57 -----------~~~~~~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                                 ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+....+..+.+
T Consensus       181 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i  248 (363)
T cd05628         181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKV  248 (363)
T ss_pred             ccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                       012346888999999998888999999999999999999999999877766555443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0578|consensus

Probab=99.92  E-value=3.6e-25  Score=159.00  Aligned_cols=112  Identities=34%  Similarity=0.612  Sum_probs=97.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..|+++++.||+|||.+ ||+||||+++||+++.+|.+|++|||++.....  .+..+.+|++.|+|||+.....|+.
T Consensus       370 qIA~Icre~l~aL~fLH~~-gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~  448 (550)
T KOG0578|consen  370 QIAAICREILQGLKFLHAR-GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGP  448 (550)
T ss_pred             HHHHHHHHHHHHHHHHHhc-ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCc
Confidence            5678999999999999997 899999999999999999999999999876543  3566789999999999999999999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~  115 (131)
                      ++||||||+.++||+.|+.||-..+.-....++..
T Consensus       449 KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~  483 (550)
T KOG0578|consen  449 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT  483 (550)
T ss_pred             cccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh
Confidence            99999999999999999999986665444444433

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.92  E-value=3.9e-25  Score=154.44  Aligned_cols=110  Identities=32%  Similarity=0.571  Sum_probs=94.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.|||+. +++||||+|.||+++.++.++++|||++....  ........+++.|+|||.+.+..++.
T Consensus       102 ~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  180 (323)
T cd05616         102 HAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK  180 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCC
Confidence            4677899999999999997 89999999999999999999999999886432  22233456788999999999888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|+.||...+.+++.+.+
T Consensus       181 ~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i  213 (323)
T cd05616         181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI  213 (323)
T ss_pred             ccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999887766655544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0193|consensus

Probab=99.92  E-value=7.5e-26  Score=163.85  Aligned_cols=113  Identities=27%  Similarity=0.469  Sum_probs=96.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccc----cccccccCCCCccceeCcccccC---
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ----LIDSMANSFVGTRSYMSPERLQG---   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~----~~~~~~~~~~~~~~~~~Pe~~~~---   75 (131)
                      +...|++|++.|+.|||.+ +|+||||++.|||+.++++|+++|||++..    .+........+...|+|||+++.   
T Consensus       489 ~~idIAqQiaqGM~YLHAK-~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~  567 (678)
T KOG0193|consen  489 TTIDIAQQIAQGMDYLHAK-NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDD  567 (678)
T ss_pred             HHHHHHHHHHHhhhhhhhh-hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhccc
Confidence            5678999999999999998 699999999999999999999999999742    23344566778889999999975   


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCCC
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~~  116 (131)
                      .+|+..+||||||+++|||++|..||.....+.+.-+++..
T Consensus       568 nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG  608 (678)
T KOG0193|consen  568 NPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG  608 (678)
T ss_pred             CCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc
Confidence            46899999999999999999999999966666665555443

>KOG0696|consensus

Probab=99.92  E-value=5.7e-25  Score=154.54  Aligned_cols=111  Identities=32%  Similarity=0.528  Sum_probs=100.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccc--ccccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~--~~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      .+...+..|+.||-+||++ ||++|||+.+|++++..|.++++|||.+++.  ....+.++.|++.|+|||++.+.+|+.
T Consensus       451 ~AvFYAaEiaigLFFLh~k-gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgk  529 (683)
T KOG0696|consen  451 VAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGK  529 (683)
T ss_pred             hhhhhhHHHHHHhhhhhcC-CeeeeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEeccccc
Confidence            3567789999999999998 8999999999999999999999999999765  344677889999999999999999999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~  114 (131)
                      ++|+||+|+++|||+.|+.||.+.+.+++-+.+.
T Consensus       530 svDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~  563 (683)
T KOG0696|consen  530 SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM  563 (683)
T ss_pred             chhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            9999999999999999999999999888776553

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.92  E-value=3.1e-25  Score=154.96  Aligned_cols=110  Identities=30%  Similarity=0.597  Sum_probs=94.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||+|||+. |++||||+|.||+++.++.++++|||+++....  .......+++.|+|||.+.+..++.
T Consensus        96 ~~~~~~~qi~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  174 (323)
T cd05571          96 RARFYGAEIVSALGYLHSC-DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR  174 (323)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCc
Confidence            4567889999999999997 899999999999999999999999999865322  2233456888999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|+|++|..||...+.+.....+
T Consensus       175 ~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~  207 (323)
T cd05571         175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI  207 (323)
T ss_pred             cccCcccchhhhhhhcCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999887766655544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0658|consensus

Probab=99.92  E-value=3.7e-25  Score=152.20  Aligned_cols=114  Identities=33%  Similarity=0.684  Sum_probs=95.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec-CCcEEEeecccccccccc-cccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~-~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      .++....|+..||+|||+. ||.||||+|.|+++|. .|.+|++|||.++....+ ...+-..+..|+|||.+.+. .|+
T Consensus       126 ~iKLYt~Qlfrgl~yLh~~-~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt  204 (364)
T KOG0658|consen  126 EIKLYTYQLFRGLAYLHSH-GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT  204 (364)
T ss_pred             eeHHHHHHHHHHHHHHHhc-CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccC
Confidence            5678899999999999995 8999999999999995 588999999999876543 33445677889999999885 699


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHhCCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAK----TLAAIFGPSR  117 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~  117 (131)
                      .+.|+||.||++.||+-|+..|++....    ++.++++...
T Consensus       205 ~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt  246 (364)
T KOG0658|consen  205 TSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT  246 (364)
T ss_pred             ceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999876643    4445555444

>KOG0597|consensus

Probab=99.92  E-value=2.8e-25  Score=160.48  Aligned_cols=112  Identities=36%  Similarity=0.659  Sum_probs=99.1

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +.+..++.|++.||.|||+. +|+|||++|.||+++.++.+|++|||+++-+...  ......|++.|+|||...+..|+
T Consensus       100 e~v~~~a~~LVsaL~yLhs~-rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd  178 (808)
T KOG0597|consen  100 EQVRAIAYDLVSALYYLHSN-RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYD  178 (808)
T ss_pred             HHHHHHHHHHHHHHHHHHhc-CcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCcc
Confidence            35788999999999999997 7999999999999999999999999999876543  34566899999999999999999


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~  114 (131)
                      ..+|+||+||++||++.|+.||-......+++.+.
T Consensus       179 ~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~  213 (808)
T KOG0597|consen  179 HTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL  213 (808)
T ss_pred             chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh
Confidence            99999999999999999999998777666666554

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.92  E-value=6.9e-25  Score=153.61  Aligned_cols=110  Identities=31%  Similarity=0.606  Sum_probs=93.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||+|||++ +++||||+|.||+++.++.++++|||++.....  .......+++.|+|||.+.+..++.
T Consensus        96 ~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  174 (328)
T cd05593          96 RTRFYGAEIVSALDYLHSG-KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR  174 (328)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCc
Confidence            4677899999999999997 899999999999999999999999999865322  2223456888999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|..||...+..+..+.+
T Consensus       175 ~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~  207 (328)
T cd05593         175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI  207 (328)
T ss_pred             cCCccccchHHHHHhhCCCCCCCCCHHHHHHHh
Confidence            999999999999999999999877766555444

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.92  E-value=9.4e-25  Score=152.56  Aligned_cols=110  Identities=32%  Similarity=0.571  Sum_probs=93.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++.++++|||++....  ........++..|+|||.+.+..++.
T Consensus       102 ~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  180 (324)
T cd05587         102 HAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGK  180 (324)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCc
Confidence            4567899999999999997 89999999999999999999999999876432  22223456788999999999888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|+.||...+..+..+.+
T Consensus       181 ~~DiwslGvil~elltG~~pf~~~~~~~~~~~i  213 (324)
T cd05587         181 SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI  213 (324)
T ss_pred             ccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999877766555544

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.92  E-value=9.6e-25  Score=152.15  Aligned_cols=110  Identities=36%  Similarity=0.673  Sum_probs=93.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||+|||+. +++||||++.||+++.++.++++|||++....  ........++..|++||.+.+..++.
T Consensus        97 ~~~~~~~qi~~al~~LH~~-~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  175 (316)
T cd05592          97 RARFYAAEIICGLQFLHKK-GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE  175 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCC
Confidence            4567899999999999997 89999999999999999999999999986432  22233456788999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|+|++|..||.+.+.++....+
T Consensus       176 ~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i  208 (316)
T cd05592         176 SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI  208 (316)
T ss_pred             cccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999877766555443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0198|consensus

Probab=99.92  E-value=2.1e-25  Score=154.04  Aligned_cols=101  Identities=41%  Similarity=0.674  Sum_probs=87.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec-CCcEEEeeccccccccc-----ccccCCCCccceeCcccccCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLID-----SMANSFVGTRSYMSPERLQGT   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~-~~~~~l~d~g~~~~~~~-----~~~~~~~~~~~~~~Pe~~~~~   76 (131)
                      .++...+|++.||+|||++ |++|+||++.||+++. ++.+|++|||.+.....     .......|++.|+|||++...
T Consensus       118 ~v~~ytr~iL~GL~ylHs~-g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g  196 (313)
T KOG0198|consen  118 LVRRYTRQILEGLAYLHSK-GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNG  196 (313)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCC
Confidence            5788999999999999987 8999999999999999 79999999998865542     223457899999999999853


Q ss_pred             -CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         77 -HYSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        77 -~~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                       .....+|+||+||++.||++|..||...
T Consensus       197 ~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~  225 (313)
T KOG0198|consen  197 EVARRESDIWSLGCTVVEMLTGKPPWSEF  225 (313)
T ss_pred             CcCCccchhhhcCCEEEeccCCCCcchhh
Confidence             3445999999999999999999999863

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.92  E-value=1e-24  Score=152.37  Aligned_cols=110  Identities=30%  Similarity=0.620  Sum_probs=93.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||.|||++ |++|+||++.||+++.++.++++|||++.....  .......+++.|+|||.+.+..++.
T Consensus        96 ~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  174 (323)
T cd05595          96 RARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR  174 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCc
Confidence            4678899999999999997 899999999999999999999999998764322  1223456888999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|..||...+.+...+..
T Consensus       175 ~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~  207 (323)
T cd05595         175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI  207 (323)
T ss_pred             hhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999877766554443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0593|consensus

Probab=99.92  E-value=4.2e-25  Score=149.54  Aligned_cols=102  Identities=36%  Similarity=0.652  Sum_probs=90.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc-cc-cccCCCCccceeCcccccC-CCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-DS-MANSFVGTRSYMSPERLQG-THYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~-~~-~~~~~~~~~~~~~Pe~~~~-~~~~   79 (131)
                      .++.+++|++.|+.|||+. +++||||+|+||++..+|.+|++|||+++... ++ .....+.|.+|+|||.+.+ .+|+
T Consensus       102 ~vk~~l~Q~l~ai~~cHk~-n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG  180 (396)
T KOG0593|consen  102 LVKKYLYQLLKAIHFCHKN-NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYG  180 (396)
T ss_pred             HHHHHHHHHHHHhhhhhhc-CeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCC
Confidence            4678999999999999997 69999999999999999999999999998765 33 3345577889999999998 5799


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ..+|+||+||++.||++|..-|++..
T Consensus       181 ~pVDiWAiGCv~aEl~~G~pL~PG~S  206 (396)
T KOG0593|consen  181 KPVDIWAIGCVFAELLTGEPLWPGRS  206 (396)
T ss_pred             CcccchhhhHHHHHHhcCCcCCCCcc
Confidence            99999999999999999999997654

>KOG0611|consensus

Probab=99.92  E-value=3.3e-25  Score=155.44  Aligned_cols=125  Identities=31%  Similarity=0.539  Sum_probs=107.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-ccccCCCCccceeCcccccCCCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHY-SV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~-~~   80 (131)
                      +++.+++||+.|+.|||.+ +++||||+..||++|.|+++|++|||++..+.. ....++.|++.|.+||++.+.+| ++
T Consensus       154 EaRhfFRQIvSAVhYCHkn-rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GP  232 (668)
T KOG0611|consen  154 EARHFFRQIVSAVHYCHKN-RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGP  232 (668)
T ss_pred             HHHHHHHHHHHHHHHHhhc-cceecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCC
Confidence            5789999999999999987 799999999999999999999999999877654 45678899999999999999876 58


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCCCCCCCCcccccCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYWHVSYPTTGC  131 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c  131 (131)
                      .+|.||||+++|.++.|.+||.+.+-..+++.   +..+.|.+-.-|++.|
T Consensus       233 EVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQ---Is~GaYrEP~~PSdA~  280 (668)
T KOG0611|consen  233 EVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQ---ISRGAYREPETPSDAS  280 (668)
T ss_pred             ccchhhHHHHHHHHhhcccccCCchHHHHHHH---hhcccccCCCCCchHH
Confidence            89999999999999999999999987665554   4555566655665544

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.92  E-value=2.1e-24  Score=151.23  Aligned_cols=113  Identities=83%  Similarity=1.289  Sum_probs=98.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .+..++.|++.++.|||++.+++|+||++.||+++.++.++++|||++............++..|++||.+.+..++.++
T Consensus       104 ~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~  183 (331)
T cd06649         104 ILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS  183 (331)
T ss_pred             HHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccccCCCCcCcCCHhHhcCCCCCchH
Confidence            35678999999999999865699999999999999999999999999876544444455688899999999888899999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCC
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~  115 (131)
                      |+||+|+++|++++|+.||...+..++...+..
T Consensus       184 DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~  216 (331)
T cd06649         184 DIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR  216 (331)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence            999999999999999999998887777766654

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.92  E-value=1e-24  Score=152.20  Aligned_cols=110  Identities=31%  Similarity=0.577  Sum_probs=94.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||+|||++ +++|+||+|.||+++.++.++++|||++....  ........+++.|+|||.+.+..++.
T Consensus        97 ~~~~~~~ql~~~L~~lH~~-~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  175 (320)
T cd05590          97 RARFYAAEITSALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP  175 (320)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCC
Confidence            4567899999999999997 89999999999999999999999999876432  22233456888999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|..||...+..+..+.+
T Consensus       176 ~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i  208 (320)
T cd05590         176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI  208 (320)
T ss_pred             ccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999888776655544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0663|consensus

Probab=99.92  E-value=8.1e-25  Score=149.67  Aligned_cols=115  Identities=32%  Similarity=0.509  Sum_probs=97.1

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCC-CC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT-HY   78 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~-~~   78 (131)
                      .+++.++.|++.|++|||.. +|+||||++.|+++...|.+|++|||+++.++..  .....+-|..|+|||.+.+. .|
T Consensus       177 ~evK~L~~QlL~glk~lH~~-wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~ty  255 (419)
T KOG0663|consen  177 GEVKTLMLQLLRGLKHLHDN-WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTY  255 (419)
T ss_pred             HHHHHHHHHHHHHHHHHhhc-eeEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCccc
Confidence            46889999999999999997 7999999999999999999999999999988754  34456778899999999885 69


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCC-HHHH---HHHhCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPD-AKTL---AAIFGPSR  117 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~-~~~~---~~~~~~~~  117 (131)
                      +.++|+||+||++.|++.+..-|++.. .+++   -++++...
T Consensus       256 st~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPt  298 (419)
T KOG0663|consen  256 STAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPS  298 (419)
T ss_pred             CcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCc
Confidence            999999999999999999998887554 3333   34444443

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.92  E-value=1.4e-24  Score=151.26  Aligned_cols=110  Identities=37%  Similarity=0.682  Sum_probs=93.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||+|||+. |++||||+|.||+++.++.++++|||++....  ........++..|+|||.+.+..++.
T Consensus        97 ~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  175 (316)
T cd05620          97 RATFYAAEIVCGLQFLHSK-GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTF  175 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCc
Confidence            4567889999999999997 89999999999999999999999999876432  22233456788999999999888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|..||...+..++.+.+
T Consensus       176 ~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~  208 (316)
T cd05620         176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI  208 (316)
T ss_pred             ccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999877766555544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.92  E-value=1e-24  Score=149.87  Aligned_cols=102  Identities=32%  Similarity=0.589  Sum_probs=89.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.||.|||++ +++||||+|.||+++.++.++++|||++...... ......++..|+|||.+.+..++.+
T Consensus       103 ~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~  181 (285)
T cd05631         103 RAIFYAAELCCGLEDLQRE-RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS  181 (285)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcc
Confidence            4567889999999999997 8999999999999999999999999998654322 2234567889999999998889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      +|+||+|+++|++++|..||...+
T Consensus       182 ~DvwslGvil~el~~g~~pf~~~~  205 (285)
T cd05631         182 PDWWGLGCLIYEMIQGQSPFRKRK  205 (285)
T ss_pred             cCchhHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0667|consensus

Probab=99.92  E-value=5.7e-25  Score=160.02  Aligned_cols=104  Identities=35%  Similarity=0.533  Sum_probs=91.6

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC--CcEEEeecccccccccccccCCCCccceeCcccccCCCCC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG--GEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~--~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ..++.++.|++.+|.+||+. +|||+||+|+||++..-  ..+||+|||.+........ +-..+..|+|||++.+.+|+
T Consensus       289 ~~ir~~~~Qil~~L~~L~~l-~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-tYiQSRfYRAPEVILGlpY~  366 (586)
T KOG0667|consen  289 PLVRKFAQQILTALLFLHEL-GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-TYIQSRFYRAPEVILGLPYD  366 (586)
T ss_pred             HHHHHHHHHHHHHHHHHHhC-CeeeccCChhheeeccCCcCceeEEecccccccCCcce-eeeeccccccchhhccCCCC
Confidence            46789999999999999987 89999999999999754  3589999999877665544 66778899999999999999


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      .+.|||||||++.||.+|..-|++.+..
T Consensus       367 ~~IDmWSLGCIlAEL~tG~PLfpG~ne~  394 (586)
T KOG0667|consen  367 TAIDMWSLGCILAELFTGEPLFPGDNEY  394 (586)
T ss_pred             CccceeehhhhHHhHhcCccccCCCCHH
Confidence            9999999999999999998888877654

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.8e-24  Score=149.11  Aligned_cols=109  Identities=31%  Similarity=0.551  Sum_probs=93.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .+..++.|++.||+|||++ |++|+||+|.||+++.++.++++|||++...... .....+++.|+|||.+.+..++.++
T Consensus       102 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~  179 (291)
T cd05612         102 TGLFYASEIVCALEYLHSK-EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-TWTLCGTPEYLAPEVIQSKGHNKAV  179 (291)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-cccccCChhhcCHHHHcCCCCCchh
Confidence            3567899999999999997 8999999999999999999999999998654332 2334678899999999888889999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      |+||+|+++|++++|..||......+..+.+
T Consensus       180 DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i  210 (291)
T cd05612         180 DWWALGILIYEMLVGYPPFFDDNPFGIYEKI  210 (291)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9999999999999999999877766555543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0588|consensus

Probab=99.91  E-value=9.9e-25  Score=159.55  Aligned_cols=113  Identities=29%  Similarity=0.516  Sum_probs=100.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccc-ccccccCCCCccceeCcccccCCCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHY-SV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~-~~~~~~~~~~~~~~~~Pe~~~~~~~-~~   80 (131)
                      ++.++++||+.|+.|||.. +++||||+++|.++|.++++|++|||.+... .+...++.+|+++|.+||++.+.+| +.
T Consensus       113 eaa~ff~QIi~gv~yCH~~-~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~  191 (786)
T KOG0588|consen  113 EAAHFFRQILDGVSYCHAF-NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGR  191 (786)
T ss_pred             HHHHHHHHHHHHHHHHhhh-cceeccCCchhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCC
Confidence            5778999999999999987 6999999999999999888999999998654 4567788999999999999999887 58


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~~  116 (131)
                      ++||||.|+++|.+++|..||.+.+...+...+...
T Consensus       192 ~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G  227 (786)
T KOG0588|consen  192 PSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG  227 (786)
T ss_pred             ccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC
Confidence            899999999999999999999988887766665443

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.91  E-value=9.2e-25  Score=152.66  Aligned_cols=108  Identities=32%  Similarity=0.605  Sum_probs=92.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||.|||+. |++||||++.||+++.++.++++|||++.....  .......+++.|+|||.+.+..++.
T Consensus        97 ~~~~~~~qi~~~L~~lH~~-giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  175 (325)
T cd05602          97 RARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR  175 (325)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCC
Confidence            4567899999999999997 899999999999999999999999999864322  2233456888999999999888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      ++|+||+|+++|+|++|..||...+..+..+
T Consensus       176 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~  206 (325)
T cd05602         176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD  206 (325)
T ss_pred             ccccccccHHHHHHhcCCCCCCCCCHHHHHH
Confidence            9999999999999999999998777655443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.91  E-value=4.9e-25  Score=154.05  Aligned_cols=111  Identities=30%  Similarity=0.609  Sum_probs=94.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.|||+..|++||||+|.||+++.++.++++|||++.....  .......++..|+|||.+.+..++.
T Consensus        96 ~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  175 (325)
T cd05594          96 RARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR  175 (325)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCC
Confidence            46778999999999999733899999999999999999999999998764321  2223456888999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|..||...+.++..+.+
T Consensus       176 ~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i  208 (325)
T cd05594         176 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI  208 (325)
T ss_pred             ccccccccceeeeeccCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999887776655554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.91  E-value=1.6e-24  Score=148.79  Aligned_cols=104  Identities=35%  Similarity=0.539  Sum_probs=90.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++.++++|||++...... ......++..|+|||.+....++.+
T Consensus       111 ~~~~i~~qi~~aL~~lH~~-~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  189 (290)
T cd07862         111 TIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP  189 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCc
Confidence            4678999999999999997 8999999999999999999999999998654322 2334567889999999988889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +|+||+|+++|++++|..||.+....
T Consensus       190 ~DiwslG~il~el~~g~~~f~~~~~~  215 (290)
T cd07862         190 VDLWSVGCIFAEMFRRKPLFRGSSDV  215 (290)
T ss_pred             cchHHHHHHHHHHHcCCCCcCCCCHH
Confidence            99999999999999999999866543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0661|consensus

Probab=99.91  E-value=2.2e-24  Score=152.75  Aligned_cols=120  Identities=28%  Similarity=0.520  Sum_probs=99.6

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccC-CCCC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-THYS   79 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-~~~~   79 (131)
                      ++++.|++||+.||+|+|++ |++|||++|+||++..+..+|++|||++++.... ....-+.|.+|+|||++.. ..|+
T Consensus       110 ~~irnim~QilqGL~hiHk~-GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys  188 (538)
T KOG0661|consen  110 SDIRNIMYQILQGLAHIHKH-GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYS  188 (538)
T ss_pred             HHHHHHHHHHHHHHHHHHhc-CcccccCChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccC
Confidence            46788999999999999986 9999999999999998889999999999987643 4556678889999999864 5689


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCC-HH---HHHHHhCCCCCCCCc
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPD-AK---TLAAIFGPSRGDGYW  122 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~-~~---~~~~~~~~~~~~~~~  122 (131)
                      .+.|+||+||+++|+.+-+..|++.+ .+   .+-+.++...++.+.
T Consensus       189 ~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~  235 (538)
T KOG0661|consen  189 SPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP  235 (538)
T ss_pred             CchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence            99999999999999999999997655 33   334456666655443

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.91  E-value=2e-24  Score=150.90  Aligned_cols=110  Identities=32%  Similarity=0.557  Sum_probs=93.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.|||++ |++||||+|.||+++.++.++++|||++.....  .......++..|+|||.+.+..++.
T Consensus       102 ~~~~i~~qi~~al~~lH~~-~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  180 (323)
T cd05615         102 QAVFYAAEISVGLFFLHRR-GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGK  180 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCC
Confidence            4678899999999999997 899999999999999999999999998764322  2233456788999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|..||.....+...+.+
T Consensus       181 ~~DiwslGvil~elltG~~pf~~~~~~~~~~~i  213 (323)
T cd05615         181 SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI  213 (323)
T ss_pred             ccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999887766554443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.91  E-value=1.7e-24  Score=150.90  Aligned_cols=110  Identities=36%  Similarity=0.669  Sum_probs=93.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.|||+. +++||||++.||+++.++.++++|||++....  ........++..|+|||.+.+..++.
T Consensus        97 ~~~~~~~qi~~al~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  175 (316)
T cd05619          97 RATFYAAEIICGLQFLHSK-GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNT  175 (316)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCc
Confidence            4577899999999999997 89999999999999999999999999876432  22233456788999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|..||...+..+..+.+
T Consensus       176 ~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i  208 (316)
T cd05619         176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI  208 (316)
T ss_pred             hhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999877766555543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.6e-24  Score=150.66  Aligned_cols=110  Identities=33%  Similarity=0.608  Sum_probs=93.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.|||++ +++||||+|.||+++.++.++++|||++.....  .......+++.|+|||.+.+..++.
T Consensus        94 ~~~~~~~qi~~~l~~lH~~-~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  172 (312)
T cd05585          94 RARFYTAELLCALENLHKF-NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTK  172 (312)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCC
Confidence            4567899999999999997 899999999999999999999999998864322  2233456888999999999888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|..||...+..+..+..
T Consensus       173 ~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~  205 (312)
T cd05585         173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI  205 (312)
T ss_pred             ccceechhHHHHHHHhCCCCcCCCCHHHHHHHH
Confidence            999999999999999999999877766554443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.91  E-value=1.2e-24  Score=154.78  Aligned_cols=110  Identities=31%  Similarity=0.549  Sum_probs=91.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCC---
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT---   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~---   76 (131)
                      .+..++.|++.||+|||++ +++||||+|.||+++.++.++++|||++......   ......+++.|+|||.+...   
T Consensus       143 ~~~~~~~qil~aL~~LH~~-~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~  221 (370)
T cd05621         143 WAKFYTAEVVLALDAIHSM-GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD  221 (370)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCC
Confidence            4667899999999999997 8999999999999999999999999998654322   22355688999999998653   


Q ss_pred             -CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         77 -HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        77 -~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                       .++.++|+||+|+++|+|++|..||...........+
T Consensus       222 ~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i  259 (370)
T cd05621         222 GYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI  259 (370)
T ss_pred             CCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence             2778999999999999999999999877655444433

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.91  E-value=1.2e-24  Score=151.98  Aligned_cols=108  Identities=33%  Similarity=0.609  Sum_probs=92.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.|||++ |++|+||++.||+++.++.++++|||++.....  .......+++.|++||.+.+..++.
T Consensus        97 ~~~~~~~qi~~~l~~lH~~-givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  175 (323)
T cd05575          97 RARFYAAEIASALGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR  175 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCc
Confidence            4567899999999999997 899999999999999999999999998864322  2223446788999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      ++|+||||+++|+|++|..||...+..+..+
T Consensus       176 ~~DvwslG~il~ell~g~~pf~~~~~~~~~~  206 (323)
T cd05575         176 TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD  206 (323)
T ss_pred             cccccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence            9999999999999999999998777655444

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.91  E-value=1.3e-24  Score=151.59  Aligned_cols=109  Identities=32%  Similarity=0.590  Sum_probs=92.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.|||+. +++|+||++.||+++.++.++++|||++.....  .......+++.|++||.+.+..++.
T Consensus        97 ~~~~~~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  175 (321)
T cd05603          97 RARFYAAEVASAIGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR  175 (321)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCC
Confidence            4567899999999999997 899999999999999999999999998764322  2223446788999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      ++|+||+|+++|+|++|..||...+.......
T Consensus       176 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  207 (321)
T cd05603         176 TVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDN  207 (321)
T ss_pred             cCcccccchhhhhhhcCCCCCCCCCHHHHHHH
Confidence            99999999999999999999987776554443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.91  E-value=1.5e-24  Score=151.41  Aligned_cols=110  Identities=31%  Similarity=0.554  Sum_probs=93.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      .+..++.|++.||.|||+. |++||||+|.||+++.++.++++|||++....  ........++..|+|||.+.+..++.
T Consensus        97 ~~~~~~~qi~~aL~~LH~~-~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  175 (321)
T cd05591          97 RSRFYAAEVTLALMFLHRH-GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGP  175 (321)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCC
Confidence            4567899999999999997 89999999999999999999999999876432  22233456788999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|+.||...+..+..+.+
T Consensus       176 ~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i  208 (321)
T cd05591         176 SVDWWALGVLMYEMMAGQPPFEADNEDDLFESI  208 (321)
T ss_pred             ccceechhHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999887766555543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.91  E-value=2.5e-24  Score=148.63  Aligned_cols=100  Identities=26%  Similarity=0.371  Sum_probs=87.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---------cccCCCCccceeCccccc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---------MANSFVGTRSYMSPERLQ   74 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---------~~~~~~~~~~~~~Pe~~~   74 (131)
                      +..++.|++.|+.|||++ +++||||+|.||+++.++.++++|||+++.....         ......+++.|++||...
T Consensus       128 ~~~i~~qi~~~l~~lH~~-~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~  206 (294)
T PHA02882        128 IKNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN  206 (294)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC
Confidence            567899999999999997 7999999999999999999999999998654211         112345788999999999


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         75 GTHYSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        75 ~~~~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      +..++.++|+||+|++++++++|..||...
T Consensus       207 ~~~~~~~~DiwSlG~~l~el~~g~~P~~~~  236 (294)
T PHA02882        207 GACVTRRGDLESLGYCMLKWAGIKLPWKGF  236 (294)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            888999999999999999999999999766

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.91  E-value=1.4e-24  Score=152.81  Aligned_cols=109  Identities=27%  Similarity=0.461  Sum_probs=93.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .+..++.|++.||.|||+. |++||||+|.||+++.++.++++|||++..... ......+++.|+|||.+.+..++.++
T Consensus       132 ~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~  209 (340)
T PTZ00426        132 VGCFYAAQIVLIFEYLQSL-NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYTLCGTPEYIAPEILLNVGHGKAA  209 (340)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCCCEEEecCCCCeecCC-CcceecCChhhcCHHHHhCCCCCccc
Confidence            4567899999999999997 899999999999999999999999999865432 22345688899999999888889999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      |+||+|+++|+|++|..||...+.....+.+
T Consensus       210 DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i  240 (340)
T PTZ00426        210 DWWTLGIFIYEILVGCPPFYANEPLLIYQKI  240 (340)
T ss_pred             cccchhhHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            9999999999999999999877765554444

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.91  E-value=3.2e-24  Score=149.84  Aligned_cols=110  Identities=33%  Similarity=0.612  Sum_probs=93.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.|||+. +++||||++.||+++.++.++++|||++.....  .......+++.|+|||.+.+..++.
T Consensus       102 ~~~~~~~qi~~al~~lH~~-~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~  180 (324)
T cd05589         102 RAVFYAACVVLGLQYLHEN-KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTR  180 (324)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCc
Confidence            4677999999999999997 899999999999999999999999998764322  2233456788999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|..||.+.+..+....+
T Consensus       181 ~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i  213 (324)
T cd05589         181 AVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI  213 (324)
T ss_pred             ccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999887766554433

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.91  E-value=2.8e-24  Score=150.17  Aligned_cols=110  Identities=31%  Similarity=0.531  Sum_probs=92.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      .+..++.|++.||.|||+. +++|+||++.||+++.++.++++|||++.....  .......+++.|+|||.+.+..++.
T Consensus       101 ~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  179 (323)
T cd05584         101 TACFYLSEISLALEHLHQQ-GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGK  179 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCC
Confidence            3566889999999999997 899999999999999999999999998764322  2223456788999999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|..||...+.....+.+
T Consensus       180 ~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~  212 (323)
T cd05584         180 AVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI  212 (323)
T ss_pred             cceecccHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999877655444433

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PTZ00284 protein kinase; Provisional

Probab=99.91  E-value=3e-24  Score=156.62  Aligned_cols=105  Identities=29%  Similarity=0.508  Sum_probs=88.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC----------------cEEEeecccccccccccccCCCCccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG----------------EIKICDFGVSGQLIDSMANSFVGTRS   66 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~----------------~~~l~d~g~~~~~~~~~~~~~~~~~~   66 (131)
                      ++..++.|++.||.|||++.|++||||+|.||+++.++                .++++|||.+..... ......+++.
T Consensus       232 ~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-~~~~~~gt~~  310 (467)
T PTZ00284        232 HLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-SRTAIVSTRH  310 (467)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-ccccccCCcc
Confidence            46789999999999999744899999999999998665                389999998654322 2234578889


Q ss_pred             eeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         67 YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        67 ~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      |+|||++.+..++.++|+|||||++|||++|+.||...+..+
T Consensus       311 Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        311 YRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             ccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            999999998889999999999999999999999998766543

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.91  E-value=9.8e-25  Score=152.52  Aligned_cols=109  Identities=31%  Similarity=0.569  Sum_probs=93.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.|||+. |++|+||++.||+++.++.++++|||+++...  ........++..|++||.+.+..++.
T Consensus        97 ~~~~~~~qi~~al~~lH~~-givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  175 (325)
T cd05604          97 RARFYAAEIASALGYLHSI-NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN  175 (325)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCC
Confidence            4677899999999999997 89999999999999999999999999886432  12233456788999999999888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      ++|+||+|+++|+|++|..||...+..++.+.
T Consensus       176 ~~DvwslG~il~el~~G~~pf~~~~~~~~~~~  207 (325)
T cd05604         176 TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN  207 (325)
T ss_pred             cCccccccceehhhhcCCCCCCCCCHHHHHHH
Confidence            99999999999999999999987776555443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.91  E-value=2.8e-24  Score=152.82  Aligned_cols=110  Identities=31%  Similarity=0.537  Sum_probs=91.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCC---
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT---   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~---   76 (131)
                      .+..++.|++.||+|||++ +++||||+|.||+++.++.++++|||++......   ......+++.|+|||.+...   
T Consensus       143 ~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~  221 (371)
T cd05622         143 WARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD  221 (371)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCC
Confidence            3567889999999999997 8999999999999999999999999998654321   22345688999999998753   


Q ss_pred             -CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         77 -HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        77 -~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                       .++.++|+||+|+++|+|++|..||...+.......+
T Consensus       222 ~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i  259 (371)
T cd05622         222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI  259 (371)
T ss_pred             ccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence             2788999999999999999999999887765444443

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.91  E-value=3.3e-24  Score=151.88  Aligned_cols=104  Identities=40%  Similarity=0.621  Sum_probs=90.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.||.|||++ |++|+||+|.||+++.++.++++|||+++..... ......++..|+|||.+.+..++.+
T Consensus       127 ~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  205 (364)
T cd07875         127 RMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN  205 (364)
T ss_pred             HHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCch
Confidence            4567899999999999997 8999999999999999999999999998755432 2234567889999999998889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +|+||+|+++|+|++|..||...+..
T Consensus       206 ~DiwSlG~il~ell~g~~pf~~~~~~  231 (364)
T cd07875         206 VDIWSVGCIMGEMIKGGVLFPGTDHI  231 (364)
T ss_pred             hhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999999876644

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.91  E-value=2e-24  Score=151.32  Aligned_cols=109  Identities=28%  Similarity=0.518  Sum_probs=93.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .+..++.|++.||+|||+. +++|+||+|.||+++.++.++++|||++...... .....+++.|+|||.+.+..++.++
T Consensus       119 ~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~  196 (329)
T PTZ00263        119 VAKFYHAELVLAFEYLHSK-DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-TFTLCGTPEYLAPEVIQSKGHGKAV  196 (329)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-cceecCChhhcCHHHHcCCCCCCcc
Confidence            3567889999999999997 8999999999999999999999999998655332 2345678899999999988889999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      |+||||+++|+|++|..||......+..+.+
T Consensus       197 DiwslG~il~elltg~~pf~~~~~~~~~~~i  227 (329)
T PTZ00263        197 DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI  227 (329)
T ss_pred             eeechHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            9999999999999999999877665544443

>KOG0033|consensus

Probab=99.91  E-value=5.4e-24  Score=140.94  Aligned_cols=123  Identities=32%  Similarity=0.552  Sum_probs=101.8

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC---CcEEEeecccccccccc-cccCCCCccceeCcccccCCCCC
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG---GEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~---~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +...++||+++|+|||++ +|+|||++|.|+++.+.   .-+|++|||++.....+ ....+.|++.|++||+++..+++
T Consensus       112 aSH~~rQiLeal~yCH~n-~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~  190 (355)
T KOG0033|consen  112 ASHCIQQILEALAYCHSN-GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYS  190 (355)
T ss_pred             HHHHHHHHHHHHHHHHhc-CceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCC
Confidence            456789999999999998 79999999999999743   34899999999876643 34467899999999999999999


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCCCC---CCCCcccccC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR---GDGYWHVSYP  127 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~  127 (131)
                      ..+|+|+-|+++|-++.|..||.+.+...+.+.+.+..   ...+|.-.-|
T Consensus       191 kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~  241 (355)
T KOG0033|consen  191 KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTP  241 (355)
T ss_pred             CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCH
Confidence            99999999999999999999999988888877665443   2235554433

>KOG0585|consensus

Probab=99.91  E-value=1.6e-24  Score=153.64  Aligned_cols=104  Identities=38%  Similarity=0.614  Sum_probs=89.0

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-------ccccCCCCccceeCccccc
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-------SMANSFVGTRSYMSPERLQ   74 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-------~~~~~~~~~~~~~~Pe~~~   74 (131)
                      .++++++++++.||+|||.. |++||||+|.|++++.+|.+|++|||++.....       .......||+.|+|||.+.
T Consensus       210 ~~Ar~ylrDvv~GLEYLH~Q-giiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~  288 (576)
T KOG0585|consen  210 QQARKYLRDVVLGLEYLHYQ-GIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCS  288 (576)
T ss_pred             HHHHHHHHHHHHHHHHHHhc-CeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhc
Confidence            36789999999999999997 899999999999999999999999999864421       1233478999999999997


Q ss_pred             CCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         75 GTH----YSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        75 ~~~----~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      +..    -+.+.|+||+|+.+|.++.|+.||-+...
T Consensus       289 ~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~  324 (576)
T KOG0585|consen  289 GGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE  324 (576)
T ss_pred             CCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence            732    36889999999999999999999986554

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2e-24  Score=151.30  Aligned_cols=107  Identities=36%  Similarity=0.641  Sum_probs=92.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      ++..++.|++.||.|||+. +++|+||++.||+++.++.++++|||++..... ......+++.|+|||.+.+..++.++
T Consensus       102 ~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~  179 (333)
T cd05600         102 HARFYMAEMFEAVDALHEL-GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-YANSVVGSPDYMAPEVLRGKGYDFTV  179 (333)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEEEeCcCCccccc-ccCCcccCccccChhHhcCCCCCCcc
Confidence            4567899999999999997 899999999999999999999999999865443 23445688899999999888899999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      |+||+|+++|+|++|..||......+...
T Consensus       180 DvwslG~il~ell~g~~pf~~~~~~~~~~  208 (333)
T cd05600         180 DYWSLGCMLYEFLCGFPPFSGSTPNETWE  208 (333)
T ss_pred             ceecchHHHhhhhhCCCCCCCCCHHHHHH
Confidence            99999999999999999998777655443

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.91  E-value=5.1e-24  Score=150.69  Aligned_cols=103  Identities=38%  Similarity=0.619  Sum_probs=89.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.||.|||++ |++||||+|.||+++.++.++++|||++...... ......++..|+|||.+.+..++.+
T Consensus       124 ~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  202 (359)
T cd07876         124 RMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKEN  202 (359)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcc
Confidence            4567899999999999997 8999999999999999999999999998654322 2234567788999999988889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      +|+||+|+++|+|++|..||...+.
T Consensus       203 ~DiwSlG~il~el~tg~~pf~~~~~  227 (359)
T cd07876         203 VDIWSVGCIMGELVKGSVIFQGTDH  227 (359)
T ss_pred             hhhHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999999986654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.8e-24  Score=153.95  Aligned_cols=108  Identities=32%  Similarity=0.553  Sum_probs=89.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-------------------------
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-------------------------   57 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-------------------------   57 (131)
                      .++.++.|++.||+|||+. |++||||+|.||+++.++.++++|||++.......                         
T Consensus       102 ~~~~~~~ql~~aL~~LH~~-givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (377)
T cd05629         102 VTRFYMAECVLAIEAVHKL-GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA  180 (377)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccc
Confidence            3567899999999999997 89999999999999999999999999875321100                         


Q ss_pred             ------------------------ccCCCCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         58 ------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        58 ------------------------~~~~~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                                              .....|++.|+|||.+.+..++.++|+||+|+++|++++|..||......+...
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~  258 (377)
T cd05629         181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYR  258 (377)
T ss_pred             cccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHH
Confidence                                    002357889999999988889999999999999999999999998766554433

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.91  E-value=4.9e-24  Score=150.51  Aligned_cols=103  Identities=40%  Similarity=0.610  Sum_probs=90.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.||.|||++ |++||||+|.||+++.++.++++|||+++..... ......++..|+|||.+.+..++.+
T Consensus       120 ~~~~~~~qi~~aL~~LH~~-givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  198 (355)
T cd07874         120 RMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN  198 (355)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCch
Confidence            4567899999999999997 8999999999999999999999999998755432 2234567889999999988889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      +|+||+|+++|+|++|..||.+.+.
T Consensus       199 ~DiwslG~il~el~~g~~pf~~~~~  223 (355)
T cd07874         199 VDIWSVGCIMGEMVRHKILFPGRDY  223 (355)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999999987664

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.91  E-value=1.4e-24  Score=153.71  Aligned_cols=109  Identities=31%  Similarity=0.556  Sum_probs=91.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--------------------------
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--------------------------   56 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--------------------------   56 (131)
                      .+..++.|++.||.|||+. |++||||+|.||+++.++.++++|||++......                          
T Consensus       102 ~~~~~~~qi~~~L~~lH~~-givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (360)
T cd05627         102 ATQFYIAETVLAIDAIHQL-GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR  180 (360)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCccccccccccccc
Confidence            4667899999999999997 8999999999999999999999999987533110                          


Q ss_pred             -----------cccCCCCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         57 -----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        57 -----------~~~~~~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                                 ......|++.|+|||++.+..++.++|+||+|+++|+|++|..||...........
T Consensus       181 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~  247 (360)
T cd05627         181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRK  247 (360)
T ss_pred             ccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHH
Confidence                       01134688899999999888899999999999999999999999987776654443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.91  E-value=2.3e-24  Score=153.60  Aligned_cols=106  Identities=33%  Similarity=0.562  Sum_probs=88.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc---------------------------
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID---------------------------   55 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~---------------------------   55 (131)
                      .++.++.|++.||.|||+. +++||||+|.||+++.++.++++|||++.....                           
T Consensus       102 ~~~~~~~qi~~al~~lH~~-~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (382)
T cd05625         102 LARFYIAELTCAVESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP  180 (382)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccccccccccccccccccc
Confidence            3567889999999999997 899999999999999999999999998642110                           


Q ss_pred             ----------------------ccccCCCCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         56 ----------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        56 ----------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                                            .......|++.|+|||.+.+..++.++|+||+||++|+|++|+.||...+..+.
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~  256 (382)
T cd05625         181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLET  256 (382)
T ss_pred             ccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHH
Confidence                                  001123578899999999888899999999999999999999999987665433

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0983|consensus

Probab=99.91  E-value=4.6e-24  Score=143.12  Aligned_cols=109  Identities=46%  Similarity=0.892  Sum_probs=91.5

Q ss_pred             HHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-ccCCCCccceeCcccccCC---CCCCc
Q psy17559          6 YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGT---HYSVQ   81 (131)
Q Consensus         6 ~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~Pe~~~~~---~~~~~   81 (131)
                      ++...++.||.||-+++|++|||++|.||++|..|++|++|||++....++. .....|-+.|++||.+...   .|+.+
T Consensus       195 k~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiR  274 (391)
T KOG0983|consen  195 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIR  274 (391)
T ss_pred             hhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchh
Confidence            5667788999999999999999999999999999999999999997766543 3445677899999999653   58999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHhC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPD--AKTLAAIFG  114 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~--~~~~~~~~~  114 (131)
                      +|+||||+.++|+.||+.||.+.+  -+.+..++.
T Consensus       275 aDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln  309 (391)
T KOG0983|consen  275 ADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN  309 (391)
T ss_pred             hhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh
Confidence            999999999999999999998744  445555544

>KOG0660|consensus

Probab=99.91  E-value=1.8e-24  Score=148.60  Aligned_cols=104  Identities=40%  Similarity=0.730  Sum_probs=90.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc----ccccCCCCccceeCcccccC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTRSYMSPERLQG-TH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~~~~~~Pe~~~~-~~   77 (131)
                      .+..+++|++.||+|+|+. +++||||+|.|++++.+..+|++|||+++....    .....-+.|.+|+|||++.. ..
T Consensus       126 H~q~f~YQiLrgLKyiHSA-nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~  204 (359)
T KOG0660|consen  126 HAQYFLYQILRGLKYIHSA-NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSE  204 (359)
T ss_pred             HHHHHHHHHHHhcchhhcc-cccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhcccc
Confidence            3567899999999999998 799999999999999999999999999987642    22234567889999999865 57


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      |+...|+||.||++.||++|+.-|.+.+.-
T Consensus       205 Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v  234 (359)
T KOG0660|consen  205 YTKAIDIWSVGCILAEMLTGKPLFPGKDYV  234 (359)
T ss_pred             ccchhhhhhhhHHHHHHHcCCCCCCCCchH
Confidence            999999999999999999999999877643

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.5e-24  Score=152.37  Aligned_cols=108  Identities=32%  Similarity=0.586  Sum_probs=90.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--------------------------
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--------------------------   56 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--------------------------   56 (131)
                      ++..++.|++.||+|||+. +++|+||+|.||+++.++.++++|||++......                          
T Consensus       102 ~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (364)
T cd05599         102 ETRFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS  180 (364)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccccccccccccccccccc
Confidence            4678999999999999997 8999999999999999999999999987543210                          


Q ss_pred             --------------cccCCCCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         57 --------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        57 --------------~~~~~~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                                    ......|++.|+|||.+....++.++|+||+||++|+|++|..||......+...
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~  249 (364)
T cd05599         181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYR  249 (364)
T ss_pred             ccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHH
Confidence                          0012357889999999988889999999999999999999999998776554443

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0659|consensus

Probab=99.91  E-value=1.1e-23  Score=140.34  Aligned_cols=110  Identities=35%  Similarity=0.612  Sum_probs=91.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc--ccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      +++.++.+++.|++|||++ .|+|||++|.|++++.+|.+|++|||+++..+...  ....+.+..|+|||.+.+. .|+
T Consensus       102 ~iK~y~~m~LkGl~y~H~~-~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg  180 (318)
T KOG0659|consen  102 DIKSYMLMTLKGLAYCHSK-WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYG  180 (318)
T ss_pred             HHHHHHHHHHHHHHHHHhh-hhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcC
Confidence            4788999999999999998 79999999999999999999999999998776432  2233678899999999885 699


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPP-DAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~-~~~~~~~~~  113 (131)
                      ..+|+||.||++.|++-|..-|++. +.+++..++
T Consensus       181 ~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If  215 (318)
T KOG0659|consen  181 TGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIF  215 (318)
T ss_pred             CcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHH
Confidence            9999999999999999888777644 344444443

>KOG0605|consensus

Probab=99.91  E-value=5.4e-24  Score=152.34  Aligned_cols=110  Identities=33%  Similarity=0.542  Sum_probs=93.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc----------------------c--c-
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----------------------S--M-   57 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~----------------------~--~-   57 (131)
                      .++..+.+++.|+.-+|+. |++||||+|+|+++|..|.+||+|||++.....                      .  . 
T Consensus       242 ~arfYiaE~vlAI~~iH~~-gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (550)
T KOG0605|consen  242 WARFYIAETVLAIESIHQL-GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPK  320 (550)
T ss_pred             HHHHHHHHHHHHHHHHHHc-CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccc
Confidence            3567788999999999997 899999999999999999999999998732100                      0  0 


Q ss_pred             ----c--------------------cCCCCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         58 ----A--------------------NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        58 ----~--------------------~~~~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                          .                    ...+|++-|+|||++.+.+|+..+|+|||||++|||+.|..||.+....+.-+.+
T Consensus       321 ~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI  400 (550)
T KOG0605|consen  321 FNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKI  400 (550)
T ss_pred             cccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                0                    0237999999999999999999999999999999999999999988877665544

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=9.5e-24  Score=155.03  Aligned_cols=110  Identities=31%  Similarity=0.476  Sum_probs=94.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      .+..++.|++.+|.|+|+. +++||||+|.||+++.++.++++|||+++.....    ......+++.|+|||.+.+..+
T Consensus       144 ~~~~i~~qll~aL~~lH~~-~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~  222 (496)
T PTZ00283        144 EAGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY  222 (496)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCC
Confidence            3567899999999999997 8999999999999999999999999998654321    2234568889999999998889


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      +.++|+||||+++|++++|..||...+..++....
T Consensus       223 s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~  257 (496)
T PTZ00283        223 SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT  257 (496)
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99999999999999999999999887776555543

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.91  E-value=5.6e-24  Score=148.89  Aligned_cols=103  Identities=33%  Similarity=0.649  Sum_probs=87.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cccCCCCccceeCcccccC--
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQG--   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~--   75 (131)
                      .+..++.|++.||.|||+. +++|+||+|.||+++.++.++++|||++......     ......++..|+|||.+..  
T Consensus       104 ~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  182 (338)
T cd07859         104 HHQFFLYQLLRALKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF  182 (338)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccc
Confidence            4577899999999999997 8999999999999999999999999998644221     1123467889999999865  


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      ..++.++|+||+|+++|++++|+.||...+.
T Consensus       183 ~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~  213 (338)
T cd07859         183 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV  213 (338)
T ss_pred             cccCchhHHHHHHHHHHHHHcCCCCCCCCCh
Confidence            5688999999999999999999999976553

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.1e-24  Score=151.87  Aligned_cols=108  Identities=36%  Similarity=0.640  Sum_probs=92.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-------------------------
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-------------------------   57 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-------------------------   57 (131)
                      .++.++.|++.||+|||+. |++|+||+|.||+++.++.++++|||++.......                         
T Consensus       102 ~~~~i~~qi~~aL~~LH~~-giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (350)
T cd05573         102 TARFYIAELVLALDSVHKL-GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH  180 (350)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccccccccccccccc
Confidence            4677899999999999997 89999999999999999999999999886543221                         


Q ss_pred             ------ccCCCCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         58 ------ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        58 ------~~~~~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                            .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+...
T Consensus       181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~  240 (350)
T cd05573         181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN  240 (350)
T ss_pred             ccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence                  234467889999999998889999999999999999999999998776554443

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.90  E-value=4.6e-24  Score=152.09  Aligned_cols=105  Identities=33%  Similarity=0.603  Sum_probs=88.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--------------------------
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--------------------------   56 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--------------------------   56 (131)
                      .++.++.|++.||+|||+. +++||||+|.||+++.++.++++|||++......                          
T Consensus       102 ~~~~~~~qi~~aL~~LH~~-givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (381)
T cd05626         102 LARFYIAELTLAIESVHKM-GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV  180 (381)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccc
Confidence            3567889999999999997 8999999999999999999999999986422100                          


Q ss_pred             -----------------------cccCCCCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         57 -----------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        57 -----------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                                             ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~  255 (381)
T cd05626         181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTE  255 (381)
T ss_pred             cccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHH
Confidence                                   0112468889999999988889999999999999999999999998766543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.90  E-value=6.3e-24  Score=148.10  Aligned_cols=110  Identities=35%  Similarity=0.613  Sum_probs=93.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||+|||+. +++|+||++.||+++.++.++++|||++....  ........++..|++||.+.+..++.
T Consensus        97 ~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~  175 (318)
T cd05570          97 RARFYAAEIVLGLQFLHER-GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGP  175 (318)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCc
Confidence            4577899999999999997 89999999999999999999999999876432  22223345788999999999888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|..||...+.....+.+
T Consensus       176 ~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i  208 (318)
T cd05570         176 AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI  208 (318)
T ss_pred             chhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999877766655544

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.90  E-value=5.9e-24  Score=146.30  Aligned_cols=105  Identities=39%  Similarity=0.636  Sum_probs=88.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccC-CCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQG-THYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~-~~~~   79 (131)
                      ++..++.|++.||+|||+. |++|+||+|.||+++.++.++++|||++.....  .......++..|+|||.+.+ ..++
T Consensus       104 ~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  182 (288)
T cd07871         104 NVKIFMFQLLRGLSYCHKR-KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS  182 (288)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccC
Confidence            4677899999999999997 899999999999999999999999998864322  12234456788999999875 4588


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      .++|+||+|+++|++++|+.||.+....+
T Consensus       183 ~~~DiwslG~~l~~l~~g~~pf~~~~~~~  211 (288)
T cd07871         183 TPIDMWGVGCILYEMATGRPMFPGSTVKE  211 (288)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999999998766543

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG4721|consensus

Probab=99.90  E-value=6.1e-25  Score=159.09  Aligned_cols=106  Identities=39%  Similarity=0.596  Sum_probs=94.1

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-ccccCCCCccceeCcccccCCCCCCcc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      ++.|..+||.|+.|||.. -||||||++.||++..+..+|++|||-+++... +....+.|+..|||||+++..+-+.++
T Consensus       214 lv~Wsk~IA~GM~YLH~h-KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKV  292 (904)
T KOG4721|consen  214 LVDWSKGIAGGMNYLHLH-KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKV  292 (904)
T ss_pred             HHHHHHHhhhhhHHHHHh-hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCccccc
Confidence            567899999999999997 499999999999999999999999998877654 345678899999999999999999999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLA  110 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~  110 (131)
                      ||||||+++|||+||..||...+..-+.
T Consensus       293 DIwSfGVVLWEmLT~EiPYkdVdssAII  320 (904)
T KOG4721|consen  293 DIWSFGVVLWEMLTGEIPYKDVDSSAII  320 (904)
T ss_pred             ceehhHHHHHHHHhcCCCccccchheeE
Confidence            9999999999999999999876654333

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.90  E-value=6.5e-24  Score=150.91  Aligned_cols=110  Identities=31%  Similarity=0.533  Sum_probs=91.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCC---
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT---   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~---   76 (131)
                      .+..++.|++.||+|||+. +++||||+|.||+++.++.++++|||++......   ......+++.|+|||.+...   
T Consensus       143 ~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  221 (370)
T cd05596         143 WARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGD  221 (370)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCC
Confidence            3567889999999999997 8999999999999999999999999998654321   22345688999999998653   


Q ss_pred             -CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         77 -HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        77 -~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                       .++.++|+||+|+++|+|++|..||...........+
T Consensus       222 ~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i  259 (370)
T cd05596         222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI  259 (370)
T ss_pred             CCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHH
Confidence             3788999999999999999999999877765444443

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.90  E-value=8.7e-24  Score=148.25  Aligned_cols=102  Identities=34%  Similarity=0.616  Sum_probs=86.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++||||+|.||+++.++.++++|||+++......    .....++..|+|||.+.+..+
T Consensus       175 ~~~~~~~qi~~aL~~LH~~-~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  253 (338)
T cd05102         175 DLICYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY  253 (338)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCC
Confidence            4567899999999999997 89999999999999999999999999986543211    112234567999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPD  105 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~  105 (131)
                      +.++|+||||+++|++++ |..||....
T Consensus       254 ~~~sDiwslG~il~el~~~g~~pf~~~~  281 (338)
T cd05102         254 TTQSDVWSFGVLLWEIFSLGASPYPGVQ  281 (338)
T ss_pred             CcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999996 999997654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.90  E-value=1.5e-23  Score=147.18  Aligned_cols=112  Identities=84%  Similarity=1.295  Sum_probs=95.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .+..++.|++.++.|||++.+++|+||++.||+++.++.++++|||++............++..|++||.+.+..++.++
T Consensus       104 ~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  183 (333)
T cd06650         104 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS  183 (333)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCCCcHH
Confidence            35678899999999999865799999999999999999999999999865544334445678899999999888899999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhC
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~  114 (131)
                      |+||+|+++|++++|..||.......+...++
T Consensus       184 DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~  215 (333)
T cd06650         184 DIWSMGLSLVEMAIGRYPIPPPDAKELELMFG  215 (333)
T ss_pred             HHHHHHHHHHHHHHCCCCCCCcchhHHHHHhc
Confidence            99999999999999999998777666655543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.90  E-value=1.9e-23  Score=152.85  Aligned_cols=110  Identities=35%  Similarity=0.590  Sum_probs=93.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++||||+|.||+++.++.++++|||++......    ......|++.|++||.+.+..+
T Consensus       170 ~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  248 (478)
T PTZ00267        170 EVGLLFYQIVLALDEVHSR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY  248 (478)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCC
Confidence            3556889999999999997 8999999999999999999999999998754332    1234568889999999988889


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      +.++|+||+|+++|+|++|..||......++.+.+
T Consensus       249 ~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~  283 (478)
T PTZ00267        249 SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV  283 (478)
T ss_pred             CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999999999999999877766555443

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.90  E-value=2.4e-24  Score=153.13  Aligned_cols=108  Identities=32%  Similarity=0.554  Sum_probs=89.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc---------------------------
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID---------------------------   55 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~---------------------------   55 (131)
                      .++.++.|++.||+|||+. +++||||+|.||+++.++.++++|||++.....                           
T Consensus       102 ~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (376)
T cd05598         102 LARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI  180 (376)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccccccccccccccccccc
Confidence            3567889999999999997 899999999999999999999999998632110                           


Q ss_pred             ------------------ccccCCCCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         56 ------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        56 ------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                                        .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||......+...
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~  254 (376)
T cd05598         181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQL  254 (376)
T ss_pred             ccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHH
Confidence                              00112367889999999998889999999999999999999999998776554433

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.90  E-value=1.5e-23  Score=143.81  Aligned_cols=104  Identities=34%  Similarity=0.513  Sum_probs=89.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      +++.++.|++.||+|+|+. |++|+||+|.||+++.++.++++|||++...... ......++..|+|||.+.+..++.+
T Consensus       109 ~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  187 (288)
T cd07863         109 TIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATP  187 (288)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCc
Confidence            4678999999999999997 8999999999999999999999999988654332 2233456788999999988889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +|+||+|+++|++++|..||......
T Consensus       188 ~DiwslG~~l~~l~~g~~~f~~~~~~  213 (288)
T cd07863         188 VDMWSVGCIFAEMFRRKPLFCGNSEA  213 (288)
T ss_pred             chhhhHHHHHHHHHhCCcCcCCCCHH
Confidence            99999999999999999999765543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.90  E-value=1.7e-23  Score=143.50  Aligned_cols=103  Identities=34%  Similarity=0.638  Sum_probs=89.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||.|||+. +++|+||+|.||+++.++.++++|||++......   ......++..|+|||.+.+..++
T Consensus       101 ~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  179 (287)
T cd07848         101 KVRSYIYQLIKAIHWCHKN-DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG  179 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCC
Confidence            4677999999999999997 8999999999999999999999999998654321   12234678889999999888899


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      .++|+||+|+++|++++|+.||.....
T Consensus       180 ~~~DiwslGvil~el~~g~~pf~~~~~  206 (287)
T cd07848         180 KAVDMWSVGCILGELSDGQPLFPGESE  206 (287)
T ss_pred             CchhHHhHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0690|consensus

Probab=99.90  E-value=7.5e-24  Score=145.17  Aligned_cols=110  Identities=31%  Similarity=0.600  Sum_probs=98.7

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCCc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      .+.....|+.||.|||++ +|++||++..|.++|++|.+|++|||++++..  .....++.|++.|+|||++....|+.+
T Consensus       270 tRFYGaEIvsAL~YLHs~-~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgra  348 (516)
T KOG0690|consen  270 TRFYGAEIVSALGYLHSR-NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRA  348 (516)
T ss_pred             hhhhhHHHHHHhhhhhhC-CeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccce
Confidence            456678899999999997 79999999999999999999999999998654  235678899999999999999999999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~  114 (131)
                      +|+|.+|+++|||++|+.||.+.+.+.+-.++.
T Consensus       349 VDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl  381 (516)
T KOG0690|consen  349 VDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL  381 (516)
T ss_pred             eehhhhhHHHHHHHhccCcccccchhHHHHHHH
Confidence            999999999999999999999888887766553

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=2.1e-24  Score=151.07  Aligned_cols=110  Identities=33%  Similarity=0.619  Sum_probs=92.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      +++.++.|++.||.|||++ +++||||+|.||+++.++.++++|||++.....  .......++..|++||.+.+. .++
T Consensus        97 ~~~~~~~qil~al~~LH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  175 (330)
T cd05586          97 RAKFYIAELVLALEHLHKY-DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT  175 (330)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCC
Confidence            4677899999999999997 899999999999999999999999999865322  223345688899999998754 478


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||+|+++|+|++|..||...+..+..+.+
T Consensus       176 ~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i  209 (330)
T cd05586         176 KHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI  209 (330)
T ss_pred             CccceeccccEEEEeccCCCCCCCCCHHHHHHHH
Confidence            9999999999999999999999887766555443

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.90  E-value=1.7e-23  Score=151.81  Aligned_cols=103  Identities=34%  Similarity=0.683  Sum_probs=86.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC-cEEEeecccccccccc-cccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG-EIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~-~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      .++.++.|++.||+|||++ +++||||+|.||+++.++ .++++|||+++..... ......+++.|+|||.+.+. .++
T Consensus       171 ~~~~~~~qi~~gL~yLH~~-~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  249 (440)
T PTZ00036        171 LVKLYSYQLCRALAYIHSK-FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYT  249 (440)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCC
Confidence            4567889999999999997 899999999999998654 6999999998755322 22345678889999998764 689


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      .++|+||+|+++|+|++|..||.+...
T Consensus       250 ~~~DiwSlGvil~elltG~~pf~~~~~  276 (440)
T PTZ00036        250 THIDLWSLGCIIAEMILGYPIFSGQSS  276 (440)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            999999999999999999999986654

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.90  E-value=4.8e-24  Score=149.24  Aligned_cols=99  Identities=32%  Similarity=0.677  Sum_probs=87.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||+|||++ |++||||+|.||+++.++.++++|||++....  ........+++.|+|||.+.+..++.
T Consensus        97 ~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  175 (327)
T cd05617          97 HARFYAAEICIALNFLHER-GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF  175 (327)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCc
Confidence            4678999999999999997 89999999999999999999999999886432  12233456888999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      ++|+||+|+++|+|++|..||.
T Consensus       176 ~~DiwslGvil~ell~g~~pf~  197 (327)
T cd05617         176 SVDWWALGVLMFEMMAGRSPFD  197 (327)
T ss_pred             hheeehhHHHHHHHHhCCCCCC
Confidence            9999999999999999999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.90  E-value=1.3e-23  Score=143.99  Aligned_cols=102  Identities=33%  Similarity=0.647  Sum_probs=88.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||.|||++ +++|+||++.||+++.++.++++|||.+......  ......++..|++||.+.+..++.
T Consensus        98 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~  176 (280)
T cd05608          98 RACFYTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF  176 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCc
Confidence            4567899999999999997 8999999999999999999999999988654322  223346788999999999888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ++|+||+|+++|++++|..||....
T Consensus       177 ~~DvwslG~il~el~~g~~pf~~~~  201 (280)
T cd05608         177 SVDYFALGVTLYEMIAARGPFRARG  201 (280)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999997543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0599|consensus

Probab=99.90  E-value=5.7e-24  Score=142.79  Aligned_cols=115  Identities=30%  Similarity=0.523  Sum_probs=99.6

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-ccccCCCCccceeCccccc------
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQ------   74 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~------   74 (131)
                      ++.+++++|+.+++.|||.+ .|+||||+|.||+++++.+++++|||++....+ .+.....|++.|+|||.+.      
T Consensus       123 K~tR~iMrqlfegVeylHa~-~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~  201 (411)
T KOG0599|consen  123 KETRRIMRQLFEGVEYLHAR-NIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYEN  201 (411)
T ss_pred             HHHHHHHHHHHHHHHHHHHh-hhhhcccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccC
Confidence            35688999999999999998 599999999999999999999999999876654 3566778999999999985      


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCCCC
Q psy17559         75 GTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR  117 (131)
Q Consensus        75 ~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  117 (131)
                      ..+|+..+|.|+.|+++|.++.|-.||-.+.+--+.+++....
T Consensus       202 ~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk  244 (411)
T KOG0599|consen  202 HPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK  244 (411)
T ss_pred             CCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence            3468899999999999999999999998777776777765544

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.90  E-value=4.4e-24  Score=149.50  Aligned_cols=100  Identities=34%  Similarity=0.601  Sum_probs=85.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT-HY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~-~~   78 (131)
                      +++.++.|++.||.|||+. +++||||++.||+++.++.++++|||++......   ......++..|+|||.+.+. .+
T Consensus       106 ~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  184 (332)
T cd05614         106 EVRFYSGEIILALEHLHKL-GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH  184 (332)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCC
Confidence            4677899999999999997 8999999999999999999999999998654221   22345688899999999764 47


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      +.++|+||+|+++|++++|..||..
T Consensus       185 ~~~~DiwslG~il~elltg~~pf~~  209 (332)
T cd05614         185 GKAVDWWSLGILIFELLTGASPFTL  209 (332)
T ss_pred             CCccccccchhhhhhhhcCCCCCCC
Confidence            8899999999999999999999963

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.90  E-value=2.5e-23  Score=146.22  Aligned_cols=102  Identities=40%  Similarity=0.705  Sum_probs=88.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccC-CCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~   81 (131)
                      ++..++.|++.||.|||+. +++||||+|.||+++.++.++++|||++...... .....++..|+|||.+.+ ..++.+
T Consensus       119 ~~~~i~~qi~~aL~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~  196 (343)
T cd07878         119 HVQFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-MTGYVATRWYRAPEIMLNWMHYNQT  196 (343)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecccCChhhEEECCCCCEEEcCCccceecCCC-cCCccccccccCchHhcCCccCCch
Confidence            4678999999999999997 8999999999999999999999999998654332 234467889999999876 468899


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      +|+||+|+++|++++|..||...+.
T Consensus       197 ~DiwslG~il~el~~g~~pf~~~~~  221 (343)
T cd07878         197 VDIWSVGCIMAELLKGKALFPGNDY  221 (343)
T ss_pred             hhhHhHHHHHHHHHHCCCCCCCCCH
Confidence            9999999999999999999976554

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.90  E-value=1.2e-23  Score=145.51  Aligned_cols=101  Identities=37%  Similarity=0.646  Sum_probs=85.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      +++.++.|++.||+|||+. +++|+||+|.||+++.++.++++|||++.....  .......+++.|+|||.+.+. .++
T Consensus       104 ~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  182 (303)
T cd07869         104 NVKLFLFQLLRGLSYIHQR-YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS  182 (303)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCC
Confidence            4678899999999999997 899999999999999999999999998754322  122334567889999998653 578


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      .++|+||+|+++|++++|..||.+.
T Consensus       183 ~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         183 TCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            8999999999999999999999754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=1.6e-23  Score=149.99  Aligned_cols=99  Identities=34%  Similarity=0.541  Sum_probs=86.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc---ccccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID---SMANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +++.++.|++.||.|||+. +++||||+|.||+++.++.++++|||++.....   .......+++.|++||.+.+..++
T Consensus       183 ~~~~i~~qi~~aL~ylH~~-~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  261 (391)
T PHA03212        183 DILAIERSVLRAIQYLHEN-RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYG  261 (391)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCC
Confidence            4678999999999999997 899999999999999999999999999854322   222345688999999999888899


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      .++|+||+|+++|++++|..||-
T Consensus       262 ~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        262 PAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             cHHHHHHHHHHHHHHHHCCCCcC
Confidence            99999999999999999998764

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.90  E-value=7e-24  Score=148.57  Aligned_cols=99  Identities=35%  Similarity=0.687  Sum_probs=86.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      .++.++.|++.||.|||++ +++||||+|.||+++.++.++++|||++.....  .......++..|+|||.+.+..++.
T Consensus        97 ~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  175 (329)
T cd05618          97 HARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF  175 (329)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCC
Confidence            4577899999999999997 899999999999999999999999998864321  2233456788999999999888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      ++|+||+|+++|++++|..||.
T Consensus       176 ~~DiwslG~il~el~~g~~Pf~  197 (329)
T cd05618         176 SVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             ccceecccHHHHHHhhCCCCCc
Confidence            9999999999999999999994

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.90  E-value=1.4e-23  Score=145.90  Aligned_cols=101  Identities=34%  Similarity=0.541  Sum_probs=84.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEe----cCCcEEEeecccccccccc-----cccCCCCccceeCcccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN----SGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERL   73 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~----~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~   73 (131)
                      .++.++.|++.||+|||+. |++||||+|.||++.    .++.++++|||++......     ......+++.|+|||.+
T Consensus       109 ~~~~i~~qi~~al~~LH~~-~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~  187 (317)
T cd07868         109 MVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL  187 (317)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHH
Confidence            3578999999999999997 899999999999994    4578999999998654321     12344678889999998


Q ss_pred             cCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         74 QGT-HYSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        74 ~~~-~~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      .+. .++.++|+||+|++++++++|..||...
T Consensus       188 ~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         188 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            764 5789999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0984|consensus

Probab=99.90  E-value=1.6e-23  Score=135.61  Aligned_cols=110  Identities=45%  Similarity=0.829  Sum_probs=92.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccC-CCCccceeCcccccC----CCCC
Q psy17559          5 PYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS-FVGTRSYMSPERLQG----THYS   79 (131)
Q Consensus         5 ~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~Pe~~~~----~~~~   79 (131)
                      -+++..+++||+|||++..++|||++|.||+++..|.+|++|||++....++-..+ ..|-..|+|||.+..    ..|+
T Consensus       151 GkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~  230 (282)
T KOG0984|consen  151 GKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYS  230 (282)
T ss_pred             hHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccce
Confidence            46888999999999998789999999999999999999999999987766553333 566678999999864    3689


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDA--KTLAAIFG  114 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~--~~~~~~~~  114 (131)
                      .++|+||||+.+.|+.+++.||..+..  +.+.|.+.
T Consensus       231 vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  231 VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            999999999999999999999986653  35555554

>PHA02988 hypothetical protein; Provisional

Probab=99.90  E-value=3.9e-23  Score=142.13  Aligned_cols=110  Identities=23%  Similarity=0.293  Sum_probs=92.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccC--CCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG--THYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~   80 (131)
                      +...++.|++.++.++|+..+++||||++.|++++.++.++++|||+++..... .....++..|+|||.+.+  ..++.
T Consensus       123 ~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~  201 (283)
T PHA02988        123 TKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-PFKNVNFMVYFSYKMLNDIFSEYTI  201 (283)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-cccccCcccccCHHHhhhccccccc
Confidence            457789999999999998547889999999999999999999999987654332 223456788999999976  57899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||||+++|++++|..||...+..++...+
T Consensus       202 k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i  234 (283)
T PHA02988        202 KDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI  234 (283)
T ss_pred             hhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999988776666554

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.89  E-value=9.7e-24  Score=147.81  Aligned_cols=99  Identities=34%  Similarity=0.680  Sum_probs=86.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      .+..++.|++.||.|||++ |++||||+|.||+++.++.++++|||++....  ........++..|+|||.+.+..++.
T Consensus        97 ~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  175 (329)
T cd05588          97 HARFYSAEISLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGF  175 (329)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCC
Confidence            4677899999999999997 89999999999999999999999999876422  22233456788999999999888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      ++|+||+|+++|++++|..||.
T Consensus       176 ~~DiwslG~~l~el~~g~~Pf~  197 (329)
T cd05588         176 SVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             ccceechHHHHHHHHHCCCCcc
Confidence            9999999999999999999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0603|consensus

Probab=99.89  E-value=2.9e-23  Score=151.04  Aligned_cols=112  Identities=29%  Similarity=0.484  Sum_probs=93.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEE-ecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILV-NSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~-~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..|+++++.++.|||++ |++||||+|.||++ ++.+.++++|||.+...... ..+..-+..|.|||++....++.+
T Consensus       416 e~~~w~~~lv~Av~~LH~~-gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-~~tp~~t~~y~APEvl~~~~yt~a  493 (612)
T KOG0603|consen  416 EASQWAAELVSAVDYLHEQ-GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-CDTPALTLQYVAPEVLAIQEYTEA  493 (612)
T ss_pred             HHHHHHHHHHHHHHHHHhc-CeeecCCChhheeecCCCCcEEEEEechhhhCchh-hcccchhhcccChhhhccCCCCcc
Confidence            3557999999999999996 89999999999999 58899999999998766554 333445668999999998889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAK-TLAAIFGPS  116 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~-~~~~~~~~~  116 (131)
                      +|+||||+++|+|++|+.||.....+ ++.+.++..
T Consensus       494 cD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~  529 (612)
T KOG0603|consen  494 CDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP  529 (612)
T ss_pred             hhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC
Confidence            99999999999999999999755544 555554443

>KOG0582|consensus

Probab=99.89  E-value=4e-23  Score=145.57  Aligned_cols=104  Identities=43%  Similarity=0.724  Sum_probs=88.5

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cc-cCCCCccceeCcccccC--
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MA-NSFVGTRSYMSPERLQG--   75 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~-~~~~~~~~~~~Pe~~~~--   75 (131)
                      +..+.+++++||.|||.. |.+|||+++.||+++.+|.++++|||.+......     .. .++++++.|++||++..  
T Consensus       128 Ia~iLre~LkaL~YLH~~-G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~  206 (516)
T KOG0582|consen  128 IATILREVLKALDYLHQN-GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQL  206 (516)
T ss_pred             HHHHHHHHHHHHHHHHhc-CceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcc
Confidence            567899999999999997 9999999999999999999999999986543221     11 46689999999999643  


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      .+|+.++||||||+...|+..|+.||....+-+
T Consensus       207 ~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk  239 (516)
T KOG0582|consen  207 HGYDFKADIWSFGITACELAHGHAPFSKYPPMK  239 (516)
T ss_pred             cCccchhhhhhhhHHHHHHhcCCCCcccCChHH
Confidence            479999999999999999999999998666543

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.89  E-value=4.5e-24  Score=148.73  Aligned_cols=110  Identities=36%  Similarity=0.582  Sum_probs=93.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||+|||+. +++|+||++.||+++.++.++++|||++......  ......++..|++||.+.+..++.
T Consensus        99 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~  177 (318)
T cd05582          99 DVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ  177 (318)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCC
Confidence            4678899999999999997 8999999999999999999999999988654322  233456788999999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|..||...+..+....+
T Consensus       178 ~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i  210 (318)
T cd05582         178 SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI  210 (318)
T ss_pred             ccceeccceEeeeeccCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999877766555443

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=2e-23  Score=149.40  Aligned_cols=102  Identities=33%  Similarity=0.489  Sum_probs=88.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||+. |++||||++.||+++.++.++++|||++......    ......++..|++||.+.+..+
T Consensus       186 ~~~~i~~ql~~aL~~LH~~-givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  264 (392)
T PHA03207        186 QAITIQRRLLEALAYLHGR-GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY  264 (392)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCC
Confidence            5678999999999999997 8999999999999999999999999998654322    1224568889999999988889


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      +.++|+||+|+++|+|++|..||.+..
T Consensus       265 ~~~~DvwslGvil~el~~g~~pf~~~~  291 (392)
T PHA03207        265 CAKTDIWSAGLVLFEMSVKNVTLFGKQ  291 (392)
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            999999999999999999999996543

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.89  E-value=2.4e-23  Score=145.95  Aligned_cols=110  Identities=30%  Similarity=0.539  Sum_probs=90.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccC----
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQG----   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~----   75 (131)
                      .+..++.|++.++.|||+. +++||||++.||+++.++.++++|||++......   ......+++.|++||.+..    
T Consensus       103 ~~~~~~~qi~~al~~lH~~-~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  181 (332)
T cd05623         103 MARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG  181 (332)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccC
Confidence            4567899999999999997 8999999999999999999999999987643221   1223468889999999862    


Q ss_pred             -CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         76 -THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        76 -~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                       ..++.++|+||+|+++|++++|..||...+..+....+
T Consensus       182 ~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i  220 (332)
T cd05623         182 KGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  220 (332)
T ss_pred             CCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence             35788999999999999999999999877765544433

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.89  E-value=9.4e-23  Score=139.69  Aligned_cols=111  Identities=28%  Similarity=0.483  Sum_probs=93.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      .+..++.|++.|++|||++ +++|+||++.||+++.++.++++|||.++.....    ......++..|++||.+.+..+
T Consensus       110 ~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~  188 (279)
T cd05111         110 RLLNWCVQIAKGMYYLEEH-RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY  188 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCc
Confidence            4677999999999999997 7999999999999999999999999988654321    1122345567999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||||+++|++++ |..||.+.......+.+.
T Consensus       189 ~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~  225 (279)
T cd05111         189 THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE  225 (279)
T ss_pred             CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999999999998 999998877776666554

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.89  E-value=6.2e-23  Score=140.52  Aligned_cols=102  Identities=32%  Similarity=0.521  Sum_probs=87.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      .+..++.|++.|++|||+. +++|+||+|.||+++.++.++++|||.+...... ......++..|++||.+.+..++.+
T Consensus        96 ~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  174 (277)
T cd05607          96 RVIHYSAQITCGILHLHSM-DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYP  174 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCc
Confidence            3467889999999999997 8999999999999999999999999987654322 2223457789999999988889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      +|+||+|+++|++++|..||....
T Consensus       175 ~DvwslGv~l~el~~g~~p~~~~~  198 (277)
T cd05607         175 VDWFAMGCSIYEMVAGRTPFKDHK  198 (277)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCc
Confidence            999999999999999999997543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=5.9e-23  Score=141.13  Aligned_cols=104  Identities=32%  Similarity=0.573  Sum_probs=89.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.|++|||+. +++|+||++.||++++++.++++|||++...... ......++..|++||.+.+..++.+
T Consensus       103 ~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  181 (285)
T cd05605         103 RAVFYAAEITCGLEDLHRE-RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFS  181 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCcc
Confidence            4667899999999999997 8999999999999999999999999988654322 2233467889999999988889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +|+||+|+++|++++|..||.+.+..
T Consensus       182 ~Diws~G~~l~el~~g~~pf~~~~~~  207 (285)
T cd05605         182 PDWWGLGCLIYEMIEGKSPFRQRKEK  207 (285)
T ss_pred             ccchhHHHHHHHHHHCCCCCCCCchh
Confidence            99999999999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.89  E-value=8.8e-23  Score=142.07  Aligned_cols=112  Identities=29%  Similarity=0.464  Sum_probs=92.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc----cCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      .+..++.|++.||+|||++ +++|+||++.||+++.++.++++|||+++.......    .....+..|++||.+....+
T Consensus       110 ~~~~~~~qi~~~L~~LH~~-~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~  188 (316)
T cd05108         110 YLLNWCVQIAKGMNYLEER-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY  188 (316)
T ss_pred             HHHHHHHHHHHHHHHHHhc-CeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCC
Confidence            3567899999999999997 899999999999999999999999999875432211    11223457999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      +.++|+||||+++|++++ |..||.+....+..+.+..
T Consensus       189 ~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~  226 (316)
T cd05108         189 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK  226 (316)
T ss_pred             CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC
Confidence            999999999999999987 9999988777766665543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=3.7e-23  Score=144.97  Aligned_cols=106  Identities=31%  Similarity=0.575  Sum_probs=88.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccC----
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQG----   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~----   75 (131)
                      +++.++.|++.||+|||++ +++|+||++.||+++.++.++++|||++......   ......+++.|++||.+..    
T Consensus       103 ~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  181 (331)
T cd05597         103 MARFYLAEMVLAIDSVHQL-GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDG  181 (331)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhcccc
Confidence            4677899999999999997 7999999999999999999999999987654322   1123457889999999863    


Q ss_pred             -CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         76 -THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        76 -~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                       ..++.++|+||+|+++|+|++|+.||......+.
T Consensus       182 ~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~  216 (331)
T cd05597         182 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  216 (331)
T ss_pred             ccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH
Confidence             3467899999999999999999999987665433

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.89  E-value=1.7e-23  Score=146.70  Aligned_cols=107  Identities=29%  Similarity=0.531  Sum_probs=89.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccC----
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQG----   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~----   75 (131)
                      .+..++.|++.+|+|||++ +++||||++.||+++.++.++++|||++......   ......+++.|+|||.+..    
T Consensus       103 ~~~~~~~qi~~~L~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  181 (331)
T cd05624         103 MARFYIAEMVLAIHSIHQL-HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG  181 (331)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccC
Confidence            4567889999999999997 8999999999999999999999999998654322   1223468889999999865    


Q ss_pred             -CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy17559         76 -THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLA  110 (131)
Q Consensus        76 -~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~  110 (131)
                       ..++.++|+||+|+++|+|++|..||...+..+..
T Consensus       182 ~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~  217 (331)
T cd05624         182 MGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  217 (331)
T ss_pred             CCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH
Confidence             35788999999999999999999999876654433

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.89  E-value=1.6e-22  Score=136.93  Aligned_cols=113  Identities=26%  Similarity=0.393  Sum_probs=93.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc-----cCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-----NSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~~~Pe~~~~~~   77 (131)
                      .+..++.|++.+++++|++ +++|+||+|.|++++.++.++++|||.+........     ....++..|++||.+....
T Consensus        96 ~~~~i~~qi~~al~~lH~~-~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  174 (257)
T cd05116          96 NITELVHQVSMGMKYLEET-NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK  174 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCC
Confidence            4678999999999999997 899999999999999999999999998865432211     1122346899999998778


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  116 (131)
                      ++.++|+||||+++|++++ |..||......++.+.+...
T Consensus       175 ~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~  214 (257)
T cd05116         175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG  214 (257)
T ss_pred             cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC
Confidence            8999999999999999997 99999887777777766543

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=2.1e-23  Score=153.37  Aligned_cols=99  Identities=37%  Similarity=0.594  Sum_probs=85.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +++.++.|++.||.|||++ +++||||+|.||+++.++.++|+|||++......   ......++..|++||.+.+..++
T Consensus       268 ~~~~i~~ql~~aL~yLH~~-gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  346 (501)
T PHA03210        268 QTRAIMKQLLCAVEYIHDK-KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC  346 (501)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCC
Confidence            3567999999999999997 8999999999999999999999999998655332   12235688899999999988899


Q ss_pred             CcchHHHHHHHHHHHHhCCC-CCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMY-PIP  102 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~-p~~  102 (131)
                      .++|+||+|+++|+|++|.. |+.
T Consensus       347 ~~~DiwSlGvil~ell~~~~~p~~  370 (501)
T PHA03210        347 EITDIWSCGLILLDMLSHDFCPIG  370 (501)
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCcc
Confidence            99999999999999998765 443

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.89  E-value=6.8e-23  Score=145.60  Aligned_cols=104  Identities=38%  Similarity=0.611  Sum_probs=87.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT-HY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~-~~   78 (131)
                      .++.++.|++.||.|||+. +++|+||+|.||+++.++.++++|||++......   ......++..|++||.+.+. .+
T Consensus       104 ~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  182 (372)
T cd07853         104 HVKVFLYQILRGLKYLHSA-GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHY  182 (372)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCC
Confidence            4677899999999999997 8999999999999999999999999988654321   12233567789999998774 47


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +.++|+||+|+++++|++|+.||...+..
T Consensus       183 ~~~~DiwslG~il~el~~g~~pf~~~~~~  211 (372)
T cd07853         183 TSAVDIWSVGCIFAELLGRRILFQAQSPI  211 (372)
T ss_pred             CcHHHHHhHHHHHHHHHcCCCCCCCCCHH
Confidence            89999999999999999999999876644

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0589|consensus

Probab=99.89  E-value=1.2e-23  Score=149.32  Aligned_cols=114  Identities=32%  Similarity=0.516  Sum_probs=101.7

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +++..|+.|++.|+.|||++ .|+||||++.|||+.+++.++++|||+++.....  ...+.+|++.|++||.+.+.+|.
T Consensus       106 ~~i~~~~~Q~~~av~ylH~~-~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn  184 (426)
T KOG0589|consen  106 ERILKWFVQILLAVNYLHEN-RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYN  184 (426)
T ss_pred             HHHHHHHHHHHHHHHHHHhh-hhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCC
Confidence            35778999999999999987 6999999999999999999999999999887654  56778999999999999999999


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~~  116 (131)
                      .++|+|||||++||+.+-+.+|...+...+...+.+.
T Consensus       185 ~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~  221 (426)
T KOG0589|consen  185 EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG  221 (426)
T ss_pred             ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc
Confidence            9999999999999999999999988877666544433

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.89  E-value=1.2e-22  Score=138.97  Aligned_cols=113  Identities=27%  Similarity=0.481  Sum_probs=93.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++.++++|||++......    ......++..|+|||.+....+
T Consensus       125 ~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  203 (283)
T cd05048         125 DFLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF  203 (283)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC
Confidence            3567999999999999997 7999999999999999999999999987644221    1122344678999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  116 (131)
                      +.++|+||||+++|++++ |..||.+...+++...+...
T Consensus       204 ~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~  242 (283)
T cd05048         204 TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR  242 (283)
T ss_pred             chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999999999999997 99999887777776665433

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.89  E-value=1.2e-22  Score=139.18  Aligned_cols=113  Identities=24%  Similarity=0.402  Sum_probs=93.3

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCCC
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +..++.|++.||.|+|++ |++|+||+|.||+++.++.++++|||+++......    .....++..|++||.+....++
T Consensus       126 ~~~~~~ql~~aL~~lH~~-gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  204 (283)
T cd05091         126 FVHIVTQIAAGMEFLSSH-HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS  204 (283)
T ss_pred             HHHHHHHHHHHHHHHHHc-CccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCC
Confidence            567889999999999997 89999999999999999999999999876543211    1233445689999999888899


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCCC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPSR  117 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~  117 (131)
                      .++|+||+|+++|++++ |..||.+....+..+.+....
T Consensus       205 ~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~  243 (283)
T cd05091         205 IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ  243 (283)
T ss_pred             cchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999999999999997 888998877776666654443

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.89  E-value=1.5e-22  Score=138.46  Aligned_cols=112  Identities=28%  Similarity=0.467  Sum_probs=92.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc----cCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||+|||++ +++|+||+|.||+++.++.++++|||+++.......    ....++..|++||...+..+
T Consensus       110 ~~~~~~~qi~~~L~~lH~~-~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~  188 (279)
T cd05109         110 DLLNWCVQIAKGMSYLEEV-RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF  188 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCC
Confidence            4677899999999999997 799999999999999999999999998865532211    11223457999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      +.++|+||||+++||+++ |..||......++...+..
T Consensus       189 ~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~  226 (279)
T cd05109         189 THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK  226 (279)
T ss_pred             CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC
Confidence            999999999999999988 9999988777766665543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.89  E-value=9e-23  Score=145.30  Aligned_cols=103  Identities=35%  Similarity=0.576  Sum_probs=86.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ |++||||+|.||+++.++.++++|||++.......    .....++..|+|||.+....+
T Consensus       213 ~~~~i~~qi~~aL~yLH~~-giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  291 (374)
T cd05106         213 DLLRFSSQVAQGMDFLASK-NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVY  291 (374)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCC
Confidence            4678999999999999997 89999999999999999999999999986543221    112233457999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDA  106 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~  106 (131)
                      +.++|+||+|+++|++++ |..||.....
T Consensus       292 ~~~~DvwSlGvil~ellt~G~~Pf~~~~~  320 (374)
T cd05106         292 TVQSDVWSYGILLWEIFSLGKSPYPGILV  320 (374)
T ss_pred             CccccHHHHHHHHHHHHhCCCCCCccccc
Confidence            999999999999999997 9999976543

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.89  E-value=9e-23  Score=144.09  Aligned_cols=101  Identities=45%  Similarity=0.760  Sum_probs=84.3

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccC-----C
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQG-----T   76 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-----~   76 (131)
                      +..++.|++.||+|||+. +++|+||++.||+++.++.++++|||++......  ......++..|++||.+..     .
T Consensus       170 ~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  248 (353)
T PLN00034        170 LADVARQILSGIAYLHRR-HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGA  248 (353)
T ss_pred             HHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCc
Confidence            467899999999999997 8999999999999999999999999998654322  2234568889999998743     2


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         77 HYSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ..+.++|+||||+++|++++|+.||....
T Consensus       249 ~~~~~~DvwslGvil~el~~g~~pf~~~~  277 (353)
T PLN00034        249 YDGYAGDIWSLGVSILEFYLGRFPFGVGR  277 (353)
T ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            24568999999999999999999997433

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.89  E-value=1.8e-22  Score=140.12  Aligned_cols=113  Identities=84%  Similarity=1.293  Sum_probs=95.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .+..++.|++.+|.|||++.+++|+||++.||+++.++.++++|||++............++..|++||.+.+..++.++
T Consensus       100 ~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  179 (308)
T cd06615         100 ILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQS  179 (308)
T ss_pred             HHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccCCCCcCccChhHhcCCCCCccc
Confidence            35688999999999999854799999999999999999999999998865544334455678899999999887889999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCC
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~  115 (131)
                      |+||+|++++++++|..||...+.......+..
T Consensus       180 DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~  212 (308)
T cd06615         180 DIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR  212 (308)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcC
Confidence            999999999999999999987766666555543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.89  E-value=1.3e-22  Score=139.40  Aligned_cols=104  Identities=33%  Similarity=0.582  Sum_probs=89.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      .+..++.|++.+|.|||++ +++|+||++.|++++.++.++++|||++...... ......++..|++||.+.+..++.+
T Consensus       103 ~~~~~~~ql~~~l~~lH~~-~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~  181 (285)
T cd05632         103 RALFYAAEILCGLEDLHRE-NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS  181 (285)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcc
Confidence            4678899999999999997 8999999999999999999999999987544321 2234467889999999988889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +|+||+|+++|++++|..||......
T Consensus       182 ~Di~slG~~l~~l~~g~~P~~~~~~~  207 (285)
T cd05632         182 PDYWGLGCLIYEMIEGQSPFRGRKEK  207 (285)
T ss_pred             cchHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999999866544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.89  E-value=4.7e-23  Score=143.13  Aligned_cols=100  Identities=34%  Similarity=0.554  Sum_probs=83.5

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEE----ecCCcEEEeecccccccccc-----cccCCCCccceeCccccc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILV----NSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQ   74 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~----~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~   74 (131)
                      +..++.|++.||.|||+. +++|+||+|.||++    +.++.++++|||+++.....     ......++..|+|||.+.
T Consensus       110 ~~~i~~qi~~aL~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  188 (317)
T cd07867         110 VKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL  188 (317)
T ss_pred             HHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhc
Confidence            568899999999999997 89999999999999    45678999999998654322     122345678899999987


Q ss_pred             CC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         75 GT-HYSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        75 ~~-~~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      +. .++.++|+||+|+++|++++|..||...
T Consensus       189 ~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         189 GARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             CCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            64 5789999999999999999999999643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.89  E-value=9.9e-23  Score=141.37  Aligned_cols=104  Identities=36%  Similarity=0.624  Sum_probs=87.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccC-CCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQG-THYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~   79 (131)
                      ++..++.|++.||.|||+. |++||||+|.||+++.++.++++|||++......  ......++..|++||.+.+ ..++
T Consensus       105 ~~~~~~~qi~~aL~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  183 (309)
T cd07872         105 NVKIFLYQILRGLAYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS  183 (309)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCC
Confidence            4567889999999999997 8999999999999999999999999988643221  2223456778999998865 4578


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      .++|+||+|++++++++|..||...+..
T Consensus       184 ~~~DiwslG~il~el~tg~~pf~~~~~~  211 (309)
T cd07872         184 TQIDMWGVGCIFFEMASGRPLFPGSTVE  211 (309)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence            9999999999999999999999876654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.88  E-value=9.8e-23  Score=139.52  Aligned_cols=100  Identities=53%  Similarity=1.026  Sum_probs=89.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .+..++.|++.|+.|||+. |++|+||++.||+++.++.++++|||++............++..|++||.+.+..++.++
T Consensus        96 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  174 (279)
T cd06619          96 VLGRIAVAVVKGLTYLWSL-KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHS  174 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCCChhhcCceeecCCCCCCcc
Confidence            3567899999999999997 899999999999999999999999999876554444456778899999999888899999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCC
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~  103 (131)
                      |+||+|+++|++++|..||..
T Consensus       175 DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         175 DVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             hHHHHHHHHHHHHhCCCCchh
Confidence            999999999999999999964

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.88  E-value=3.5e-22  Score=137.55  Aligned_cols=110  Identities=26%  Similarity=0.444  Sum_probs=91.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.+++|||++ +++|+||+|.||+++.++.++++|||++......    ......++..|++||.+.+..+
T Consensus       124 ~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  202 (291)
T cd05094         124 QMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF  202 (291)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC
Confidence            4578999999999999997 8999999999999999999999999988644321    1223345678999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      +.++|+||+|+++|++++ |..||......+..+..
T Consensus       203 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  238 (291)
T cd05094         203 TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI  238 (291)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999999999998 99999776666555544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.88  E-value=9.9e-23  Score=139.70  Aligned_cols=101  Identities=31%  Similarity=0.589  Sum_probs=86.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccC-CCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~   81 (131)
                      ++..++.|++.||+|||+. +++|+||++.||+++.++.++++|||++............++..|++||.+.. ..++.+
T Consensus        98 ~~~~i~~qi~~al~~lH~~-~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  176 (279)
T cd05633          98 EMRFYATEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSS  176 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCCcCccCHHHhcCCCCCCch
Confidence            4677899999999999997 79999999999999999999999999886544333334567889999998864 557899


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      +|+||+|++++++++|..||...
T Consensus       177 ~Di~slG~~l~~l~~g~~pf~~~  199 (279)
T cd05633         177 ADWFSLGCMLFKLLRGHSPFRQH  199 (279)
T ss_pred             hhhHHHHHHHHHHHhCCCCcCCC
Confidence            99999999999999999999643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0695|consensus

Probab=99.88  E-value=1e-22  Score=140.35  Aligned_cols=99  Identities=33%  Similarity=0.678  Sum_probs=90.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      .++.....|..||.|||++ ||++|||+.+|+++|..|.+|+.|+|.+++..  ...+.++.|++.|.|||++++..|+.
T Consensus       352 harfys~ei~lal~flh~r-giiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygf  430 (593)
T KOG0695|consen  352 HARFYSAEICLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF  430 (593)
T ss_pred             HhhhhhHHHHHHHHHHhhc-CeeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCc
Confidence            4567788899999999998 89999999999999999999999999987653  23567889999999999999999999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      ++|+|++|++++||++|+.||.
T Consensus       431 svdwwalgvlmfemmagrspfd  452 (593)
T KOG0695|consen  431 SVDWWALGVLMFEMMAGRSPFD  452 (593)
T ss_pred             eehHHHHHHHHHHHHcCCCCcc
Confidence            9999999999999999999994

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.88  E-value=3.6e-22  Score=137.90  Aligned_cols=112  Identities=30%  Similarity=0.373  Sum_probs=90.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-ccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.|++|||++ |++|+||+|.||+++.++.++++|||++....... ......+..|++||......++.+
T Consensus       120 ~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  198 (297)
T cd05089         120 QLLQFASDVATGMQYLSEK-QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK  198 (297)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCch
Confidence            4577899999999999997 89999999999999999999999999875432211 111122346999999988888999


Q ss_pred             chHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         82 SDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        82 ~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      +|+||||+++|+|++ |..||......+..+.+..
T Consensus       199 ~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~  233 (297)
T cd05089         199 SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  233 (297)
T ss_pred             hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence            999999999999997 9999988777665555443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.88  E-value=2.2e-23  Score=145.90  Aligned_cols=108  Identities=30%  Similarity=0.540  Sum_probs=89.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCccccc-----
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQ-----   74 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~-----   74 (131)
                      .+..++.|++.||+|||+. +++|+||++.||+++.++.++++|||++......   ......+++.|+|||.+.     
T Consensus       103 ~~~~~~~qi~~aL~~lH~~-~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  181 (330)
T cd05601         103 MAQFYLAELVLAIHSVHQM-GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGD  181 (330)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhcccccc
Confidence            3567889999999999997 8999999999999999999999999998654322   122346788999999986     


Q ss_pred             -CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         75 -GTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        75 -~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                       ...++.++|+||+|+++|+|++|..||..........
T Consensus       182 ~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~  219 (330)
T cd05601         182 GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN  219 (330)
T ss_pred             ccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH
Confidence             3457789999999999999999999998666544333

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0610|consensus

Probab=99.88  E-value=3.4e-22  Score=139.76  Aligned_cols=114  Identities=38%  Similarity=0.612  Sum_probs=93.2

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc---------------------------
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI---------------------------   54 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~---------------------------   54 (131)
                      +.++..+..++.||+|||.. ||++|||+|+||++-++|.+.|+||.++....                           
T Consensus       179 ~~aRFYaAEvl~ALEYLHml-GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~  257 (459)
T KOG0610|consen  179 SAARFYAAEVLLALEYLHML-GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSC  257 (459)
T ss_pred             hhHHHHHHHHHHHHHHHHhh-ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccc
Confidence            35778899999999999986 99999999999999999999999999752110                           


Q ss_pred             -------ccc------------------------ccCCCCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         55 -------DSM------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        55 -------~~~------------------------~~~~~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                             ...                        ...++||..|+|||++.+.+.+.++|+|+||+++|||+.|..||.+
T Consensus       258 f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG  337 (459)
T KOG0610|consen  258 FSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKG  337 (459)
T ss_pred             cccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCC
Confidence                   000                        0124678889999999999999999999999999999999999986


Q ss_pred             CCHH-HHHHHhCCC
Q psy17559        104 PDAK-TLAAIFGPS  116 (131)
Q Consensus       104 ~~~~-~~~~~~~~~  116 (131)
                      .+.+ .+..++.+.
T Consensus       338 ~~~~~Tl~NIv~~~  351 (459)
T KOG0610|consen  338 SNNKETLRNIVGQP  351 (459)
T ss_pred             CCchhhHHHHhcCC
Confidence            6654 555555443

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.88  E-value=1.8e-22  Score=139.69  Aligned_cols=107  Identities=26%  Similarity=0.418  Sum_probs=87.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||+|||+. +++|+||+|.||+++.++.++++|||+++......    .....++..|++||.+....+
T Consensus       139 ~~~~i~~~i~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  217 (304)
T cd05096         139 SLLHVALQIASGMKYLSSL-NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF  217 (304)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC
Confidence            3568999999999999997 89999999999999999999999999986543221    122344668999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh--CCCCCCCCCHHHHH
Q psy17559         79 SVQSDIWSLGLSLVEMAI--GMYPIPPPDAKTLA  110 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~--g~~p~~~~~~~~~~  110 (131)
                      +.++|+||||+++|++++  +..||.....++..
T Consensus       218 ~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~  251 (304)
T cd05096         218 TTASDVWAFGVTLWEILMLCKEQPYGELTDEQVI  251 (304)
T ss_pred             CchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHH
Confidence            999999999999999985  66788766655443

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.88  E-value=4.6e-22  Score=134.47  Aligned_cols=111  Identities=26%  Similarity=0.454  Sum_probs=92.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .+..++.|++.+|++||++ |++|+||+|.||+++.++.++++|||++....... .....+..|++||......++.++
T Consensus       103 ~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~  180 (256)
T cd05082         103 CLLKFSLDVCEAMEYLEAN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALREKKFSTKS  180 (256)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeccccchheEEEcCCCcEEecCCccceeccccC-CCCccceeecCHHHHccCCCCchh
Confidence            4567899999999999997 89999999999999999999999999876543221 222334579999999888889999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         83 DIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        83 d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      |+||+|+++|++++ |..||......+....+..
T Consensus       181 Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~  214 (256)
T cd05082         181 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK  214 (256)
T ss_pred             hhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence            99999999999997 9999988777766665543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0201|consensus

Probab=99.88  E-value=4.5e-23  Score=144.85  Aligned_cols=113  Identities=38%  Similarity=0.681  Sum_probs=96.8

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCCc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      +..++++++.|+.|+|++ +.+||||++.||++..+|.++++|||++.....  ....+++|++.|||||++....|+.+
T Consensus       113 i~~ilre~l~~l~ylH~~-~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~K  191 (467)
T KOG0201|consen  113 IAVILREVLKGLDYLHSE-KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTK  191 (467)
T ss_pred             eeeehHHHHHHhhhhhhc-ceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhccccccch
Confidence            456789999999999998 799999999999999999999999999865543  34478899999999999998899999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR  117 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  117 (131)
                      +|+||||++.+||.+|..|+....+....-++.+..
T Consensus       192 ADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~  227 (467)
T KOG0201|consen  192 ADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA  227 (467)
T ss_pred             hhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC
Confidence            999999999999999999998777655554444433

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.88  E-value=5.5e-22  Score=133.74  Aligned_cols=110  Identities=37%  Similarity=0.582  Sum_probs=92.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.++.|||+. |++|+||++.||+++.++.++++|||++......  ......++..|++||......++.
T Consensus       102 ~~~~i~~~l~~al~~lH~~-~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  180 (256)
T cd08529         102 QVWRFFIQILLGLAHLHSK-KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNE  180 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCC
Confidence            4567899999999999997 8999999999999999999999999987654322  223345677899999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||||++++++++|..||......+..+.+
T Consensus       181 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  213 (256)
T cd08529         181 KSDVWALGVVLYECCTGKHPFDANNQGALILKI  213 (256)
T ss_pred             ccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999877766554443

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=4.5e-22  Score=134.71  Aligned_cols=104  Identities=38%  Similarity=0.620  Sum_probs=88.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc-----cCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-----NSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~~~Pe~~~~~~   77 (131)
                      .+..++.|++.++.+||+. +++|+||++.||+++.++.++++|||.+........     ....++..|++||.+.+..
T Consensus       105 ~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  183 (263)
T cd06625         105 VTRKYTRQILEGVEYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG  183 (263)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCC
Confidence            3567899999999999997 899999999999999999999999998764432111     2345667899999999888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      ++.++|+||+|+++|++++|..||...+..
T Consensus       184 ~~~~~Di~slG~il~el~~g~~p~~~~~~~  213 (263)
T cd06625         184 YGRKADVWSVGCTVVEMLTEKPPWAEFEAM  213 (263)
T ss_pred             CCchhhhHHHHHHHHHHHhCCCCccccchH
Confidence            999999999999999999999999766544

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.88  E-value=6.4e-22  Score=134.33  Aligned_cols=112  Identities=29%  Similarity=0.512  Sum_probs=92.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccccc---CCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN---SFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~---~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.+|++||++ +++|+||+|.||+++.++.++++|||.+.........   ....+..|++||...+..++
T Consensus       105 ~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  183 (263)
T cd05052         105 VLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS  183 (263)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCC
Confidence            3567899999999999997 8999999999999999999999999988654332111   12234579999999888899


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      .++|+||||+++|++++ |..||...+.++..+.+..
T Consensus       184 ~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  220 (263)
T cd05052         184 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK  220 (263)
T ss_pred             chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC
Confidence            99999999999999998 9999988877776665543

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.88  E-value=4.2e-22  Score=136.95  Aligned_cols=110  Identities=27%  Similarity=0.453  Sum_probs=90.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.+|+|||++ |++|+||+|.||+++.++.++++|||.+......    ......++..|++||.+.+..+
T Consensus       121 ~~~~~~~ql~~aL~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  199 (288)
T cd05093         121 QMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF  199 (288)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCC
Confidence            4567899999999999997 8999999999999999999999999988654321    1122334567999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      +.++|+||||+++++|++ |..||......+....+
T Consensus       200 ~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i  235 (288)
T cd05093         200 TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  235 (288)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999999999998 99999877665544443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.88  E-value=2.5e-22  Score=138.07  Aligned_cols=102  Identities=32%  Similarity=0.599  Sum_probs=88.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.|+.|||+. +++|+||++.||+++.++.++++|||++...... ......++..|+|||.+.+..++.+
T Consensus       103 ~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~  181 (285)
T cd05630         103 RAVFYAAEICCGLEDLHQE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS  181 (285)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCc
Confidence            4677899999999999997 8999999999999999999999999987654322 2223467889999999988889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      +|+||+|+++|++++|..||....
T Consensus       182 ~DiwslG~~l~~l~~g~~Pf~~~~  205 (285)
T cd05630         182 PDWWALGCLLYEMIAGQSPFQQRK  205 (285)
T ss_pred             cccHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999997543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.88  E-value=4.9e-22  Score=135.24  Aligned_cols=111  Identities=24%  Similarity=0.460  Sum_probs=91.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      .+..++.|++.|++|||++ +++|+||+|.||+++.++.++++|||+++......    ......+..|++||......+
T Consensus       113 ~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~  191 (272)
T cd05075         113 MLVKFMTDIASGMEYLSSK-SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVY  191 (272)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCc
Confidence            3567899999999999997 89999999999999999999999999987543221    122234567999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||+|+++|++++ |..||......+....+.
T Consensus       192 ~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  228 (272)
T cd05075         192 TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR  228 (272)
T ss_pred             ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999999999998 899998776665555443

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.88  E-value=4.2e-22  Score=136.48  Aligned_cols=101  Identities=30%  Similarity=0.577  Sum_probs=87.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCC-CCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGT-HYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~   81 (131)
                      +++.++.|++.++.|||+. +++|+|+++.||+++.++.++++|||.+............++..|++||.+... .++.+
T Consensus        98 ~~~~~~~ql~~~l~~lH~~-~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  176 (278)
T cd05606          98 EMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS  176 (278)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcCCcCcHHhcCCCCCCcc
Confidence            5678999999999999997 799999999999999999999999998865443333445678899999998754 57899


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      +|+||+|++++++++|..||...
T Consensus       177 ~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         177 ADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             cchHhHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.88  E-value=5.7e-22  Score=135.84  Aligned_cols=110  Identities=25%  Similarity=0.450  Sum_probs=91.1

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCCC
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +..++.|++.+|.|||++ +++|+||+|.||+++.++.++++|||++......    ......++..|++||.+.+..++
T Consensus       126 ~~~i~~~i~~al~~lH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  204 (283)
T cd05090         126 FLHIAIQIAAGMEYLSSH-FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS  204 (283)
T ss_pred             HHHHHHHHHHHHHHHHhc-CeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCC
Confidence            456899999999999997 8999999999999999999999999998654321    12223345679999999888889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      .++|+||||+++|++++ |..||.+....++.+.+.
T Consensus       205 ~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~  240 (283)
T cd05090         205 SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR  240 (283)
T ss_pred             chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            99999999999999998 999998777666555554

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.88  E-value=6.1e-22  Score=134.64  Aligned_cols=111  Identities=22%  Similarity=0.434  Sum_probs=91.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||+. +++|+||+|.||++++++.++++|||+++......    ......+..|++||.+....+
T Consensus       114 ~~~~~~~~i~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~  192 (273)
T cd05035         114 TLLKFMVDIALGMEYLSNR-NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY  192 (273)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCC
Confidence            3567899999999999997 79999999999999999999999999986543221    111233457999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||+|+++|++++ |..||......+..+.+.
T Consensus       193 ~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~  229 (273)
T cd05035         193 TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR  229 (273)
T ss_pred             CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            999999999999999998 999998777665555443

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.88  E-value=3.9e-22  Score=140.26  Aligned_cols=102  Identities=33%  Similarity=0.606  Sum_probs=86.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      .+..++.|++.||+|||++ +++|+||+|.||+++.++.++++|||++.......    .....++..|++||.+.+..+
T Consensus       174 ~~~~~~~qi~~aL~~lH~~-~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  252 (337)
T cd05054         174 DLISYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVY  252 (337)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCC
Confidence            4677899999999999997 89999999999999999999999999986543211    122334567999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPD  105 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~  105 (131)
                      +.++|+||+|++++++++ |..||....
T Consensus       253 ~~~~Di~SlGv~l~el~t~g~~p~~~~~  280 (337)
T cd05054         253 TTQSDVWSFGVLLWEIFSLGASPYPGVQ  280 (337)
T ss_pred             CccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999999999997 999997544

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG1095|consensus

Probab=99.88  E-value=8.9e-23  Score=156.49  Aligned_cols=112  Identities=28%  Similarity=0.495  Sum_probs=95.4

Q ss_pred             CCchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccC----CCCccceeCcccccCC
Q psy17559          1 LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS----FVGTRSYMSPERLQGT   76 (131)
Q Consensus         1 ~~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~----~~~~~~~~~Pe~~~~~   76 (131)
                      |+++..++.|+|.|+.||+++ .++||||..+|++++....+|++|||+++..-......    ..-...||+||.+...
T Consensus       801 ~~dLl~~a~dvA~G~~YLe~~-~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~  879 (1025)
T KOG1095|consen  801 MRDLLAFALDVAKGMNYLESK-HFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG  879 (1025)
T ss_pred             HHHHHHHHHHHhhhhHHHHhC-CCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhc
Confidence            457889999999999999998 59999999999999999999999999998443322221    1233589999999998


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         77 HYSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      .++.++|+||||+++||+++ |..||+..+..++...+
T Consensus       880 iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~  917 (1025)
T KOG1095|consen  880 IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV  917 (1025)
T ss_pred             ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH
Confidence            99999999999999999987 89999999988777744

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.87  E-value=1.1e-21  Score=132.93  Aligned_cols=111  Identities=27%  Similarity=0.469  Sum_probs=91.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCC---CccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~---~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.++.+||++ +++|+||++.||+++.++.++++|||++............   .+..|++||...+..++
T Consensus       104 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  182 (261)
T cd05068         104 QLIDMAAQVASGMAYLEAQ-NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFS  182 (261)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCC
Confidence            4678899999999999997 8999999999999999999999999988655432211122   23479999999888889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      .++|+||||++++++++ |+.||.+...........
T Consensus       183 ~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~  218 (261)
T cd05068         183 IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD  218 (261)
T ss_pred             chhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            99999999999999998 999998877665555443

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.87  E-value=7.2e-22  Score=133.89  Aligned_cols=112  Identities=27%  Similarity=0.387  Sum_probs=91.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-----ccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.++.|||++ |++|+||+|.||+++.++.++++|||++.......     .....++..|++||.+....
T Consensus        96 ~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  174 (257)
T cd05115          96 NVVELMHQVSMGMKYLEGK-NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK  174 (257)
T ss_pred             HHHHHHHHHHHHHHHHHhc-CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCC
Confidence            5678999999999999997 89999999999999999999999999886432211     11112245799999998878


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      ++.++|+||||+++|++++ |..||......+....+..
T Consensus       175 ~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  213 (257)
T cd05115         175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ  213 (257)
T ss_pred             CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC
Confidence            8999999999999999996 9999987776666555543

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.87  E-value=1e-21  Score=134.17  Aligned_cols=111  Identities=26%  Similarity=0.429  Sum_probs=92.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.++.++|++ +++|+||+|.||+++.++.++++|||.+.......    .....++..|+|||.+.+..+
T Consensus       123 ~~~~~~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  201 (280)
T cd05049         123 QLLQIAVQIASGMVYLASQ-HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF  201 (280)
T ss_pred             HHHHHHHHHHHHHHHHhhC-CeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCc
Confidence            4567899999999999997 89999999999999999999999999886432211    122334568999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||+|+++|++++ |..||.....++....+.
T Consensus       202 ~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         202 TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            999999999999999998 999998777666665544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG1187|consensus

Probab=99.87  E-value=1.2e-22  Score=143.79  Aligned_cols=101  Identities=31%  Similarity=0.508  Sum_probs=86.9

Q ss_pred             chhHHHHHHHHHHHHHHhcC--CcEecCCCCCcEEEecCCcEEEeeccccccccc-cc-ccCC-CCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKH--AIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SM-ANSF-VGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~--~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-~~-~~~~-~~~~~~~~Pe~~~~~~   77 (131)
                      +..+|+.++|.||+|||+..  .++||||++.||++|.+..+|++|||++..... .. .... .|+..|++||+.....
T Consensus       175 ~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~  254 (361)
T KOG1187|consen  175 TRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGK  254 (361)
T ss_pred             HHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCC
Confidence            45689999999999999953  499999999999999999999999999965443 21 1222 7889999999998888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      .+.++|+||||+++.|+++|+.+...
T Consensus       255 lt~KsDVySFGVvllElitgr~~~d~  280 (361)
T KOG1187|consen  255 LTEKSDVYSFGVVLLELITGRKAVDQ  280 (361)
T ss_pred             cCcccccccchHHHHHHHhCCcccCC
Confidence            99999999999999999999987753

>KOG0612|consensus

Probab=99.87  E-value=2.2e-22  Score=153.90  Aligned_cols=119  Identities=33%  Similarity=0.583  Sum_probs=95.7

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc-c--ccccCCCCccceeCcccccC-----
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-D--SMANSFVGTRSYMSPERLQG-----   75 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~-~--~~~~~~~~~~~~~~Pe~~~~-----   75 (131)
                      ++.....++.||.-+|+- |++|||++|+||++|..|.++++|||.+-.+. +  -.....+|||-|.+||++..     
T Consensus       177 ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~  255 (1317)
T KOG0612|consen  177 ARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGK  255 (1317)
T ss_pred             HHHHHHHHHHHHHHHHhc-cceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCc
Confidence            456778899999999996 89999999999999999999999999886554 2  24567899999999999963     


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCCCCCCCCcccccC
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYWHVSYP  127 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  127 (131)
                      +.|+..+|+||+|+++|||+.|..||-...   ++..++++.... ..++||
T Consensus       256 g~yG~ecDwWSlGV~~YEMlyG~TPFYads---lveTY~KIm~hk-~~l~FP  303 (1317)
T KOG0612|consen  256 GEYGRECDWWSLGVFMYEMLYGETPFYADS---LVETYGKIMNHK-ESLSFP  303 (1317)
T ss_pred             cccCCccchhhhHHHHHHHHcCCCcchHHH---HHHHHHHHhchh-hhcCCC
Confidence            458999999999999999999999998554   444444443321 135566

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.87  E-value=5.9e-22  Score=135.86  Aligned_cols=106  Identities=54%  Similarity=1.030  Sum_probs=88.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCC-----
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH-----   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-----   77 (131)
                      .+..++.|++.++.|||+..+++|+||+|.||+++.++.++++|||.+............++..|++||.+.+..     
T Consensus       103 ~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  182 (286)
T cd06622         103 VLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNP  182 (286)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccC
Confidence            467889999999999997558999999999999999999999999988665444444456677899999986533     


Q ss_pred             -CCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         78 -YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        78 -~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                       ++.++|+||+|+++|++++|..||.......
T Consensus       183 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  214 (286)
T cd06622         183 TYTVQSDVWSLGLSILEMALGRYPYPPETYAN  214 (286)
T ss_pred             CCCcccchHhHHHHHHHHHhCCCCCCCcchhh
Confidence             4788999999999999999999997655443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0580|consensus

Probab=99.87  E-value=1.7e-22  Score=132.83  Aligned_cols=113  Identities=31%  Similarity=0.502  Sum_probs=101.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .....++|++.|+.|||.+ .++|||++|.|++++.++..+++|||-+.....+...+..|+..|.+||...+...+..+
T Consensus       125 ~~a~Yi~q~A~Al~y~h~k-~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~V  203 (281)
T KOG0580|consen  125 RAATYIKQLANALLYCHLK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFV  203 (281)
T ss_pred             chhHHHHHHHHHHHHhccC-CcccCCCCHHHhccCCCCCeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccchh
Confidence            3567899999999999998 699999999999999999999999998766666677788999999999999999999999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCCC
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~~  116 (131)
                      |+|++|++.||++.|..||.+...++..+.+.+.
T Consensus       204 d~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~  237 (281)
T KOG0580|consen  204 DLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV  237 (281)
T ss_pred             hHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc
Confidence            9999999999999999999988877777766443

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.87  E-value=1e-21  Score=136.65  Aligned_cols=112  Identities=30%  Similarity=0.516  Sum_probs=91.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ |++|+||++.|++++.++.++++|||.++......    .....++..|++||.+....+
T Consensus       135 ~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  213 (314)
T cd05099         135 DLVSCAYQVARGMEYLESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY  213 (314)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc
Confidence            3567899999999999987 89999999999999999999999999986553221    111123357999999988888


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      +.++|+||||+++|++++ |..||.....++..+....
T Consensus       214 ~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~  251 (314)
T cd05099         214 THQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE  251 (314)
T ss_pred             CccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999999999998 8999988777666665543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.87  E-value=7e-22  Score=133.67  Aligned_cols=110  Identities=25%  Similarity=0.403  Sum_probs=89.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCC---CCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF---VGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~---~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.++.+||+. +++|+|++|.||+++.++.++++|||.++..........   ..+..|++||.+.+..++
T Consensus       101 ~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~  179 (256)
T cd05059         101 WLLDMCSDVCEAMEYLESN-GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS  179 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCC
Confidence            4577899999999999997 799999999999999999999999998765433222111   223469999999888889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||+|+++|++++ |..||......+....+
T Consensus       180 ~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  214 (256)
T cd05059         180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV  214 (256)
T ss_pred             chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence            99999999999999998 89999876655555444

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.87  E-value=1.1e-21  Score=132.49  Aligned_cols=111  Identities=30%  Similarity=0.492  Sum_probs=91.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      .+..++.|++.||.+||++ +++|+||+|.||+++.++.++++|||.+......     ......++..|++||.+.+..
T Consensus        98 ~~~~~~~qi~~~L~~lH~~-~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~  176 (257)
T cd05040          98 TLCDYAVQIANGMRYLESK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT  176 (257)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccC
Confidence            4567889999999999997 8999999999999999999999999988654321     112234556899999998888


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      ++.++|+||+|++++++++ |..||......+..+...
T Consensus       177 ~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~  214 (257)
T cd05040         177 FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID  214 (257)
T ss_pred             cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999999999999998 999997766665554443

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.87  E-value=1e-21  Score=132.57  Aligned_cols=102  Identities=46%  Similarity=0.834  Sum_probs=89.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccc--ccccccCCCCccceeCccccc-CCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMANSFVGTRSYMSPERLQ-GTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~--~~~~~~~~~~~~~~~~Pe~~~-~~~~~   79 (131)
                      ++..++.|++.+|.+||+. +++|+||+|.||+++.++.++++|||.+...  .........++..|++||... +...+
T Consensus        99 ~~~~~~~qi~~~L~~Lh~~-~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  177 (260)
T PF00069_consen   99 EILKIAYQILEALAYLHSK-GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYT  177 (260)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBS
T ss_pred             ccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            5678999999999999997 8999999999999999999999999998642  223344556778899999998 77889


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      .++|+||+|++++++++|..||....
T Consensus       178 ~~~Di~slG~il~~l~~~~~p~~~~~  203 (260)
T PF00069_consen  178 RKSDIWSLGIILYELLTGKLPFEESN  203 (260)
T ss_dssp             THHHHHHHHHHHHHHHHSSSSSTTSS
T ss_pred             cccccccccccccccccccccccccc
Confidence            99999999999999999999998763

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.87  E-value=1.1e-21  Score=135.05  Aligned_cols=108  Identities=31%  Similarity=0.550  Sum_probs=91.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .+..++.|++.+|.+||+. +++|+||+|.||+++.++.++++|||++...... .....+++.|++||.+.....+.++
T Consensus       102 ~~~~~~~qil~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~  179 (290)
T cd05580         102 VARFYAAQVVLALEYLHSL-DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TYTLCGTPEYLAPEIILSKGYGKAV  179 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-CCCCCCCccccChhhhcCCCCCccc
Confidence            4567889999999999997 8999999999999999999999999988665443 3344577889999999877788999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      |+||+|++++++++|..||...+.....+.
T Consensus       180 Di~slG~il~~l~~g~~p~~~~~~~~~~~~  209 (290)
T cd05580         180 DWWALGILIYEMLAGYPPFFDDNPIQIYEK  209 (290)
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999999999987775544443

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.87  E-value=8.7e-22  Score=134.31  Aligned_cols=111  Identities=25%  Similarity=0.445  Sum_probs=92.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.|+.|||+. +++|+||+|.||+++.++.++++|||.++......    .....++..|++||.+....+
T Consensus       120 ~~~~~~~~i~~~l~~lH~~-~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  198 (277)
T cd05032         120 KFIQMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF  198 (277)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCC
Confidence            4567899999999999997 79999999999999999999999999876543221    122344568999999988888


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||||+++|++++ |..||.....++..+...
T Consensus       199 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  235 (277)
T cd05032         199 TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI  235 (277)
T ss_pred             CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence            999999999999999998 999998777776666554

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.87  E-value=6.3e-22  Score=137.13  Aligned_cols=111  Identities=31%  Similarity=0.375  Sum_probs=90.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-ccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      +++.++.|++.|++|||++ |++|+||+|.||+++.++.++++|||++....... ......+..|++||......++.+
T Consensus       125 ~~~~~~~qi~~al~~LH~~-gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  203 (303)
T cd05088         125 QLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN  203 (303)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCccc
Confidence            4678999999999999997 89999999999999999999999999875332111 111223457999999987778999


Q ss_pred             chHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         82 SDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        82 ~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      +|+||||++++++++ |..||...+..+..+.+.
T Consensus       204 ~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  237 (303)
T cd05088         204 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  237 (303)
T ss_pred             ccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence            999999999999998 999998777666555543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.87  E-value=7.7e-22  Score=139.30  Aligned_cols=103  Identities=40%  Similarity=0.633  Sum_probs=88.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-ccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.||+|||+. |++|+||+|.||+++.++.++++|||.+....... .....++..|++||.+.+..++.+
T Consensus       119 ~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  197 (353)
T cd07850         119 RMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN  197 (353)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCc
Confidence            4567899999999999997 89999999999999999999999999986554322 223456778999999988889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      +|+||+|++++++++|..||...+.
T Consensus       198 ~DvwslG~~l~~l~~g~~pf~~~~~  222 (353)
T cd07850         198 VDIWSVGCIMGEMIRGTVLFPGTDH  222 (353)
T ss_pred             hhhHhHHHHHHHHHHCCCCCCCCCH
Confidence            9999999999999999999986653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.87  E-value=1e-21  Score=134.18  Aligned_cols=111  Identities=24%  Similarity=0.425  Sum_probs=91.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.+++|||+. +++|+||+|.||+++.++.++++|||++.......    .....++..|++||.+.+..+
T Consensus       120 ~~~~~~~~l~~~l~~lH~~-~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  198 (277)
T cd05062         120 KMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF  198 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc
Confidence            3567889999999999997 89999999999999999999999999876443211    112234567999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||||+++|++++ |..||.....++..+.+.
T Consensus       199 ~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (277)
T cd05062         199 TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM  235 (277)
T ss_pred             CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999999999998 788998777766665543

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.87  E-value=1e-21  Score=132.38  Aligned_cols=111  Identities=30%  Similarity=0.496  Sum_probs=93.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.|+.+||++ +++|+||+|.||+++.++.++++|||.+......    ......++..|++||......+
T Consensus       106 ~~~~~~~~l~~al~~lH~~-~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  184 (262)
T cd00192         106 DLLSFAIQIAKGMEYLASK-KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIF  184 (262)
T ss_pred             HHHHHHHHHHHHHHHHHcC-CcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCc
Confidence            4678999999999999997 8999999999999999999999999988765432    1233455678999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||+|++++++++ |..||......+..+.+.
T Consensus       185 ~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~  221 (262)
T cd00192         185 TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR  221 (262)
T ss_pred             chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            999999999999999998 699998877766665554

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.87  E-value=1.5e-21  Score=131.83  Aligned_cols=109  Identities=36%  Similarity=0.555  Sum_probs=91.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.+++++|++ +++|+||++.||+++.++.++++|||++.....  .......+++.|++||...+..++.
T Consensus       103 ~~~~~~~~l~~~l~~lH~~-~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  181 (257)
T cd08223         103 QVVEWFVQIAMALQYLHEK-HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNY  181 (257)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCc
Confidence            4678999999999999997 899999999999999999999999998764432  1223345677899999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      ++|+||+|++++++++|..||...+.......
T Consensus       182 ~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~  213 (257)
T cd08223         182 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYR  213 (257)
T ss_pred             hhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            99999999999999999999987776554443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=3.7e-22  Score=145.35  Aligned_cols=98  Identities=36%  Similarity=0.558  Sum_probs=84.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ |++||||++.||+++.++.++|+|||++......    ......++..|++||.+.+..+
T Consensus       261 ~~~~i~~qi~~aL~yLH~~-gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~  339 (461)
T PHA03211        261 QVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPY  339 (461)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCC
Confidence            5678999999999999997 8999999999999999999999999998654321    1223468889999999988889


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPI  101 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~  101 (131)
                      +.++|+||||+++||+++|..++
T Consensus       340 ~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        340 TPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             CchHHHHHHHHHHHHHHHcCCCc
Confidence            99999999999999998876543

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.87  E-value=1e-21  Score=136.15  Aligned_cols=112  Identities=31%  Similarity=0.512  Sum_probs=91.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||+|||+. |++|+||+|.||+++.++.++++|||.+.......    ......+..|++||.+.+..+
T Consensus       141 ~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  219 (307)
T cd05098         141 DLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY  219 (307)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC
Confidence            4567899999999999987 89999999999999999999999999876543211    111123457999999988888


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      +.++|+||+|+++|++++ |..||.....+++.+.+..
T Consensus       220 ~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~  257 (307)
T cd05098         220 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE  257 (307)
T ss_pred             CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHc
Confidence            999999999999999998 8899988777766665543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.87  E-value=7e-22  Score=151.67  Aligned_cols=103  Identities=32%  Similarity=0.512  Sum_probs=87.5

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--------------------cccCCCC
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--------------------MANSFVG   63 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--------------------~~~~~~~   63 (131)
                      +..++.|++.||+|||+. |++||||+|.||+++.++.++++|||++......                    ......|
T Consensus       115 iL~I~~QIa~AL~yLHs~-GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vG  193 (932)
T PRK13184        115 FLSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG  193 (932)
T ss_pred             HHHHHHHHHHHHHHHHHC-CccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCC
Confidence            467889999999999997 8999999999999999999999999988644100                    0112457


Q ss_pred             ccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         64 TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        64 ~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      ++.|+|||.+.+..++.++|+||+|+++++|++|..||...+..
T Consensus       194 T~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        194 TPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            88999999998888999999999999999999999999765443

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=4.6e-22  Score=140.82  Aligned_cols=98  Identities=36%  Similarity=0.507  Sum_probs=83.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-ccccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.||.|||++ +++||||++.||+++.++.++++|||.+..... .......++..|++||.+.+..++.+
T Consensus       158 ~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  236 (357)
T PHA03209        158 QALIIEKQILEGLRYLHAQ-RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSK  236 (357)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCch
Confidence            4678999999999999997 899999999999999999999999998864322 22234567889999999988889999


Q ss_pred             chHHHHHHHHHHHHhCCCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPI  101 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~  101 (131)
                      +|+||+|+++|+++++..++
T Consensus       237 ~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        237 ADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             hhHHHHHHHHHHHHHcCCcc
Confidence            99999999999999754443

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.87  E-value=1.3e-21  Score=135.36  Aligned_cols=111  Identities=30%  Similarity=0.510  Sum_probs=91.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ |++|+||++.||+++.++.++++|||.++......    .....++..|++||.+.+..+
T Consensus       138 ~~~~~~~qi~~al~~LH~~-givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  216 (304)
T cd05101         138 DLVSCTYQVARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY  216 (304)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC
Confidence            3567889999999999997 89999999999999999999999999986553211    112234467999999988888


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||||+++|++++ |..||.....+++.+.+.
T Consensus       217 ~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  253 (304)
T cd05101         217 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK  253 (304)
T ss_pred             CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence            999999999999999997 788998777777666554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.87  E-value=1.2e-21  Score=133.36  Aligned_cols=107  Identities=37%  Similarity=0.676  Sum_probs=87.6

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccC-----C
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQG-----T   76 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~-----~   76 (131)
                      +..++.|++.+++|||++ +++|+|+++.||+++.++.++++|||++.....  .......++..|++||.+..     .
T Consensus       113 ~~~~~~qi~~~l~~LH~~-~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~  191 (272)
T cd06637         113 IAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA  191 (272)
T ss_pred             HHHHHHHHHHHHHHHHHC-CCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCC
Confidence            567899999999999997 799999999999999999999999999865432  12234567778999999862     3


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         77 HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      .++.++|+||+|+++|++++|..||..........
T Consensus       192 ~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~  226 (272)
T cd06637         192 TYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF  226 (272)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence            57889999999999999999999997655443333

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.87  E-value=1.1e-21  Score=134.24  Aligned_cols=112  Identities=27%  Similarity=0.505  Sum_probs=90.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC---cEEEeeccccccccccc----ccCCCCccceeCcccccC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG---EIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQG   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~---~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~   75 (131)
                      ++..++.|++.+++|||++ +++|+||++.||+++.++   .++++|||.++......    ......+..|++||.+.+
T Consensus       117 ~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  195 (277)
T cd05036         117 DLLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD  195 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhc
Confidence            4567899999999999997 799999999999998654   48999999886543211    112223457999999988


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         76 THYSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      ..++.++|+||||+++|++++ |..||.....++....+..
T Consensus       196 ~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~  236 (277)
T cd05036         196 GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG  236 (277)
T ss_pred             CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            889999999999999999996 9999988777666665543

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.87  E-value=1.2e-21  Score=133.49  Aligned_cols=111  Identities=31%  Similarity=0.375  Sum_probs=89.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-ccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.|++|||+. |++|+||+|.|++++.++.++++|||++....... ......+..|++||.+....++.+
T Consensus       113 ~~~~~~~~i~~al~~lH~~-~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~  191 (270)
T cd05047         113 QLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN  191 (270)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCch
Confidence            4578899999999999997 89999999999999999999999999875322111 111223456999999988888999


Q ss_pred             chHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         82 SDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        82 ~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      +|+||||++++++++ |..||......+..+.+.
T Consensus       192 ~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~  225 (270)
T cd05047         192 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  225 (270)
T ss_pred             hhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh
Confidence            999999999999996 999998777666555543

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.87  E-value=8.4e-22  Score=133.46  Aligned_cols=110  Identities=27%  Similarity=0.497  Sum_probs=90.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---ccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.+++|||+. +++|+||+|.||+++.++.++++|||.+.......   .....++..|++||......++
T Consensus       104 ~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  182 (261)
T cd05072         104 KLIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT  182 (261)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCC
Confidence            4567889999999999997 79999999999999999999999999986543321   1122345579999999888889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||||+++|++++ |..||......+....+
T Consensus       183 ~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~  217 (261)
T cd05072         183 IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL  217 (261)
T ss_pred             hhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH
Confidence            99999999999999998 99999877665555444

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.87  E-value=1.5e-21  Score=135.24  Aligned_cols=111  Identities=28%  Similarity=0.476  Sum_probs=91.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      .+..++.|++.||.|||++ +++|+||+|.||+++.++.++++|||++.......    .....++..|++||.+.+..+
T Consensus       110 ~~~~~~~qi~~~L~~LH~~-~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~  188 (303)
T cd05110         110 LLLNWCVQIAKGMMYLEER-RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF  188 (303)
T ss_pred             HHHHHHHHHHHHHHHHhhc-CeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCC
Confidence            4578899999999999997 79999999999999999999999999986543211    112233567999999988888


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||||+++|++++ |..||.+....+..+.+.
T Consensus       189 ~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~  225 (303)
T cd05110         189 THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE  225 (303)
T ss_pred             ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            999999999999999987 899998777666665554

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.87  E-value=1.1e-21  Score=132.79  Aligned_cols=110  Identities=28%  Similarity=0.445  Sum_probs=90.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccccc---CCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN---SFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~---~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.|++|||++ +++|+||++.||+++.++.++++|||.++........   ...++..|++||...+..++
T Consensus       101 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~  179 (256)
T cd05113         101 QLLEMCKDVCEGMAYLESK-QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFS  179 (256)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCccc
Confidence            4678999999999999997 8999999999999999999999999987654332211   12234579999999887889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||||+++|++++ |..||...+..+....+
T Consensus       180 ~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~  214 (256)
T cd05113         180 SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV  214 (256)
T ss_pred             chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence            99999999999999998 99999877766555444

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.87  E-value=1e-21  Score=139.92  Aligned_cols=102  Identities=34%  Similarity=0.594  Sum_probs=85.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc----cCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||+. +++|+||+|.||+++.++.++++|||++........    ....++..|++||.+.+..+
T Consensus       215 ~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  293 (375)
T cd05104         215 DLLSFSYQVAKGMSFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVY  293 (375)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCC
Confidence            4678899999999999997 899999999999999999999999999865432211    11223457999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPD  105 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~  105 (131)
                      +.++|+||||+++|++++ |..||....
T Consensus       294 ~~~sDi~slG~~l~ellt~g~~p~~~~~  321 (375)
T cd05104         294 TFESDVWSYGILLWEIFSLGSSPYPGMP  321 (375)
T ss_pred             CCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence            999999999999999997 899997554

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.87  E-value=1.5e-21  Score=131.92  Aligned_cols=112  Identities=27%  Similarity=0.470  Sum_probs=91.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc---cCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      .+..++.|++.+|+|||+. +++|+||++.|++++.++.++++|||.+........   ....++..|++||.+.+..++
T Consensus       101 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  179 (256)
T cd05114         101 MLLSMCQDVCEGMEYLERN-SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS  179 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccc
Confidence            3577899999999999997 899999999999999999999999998765432211   122334579999999888889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      .++|+||+|+++|++++ |+.||...+..+..+.+..
T Consensus       180 ~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~  216 (256)
T cd05114         180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR  216 (256)
T ss_pred             hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC
Confidence            99999999999999999 8999988877666555543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.87  E-value=1.7e-21  Score=132.56  Aligned_cols=105  Identities=22%  Similarity=0.393  Sum_probs=84.0

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccC----
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQG----   75 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~----   75 (131)
                      +..++.|++.|++|||+. +++|+||+|.|++++.++.++++|||++......    ......++..|++||....    
T Consensus       102 ~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  180 (269)
T cd05042         102 LQRMACEVASGLLWLHQA-DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD  180 (269)
T ss_pred             HHHHHHHHHHHHHHHHhc-CEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhcccc
Confidence            467899999999999997 7999999999999999999999999987543221    1122334567999998743    


Q ss_pred             ---CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy17559         76 ---THYSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTL  109 (131)
Q Consensus        76 ---~~~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~  109 (131)
                         ..++.++|+||+|+++|++++ |..||......+.
T Consensus       181 ~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~  218 (269)
T cd05042         181 LLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV  218 (269)
T ss_pred             ccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH
Confidence               346789999999999999998 7889987665433

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.87  E-value=1.3e-21  Score=134.60  Aligned_cols=112  Identities=30%  Similarity=0.518  Sum_probs=92.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.++.|||+. +++|+||+|.||+++.++.++++|||++.......    .....++..|++||...+..+
T Consensus       128 ~~~~i~~~i~~~l~~LH~~-~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~  206 (290)
T cd05045         128 DLISFAWQISRGMQYLAEM-KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY  206 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc
Confidence            3568899999999999987 89999999999999999999999999886542211    122234557999999888888


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      +.++|+||||++++++++ |..||.+...+++.+.+..
T Consensus       207 ~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~  244 (290)
T cd05045         207 TTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT  244 (290)
T ss_pred             chHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Confidence            999999999999999998 9999998887777766543

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0584|consensus

Probab=99.87  E-value=2.1e-22  Score=146.39  Aligned_cols=115  Identities=35%  Similarity=0.570  Sum_probs=97.4

Q ss_pred             CchhHHHHHHHHHHHHHHhc-CCcEecCCCCCcEEEe-cCCcEEEeecccccccccccccCCCCccceeCcccccCCCCC
Q psy17559          2 KQVPYSSFQVLKGLTYLREK-HAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~-~~~~h~~l~~~~il~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +.++.|++||+.||.|||+. ..|+||||+.+|||+. .-|.||++|+|++.....+......||+-|||||... ..|.
T Consensus       143 kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~Yn  221 (632)
T KOG0584|consen  143 KAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYN  221 (632)
T ss_pred             HHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccceeccCccccChHHHh-hhcc
Confidence            56789999999999999995 3699999999999998 5688999999999887777777789999999999996 6799


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhCCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPP-DAKTLAAIFGPSR  117 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~  117 (131)
                      ..+||||||..+.||+|+..||.-- +..++++.+-...
T Consensus       222 E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGi  260 (632)
T KOG0584|consen  222 ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGI  260 (632)
T ss_pred             hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCC
Confidence            9999999999999999999999632 3334555444333

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.87  E-value=1.8e-21  Score=131.83  Aligned_cols=110  Identities=28%  Similarity=0.484  Sum_probs=90.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc---cCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.+++|||+. +++|+||++.||+++.++.++++|||.+........   ....++..|++||...+..++
T Consensus       103 ~~~~~~~~l~~al~~lH~~-~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  181 (260)
T cd05070         103 NLVDMAAQVAAGMAYIERM-NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT  181 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCc
Confidence            4678999999999999997 799999999999999999999999999865432211   122334579999999888889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||||+++|++++ |..||...+..+....+
T Consensus       182 ~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~  216 (260)
T cd05070         182 IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV  216 (260)
T ss_pred             chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            99999999999999998 89999877666555544

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG4717|consensus

Probab=99.87  E-value=8.8e-22  Score=141.71  Aligned_cols=111  Identities=28%  Similarity=0.504  Sum_probs=94.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEe-cCCcEEEeeccccccccc-ccccCCCCccceeCcccccCCCCC-
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYS-   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~-~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~-   79 (131)
                      .+++.++||+.|+.|||+-+ ++||||+|+|+.+- +-|-+|+.|||++..+.+ .+..+..|+..|-|||++.+..|+ 
T Consensus       119 La~kYF~QI~~AI~YCHqLH-VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDA  197 (864)
T KOG4717|consen  119 LAKKYFAQIVHAISYCHQLH-VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDA  197 (864)
T ss_pred             HHHHHHHHHHHHHHHHhhhh-hhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCC
Confidence            35788999999999999985 99999999999765 668899999999977654 466788999999999999998886 


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~  114 (131)
                      +++|+||||+++|-+++|+.||+.-+..+...++.
T Consensus       198 PAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm  232 (864)
T KOG4717|consen  198 PAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM  232 (864)
T ss_pred             cchhhhHHHHHHHHHHhCCCccccccchhhhhhhh
Confidence            78999999999999999999998555544444443

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.87  E-value=2e-21  Score=131.47  Aligned_cols=111  Identities=28%  Similarity=0.431  Sum_probs=91.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc-----cCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-----NSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~~~Pe~~~~~~   77 (131)
                      .+..++.|++.++++||+. +++|+||++.|++++.++.++++|||.+........     ....++..|++||.+.+..
T Consensus        96 ~~~~~~~qi~~~l~~lh~~-~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  174 (257)
T cd05060          96 DLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK  174 (257)
T ss_pred             HHHHHHHHHHHHHHHHhhc-CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCC
Confidence            4678999999999999997 799999999999999999999999998865432211     1111235799999998888


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      ++.++|+||||+++|++++ |..||...+..++.+.+.
T Consensus       175 ~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~  212 (257)
T cd05060         175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE  212 (257)
T ss_pred             CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence            9999999999999999997 999998777666665553

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.87  E-value=1.2e-21  Score=134.26  Aligned_cols=110  Identities=28%  Similarity=0.438  Sum_probs=89.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.|++|||+. +++|+||+|.||++++++.++++|||++.......    .....++..|++||.+.+..+
T Consensus       123 ~~~~~~~qi~~al~~LH~~-~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  201 (280)
T cd05092         123 QMLAIASQIASGMVYLASL-HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF  201 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc
Confidence            4567889999999999997 89999999999999999999999999876443211    112233567999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      +.++|+||||+++|++++ |..||......+.....
T Consensus       202 ~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         202 TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            999999999999999998 89999766655444433

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.87  E-value=1.6e-21  Score=132.68  Aligned_cols=111  Identities=24%  Similarity=0.309  Sum_probs=90.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---ccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.|++|||+. +++|+||+|.|++++.++.++++|||.........   .....++..|++||.+.+..++
T Consensus       108 ~~~~~~~~i~~al~~lH~~-~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  186 (266)
T cd05064         108 QLMGMLPGLASGMKYLSEM-GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS  186 (266)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCcc
Confidence            4678999999999999997 89999999999999999999999999765432211   1122334679999999888899


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      .++|+||+|+++|++++ |..||......+..+.+.
T Consensus       187 ~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~  222 (266)
T cd05064         187 SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE  222 (266)
T ss_pred             chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH
Confidence            99999999999999775 999998777666555543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=1.4e-21  Score=133.32  Aligned_cols=110  Identities=40%  Similarity=0.729  Sum_probs=92.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.++.+||+. +++|+||++.|++++.++.++++|||++......  ......++..|++||.+.+..++.
T Consensus        99 ~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  177 (274)
T cd06609          99 YIAFILREVLLGLEYLHEE-GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE  177 (274)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCc
Confidence            4678899999999999997 7999999999999999999999999988665432  223445677899999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|..||...+.......+
T Consensus       178 ~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~  210 (274)
T cd06609         178 KADIWSLGITAIELAKGEPPLSDLHPMRVLFLI  210 (274)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh
Confidence            999999999999999999999866655444433

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0604|consensus

Probab=99.86  E-value=1.4e-22  Score=137.26  Aligned_cols=101  Identities=28%  Similarity=0.441  Sum_probs=89.1

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec---CCcEEEeecccccccc-cccccCCCCccceeCcccccCCC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~---~~~~~l~d~g~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      +++..+++||..|++|||+. .|.|||++|+|++...   |..+|++|||++++.. +....+..-++.|.|||++....
T Consensus       161 rea~eI~~qI~~Av~~lH~~-nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eK  239 (400)
T KOG0604|consen  161 REASEIMKQIGLAVRYLHSM-NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEK  239 (400)
T ss_pred             HHHHHHHHHHHHHHHHHHhc-chhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchh
Confidence            35778999999999999997 5999999999999874   4558999999998765 44566777889999999999889


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      |+.+.|+||+|+++|-+++|..||-+
T Consensus       240 ydkscdmwSlgVimYIlLCGyPPFYS  265 (400)
T KOG0604|consen  240 YDKSCDMWSLGVIMYILLCGYPPFYS  265 (400)
T ss_pred             cCCCCCccchhHHHHHhhcCCCcccc
Confidence            99999999999999999999999953

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.86  E-value=1.5e-21  Score=134.80  Aligned_cols=103  Identities=34%  Similarity=0.619  Sum_probs=88.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.++.|||+. |++|+||+|.||+++.++.++++|||.+......  ......++..|++||.+.+..++.
T Consensus       117 ~~~~i~~ql~~aL~~LH~~-gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  195 (296)
T cd06654         117 QIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP  195 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCc
Confidence            4568899999999999997 8999999999999999999999999987654322  122346777899999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      ++|+||||+++|++++|..||.....
T Consensus       196 ~~Dv~s~Gvil~~l~~g~~pf~~~~~  221 (296)
T cd06654         196 KVDIWSLGIMAIEMIEGEPPYLNENP  221 (296)
T ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999999999976654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.86  E-value=3.2e-21  Score=130.24  Aligned_cols=111  Identities=31%  Similarity=0.489  Sum_probs=91.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      ++..++.|++.++.++|+. |++|+|++|.||+++.++.++++|||.+....... ........|++||.+....++.++
T Consensus       101 ~~~~~~~qi~~al~~lH~~-~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~y~~pe~~~~~~~~~~~  178 (254)
T cd05083         101 QLLQFSLDVAEGMEYLESK-KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-DNSKLPVKWTAPEALKHKKFSSKS  178 (254)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCcEEECCCccceeccccC-CCCCCCceecCHHHhccCCcCchh
Confidence            3567899999999999987 89999999999999999999999999876543221 122334579999999888889999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         83 DIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        83 d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      |+||+|++++++++ |..||......+....+..
T Consensus       179 Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  212 (254)
T cd05083         179 DVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK  212 (254)
T ss_pred             hHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC
Confidence            99999999999997 9999988877766665543

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.86  E-value=2.6e-21  Score=132.56  Aligned_cols=106  Identities=40%  Similarity=0.653  Sum_probs=87.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCccccc-----C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQ-----G   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~-----~   75 (131)
                      ++..++.|++.+|.|||+. +++|+||++.||+++.++.++++|||++......  ......++..|++||.+.     .
T Consensus       104 ~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  182 (282)
T cd06643         104 QIRVVCKQTLEALNYLHEN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD  182 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCC
Confidence            4577899999999999997 8999999999999999999999999987654321  223445778899999874     3


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      ..++.++|+||+|+++|++++|..||...+..+.
T Consensus       183 ~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~  216 (282)
T cd06643         183 RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV  216 (282)
T ss_pred             CCCCccchhhhHHHHHHHHccCCCCccccCHHHH
Confidence            4567899999999999999999999987665443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG1026|consensus

Probab=99.86  E-value=4.7e-22  Score=148.45  Aligned_cols=116  Identities=26%  Similarity=0.396  Sum_probs=99.2

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccccc----CCCCccceeCcccccCCC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~~~~Pe~~~~~~   77 (131)
                      .+.+.|+.|||.|+.||-+. .++||||-.+|+++.++-.||++|||+++..-.....    ...-.++||+||.+..+.
T Consensus       603 ~q~L~iA~QIAaGM~YLs~~-~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k  681 (774)
T KOG1026|consen  603 SQFLHIATQIAAGMEYLSSH-HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK  681 (774)
T ss_pred             HHHHHHHHHHHHHHHHHHhC-cccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc
Confidence            36788999999999999887 5999999999999999999999999998755332221    233456899999999999


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPSRG  118 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~  118 (131)
                      ++.++||||+|+++||+++ |..||.+...+++.+.+.+..-
T Consensus       682 FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l  723 (774)
T KOG1026|consen  682 FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL  723 (774)
T ss_pred             ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence            9999999999999999985 9999999999999888865543

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.86  E-value=1.2e-21  Score=135.44  Aligned_cols=105  Identities=35%  Similarity=0.614  Sum_probs=87.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      .+..++.|++.||.|||+. +++|+||++.||+++.++.++++|||++......  ......++..|++||.+.+. .++
T Consensus       105 ~~~~~~~qi~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  183 (301)
T cd07873         105 NVKLFLFQLLRGLNYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYS  183 (301)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCc
Confidence            4667889999999999997 8999999999999999999999999987643221  12233557789999988653 478


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      .++|+||+|+++|+|++|..||...+..+
T Consensus       184 ~~~Dv~slG~~l~el~tg~~~f~~~~~~~  212 (301)
T cd07873         184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEE  212 (301)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            89999999999999999999998766543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0666|consensus

Probab=99.86  E-value=4.6e-22  Score=135.52  Aligned_cols=99  Identities=33%  Similarity=0.582  Sum_probs=84.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC----CcEEEeeccccccccccc-----ccCCCCccceeCcccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG----GEIKICDFGVSGQLIDSM-----ANSFVGTRSYMSPERL   73 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~----~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~Pe~~   73 (131)
                      .++.++.||++|+.|||++ .++||||+|.||++..+    |.||++|+|+++......     ....+.|+.|+|||.+
T Consensus       133 mvKsilwQil~Gv~YLH~N-WvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELL  211 (438)
T KOG0666|consen  133 MVKSILWQILDGVHYLHSN-WVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELL  211 (438)
T ss_pred             HHHHHHHHHHhhhHHHhhh-heeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHh
Confidence            3678899999999999998 69999999999999876    889999999998775432     2234567899999999


Q ss_pred             cCC-CCCCcchHHHHHHHHHHHHhCCCCCC
Q psy17559         74 QGT-HYSVQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        74 ~~~-~~~~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      .+. .|+.+.|+|++||++.|+++-...|.
T Consensus       212 LGa~hYT~AiDvWAiGCIfaElLtl~PlF~  241 (438)
T KOG0666|consen  212 LGARHYTKAIDVWAIGCIFAELLTLEPLFK  241 (438)
T ss_pred             cccccccchhhhHHHHHHHHHHHccCcccc
Confidence            885 58999999999999999998665553

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.86  E-value=3.1e-21  Score=130.05  Aligned_cols=112  Identities=29%  Similarity=0.397  Sum_probs=90.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccccc----CCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.+|.|||++ +++|+||+|.||+++.++.++++|||.+.........    ....+..|++||.+.+..+
T Consensus        95 ~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  173 (252)
T cd05084          95 ELIQMVENAAAGMEYLESK-HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY  173 (252)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCC
Confidence            4577899999999999997 8999999999999999999999999987654322111    1122346999999988888


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      +.++|+||+|+++|++++ |..||.....+.....+..
T Consensus       174 ~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~  211 (252)
T cd05084         174 SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ  211 (252)
T ss_pred             ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc
Confidence            999999999999999997 8999987766655555443

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.86  E-value=3.2e-21  Score=135.24  Aligned_cols=110  Identities=31%  Similarity=0.515  Sum_probs=90.8

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCCC
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +..++.|++.||.|||++ |++|+||+|.||+++.++.++++|||+++......    .....++..|++||.+....++
T Consensus       136 ~~~~~~qi~~al~~LH~~-givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  214 (334)
T cd05100         136 LVSCAYQVARGMEYLASQ-KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT  214 (334)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC
Confidence            456889999999999997 89999999999999999999999999886543211    1112234579999999888899


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      .++|+||||+++|++++ |..||.....++....+.
T Consensus       215 ~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  250 (334)
T cd05100         215 HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK  250 (334)
T ss_pred             chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            99999999999999998 899998887777766553

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.86  E-value=1.5e-21  Score=134.67  Aligned_cols=106  Identities=37%  Similarity=0.643  Sum_probs=89.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.++.|||+. +++|+||++.||+++.++.++++|||++......  ......++..|++||......++.
T Consensus       119 ~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  197 (292)
T cd06658         119 QIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT  197 (292)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCc
Confidence            4678899999999999997 7999999999999999999999999987644321  122345677899999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      ++|+||+|++++++++|..||...+....
T Consensus       198 ~~Dv~slGvil~el~~g~~p~~~~~~~~~  226 (292)
T cd06658         198 EVDIWSLGIMVIEMIDGEPPYFNEPPLQA  226 (292)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999999999999976665443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=2.9e-21  Score=131.21  Aligned_cols=103  Identities=36%  Similarity=0.601  Sum_probs=87.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      .++.++.|++.++.+||+. +++|+||++.||+++.++.++++|||+++.....     ......++..|++||.+.+..
T Consensus       107 ~~~~~~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  185 (264)
T cd06653         107 VTRRYTRQILQGVSYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG  185 (264)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCC
Confidence            4567899999999999997 8999999999999999999999999988654321     112345677899999998888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      ++.++|+||+|++++++++|..||.....
T Consensus       186 ~~~~~Di~slG~il~~l~~g~~p~~~~~~  214 (264)
T cd06653         186 YGRKADVWSVACTVVEMLTEKPPWAEYEA  214 (264)
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCccCH
Confidence            89999999999999999999999976543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0671|consensus

Probab=99.86  E-value=1.1e-22  Score=140.98  Aligned_cols=105  Identities=30%  Similarity=0.529  Sum_probs=89.8

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC--------------------CcEEEeecccccccccccccCC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG--------------------GEIKICDFGVSGQLIDSMANSF   61 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~--------------------~~~~l~d~g~~~~~~~~~~~~~   61 (131)
                      .+++.|++|++.++++||+. +++|.||+|+||++.+.                    ..++++|||.+...... ....
T Consensus       192 ~~ir~m~~QL~~sv~fLh~~-kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-hs~i  269 (415)
T KOG0671|consen  192 DHIRHMGYQLLESVAFLHDL-KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-HSTI  269 (415)
T ss_pred             HHHHHHHHHHHHHHHHHHhc-ceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-ccee
Confidence            46889999999999999997 69999999999998432                    13789999988654433 2556


Q ss_pred             CCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         62 VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        62 ~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      +.|..|+|||++.+.+++..+|+||+||++.|+.+|..-|+..+..+
T Consensus       270 VsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  270 VSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             eeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence            78889999999999999999999999999999999999998777544

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.86  E-value=3.8e-21  Score=129.91  Aligned_cols=111  Identities=30%  Similarity=0.464  Sum_probs=93.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      ++..++.|++.++.|||++ +++|+||++.||+++.++.++++|||.+........ ....+..|++||.+....++.++
T Consensus       103 ~~~~~~~qi~~~l~~lh~~-~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~ape~~~~~~~~~~~  180 (256)
T cd05039         103 QQLGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-SGKLPVKWTAPEALREKKFSTKS  180 (256)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccchhcccceEEEeCCCCEEEcccccccccccccc-cCCCcccccCchhhcCCcCCcHH
Confidence            4678999999999999997 899999999999999999999999998876533222 22334579999999888889999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         83 DIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        83 d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      |+||+|++++++++ |..||.....+++...+..
T Consensus       181 Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~  214 (256)
T cd05039         181 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK  214 (256)
T ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Confidence            99999999999997 9999988877776665543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.86  E-value=1.9e-21  Score=134.52  Aligned_cols=110  Identities=35%  Similarity=0.596  Sum_probs=91.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.++.+||+. +++|+||++.||+++.++.++++|||++......  ......++..|++||.+.+..++.
T Consensus       118 ~~~~~~~qi~~~L~~LH~~-~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  196 (297)
T cd06659         118 QIATVCESVLQALCYLHSQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT  196 (297)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCc
Confidence            4677899999999999997 7999999999999999999999999987543321  123345778899999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|++++++++|..||......+....+
T Consensus       197 ~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~  229 (297)
T cd06659         197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL  229 (297)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999766655444443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.86  E-value=2.5e-21  Score=131.21  Aligned_cols=110  Identities=27%  Similarity=0.457  Sum_probs=90.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc---cCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||+|||+. |++|+||++.|+++++++.++++|||.+........   ....++..|++||...+..++
T Consensus       103 ~~~~~~~~l~~al~~lH~~-~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~  181 (260)
T cd05069         103 QLVDMAAQIADGMAYIERM-NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT  181 (260)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcC
Confidence            4578899999999999987 899999999999999999999999998865432211   122345679999999888889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||+|+++|++++ |..||......+.....
T Consensus       182 ~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~  216 (260)
T cd05069         182 IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV  216 (260)
T ss_pred             hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            99999999999999998 99999876655544433

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.86  E-value=1.5e-21  Score=134.26  Aligned_cols=112  Identities=30%  Similarity=0.488  Sum_probs=91.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.|++|||+. +++|+||+|.||+++.++.++++|||.+.......    .....++..|++||......+
T Consensus       133 ~~~~i~~qi~~al~~LH~~-~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  211 (293)
T cd05053         133 DLVSFAYQVARGMEFLASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY  211 (293)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc
Confidence            3567899999999999997 89999999999999999999999999886543321    111223457999999888888


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      +.++|+||||+++|++++ |..||......+..+....
T Consensus       212 ~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  249 (293)
T cd05053         212 THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE  249 (293)
T ss_pred             CcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999999999987 9999988877666665543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.86  E-value=1.3e-21  Score=132.13  Aligned_cols=110  Identities=33%  Similarity=0.524  Sum_probs=92.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      .+..++.|++.|+++||+. +++|+||++.||+++.++.++++|||.+......  ......++..|++||.+.+..++.
T Consensus       101 ~~~~~~~~i~~al~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  179 (255)
T cd08219         101 TILQWFVQMCLGVQHIHEK-RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNN  179 (255)
T ss_pred             HHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCc
Confidence            3567899999999999997 8999999999999999999999999987654321  123345777899999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|..||...+.......+
T Consensus       180 ~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~  212 (255)
T cd08219         180 KSDIWSLGCILYELCTLKHPFQANSWKNLILKV  212 (255)
T ss_pred             hhhhhhhchhheehhhccCCCCCCCHHHHHHHH
Confidence            999999999999999999999877766554444

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.86  E-value=2.7e-21  Score=131.32  Aligned_cols=110  Identities=25%  Similarity=0.447  Sum_probs=90.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc---cCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.+|+++|++ +++|+||+|.||+++.++.++++|||.+........   ....++..|++||...+..++
T Consensus       103 ~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~  181 (262)
T cd05071         103 QLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT  181 (262)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCC
Confidence            4678899999999999997 799999999999999999999999998865432211   122345679999999888889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||+|+++|++++ |..||......+.....
T Consensus       182 ~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~  216 (262)
T cd05071         182 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV  216 (262)
T ss_pred             chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH
Confidence            99999999999999998 89899877665554443

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=2.5e-21  Score=131.08  Aligned_cols=108  Identities=32%  Similarity=0.588  Sum_probs=91.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .+..++.|++.||.|+|+. +++|+||++.||+++.++.++++|||++.....  .....++..|++||.+.+..++.++
T Consensus        98 ~~~~i~~qi~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~  174 (260)
T cd05611          98 WAKQYIAEVVLGVEDLHQR-GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--NKKFVGTPDYLAPETILGVGDDKMS  174 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEeecccceeccc--cccCCCCcCccChhhhcCCCCcchh
Confidence            4678999999999999997 799999999999999999999999998764332  2334567789999999887789999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      |+||+|+++|++++|..||...+........
T Consensus       175 Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  205 (260)
T cd05611         175 DWWSLGCVIFEFLFGYPPFHAETPDAVFDNI  205 (260)
T ss_pred             hhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            9999999999999999999877766554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.86  E-value=3.4e-21  Score=130.84  Aligned_cols=102  Identities=38%  Similarity=0.610  Sum_probs=86.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      .+..++.|++.+|++||+. +++|+||++.||+++.++.++++|||.+......     ......++..|++||...+..
T Consensus       107 ~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  185 (265)
T cd06652         107 VTRKYTRQILEGVSYLHSN-MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG  185 (265)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCC
Confidence            3567899999999999997 7999999999999999999999999987644321     122345677899999998878


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ++.++|+||||+++|++++|..||....
T Consensus       186 ~~~~~Dv~slG~il~el~~g~~p~~~~~  213 (265)
T cd06652         186 YGRKADIWSVGCTVVEMLTEKPPWAEFE  213 (265)
T ss_pred             CCcchhHHHHHHHHHHHhhCCCCCCccc
Confidence            8999999999999999999999997654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.86  E-value=1.8e-21  Score=133.37  Aligned_cols=102  Identities=26%  Similarity=0.456  Sum_probs=85.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-----ccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.++.|||++ +++|+||+|.||+++.++.++++|||++.......     .....++..|++||.+....
T Consensus       108 ~~~~i~~~l~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~  186 (283)
T cd05080         108 QLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK  186 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccC
Confidence            4678899999999999997 79999999999999999999999999986543221     11223455689999998888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ++.++|+||||++++++++|..||....
T Consensus       187 ~~~~~Di~slG~~l~el~tg~~p~~~~~  214 (283)
T cd05080         187 FSYASDVWSFGVTLYELLTHCDSKQSPP  214 (283)
T ss_pred             CCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence            8999999999999999999999986443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0665|consensus

Probab=99.86  E-value=5.9e-22  Score=134.87  Aligned_cols=103  Identities=40%  Similarity=0.660  Sum_probs=91.8

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++++.+.+|.+.|++++|+. ||+||||+|.||++..+..+|+.|||+++..... .....+.+..|.|||++.+.++..
T Consensus       118 ~tis~i~yq~~~~ik~lhs~-~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke  196 (369)
T KOG0665|consen  118 ETISYILYQMLCGIKHLHSA-GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKE  196 (369)
T ss_pred             HHHHHHHHHHHHHHHHHHhc-ceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcc
Confidence            46789999999999999997 8999999999999999999999999999776554 344456777899999999999999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      .+|+||+||++.||+.|..-|++.+
T Consensus       197 ~vdiwSvGci~gEli~~~Vlf~g~d  221 (369)
T KOG0665|consen  197 NVDIWSVGCIMGELILGTVLFPGKD  221 (369)
T ss_pred             cchhhhhhhHHHHHhhceEEecCch
Confidence            9999999999999999999887554

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.86  E-value=2.9e-21  Score=130.81  Aligned_cols=109  Identities=28%  Similarity=0.508  Sum_probs=87.3

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc------cccCCCCccceeCcccccCCC
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS------MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      +..++.|++.|+.|||+. +++|+||++.||+++.++.++++|||++......      ......++..|++||.+....
T Consensus       100 ~~~~~~~i~~~l~~lH~~-~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  178 (262)
T cd05058         100 LIGFGLQVAKGMEYLASK-KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK  178 (262)
T ss_pred             HHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCc
Confidence            467888999999999997 7999999999999999999999999987643221      111223455799999998888


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      ++.++|+||||+++|++++ |..||...+..+....+
T Consensus       179 ~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~  215 (262)
T cd05058         179 FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL  215 (262)
T ss_pred             cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            8999999999999999998 56677766655555444

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.86  E-value=3.7e-21  Score=131.58  Aligned_cols=112  Identities=28%  Similarity=0.447  Sum_probs=92.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc----cCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      .+..++.|++.|++|||+. +++|+||++.||+++.++.++++|||.++.......    .....+..|++||......+
T Consensus       110 ~~~~~~~qi~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~  188 (279)
T cd05057         110 YLLNWCVQIAKGMSYLEEK-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY  188 (279)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCc
Confidence            4678899999999999997 899999999999999999999999998865432111    11122457999999987788


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      +.++|+||+|++++++++ |..||.....+++.+.+..
T Consensus       189 ~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  226 (279)
T cd05057         189 THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK  226 (279)
T ss_pred             CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Confidence            999999999999999998 9999998887777776654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.86  E-value=4.7e-21  Score=129.06  Aligned_cols=112  Identities=39%  Similarity=0.567  Sum_probs=95.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .+..++.|++.|+++||+. |++|+||++.||+++.++.++++|||++............++..|++||.+.+..++.++
T Consensus       104 ~~~~~~~~l~~al~~lh~~-~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~  182 (256)
T cd08530         104 EIWRIFIQLLRGLQALHEQ-KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKS  182 (256)
T ss_pred             HHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEEecCCcEEEeeccchhhhccCCcccccCCccccCHHHHCCCCCCchh
Confidence            4568899999999999997 899999999999999999999999998866544433445677789999999888888999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCC
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~  115 (131)
                      |+||+|++++++++|+.||...+.++.......
T Consensus       183 D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~  215 (256)
T cd08530         183 DIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR  215 (256)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence            999999999999999999988777665555443

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.86  E-value=3.1e-21  Score=131.96  Aligned_cols=111  Identities=28%  Similarity=0.451  Sum_probs=92.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||+|||+. +++|+||++.|++++.++.++++|||+++......    .....++..|++||.+....+
T Consensus       118 ~~~~i~~~i~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~  196 (280)
T cd05043         118 QLVHMAIQIACGMSYLHKR-GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY  196 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC
Confidence            4567899999999999987 79999999999999999999999999986543221    122344567999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||+|+++|++++ |..||...+..+....+.
T Consensus       197 ~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  233 (280)
T cd05043         197 SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK  233 (280)
T ss_pred             CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH
Confidence            999999999999999998 999998777666665443

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.86  E-value=3.6e-21  Score=130.01  Aligned_cols=112  Identities=33%  Similarity=0.514  Sum_probs=94.8

Q ss_pred             chhHHHHHHHHHHHHHH-----hcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc--ccCCCCccceeCcccccC
Q psy17559          3 QVPYSSFQVLKGLTYLR-----EKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVGTRSYMSPERLQG   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh-----~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~Pe~~~~   75 (131)
                      ++..++.|++.++.++|     +. +++|+||++.||+++.++.++++|||.+.......  .....++..|++||.+..
T Consensus       106 ~~~~~~~~i~~~l~~lH~~~~~~~-~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~  184 (265)
T cd08217         106 FIWRILTQLLLALYECHNRSDPGN-TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH  184 (265)
T ss_pred             HHHHHHHHHHHHHHHHhcCccccC-cceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcC
Confidence            46788999999999999     76 79999999999999999999999999886654322  234467788999999988


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCC
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~  115 (131)
                      ..++.++|+||+|++++++++|..||...+.+...+....
T Consensus       185 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  224 (265)
T cd08217         185 MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE  224 (265)
T ss_pred             CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc
Confidence            8889999999999999999999999988776666655543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.86  E-value=3.7e-21  Score=129.68  Aligned_cols=107  Identities=43%  Similarity=0.718  Sum_probs=90.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.++.|||+. +++|+|+++.||+++.++.++++|||.+......  ......++..|++||.+.+..++.
T Consensus       100 ~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  178 (256)
T cd06612         100 EIAAILYQTLKGLEYLHSN-KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN  178 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCc
Confidence            4578999999999999997 7999999999999999999999999987654332  223345677899999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLA  110 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~  110 (131)
                      ++|+||+|++++++++|..||......+..
T Consensus       179 ~~Di~s~G~il~~l~~g~~p~~~~~~~~~~  208 (256)
T cd06612         179 KADIWSLGITAIEMAEGKPPYSDIHPMRAI  208 (256)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCcchhhhh
Confidence            999999999999999999999766544333

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.86  E-value=1e-21  Score=134.83  Aligned_cols=103  Identities=50%  Similarity=0.897  Sum_probs=86.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCC---CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT---HY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~---~~   78 (131)
                      ++..++.|++.||+|||+..+++|+||++.||+++.++.++++|||++...... ......++..|++||.+...   .+
T Consensus       108 ~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  187 (288)
T cd06616         108 ILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGY  187 (288)
T ss_pred             HHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCC
Confidence            457889999999999997557999999999999999999999999988654332 22334567789999998765   58


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      +.++|+||+|+++|++++|..||....
T Consensus       188 ~~~~Di~slG~il~el~~g~~p~~~~~  214 (288)
T cd06616         188 DVRSDVWSLGITLYEVATGKFPYPKWN  214 (288)
T ss_pred             cchhhhhHHHHHHHHHHhCCCCchhcc
Confidence            899999999999999999999997554

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.86  E-value=4.5e-21  Score=130.40  Aligned_cols=106  Identities=25%  Similarity=0.425  Sum_probs=85.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCc-------EEEeecccccccccccccCCCCccceeCccccc-
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE-------IKICDFGVSGQLIDSMANSFVGTRSYMSPERLQ-   74 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~-------~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~-   74 (131)
                      .+..++.|++.|++|||++ +++|+||+|.||+++.++.       ++++|||++......  ....++..|++||.+. 
T Consensus       106 ~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~y~aPE~~~~  182 (262)
T cd05077         106 WKFKVAKQLASALSYLEDK-DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR--QECVERIPWIAPECVED  182 (262)
T ss_pred             HHHHHHHHHHHHHHHhhhC-CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc--ccccccccccChhhhcC
Confidence            3567899999999999997 8999999999999986654       799999987544321  2335667899999886 


Q ss_pred             CCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCHHHHHH
Q psy17559         75 GTHYSVQSDIWSLGLSLVEMA-IGMYPIPPPDAKTLAA  111 (131)
Q Consensus        75 ~~~~~~~~d~~slg~~l~~l~-~g~~p~~~~~~~~~~~  111 (131)
                      +..++.++|+||||+++|+++ .|..||......+..+
T Consensus       183 ~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~  220 (262)
T cd05077         183 SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER  220 (262)
T ss_pred             CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH
Confidence            456889999999999999997 6888987766554444

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.86  E-value=3.8e-21  Score=132.88  Aligned_cols=105  Identities=32%  Similarity=0.599  Sum_probs=89.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.++.+||+. |++|+||++.||+++.++.++++|||++......  ......++..|++||.+.+..++.
T Consensus       116 ~~~~i~~~l~~al~~LH~~-~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  194 (296)
T cd06655         116 QIAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP  194 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCc
Confidence            5678899999999999997 8999999999999999999999999987644322  122345677899999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      ++|+||+|+++|++++|..||...+...
T Consensus       195 ~~Dv~slGvil~~lltg~~pf~~~~~~~  222 (296)
T cd06655         195 KVDIWSLGIMAIEMVEGEPPYLNENPLR  222 (296)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999999998766543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0032|consensus

Probab=99.86  E-value=2e-21  Score=138.22  Aligned_cols=111  Identities=31%  Similarity=0.525  Sum_probs=96.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC----CcEEEeeccccccccc-ccccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG----GEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~----~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.+++|||+. |++|||++|+|+++...    +.++++|||++..... .......|++.|+|||++....
T Consensus       136 da~~~~~~il~av~~lH~~-gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~  214 (382)
T KOG0032|consen  136 DAAGIIRQILEAVKYLHSL-GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRP  214 (382)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCC
Confidence            5678999999999999997 89999999999999743    4699999999977654 3456778999999999999899


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~  114 (131)
                      ++..+|+||+|++.|.|++|..||...........+.
T Consensus       215 y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~  251 (382)
T KOG0032|consen  215 YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL  251 (382)
T ss_pred             CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH
Confidence            9999999999999999999999998887665555443

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.86  E-value=4.2e-21  Score=130.49  Aligned_cols=104  Identities=38%  Similarity=0.621  Sum_probs=87.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ....++.|++.++.+||+. +++|+|+++.||+++.++.++++|||++......     ......++..|++||.+.+..
T Consensus       107 ~~~~~~~qi~~~l~~LH~~-~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  185 (266)
T cd06651         107 VTRKYTRQILEGMSYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG  185 (266)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCC
Confidence            3457899999999999987 7999999999999999999999999987643221     112345677899999998888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      ++.++|+||+|+++|++++|..||...+..
T Consensus       186 ~~~~~Dv~slG~i~~el~~g~~pf~~~~~~  215 (266)
T cd06651         186 YGRKADVWSLGCTVVEMLTEKPPWAEYEAM  215 (266)
T ss_pred             CCchhhhHHHHHHHHHHHHCCCCccccchH
Confidence            899999999999999999999999766543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.86  E-value=2.3e-21  Score=133.75  Aligned_cols=107  Identities=27%  Similarity=0.434  Sum_probs=87.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.|++|||+. +++|+||+|.||+++.++.++++|||++.......    ......+..|++||......+
T Consensus       131 ~~~~~~~~i~~al~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~  209 (296)
T cd05095         131 TLIFMATQIASGMKYLSSL-NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF  209 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc
Confidence            4678899999999999997 89999999999999999999999999986543221    112233467899998887889


Q ss_pred             CCcchHHHHHHHHHHHHh--CCCCCCCCCHHHHH
Q psy17559         79 SVQSDIWSLGLSLVEMAI--GMYPIPPPDAKTLA  110 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~--g~~p~~~~~~~~~~  110 (131)
                      +.++|+||||+++|++++  +..||......+..
T Consensus       210 ~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~  243 (296)
T cd05095         210 TTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI  243 (296)
T ss_pred             cchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence            999999999999999997  77898766554443

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.86  E-value=2.4e-21  Score=132.11  Aligned_cols=100  Identities=30%  Similarity=0.582  Sum_probs=87.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC-cEEEeecccccccccccccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG-EIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.|+.+||+. |++|+||++.||+++.++ .++++|||.+......  ....++..|++||.+.+..++.+
T Consensus       110 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~  186 (267)
T PHA03390        110 EVKKIIRQLVEALNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--SCYDGTLDYFSPEKIKGHNYDVS  186 (267)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--ccCCCCCcccChhhhcCCCCCch
Confidence            5678999999999999997 899999999999999888 8999999987654332  23456778999999988888999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      +|+||+|++++++++|..||....
T Consensus       187 ~DvwslG~il~~l~~g~~p~~~~~  210 (267)
T PHA03390        187 FDWWAVGVLTYELLTGKHPFKEDE  210 (267)
T ss_pred             hhHHHHHHHHHHHHHCCCCCCCCC
Confidence            999999999999999999997544

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.86  E-value=4.5e-21  Score=129.56  Aligned_cols=111  Identities=33%  Similarity=0.540  Sum_probs=92.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----------cccCCCCccceeCccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----------MANSFVGTRSYMSPER   72 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----------~~~~~~~~~~~~~Pe~   72 (131)
                      ++..++.|++.+|++||+. +++|+||++.||+++.++.++++|||++......          ......++..|++||.
T Consensus        94 ~~~~i~~qi~~~L~~lH~~-~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~  172 (265)
T cd05579          94 VARIYIAEIVLALEYLHSN-GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV  172 (265)
T ss_pred             HHHHHHHHHHHHHHHHHHc-CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHH
Confidence            4567899999999999997 8999999999999999999999999987543222          1223346678999999


Q ss_pred             ccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhC
Q psy17559         73 LQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        73 ~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~  114 (131)
                      ......+.++|+||+|++++++++|..||.....++......
T Consensus       173 ~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~  214 (265)
T cd05579         173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL  214 (265)
T ss_pred             hcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence            988788999999999999999999999998777665554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.86  E-value=3.7e-21  Score=130.73  Aligned_cols=110  Identities=30%  Similarity=0.514  Sum_probs=89.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC-----cEEEeeccccccccccc----ccCCCCccceeCcccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG-----EIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERL   73 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~-----~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~   73 (131)
                      ++..++.|++.+++|||++ +++|+||++.||+++.++     .++++|||++.......    ......+..|++||.+
T Consensus       107 ~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  185 (269)
T cd05044         107 ELLDICLDVAKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESL  185 (269)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHH
Confidence            4567899999999999997 799999999999999877     79999999876543221    1122345679999999


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         74 QGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        74 ~~~~~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      ....++.++|+||||+++|++++ |..||...+..+....+
T Consensus       186 ~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~  226 (269)
T cd05044         186 LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV  226 (269)
T ss_pred             ccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH
Confidence            88889999999999999999998 99999876665555443

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.86  E-value=3.9e-21  Score=132.13  Aligned_cols=110  Identities=24%  Similarity=0.447  Sum_probs=90.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.|++|||++ +++|+||+|.||+++.++.++++|||+++......    .....++..|++||.+....+
T Consensus       120 ~~~~~~~~l~~~l~~lH~~-~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~  198 (288)
T cd05061         120 EMIQMAAEIADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF  198 (288)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCC
Confidence            3567899999999999997 89999999999999999999999999876443211    112233557999999988888


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      +.++|+||+|+++|++++ |..||.+...++..+.+
T Consensus       199 ~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~  234 (288)
T cd05061         199 TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV  234 (288)
T ss_pred             ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999999999998 78899887777666544

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.86  E-value=3.7e-21  Score=130.34  Aligned_cols=111  Identities=26%  Similarity=0.469  Sum_probs=91.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---ccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.+|+|||+. +++|+||+|.|++++.++.++++|||.+.......   .....++..|++||.+....++
T Consensus       103 ~~~~i~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~  181 (260)
T cd05067         103 KLIDMAAQIAEGMAFIERK-NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT  181 (260)
T ss_pred             HHHHHHHHHHHHHHHHhcC-CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcC
Confidence            4567889999999999987 89999999999999999999999999886544211   1122345679999999888889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      .++|+||||++++++++ |..||...+..+..+.+.
T Consensus       182 ~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  217 (260)
T cd05067         182 IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE  217 (260)
T ss_pred             cccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Confidence            99999999999999998 999998777666655543

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.86  E-value=4.4e-21  Score=130.22  Aligned_cols=103  Identities=45%  Similarity=0.706  Sum_probs=87.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--------cccCCCCccceeCccccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--------MANSFVGTRSYMSPERLQ   74 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--------~~~~~~~~~~~~~Pe~~~   74 (131)
                      ++..++.|++.++++||+. +++|+||+|.||+++.++.++++|||.++.....        ......++..|++||.+.
T Consensus       107 ~~~~~~~~l~~~l~~lH~~-~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~  185 (267)
T cd06628         107 LVRNFVRQILKGLNYLHNR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK  185 (267)
T ss_pred             HHHHHHHHHHHHHHHHHhc-CcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhc
Confidence            4567899999999999997 8999999999999999999999999987654321        111234667899999998


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         75 GTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        75 ~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      ...++.++|+||+|+++|++++|..||...+.
T Consensus       186 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  217 (267)
T cd06628         186 QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ  217 (267)
T ss_pred             cCCCCchhhhHHHHHHHHHHhhCCCCCCCccH
Confidence            88888999999999999999999999986554

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=4.6e-21  Score=129.64  Aligned_cols=105  Identities=40%  Similarity=0.673  Sum_probs=88.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCC---C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT---H   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~---~   77 (131)
                      ++..++.|++.++.|||+. +++|+||++.||+++.++.++++|||.+......  ......++..|++||.....   .
T Consensus       102 ~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~  180 (262)
T cd06613         102 QIAYVCRETLKGLAYLHET-GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGG  180 (262)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCC
Confidence            4567999999999999997 8999999999999999999999999987654322  22334567789999998776   7


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      ++.++|+||+|+++|+|++|..||.......
T Consensus       181 ~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~  211 (262)
T cd06613         181 YDGKCDIWALGITAIELAELQPPMFDLHPMR  211 (262)
T ss_pred             cCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            8889999999999999999999997665443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.85  E-value=3.1e-21  Score=134.79  Aligned_cols=105  Identities=40%  Similarity=0.680  Sum_probs=89.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-----ccCCCCccceeCcccccCC-
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGT-   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~Pe~~~~~-   76 (131)
                      .+..++.|++.+|++||+. |++|+||++.||+++.++.++++|||.+.......     .....++..|++||.+.+. 
T Consensus       104 ~~~~i~~~l~~~l~~LH~~-gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  182 (330)
T cd07834         104 HIQYFLYQILRGLKYLHSA-NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS  182 (330)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeeccc
Confidence            4567999999999999997 89999999999999999999999999886554321     2334567789999999877 


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         77 HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      .++.++|+||+|++++++++|..||...+..+
T Consensus       183 ~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~  214 (330)
T cd07834         183 RYTKAIDIWSVGCIFAELLTRKPLFPGRDYID  214 (330)
T ss_pred             CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH
Confidence            78999999999999999999999998776543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.85  E-value=4e-21  Score=129.74  Aligned_cols=104  Identities=26%  Similarity=0.423  Sum_probs=85.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC-------cEEEeecccccccccccccCCCCccceeCcccccC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG-------EIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~-------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~   75 (131)
                      .+..++.|++.||+|||+. +++|+||+|.||+++.++       .++++|||++.....  .....+...|++||.+..
T Consensus       102 ~~~~~~~~i~~~l~~LH~~-~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~  178 (259)
T cd05037         102 WKLDVAKQLASALHYLEDK-KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS--REERVERIPWIAPECIRN  178 (259)
T ss_pred             HHHHHHHHHHHHHHHHhhC-CeecccCccceEEEecCccccCCceeEEeCCCCccccccc--ccccccCCCccChhhhcC
Confidence            4567889999999999997 799999999999999877       699999998865433  223445668999999987


Q ss_pred             C--CCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy17559         76 T--HYSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTL  109 (131)
Q Consensus        76 ~--~~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~  109 (131)
                      .  .++.++|+||+|+++|++++ |..||......+.
T Consensus       179 ~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~  215 (259)
T cd05037         179 GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK  215 (259)
T ss_pred             CCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH
Confidence            6  68899999999999999998 5888876654433

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.85  E-value=7e-21  Score=131.06  Aligned_cols=105  Identities=40%  Similarity=0.661  Sum_probs=86.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccC-----
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQG-----   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-----   75 (131)
                      ++..++.|++.++.+||+. +++|+|+++.||+++.++.++++|||.+......  ......++..|++||.+.+     
T Consensus       111 ~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  189 (292)
T cd06644         111 QIQVICRQMLEALQYLHSM-KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD  189 (292)
T ss_pred             HHHHHHHHHHHHHHHHhcC-CeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccC
Confidence            4678899999999999987 8999999999999999999999999987543221  2233456778999999853     


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      ..++.++|+||||+++|++++|..||...+...
T Consensus       190 ~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  222 (292)
T cd06644         190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMR  222 (292)
T ss_pred             CCCCchhhhHhHHHHHHHHhcCCCCCccccHHH
Confidence            346788999999999999999999997665443

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.85  E-value=3.3e-21  Score=131.95  Aligned_cols=98  Identities=37%  Similarity=0.601  Sum_probs=82.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      ++..++.|++.||.|||+. +++|+||++.||+++.++.++++|||++......  ......++..|++||.+.+. .++
T Consensus       100 ~~~~~~~qi~~al~~LH~~-~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  178 (284)
T cd07839         100 IVKSFMFQLLKGLAFCHSH-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS  178 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccC
Confidence            4678999999999999997 8999999999999999999999999987654321  12234556789999998764 468


Q ss_pred             CcchHHHHHHHHHHHHhCCCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPI  101 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~  101 (131)
                      .++|+||+|+++|+|++|..|+
T Consensus       179 ~~~DiwslG~il~~l~tg~~p~  200 (284)
T cd07839         179 TSIDMWSAGCIFAELANAGRPL  200 (284)
T ss_pred             cHHHHHHHHHHHHHHHhcCCCC
Confidence            9999999999999999988885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.85  E-value=2.9e-21  Score=132.21  Aligned_cols=103  Identities=33%  Similarity=0.544  Sum_probs=85.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      ++..++.|++.||.|||+. +++|+||++.||+++.++.++++|||++......  ......++..|++||.+.+. .++
T Consensus       102 ~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  180 (285)
T cd07861         102 LVKSYLYQILQGILFCHSR-RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYS  180 (285)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcC
Confidence            4567899999999999997 8999999999999999999999999987644321  11233456789999988654 468


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      .++|+||+|++++++++|..||.....
T Consensus       181 ~~~Dv~slG~il~~l~tg~~~~~~~~~  207 (285)
T cd07861         181 TPVDIWSIGTIFAEMATKKPLFHGDSE  207 (285)
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            899999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.85  E-value=7.3e-21  Score=128.03  Aligned_cols=111  Identities=32%  Similarity=0.450  Sum_probs=90.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc---cCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.++.|+|++ +++|+||++.||+++.++.++++|||++........   .....+..|++||.+....++
T Consensus        94 ~~~~~~~~i~~~l~~lH~~-~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  172 (250)
T cd05085          94 QLVKFALDAAAGMAYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS  172 (250)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCC
Confidence            4577889999999999987 899999999999999999999999998764432211   112334569999999888889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      .++|+||+|+++|++++ |..||...........+.
T Consensus       173 ~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~  208 (250)
T cd05085         173 SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE  208 (250)
T ss_pred             chhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence            99999999999999998 999998777665544443

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.85  E-value=5e-21  Score=130.98  Aligned_cols=104  Identities=33%  Similarity=0.498  Sum_probs=88.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.||++||+. +++|+|+++.||+++.++.++++|||.+...... ......++..|++||.+.+..++.+
T Consensus       108 ~~~~~~~~i~~al~~LH~~-~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~  186 (287)
T cd07838         108 TIKDLMRQLLRGVDFLHSH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATP  186 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeccCChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCc
Confidence            4678999999999999997 7999999999999999999999999987654322 2223346678999999988888999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +|+||+|+++|++++|..||......
T Consensus       187 ~Di~s~G~~l~~l~~~~~~~~~~~~~  212 (287)
T cd07838         187 VDMWSVGCIFAELFRRRPLFRGTSEA  212 (287)
T ss_pred             chhhhHHHHHHHHHhCCCcccCCChH
Confidence            99999999999999999999866644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.85  E-value=5.1e-21  Score=129.68  Aligned_cols=102  Identities=34%  Similarity=0.621  Sum_probs=88.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.+|+|+|+. +++|+||++.||+++.++.++++|||.+...... ......++..|++||.+....++.+
T Consensus        94 ~~~~~~~~i~~~l~~lH~~-~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~  172 (262)
T cd05572          94 TARFYIACVVLAFEYLHNR-GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS  172 (262)
T ss_pred             HHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCCh
Confidence            4567889999999999997 8999999999999999999999999988655432 2233456778999999888788999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      +|+||+|+++|++++|..||...+
T Consensus       173 ~Di~slG~il~~l~~g~~p~~~~~  196 (262)
T cd05572         173 VDYWSLGILLYELLTGRPPFGEDD  196 (262)
T ss_pred             hhhhhhHHHHHHHHhCCCCcCCCC
Confidence            999999999999999999997665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.85  E-value=5.7e-21  Score=131.47  Aligned_cols=109  Identities=27%  Similarity=0.410  Sum_probs=88.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||+|||+. +++|+||+|.||+++.++.++++|||.+.......    .....++..|++||.+....+
T Consensus       131 ~~~~~~~~i~~al~~LH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  209 (296)
T cd05051         131 TLLYMATQIASGMRYLESL-NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF  209 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHc-CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC
Confidence            4578899999999999997 89999999999999999999999999876543221    123344567999999988788


Q ss_pred             CCcchHHHHHHHHHHHHh--CCCCCCCCCHHHHHHH
Q psy17559         79 SVQSDIWSLGLSLVEMAI--GMYPIPPPDAKTLAAI  112 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~--g~~p~~~~~~~~~~~~  112 (131)
                      +.++|+||||+++|++++  +..||......+..+.
T Consensus       210 ~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~  245 (296)
T cd05051         210 TTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIEN  245 (296)
T ss_pred             CccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHH
Confidence            999999999999999987  7788876655544443

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.85  E-value=3.8e-21  Score=132.92  Aligned_cols=105  Identities=30%  Similarity=0.454  Sum_probs=87.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc------ccCCCCccceeCcccccCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM------ANSFVGTRSYMSPERLQGT   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~~~~~~Pe~~~~~   76 (131)
                      +++.++.|++.||.|||+. +++|+||++.||+++.++.++++|||.+.......      .....++..|++||.+.+.
T Consensus       120 ~~~~i~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  198 (310)
T cd07865         120 EIKKVMKMLLNGLYYIHRN-KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE  198 (310)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCC
Confidence            5678999999999999997 89999999999999999999999999886543211      1233456789999988664


Q ss_pred             -CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         77 -HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        77 -~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                       .++.++|+||+|+++|++++|..||...+...
T Consensus       199 ~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~  231 (310)
T cd07865         199 RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH  231 (310)
T ss_pred             cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence             36789999999999999999999998766543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=5.7e-21  Score=132.81  Aligned_cols=105  Identities=36%  Similarity=0.588  Sum_probs=87.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--------------------------
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--------------------------   56 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--------------------------   56 (131)
                      .+..++.|++.+|.|||+. |++|+||+++||+++.++.++++|||.+......                          
T Consensus       104 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (316)
T cd05574         104 VARFYAAEVLLALEYLHLL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS  182 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhc
Confidence            3566889999999999997 8999999999999999999999999986533211                          


Q ss_pred             -----cccCCCCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         57 -----MANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        57 -----~~~~~~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                           ......++..|++||.+.+..++.++|+||||+++|++++|..||...+...
T Consensus       183 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  239 (316)
T cd05574         183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE  239 (316)
T ss_pred             ccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence                 0112356778999999988888999999999999999999999997666543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.85  E-value=6.5e-21  Score=129.02  Aligned_cols=111  Identities=29%  Similarity=0.472  Sum_probs=91.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc--ccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.|+.|||+. |++|+||++.||+++.++.++++|||.+.......  .....++..|++||......++.
T Consensus       105 ~~~~~~~~i~~al~~lH~~-~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~  183 (261)
T cd05148         105 SLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFST  183 (261)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCc
Confidence            4577899999999999997 89999999999999999999999999886543221  11223455799999998888899


Q ss_pred             cchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         81 QSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      ++|+||||++++++++ |+.||......+....+.
T Consensus       184 ~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~  218 (261)
T cd05148         184 KSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT  218 (261)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence            9999999999999998 899998776655555443

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.85  E-value=5e-21  Score=130.19  Aligned_cols=111  Identities=29%  Similarity=0.498  Sum_probs=92.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      +++.++.|++.++.+||+..+++|+||++.||+++.++.++++|||.+...... ......++..|++||.+.+..++.+
T Consensus       114 ~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~  193 (269)
T cd08528         114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEK  193 (269)
T ss_pred             HHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchH
Confidence            457789999999999997447999999999999999999999999988654432 2234567778999999988888999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      +|+||+|+++|++++|..||...+.......+
T Consensus       194 ~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~  225 (269)
T cd08528         194 ADVWAFGCILYQMCTLQPPFYSTNMLSLATKI  225 (269)
T ss_pred             HHHHHHHHHHHHHHhCCCcccccCHHHHHHHH
Confidence            99999999999999999999877665544443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.85  E-value=4.6e-21  Score=130.52  Aligned_cols=110  Identities=22%  Similarity=0.441  Sum_probs=90.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      .+..++.|++.+++|||++ +++|+||+|.||+++.++.++++|||.+......    ......++..|++||......+
T Consensus       114 ~~~~~~~~i~~~l~~lH~~-~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~  192 (273)
T cd05074         114 TLVRFMIDIASGMEYLSSK-NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVY  192 (273)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCcc
Confidence            3578999999999999997 8999999999999999999999999987654321    1122234467899999988888


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      +.++|+||+|+++|++++ |..||...+..+.....
T Consensus       193 ~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~  228 (273)
T cd05074         193 TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL  228 (273)
T ss_pred             chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence            999999999999999998 89999877766554443

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.85  E-value=4.1e-21  Score=133.23  Aligned_cols=107  Identities=36%  Similarity=0.515  Sum_probs=88.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccC-CCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQG-THYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~   79 (131)
                      ++..++.|++.++.|||+. +++|+||++.||+++.++.++++|||.+......  ......++..|++||.+.+ ..++
T Consensus       109 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  187 (309)
T cd07845         109 QVKCLMLQLLRGLQYLHEN-FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYT  187 (309)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcC
Confidence            4577999999999999997 8999999999999999999999999988655432  1122234667999999865 4578


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLA  110 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~  110 (131)
                      .++|+||+|+++|++++|..||...+..+..
T Consensus       188 ~~~DvwslG~il~el~~g~~~f~~~~~~~~~  218 (309)
T cd07845         188 TAIDMWAVGCILAELLAHKPLLPGKSEIEQL  218 (309)
T ss_pred             chHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999999999999999999999876655443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.85  E-value=1.1e-20  Score=128.71  Aligned_cols=105  Identities=22%  Similarity=0.384  Sum_probs=84.7

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCC---
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGT---   76 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~---   76 (131)
                      +..++.|++.+++|||++ +++|+||++.|++++.++.++++|||.+.......    .....++..|++||.+...   
T Consensus       102 ~~~~~~qi~~al~~lH~~-~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  180 (269)
T cd05087         102 LQRMACEIALGLLHLHKN-NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN  180 (269)
T ss_pred             HHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhcccccc
Confidence            457889999999999997 89999999999999999999999999875432211    1223456679999988532   


Q ss_pred             ----CCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy17559         77 ----HYSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTL  109 (131)
Q Consensus        77 ----~~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~  109 (131)
                          .++.++|+||||+++|++++ |..||......+.
T Consensus       181 ~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~  218 (269)
T cd05087         181 LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV  218 (269)
T ss_pred             ccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence                35789999999999999996 9999987665544

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.85  E-value=2.7e-21  Score=131.23  Aligned_cols=102  Identities=36%  Similarity=0.584  Sum_probs=86.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.+++|||+. +++|+||++.||+++.++.++++|||.+......  ......++..|++||.+.+..++.
T Consensus       107 ~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~  185 (267)
T cd08229         107 TVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF  185 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccc
Confidence            4567899999999999997 8999999999999999999999999987544321  122345677899999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ++|+||+|+++|++++|..||....
T Consensus       186 ~~Dv~slG~il~~l~~g~~p~~~~~  210 (267)
T cd08229         186 KSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             hhhHHHHHHHHHHHHhCCCCccccc
Confidence            9999999999999999999996544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.85  E-value=6e-21  Score=130.66  Aligned_cols=102  Identities=40%  Similarity=0.727  Sum_probs=85.1

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCccccc-----CC
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQ-----GT   76 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~-----~~   76 (131)
                      +..++.|++.+++|||+. +++|+|+++.||+++.++.++++|||.+.....  .......++..|++||.+.     ..
T Consensus       123 ~~~~~~qi~~al~~LH~~-~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~  201 (282)
T cd06636         123 IAYICREILRGLAHLHAH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA  201 (282)
T ss_pred             HHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCc
Confidence            567889999999999997 899999999999999999999999998764432  1223455778899999875     24


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         77 HYSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      .++.++|+||+|+++|++++|..||.....
T Consensus       202 ~~~~~~DvwslG~~l~el~~g~~p~~~~~~  231 (282)
T cd06636         202 TYDYRSDIWSLGITAIEMAEGAPPLCDMHP  231 (282)
T ss_pred             CCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence            577899999999999999999999975543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.85  E-value=9.4e-21  Score=127.91  Aligned_cols=110  Identities=37%  Similarity=0.615  Sum_probs=92.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.++.|||+. +++|+||++.||+++.++.++++|||.+......  ......++..|.+||...+..++.
T Consensus       102 ~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~  180 (256)
T cd08221         102 MVLWYLFQIVSAVSYIHKA-GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF  180 (256)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCC
Confidence            4567899999999999987 7999999999999999999999999987654322  223445778899999998877889


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|++++++++|..||......+.....
T Consensus       181 ~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~  213 (256)
T cd08221         181 KSDIWALGCVLYELLTLKRTFDATNPLNLVVKI  213 (256)
T ss_pred             cchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999876665554443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.85  E-value=8e-21  Score=129.09  Aligned_cols=111  Identities=28%  Similarity=0.403  Sum_probs=89.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccccc-----CCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN-----SFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~-----~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.|+.|||+. +++|+|+++.||+++.++.++++|||++.........     ....+..|++||.+....
T Consensus       108 ~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  186 (268)
T cd05063         108 QLVGMLRGIAAGMKYLSDM-NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK  186 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCC
Confidence            4677899999999999997 8999999999999999999999999987644321111     111234699999998888


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      ++.++|+||+|+++|++++ |..||......+..+.+.
T Consensus       187 ~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~  224 (268)
T cd05063         187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN  224 (268)
T ss_pred             cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh
Confidence            8999999999999999987 999997766666555553

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.85  E-value=2.9e-21  Score=131.14  Aligned_cols=102  Identities=35%  Similarity=0.576  Sum_probs=87.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||+|||++ +++|+||++.||+++.++.++++|||.+......  ......++..|++||.+.+..++.
T Consensus       107 ~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  185 (267)
T cd08228         107 TVWKYFVQLCSAVEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF  185 (267)
T ss_pred             HHHHHHHHHHHHHHHHhhC-CeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCc
Confidence            4578899999999999997 8999999999999999999999999987654322  122345777899999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ++|+||+|+++|++++|..||....
T Consensus       186 ~~Di~slG~~l~el~~g~~p~~~~~  210 (267)
T cd08228         186 KSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             hhhHHHHHHHHHHHhcCCCCCcccc
Confidence            9999999999999999999996543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.85  E-value=6e-21  Score=129.36  Aligned_cols=110  Identities=26%  Similarity=0.496  Sum_probs=90.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---ccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.++.+||+. +++|+||++.|++++.++.++++|||.+.......   .....++..|++||.+....++
T Consensus       103 ~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~  181 (260)
T cd05073         103 KLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT  181 (260)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcC
Confidence            4567889999999999997 89999999999999999999999999876543221   1122334569999999888889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||||++++++++ |..||...+.....+.+
T Consensus       182 ~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~  216 (260)
T cd05073         182 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL  216 (260)
T ss_pred             ccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            99999999999999998 99999877766555544

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.85  E-value=6.5e-21  Score=134.34  Aligned_cols=103  Identities=40%  Similarity=0.701  Sum_probs=86.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccC-CCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~   81 (131)
                      ++..++.|++.|+.|||+. +++|+||++.||+++.++.++++|||++...... .....++..|++||.+.+ ..++.+
T Consensus       121 ~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~  198 (345)
T cd07877         121 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-MTGYVATRWYRAPEIMLNWMHYNQT  198 (345)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEcCCCCEEEeccccccccccc-ccccccCCCccCHHHHhCccCCCch
Confidence            4567899999999999997 8999999999999999999999999987654332 223456778999998865 457889


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +|+||+|++++++++|..||...+..
T Consensus       199 ~DvwslG~il~el~~g~~pf~~~~~~  224 (345)
T cd07877         199 VDIWSVGCIMAELLTGRTLFPGTDHI  224 (345)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999999765543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.85  E-value=7.9e-21  Score=130.59  Aligned_cols=109  Identities=35%  Similarity=0.603  Sum_probs=90.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.+++++|+. +++|+||++.||+++.++.++++|||.+......  ......++..|++||...+..++.
T Consensus       116 ~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  194 (285)
T cd06648         116 QIATVCLAVLKALSFLHAQ-GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGT  194 (285)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCC
Confidence            4567899999999999997 8999999999999999999999999976543221  122345677899999998878899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      ++|+||+|++++++++|..||...+.....+.
T Consensus       195 ~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~  226 (285)
T cd06648         195 EVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR  226 (285)
T ss_pred             cccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH
Confidence            99999999999999999999976655444433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.85  E-value=2.1e-21  Score=149.29  Aligned_cols=100  Identities=20%  Similarity=0.193  Sum_probs=78.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC-------------------CcEEEeecccccccccc-------
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG-------------------GEIKICDFGVSGQLIDS-------   56 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~-------------------~~~~l~d~g~~~~~~~~-------   56 (131)
                      +++.+++|++.||+|||++ ||+||||+|.||+++..                   +.++++|||+++.....       
T Consensus        81 ~~~~i~~qi~~al~~lH~~-gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~  159 (793)
T PLN00181         81 ECFHVFRQIVEIVNAAHSQ-GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEK  159 (793)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhh
Confidence            5678999999999999987 89999999999999643                   34566666665432100       


Q ss_pred             -----------cccCCCCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         57 -----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        57 -----------~~~~~~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                                 ......+++.|+|||.+.+..++.++|+|||||++|||+++..|+..
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~  217 (793)
T PLN00181        160 LEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE  217 (793)
T ss_pred             hhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence                       00012467789999999888899999999999999999998888753

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.85  E-value=4.3e-21  Score=134.46  Aligned_cols=103  Identities=34%  Similarity=0.623  Sum_probs=86.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc------cccCCCCccceeCcccccC-
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS------MANSFVGTRSYMSPERLQG-   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~~~~~~Pe~~~~-   75 (131)
                      +++.++.|++.||+|||+. |++|+||+|.||+++.++.++++|||.+......      ......++..|++||.+.+ 
T Consensus       106 ~~~~~~~qi~~aL~~LH~~-givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~  184 (332)
T cd07857         106 HFQSFIYQILCGLKYIHSA-NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSF  184 (332)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCC
Confidence            4677899999999999987 8999999999999999999999999988654321      1123457788999998765 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      ..++.++|+||+|++++++++|..||...+.
T Consensus       185 ~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~  215 (332)
T cd07857         185 QSYTKAIDVWSVGCILAELLGRKPVFKGKDY  215 (332)
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH
Confidence            4578999999999999999999999976553

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.85  E-value=2.5e-21  Score=131.49  Aligned_cols=110  Identities=32%  Similarity=0.576  Sum_probs=90.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc----ccccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      +...++.|++.||.|||++ +++|++|++.||+++.++.+|++|||+......    ...........|++||.+....+
T Consensus       104 ~~~~i~~~i~~~l~~Lh~~-~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  182 (259)
T PF07714_consen  104 QRLSIAIQIAEALSYLHSN-NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEY  182 (259)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEE
T ss_pred             ccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            4678999999999999998 799999999999999999999999998865521    11233345668999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      +.++|+||||+++||+++ |..||...+..++...+
T Consensus       183 ~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~  218 (259)
T PF07714_consen  183 TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL  218 (259)
T ss_dssp             SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccc
Confidence            999999999999999999 78999888877765555

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.85  E-value=7.7e-21  Score=130.08  Aligned_cols=103  Identities=35%  Similarity=0.637  Sum_probs=86.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccC-CCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQG-THYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~   79 (131)
                      ++..++.|++.+|.|||+. +++|+||++.||+++.++.++++|||++......  ......++..|++||.+.+ ..++
T Consensus       101 ~~~~~~~ql~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  179 (286)
T cd07847         101 LIKKIIWQTLQAVNFCHKH-NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYG  179 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcC
Confidence            4678999999999999997 8999999999999999999999999988654332  1223446678999999876 4578


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      .++|+||+|++++++++|..||.....
T Consensus       180 ~~~Di~slG~i~~~l~~g~~p~~~~~~  206 (286)
T cd07847         180 PPVDVWAIGCVFAELLTGQPLWPGKSD  206 (286)
T ss_pred             chhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence            899999999999999999999986554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.85  E-value=1e-20  Score=128.52  Aligned_cols=111  Identities=28%  Similarity=0.406  Sum_probs=90.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--cc--ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SM--ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~--~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.++.|||+. +++|+|+++.||+++.++.++++|||++.....  ..  .....++..|++||.+.+..+
T Consensus       107 ~~~~~~~~l~~~l~~Lh~~-~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~  185 (266)
T cd05033         107 QLVGMLRGIASGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF  185 (266)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCC
Confidence            4678899999999999997 799999999999999999999999998876531  11  112233457999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||+|+++|++++ |..||......+....+.
T Consensus       186 ~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~  222 (266)
T cd05033         186 TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE  222 (266)
T ss_pred             ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Confidence            999999999999999987 999997776665555443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.85  E-value=3.5e-21  Score=131.67  Aligned_cols=102  Identities=44%  Similarity=0.869  Sum_probs=85.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-ccCCCCccceeCcccccC----CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-ANSFVGTRSYMSPERLQG----TH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~Pe~~~~----~~   77 (131)
                      ++..++.|++.++.|||++.+++|+||++.||+++.++.++++|||.+....... .....++..|++||.+.+    ..
T Consensus       104 ~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  183 (283)
T cd06617         104 ILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG  183 (283)
T ss_pred             HHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccc
Confidence            4668999999999999985479999999999999999999999999986543322 222456778999998865    34


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      ++.++|+||+|+++|++++|+.||...
T Consensus       184 ~~~~~Di~slG~~l~~l~~g~~p~~~~  210 (283)
T cd06617         184 YDVKSDVWSLGITMIELATGRFPYDSW  210 (283)
T ss_pred             cCccccchhhHHHHHHHHhCCCCCCcc
Confidence            678999999999999999999999743

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.85  E-value=5e-21  Score=134.32  Aligned_cols=103  Identities=37%  Similarity=0.688  Sum_probs=85.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cccCCCCccceeCcccccC-C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQG-T   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~-~   76 (131)
                      .+..++.|++.||++||+. +++|+||++.||+++.++.++++|||++......     ......++..|+|||.+.. .
T Consensus       107 ~~~~i~~ql~~aL~~LH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  185 (336)
T cd07849         107 HIQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSK  185 (336)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCC
Confidence            4567899999999999997 8999999999999999999999999987654321     1122456778999998754 4


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         77 HYSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      .++.++|+||+|++++++++|+.||...+.
T Consensus       186 ~~~~~~DvwslGvil~el~~G~~~f~~~~~  215 (336)
T cd07849         186 GYTKAIDIWSVGCILAEMLSNRPLFPGKDY  215 (336)
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            578999999999999999999999976554

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.85  E-value=5.6e-21  Score=134.49  Aligned_cols=102  Identities=39%  Similarity=0.646  Sum_probs=86.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccC-CCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~   81 (131)
                      ++..++.|++.||+|||+. +++|+||++.||+++.++.++++|||++...... .....++..|++||.+.+ ..++.+
T Consensus       118 ~~~~~~~qi~~aL~~LH~~-~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~  195 (342)
T cd07879         118 KVQYLVYQMLCGLKYIHSA-GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-MTGYVVTRWYRAPEVILNWMHYNQT  195 (342)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-CCCceeeecccChhhhcCccccCch
Confidence            4567899999999999997 7999999999999999999999999987654321 223355678999999876 457889


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      +|+||+|+++|++++|+.||.+.+.
T Consensus       196 ~Dv~slGvil~el~~g~~pf~~~~~  220 (342)
T cd07879         196 VDIWSVGCIMAEMLTGKTLFKGKDY  220 (342)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999999987664

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.85  E-value=8.6e-21  Score=131.45  Aligned_cols=109  Identities=31%  Similarity=0.534  Sum_probs=89.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----------------cccCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----------------MANSFVGTR   65 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----------------~~~~~~~~~   65 (131)
                      .+..++.|++.|++|||+. +++|+||+|.||+++.++.++++|||.++.....                 ......++.
T Consensus       102 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (305)
T cd05609         102 MARMYFAETVLALEYLHNY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP  180 (305)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCc
Confidence            3567889999999999997 8999999999999999999999999987531100                 011234566


Q ss_pred             ceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         66 SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        66 ~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      .|++||.+....++.++|+||||+++|++++|..||.+...+++.+.
T Consensus       181 ~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~  227 (305)
T cd05609         181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ  227 (305)
T ss_pred             cccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            89999999888889999999999999999999999987776654443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.85  E-value=9.1e-21  Score=127.65  Aligned_cols=111  Identities=29%  Similarity=0.421  Sum_probs=90.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc----cCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      .+..++.|++.++.+||++ +++|+|+++.||+++.++.++++|||.+........    .....+..|++||.+.+..+
T Consensus        94 ~~~~~~~~~~~~l~~lH~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~  172 (251)
T cd05041          94 KLLQMSLDAAAGMEYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY  172 (251)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCC
Confidence            4567889999999999987 799999999999999999999999998765432111    11222456999999988888


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||+|++++++++ |..||...........+.
T Consensus       173 ~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~  209 (251)
T cd05041         173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE  209 (251)
T ss_pred             CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh
Confidence            999999999999999998 899998777665555553

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.85  E-value=7.9e-21  Score=128.26  Aligned_cols=111  Identities=26%  Similarity=0.448  Sum_probs=91.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccccc---CCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN---SFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~---~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      .+..++.|++.++++||+. +++|+|+++.|++++.++.++++|||.+.........   ....+..|++||.+.+..++
T Consensus       101 ~~~~~~~~l~~~l~~lH~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~  179 (256)
T cd05112         101 TLLGMCLDVCEGMAYLESS-NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS  179 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcC
Confidence            4678899999999999987 7999999999999999999999999987654322111   22234579999999888889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      .++|+||+|+++|++++ |..||.........+.+.
T Consensus       180 ~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  215 (256)
T cd05112         180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN  215 (256)
T ss_pred             hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh
Confidence            99999999999999998 999998777666665543

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.85  E-value=6.6e-21  Score=130.89  Aligned_cols=110  Identities=28%  Similarity=0.449  Sum_probs=90.3

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCCC
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +..++.|++.+|.+||++ +++|+||+|.||+++.++.++++|||.+......    .......+..|++||...+..++
T Consensus       132 ~~~~~~~i~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  210 (288)
T cd05050         132 QLCIAKQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT  210 (288)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC
Confidence            568999999999999997 8999999999999999999999999987643221    11222345579999999888899


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      .++|+||||+++|++++ |..||.+...++....+.
T Consensus       211 ~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~  246 (288)
T cd05050         211 TESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVR  246 (288)
T ss_pred             chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence            99999999999999997 888997777666655544

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.85  E-value=6.5e-21  Score=129.01  Aligned_cols=110  Identities=28%  Similarity=0.479  Sum_probs=90.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---ccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.++.|||++ +++|+||++.||+++.++.++++|||.+.......   ......+..|++||.+.+..++
T Consensus       104 ~~~~~~~~i~~al~~lh~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~  182 (261)
T cd05034         104 QLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFT  182 (261)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcC
Confidence            4578999999999999997 79999999999999999999999999876543211   1122234579999999888889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||+|++++++++ |+.||.+....+..+..
T Consensus       183 ~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~  217 (261)
T cd05034         183 IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV  217 (261)
T ss_pred             chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            99999999999999998 99999877665544443

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.85  E-value=6.5e-21  Score=131.44  Aligned_cols=107  Identities=28%  Similarity=0.438  Sum_probs=87.0

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCCC
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +..++.|++.|+.|||+. +++|+||+|.|++++.++.++++|||++.......    .....++..|++||......++
T Consensus       131 ~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  209 (295)
T cd05097         131 LLYMAVQIASGMKYLASL-NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT  209 (295)
T ss_pred             HHHHHHHHHHHHHHHHhc-CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcC
Confidence            467899999999999997 89999999999999999999999999876543211    1122345679999999888899


Q ss_pred             CcchHHHHHHHHHHHHh--CCCCCCCCCHHHHHH
Q psy17559         80 VQSDIWSLGLSLVEMAI--GMYPIPPPDAKTLAA  111 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~--g~~p~~~~~~~~~~~  111 (131)
                      .++|+||||++++++++  +..||.....++..+
T Consensus       210 ~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~  243 (295)
T cd05097         210 TASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE  243 (295)
T ss_pred             chhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence            99999999999999987  677887666554433

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.85  E-value=7.9e-21  Score=129.83  Aligned_cols=109  Identities=39%  Similarity=0.710  Sum_probs=90.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      .+..++.|++.++.|||++ +++|+||++.||+++.++.++++|||++......  ......++..|++||.+.+..++.
T Consensus       102 ~~~~~~~~i~~~l~~lH~~-~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  180 (277)
T cd06642         102 YIATILREILKGLDYLHSE-RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF  180 (277)
T ss_pred             HHHHHHHHHHHHHHHHhcC-CeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCch
Confidence            4567899999999999997 8999999999999999999999999987654322  122345677899999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      ++|+||+|++++++++|..||...........
T Consensus       181 ~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~  212 (277)
T cd06642         181 KADIWSLGITAIELAKGEPPNSDLHPMRVLFL  212 (277)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCcccchhhHHhh
Confidence            99999999999999999999976554444433

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.85  E-value=3.5e-21  Score=132.09  Aligned_cols=103  Identities=57%  Similarity=1.051  Sum_probs=88.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .+..++.|++.++.|||+.++++|+||++.|++++.++.++++|||++............++..|++||.+.+..++.++
T Consensus       104 ~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  183 (284)
T cd06620         104 ILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKS  183 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCccccCcccCCHHHHccCCCCccc
Confidence            45678999999999999855899999999999999999999999998765443333445678899999999888889999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      |+||+|++++++++|..||....
T Consensus       184 Di~slG~~l~~l~tg~~p~~~~~  206 (284)
T cd06620         184 DVWSLGISIIELALGKFPFAFSN  206 (284)
T ss_pred             hHHHHHHHHHHHHhCCCCCcccc
Confidence            99999999999999999997544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.85  E-value=4.9e-21  Score=131.69  Aligned_cols=102  Identities=37%  Similarity=0.600  Sum_probs=84.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      ++..++.|++.||.|||+. +++|+||++.||+++.++.++++|||++.....  .......++..|++||.+.+. .++
T Consensus       104 ~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  182 (291)
T cd07870         104 NVRLFMFQLLRGLAYIHGQ-HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYS  182 (291)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCC
Confidence            4567889999999999997 899999999999999999999999998764322  112233457789999998753 478


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      .++|+||+|+++|++++|..||....
T Consensus       183 ~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         183 SALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCch
Confidence            89999999999999999999997544

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.85  E-value=2.2e-20  Score=127.25  Aligned_cols=107  Identities=17%  Similarity=0.347  Sum_probs=83.5

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccC----
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQG----   75 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~----   75 (131)
                      +..++.|++.||+|||+. +++|+||++.||+++.++.++++|||++......    ......++..|++||.+..    
T Consensus       101 ~~~~~~~i~~al~~lH~~-~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  179 (268)
T cd05086         101 LQRMACEIAAGVTHMHKH-NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG  179 (268)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCc
Confidence            467889999999999997 7999999999999999999999999987432111    1123456678999998743    


Q ss_pred             ---CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy17559         76 ---THYSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAA  111 (131)
Q Consensus        76 ---~~~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~  111 (131)
                         ..++.++|+||||+++|++++ +..||......+...
T Consensus       180 ~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~  219 (268)
T cd05086         180 LITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN  219 (268)
T ss_pred             cccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence               235788999999999999986 577887665544333

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.85  E-value=1.1e-20  Score=129.11  Aligned_cols=103  Identities=30%  Similarity=0.525  Sum_probs=85.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccC-CCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-THYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~   80 (131)
                      ++..++.|++.||+|||++ +++|+||++.||+++. +.++++|||++...... ......++..|++||.+.. ..++.
T Consensus       101 ~~~~~~~qi~~~L~~LH~~-~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  178 (282)
T cd07831         101 RVKSYMYQLLKSLDHMHRN-GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGP  178 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCc
Confidence            4678999999999999997 8999999999999999 99999999988654322 2223456778999997654 45688


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      ++|+||+|++++++++|..||...+..
T Consensus       179 ~~Di~slGv~l~el~~~~~p~~~~~~~  205 (282)
T cd07831         179 KMDIWAVGCVFFEILSLFPLFPGTNEL  205 (282)
T ss_pred             chhHHHHHHHHHHHHcCCcCCCCCCHH
Confidence            999999999999999999999876543

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.85  E-value=1.3e-20  Score=129.60  Aligned_cols=104  Identities=38%  Similarity=0.652  Sum_probs=86.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCC----
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT----   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~----   76 (131)
                      .+..++.|++.++++||+. +++|+||++.||+++.++.++++|||.+......  ......++..|++||.+...    
T Consensus       129 ~~~~~~~qi~~al~~lH~~-~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  207 (291)
T cd06639         129 MISYILYGALLGLQHLHNN-RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYD  207 (291)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcc
Confidence            4567899999999999997 8999999999999999999999999987654321  12234567789999987543    


Q ss_pred             -CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         77 -HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        77 -~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                       .++.++|+||+|+++|++++|+.||...+..
T Consensus       208 ~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~  239 (291)
T cd06639         208 YSYDARCDVWSLGITAIELGDGDPPLFDMHPV  239 (291)
T ss_pred             cccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence             3678999999999999999999999866543

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.85  E-value=6.2e-21  Score=129.59  Aligned_cols=102  Identities=38%  Similarity=0.669  Sum_probs=85.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCccccc---CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQ---GTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~---~~~   77 (131)
                      ++..++.|++.++.|||+. |++|+||++.||+++.++.++++|||++......  ......++..|+|||.+.   ...
T Consensus       107 ~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  185 (267)
T cd06645         107 QIAYVSRETLQGLYYLHSK-GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG  185 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCC
Confidence            4677899999999999997 8999999999999999999999999987654322  223446778899999874   345


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ++.++|+||+|+++|++++|..||....
T Consensus       186 ~~~~~DvwSlG~il~~l~~~~~p~~~~~  213 (267)
T cd06645         186 YNQLCDIWAVGITAIELAELQPPMFDLH  213 (267)
T ss_pred             CCchhhhHHHHHHHHHHhcCCCCccccc
Confidence            7889999999999999999999986544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.85  E-value=1.2e-20  Score=126.41  Aligned_cols=104  Identities=45%  Similarity=0.799  Sum_probs=89.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-ccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.++.+||+. +++|+|+++.||+++.++.++++|||.+....... .....++..|++||.+.+...+.+
T Consensus        99 ~~~~i~~~i~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~  177 (253)
T cd05122          99 QIAYVCKELLKGLEYLHSN-GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK  177 (253)
T ss_pred             HHHHHHHHHHHHHHHhhcC-CEecCCCCHHHEEEccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCcc
Confidence            4567899999999999996 89999999999999999999999999886654432 344566778999999988888999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +|+||+|++++++++|..||...+..
T Consensus       178 ~Dv~slG~il~~l~~g~~p~~~~~~~  203 (253)
T cd05122         178 ADIWSLGITAIELAEGKPPYSELPPM  203 (253)
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCCchH
Confidence            99999999999999999999876443

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.85  E-value=1.3e-20  Score=128.78  Aligned_cols=109  Identities=40%  Similarity=0.725  Sum_probs=90.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.+++++|+. +++|+||++.||+++.++.++++|||.+......  ......++..|++||.+.+..++.
T Consensus       102 ~~~~~~~~l~~~l~~lh~~-~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~  180 (277)
T cd06640         102 QIATMLKEILKGLDYLHSE-KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS  180 (277)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCcc
Confidence            3567889999999999997 7999999999999999999999999988654322  122335667899999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      ++|+||||+++|++++|..||...........
T Consensus       181 ~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~  212 (277)
T cd06640         181 KADIWSLGITAIELAKGEPPNSDMHPMRVLFL  212 (277)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh
Confidence            99999999999999999999986665544443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.84  E-value=9.5e-21  Score=129.62  Aligned_cols=103  Identities=34%  Similarity=0.609  Sum_probs=86.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---ccCCCCccceeCcccccCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGT-HY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~-~~   78 (131)
                      ++..++.|++.+|.|||+. +++|+||++.||+++.++.++++|||.+.......   .....++..|++||.+.+. .+
T Consensus       100 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  178 (286)
T cd07832         100 QVKSYMRMLLKGVAYMHAN-GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY  178 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccC
Confidence            4678899999999999997 89999999999999999999999999876553321   2344677789999998654 36


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      +.++|+||+|++++++++|..+|.....
T Consensus       179 ~~~~Di~slG~~l~~l~tg~~~~~~~~~  206 (286)
T cd07832         179 DPGVDLWAVGCIFAELLNGSPLFPGEND  206 (286)
T ss_pred             CchhHHHHHHHHHHHHHcCCcCcCCCCH
Confidence            8999999999999999999888875553

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.84  E-value=9.2e-21  Score=130.44  Aligned_cols=104  Identities=35%  Similarity=0.557  Sum_probs=87.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH-YS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~-~~   79 (131)
                      ++..++.|++.||+|||+. +++|+||++.||+++.++.++++|||++......  ......++..|++||.+.+.. ++
T Consensus       107 ~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  185 (293)
T cd07843         107 EVKCLMLQLLSGVAHLHDN-WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYS  185 (293)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCcccc
Confidence            4678999999999999997 8999999999999999999999999988655432  222345567899999987643 68


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      .++|+||+|++++++++|..||......
T Consensus       186 ~~~Di~slG~~l~~l~~g~~~f~~~~~~  213 (293)
T cd07843         186 TAIDMWSVGCIFAELLTKKPLFPGKSEI  213 (293)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence            8999999999999999999999766543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0664|consensus

Probab=99.84  E-value=9.2e-22  Score=132.46  Aligned_cols=103  Identities=37%  Similarity=0.608  Sum_probs=88.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---ccCCCCccceeCcccccCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGT-HY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~-~~   78 (131)
                      .++-+.+||+.||+|||+. +|.||||+|.|.++.+|-..|++|||+++......   ....+.+..|++||++-+. .|
T Consensus       157 HvKVFlYQILRGLKYLHsA-~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhY  235 (449)
T KOG0664|consen  157 HVKVFVYQILRGLKYLHTA-NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRY  235 (449)
T ss_pred             hhhhhHHHHHhhhHHHhhc-chhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhh
Confidence            4678899999999999998 79999999999999999999999999998664322   2234556789999999774 58


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      +..+|+||.||++.|++.++.-|+....
T Consensus       236 s~AvDiWSVGCIFaELLgRrILFQAq~P  263 (449)
T KOG0664|consen  236 TGAVDIWSVGCIFAELLQRKILFQAAGP  263 (449)
T ss_pred             cCccceehhhHHHHHHHhhhhhhhccCh
Confidence            9999999999999999999999975553

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.84  E-value=3.1e-20  Score=128.77  Aligned_cols=105  Identities=35%  Similarity=0.619  Sum_probs=87.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCccccc---CCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQ---GTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~   79 (131)
                      ++..++.|++.+|.|||+. +++|+||++.||+++.++.++++|||.+......  ....++..|++||.+.   ...++
T Consensus       116 ~~~~~~~ql~~~L~~LH~~-~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~  192 (307)
T cd06607         116 EIAAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--NSFVGTPYWMAPEVILAMDEGQYD  192 (307)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceecCCCcccEEECCCCCEEEeecCcceecCCC--CCccCCccccCceeeeccCCCCCC
Confidence            4567899999999999997 8999999999999999999999999987543322  2345677899999874   34578


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLA  110 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~  110 (131)
                      .++|+||||+++|++++|..||...+.....
T Consensus       193 ~~sDv~s~G~il~el~tg~~p~~~~~~~~~~  223 (307)
T cd06607         193 GKVDVWSLGITCIELAERKPPLFNMNAMSAL  223 (307)
T ss_pred             cccchHHHHHHHHHHHcCCCCCCCccHHHHH
Confidence            8999999999999999999999776654433

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.84  E-value=1.2e-20  Score=129.22  Aligned_cols=103  Identities=36%  Similarity=0.652  Sum_probs=87.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT-HY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~-~~   78 (131)
                      ++..++.|++.++.|||+. +++|+|+++.||+++.++.++++|||.+......   ......++..|++||.+.+. .+
T Consensus       101 ~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~  179 (288)
T cd07833         101 AVRSYIWQLLQAIAYCHSH-NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY  179 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCc
Confidence            4678899999999999997 7999999999999999999999999987654322   22334566789999999887 78


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      +.++|+||+|+++|++++|..||.....
T Consensus       180 ~~~~Dv~slG~~l~~l~~g~~~~~~~~~  207 (288)
T cd07833         180 GKPVDVWAIGCIMAELLDGEPLFPGDSD  207 (288)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            8999999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.84  E-value=9.4e-21  Score=131.02  Aligned_cols=104  Identities=35%  Similarity=0.578  Sum_probs=85.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-------------ccCCCCccceeC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-------------ANSFVGTRSYMS   69 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-------------~~~~~~~~~~~~   69 (131)
                      ++..++.|++.+|+|||+. |++|+||++.||+++.++.++++|||++.......             .....++..|++
T Consensus       116 ~~~~i~~~l~~al~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~a  194 (311)
T cd07866         116 QIKCYMLQLLEGINYLHEN-HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRP  194 (311)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCC
Confidence            4678999999999999997 89999999999999999999999999876442211             012234667999


Q ss_pred             cccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         70 PERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        70 Pe~~~~~-~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      ||.+.+. .++.++|+||+|++++++++|..||.+....
T Consensus       195 PE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~  233 (311)
T cd07866         195 PELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI  233 (311)
T ss_pred             hHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9987654 4788999999999999999999999766544

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.84  E-value=7e-21  Score=130.84  Aligned_cols=101  Identities=54%  Similarity=1.020  Sum_probs=87.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .+..++.|++.+|.|||+. +++|+||++.||+++.++.++++|||++............++..|++||.+.+..++.++
T Consensus       106 ~~~~i~~~i~~~L~~lH~~-~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~  184 (287)
T cd06621         106 VLGKIAESVLKGLSYLHSR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITS  184 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecCCeEEEeeccccccccccccccccCCccccCHHHhcCCCCCchh
Confidence            3567999999999999997 899999999999999999999999999765543333344566789999999888889999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCC
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      |+||+|+++|++++|..||...
T Consensus       185 Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         185 DVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             hHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999999999999755

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.84  E-value=7.3e-21  Score=128.96  Aligned_cols=102  Identities=37%  Similarity=0.587  Sum_probs=87.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.++++||+. |++|+||+|.||+++.++.++++|||.+......  ......++..|++||.+.+..++.
T Consensus       107 ~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~  185 (267)
T cd08224         107 TIWKYFVQLCSALEHMHSK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF  185 (267)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCc
Confidence            4678899999999999997 8999999999999999999999999987644322  122345677899999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ++|+||+|+++|++++|..||....
T Consensus       186 ~~Di~slG~il~~l~~g~~p~~~~~  210 (267)
T cd08224         186 KSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             hhcHHHHHHHHHHHHHCCCCcccCC
Confidence            9999999999999999999996543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.84  E-value=5.3e-21  Score=131.43  Aligned_cols=102  Identities=36%  Similarity=0.623  Sum_probs=84.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccC-CCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQG-THYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~-~~~~   79 (131)
                      +++.++.|++.||.|||+. +++|+||++.||+++.++.++++|||.+.....  .......++..|++||.+.+ ..++
T Consensus       104 ~~~~~~~ql~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  182 (291)
T cd07844         104 NVRLFLFQLLRGLAYCHQR-RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYS  182 (291)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccC
Confidence            4678899999999999997 799999999999999999999999998754321  11122345668999998865 4578


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      .++|+||+|+++|++++|..||....
T Consensus       183 ~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         183 TSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            89999999999999999999997554

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.84  E-value=1e-20  Score=129.35  Aligned_cols=104  Identities=37%  Similarity=0.564  Sum_probs=87.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---ccCCCCccceeCcccccC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQG-THY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~-~~~   78 (131)
                      ++..++.|++.|+++||+. +++|+||++.||++++++.++++|||.+.......   .....++..|++||.+.+ ..+
T Consensus       101 ~~~~i~~~i~~al~~LH~~-~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~  179 (287)
T cd07840         101 QIKCYMKQLLEGLQYLHSN-GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRY  179 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccC
Confidence            4678999999999999997 89999999999999999999999999886554322   223345668999998765 357


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +.++|+||||++++++++|..||...+..
T Consensus       180 ~~~~Dv~slG~~l~el~t~~~p~~~~~~~  208 (287)
T cd07840         180 GPEVDMWSVGCILAELFLGKPIFQGSTEL  208 (287)
T ss_pred             ChHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence            89999999999999999999999866644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.84  E-value=3.4e-21  Score=130.56  Aligned_cols=101  Identities=68%  Similarity=1.143  Sum_probs=87.7

Q ss_pred             chhHHHHHHHHHHHHHHh-cCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLRE-KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~-~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      .+..++.|++.++.++|+ . +++|+||+++||+++.++.++++|||.+............++..|++||...+..++.+
T Consensus       101 ~~~~~~~~l~~~l~~lH~~~-~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~  179 (265)
T cd06605         101 ILGKIAVAVLKGLTYLHEKH-KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVK  179 (265)
T ss_pred             HHHHHHHHHHHHHHHHcCCC-CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCCCch
Confidence            356789999999999999 6 89999999999999999999999999876554333333667778999999988889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      +|+||+|++++++++|..||...
T Consensus       180 ~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         180 SDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCcc
Confidence            99999999999999999999654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.84  E-value=2.3e-20  Score=134.09  Aligned_cols=102  Identities=31%  Similarity=0.585  Sum_probs=85.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.|+.|||+. +++|+||++.||+++.++.++++|||++......    ......++..|++||.+.+..+
T Consensus       238 ~~~~~~~qi~~aL~~LH~~-~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  316 (400)
T cd05105         238 DLLSFTYQVARGMEFLASK-NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY  316 (400)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC
Confidence            4567999999999999997 7999999999999999999999999998654321    1122345567999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPD  105 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~  105 (131)
                      +.++|+||||+++|++++ |..||....
T Consensus       317 ~~~~DiwSlGvil~ellt~g~~P~~~~~  344 (400)
T cd05105         317 TTLSDVWSYGILLWEIFSLGGTPYPGMI  344 (400)
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence            999999999999999986 899997654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.84  E-value=1.5e-20  Score=127.95  Aligned_cols=110  Identities=30%  Similarity=0.451  Sum_probs=88.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc-----cCCCC--ccceeCcccccC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-----NSFVG--TRSYMSPERLQG   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~-----~~~~~--~~~~~~Pe~~~~   75 (131)
                      ++..++.|++.|+++||+. |++|+||++.|++++.++.++++|||++........     ....+  +..|++||.+.+
T Consensus       107 ~~~~i~~~l~~al~~lH~~-g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  185 (269)
T cd05065         107 QLVGMLRGIAAGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY  185 (269)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhcc
Confidence            4677889999999999997 899999999999999999999999998764432111     11111  346999999988


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         76 THYSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      ..++.++|+||+|+++|++++ |..||...+..+..+.+
T Consensus       186 ~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i  224 (269)
T cd05065         186 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI  224 (269)
T ss_pred             CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            888999999999999999886 99999877766555544

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG2345|consensus

Probab=99.84  E-value=6.7e-21  Score=126.06  Aligned_cols=99  Identities=32%  Similarity=0.471  Sum_probs=83.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCC--cEecCCCCCcEEEecCCcEEEeecccccccccc---c--------ccCCCCccceeC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---M--------ANSFVGTRSYMS   69 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~--~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~--------~~~~~~~~~~~~   69 (131)
                      +++.++.+++.||.+||+. .  +.|+||+|.||++.+.+..++.|||.+....-.   .        -.....+..|+|
T Consensus       128 ~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRA  206 (302)
T KOG2345|consen  128 QILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRA  206 (302)
T ss_pred             HHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccC
Confidence            5678999999999999996 5  999999999999999999999999987654211   0        012357889999


Q ss_pred             cccccC---CCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy17559         70 PERLQG---THYSVQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        70 Pe~~~~---~~~~~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      ||.+.-   ...+.++|+|||||++|.++.|..||.
T Consensus       207 PELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe  242 (302)
T KOG2345|consen  207 PELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE  242 (302)
T ss_pred             chheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence            999853   457899999999999999999999996

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.84  E-value=6.4e-21  Score=130.37  Aligned_cols=103  Identities=33%  Similarity=0.590  Sum_probs=87.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.++.|||+. +++|+||++.||+++.++.++++|||.+...... ......++..|++||.+.+..++.+
T Consensus        96 ~~~~~~~ql~~~l~~lH~~-~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~  174 (277)
T cd05577          96 RAIFYAAQIICGLEHLHQR-RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS  174 (277)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCch
Confidence            4567889999999999997 8999999999999999999999999987644321 2223456678999999988788999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      +|+||+|++++++++|..||...+.
T Consensus       175 ~Di~slG~il~~l~~g~~p~~~~~~  199 (277)
T cd05577         175 VDWFALGCTLYEMIAGRSPFRQRKE  199 (277)
T ss_pred             hhhHHHHHHHHHHhhCCCCCCCCcc
Confidence            9999999999999999999976543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.84  E-value=1.1e-20  Score=128.15  Aligned_cols=104  Identities=36%  Similarity=0.625  Sum_probs=87.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--------ccccCCCCccceeCccccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--------SMANSFVGTRSYMSPERLQ   74 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--------~~~~~~~~~~~~~~Pe~~~   74 (131)
                      .+..++.|++.+++++|+. +++|+||++.|++++.++.++++|||.+.....        .......++..|++||...
T Consensus       103 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~  181 (265)
T cd06631         103 VFCKYTKQILDGVAYLHNN-CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN  181 (265)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhc
Confidence            3567889999999999997 799999999999999999999999998754321        1122345677899999998


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         75 GTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        75 ~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +..++.++|+||+|++++++++|..||...+..
T Consensus       182 ~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~  214 (265)
T cd06631         182 ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL  214 (265)
T ss_pred             CCCCcchhhHHHHHHHHHHHHhCCCccccCChH
Confidence            888899999999999999999999999765543

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.84  E-value=2.1e-20  Score=130.74  Aligned_cols=103  Identities=31%  Similarity=0.514  Sum_probs=82.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-c--------cccCCCCccceeCcccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-S--------MANSFVGTRSYMSPERL   73 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-~--------~~~~~~~~~~~~~Pe~~   73 (131)
                      +++.++.|++.||+|||++ +++|+||++.||+++.++.+++.||+....... .        ......++..|++||.+
T Consensus       102 ~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  180 (327)
T cd08227         102 AIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVL  180 (327)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHh
Confidence            4678999999999999997 899999999999999999999999875432211 0        11122455679999998


Q ss_pred             cC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         74 QG--THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        74 ~~--~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      .+  ..++.++|+||+|++++++++|..||.....
T Consensus       181 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  215 (327)
T cd08227         181 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA  215 (327)
T ss_pred             hcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence            76  3588999999999999999999999975543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.84  E-value=7e-21  Score=131.58  Aligned_cols=103  Identities=34%  Similarity=0.623  Sum_probs=87.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc--ccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.+|.+||+. +++|+||++.||+++.++.++++|||.+.......  .....++..|++||...+..++.
T Consensus       116 ~~~~~~~~l~~~L~~LH~~-~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  194 (297)
T cd06656         116 QIAAVCRECLQALDFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP  194 (297)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCc
Confidence            4567889999999999997 89999999999999999999999999876543221  22345677899999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      ++|+||+|+++|++++|..||...+.
T Consensus       195 ~~Di~slGvil~~l~tg~~pf~~~~~  220 (297)
T cd06656         195 KVDIWSLGIMAIEMVEGEPPYLNENP  220 (297)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence            99999999999999999999975543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.84  E-value=8.1e-21  Score=129.02  Aligned_cols=102  Identities=35%  Similarity=0.663  Sum_probs=84.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccC---CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQG---TH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~---~~   77 (131)
                      ++..++.|++.++.|||+. +++|+|+++.||+++.++.++++|||.+......  ......++..|++||.+..   ..
T Consensus       107 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  185 (267)
T cd06646         107 QIAYVCRETLQGLAYLHSK-GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGG  185 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCC
Confidence            4567899999999999997 8999999999999999999999999998755322  1233456778999998853   34


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ++.++|+||+|++++++++|..||....
T Consensus       186 ~~~~~Dvws~G~il~el~~g~~p~~~~~  213 (267)
T cd06646         186 YNQLCDIWAVGITAIELAELQPPMFDLH  213 (267)
T ss_pred             CcchhhHHHHHHHHHHHHhCCCCccccc
Confidence            6789999999999999999999986444

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.84  E-value=1.3e-20  Score=130.56  Aligned_cols=104  Identities=33%  Similarity=0.607  Sum_probs=86.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.++.|||++ +++|+||+|.||+++.++.++++|||.+.......    .....++..|++||.+....+
T Consensus       142 ~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  220 (302)
T cd05055         142 DLLSFSYQVAKGMAFLASK-NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVY  220 (302)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCC
Confidence            4677899999999999997 79999999999999999999999999886543221    112234567999999988888


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAK  107 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~  107 (131)
                      +.++|+||+|+++|++++ |..||......
T Consensus       221 ~~~~DiwslGvil~el~t~g~~p~~~~~~~  250 (302)
T cd05055         221 TFESDVWSYGILLWEIFSLGSNPYPGMPVD  250 (302)
T ss_pred             CcHhHHHHHHHHHHHHHhCCCCCcCCCCch
Confidence            999999999999999998 99999765543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.84  E-value=1.7e-20  Score=129.10  Aligned_cols=103  Identities=34%  Similarity=0.539  Sum_probs=85.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec-CCcEEEeecccccccccc--cccCCCCccceeCcccccC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQG-THY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~-~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~   78 (131)
                      ++..++.|++.||.|||++ +++|+||++.||+++. ++.++++|||.+......  ......+++.|++||.+.+ ..+
T Consensus       111 ~~~~~~~qi~~~L~~LH~~-~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  189 (295)
T cd07837         111 TIKSFMYQLLKGVAHCHKH-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHY  189 (295)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCC
Confidence            4677899999999999997 8999999999999998 889999999987654321  1223345678999998865 357


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      +.++|+||+|+++|++++|..||.....
T Consensus       190 ~~~~Di~slG~~l~~l~~g~~~~~~~~~  217 (295)
T cd07837         190 STPVDIWSVGCIFAEMSRKQPLFPGDSE  217 (295)
T ss_pred             CchHHHHHHHHHHHHHHcCCCCCCCCCH
Confidence            8999999999999999999999976543

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=2e-20  Score=127.70  Aligned_cols=107  Identities=39%  Similarity=0.690  Sum_probs=88.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccC-CCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQG-THYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~   79 (131)
                      .+..++.|++.++++||+. |++|+||+++||+++.++.++++|||.+......  ......++..|++||.+.. ..++
T Consensus       102 ~~~~i~~~i~~~l~~lh~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  180 (277)
T cd06917         102 YISVIIREVLVALKYIHKV-GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYD  180 (277)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccc
Confidence            4577899999999999997 8999999999999999999999999987654332  2233457778999998865 3468


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLA  110 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~  110 (131)
                      .++|+||+|+++|++++|..||...+.....
T Consensus       181 ~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~  211 (277)
T cd06917         181 TKADIWSLGITIYEMATGNPPYSDVDAFRAM  211 (277)
T ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCChhhhh
Confidence            9999999999999999999999876654433

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.84  E-value=2.9e-20  Score=125.23  Aligned_cols=112  Identities=30%  Similarity=0.492  Sum_probs=92.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccccc---CCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN---SFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~---~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.++.+||+. +++|+|+++.||+++.++.++++|||.+.........   ...++..|++||......++
T Consensus       104 ~~~~~~~ql~~~l~~lh~~-~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~  182 (258)
T smart00219      104 DLLSFALQIARGMEYLESK-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFT  182 (258)
T ss_pred             HHHHHHHHHHHHHHHHhcC-CeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCC
Confidence            4578899999999999997 8999999999999999999999999988655432111   12245689999999777889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      .++|+||+|++++++++ |..||.........+....
T Consensus       183 ~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~  219 (258)
T smart00219      183 SKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK  219 (258)
T ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence            99999999999999998 8899987776666655543

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG4279|consensus

Probab=99.84  E-value=9e-22  Score=145.61  Aligned_cols=99  Identities=43%  Similarity=0.776  Sum_probs=87.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEe-cCCcEEEeecccccccc--cccccCCCCccceeCcccccCC--C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGT--H   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~-~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~--~   77 (131)
                      ++-....||++||.|||+. -|+||||+.+|+++. -.|.+|++|||-++...  .+.++++.|+..|+|||++..+  +
T Consensus       676 tm~fYtkQILeGLkYLHen-~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RG  754 (1226)
T KOG4279|consen  676 TMNFYTKQILEGLKYLHEN-KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRG  754 (1226)
T ss_pred             HHHHHHHHHHHHhhhhhhc-ceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcC
Confidence            4556789999999999998 499999999999998 47889999999887653  4567889999999999999864  5


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      |+.++|+|||||.+.||.||+.||-
T Consensus       755 YG~aADIWS~GCT~vEMATGrPPF~  779 (1226)
T KOG4279|consen  755 YGKAADIWSFGCTMVEMATGRPPFV  779 (1226)
T ss_pred             CCchhhhhhccceeEeeccCCCCee
Confidence            8999999999999999999999994

>KOG4278|consensus

Probab=99.84  E-value=5.3e-21  Score=140.33  Aligned_cols=113  Identities=30%  Similarity=0.555  Sum_probs=99.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCC---ccceeCcccccCCCCCC
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVG---TRSYMSPERLQGTHYSV   80 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~---~~~~~~Pe~~~~~~~~~   80 (131)
                      ++.|+-||..|++||..+ .+|||||-.+|+++.++..+|++|||+++.+.........|   .+.|+|||.+..+.++.
T Consensus       367 LlyMAtQIsSaMeYLEkk-nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSi  445 (1157)
T KOG4278|consen  367 LLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSI  445 (1157)
T ss_pred             HHHHHHHHHHHHHHHHHh-hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCccccccccccc
Confidence            468999999999999887 59999999999999999999999999998776554433333   35799999999999999


Q ss_pred             cchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCCC
Q psy17559         81 QSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPSR  117 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~  117 (131)
                      ++|+|+||+++||+.+ |..||++.+...+..++.+..
T Consensus       446 KSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy  483 (1157)
T KOG4278|consen  446 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY  483 (1157)
T ss_pred             chhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc
Confidence            9999999999999975 999999999999999887653

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.84  E-value=1.6e-20  Score=129.69  Aligned_cols=110  Identities=34%  Similarity=0.583  Sum_probs=91.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      .+..++.|++.+++|||+. |++|+|+++.||+++.++.++++|||.+......  ......++..|++||.+....++.
T Consensus       117 ~~~~~~~ql~~~l~~lH~~-givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~  195 (292)
T cd06657         117 QIAAVCLAVLKALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGP  195 (292)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCc
Confidence            4567899999999999997 8999999999999999999999999987544321  122345677899999998778899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|..||......+..+.+
T Consensus       196 ~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~  228 (292)
T cd06657         196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI  228 (292)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999877655544444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG1989|consensus

Probab=99.84  E-value=5.5e-21  Score=142.93  Aligned_cols=102  Identities=31%  Similarity=0.469  Sum_probs=85.9

Q ss_pred             chhHHHHHHHHHHHHHHhc-CCcEecCCCCCcEEEecCCcEEEeecccccccccccc-----------cCCCCccceeCc
Q psy17559          3 QVPYSSFQVLKGLTYLREK-HAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-----------NSFVGTRSYMSP   70 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~-~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~-----------~~~~~~~~~~~P   70 (131)
                      ++++|++|++.|+.+||.. ..+||||||-+|+|+..++..||||||.+........           -....|+.|++|
T Consensus       145 eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsP  224 (738)
T KOG1989|consen  145 EVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSP  224 (738)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccCh
Confidence            6889999999999999985 2499999999999999999999999998864432221           123568899999


Q ss_pred             cccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         71 ERLQ---GTHYSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        71 e~~~---~~~~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      |.+.   +...+.++|||+|||++|.|.....||..-
T Consensus       225 EMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  225 EMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             HHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            9885   456899999999999999999999999644

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.84  E-value=2.4e-20  Score=126.94  Aligned_cols=110  Identities=28%  Similarity=0.491  Sum_probs=88.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---ccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.++.|+|+. +++|+||++.|++++.++.++++|||++.......   .....++..|++||.+....++
T Consensus       108 ~~~~~~~~l~~~l~~lH~~-~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  186 (270)
T cd05056         108 SLILYSYQLSTALAYLESK-RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT  186 (270)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCC
Confidence            4567889999999999997 89999999999999999999999999876543221   1112233579999998887889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||||++++++++ |..||......+....+
T Consensus       187 ~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~  221 (270)
T cd05056         187 SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI  221 (270)
T ss_pred             chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            99999999999999885 99999877655444433

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.84  E-value=1.3e-20  Score=130.01  Aligned_cols=102  Identities=47%  Similarity=0.934  Sum_probs=84.5

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCC----C
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH----Y   78 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~----~   78 (131)
                      +..++.|++.++.|||+..+++|+||++.||+++.++.++++|||.+...... ......++..|++||.+.+..    +
T Consensus       116 ~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  195 (296)
T cd06618         116 LGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKY  195 (296)
T ss_pred             HHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCcccc
Confidence            45799999999999998548999999999999999999999999987654322 122334567899999986543    7


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      +.++|+||||+++|++++|..||....
T Consensus       196 ~~~~Di~slG~il~el~~g~~p~~~~~  222 (296)
T cd06618         196 DIRADVWSLGISLVELATGQFPYKNCK  222 (296)
T ss_pred             ccchhHHHHHHHHHHHHhCCCCCCcch
Confidence            889999999999999999999997643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.84  E-value=2e-20  Score=128.15  Aligned_cols=103  Identities=36%  Similarity=0.577  Sum_probs=85.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH-YS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~-~~   79 (131)
                      ++..++.|++.|++|||+. +++|+||++.||+++.++.++++|||++......  ......++..|++||...+.. ++
T Consensus       101 ~~~~~~~~i~~~l~~lh~~-~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  179 (284)
T cd07860         101 LIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS  179 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCC
Confidence            4678899999999999997 8999999999999999999999999987654322  122234567899999887644 57


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      .++|+||+|+++|++++|..||...+.
T Consensus       180 ~~~Dv~slG~il~~l~tg~~p~~~~~~  206 (284)
T cd07860         180 TAVDIWSLGCIFAEMVTRRALFPGDSE  206 (284)
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            889999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.84  E-value=1.4e-20  Score=131.96  Aligned_cols=103  Identities=38%  Similarity=0.655  Sum_probs=86.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc------ccCCCCccceeCcccccC-
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM------ANSFVGTRSYMSPERLQG-   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~~~~~~Pe~~~~-   75 (131)
                      .+..++.|++.||.|||+. +++|+||++.||+++.++.++++|||.+.......      .....++..|++||.+.. 
T Consensus       108 ~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~  186 (334)
T cd07855         108 HIRYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSL  186 (334)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCC
Confidence            4678999999999999997 89999999999999999999999999886543211      123456778999998865 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      ..++.++|+||+|+++|++++|..||...+.
T Consensus       187 ~~~~~~~Di~slG~~l~el~~g~~pf~~~~~  217 (334)
T cd07855         187 PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY  217 (334)
T ss_pred             cccccccchHHHHHHHHHHHcCCCccCCCCh
Confidence            4578999999999999999999999976654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=2.3e-20  Score=127.65  Aligned_cols=106  Identities=36%  Similarity=0.668  Sum_probs=87.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCccccc-----C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQ-----G   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~-----~   75 (131)
                      ++..++.|++.++.|||+. +++|+|+++.|++++.++.++++|||.+......  ......++..|++||.+.     .
T Consensus       104 ~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  182 (280)
T cd06611         104 QIRYVCRQMLEALNFLHSH-KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKD  182 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCC
Confidence            5678999999999999997 8999999999999999999999999987543321  223345677899999875     2


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      ..++.++|+||+|+++|++++|..||...+..+.
T Consensus       183 ~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~  216 (280)
T cd06611         183 NPYDYKADIWSLGITLIELAQMEPPHHELNPMRV  216 (280)
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH
Confidence            3467899999999999999999999987665443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.84  E-value=1.5e-20  Score=127.29  Aligned_cols=104  Identities=40%  Similarity=0.710  Sum_probs=87.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc------ccCCCCccceeCcccccCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM------ANSFVGTRSYMSPERLQGT   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~~~~~~Pe~~~~~   76 (131)
                      .+..++.|++.++++||+. +++|+||++.||++++++.++++|||.+.......      .....++..|++||.+...
T Consensus       103 ~~~~~~~ql~~al~~lh~~-~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~  181 (267)
T cd06610         103 IIATVLKEVLKGLEYLHSN-GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV  181 (267)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccc
Confidence            4567899999999999987 89999999999999999999999999875443221      1233567789999998766


Q ss_pred             -CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         77 -HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        77 -~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                       .++.++|+||+|++++++++|..||......
T Consensus       182 ~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~  213 (267)
T cd06610         182 HGYDFKADIWSFGITAIELATGAAPYSKYPPM  213 (267)
T ss_pred             cCcCcccchHhHhHHHHHHHhCCCCccccChh
Confidence             6889999999999999999999999765543

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.84  E-value=1.5e-20  Score=132.04  Aligned_cols=103  Identities=35%  Similarity=0.679  Sum_probs=86.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccC-CCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQG-THYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~   79 (131)
                      .+..++.|++.||.|||++ +++|+||++.||+++.++.++++|||++......  ......++..|++||.+.. ..++
T Consensus       109 ~~~~i~~qi~~aL~~LH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  187 (337)
T cd07858         109 HCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYT  187 (337)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCC
Confidence            4677899999999999997 7999999999999999999999999988654322  1223356778999998764 4588


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      .++|+||+|+++|++++|+.||...+.
T Consensus       188 ~~~DiwslG~il~~l~~g~~pf~~~~~  214 (337)
T cd07858         188 TAIDVWSVGCIFAELLGRKPLFPGKDY  214 (337)
T ss_pred             CcccHHHHHHHHHHHHcCCCCCCCCCh
Confidence            999999999999999999999976654

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.84  E-value=1.5e-20  Score=127.19  Aligned_cols=102  Identities=38%  Similarity=0.644  Sum_probs=88.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.++.|||+. +++|+||++.||++++++.++++|||.+...... ......++..|++||.+....++.+
T Consensus       101 ~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~  179 (258)
T cd05578         101 QVKFWICEIVLALEYLHSK-GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVA  179 (258)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCc
Confidence            4677899999999999997 8999999999999999999999999987654332 2233456778999999988888999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      +|+||+|+++|++++|..||....
T Consensus       180 ~Di~slG~~l~~l~~g~~p~~~~~  203 (258)
T cd05578         180 VDWWSLGVTAYECLRGKRPYRGHS  203 (258)
T ss_pred             ccchhhHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999998766

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.84  E-value=2.5e-20  Score=129.44  Aligned_cols=103  Identities=33%  Similarity=0.537  Sum_probs=84.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---------cccCCCCccceeCcccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---------MANSFVGTRSYMSPERL   73 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---------~~~~~~~~~~~~~Pe~~   73 (131)
                      .+..++.|++.||.|||+. +++|+||++.||+++.++.++++||+.+......         ......++..|++||.+
T Consensus       102 ~~~~~~~~l~~~L~~LH~~-~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  180 (314)
T cd08216         102 AIAFILKDVLNALDYIHSK-GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL  180 (314)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHh
Confidence            3567899999999999997 7999999999999999999999999977543211         11223456679999998


Q ss_pred             cCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         74 QGT--HYSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        74 ~~~--~~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      ...  .++.++|+||+|++++++++|..||.....
T Consensus       181 ~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~  215 (314)
T cd08216         181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA  215 (314)
T ss_pred             cCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            663  578899999999999999999999986543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.84  E-value=8.1e-21  Score=131.69  Aligned_cols=102  Identities=33%  Similarity=0.540  Sum_probs=84.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec----CCcEEEeeccccccccccc-----ccCCCCccceeCcccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS----GGEIKICDFGVSGQLIDSM-----ANSFVGTRSYMSPERL   73 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~----~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~Pe~~   73 (131)
                      .++.++.|++.++.|||++ +++|+||++.||+++.    ++.++++|||++.......     .....++..|+|||.+
T Consensus       109 ~~~~i~~qi~~~l~~lH~~-~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  187 (316)
T cd07842         109 MVKSLLWQILNGVHYLHSN-WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELL  187 (316)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHH
Confidence            4567899999999999997 7999999999999998    8899999999876543221     1223456789999988


Q ss_pred             cCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         74 QGT-HYSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        74 ~~~-~~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      .+. .++.++|+||+|++++++++|+.||....
T Consensus       188 ~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         188 LGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             hCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            663 57889999999999999999999997554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.84  E-value=2e-20  Score=131.74  Aligned_cols=102  Identities=34%  Similarity=0.620  Sum_probs=84.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.|++|||++ +++|+||+|.||+++.++.++++|||++.......    .....++..|++||.+.+..+
T Consensus       180 ~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  258 (343)
T cd05103         180 DLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY  258 (343)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCC
Confidence            4567899999999999997 89999999999999999999999999886542211    112233457999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPD  105 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~  105 (131)
                      +.++|+||||+++|++++ |..||....
T Consensus       259 ~~~~Di~slG~~l~el~~~g~~p~~~~~  286 (343)
T cd05103         259 TIQSDVWSFGVLLWEIFSLGASPYPGVK  286 (343)
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence            999999999999999996 999997544

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.84  E-value=2.6e-20  Score=125.71  Aligned_cols=109  Identities=33%  Similarity=0.529  Sum_probs=91.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.++.+||+. +++|+||++.||+++.++.++++|||.+......  ......++..|++||...+..++.
T Consensus       102 ~~~~~~~~l~~~l~~lh~~-~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~  180 (256)
T cd08218         102 QILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN  180 (256)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCC
Confidence            3567899999999999997 8999999999999999999999999987654322  122345677899999998888889


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      ++|+||+|++++++++|..||...+..+....
T Consensus       181 ~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~  212 (256)
T cd08218         181 KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK  212 (256)
T ss_pred             ccchhHHHHHHHHHHcCCCCccCCCHHHHHHH
Confidence            99999999999999999999987766554443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.83  E-value=1.5e-20  Score=120.85  Aligned_cols=90  Identities=29%  Similarity=0.377  Sum_probs=77.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      ++..++.|++.||.|||+. +      ++.||+++.++.+++  ||.+......   ...+++.|+|||.+.+..++.++
T Consensus        18 ~~~~i~~qi~~~L~~lH~~-~------kp~Nil~~~~~~~~~--fG~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~   85 (176)
T smart00750       18 EIWAVCLQCLRALRELHRQ-A------KSGNILLTWDGLLKL--DGSVAFKTPE---QSRVDPYFMAPEVIQGQSYTEKA   85 (176)
T ss_pred             HHHHHHHHHHHHHHHHHhc-C------CcccEeEcCccceee--ccceEeeccc---cCCCcccccChHHhcCCCCcchh
Confidence            5788999999999999987 4      999999999999988  8887554332   22577899999999998899999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCC
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      |+||+|+++|++++|..||...
T Consensus        86 DiwSlG~il~elltg~~p~~~~  107 (176)
T smart00750       86 DIYSLGITLYEALDYELPYNEE  107 (176)
T ss_pred             hHHHHHHHHHHHHhCCCCcccc
Confidence            9999999999999999999644

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.83  E-value=3.5e-20  Score=124.65  Aligned_cols=111  Identities=39%  Similarity=0.577  Sum_probs=93.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.++.+||+. |++|+||+++||+++.++.++++|||.+......  ......++..|++||......++.
T Consensus       104 ~~~~i~~~i~~~l~~lh~~-~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~  182 (258)
T cd08215         104 QILDWFVQLCLALKYLHSR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNY  182 (258)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCc
Confidence            4678899999999999997 8999999999999999999999999987654332  223345677899999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~  114 (131)
                      ++|+||+|++++++++|..||...+..+......
T Consensus       183 ~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~  216 (258)
T cd08215         183 KSDIWSLGCVLYELCTLKHPFEGENLLELALKIL  216 (258)
T ss_pred             cccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh
Confidence            9999999999999999999998777665555443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.83  E-value=2.5e-20  Score=126.13  Aligned_cols=101  Identities=40%  Similarity=0.720  Sum_probs=85.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc------ccCCCCccceeCcccccCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM------ANSFVGTRSYMSPERLQGT   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~~~~~~Pe~~~~~   76 (131)
                      .+..++.|++.++.+||+. +++|+||++.||+++.++.++++|||.+.......      .....++..|++||.+...
T Consensus       100 ~~~~i~~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~  178 (264)
T cd06626         100 VIRVYTLQLLEGLAYLHSH-GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG  178 (264)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCC
Confidence            4567899999999999997 89999999999999999999999999876543221      1123566789999999876


Q ss_pred             C---CCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         77 H---YSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        77 ~---~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      .   ++.++|+||+|++++++++|..||...
T Consensus       179 ~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~  209 (264)
T cd06626         179 KGKGHGRAADIWSLGCVVLEMATGKRPWSEL  209 (264)
T ss_pred             CCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence            5   789999999999999999999999755

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=2.2e-20  Score=126.93  Aligned_cols=103  Identities=41%  Similarity=0.728  Sum_probs=84.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccC-----
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQG-----   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~-----   75 (131)
                      .+..++.|++.||.|||+. +++|+||++.||+++.++.++++|||.+.....  .......++..|++||.+..     
T Consensus       114 ~~~~~~~ql~~al~~lH~~-~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  192 (275)
T cd06608         114 WIAYILRETLRGLAYLHEN-KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPD  192 (275)
T ss_pred             HHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhccccccc
Confidence            3567899999999999997 899999999999999999999999998765432  12234456778999998753     


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      ..++.++|+||+|++++++++|..||.....
T Consensus       193 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  223 (275)
T cd06608         193 ASYDARSDVWSLGITAIELADGKPPLCDMHP  223 (275)
T ss_pred             CCccccccHHHhHHHHHHHHhCCCCccccch
Confidence            2367889999999999999999999975543

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.83  E-value=2.4e-20  Score=126.15  Aligned_cols=102  Identities=57%  Similarity=1.021  Sum_probs=87.7

Q ss_pred             chhHHHHHHHHHHHHHHh-cCCcEecCCCCCcEEEecCCcEEEeecccccccccccc--cCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLRE-KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~-~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.++.++|+ . +++|++|++.||+++.++.++++|||.+........  ....++..|++||.+....++
T Consensus       100 ~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~  178 (264)
T cd06623         100 VLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYS  178 (264)
T ss_pred             HHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCC
Confidence            457899999999999999 7 899999999999999999999999998765533221  234567789999999888889


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      .++|+||||+++|++++|..||...+
T Consensus       179 ~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         179 YAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCcccc
Confidence            99999999999999999999997663

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.83  E-value=2.9e-20  Score=130.46  Aligned_cols=101  Identities=42%  Similarity=0.713  Sum_probs=84.4

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-------cccCCCCccceeCcccccC-
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-------MANSFVGTRSYMSPERLQG-   75 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~-   75 (131)
                      +..++.|++.+|.|||+. |++|+||++.||+++.++.++++|||.+......       ......++..|++||.+.. 
T Consensus       109 ~~~i~~qi~~~L~~LH~~-~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  187 (337)
T cd07852         109 KRYIMYQLLKALKYIHSG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGS  187 (337)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeecc
Confidence            456899999999999997 8999999999999999999999999987644221       1123356778999998765 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ..++.++|+||+|+++|++++|+.||....
T Consensus       188 ~~~~~~sDi~slG~~l~el~tg~~pf~~~~  217 (337)
T cd07852         188 TRYTKGVDMWSVGCILGEMLLGKPLFPGTS  217 (337)
T ss_pred             ccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence            457889999999999999999999997554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.83  E-value=3.1e-20  Score=126.32  Aligned_cols=110  Identities=27%  Similarity=0.389  Sum_probs=88.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc-----cCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-----NSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.++++||+. +++|+||++.|++++.++.++++|||.+........     .....+..|++||.+.+..
T Consensus       107 ~~~~i~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~  185 (267)
T cd05066         107 QLVGMLRGIASGMKYLSDM-GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK  185 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCc
Confidence            4577899999999999997 799999999999999999999999998865432211     1112235799999998888


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      ++.++|+||+|++++++++ |..||......+....+
T Consensus       186 ~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~  222 (267)
T cd05066         186 FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI  222 (267)
T ss_pred             cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH
Confidence            9999999999999999886 99999876655444443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.83  E-value=2.3e-20  Score=130.83  Aligned_cols=105  Identities=35%  Similarity=0.525  Sum_probs=86.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc----------------ccccCCCCccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----------------SMANSFVGTRS   66 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~----------------~~~~~~~~~~~   66 (131)
                      .+..++.|++.+|++||+. |++|+||++.||+++.++.++++|||.+.....                .......++..
T Consensus       120 ~~~~~~~ql~~aL~~LH~~-~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (335)
T PTZ00024        120 QVKCILLQILNGLNVLHKW-YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLW  198 (335)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccC
Confidence            4677999999999999997 899999999999999999999999998765431                01112234667


Q ss_pred             eeCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         67 YMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        67 ~~~Pe~~~~~-~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      |++||.+.+. .++.++|+||+|++++++++|..||...+..+
T Consensus       199 y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        199 YRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999998764 46889999999999999999999998776543

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.83  E-value=3.3e-20  Score=127.72  Aligned_cols=103  Identities=32%  Similarity=0.553  Sum_probs=84.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec-CCcEEEeecccccccccc--cccCCCCccceeCcccccCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT-HY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~-~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~-~~   78 (131)
                      .+..++.|++.||.|||++ +++|+||++.||+++. ++.++++|||++......  ......++..|++||.+.+. .+
T Consensus       103 ~~~~~~~qi~~aL~~LH~~-~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~  181 (294)
T PLN00009        103 LIKTYLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHY  181 (294)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCC
Confidence            3567889999999999997 7999999999999985 557899999988654321  12233556789999988663 57


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      +.++|+||+|+++|++++|..||.....
T Consensus       182 ~~~~Dv~slG~i~~~l~tg~~pf~~~~~  209 (294)
T PLN00009        182 STPVDIWSVGCIFAEMVNQKPLFPGDSE  209 (294)
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            8899999999999999999999976554

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.83  E-value=1.4e-20  Score=126.24  Aligned_cols=98  Identities=27%  Similarity=0.376  Sum_probs=83.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      ++..++.|++.+|.|+|++ +++|+||+|.||+++.++.++++|||.+...... .....++..|++||...+..++.++
T Consensus        86 ~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~  163 (237)
T cd05576          86 CVKRWAAEMVVALDALHRE-GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-CDGEAVENMYCAPEVGGISEETEAC  163 (237)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCCCEEEecccchhccccc-cccCCcCccccCCcccCCCCCCchh
Confidence            4577899999999999997 8999999999999999999999999976544332 1223445679999999877889999


Q ss_pred             hHHHHHHHHHHHHhCCCCCC
Q psy17559         83 DIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~  102 (131)
                      |+||+|++++++++|..|+.
T Consensus       164 DvwslG~il~el~~g~~~~~  183 (237)
T cd05576         164 DWWSLGAILFELLTGKTLVE  183 (237)
T ss_pred             hHHHHHHHHHHHHHCcchhh
Confidence            99999999999999987765

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.83  E-value=2.8e-20  Score=128.23  Aligned_cols=103  Identities=35%  Similarity=0.617  Sum_probs=85.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccC-CCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQG-THYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~   79 (131)
                      ++..++.|++.||.|||++ |++|+||++.||+++.++.++++|||++......  ......++..|++||.+.+ ..++
T Consensus       103 ~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  181 (298)
T cd07841         103 DIKSYMLMTLRGLEYLHSN-WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYG  181 (298)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCC
Confidence            4678999999999999997 8999999999999999999999999988654332  2223345678999998854 3568


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      .++|+||+|++++++++|..||.....
T Consensus       182 ~~~Dv~slG~il~e~~~g~~~~~~~~~  208 (298)
T cd07841         182 VGVDMWSVGCIFAELLLRVPFLPGDSD  208 (298)
T ss_pred             cHHHHHHHHHHHHHHHcCCccccCCcc
Confidence            899999999999999999877865543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.83  E-value=7.6e-20  Score=122.92  Aligned_cols=110  Identities=37%  Similarity=0.652  Sum_probs=92.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.++.++|+. +++|+||++.||+++.++.++++|||.+......  ......++..|++||...+...+.
T Consensus        94 ~~~~~~~qi~~~l~~lh~~-~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~  172 (250)
T cd05123          94 RARFYAAEIVLALEYLHSL-GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK  172 (250)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCc
Confidence            4677899999999999997 7999999999999999999999999987654332  233455677899999998878889


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|++++++++|..||...+.....+.+
T Consensus       173 ~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~  205 (250)
T cd05123         173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI  205 (250)
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999877755544444

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.83  E-value=3.1e-20  Score=126.82  Aligned_cols=104  Identities=34%  Similarity=0.599  Sum_probs=87.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc--ccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      ++..++.|++.++.+||+. +++|+||++.||+++.++.++++|||.+.......  .....++..|++||.+.+. .++
T Consensus        99 ~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~  177 (283)
T cd05118          99 LIKSYLYQLLQGLAFCHSH-GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS  177 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCC
Confidence            4577999999999999997 79999999999999999999999999876543321  2234466789999998776 688


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      .++|+||+|++++++++|+.||...+..
T Consensus       178 ~~~Di~slG~~l~~l~tg~~~~~~~~~~  205 (283)
T cd05118         178 TPVDIWSVGCIFAELLSRRPLFPGKSEI  205 (283)
T ss_pred             chhHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999999999999999999766643

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.83  E-value=4.4e-20  Score=124.44  Aligned_cols=109  Identities=36%  Similarity=0.503  Sum_probs=89.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC-CcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG-GEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~-~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      .+..++.|++.++.++|+. +++|+||++.||+++.+ +.++++|||.+...... ......++..|++||.+.+..++.
T Consensus       102 ~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  180 (256)
T cd08220         102 TILHFFVQILLALHHVHTK-LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQ  180 (256)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCc
Confidence            4577899999999999997 89999999999999854 45799999988655432 223345677899999998888889


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      ++|+||+|++++++++|..||...+.......
T Consensus       181 ~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~  212 (256)
T cd08220         181 KSDIWALGCVLYELASLKRAFEAANLPALVLK  212 (256)
T ss_pred             ccchHHHHHHHHHHHhCCCCcccCchHHHHHH
Confidence            99999999999999999999987765544443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.83  E-value=4.8e-20  Score=124.31  Aligned_cols=103  Identities=38%  Similarity=0.721  Sum_probs=87.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH-YSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~-~~~   80 (131)
                      .+..++.|++.++++||+. +++|+||++.||+++.++.++++|||.+...... ......++..|++||...... ++.
T Consensus       103 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~  181 (258)
T cd06632         103 VIRLYTRQILLGLEYLHDR-NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGL  181 (258)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCc
Confidence            3556899999999999997 8999999999999999999999999987654322 233455777899999987766 889


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      ++|+||+|+++|++++|..||.....
T Consensus       182 ~~D~~slG~~l~~l~~g~~pf~~~~~  207 (258)
T cd06632         182 AADIWSLGCTVLEMATGKPPWSQLEG  207 (258)
T ss_pred             hhhhHHHHHHHHHHHhCCCCcccCcH
Confidence            99999999999999999999976553

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.83  E-value=2.7e-20  Score=128.42  Aligned_cols=104  Identities=34%  Similarity=0.609  Sum_probs=87.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.++++||+. |++|+||++.||+++.++.++++|||++......  ......++..|++||.+....++.
T Consensus       116 ~~~~i~~~l~~al~~LH~~-gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  194 (293)
T cd06647         116 QIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP  194 (293)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCc
Confidence            4567899999999999997 8999999999999999999999999987544322  122335677899999998878899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      ++|+||+|+++|++++|..||...+..
T Consensus       195 ~~Dv~slG~ll~~ll~g~~pf~~~~~~  221 (293)
T cd06647         195 KVDIWSLGIMAIEMVEGEPPYLNENPL  221 (293)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCChh
Confidence            999999999999999999999766543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.83  E-value=1.4e-20  Score=129.10  Aligned_cols=98  Identities=29%  Similarity=0.500  Sum_probs=82.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-----ccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.+|.|+|++ |++|+||+|.||+++.++.++++|||++.......     .....++..|++||.+.+..
T Consensus       110 ~~~~i~~~i~~aL~~lH~~-gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~  188 (284)
T cd05079         110 QQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK  188 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCC
Confidence            4578899999999999997 89999999999999999999999999886543211     12334556799999998888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPI  101 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~  101 (131)
                      ++.++|+||||+++++++++..|.
T Consensus       189 ~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         189 FYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             CCccccchhhhhhhhhhhcCCCCC
Confidence            899999999999999999876654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.83  E-value=2.8e-20  Score=130.97  Aligned_cols=103  Identities=40%  Similarity=0.711  Sum_probs=87.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccC-CCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~   81 (131)
                      ++..++.|++.++.+||+. |++|+||++.||+++.++.++++|||.+...... .....++..|++||.+.. ..++.+
T Consensus       119 ~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~  196 (343)
T cd07851         119 HIQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-MTGYVATRWYRAPEIMLNWMHYNQT  196 (343)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEcccccccccccc-ccCCcccccccCHHHHhCCCCCCch
Confidence            4677899999999999997 8999999999999999999999999988654332 233456678999999865 367899


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +|+||+|++++++++|..||...+..
T Consensus       197 ~DvwslGv~l~elltg~~pf~~~~~~  222 (343)
T cd07851         197 VDIWSVGCIMAELLTGKTLFPGSDHI  222 (343)
T ss_pred             HhHHHHHHHHHHHHhCCCCCCCCChH
Confidence            99999999999999999999766544

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1035|consensus

Probab=99.83  E-value=1.4e-20  Score=145.03  Aligned_cols=93  Identities=41%  Similarity=0.673  Sum_probs=79.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--------------------cccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--------------------DSMANSFV   62 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--------------------~~~~~~~~   62 (131)
                      .+++++++|++||.|+|+. |++||||+|.|||++.+..||++|||++....                    .+.....+
T Consensus       698 ~~wrLFreIlEGLaYIH~~-giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~V  776 (1351)
T KOG1035|consen  698 EAWRLFREILEGLAYIHDQ-GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQV  776 (1351)
T ss_pred             HHHHHHHHHHHHHHHHHhC-ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccccccc
Confidence            4689999999999999997 89999999999999999999999999986510                    01223457


Q ss_pred             CccceeCcccccCC---CCCCcchHHHHHHHHHHHHh
Q psy17559         63 GTRSYMSPERLQGT---HYSVQSDIWSLGLSLVEMAI   96 (131)
Q Consensus        63 ~~~~~~~Pe~~~~~---~~~~~~d~~slg~~l~~l~~   96 (131)
                      ||.-|+|||++.+.   .|..++|+||+|++++||+.
T Consensus       777 GTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  777 GTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             ceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc
Confidence            88899999999764   49999999999999999953

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.83  E-value=4.4e-20  Score=126.36  Aligned_cols=103  Identities=32%  Similarity=0.556  Sum_probs=85.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      ++..++.|++.+|.|||+. +++|+|+++.||+++.++.++++|||.+......  ......++..|++||.+.+. .++
T Consensus       100 ~~~~~~~~i~~~L~~lH~~-~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  178 (283)
T cd07835         100 LIKSYLYQLLQGIAYCHSH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYS  178 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccC
Confidence            4577899999999999997 7999999999999999999999999988644321  11223456789999988664 468


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      .++|+||+|+++|++++|..||...+.
T Consensus       179 ~~~Di~slG~~l~~l~~g~~pf~~~~~  205 (283)
T cd07835         179 TPVDIWSIGCIFAEMVNRRPLFPGDSE  205 (283)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            899999999999999999999976654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0579|consensus

Probab=99.83  E-value=2.7e-20  Score=136.90  Aligned_cols=107  Identities=38%  Similarity=0.662  Sum_probs=91.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCccccc-----C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQ-----G   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~-----~   75 (131)
                      ++..+++|++.||.|||+. .|+||||+..||++..+|.++++|||++.....  .....+.|++.|+|||++-     .
T Consensus       131 QIqvvc~q~ldALn~LHs~-~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD  209 (1187)
T KOG0579|consen  131 QIQVVCYQVLDALNWLHSQ-NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKD  209 (1187)
T ss_pred             HHHHHHHHHHHHHHHHhhc-chhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccC
Confidence            5678999999999999998 599999999999999999999999999865432  3456789999999999873     4


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLA  110 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~  110 (131)
                      .+|++++|+||||+.+.+|..+..|-...+.-.+.
T Consensus       210 ~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl  244 (1187)
T KOG0579|consen  210 QPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL  244 (1187)
T ss_pred             CCchhhhhHHhhhhHHHHHhccCCCccccchHHHH
Confidence            57999999999999999999999887666654433

>KOG0669|consensus

Probab=99.83  E-value=1.8e-20  Score=124.87  Aligned_cols=105  Identities=29%  Similarity=0.465  Sum_probs=90.3

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc------cccCCCCccceeCcccccC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS------MANSFVGTRSYMSPERLQG   75 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~~~~~~Pe~~~~   75 (131)
                      .++++++.++.+||.|+|.. -++|||+++.|++++.++.++++|||+++.....      .....+.+.+|++||.+.+
T Consensus       124 s~Ikk~Mk~Lm~GL~~iHr~-kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG  202 (376)
T KOG0669|consen  124 SEIKKVMKGLMNGLYYIHRN-KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG  202 (376)
T ss_pred             HHHHHHHHHHHHHHHHHHHh-hHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhc
Confidence            46789999999999999997 5999999999999999999999999998655332      2334455889999999987


Q ss_pred             C-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         76 T-HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        76 ~-~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      . .++++.|+|..||++.+|.+++..+++....
T Consensus       203 ~r~yg~~iDiWgAgCimaeMwtrspimqgnteq  235 (376)
T KOG0669|consen  203 DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ  235 (376)
T ss_pred             ccccCCcchhHhHHHHHHHHHccCccccCChHH
Confidence            5 6899999999999999999999999866644

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.83  E-value=1.2e-19  Score=126.37  Aligned_cols=103  Identities=37%  Similarity=0.665  Sum_probs=86.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCccccc---CCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQ---GTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~   79 (131)
                      ++..++.|++.++.|||+. |++|+||++.||+++.++.++++|||.+.....  .....++..|++||.+.   ...++
T Consensus       122 ~~~~~~~qi~~al~~LH~~-gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~  198 (313)
T cd06633         122 EIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--ANSFVGTPYWMAPEVILAMDEGQYD  198 (313)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCChhhEEECCCCCEEEeecCCCcccCC--CCCccccccccChhhccccCCCCCC
Confidence            3566889999999999997 899999999999999999999999998754322  23456777899999984   34578


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      .++|+||+|+++|++++|..||...+...
T Consensus       199 ~~sDv~slGvil~el~~g~~p~~~~~~~~  227 (313)
T cd06633         199 GKVDVWSLGITCIELAERKPPLFNMNAMS  227 (313)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            89999999999999999999997666443

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.83  E-value=1.2e-19  Score=126.54  Aligned_cols=102  Identities=37%  Similarity=0.659  Sum_probs=85.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCccccc---CCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQ---GTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~   79 (131)
                      ++..++.|++.++.|||+. +++|+||++.||+++.++.++++|||++.....  .....++..|++||.+.   ...++
T Consensus       126 ~~~~i~~~i~~~l~~lH~~-~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~  202 (317)
T cd06635         126 EIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASIASP--ANSFVGTPYWMAPEVILAMDEGQYD  202 (317)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCcccEEECCCCCEEEecCCCccccCC--cccccCCccccChhhhhcCCCCCCC
Confidence            4567899999999999997 899999999999999999999999998754332  23345677899999974   34578


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      .++|+||+|+++|++++|..||...+..
T Consensus       203 ~~~Dv~slGvil~el~~g~~p~~~~~~~  230 (317)
T cd06635         203 GKVDVWSLGITCIELAERKPPLFNMNAM  230 (317)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCccHH
Confidence            8999999999999999999998765544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG1006|consensus

Probab=99.83  E-value=1.6e-21  Score=130.44  Aligned_cols=97  Identities=48%  Similarity=0.918  Sum_probs=81.9

Q ss_pred             HHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccC--CCCCCcchHHH
Q psy17559         10 QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--THYSVQSDIWS   86 (131)
Q Consensus        10 q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~--~~~~~~~d~~s   86 (131)
                      -.+.||.||-++..++|||++|.||+++..|.+|++|||++.....+ ....-.|-.+|+|||.+..  .+++.++|+||
T Consensus       175 atV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWS  254 (361)
T KOG1006|consen  175 ATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWS  254 (361)
T ss_pred             eehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhh
Confidence            34579999987667999999999999999999999999998655443 3334467778999999965  35899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCH
Q psy17559         87 LGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        87 lg~~l~~l~~g~~p~~~~~~  106 (131)
                      ||+.++|+.+|..|+..++.
T Consensus       255 LGITL~EvAtG~fPyr~w~s  274 (361)
T KOG1006|consen  255 LGITLYEVATGNFPYRKWDS  274 (361)
T ss_pred             hcceEeeeecCCCCcchHHH
Confidence            99999999999999988774

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.83  E-value=6.9e-20  Score=125.70  Aligned_cols=105  Identities=41%  Similarity=0.711  Sum_probs=88.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.++.+||+. |++|+|+++.||+++.++.++++|||.+......  ......++..|++||.+.+..++.
T Consensus       117 ~~~~i~~~i~~~L~~lH~~-gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  195 (286)
T cd06614         117 QIAYVCREVLQGLEYLHSQ-NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP  195 (286)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCC
Confidence            4567899999999999997 8999999999999999999999999987543221  122334667899999998878899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      ++|+||+|+++|++++|..||...+...
T Consensus       196 ~~Dv~slGvil~~l~~g~~p~~~~~~~~  223 (286)
T cd06614         196 KVDIWSLGIMCIEMAEGEPPYLREPPLR  223 (286)
T ss_pred             ccccHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999999998766543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.83  E-value=8.1e-20  Score=124.72  Aligned_cols=104  Identities=38%  Similarity=0.601  Sum_probs=87.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      ++..++.|++.++.+||+. +++|+||++.||+++.++.++++|||.+......  .......+..|++||.+... .++
T Consensus        99 ~~~~~~~~i~~~l~~LH~~-~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  177 (282)
T cd07829          99 LIKSIMYQLLRGLAYCHSH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYS  177 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCC
Confidence            4678899999999999997 8999999999999999999999999987654322  12233445679999998766 688


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      .++|+||+|++++++++|..||......
T Consensus       178 ~~~Dv~slG~~l~~l~~~~~~~~~~~~~  205 (282)
T cd07829         178 TAVDIWSVGCIFAEMITGKPLFPGDSEI  205 (282)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCccHH
Confidence            9999999999999999999999766543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.83  E-value=5.4e-20  Score=124.63  Aligned_cols=106  Identities=24%  Similarity=0.385  Sum_probs=84.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCc--------EEEeecccccccccccccCCCCccceeCccccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE--------IKICDFGVSGQLIDSMANSFVGTRSYMSPERLQ   74 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~--------~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~   74 (131)
                      .+..++.|++.|++|||++ +++|+||++.||+++.++.        ++++|||.+.....  .....++..|++||.+.
T Consensus       101 ~~~~~~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~y~aPE~~~  177 (258)
T cd05078         101 WKLEVAKQLAWALHFLEDK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP--KEILLERIPWVPPECIE  177 (258)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEecccccccCCCceEEecccccccccCC--chhccccCCccCchhcc
Confidence            3467899999999999997 8999999999999987654        58999998754432  22345677899999997


Q ss_pred             CC-CCCCcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHH
Q psy17559         75 GT-HYSVQSDIWSLGLSLVEMAIG-MYPIPPPDAKTLAA  111 (131)
Q Consensus        75 ~~-~~~~~~d~~slg~~l~~l~~g-~~p~~~~~~~~~~~  111 (131)
                      +. .++.++|+||+|+++|++++| ..||...+......
T Consensus       178 ~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~  216 (258)
T cd05078         178 NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ  216 (258)
T ss_pred             CCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH
Confidence            64 578999999999999999998 56776655544333

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.83  E-value=2.7e-20  Score=143.78  Aligned_cols=103  Identities=37%  Similarity=0.590  Sum_probs=83.5

Q ss_pred             chhHHHHHHHHHHHHHHhc------CCcEecCCCCCcEEEecC-----------------CcEEEeecccccccccc-cc
Q psy17559          3 QVPYSSFQVLKGLTYLREK------HAIIHRDVKPSNILVNSG-----------------GEIKICDFGVSGQLIDS-MA   58 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~------~~~~h~~l~~~~il~~~~-----------------~~~~l~d~g~~~~~~~~-~~   58 (131)
                      .++.++.||+.||.|||+.      .+|+|+||+|.||+++..                 ..++|+|||++...... ..
T Consensus       119 ~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~  198 (1021)
T PTZ00266        119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMA  198 (1021)
T ss_pred             HHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccc
Confidence            4678999999999999983      249999999999999642                 34899999998655322 23


Q ss_pred             cCCCCccceeCcccccC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         59 NSFVGTRSYMSPERLQG--THYSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        59 ~~~~~~~~~~~Pe~~~~--~~~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ....+++.|+|||.+.+  ..++.++|+|||||++|+|++|..||...+
T Consensus       199 ~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        199 HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence            34568889999999865  347889999999999999999999997443

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.83  E-value=4.6e-20  Score=126.42  Aligned_cols=102  Identities=38%  Similarity=0.662  Sum_probs=85.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccC-----C
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQG-----T   76 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-----~   76 (131)
                      +..++.|++.++.|||+. +++|+||++.||+++.++.++++|||.+......  ......++..|++||.+..     .
T Consensus       126 ~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  204 (286)
T cd06638         126 IAYILHEALMGLQHLHVN-KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDS  204 (286)
T ss_pred             HHHHHHHHHHHHHHHHhC-CccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccc
Confidence            566899999999999997 7999999999999999999999999987654321  2233457788999998753     3


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         77 HYSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      .++.++|+||+|+++|++++|..||.....
T Consensus       205 ~~~~~~Dv~slGvi~~el~~g~~p~~~~~~  234 (286)
T cd06638         205 TYDARCDVWSLGITAIELGDGDPPLADLHP  234 (286)
T ss_pred             cccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence            478899999999999999999999976554

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.83  E-value=3.4e-20  Score=127.04  Aligned_cols=101  Identities=33%  Similarity=0.501  Sum_probs=82.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc-----cCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-----NSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~~~Pe~~~~~~   77 (131)
                      .+..++.|++.||.|||++ |++|+||++.||+++.++.++++|||++........     ....+...|++||...+..
T Consensus       109 ~~~~~~~~l~~aL~~LH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  187 (284)
T cd05081         109 KLLLYASQICKGMEYLGSK-RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK  187 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCC
Confidence            4567899999999999997 899999999999999999999999998865432211     1112234589999998888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      ++.++|+||+|+++++++++..++...
T Consensus       188 ~~~~~Di~slG~~l~el~~~~~~~~~~  214 (284)
T cd05081         188 FSVASDVWSFGVVLYELFTYSDKSCSP  214 (284)
T ss_pred             cChHHHHHHHHHHHHHHhhcCCcCCCc
Confidence            899999999999999999987766433

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.83  E-value=7.9e-20  Score=124.63  Aligned_cols=110  Identities=25%  Similarity=0.385  Sum_probs=88.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.+|.|||+. +++|+||+|.|++++.++.++++|+|++......   ......++..|++||.+.+..++
T Consensus       118 ~~~~~~~~l~~~l~~LH~~-~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~  196 (275)
T cd05046         118 QKVALCTQIALGMDHLSNA-RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFS  196 (275)
T ss_pred             HHHHHHHHHHHHHHHhhhc-CcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCC
Confidence            4567899999999999997 7999999999999999999999999987543221   11233445679999998877788


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||+|++++++++ |..||............
T Consensus       197 ~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~  231 (275)
T cd05046         197 TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL  231 (275)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH
Confidence            99999999999999998 88899766655544443

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.83  E-value=3.5e-20  Score=127.38  Aligned_cols=100  Identities=34%  Similarity=0.566  Sum_probs=83.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCC--C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT--H   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~--~   77 (131)
                      ++..++.|++.+|.+||+. +++|+||++.||+++.++.++++|||++......   ......++..|++||.+...  .
T Consensus       106 ~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  184 (290)
T cd05613         106 EVQIYSGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG  184 (290)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCC
Confidence            4566788999999999997 8999999999999999999999999988654321   12234567789999998753  4


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      ++.++|+||+|+++|++++|..||..
T Consensus       185 ~~~~~Dv~slG~~l~~ll~g~~p~~~  210 (290)
T cd05613         185 HDKAVDWWSMGVLMYELLTGASPFTV  210 (290)
T ss_pred             CCccccHHHHHHHHHHHhcCCCCCCc
Confidence            67889999999999999999999963

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.83  E-value=6.6e-20  Score=127.32  Aligned_cols=103  Identities=37%  Similarity=0.650  Sum_probs=85.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCccccc---CCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQ---GTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~   79 (131)
                      ++..++.|++.++.|||+. +++|+||++.||+++.++.++++|||++.....  .....++..|++||.+.   ...++
T Consensus       116 ~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~  192 (308)
T cd06634         116 EIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANXFVGTPYWMAPEVILAMDEGQYD  192 (308)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCHHhEEECCCCcEEECCcccceeecC--cccccCCccccCHHHHhhcccCCCC
Confidence            4567889999999999997 799999999999999999999999998754432  22345677899999974   34578


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      .++|+||+|+++|++++|..||...+..+
T Consensus       193 ~~~Di~slG~il~el~~g~~p~~~~~~~~  221 (308)
T cd06634         193 GKVDVWSLGITCIELAERKPPLFNMNAMS  221 (308)
T ss_pred             cccchHHHHHHHHHHHcCCCCCccccHHH
Confidence            89999999999999999999987665443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0577|consensus

Probab=99.83  E-value=7.1e-21  Score=138.74  Aligned_cols=101  Identities=38%  Similarity=0.651  Sum_probs=87.4

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccC---CCCCC
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG---THYSV   80 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~---~~~~~   80 (131)
                      +..|..+.+.||+|||+. +.|||||+..||++.+.|.||++|||.+....+  ..+++|++.|+|||++..   +.|+.
T Consensus       128 IAAi~~gaL~gLaYLHS~-~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--AnsFvGTPywMAPEVILAMDEGqYdg  204 (948)
T KOG0577|consen  128 IAAITHGALQGLAYLHSH-NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDG  204 (948)
T ss_pred             HHHHHHHHHHHHHHHHHh-hHHhhhccccceEecCCCeeeeccccchhhcCc--hhcccCCccccchhHheeccccccCC
Confidence            445777888999999997 799999999999999999999999998865433  467899999999999864   57999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      ++||||||+...|+..++.|.-+.+.-
T Consensus       205 kvDvWSLGITCIELAERkPPlFnMNAM  231 (948)
T KOG0577|consen  205 KVDVWSLGITCIELAERKPPLFNMNAM  231 (948)
T ss_pred             ccceeeccchhhhhhhcCCCccCchHH
Confidence            999999999999999999996555543

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.82  E-value=4.6e-20  Score=126.21  Aligned_cols=104  Identities=36%  Similarity=0.623  Sum_probs=86.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      ++..++.|++.+|.|||+. +++|+|+++.||+++.++.++++|||.+......  ......++..|++||.+.+. .++
T Consensus       101 ~~~~~~~qi~~~l~~lH~~-~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  179 (284)
T cd07836         101 TVKSFTYQLLKGIAFCHEN-RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYS  179 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCC
Confidence            4577899999999999997 8999999999999999999999999987543321  11233456789999988653 468


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      .++|+||+|++++++++|..||...+..
T Consensus       180 ~~~Dv~slG~~l~~l~~g~~~~~~~~~~  207 (284)
T cd07836         180 TSIDIWSVGCIMAEMITGRPLFPGTNNE  207 (284)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            8999999999999999999999866544

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG1024|consensus

Probab=99.82  E-value=3.2e-20  Score=129.86  Aligned_cols=124  Identities=24%  Similarity=0.357  Sum_probs=104.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      +.+.|+.|++.|++|+|+. |++|.||-.+|+++|+.-.+|++|=.+++-..+..    .........|++||.+....+
T Consensus       397 qlV~masQla~am~hlh~~-~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y  475 (563)
T KOG1024|consen  397 QLVLMASQLAMAMEHLHNH-GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY  475 (563)
T ss_pred             HHHHHHHHHHHHHHHHHhc-CcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhh
Confidence            4678999999999999987 89999999999999999999999988877654432    234456678999999999999


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCCCCCCCcccccCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPSRGDGYWHVSYPT  128 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  128 (131)
                      +..+|+||||+++||+++ |+.|+...++.+++..+.+. ...-.+.|+|.
T Consensus       476 ssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG-yRlaQP~NCPD  525 (563)
T KOG1024|consen  476 SSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG-YRLAQPFNCPD  525 (563)
T ss_pred             cchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc-ceecCCCCCcH
Confidence            999999999999999986 99999999999998887433 33455667664

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.82  E-value=8.9e-20  Score=122.63  Aligned_cols=103  Identities=42%  Similarity=0.682  Sum_probs=88.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc--ccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      .+..++.|++.++.+||+. |++|+|+++.||+++.++.++++|||.+.......  .....++..|++||...+..++.
T Consensus       100 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~  178 (254)
T cd06627         100 LVAVYVYQVLQGLAYLHEQ-GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST  178 (254)
T ss_pred             HHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCc
Confidence            3567899999999999987 89999999999999999999999999886554322  23345677899999998877889


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      ++|+|++|++++++++|..||...+.
T Consensus       179 ~~Dv~~lG~~l~~l~~g~~p~~~~~~  204 (254)
T cd06627         179 ASDIWSLGCTVIELLTGNPPYYDLNP  204 (254)
T ss_pred             chhHHHHHHHHHHHHhCCCCCCCccH
Confidence            99999999999999999999976553

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.82  E-value=6.7e-20  Score=123.19  Aligned_cols=102  Identities=41%  Similarity=0.700  Sum_probs=88.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.++.|||+. +++|+|+++.||+++.++.++++|||.+.......    .....++..|++||.......
T Consensus       102 ~~~~~~~~l~~~l~~lh~~-~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~  180 (260)
T cd06606         102 VIRKYTRQILEGLAYLHSN-GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY  180 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCC
Confidence            4578999999999999997 89999999999999999999999999876554332    344567778999999988889


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      +.++|+||+|++++++++|..||...+
T Consensus       181 ~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         181 GRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999997665

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.82  E-value=5.6e-20  Score=125.92  Aligned_cols=103  Identities=39%  Similarity=0.710  Sum_probs=85.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      ++..++.|++.+++|||+. +++|+|+++.||+++.++.++++|||++......  ......++..|++||...+. .++
T Consensus       101 ~~~~~~~~i~~~l~~LH~~-~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  179 (286)
T cd07846         101 RVRKYLFQILRGIEFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG  179 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccC
Confidence            4677899999999999997 8999999999999999999999999987654322  12234567789999998653 467


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      .++|+||+|++++++++|..||.....
T Consensus       180 ~~~Dv~slG~~l~el~~g~~~~~~~~~  206 (286)
T cd07846         180 RAVDIWAVGCLVTEMLTGEPLFPGDSD  206 (286)
T ss_pred             chHhHHHHHHHHHHHHcCCCCCCCCch
Confidence            889999999999999999999976553

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG4250|consensus

Probab=99.82  E-value=2.9e-20  Score=137.00  Aligned_cols=101  Identities=38%  Similarity=0.665  Sum_probs=86.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec--CCc--EEEeeccccccccc-ccccCCCCccceeCcccccC-C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS--GGE--IKICDFGVSGQLID-SMANSFVGTRSYMSPERLQG-T   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~--~~~--~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~-~   76 (131)
                      ++..+..++..||+|||+. ||+||||+|.||++-.  +|.  .|++|||.++...+ .......||..|++||.... .
T Consensus       121 e~l~lL~d~~~al~~LrEn-~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~  199 (732)
T KOG4250|consen  121 EFLDLLSDLVSALRHLREN-GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQK  199 (732)
T ss_pred             HHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhcc
Confidence            4567889999999999986 8999999999999753  233  59999999988754 45567889999999999984 7


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         77 HYSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      .|+..+|.||||+++|+.+||..||.+.
T Consensus       200 ~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  200 KYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             CcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            8999999999999999999999999533

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.82  E-value=4.2e-20  Score=125.37  Aligned_cols=102  Identities=38%  Similarity=0.723  Sum_probs=85.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC-cEEEeecccccccccc------cccCCCCccceeCcccccC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG-EIKICDFGVSGQLIDS------MANSFVGTRSYMSPERLQG   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~-~~~l~d~g~~~~~~~~------~~~~~~~~~~~~~Pe~~~~   75 (131)
                      .+..++.|++.|+.+||++ +++|+||++.||+++.++ .++++|||.+......      ......++..|++||.+.+
T Consensus       104 ~~~~~~~ql~~al~~LH~~-~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~  182 (268)
T cd06630         104 VIINYTEQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG  182 (268)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhcc
Confidence            4577899999999999997 899999999999998765 5899999987654322      1122356778999999988


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ..++.++|+||+|++++++++|..||...+
T Consensus       183 ~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  212 (268)
T cd06630         183 EQYGRSCDVWSVGCVIIEMATAKPPWNAEK  212 (268)
T ss_pred             CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            788999999999999999999999996444

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0668|consensus

Probab=99.82  E-value=5.1e-20  Score=121.21  Aligned_cols=110  Identities=29%  Similarity=0.515  Sum_probs=90.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec-CCcEEEeecccccccccccc-cCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~-~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      +++..+++++.||.|||+. ||.|||++|.|++++. .-..+++|||++....+... ...+.+..|-.||.+... .++
T Consensus       133 dIryY~~elLkALdyCHS~-GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YD  211 (338)
T KOG0668|consen  133 DIRYYIYELLKALDYCHSM-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYD  211 (338)
T ss_pred             hHHHHHHHHHHHHhHHHhc-CcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhcc
Confidence            5678899999999999997 9999999999999994 55689999999987766543 344556677889999764 589


Q ss_pred             CcchHHHHHHHHHHHHhCCCCC--CCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPI--PPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~--~~~~~~~~~~~~  113 (131)
                      .+-|+|||||.+..|+..+-||  ...+.++++++.
T Consensus       212 YSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIa  247 (338)
T KOG0668|consen  212 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIA  247 (338)
T ss_pred             ccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHH
Confidence            9999999999999999999998  355566666543

>KOG4645|consensus

Probab=99.82  E-value=3.3e-21  Score=149.13  Aligned_cols=102  Identities=42%  Similarity=0.684  Sum_probs=87.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc------cccCCCCccceeCcccccCC--
Q psy17559          5 PYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS------MANSFVGTRSYMSPERLQGT--   76 (131)
Q Consensus         5 ~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~--   76 (131)
                      .....|++.|+.|||+. ||+|||+++.||+++.+|.+|++|||.+......      ......||+-|||||++.+.  
T Consensus      1337 ~vyt~qll~gla~LH~~-gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~ 1415 (1509)
T KOG4645|consen 1337 RVYTKQLLEGLAYLHEH-GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKG 1415 (1509)
T ss_pred             HHHHHHHHHHHHHHHhc-CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhccccc
Confidence            34567999999999986 8999999999999999999999999998765433      23456799999999999763  


Q ss_pred             -CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         77 -HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        77 -~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                       +...++|+||+||++.||++|+-||...+.+
T Consensus      1416 kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1416 KGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred             CCCCcchhhhcccceEEEeecCCCchhhccch
Confidence             4678899999999999999999999766643

>KOG0596|consensus

Probab=99.82  E-value=4.6e-20  Score=133.18  Aligned_cols=113  Identities=35%  Similarity=0.565  Sum_probs=91.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCC--
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTH--   77 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~--   77 (131)
                      ++.+-.|++.++.++|+. ||+|.||+|.|+++- .|.+|++|||++.-....    .....+||+.|++||.+....  
T Consensus       462 lk~ywkqML~aV~~IH~~-gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~  539 (677)
T KOG0596|consen  462 LKFYWKQMLLAVKTIHQH-GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSS  539 (677)
T ss_pred             HHHHHHHHHHHHHHHHHh-ceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhcccc
Confidence            456678999999999997 899999999999875 578999999999766433    235678999999999985322  


Q ss_pred             ---------CCCcchHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHhCCCCC
Q psy17559         78 ---------YSVQSDIWSLGLSLVEMAIGMYPIPPPD--AKTLAAIFGPSRG  118 (131)
Q Consensus        78 ---------~~~~~d~~slg~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~  118 (131)
                               .++++|+||+||++|+|+.|..||....  ...+.++..+...
T Consensus       540 ~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~  591 (677)
T KOG0596|consen  540 RENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE  591 (677)
T ss_pred             ccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence                     4688999999999999999999998655  3456666666543

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.82  E-value=8e-20  Score=125.02  Aligned_cols=107  Identities=28%  Similarity=0.412  Sum_probs=84.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC-------cEEEeecccccccccccccCCCCccceeCcccccC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG-------EIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~-------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~   75 (131)
                      .+..++.|++.||+|||++ +++|+||+|.||+++..+       .++++|||.+......  ....++..|++||.+..
T Consensus       118 ~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~  194 (274)
T cd05076         118 WKITVAQQLASALSYLEDK-NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPG  194 (274)
T ss_pred             HHHHHHHHHHHHHHHHHcC-CccCCCCCcccEEEeccCcccCccceeeecCCccccccccc--cccccCCcccCchhhcC
Confidence            4567899999999999997 899999999999997543       3799999986543221  22345678999998865


Q ss_pred             -CCCCCcchHHHHHHHHHHH-HhCCCCCCCCCHHHHHHH
Q psy17559         76 -THYSVQSDIWSLGLSLVEM-AIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        76 -~~~~~~~d~~slg~~l~~l-~~g~~p~~~~~~~~~~~~  112 (131)
                       ..++.++|+||||+++|++ ++|..||......+..+.
T Consensus       195 ~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  233 (274)
T cd05076         195 GNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF  233 (274)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence             4688999999999999998 479999976665544443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG4236|consensus

Probab=99.82  E-value=2.4e-21  Score=139.75  Aligned_cols=98  Identities=36%  Similarity=0.687  Sum_probs=88.7

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC---cEEEeeccccccccc-ccccCCCCccceeCcccccCCCCC
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG---EIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~---~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      .+.++.||+.||+|||-+ +|+|+||+|+|+++.+..   .+|++|||+++..+. +..+..+|++.|+|||+++..+|.
T Consensus       666 TkFlvtQIL~ALr~LH~k-nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyN  744 (888)
T KOG4236|consen  666 TKFLVTQILVALRYLHFK-NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYN  744 (888)
T ss_pred             HHHHHHHHHHHHHHhhhc-ceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhcccc
Confidence            467889999999999998 799999999999998654   389999999988764 456778999999999999999999


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      .+-|+||.|+++|.-+.|..||.
T Consensus       745 rSLDMWSVGVIiYVsLSGTFPFN  767 (888)
T KOG4236|consen  745 RSLDMWSVGVIIYVSLSGTFPFN  767 (888)
T ss_pred             ccccceeeeEEEEEEecccccCC
Confidence            99999999999999999999997

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.82  E-value=6.6e-20  Score=129.15  Aligned_cols=102  Identities=39%  Similarity=0.664  Sum_probs=86.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccC-CCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~   81 (131)
                      ++..++.|++.|++|||+. |++|+||++.||+++.++.++++|||.+...... .....++..|++||.+.+ ..++.+
T Consensus       119 ~~~~i~~qi~~al~~LH~~-gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~  196 (343)
T cd07880         119 RIQFLVYQMLKGLKYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-MTGYVVTRWYRAPEVILNWMHYTQT  196 (343)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccccccccC-ccccccCCcccCHHHHhCCCCCCcH
Confidence            4677899999999999997 8999999999999999999999999988654332 223355778999999865 357889


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      +|+||+|++++++++|..||...+.
T Consensus       197 ~Di~slG~ll~~l~~g~~pf~~~~~  221 (343)
T cd07880         197 VDIWSVGCIMAEMLTGKPLFKGHDH  221 (343)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999999986654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.82  E-value=9.4e-20  Score=124.60  Aligned_cols=110  Identities=40%  Similarity=0.722  Sum_probs=90.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      .+..++.|++.++.+||++ +++|+||++.||+++.++.++++|||.+......  ......++..|++||.+....++.
T Consensus       102 ~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  180 (277)
T cd06641         102 QIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS  180 (277)
T ss_pred             HHHHHHHHHHHHHHHHccC-CeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCc
Confidence            4567899999999999997 8999999999999999999999999987544321  122345677899999998877889


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|++++++++|..||............
T Consensus       181 ~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  213 (277)
T cd06641         181 KADIWSLGITAIELAKGEPPHSELHPMKVLFLI  213 (277)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH
Confidence            999999999999999999999866655444433

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.82  E-value=8e-20  Score=126.10  Aligned_cols=104  Identities=34%  Similarity=0.461  Sum_probs=85.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---ccCCCCccceeCcccccCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGT-HY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~-~~   78 (131)
                      ++..++.|++.||+|||+. +++|+||++.||+++.++.++++|||.+.......   .....++..|++||.+.+. .+
T Consensus       117 ~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~  195 (302)
T cd07864         117 HIKSFMKQLLEGLNYCHKK-NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERY  195 (302)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCC
Confidence            5678999999999999997 89999999999999999999999999876543211   1223446679999988653 46


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +.++|+||+|++++++++|+.||...+..
T Consensus       196 ~~~~Di~slG~~~~el~~g~~~~~~~~~~  224 (302)
T cd07864         196 GPAIDVWSCGCILGELFTKKPIFQANQEL  224 (302)
T ss_pred             CchhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence            88999999999999999999999765543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0608|consensus

Probab=99.82  E-value=4.7e-20  Score=135.41  Aligned_cols=102  Identities=35%  Similarity=0.617  Sum_probs=86.0

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc---cccc----------------------
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI---DSMA----------------------   58 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~---~~~~----------------------   58 (131)
                      ++..+..+.+|+++.|.. |+|||||+|+||++|.+|.+||.|||++....   +++.                      
T Consensus       731 ARFYIAEltcAiesVHkm-GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~  809 (1034)
T KOG0608|consen  731 ARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADIS  809 (1034)
T ss_pred             HHHHHHHHHHHHHHHHhc-cceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhcccc
Confidence            566788899999999986 99999999999999999999999999874221   1100                      


Q ss_pred             -------------------cCCCCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         59 -------------------NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        59 -------------------~~~~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                                         ...+|+..|+|||++...++...+|+||.|++++||+.|+.||-....
T Consensus       810 ~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  810 KCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTP  876 (1034)
T ss_pred             ccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCC
Confidence                               023688899999999999999999999999999999999999965543

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.82  E-value=7.8e-20  Score=124.32  Aligned_cols=102  Identities=42%  Similarity=0.757  Sum_probs=83.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec-CCcEEEeeccccccccc--ccccCCCCccceeCcccccCC--C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGT--H   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~-~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~--~   77 (131)
                      ++..++.|++.++.|||++ +++|+||++.||+++. ++.++++|||.+.....  .......++..|++||.+...  .
T Consensus       109 ~~~~~~~qi~~al~~lH~~-~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  187 (268)
T cd06624         109 TIIFYTKQILEGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRG  187 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhcccccc
Confidence            3456789999999999997 8999999999999986 67899999998764432  122234567789999998654  3


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ++.++|+||+|+++|++++|..||...+
T Consensus       188 ~~~~~Dv~slGvvl~~l~~g~~p~~~~~  215 (268)
T cd06624         188 YGAPADIWSLGCTIVEMATGKPPFIELG  215 (268)
T ss_pred             CCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence            7889999999999999999999996443

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.82  E-value=1.3e-19  Score=130.22  Aligned_cols=102  Identities=32%  Similarity=0.597  Sum_probs=85.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||+. +++|+||++.||+++.++.++++|||+++.....    ......++..|++||.+....+
T Consensus       240 ~~~~~~~qi~~aL~~LH~~-~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  318 (401)
T cd05107         240 DLVGFSYQVANGMEFLASK-NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY  318 (401)
T ss_pred             HHHHHHHHHHHHHHHHhcC-CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC
Confidence            3567889999999999987 8999999999999999999999999998654221    1122345667999999988888


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPD  105 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~  105 (131)
                      +.++|+||+|++++|+++ |..||....
T Consensus       319 ~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         319 TTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             CcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999999999997 888997544

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.82  E-value=1.8e-19  Score=122.68  Aligned_cols=103  Identities=42%  Similarity=0.662  Sum_probs=85.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCC-
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTH-   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~-   77 (131)
                      .+..++.|++.++.++|+. +++|+||++.||+++.++.++++|||.+......    ......++..|++||...... 
T Consensus       109 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~  187 (272)
T cd06629         109 LVRFFTEQVLEGLAYLHSK-GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQ  187 (272)
T ss_pred             HHHHHHHHHHHHHHHHhhC-CeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccC
Confidence            3567889999999999997 7999999999999999999999999987654321    122345677899999987644 


Q ss_pred             -CCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         78 -YSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        78 -~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                       ++.++|+||+|++++++++|..||...+.
T Consensus       188 ~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  217 (272)
T cd06629         188 GYSAKVDIWSLGCVVLEMFAGRRPWSDEEA  217 (272)
T ss_pred             CCCccchhHHHHHHHHHHHhCCCCCcCcch
Confidence             78999999999999999999999975544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.82  E-value=1.2e-19  Score=127.13  Aligned_cols=101  Identities=40%  Similarity=0.732  Sum_probs=85.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccC-CCCCCcc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQS   82 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~   82 (131)
                      +..++.|++.+|++||+. +++|++|++.|++++.++.++++|||.+...... .....++..|++||.+.+ ..++.++
T Consensus       110 ~~~~~~ql~~aL~~LH~~-~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~  187 (328)
T cd07856         110 IQYFLYQILRGLKYVHSA-GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-MTGYVSTRYYRAPEIMLTWQKYDVEV  187 (328)
T ss_pred             HHHHHHHHHHHHHHHHhC-CcccCCCCHHHEeECCCCCEEeCccccccccCCC-cCCCcccccccCceeeeccCCcCcHH
Confidence            456889999999999997 7999999999999999999999999987644322 223355678999998765 4688999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      |+||+|++++++++|..||.....
T Consensus       188 Dv~slG~il~el~tg~~~f~~~~~  211 (328)
T cd07856         188 DIWSAGCIFAEMLEGKPLFPGKDH  211 (328)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999976654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.81  E-value=9.3e-20  Score=128.28  Aligned_cols=103  Identities=28%  Similarity=0.504  Sum_probs=83.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec-CCcEEEeecccccccccc-----cccCCCCccceeCcccccC-
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQG-   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~-~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~-   75 (131)
                      +++.++.|++.|+.|||+. |++|+||++.||+++. ++.++++|||.+......     ......++..|+|||.+.. 
T Consensus       115 ~~~~~~~qi~~aL~~LH~~-givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  193 (342)
T cd07854         115 HARLFMYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP  193 (342)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCc
Confidence            4678899999999999997 8999999999999984 557899999988644221     1122345678999998754 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      ..++.++|+||+|+++|++++|+.||.....
T Consensus       194 ~~~~~~~DiwSlGvil~el~~g~~pf~~~~~  224 (342)
T cd07854         194 NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE  224 (342)
T ss_pred             cccCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            4578899999999999999999999976553

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.81  E-value=6.8e-20  Score=136.39  Aligned_cols=98  Identities=31%  Similarity=0.448  Sum_probs=77.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec-CCcEEEeeccccccccc---ccccCCCCccceeCcccccCCC--
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLID---SMANSFVGTRSYMSPERLQGTH--   77 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~-~~~~~l~d~g~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~--   77 (131)
                      +..++.|++.+|.|||++ +++||||+|.||+++. ++.++++|||++.....   .......+++.|++||.+....  
T Consensus       257 i~~i~~qll~aL~yLH~~-gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~  335 (566)
T PLN03225        257 IQTIMRQILFALDGLHST-GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQT  335 (566)
T ss_pred             HHHHHHHHHHHHHHHHHC-CEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCC
Confidence            457899999999999997 8999999999999985 67899999999865432   1233456788999999653321  


Q ss_pred             --------------------CCCcchHHHHHHHHHHHHhCCCCCC
Q psy17559         78 --------------------YSVQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        78 --------------------~~~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                                          +..++|+||+||++|||+++..++.
T Consensus       336 ~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~  380 (566)
T PLN03225        336 PSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD  380 (566)
T ss_pred             CCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc
Confidence                                2345699999999999998765543

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.81  E-value=2.5e-19  Score=122.52  Aligned_cols=104  Identities=33%  Similarity=0.545  Sum_probs=86.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccC-CCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-THYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~   80 (131)
                      ++..++.|++.++.|||+. +++|+||++.||+++.++.++++|||.+...... ......++..|++||.+.. ..++.
T Consensus       100 ~~~~~~~~l~~~l~~Lh~~-~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  178 (283)
T cd07830         100 VIRSIIYQILQGLAHIHKH-GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSS  178 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCC
Confidence            4678899999999999997 8999999999999999999999999988655432 2233456778999998854 45789


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      ++|+||||++++++++|..||......
T Consensus       179 ~~Di~s~G~~l~el~~g~~~~~~~~~~  205 (283)
T cd07830         179 PVDIWALGCIMAELYTLRPLFPGSSEI  205 (283)
T ss_pred             ccchhhHHHHHHHHHhCCCccCCCChH
Confidence            999999999999999999999765543

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0194|consensus

Probab=99.81  E-value=9.8e-21  Score=136.55  Aligned_cols=110  Identities=29%  Similarity=0.442  Sum_probs=92.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc--ccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +...++.+.+.||+|||++ .++||||-.+|+++..++.+|++|||+++......  ....--...|+|||.+....++.
T Consensus       263 ek~~~~~~AA~Gl~YLh~k-~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~  341 (474)
T KOG0194|consen  263 EKLRFCYDAARGLEYLHSK-NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSF  341 (474)
T ss_pred             HHHHHHHHHHhHHHHHHHC-CCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCcccc
Confidence            4567899999999999998 69999999999999999999999999986543211  11223346899999999999999


Q ss_pred             cchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||||+++||+++ |..||.+....++.+.+
T Consensus       342 kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI  375 (474)
T KOG0194|consen  342 KTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI  375 (474)
T ss_pred             ccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH
Confidence            9999999999999987 78899998887777766

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.81  E-value=1.4e-19  Score=123.36  Aligned_cols=106  Identities=38%  Similarity=0.582  Sum_probs=89.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----------------------ccC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----------------------ANS   60 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----------------------~~~   60 (131)
                      ++..++.|++.+|.+||+. +++|+|+++.||+++.++.++++|||.+.......                      ...
T Consensus       103 ~~~~i~~ql~~~l~~Lh~~-~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (280)
T cd05581         103 CTRFYAAEILLALEYLHSK-GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS  181 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCcccccccccccccccc
Confidence            5678999999999999997 89999999999999999999999999875443211                      122


Q ss_pred             CCCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         61 FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        61 ~~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      ..++..|++||......++.++|+||+|++++++++|..||........
T Consensus       182 ~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  230 (280)
T cd05581         182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT  230 (280)
T ss_pred             ccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence            3456789999998887889999999999999999999999987765433

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0586|consensus

Probab=99.81  E-value=1.4e-20  Score=136.68  Aligned_cols=108  Identities=34%  Similarity=0.585  Sum_probs=95.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-ccccCCCCccceeCcccccCCCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHY-SV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~-~~   80 (131)
                      +++..+.|++.+++|||++ .++||||+..|++++.+.+++++|||++..... ....+..|++.|.|||+..+..+ ++
T Consensus       156 ~ar~~F~q~vsaveYcH~k-~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gp  234 (596)
T KOG0586|consen  156 EARAKFRQIVSAVEYCHSK-NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGP  234 (596)
T ss_pred             hhhhhhHHHHHHHHHHhhc-ceeccccchhhcccccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCc
Confidence            4677899999999999998 799999999999999999999999999877653 45678899999999999988765 58


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      .+|+|++|+++|-++.|..||.+....++..
T Consensus       235 e~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~  265 (596)
T KOG0586|consen  235 EVDIWSLGVVLYALVEGSLPFDGQNLKELRP  265 (596)
T ss_pred             ceehhhhhhhheeeeecccccCCcccccccc
Confidence            8999999999999999999998777654443

>KOG0607|consensus

Probab=99.81  E-value=8.5e-20  Score=124.99  Aligned_cols=102  Identities=33%  Similarity=0.566  Sum_probs=82.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCc---EEEeecccccccc--c-------ccccCCCCccceeCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLI--D-------SMANSFVGTRSYMSP   70 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~---~~l~d~g~~~~~~--~-------~~~~~~~~~~~~~~P   70 (131)
                      ++..+..+|+.||.+||++ ||.|||++|.||+-.....   +|++||.+.....  .       +...+.+|+..||||
T Consensus       177 EAs~vvkdia~aLdFlH~k-gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAP  255 (463)
T KOG0607|consen  177 EASRVVKDIASALDFLHTK-GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAP  255 (463)
T ss_pred             HHHHHHHHHHHHHHHHhhc-CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcch
Confidence            5678999999999999998 8999999999999764333   7999998765432  1       123356788899999


Q ss_pred             ccccC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         71 ERLQG-----THYSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        71 e~~~~-----~~~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      |+...     .-|+.+.|.||||+++|=|++|..||.+.-
T Consensus       256 EVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C  295 (463)
T KOG0607|consen  256 EVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC  295 (463)
T ss_pred             hHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence            98752     348899999999999999999999996443

>KOG0200|consensus

Probab=99.81  E-value=7.9e-20  Score=137.08  Aligned_cols=113  Identities=28%  Similarity=0.484  Sum_probs=92.1

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccccc---CCC--CccceeCcccccCC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN---SFV--GTRSYMSPERLQGT   76 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~---~~~--~~~~~~~Pe~~~~~   76 (131)
                      .++..++.||+.|++||+++ .++||||-.+||++..+..+|++|||+++...+....   ...  -...|+|||.+...
T Consensus       418 ~dLlsfa~QIa~GMe~L~~~-~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~  496 (609)
T KOG0200|consen  418 KDLLSFAYQIANGMEYLASV-PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR  496 (609)
T ss_pred             HHHHHHHHHHHHHHHHHhhC-CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC
Confidence            35778999999999999998 5999999999999999999999999999854432211   111  23469999999999


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHhCC
Q psy17559         77 HYSVQSDIWSLGLSLVEMAI-GMYPIPPPD-AKTLAAIFGP  115 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~-g~~p~~~~~-~~~~~~~~~~  115 (131)
                      .++.++|+||+|+++||+++ |..|+.+.. .+++.+.+.+
T Consensus       497 ~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~  537 (609)
T KOG0200|consen  497 VFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKE  537 (609)
T ss_pred             cccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhc
Confidence            99999999999999999986 889998755 5555554443

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.81  E-value=5.7e-20  Score=125.58  Aligned_cols=101  Identities=34%  Similarity=0.520  Sum_probs=84.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc-----cCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-----NSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.+|.+||++ |++|+||++.||+++.++.++++|||.+........     ....+...|++||......
T Consensus       110 ~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~  188 (284)
T cd05038         110 RLLLFSSQICKGMDYLGSQ-RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK  188 (284)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCC
Confidence            4577899999999999997 899999999999999999999999998876542111     1123345689999998888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      ++.++|+||+|++++++++|..|+...
T Consensus       189 ~~~~~Di~slG~~l~el~tg~~p~~~~  215 (284)
T cd05038         189 FSSASDVWSFGVTLYELFTYGDPSQSP  215 (284)
T ss_pred             CCcccchHHHhhhhheeeccCCCcccc
Confidence            899999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0662|consensus

Probab=99.81  E-value=1.2e-19  Score=115.86  Aligned_cols=105  Identities=34%  Similarity=0.563  Sum_probs=89.9

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCC-CC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT-HY   78 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~-~~   78 (131)
                      +.++.++.|++.++.+||+. .+.|||++|.|.++..+|..+++|||+++-.+-+  .....+.+..|++|+++.+. -|
T Consensus       101 ~~~rsfmlqllrgl~fchsh-nvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly  179 (292)
T KOG0662|consen  101 EIVRSFMLQLLRGLGFCHSH-NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY  179 (292)
T ss_pred             HHHHHHHHHHHhhhhhhhhh-hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehh
Confidence            34678899999999999998 5999999999999999999999999998766532  34556778899999999885 48


Q ss_pred             CCcchHHHHHHHHHHHH-hCCCCCCCCCHH
Q psy17559         79 SVQSDIWSLGLSLVEMA-IGMYPIPPPDAK  107 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~-~g~~p~~~~~~~  107 (131)
                      +.+.|+||.||++.|+. .|+.-|++.+.+
T Consensus       180 ~tsidmwsagcifaelanagrplfpg~dvd  209 (292)
T KOG0662|consen  180 STSIDMWSAGCIFAELANAGRPLFPGNDVD  209 (292)
T ss_pred             ccchHhhhcchHHHHHhhcCCCCCCCCcHH
Confidence            99999999999999996 578778876654

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.81  E-value=1.4e-19  Score=124.24  Aligned_cols=100  Identities=35%  Similarity=0.567  Sum_probs=83.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---ccCCCCccceeCcccccCCC--
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTH--   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~--   77 (131)
                      +++.++.|++.+|.+||+. +++|+||++.||+++.++.++++|||++.......   .....++..|++||...+..  
T Consensus       106 ~~~~~~~ql~~~l~~lH~~-~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  184 (288)
T cd05583         106 EVRVYIAEIVLALDHLHQL-GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGG  184 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCC
Confidence            4567888999999999997 89999999999999999999999999876543221   12235677899999987654  


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      .+.++|+||+|++++++++|..||..
T Consensus       185 ~~~~~Dv~slG~il~el~tg~~p~~~  210 (288)
T cd05583         185 HDKAVDWWSLGVLTFELLTGASPFTV  210 (288)
T ss_pred             CcchhhhHHHHHHHHHHHhCCCCccc
Confidence            78899999999999999999999963

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0670|consensus

Probab=99.81  E-value=1.1e-20  Score=135.86  Aligned_cols=114  Identities=30%  Similarity=0.542  Sum_probs=99.0

Q ss_pred             CCchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC-CcEEEeecccccccccccccCCCCccceeCcccccCCCCC
Q psy17559          1 LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG-GEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         1 ~~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++++...+.|+..||..|-.- |++|.||+|+||++..+ ..++|||||.+.............+..|.|||++.+.+|+
T Consensus       535 ikaVRsYaqQLflALklLK~c-~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd  613 (752)
T KOG0670|consen  535 IKAVRSYAQQLFLALKLLKKC-GVLHADIKPDNILVNESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYD  613 (752)
T ss_pred             ehHHHHHHHHHHHHHHHHHhc-CeeecccCccceEeccCcceeeeccCccccccccccccHHHHHHhccCcceeecCccc
Confidence            467888999999999999765 89999999999999865 4579999999877665544444556689999999999999


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~  115 (131)
                      +..|+||.||.+||+.+|++-|++.....+.+++..
T Consensus       614 ~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me  649 (752)
T KOG0670|consen  614 YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME  649 (752)
T ss_pred             CCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence            999999999999999999999999999988887753

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.81  E-value=2.6e-19  Score=120.75  Aligned_cols=108  Identities=38%  Similarity=0.580  Sum_probs=88.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCc-EEEeeccccccccccc--ccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE-IKICDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~-~~l~d~g~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      .+..++.|++.++.|||+. +++|+|+++.||+++.++. ++++|||.+.......  .....++..|++||......++
T Consensus       102 ~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~  180 (257)
T cd08225         102 QILSWFVQISLGLKHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYN  180 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCC
Confidence            3567899999999999997 7999999999999998765 6999999876543321  2233567789999999887889


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      .++|+||+|++++++++|..||...+..+...
T Consensus       181 ~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  212 (257)
T cd08225         181 NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL  212 (257)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence            99999999999999999999998666544433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.81  E-value=2.5e-19  Score=125.34  Aligned_cols=103  Identities=29%  Similarity=0.503  Sum_probs=81.5

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc---cc------ccCCCCccceeCccccc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID---SM------ANSFVGTRSYMSPERLQ   74 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~---~~------~~~~~~~~~~~~Pe~~~   74 (131)
                      +..++.|++.||+|||++ +++|+||+|.||+++.++.+++.||+.......   ..      .....++..|++||.+.
T Consensus       103 ~~~~~~qi~~aL~~lH~~-~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  181 (328)
T cd08226         103 IGNILFGALRGLNYLHQN-GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLR  181 (328)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhc
Confidence            457899999999999987 899999999999999999999999874322111   00      01122345699999997


Q ss_pred             CC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         75 GT--HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        75 ~~--~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +.  .++.++|+||+|+++|++++|..||......
T Consensus       182 ~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~  216 (328)
T cd08226         182 QDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT  216 (328)
T ss_pred             CCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH
Confidence            63  4789999999999999999999999866543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0196|consensus

Probab=99.80  E-value=1.3e-20  Score=140.24  Aligned_cols=112  Identities=28%  Similarity=0.432  Sum_probs=94.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCc--cceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGT--RSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~--~~~~~Pe~~~~~~   77 (131)
                      +++.|.+.|+.|++||-+. +++||||..+||+++.+..+|++|||+++...+.   ...+..|+  .+|+|||.+...+
T Consensus       732 QLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RK  810 (996)
T KOG0196|consen  732 QLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK  810 (996)
T ss_pred             hHHHHHHHHHHHhHHHhhc-CchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcc
Confidence            6788999999999999875 8999999999999999999999999999865432   23344444  4799999999999


Q ss_pred             CCCcchHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHhCC
Q psy17559         78 YSVQSDIWSLGLSLVEMA-IGMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~-~g~~p~~~~~~~~~~~~~~~  115 (131)
                      ++.++|+||+|+++||.+ .|.-||=....+++.+.+.+
T Consensus       811 FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~  849 (996)
T KOG0196|consen  811 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ  849 (996)
T ss_pred             cCchhhccccceEEEEecccCCCcccccchHHHHHHHHh
Confidence            999999999999999987 48999876776666666543

>KOG0199|consensus

Probab=99.79  E-value=1.2e-19  Score=134.28  Aligned_cols=111  Identities=28%  Similarity=0.458  Sum_probs=94.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-----ccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      .+...+.||+.|+.||.++ +++||||-.+|+++.....+|++|||+.+-.+...     ....--...|.+||.++...
T Consensus       213 ~Lcdya~QiA~aM~YLesk-rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k  291 (1039)
T KOG0199|consen  213 RLCDYAMQIAKAMQYLESK-RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRK  291 (1039)
T ss_pred             HHHHHHHHHHHHHHHHhhh-hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccc
Confidence            3456899999999999988 79999999999999999999999999987654321     11222345799999999999


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      ++.++|+|++|+.+|||++ |..||.+...-.+.+.++
T Consensus       292 FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD  329 (1039)
T KOG0199|consen  292 FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID  329 (1039)
T ss_pred             ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc
Confidence            9999999999999999986 899999999888888877

>KOG1152|consensus

Probab=99.79  E-value=2.8e-20  Score=134.97  Aligned_cols=100  Identities=34%  Similarity=0.587  Sum_probs=91.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCC-CCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY-SVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~   81 (131)
                      +++.+++|++.|+++||+. ||+||||+.+|+.++.+|.++++|||.+.....+.-..++|+..|.|||++.+.+| +..
T Consensus       671 eAk~IFkQV~agi~hlh~~-~ivhrdikdenvivd~~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~  749 (772)
T KOG1152|consen  671 EAKLIFKQVVAGIKHLHDQ-GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKP  749 (772)
T ss_pred             HHHHHHHHHHhcccccccc-CceecccccccEEEecCCeEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCc
Confidence            5788999999999999997 89999999999999999999999999998877777788999999999999999876 567


Q ss_pred             chHHHHHHHHHHHHhCCCCCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      .|+|++|+++|.++....||-+
T Consensus       750 qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  750 QDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             chhhhhhheeeEEEeccCCCcC
Confidence            8999999999999999988853

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.79  E-value=1.3e-18  Score=117.79  Aligned_cols=105  Identities=41%  Similarity=0.622  Sum_probs=86.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.++.+||+. |++|+|+++.|++++. +.++++|||.+......  ......++..|++||......++.
T Consensus       107 ~~~~~~~~l~~~l~~lH~~-~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~  184 (260)
T cd08222         107 QVCEWFIQLLLGVHYMHQR-RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDS  184 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHc-CccccCCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCc
Confidence            4567899999999999997 8999999999999975 56999999987654322  223345677899999988777889


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      ++|+||+|++++++++|..||........
T Consensus       185 ~~Dv~slG~~~~~l~~~~~~~~~~~~~~~  213 (260)
T cd08222         185 KSDIWSLGCILYEMCCLAHAFEGQNFLSV  213 (260)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence            99999999999999999999976554433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.79  E-value=1e-18  Score=116.14  Aligned_cols=113  Identities=40%  Similarity=0.714  Sum_probs=94.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.+++.++.+||+. +++|+|+++.||+++.++.++++|||.+...... ......+...|++||......++.+
T Consensus        88 ~~~~~~~~l~~~l~~lh~~-~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~  166 (244)
T smart00220       88 EARFYARQILSALEYLHSN-GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKA  166 (244)
T ss_pred             HHHHHHHHHHHHHHHHHHc-CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCch
Confidence            4678899999999999997 8999999999999999999999999988665432 2334556778999999987788899


Q ss_pred             chHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPP-PDAKTLAAIFGPS  116 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~-~~~~~~~~~~~~~  116 (131)
                      +|+|++|++++++++|..||.. .+.+...+.+...
T Consensus       167 ~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~  202 (244)
T smart00220      167 VDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKP  202 (244)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc
Confidence            9999999999999999999977 5555555555433

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG3653|consensus

Probab=99.77  E-value=1.3e-18  Score=123.67  Aligned_cols=95  Identities=35%  Similarity=0.526  Sum_probs=79.2

Q ss_pred             chhHHHHHHHHHHHHHHhc--------CCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCc
Q psy17559          3 QVPYSSFQVLKGLTYLREK--------HAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSP   70 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~--------~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~P   70 (131)
                      ...+|+..++.||+|||+.        .+|+||||++.||++.+++++-++|||++......    ..-..+||.+||||
T Consensus       308 ~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAP  387 (534)
T KOG3653|consen  308 SLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAP  387 (534)
T ss_pred             HHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCH
Confidence            3568899999999999984        36999999999999999999999999999766432    23346899999999


Q ss_pred             ccccCC-CCC-----CcchHHHHHHHHHHHHhC
Q psy17559         71 ERLQGT-HYS-----VQSDIWSLGLSLVEMAIG   97 (131)
Q Consensus        71 e~~~~~-~~~-----~~~d~~slg~~l~~l~~g   97 (131)
                      |++.+. .+.     .+.|+||+|.++||++++
T Consensus       388 EvLEgainl~d~~Afkr~DvYamgLVLWEi~SR  420 (534)
T KOG3653|consen  388 EVLEGAINLQDRDAFKRIDVYAMGLVLWEIASR  420 (534)
T ss_pred             HHHhhhcccccHHHHHHHHHHHHHHHHHHHHhh
Confidence            999763 222     458999999999999864

>KOG1025|consensus

Probab=99.76  E-value=1.3e-18  Score=130.58  Aligned_cols=116  Identities=28%  Similarity=0.521  Sum_probs=99.3

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc--ccCCCC--ccceeCcccccCCC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVG--TRSYMSPERLQGTH   77 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~--~~~~~~--~~~~~~Pe~~~~~~   77 (131)
                      ++++-|..||+.|+.|||++ +++||||-.+|+++.+-..+|+.|||+++......  .....+  .+.|+|-|.+....
T Consensus       798 q~lLnw~~QIAkgM~YLe~q-rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~  876 (1177)
T KOG1025|consen  798 QDLLNWCYQIAKGMKYLEEQ-RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRK  876 (1177)
T ss_pred             HHHHHHHHHHHHHHHHHHhc-chhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccC
Confidence            45778999999999999987 79999999999999999999999999987654322  122222  35789999999999


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPSRG  118 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~  118 (131)
                      ++.++|+||+|+.+||++| |..|+.+...+++..++.+..+
T Consensus       877 ~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR  918 (1177)
T KOG1025|consen  877 YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER  918 (1177)
T ss_pred             CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc
Confidence            9999999999999999986 9999999999999999876654

>KOG0574|consensus

Probab=99.76  E-value=1.3e-19  Score=123.56  Aligned_cols=103  Identities=42%  Similarity=0.718  Sum_probs=90.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..+++..+.||+|||.. .-+||||+..||++..+|.+|++|||++....+.  +..+..|++.|+|||++..-+|..
T Consensus       130 EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~  208 (502)
T KOG0574|consen  130 EISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDT  208 (502)
T ss_pred             HHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccch
Confidence            3567888999999999996 4799999999999999999999999998766543  346778999999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      .+|+||||+...||..|+.||...-+
T Consensus       209 ~ADIWSLGITaIEMAEG~PPYsDIHP  234 (502)
T KOG0574|consen  209 KADIWSLGITAIEMAEGRPPYSDIHP  234 (502)
T ss_pred             hhhHhhhcchhhhhhcCCCCcccccc
Confidence            99999999999999999999975443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.76  E-value=6.3e-18  Score=111.57  Aligned_cols=110  Identities=35%  Similarity=0.636  Sum_probs=88.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccc-cCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERL-QGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~-~~~~~   78 (131)
                      .+..++.|++.++.++|+. +++|+|+++.|++++.++.++++|||.+......   ......+...|++||.. ....+
T Consensus        99 ~~~~~~~~l~~~l~~lh~~-~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~  177 (225)
T smart00221       99 EARFYLRQILEALEYLHSL-GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGY  177 (225)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCC
Confidence            3567889999999999997 8999999999999999999999999987655432   22334556679999998 55667


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCC-CC-HHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPP-PD-AKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~-~~-~~~~~~~~  113 (131)
                      +.++|+|++|++++++++|..||.. .+ ..++.+.+
T Consensus       178 ~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~  214 (225)
T smart00221      178 GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW  214 (225)
T ss_pred             CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence            7899999999999999999999976 33 33444444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1151|consensus

Probab=99.76  E-value=1.6e-18  Score=123.34  Aligned_cols=125  Identities=32%  Similarity=0.482  Sum_probs=96.6

Q ss_pred             CchhHHHHHHHHHHHHHHhc-CCcEecCCCCCcEEEec---CCcEEEeecccccccccc---------cccCCCCcccee
Q psy17559          2 KQVPYSSFQVLKGLTYLREK-HAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDS---------MANSFVGTRSYM   68 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~-~~~~h~~l~~~~il~~~---~~~~~l~d~g~~~~~~~~---------~~~~~~~~~~~~   68 (131)
                      ++++.|++|++.||.||.+. ..|+|-||+|.||++-.   .|.+|+.|||+++.+.+.         .+....|+-+|+
T Consensus       568 KEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYL  647 (775)
T KOG1151|consen  568 KEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYL  647 (775)
T ss_pred             HHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeec
Confidence            46788999999999999873 36999999999999864   466899999998765321         234556788999


Q ss_pred             CcccccCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCCCCCCCCcccccCC
Q psy17559         69 SPERLQGT----HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYWHVSYPT  128 (131)
Q Consensus        69 ~Pe~~~~~----~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  128 (131)
                      +||.+...    ..+.++|+||+|+++|+.+.|+.||......  ..++.....-+-.++.||.
T Consensus       648 PPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdILqeNTIlkAtEVqFP~  709 (775)
T KOG1151|consen  648 PPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDILQENTILKATEVQFPP  709 (775)
T ss_pred             CcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHHhhhchhcceeccCCC
Confidence            99988643    3689999999999999999999999855433  3344444555555666765

>KOG4257|consensus

Probab=99.76  E-value=7e-19  Score=129.06  Aligned_cols=110  Identities=27%  Similarity=0.496  Sum_probs=92.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccC-CC--CccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS-FV--GTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~-~~--~~~~~~~Pe~~~~~~~~   79 (131)
                      ++...++|+..+|.|||++ .++||||-.+||++.+...+|++|||+++......... ..  -.+.|++||.+....++
T Consensus       492 tL~ly~~Qi~talaYLeSk-rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFT  570 (974)
T KOG4257|consen  492 TLTLYCYQICTALAYLESK-RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFT  570 (974)
T ss_pred             HHHHHHHHHHHHHHHHHhh-chhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhccc
Confidence            4567899999999999998 59999999999999999999999999998876543221 12  24579999999999999


Q ss_pred             CcchHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMA-IGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~-~g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+|=||+.+||++ -|..||++-...++.--+
T Consensus       571 tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i  605 (974)
T KOG4257|consen  571 TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI  605 (974)
T ss_pred             chhhHHHHHHHHHHHHHhcCCccccccccceEEEe
Confidence            9999999999999997 499999887766554443

>KOG1094|consensus

Probab=99.75  E-value=4.8e-18  Score=123.76  Aligned_cols=113  Identities=26%  Similarity=0.341  Sum_probs=94.5

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccccc----CCCCccceeCcccccCCCCC
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ...|+.||+.|++||.+- .++|||+.+.|++++.++++|++|||.++..-.....    ..+-.++|+|+|.+..++++
T Consensus       639 ~vsi~tqiasgmaYLes~-nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFt  717 (807)
T KOG1094|consen  639 GVSICTQIASGMAYLESL-NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFT  717 (807)
T ss_pred             hHHHHHHHHHHHHHHHhh-chhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcccc
Confidence            467999999999999987 5999999999999999999999999998744322222    23446799999999999999


Q ss_pred             CcchHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHhCCCC
Q psy17559         80 VQSDIWSLGLSLVEMA--IGMYPIPPPDAKTLAAIFGPSR  117 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~--~g~~p~~~~~~~~~~~~~~~~~  117 (131)
                      .++|+|+||+.+||++  +...||.....+++.+..+...
T Consensus       718 taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~  757 (807)
T KOG1094|consen  718 TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFF  757 (807)
T ss_pred             chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhc
Confidence            9999999999999984  6899998888777777665433

>KOG1027|consensus

Probab=99.74  E-value=5.8e-19  Score=132.08  Aligned_cols=100  Identities=33%  Similarity=0.484  Sum_probs=84.3

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec---CC--cEEEeeccccccccccc-----ccCCCCccceeCcccc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS---GG--EIKICDFGVSGQLIDSM-----ANSFVGTRSYMSPERL   73 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~---~~--~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~Pe~~   73 (131)
                      .+.+..|++.||++||+- +|+||||+|.||+++.   ++  .++++|||++++....+     .....|+-.|+|||.+
T Consensus       608 ~~~~l~q~~~GlaHLHsl-~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L  686 (903)
T KOG1027|consen  608 PISVLSQIASGLAHLHSL-KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQL  686 (903)
T ss_pred             HHHHHHHHHHHHHHHHhc-ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHH
Confidence            467889999999999996 7999999999999986   33  47999999998775432     3345678899999999


Q ss_pred             cCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q psy17559         74 QGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPP  104 (131)
Q Consensus        74 ~~~~~~~~~d~~slg~~l~~l~~-g~~p~~~~  104 (131)
                      .......++|++|+||++|+.++ |..||...
T Consensus       687 ~~~~~~~avDiFslGCvfyYvltgG~HpFGd~  718 (903)
T KOG1027|consen  687 REDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS  718 (903)
T ss_pred             hccccCcccchhhcCceEEEEecCCccCCCch
Confidence            98888889999999999999876 59999743

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.73  E-value=8.8e-18  Score=131.59  Aligned_cols=96  Identities=22%  Similarity=0.434  Sum_probs=78.6

Q ss_pred             chhHHHHHHHHHHHHHH---hcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLR---EKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh---~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +...++.|++.|++|+|   +. +++|||+++.||+++.++..++. ++.......  .....++..|+|||.+.+..++
T Consensus       781 ~~~~i~~~ia~~L~yLH~~~~~-~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~  856 (968)
T PLN00113        781 RRRKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--DTKCFISSAYVAPETRETKDIT  856 (968)
T ss_pred             HHHHHHHHHHHHHHHhccCCCC-CeecCCCCHHhEEECCCCceEEE-ecccccccc--CCCccccccccCcccccCCCCC
Confidence            46789999999999999   44 79999999999999988877664 444322211  1223567899999999888899


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      .++|+||||+++||+++|+.||.
T Consensus       857 ~~sDv~S~Gvvl~el~tg~~p~~  879 (968)
T PLN00113        857 EKSDIYGFGLILIELLTGKSPAD  879 (968)
T ss_pred             cccchhhHHHHHHHHHhCCCCCC
Confidence            99999999999999999999985

>KOG2052|consensus

Probab=99.72  E-value=1.3e-17  Score=118.02  Aligned_cols=94  Identities=36%  Similarity=0.520  Sum_probs=77.7

Q ss_pred             chhHHHHHHHHHHHHHHhc-------CCcEecCCCCCcEEEecCCcEEEeeccccccccc------ccccCCCCccceeC
Q psy17559          3 QVPYSSFQVLKGLTYLREK-------HAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------SMANSFVGTRSYMS   69 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~-------~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~~~~~~   69 (131)
                      .+.+++..++.||++||..       ..|.||||++.||++.+++.+-++|+|++.....      ......+||.+|+|
T Consensus       309 ~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMA  388 (513)
T KOG2052|consen  309 GMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMA  388 (513)
T ss_pred             HHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccC
Confidence            5678999999999999983       4699999999999999999999999999854432      23356789999999


Q ss_pred             cccccCCC----C--CCcchHHHHHHHHHHHHh
Q psy17559         70 PERLQGTH----Y--SVQSDIWSLGLSLVEMAI   96 (131)
Q Consensus        70 Pe~~~~~~----~--~~~~d~~slg~~l~~l~~   96 (131)
                      ||++...-    +  -..+|+||||+++||+..
T Consensus       389 PEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  389 PEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             hHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            99996531    1  256999999999999864

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.72  E-value=3.8e-17  Score=120.03  Aligned_cols=99  Identities=30%  Similarity=0.454  Sum_probs=77.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc---cCCCCccceeCcccccCCC--
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTH--   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~Pe~~~~~~--   77 (131)
                      .++.++.|++.+|.|+|+. +++||||++.||+++.++.++++|||++........   .....++.|++||.+....  
T Consensus       310 ~~~~i~~ql~~aL~~lH~~-~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~  388 (507)
T PLN03224        310 VIKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSC  388 (507)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCC
Confidence            3567899999999999997 799999999999999999999999999854432211   1123367899999875422  


Q ss_pred             --------------------CCCcchHHHHHHHHHHHHhCCC-CCC
Q psy17559         78 --------------------YSVQSDIWSLGLSLVEMAIGMY-PIP  102 (131)
Q Consensus        78 --------------------~~~~~d~~slg~~l~~l~~g~~-p~~  102 (131)
                                          ...+.|+||+|+++++|+++.. ||.
T Consensus       389 ~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~  434 (507)
T PLN03224        389 PRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA  434 (507)
T ss_pred             CccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence                                1134699999999999999875 664

>KOG1345|consensus

Probab=99.69  E-value=8.7e-18  Score=113.02  Aligned_cols=97  Identities=25%  Similarity=0.472  Sum_probs=75.5

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec--CCcEEEeecccccccccccccCCCCccceeCcccccC---C--
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS--GGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG---T--   76 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~--~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~---~--   76 (131)
                      .++++.|++.|+.|||++ .++||||+.+||++-.  ...+|++|||..+..+...... .-...|-+||.+..   +  
T Consensus       123 ~K~v~~ql~SAi~fMHsk-nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~-~~~~~y~~pe~~~~~~ne~~  200 (378)
T KOG1345|consen  123 TKKVFAQLLSAIEFMHSK-NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKYL-EYVNNYHAPELCDTVVNEKL  200 (378)
T ss_pred             HHHHHHHHHHHHHHhhcc-chhhcccccceEEEecCCccEEEeeecccccccCceehhh-hhhcccCCcHHHhhccccce
Confidence            468999999999999998 5999999999999863  3469999999987654432111 11234667776643   2  


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCC
Q psy17559         77 HYSVQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      ...+..|+|.||++++.+++|..||+
T Consensus       201 ~~~ps~D~WqfGIi~f~cltG~~PWQ  226 (378)
T KOG1345|consen  201 VVNPSTDIWQFGIIFFYCLTGKFPWQ  226 (378)
T ss_pred             EecccccchheeeeeeeeecCCCcch
Confidence            24688999999999999999999997

>KOG0587|consensus

Probab=99.68  E-value=7.2e-17  Score=121.57  Aligned_cols=100  Identities=40%  Similarity=0.716  Sum_probs=86.3

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccC-----C
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQG-----T   76 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~-----~   76 (131)
                      +..+++.++.|+.+||.. .++|||++-.||++..++.||+.|||++....  .....+..|++.|+|||++.-     .
T Consensus       125 IaYI~re~lrgl~HLH~n-kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~  203 (953)
T KOG0587|consen  125 IAYILREILRGLAHLHNN-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDA  203 (953)
T ss_pred             HHHHHHHHHHHHHHHhhc-ceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCC
Confidence            467888999999999997 59999999999999999999999999986543  335567889999999999853     3


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         77 HYSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      .|+.++|+||||++..||..|..|+...
T Consensus       204 tyd~R~D~WsLGITaIEladG~PPl~Dm  231 (953)
T KOG0587|consen  204 TYDYRSDLWSLGITAIEMAEGAPPLCDM  231 (953)
T ss_pred             CcccccchhhccceeehhcCCCCCccCc
Confidence            5789999999999999999999988543

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.66  E-value=5.8e-16  Score=117.56  Aligned_cols=48  Identities=42%  Similarity=0.677  Sum_probs=44.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      .++.++.|++.||.|||+. +++|+||+|.||+++.++.++|+|||+++
T Consensus       105 ~~~~i~~qil~aL~yLH~~-gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610         105 MAVKYISEVALALDYLHRH-GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            4678999999999999997 89999999999999999999999999763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1165|consensus

Probab=99.66  E-value=2.6e-16  Score=108.44  Aligned_cols=114  Identities=31%  Similarity=0.455  Sum_probs=96.2

Q ss_pred             CCchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC-----cEEEeecccccccccccc---------cCCCCccc
Q psy17559          1 LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG-----EIKICDFGVSGQLIDSMA---------NSFVGTRS   66 (131)
Q Consensus         1 ~~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~-----~~~l~d~g~~~~~~~~~~---------~~~~~~~~   66 (131)
                      ++++..++.|++.-++++|++ .+|+|||+|+|+++...+     .+.++|||+++...++.+         ....|+.+
T Consensus       123 vKTV~miA~Qmi~rie~vH~k-~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTAR  201 (449)
T KOG1165|consen  123 VKTVAMIAKQMITRIEYVHEK-DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTAR  201 (449)
T ss_pred             HHhHHHHHHHHHHHHHHHHhc-ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcccccccccccee
Confidence            468899999999999999998 599999999999997543     378999999988765432         24468889


Q ss_pred             eeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCC
Q psy17559         67 YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        67 ~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~  115 (131)
                      ||+-....+...|.+.|+-|+|.++++.+-|..||++...+...+...+
T Consensus       202 YMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK  250 (449)
T KOG1165|consen  202 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK  250 (449)
T ss_pred             eeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH
Confidence            9998888888899999999999999999999999998876655555443

>KOG1164|consensus

Probab=99.65  E-value=6.6e-16  Score=108.25  Aligned_cols=103  Identities=31%  Similarity=0.419  Sum_probs=86.9

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC-----CcEEEeeccccc--cccc-c-----c----ccCCCCc
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG-----GEIKICDFGVSG--QLID-S-----M----ANSFVGT   64 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~-----~~~~l~d~g~~~--~~~~-~-----~----~~~~~~~   64 (131)
                      .++..++.|++.+|+++|+. |++|||++|.|+.+...     ..+.+.|||+++  .... .     .    .....|+
T Consensus       122 ~T~l~ia~q~l~~l~~lH~~-G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT  200 (322)
T KOG1164|consen  122 KTVLRIAIQNLNALEDLHSK-GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGT  200 (322)
T ss_pred             hHHHHHHHHHHHHHHHHHhc-CcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCc
Confidence            46789999999999999997 89999999999999854     358999999998  3211 0     1    1234588


Q ss_pred             cceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         65 RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        65 ~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ..|.++....+...+++.|+||+++++.++..|..||....
T Consensus       201 ~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  201 LRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             cccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence            99999999999999999999999999999999999997655

>KOG1290|consensus

Probab=99.63  E-value=5.7e-16  Score=110.88  Aligned_cols=40  Identities=43%  Similarity=0.678  Sum_probs=36.8

Q ss_pred             CccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy17559         63 GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        63 ~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      .|..|++||++.+..|+..+|+||++|+++||+||..-|.
T Consensus       413 QTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFe  452 (590)
T KOG1290|consen  413 QTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFE  452 (590)
T ss_pred             hhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeec
Confidence            4567999999999999999999999999999999988885

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.60  E-value=3.1e-15  Score=97.09  Aligned_cols=91  Identities=48%  Similarity=0.841  Sum_probs=77.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec-CCcEEEeeccccccccccc--ccCCCCccceeCcccccCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGT-HY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~-~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~-~~   78 (131)
                      ++..++.+++.++.+||+. +++|+|+++.||+++. ++.++++||+.+.......  .....+...|++||..... ..
T Consensus        93 ~~~~~~~~l~~~l~~lh~~-~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~  171 (215)
T cd00180          93 EILRILLQILEGLEYLHSN-GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY  171 (215)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCC
Confidence            4678899999999999997 8999999999999998 8999999999886554332  3334566789999999776 78


Q ss_pred             CCcchHHHHHHHHHHH
Q psy17559         79 SVQSDIWSLGLSLVEM   94 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l   94 (131)
                      +.+.|+|++|++++++
T Consensus       172 ~~~~D~~~lg~~~~~l  187 (215)
T cd00180         172 SEKSDIWSLGVILYEL  187 (215)
T ss_pred             CchhhhHHHHHHHHHH
Confidence            8999999999999988

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167|consensus

Probab=99.59  E-value=9.1e-16  Score=107.75  Aligned_cols=100  Identities=30%  Similarity=0.488  Sum_probs=80.7

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec-CCcEEEeecccccccc---------c------cc--------
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLI---------D------SM--------   57 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~-~~~~~l~d~g~~~~~~---------~------~~--------   57 (131)
                      .+++..++.++.||+++|.+ ||+|||++|.|++++. .+.-.|.|||++....         .      ..        
T Consensus       132 ~~i~~Yl~~ll~Al~~~h~~-GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~  210 (418)
T KOG1167|consen  132 AEIRWYLRNLLKALAHLHKN-GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHC  210 (418)
T ss_pred             HHHHHHHHHHHHHhhhhhcc-CccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccc
Confidence            35677889999999999997 9999999999999984 5677899999875110         0      00        


Q ss_pred             -----------------------ccCCCCccceeCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCC
Q psy17559         58 -----------------------ANSFVGTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        58 -----------------------~~~~~~~~~~~~Pe~~~~~-~~~~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                                             .-...|+++|+|||++... ..+.++|+||.|+++.-+++++.||-
T Consensus       211 ~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  211 QSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFF  279 (418)
T ss_pred             cccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccc
Confidence                                   0013588899999999764 47899999999999999999999983

>KOG1163|consensus

Probab=99.59  E-value=8.4e-16  Score=102.12  Aligned_cols=111  Identities=29%  Similarity=0.418  Sum_probs=91.1

Q ss_pred             CCchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC---CcEEEeeccccccccccc---------ccCCCCcccee
Q psy17559          1 LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG---GEIKICDFGVSGQLIDSM---------ANSFVGTRSYM   68 (131)
Q Consensus         1 ~~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~---~~~~l~d~g~~~~~~~~~---------~~~~~~~~~~~   68 (131)
                      |+++..++.|++.-++|+|.+ +++||||+|+|++..-+   ..+.++|||+++...+..         .....||.+|.
T Consensus       110 mkTvLMLaDQml~RiEyvH~r-~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYA  188 (341)
T KOG1163|consen  110 MKTVLMLADQMLSRIEYVHLR-NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYA  188 (341)
T ss_pred             HHhHHHHHHHHHHHHHHHHhh-ccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeeh
Confidence            468899999999999999998 79999999999998743   457899999997664432         23446788888


Q ss_pred             CcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         69 SPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        69 ~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      +-....+...+.+.|+-|+|.++.+..-|..||++.....-.|.
T Consensus       189 SinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK  232 (341)
T KOG1163|consen  189 SINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK  232 (341)
T ss_pred             hhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence            87777777789999999999999999999999998776544443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.58  E-value=1.8e-15  Score=103.77  Aligned_cols=99  Identities=21%  Similarity=0.369  Sum_probs=71.3

Q ss_pred             HHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccC--------CC
Q psy17559          6 YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG--------TH   77 (131)
Q Consensus         6 ~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~   77 (131)
                      .+..|++..++++|.. |++|+||++.|++++.+|.+.++||+.....+..... ...+..|.+||....        ..
T Consensus       149 ~lT~Q~I~lvA~Lh~~-GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~  226 (288)
T PF14531_consen  149 SLTVQMIRLVANLHSY-GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAP  226 (288)
T ss_dssp             HHHHHHHHHHHHHHHT-TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEE
T ss_pred             HHHHHHHHHHHHHhhc-ceEecccceeeEEEcCCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccce
Confidence            3457889999999997 8999999999999999999999999876555443222 333456788887643        24


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      ++.+.|.|++|+++|.+.++..||.....
T Consensus       227 ~t~~~DaW~LG~~ly~lWC~~lPf~~~~~  255 (288)
T PF14531_consen  227 YTFATDAWQLGITLYSLWCGRLPFGLSSP  255 (288)
T ss_dssp             E-HHHHHHHHHHHHHHHHHSS-STCCCGG
T ss_pred             eeeccCHHHHHHHHHHHHHccCCCCCCCc
Confidence            68889999999999999999999975543

>KOG0590|consensus

Probab=99.57  E-value=1.5e-15  Score=113.66  Aligned_cols=104  Identities=32%  Similarity=0.600  Sum_probs=87.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc------ccccCCCCccceeCcccccCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------SMANSFVGTRSYMSPERLQGT   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~~~~~~Pe~~~~~   76 (131)
                      ++-.++.|++.|++|+|+. |+.|||++++|+++..++.++++|||.+....-      .......|+.+|+|||.+...
T Consensus       421 e~~c~fKqL~~Gv~y~h~~-GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~  499 (601)
T KOG0590|consen  421 EADCFFKQLLRGVKYLHSM-GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGK  499 (601)
T ss_pred             hhhHHHHHHHHHHHHHHhc-CceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCccccccc
Confidence            5667899999999999997 999999999999999999999999998754432      122345788899999999998


Q ss_pred             CCC-CcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         77 HYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        77 ~~~-~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      .|. ...|+||.|+++..|.+|+.||.....+
T Consensus       500 ~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~  531 (601)
T KOG0590|consen  500 EYDPRAVDVWSCGIIYICMILGRFPWKVAKKS  531 (601)
T ss_pred             ccCcchhhhhhccceEEEEecCCCcccccccc
Confidence            886 4589999999999999999999644443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.52  E-value=5.8e-14  Score=96.02  Aligned_cols=102  Identities=43%  Similarity=0.739  Sum_probs=87.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC-cEEEeecccccccccc--------cccCCCCccceeCcccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG-EIKICDFGVSGQLIDS--------MANSFVGTRSYMSPERL   73 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~-~~~l~d~g~~~~~~~~--------~~~~~~~~~~~~~Pe~~   73 (131)
                      ....+..|++.++.++|+. +++|||++|.|++++..+ .+++.|||.+......        ......++..|.+||..
T Consensus       102 ~~~~~~~~~~~~l~~~H~~-~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~  180 (384)
T COG0515         102 EALFILAQILSALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL  180 (384)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHh
Confidence            4677899999999999997 799999999999999888 6999999988644322        23556788899999999


Q ss_pred             cC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         74 QG---THYSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        74 ~~---~~~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      .+   ...+...|+|++|+++++++.+..||....
T Consensus       181 ~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~  215 (384)
T COG0515         181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK  215 (384)
T ss_pred             cCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            87   578899999999999999999999987665

>KOG0606|consensus

Probab=99.50  E-value=3.2e-14  Score=109.52  Aligned_cols=103  Identities=32%  Similarity=0.587  Sum_probs=87.2

Q ss_pred             HHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----------------cccCCCCccceeCccc
Q psy17559         10 QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----------------MANSFVGTRSYMSPER   72 (131)
Q Consensus        10 q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----------------~~~~~~~~~~~~~Pe~   72 (131)
                      +.+.+++|+|+. |++|||++++|.++..-|.+|+.|||+++.....                 ......+++.|.+||+
T Consensus       151 dmvla~Eylh~y-givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV  229 (1205)
T KOG0606|consen  151 DMVLAVEYLHSY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV  229 (1205)
T ss_pred             hhhHHhHhhccC-CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence            346789999997 8999999999999999999999999987543111                 1234578999999999


Q ss_pred             ccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         73 LQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        73 ~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      +...+|+..+|+|++|+++|+.+-|..||.+...+++...+
T Consensus       230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v  270 (1205)
T KOG0606|consen  230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV  270 (1205)
T ss_pred             hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh
Confidence            99989999999999999999999999999988877655544

>KOG0603|consensus

Probab=99.48  E-value=2.3e-14  Score=105.10  Aligned_cols=95  Identities=29%  Similarity=0.456  Sum_probs=82.6

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcch
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD   83 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~d   83 (131)
                      ++.....++-+++++|+. +++|+|+++.||+++.+|.+++.|||+++..-.....  .|+..|++||+..  ....++|
T Consensus        99 ~~~~~aelaLald~lh~l-~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--cgt~eymApEI~~--gh~~a~D  173 (612)
T KOG0603|consen   99 VAFYLAELALALDHLHKL-GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--CGTYEYRAPEIIN--GHLSAAD  173 (612)
T ss_pred             HHHHHHHHHHHHhhcchh-HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--ccchhhhhhHhhh--ccCCccc
Confidence            445667778899999997 8999999999999999999999999998765443222  7888999999997  5678899


Q ss_pred             HHHHHHHHHHHHhCCCCCCC
Q psy17559         84 IWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        84 ~~slg~~l~~l~~g~~p~~~  103 (131)
                      .||+|++.+++++|..||..
T Consensus       174 ~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  174 WWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             chhhhhhHHHHhhCCCCCch
Confidence            99999999999999999997

>KOG1033|consensus

Probab=99.39  E-value=8.1e-14  Score=100.57  Aligned_cols=90  Identities=40%  Similarity=0.623  Sum_probs=77.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-c-------cccCCCCccceeCccccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-S-------MANSFVGTRSYMSPERLQ   74 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-~-------~~~~~~~~~~~~~Pe~~~   74 (131)
                      .++.++.|++.++.|   + +.+|+|+++.||+...+..+++.|||+...... .       ......++..|++||.+.
T Consensus       360 ~~~~~~~q~~~~~~y---k-~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~  435 (516)
T KOG1033|consen  360 LMLDIFKQIAPAVEY---K-GLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIR  435 (516)
T ss_pred             HHHHHHHhhccchhh---c-cchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHh
Confidence            467788899999988   4 799999999999999888999999998754322 1       234557899999999999


Q ss_pred             CCCCCCcchHHHHHHHHHHHHh
Q psy17559         75 GTHYSVQSDIWSLGLSLVEMAI   96 (131)
Q Consensus        75 ~~~~~~~~d~~slg~~l~~l~~   96 (131)
                      +..|+.++|+||||++++|++.
T Consensus       436 g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  436 GQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hhhhhhhcchhhHHHHHHHHHH
Confidence            9999999999999999999976

>KOG0576|consensus

Probab=99.37  E-value=6.4e-13  Score=98.53  Aligned_cols=99  Identities=38%  Similarity=0.701  Sum_probs=84.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCccccc---CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQ---GTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~---~~~   77 (131)
                      ++..+++..+.++.|+|+. |=+|||++..||++.+.|.++++|||.+.....  .+...+.|++.|+|||+..   ...
T Consensus       113 qiayvcRetl~gl~ylhs~-gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkgg  191 (829)
T KOG0576|consen  113 QIAYVCRETLQGLKYLHSQ-GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG  191 (829)
T ss_pred             HHHHHHhhhhccchhhhcC-CcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhccc
Confidence            4567888999999999997 789999999999999999999999999866543  3456789999999999874   356


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      |...+|+|+.|+...|+-.-+.|..
T Consensus       192 ynqlcdiwa~gitAiel~eLqpplf  216 (829)
T KOG0576|consen  192 YNQLCDIWALGITAIELGELQPPLF  216 (829)
T ss_pred             ccccccccccccchhhhhhcCCccc
Confidence            8899999999999888876676643

>KOG1240|consensus

Probab=99.35  E-value=1.8e-12  Score=100.70  Aligned_cols=97  Identities=25%  Similarity=0.386  Sum_probs=75.6

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc----cccc-----cCCCCccceeCccccc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI----DSMA-----NSFVGTRSYMSPERLQ   74 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~----~~~~-----~~~~~~~~~~~Pe~~~   74 (131)
                      -+-++.|++.|+..||+. |+.|+|||.+||++..=.++.++||..-+..-    ++..     .+......|.|||.+.
T Consensus       122 KkWiaFQLL~al~qcH~~-gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv  200 (1431)
T KOG1240|consen  122 KKWIAFQLLKALSQCHKL-GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFV  200 (1431)
T ss_pred             HHHHHHHHHHHHHHHHHc-CccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhh
Confidence            356889999999999997 89999999999999999999999997654321    1111     1223344799999885


Q ss_pred             CC----------C-CCCcchHHHHHHHHHHHHh-CCCCC
Q psy17559         75 GT----------H-YSVQSDIWSLGLSLVEMAI-GMYPI  101 (131)
Q Consensus        75 ~~----------~-~~~~~d~~slg~~l~~l~~-g~~p~  101 (131)
                      ..          . .+++=|++|+||++.|+++ |+.+|
T Consensus       201 ~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF  239 (1431)
T KOG1240|consen  201 SALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF  239 (1431)
T ss_pred             ccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc
Confidence            42          1 5678899999999999975 78888

>KOG4158|consensus

Probab=99.35  E-value=4.2e-12  Score=89.99  Aligned_cols=99  Identities=24%  Similarity=0.303  Sum_probs=75.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEe--cCCc--EEEeeccccc--cccc------ccccCCCCccceeCcc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN--SGGE--IKICDFGVSG--QLID------SMANSFVGTRSYMSPE   71 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~--~~~~--~~l~d~g~~~--~~~~------~~~~~~~~~~~~~~Pe   71 (131)
                      ...++.|+++++.|||.. |+.|||++++||++.  .++.  ..++|||.+-  ....      +..-...|....+|||
T Consensus       343 ~~~~laQlLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPE  421 (598)
T KOG4158|consen  343 GRVILAQLLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPE  421 (598)
T ss_pred             HHHHHHHHHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchh
Confidence            456889999999999986 899999999999985  3332  6899999652  2211      1222345677789999


Q ss_pred             cccCCC------CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         72 RLQGTH------YSVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        72 ~~~~~~------~~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      +....+      --.++|.|+.|.+.||+++...||-+
T Consensus       422 i~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  422 IATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             hhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence            985432      12578999999999999999999975

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.24  E-value=1.8e-11  Score=87.09  Aligned_cols=70  Identities=23%  Similarity=0.351  Sum_probs=56.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCcEecCC-CCCcEEEecCCcEEEeeccccccccccc----------ccCCCCccceeCcccc
Q psy17559          5 PYSSFQVLKGLTYLREKHAIIHRDV-KPSNILVNSGGEIKICDFGVSGQLIDSM----------ANSFVGTRSYMSPERL   73 (131)
Q Consensus         5 ~~~~~q~~~~l~~lh~~~~~~h~~l-~~~~il~~~~~~~~l~d~g~~~~~~~~~----------~~~~~~~~~~~~Pe~~   73 (131)
                      ..++.|++.+|.+||+. |++|||| +|.||+++.++.++++|||+++......          .....+++.|.+||.+
T Consensus       114 ~~~~~~i~~aL~~lH~~-gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~  192 (365)
T PRK09188        114 PAWFRSAHRALRDLHRA-GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL  192 (365)
T ss_pred             HHHHHHHHHHHHHHHHC-CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence            46789999999999997 8999999 8999999988999999999987543211          1234556678899988


Q ss_pred             cC
Q psy17559         74 QG   75 (131)
Q Consensus        74 ~~   75 (131)
                      ..
T Consensus       193 ~~  194 (365)
T PRK09188        193 TP  194 (365)
T ss_pred             Ch
Confidence            54

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.23  E-value=2.1e-11  Score=80.45  Aligned_cols=97  Identities=14%  Similarity=0.081  Sum_probs=68.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCcEecCC-CCCcEEEecCCcEEEeecccccccccccc-------cC--------CCCcccee
Q psy17559          5 PYSSFQVLKGLTYLREKHAIIHRDV-KPSNILVNSGGEIKICDFGVSGQLIDSMA-------NS--------FVGTRSYM   68 (131)
Q Consensus         5 ~~~~~q~~~~l~~lh~~~~~~h~~l-~~~~il~~~~~~~~l~d~g~~~~~~~~~~-------~~--------~~~~~~~~   68 (131)
                      ..++.|++.++.++|+. |++|+|| ++.||+++.++.++++|||++........       +.        ...++.++
T Consensus        94 ~~~~~qi~~~L~~lH~~-GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l  172 (218)
T PRK12274         94 LAYFRAARRLLQQLHRC-GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAAL  172 (218)
T ss_pred             HHHHHHHHHHHHHHHHC-cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            35778999999999997 8999999 68999999999999999999874432210       00        01122333


Q ss_pred             CcccccC-CCCC-CcchHHHHHHHHHHHHhCCCCCC
Q psy17559         69 SPERLQG-THYS-VQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        69 ~Pe~~~~-~~~~-~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      .|+.... ...+ .+.++++.|.-+|.++|+..+.-
T Consensus       173 ~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        173 TPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             CHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            3433222 1334 55677888999999999988764

>KOG1023|consensus

Probab=99.21  E-value=3.4e-11  Score=87.81  Aligned_cols=98  Identities=28%  Similarity=0.405  Sum_probs=78.2

Q ss_pred             HHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc----ccccCCCCccceeCcccccCC---C-
Q psy17559          6 YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTRSYMSPERLQGT---H-   77 (131)
Q Consensus         6 ~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~---~-   77 (131)
                      .++++++.||.|+|......|+.+++.|++++....+|++|||+......    ...........|++||.++..   . 
T Consensus        52 s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~  131 (484)
T KOG1023|consen   52 SFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSL  131 (484)
T ss_pred             HHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccc
Confidence            46889999999999975459999999999999999999999998754421    111111234578999999763   1 


Q ss_pred             ---CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         78 ---YSVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        78 ---~~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                         .+.+.|+||+|++++|+++++.||..
T Consensus       132 ~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen  132 ESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             cccccccCCeehHHHHHHHHHhccCcccc
Confidence               46779999999999999999999964

>KOG0195|consensus

Probab=99.17  E-value=6.5e-11  Score=80.52  Aligned_cols=102  Identities=20%  Similarity=0.287  Sum_probs=74.6

Q ss_pred             CchhHHHHHHHHHHHHHHhcCC-cEecCCCCCcEEEecCCcEEEe--ecccccccccccccCCCCccceeCcccccCCC-
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHA-IIHRDVKPSNILVNSGGEIKIC--DFGVSGQLIDSMANSFVGTRSYMSPERLQGTH-   77 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~-~~h~~l~~~~il~~~~~~~~l~--d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-   77 (131)
                      .++++++.+++.+++|||+-.. +..-.|++..+++|++.+.+++  |..++..     .....-.+.|++||.+...+ 
T Consensus       289 sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq-----e~gr~y~pawmspealqrkpe  363 (448)
T KOG0195|consen  289 SQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-----EVGRAYSPAWMSPEALQRKPE  363 (448)
T ss_pred             chHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-----ccccccCcccCCHHHHhcCch
Confidence            4688999999999999999533 4444788999999988776543  3222211     11122346899999997643 


Q ss_pred             --CCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         78 --YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        78 --~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                        --.++|+|||++++||+.++..||.....-+
T Consensus       364 d~n~raadmwsfaillwel~trevpfadlspme  396 (448)
T KOG0195|consen  364 DLNIRAADMWSFAILLWELNTREVPFADLSPME  396 (448)
T ss_pred             hcchhhhhHHHHHHHHHHhhccccccccCCchh
Confidence              2367999999999999999999997665543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.10  E-value=1.6e-10  Score=75.46  Aligned_cols=50  Identities=24%  Similarity=0.300  Sum_probs=44.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL   53 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~   53 (131)
                      ++..++.|++.++.++|+..|++|+|++|.||+++ ++.++++|||++...
T Consensus       118 ~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~  167 (190)
T cd05145         118 EAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceec
Confidence            56789999999999999933899999999999998 789999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.08  E-value=1.4e-10  Score=75.79  Aligned_cols=49  Identities=22%  Similarity=0.333  Sum_probs=43.1

Q ss_pred             chhHHHHHHHHHHHHH-HhcCCcEecCCCCCcEEEecCCcEEEeeccccccc
Q psy17559          3 QVPYSSFQVLKGLTYL-REKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL   53 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~l-h~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~   53 (131)
                      ++..++.|++.+|.++ |+. |++|+|++|.||+++ ++.++++|||++...
T Consensus       118 ~~~~i~~qi~~~L~~l~H~~-giiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         118 KARELYLQVIQIMRILYQDC-RLVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             HHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            4678899999999999 676 899999999999998 478999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.06  E-value=7e-11  Score=79.11  Aligned_cols=77  Identities=18%  Similarity=0.294  Sum_probs=56.2

Q ss_pred             HHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcchHH
Q psy17559          6 YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW   85 (131)
Q Consensus         6 ~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~d~~   85 (131)
                      ....+++.++..+|+. |++|+|++|.|++++.++ ++++|||............          .......+..++|+|
T Consensus       139 ~~~~~i~~~l~~lH~~-gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d----------~~vler~y~~~~di~  206 (232)
T PRK10359        139 DVKAKIKASIESLHQH-GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD----------RIDLERHYGIKNEIK  206 (232)
T ss_pred             HHHHHHHHHHHHHHHc-CCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH----------HHHHHhHhccccccc
Confidence            3567899999999997 899999999999999888 9999998765432211110          011222355789999


Q ss_pred             HHHHHHHHH
Q psy17559         86 SLGLSLVEM   94 (131)
Q Consensus        86 slg~~l~~l   94 (131)
                      +||+.+...
T Consensus       207 ~lg~~~~~~  215 (232)
T PRK10359        207 DLGYYLLIY  215 (232)
T ss_pred             ceeEeehHH
Confidence            999986544

>KOG1166|consensus

Probab=99.05  E-value=5.1e-10  Score=87.17  Aligned_cols=95  Identities=28%  Similarity=0.397  Sum_probs=76.5

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec-------CCcEEEeecccccccc---cc-cccCCCCccceeCccc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-------GGEIKICDFGVSGQLI---DS-MANSFVGTRSYMSPER   72 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~-------~~~~~l~d~g~~~~~~---~~-~~~~~~~~~~~~~Pe~   72 (131)
                      +..++.|++..++++|.. +|||+||+|+|+++..       +..++|+|||.+.-+.   +. +-.....+-.+.++|.
T Consensus       796 v~~~~~qml~ive~lH~~-~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM  874 (974)
T KOG1166|consen  796 VMFFSCQMLRIVEHLHAM-GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEM  874 (974)
T ss_pred             hhHHHHHHHHHHHHHHhc-ceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHH
Confidence            567889999999999986 7999999999999953       2348999999875432   21 1223345557889999


Q ss_pred             ccCCCCCCcchHHHHHHHHHHHHhCCC
Q psy17559         73 LQGTHYSVQSDIWSLGLSLVEMAIGMY   99 (131)
Q Consensus        73 ~~~~~~~~~~d~~slg~~l~~l~~g~~   99 (131)
                      ..+.++++.+|.|.++.+++-|+.|+.
T Consensus       875 ~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  875 REGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             hcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            999999999999999999999998753

>smart00090 RIO RIO-like kinase

Probab=98.87  E-value=3.8e-09  Score=71.33  Aligned_cols=48  Identities=27%  Similarity=0.342  Sum_probs=43.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCC-cEecCCCCCcEEEecCCcEEEeeccccccc
Q psy17559          4 VPYSSFQVLKGLTYLREKHA-IIHRDVKPSNILVNSGGEIKICDFGVSGQL   53 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~-~~h~~l~~~~il~~~~~~~~l~d~g~~~~~   53 (131)
                      +..++.|++.++.++|+. | ++|+|++|.||+++ ++.++++|||.+...
T Consensus       150 ~~~i~~qi~~~l~~LH~~-g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      150 EFELYDDILEEMRKLYKE-GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             HHHHHHHHHHHHHHHHhc-CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            568899999999999997 8 99999999999999 788999999987543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.85  E-value=2.2e-08  Score=72.18  Aligned_cols=99  Identities=15%  Similarity=0.196  Sum_probs=80.0

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccc-ccccccCCCCccceeCcccccC-----CC
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRSYMSPERLQG-----TH   77 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~-~~~~~~~~~~~~~~~~Pe~~~~-----~~   77 (131)
                      ++++++.++.+.+.+|+. |..-+|++++|+++++++.+.+.|-...+.. .+....+.++...|++||.-.-     -.
T Consensus       119 llrvaRnlA~aFA~lH~~-Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~  197 (637)
T COG4248         119 LLRVARNLASAFATLHEH-GHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFE  197 (637)
T ss_pred             HHHHHHHHHHHHHHHHhc-CCcccccCccceeeecCceEEEEcccceeeccCCceEecccCccccCCHHHhccccccccC
Confidence            467899999999999986 8999999999999999999999985543322 3334567788899999998752     23


Q ss_pred             CCCcchHHHHHHHHHHHHhC-CCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIG-MYPIPP  103 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g-~~p~~~  103 (131)
                      -+...|.+.||+++++++.| +.||.+
T Consensus       198 r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         198 RTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             CCccccchhHHHHHHHHHhcCCCCCCc
Confidence            45778999999999999765 999964

>KOG0590|consensus

Probab=98.83  E-value=6.6e-10  Score=83.71  Aligned_cols=102  Identities=35%  Similarity=0.602  Sum_probs=84.5

Q ss_pred             hhHHHHHHHHHHHHHH-hcCCcEecCCCCCcEEEecCC-cEEEeeccccccccc--c---cccCCCC-ccceeCcccccC
Q psy17559          4 VPYSSFQVLKGLTYLR-EKHAIIHRDVKPSNILVNSGG-EIKICDFGVSGQLID--S---MANSFVG-TRSYMSPERLQG   75 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh-~~~~~~h~~l~~~~il~~~~~-~~~l~d~g~~~~~~~--~---~~~~~~~-~~~~~~Pe~~~~   75 (131)
                      +.....|+..++.|+| .. ++.|++++|.|.+++.++ ..+.+|||++.....  +   ......| ++.|.+||...+
T Consensus       125 ~~~~~~ql~s~l~~~H~~~-~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~  203 (601)
T KOG0590|consen  125 ASRYLPQLNSGLSYLHPEN-GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSG  203 (601)
T ss_pred             hhhhhhhhccCccccCccc-ccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccc
Confidence            4567889999999999 55 899999999999999998 899999999876544  1   2234456 889999999988


Q ss_pred             C-CCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         76 T-HYSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        76 ~-~~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      . ......|+||.|+++.-+++|..||.....
T Consensus       204 ~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~  235 (601)
T KOG0590|consen  204 KAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR  235 (601)
T ss_pred             hhhcCCCcccccccccccccccCCCCcccccc
Confidence            4 457889999999999999999999864443

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=98.81  E-value=9e-09  Score=69.60  Aligned_cols=46  Identities=17%  Similarity=0.295  Sum_probs=41.4

Q ss_pred             HHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccc
Q psy17559          6 YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ   52 (131)
Q Consensus         6 ~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~   52 (131)
                      ....|++.++++||+. |++|+|++|.||+++.++.++++|||.+..
T Consensus       146 ~~~~~i~~~l~~lH~~-GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        146 EQWQAIGQLIARFHDA-GVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             HHHHHHHHHHHHHHHC-CCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            3467899999999997 899999999999999888999999998754

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=98.80  E-value=1.2e-08  Score=66.96  Aligned_cols=49  Identities=24%  Similarity=0.258  Sum_probs=44.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ   52 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~   52 (131)
                      ....++.+++.++.++|+. |++|+|++|.|++++.++.++++|||.+..
T Consensus       126 ~~~~~~~~i~~~l~~lh~~-gi~H~Dl~p~Nill~~~~~~~liDfg~~~~  174 (198)
T cd05144         126 DPEEVLDEILEEIVKAYKH-GIIHGDLSEFNILVDDDEKIYIIDWPQMVS  174 (198)
T ss_pred             cHHHHHHHHHHHHHHHHHC-CCCcCCCCcccEEEcCCCcEEEEECCcccc
Confidence            4567889999999999997 899999999999999999999999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.74  E-value=2.2e-08  Score=64.82  Aligned_cols=51  Identities=24%  Similarity=0.312  Sum_probs=44.7

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccc
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL   53 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~   53 (131)
                      +++..++.+++.++.++|...+++|+|++|.|++++ ++.++++|||.+...
T Consensus       114 ~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         114 EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence            356789999999999999833899999999999999 889999999987544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK14879 serine/threonine protein kinase; Provisional

Probab=98.62  E-value=8.7e-08  Score=63.17  Aligned_cols=47  Identities=30%  Similarity=0.439  Sum_probs=42.4

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ   52 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~   52 (131)
                      ...++.+++.++.++|+. +++|+|++|.|++++ ++.++++|||.+..
T Consensus        97 ~~~i~~~i~~~l~~lH~~-~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         97 ELELSREIGRLVGKLHSA-GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             HHHHHHHHHHHHHHHHhC-CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            457889999999999997 899999999999999 78899999998764

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=98.62  E-value=9.8e-08  Score=62.41  Aligned_cols=46  Identities=24%  Similarity=0.348  Sum_probs=41.7

Q ss_pred             HHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccc
Q psy17559          6 YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL   53 (131)
Q Consensus         6 ~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~   53 (131)
                      .++.|++.++.++|+. |++|+|+++.|++++ ++.+++.|||.+...
T Consensus        94 ~~~~~i~~~l~~lH~~-gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        94 ELLREIGRLVGKLHKA-GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             HHHHHHHHHHHHHHHC-CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            6789999999999997 899999999999999 788999999987543

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=98.56  E-value=8.3e-08  Score=71.81  Aligned_cols=48  Identities=25%  Similarity=0.350  Sum_probs=42.8

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL   53 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~   53 (131)
                      ...++.|++.++.+||+. +++|+|++|.||++ .++.++++|||+++..
T Consensus       430 ~~~~~~~i~~~L~~lH~~-giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        430 NPELVRKVGEIVAKLHKA-GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             HHHHHHHHHHHHHHHHhC-CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            456889999999999997 89999999999999 6778999999998653

>PRK10345 hypothetical protein; Provisional

Probab=98.55  E-value=1.6e-07  Score=62.42  Aligned_cols=42  Identities=33%  Similarity=0.393  Sum_probs=34.9

Q ss_pred             HHHHHHHHHH-HHHHhcCCcEecCCCCCcEEEecC----CcEEEeecc
Q psy17559          6 YSSFQVLKGL-TYLREKHAIIHRDVKPSNILVNSG----GEIKICDFG   48 (131)
Q Consensus         6 ~~~~q~~~~l-~~lh~~~~~~h~~l~~~~il~~~~----~~~~l~d~g   48 (131)
                      .++.|++.++ +|||+. +|+||||+|.||+++.+    ..++++|++
T Consensus       108 ~~~~~~L~~l~~yLh~~-~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345        108 AQLRQLLKKLKRYLLDN-RIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             HHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            4577888777 999997 79999999999999743    369999944

>KOG1243|consensus

Probab=98.45  E-value=7.9e-07  Score=66.89  Aligned_cols=92  Identities=26%  Similarity=0.433  Sum_probs=68.0

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc--ccCCCCccceeCcccccCCCCCCc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      +..-+.||+.||.+||.+..++|+++....+++...|.-++++|.+........  .........+..|+.+....  ..
T Consensus       106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s  183 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WS  183 (690)
T ss_pred             HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cc
Confidence            344578999999999976679999999999999999999999988764332211  11111222456666554433  56


Q ss_pred             chHHHHHHHHHHHHhC
Q psy17559         82 SDIWSLGLSLVEMAIG   97 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g   97 (131)
                      .|.|-||+++++++.|
T Consensus       184 ~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  184 IDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhhHHHHHHHHhCc
Confidence            7999999999999988

>KOG2137|consensus

Probab=98.41  E-value=4e-08  Score=73.82  Aligned_cols=94  Identities=26%  Similarity=0.446  Sum_probs=72.5

Q ss_pred             HHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----------cccCCCCccceeCcccccCCC
Q psy17559          9 FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----------MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         9 ~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----------~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      .++++|+.++|...+++|+++.|+++.+..++..|++.|+.+....+.           ..........|.+||++.+..
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            345578999999778999999999999999999999999876433221           111123345799999998877


Q ss_pred             CCCcchHHHHHHHHHHHH-hCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMA-IGMYPIP  102 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~-~g~~p~~  102 (131)
                      -...+|++|+|+++|.+. +|+..+.
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~  211 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIA  211 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhh
Confidence            889999999999999887 5555543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.26  E-value=2.5e-06  Score=52.58  Aligned_cols=48  Identities=29%  Similarity=0.394  Sum_probs=41.9

Q ss_pred             hhHHHHHHHHHHHHHHhc--CCcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559          4 VPYSSFQVLKGLTYLREK--HAIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~--~~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      ...++.+++.+++.+|..  .+++|+|+++.|++++..+.+++.||+.+.
T Consensus        88 ~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          88 KEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             HHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            456788999999999984  269999999999999988899999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1266|consensus

Probab=98.20  E-value=3.9e-06  Score=58.96  Aligned_cols=97  Identities=26%  Similarity=0.321  Sum_probs=71.4

Q ss_pred             CchhHHHHHHHHHHHHHHhc-CCcEecCCCCCcEEEecCCcEEEeecccccccc------cccccCCCCccceeCccccc
Q psy17559          2 KQVPYSSFQVLKGLTYLREK-HAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI------DSMANSFVGTRSYMSPERLQ   74 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~-~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~------~~~~~~~~~~~~~~~Pe~~~   74 (131)
                      +..++|+-||..||.|||+. ..++|+++..+.+++..+|-+++..........      ........+.+.|.+|+.-.
T Consensus       176 ~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~  255 (458)
T KOG1266|consen  176 KAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT  255 (458)
T ss_pred             HHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc
Confidence            46789999999999999994 359999999999999988888775432211110      00112233456788888887


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCC
Q psy17559         75 GTHYSVQSDIWSLGLSLVEMAIGM   98 (131)
Q Consensus        75 ~~~~~~~~d~~slg~~l~~l~~g~   98 (131)
                      .......+|+|+||....+|..+.
T Consensus       256 ~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  256 TTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccccccchhhhhhhHHHHHHHHhe
Confidence            777889999999998888886554

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.15  E-value=4e-06  Score=55.12  Aligned_cols=47  Identities=26%  Similarity=0.392  Sum_probs=39.2

Q ss_pred             hhHHHHHHHHHHHHH-HhcCCcEecCCCCCcEEEecCCcEEEeecccccc
Q psy17559          4 VPYSSFQVLKGLTYL-REKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ   52 (131)
Q Consensus         4 ~~~~~~q~~~~l~~l-h~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~   52 (131)
                      ...+..|++.++..+ |.. |++|+||++.||++. ++.+.++||+-+..
T Consensus       126 ~~~i~~~i~~~l~~l~H~~-glVHGDLs~~NIL~~-~~~v~iIDF~qav~  173 (197)
T cd05146         126 MKNAYYQVLSMMKQLYKEC-NLVHADLSEYNMLWH-DGKVWFIDVSQSVE  173 (197)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEE-CCcEEEEECCCcee
Confidence            355678999999988 776 899999999999997 46799999986643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.07  E-value=1.1e-05  Score=51.16  Aligned_cols=46  Identities=26%  Similarity=0.421  Sum_probs=38.6

Q ss_pred             hHHHHHHHHHHHHHHhcC----CcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559          5 PYSSFQVLKGLTYLREKH----AIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus         5 ~~~~~q~~~~l~~lh~~~----~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      .....+++.+++.||...    +++|+|+++.|++++ ++.++++||+.+.
T Consensus        86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            456789999999999862    149999999999998 6678999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0606|consensus

Probab=98.03  E-value=1.1e-05  Score=63.68  Aligned_cols=109  Identities=26%  Similarity=0.442  Sum_probs=83.2

Q ss_pred             HHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc---------------------c-----------
Q psy17559          8 SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI---------------------D-----------   55 (131)
Q Consensus         8 ~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~---------------------~-----------   55 (131)
                      ...+..+.++||+.. +.|+++.+++.+...++...+.+++.....+                     .           
T Consensus       910 i~~~vqs~e~L~s~~-r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~  988 (1205)
T KOG0606|consen  910 ILERVQSLESLHSSL-RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADE  988 (1205)
T ss_pred             hHHHHhhhhccccch-hhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccch
Confidence            345556889999863 8999999999999988888888876221110                     0           


Q ss_pred             -ccccCCCCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCCCC
Q psy17559         56 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR  117 (131)
Q Consensus        56 -~~~~~~~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  117 (131)
                       .......+++.|.+||...+......+|+|+.|..+++.++|..||.....+++.+.+....
T Consensus       989 ~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~ 1051 (1205)
T KOG0606|consen  989 ARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRD 1051 (1205)
T ss_pred             hhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCC
Confidence             00112357788999999999888999999999999999999999999888877666554443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.03  E-value=1e-05  Score=53.59  Aligned_cols=47  Identities=23%  Similarity=0.294  Sum_probs=41.4

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC---cEEEeeccccc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG---EIKICDFGVSG   51 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~---~~~l~d~g~~~   51 (131)
                      ...++.+++..++-||+. |++|+|+++.||+++.++   .+.++||+.++
T Consensus       120 ~~~ll~~l~~~i~~lH~~-gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen  120 RRELLRALARLIAKLHDA-GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             HHHHHHHHHHHHHHHHHC-cCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            457888999999999997 899999999999999876   68999998654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.01  E-value=1e-05  Score=55.67  Aligned_cols=47  Identities=15%  Similarity=0.122  Sum_probs=40.4

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec-------CCcEEEeeccccc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-------GGEIKICDFGVSG   51 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~-------~~~~~l~d~g~~~   51 (131)
                      ...++.+++..++-||.. |++|+|+++.||+++.       +..+.++||+.++
T Consensus       140 ~~~ll~~la~~i~~LH~~-Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        140 KRMLIKRVATMVRDMHAA-GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHHHHHHHHHHHHHHHC-cCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            346788999999999997 8999999999999985       3568999998764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.00  E-value=1.7e-05  Score=58.18  Aligned_cols=49  Identities=29%  Similarity=0.449  Sum_probs=40.3

Q ss_pred             hHHHHHHHH-HHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc
Q psy17559          5 PYSSFQVLK-GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI   54 (131)
Q Consensus         5 ~~~~~q~~~-~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~   54 (131)
                      ..++.+++. .+..+|.. |++|+|++|.|++++.++.+++.|||.+....
T Consensus       259 ~~ia~~~~~~~l~ql~~~-g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       259 KALAENLARSFLNQVLRD-GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHHHHHHHHHhC-CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            345666665 46788876 89999999999999999999999999886554

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.88  E-value=6.4e-05  Score=49.15  Aligned_cols=48  Identities=27%  Similarity=0.445  Sum_probs=35.5

Q ss_pred             chhHHHHHHHHHHHHH-HhcCCcEecCCCCCcEEEecCCcEEEeecccccc
Q psy17559          3 QVPYSSFQVLKGLTYL-REKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ   52 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~l-h~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~   52 (131)
                      +...+..+++..+..+ |.. |++|+||++.||+++.+ .+.++||+-+..
T Consensus       107 ~~~~~~~~il~~~~~~~~~~-givHGDLs~~NIlv~~~-~~~iIDf~qav~  155 (188)
T PF01163_consen  107 EPKELLEEILEEIIKMLHKA-GIVHGDLSEYNILVDDG-KVYIIDFGQAVD  155 (188)
T ss_dssp             THHHHHHHHHHHHHHHHHCT-TEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred             hHHHHHHHHHHHHHHHHHhc-CceecCCChhhEEeecc-eEEEEecCccee
Confidence            4567778888755554 665 89999999999999877 899999986543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0601|consensus

Probab=97.82  E-value=1.1e-05  Score=59.79  Aligned_cols=97  Identities=31%  Similarity=0.426  Sum_probs=74.4

Q ss_pred             hhHHHHHHHH----HHHHHHhcCCcEecCCCCCcEEEecC-CcEEEeeccccccccccc-------ccCCCCccceeCcc
Q psy17559          4 VPYSSFQVLK----GLTYLREKHAIIHRDVKPSNILVNSG-GEIKICDFGVSGQLIDSM-------ANSFVGTRSYMSPE   71 (131)
Q Consensus         4 ~~~~~~q~~~----~l~~lh~~~~~~h~~l~~~~il~~~~-~~~~l~d~g~~~~~~~~~-------~~~~~~~~~~~~Pe   71 (131)
                      ++....+...    |+.++|+. .++|.++++.|+++..+ ..+++.||++....+...       .....+...|++||
T Consensus       220 l~~~~~~~~~~~~~al~~~hs~-~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke  298 (524)
T KOG0601|consen  220 LWNSLRDWLSRDVTALSHLHSN-NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKE  298 (524)
T ss_pred             hhhHHhhhhhcccccccccCCC-cccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChh
Confidence            3445555556    99999997 69999999999999988 788999999876554321       11225667899999


Q ss_pred             cccCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy17559         72 RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        72 ~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      ...+ .++...|++++|-++.+...+.....
T Consensus       299 ~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  299 LLNG-LATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             hhcc-ccchHhhhcchhhhhHhhHhhccccc
Confidence            9866 46788999999999998877665543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=97.65  E-value=0.00016  Score=47.16  Aligned_cols=44  Identities=30%  Similarity=0.420  Sum_probs=34.7

Q ss_pred             HHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccc
Q psy17559          7 SSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ   52 (131)
Q Consensus         7 ~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~   52 (131)
                      +++.+=.-+.-||.. |++|+||.++|+.+...+ +.++|||++..
T Consensus        97 ~~r~vG~~vg~lH~~-givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          97 LLREVGRLVGKLHKA-GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             HHHHHHHHHHHHHhc-CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            344444456779987 899999999999997654 88999999753

>PRK09902 hypothetical protein; Provisional

Probab=97.57  E-value=0.00015  Score=48.18  Aligned_cols=46  Identities=15%  Similarity=0.054  Sum_probs=40.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCc--EEEeeccccc
Q psy17559          5 PYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE--IKICDFGVSG   51 (131)
Q Consensus         5 ~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~--~~l~d~g~~~   51 (131)
                      ..+..+++..++-||.. |+.|+|+.+.||+++.++.  +.++||.-++
T Consensus       131 ~~il~~va~~ia~LH~~-Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        131 QAMLKAVALAFKKMHSV-NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             HHHHHHHHHHHHHHHHC-CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            47888999999999997 8999999999999986666  8999997654

>KOG0601|consensus

Probab=97.52  E-value=3.6e-05  Score=57.17  Aligned_cols=95  Identities=33%  Similarity=0.347  Sum_probs=65.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC-CcEEEeecccccccccccccCCCCccce-eCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG-GEIKICDFGVSGQLIDSMANSFVGTRSY-MSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~-~~Pe~~~~~~~~~   80 (131)
                      ..+++..|++.++.++|++ .++|+|+++.||++..+ +..++.|++.+....-........+..| .++.......+..
T Consensus       367 ~~~~~~~q~~~~l~~i~s~-~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~  445 (524)
T KOG0601|consen  367 PRLRLTAQILTALNVIHSK-LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLS  445 (524)
T ss_pred             hhhhhHHHHHhccccccch-hhhcccccccceeeccchhhhhccccccccccceecccccccccccccchhhcccccccc
Confidence            3567888999999999997 79999999999999876 6778888887643211111111112223 2444455556778


Q ss_pred             cchHHHHHHHHHHHHhCC
Q psy17559         81 QSDIWSLGLSLVEMAIGM   98 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~   98 (131)
                      ++|+++||.-+.+.+++.
T Consensus       446 ~~~~~sl~~~~~e~~~~~  463 (524)
T KOG0601|consen  446 KADIFSLGLSVDEAITGS  463 (524)
T ss_pred             ccccccccccccccccCc
Confidence            899999998877766543

>KOG3087|consensus

Probab=97.44  E-value=0.00039  Score=45.51  Aligned_cols=48  Identities=31%  Similarity=0.414  Sum_probs=38.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCc---EEEeeccccccc
Q psy17559          5 PYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQL   53 (131)
Q Consensus         5 ~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~---~~l~d~g~~~~~   53 (131)
                      ..++.++=..+.-||.+ +++|+||..+||++..++.   +.+.|||++...
T Consensus       116 ~~~~~~iG~~igklH~n-diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  116 AELARRIGELIGKLHDN-DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             HHHHHHHHHHHHHhhhC-CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            35667777788889997 7999999999999976543   589999987543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.24  E-value=0.00091  Score=44.85  Aligned_cols=43  Identities=23%  Similarity=0.378  Sum_probs=35.1

Q ss_pred             HHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559          7 SSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus         7 ~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      +...+..++..+|+. |+.|+|.+|.|+++..+ .+++.|++..+
T Consensus       140 ~~~ki~~~ikqlH~~-G~~HGD~hpgNFlv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  140 LAEKIVEAIKQLHKH-GFYHGDPHPGNFLVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             HHHHHHHHHHHHHHc-CCccCCCCcCcEEEECC-cEEEEECcccc
Confidence            445677889999997 99999999999988854 48899986543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.24  E-value=0.00083  Score=46.38  Aligned_cols=46  Identities=24%  Similarity=0.338  Sum_probs=36.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGV   49 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~   49 (131)
                      ....++..++.-++-.-.. |++|+|++.-||+++.+|.+.++||.=
T Consensus       203 n~~~il~~il~~~~~~~~~-GiVHGDlSefNIlV~~dg~~~vIDwPQ  248 (304)
T COG0478         203 NPDEILDKILEEVRKAYRR-GIVHGDLSEFNILVTEDGDIVVIDWPQ  248 (304)
T ss_pred             CHHHHHHHHHHHHHHHHHc-CccccCCchheEEEecCCCEEEEeCcc
Confidence            3445566666666655544 899999999999999999999999953

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=97.18  E-value=0.00079  Score=50.75  Aligned_cols=38  Identities=32%  Similarity=0.547  Sum_probs=31.4

Q ss_pred             HHHHHhcCCcEecCCCCCcEEEecCC----cEEEeeccccccc
Q psy17559         15 LTYLREKHAIIHRDVKPSNILVNSGG----EIKICDFGVSGQL   53 (131)
Q Consensus        15 l~~lh~~~~~~h~~l~~~~il~~~~~----~~~l~d~g~~~~~   53 (131)
                      +..++.. |++|+|++|.||+++.++    .+++.|||.....
T Consensus       273 ~~Qif~~-GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        273 FTQVFRD-GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             HHHHHhC-CeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence            3444554 899999999999999887    8999999987654

>KOG3741|consensus

Probab=95.93  E-value=0.03  Score=42.23  Aligned_cols=79  Identities=24%  Similarity=0.301  Sum_probs=57.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .++.++.|+..||.++|+. |+.-+-|.+.+|+++.+-+++++.-|..........            +.+   .-..+.
T Consensus       394 ~lW~y~~QLtaaL~sIHss-GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~------------~~l---e~~Qq~  457 (655)
T KOG3741|consen  394 VLWSYISQLTAALYSIHSS-GLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT------------EPL---ESQQQN  457 (655)
T ss_pred             HHHHHHHHHHHHHHHHHhc-CceeecccHhHeEeeCcceEEEecccceeeecCCCC------------cch---hHHhhh
Confidence            4678899999999999997 899999999999999877777776555432221110            011   112556


Q ss_pred             hHHHHHHHHHHHHhC
Q psy17559         83 DIWSLGLSLVEMAIG   97 (131)
Q Consensus        83 d~~slg~~l~~l~~g   97 (131)
                      |.-.||.++..+.+|
T Consensus       458 D~~~lG~ll~aLAt~  472 (655)
T KOG3741|consen  458 DLRDLGLLLLALATG  472 (655)
T ss_pred             hHHHHHHHHHHHhhc
Confidence            888899999999887

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=95.77  E-value=0.028  Score=42.42  Aligned_cols=49  Identities=35%  Similarity=0.533  Sum_probs=36.9

Q ss_pred             hHHHHHHHHH-HHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc
Q psy17559          5 PYSSFQVLKG-LTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI   54 (131)
Q Consensus         5 ~~~~~q~~~~-l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~   54 (131)
                      +.++..++.+ ++.+-. .|++|.|.+|.|+++..++...+.|||......
T Consensus       267 k~ia~~~~~~f~~q~~~-dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         267 KELAELLVRAFLRQLLR-DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             HHHHHHHHHHHHHHHHh-cCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            3455555443 444443 489999999999999999999999999876553

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=95.70  E-value=0.033  Score=38.23  Aligned_cols=47  Identities=26%  Similarity=0.268  Sum_probs=37.5

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      +..+..+++..++-|-...+++|+||+.-||++. ++.+.++|++=+.
T Consensus       168 ~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV  214 (268)
T COG1718         168 AEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAV  214 (268)
T ss_pred             HHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECcccc
Confidence            4556667777777776644899999999999999 8889999997553

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=95.34  E-value=0.018  Score=37.77  Aligned_cols=30  Identities=17%  Similarity=0.406  Sum_probs=25.4

Q ss_pred             CCcEecCCCCCcEEEec--CCcEEEeeccccc
Q psy17559         22 HAIIHRDVKPSNILVNS--GGEIKICDFGVSG   51 (131)
Q Consensus        22 ~~~~h~~l~~~~il~~~--~~~~~l~d~g~~~   51 (131)
                      .+++|+|+.+.|++++.  ++.+.++||+.+.
T Consensus       174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             cEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence            36999999999999998  5667899998654

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.15  E-value=0.067  Score=37.26  Aligned_cols=30  Identities=23%  Similarity=0.408  Sum_probs=26.1

Q ss_pred             CcEecCCCCCcEEEecC----CcEEEeecccccc
Q psy17559         23 AIIHRDVKPSNILVNSG----GEIKICDFGVSGQ   52 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~----~~~~l~d~g~~~~   52 (131)
                      +++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            68999999999999874    7899999987643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=95.10  E-value=0.029  Score=37.53  Aligned_cols=29  Identities=28%  Similarity=0.533  Sum_probs=25.3

Q ss_pred             CcEecCCCCCcEEEec-CCcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNS-GGEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~-~~~~~l~d~g~~~   51 (131)
                      +++|+|+.+.||+++. ++.+.+.||..+.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            6999999999999997 5779999997653

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.97  E-value=0.047  Score=39.76  Aligned_cols=50  Identities=24%  Similarity=0.386  Sum_probs=40.5

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccc
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ   52 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~   52 (131)
                      +++..++.+.+..+.-+..+-..-||++...||+++ +|.+.++||.+++-
T Consensus       321 ~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         321 EEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             HHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            356677777777777666654588999999999999 99999999998763

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=94.87  E-value=0.034  Score=37.39  Aligned_cols=29  Identities=38%  Similarity=0.678  Sum_probs=24.7

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      +++|+|+.+.|++++.++...+.||+.+.
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            58999999999999876666899998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.75  E-value=0.072  Score=37.15  Aligned_cols=28  Identities=29%  Similarity=0.490  Sum_probs=24.2

Q ss_pred             CCcEecCCCCCcEEEecCCcEEEeecccc
Q psy17559         22 HAIIHRDVKPSNILVNSGGEIKICDFGVS   50 (131)
Q Consensus        22 ~~~~h~~l~~~~il~~~~~~~~l~d~g~~   50 (131)
                      .+++|+|+.+.|++++. +.+.+.||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            37899999999999987 56789999855

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=94.67  E-value=0.071  Score=34.91  Aligned_cols=48  Identities=29%  Similarity=0.309  Sum_probs=40.1

Q ss_pred             chhHHHHHHHHHHHHHHhc--CCcEecCCCCCcEEEecCCcEEEeecccc
Q psy17559          3 QVPYSSFQVLKGLTYLREK--HAIIHRDVKPSNILVNSGGEIKICDFGVS   50 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~--~~~~h~~l~~~~il~~~~~~~~l~d~g~~   50 (131)
                      +..+++.+++..+.+++..  ..+.-.|++++|+.+.+++.+++.|....
T Consensus        60 ~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v  109 (188)
T PF12260_consen   60 QRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDV  109 (188)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhc
Confidence            4568899999999999762  14777899999999999999999998754

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK05231 homoserine kinase; Provisional

Probab=94.40  E-value=0.039  Score=38.75  Aligned_cols=29  Identities=24%  Similarity=0.327  Sum_probs=25.1

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      +++|+|+.+.|++++.+....+.||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            79999999999999866556899998764

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=94.23  E-value=0.032  Score=36.78  Aligned_cols=29  Identities=52%  Similarity=0.864  Sum_probs=20.1

Q ss_pred             CcEecCCCCCcEEEe-cCCcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVN-SGGEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~-~~~~~~l~d~g~~~   51 (131)
                      +++|+|+++.|++++ .++.+.+.||+.+.
T Consensus       167 ~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  167 VLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             EEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             EEEEeccccccceeeeccceeEEEecccce
Confidence            699999999999999 56666899997653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=94.08  E-value=0.055  Score=36.48  Aligned_cols=29  Identities=31%  Similarity=0.446  Sum_probs=25.4

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      .++|+|+.+.|++++.++...++||+.+.
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            58999999999999987778899998653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=93.85  E-value=0.13  Score=35.70  Aligned_cols=45  Identities=20%  Similarity=0.378  Sum_probs=33.0

Q ss_pred             HHHHHHHHHHHHhc-CCcEecCCCCCcEEEecCCcEEEeecccccc
Q psy17559          8 SFQVLKGLTYLREK-HAIIHRDVKPSNILVNSGGEIKICDFGVSGQ   52 (131)
Q Consensus         8 ~~q~~~~l~~lh~~-~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~   52 (131)
                      +..+-..+.-.+.. ..+.|.|+.+.|++.+..+.++++||..+..
T Consensus       138 ~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         138 LKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            33343444444443 2589999999999999989999999987643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=93.75  E-value=0.064  Score=37.57  Aligned_cols=30  Identities=27%  Similarity=0.476  Sum_probs=26.3

Q ss_pred             CCcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         22 HAIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        22 ~~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      .+++|+|+++.|++++.++.+.+.||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            479999999999999988777899998763

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=93.61  E-value=0.06  Score=37.31  Aligned_cols=29  Identities=24%  Similarity=0.368  Sum_probs=25.6

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      +++|+|+++.|++++.++.+.+.||+.+.
T Consensus       176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         176 GVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            69999999999999987777899998654

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=93.41  E-value=0.078  Score=36.09  Aligned_cols=29  Identities=31%  Similarity=0.562  Sum_probs=24.8

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeecccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSGQ   52 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~~   52 (131)
                      .++|+|+++.|++++.++ +.+.||..+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            589999999999998876 78999987643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=93.39  E-value=0.042  Score=36.30  Aligned_cols=30  Identities=43%  Similarity=0.828  Sum_probs=21.0

Q ss_pred             CcEecCCCCCcEEE-ecCCcEEEeecccccc
Q psy17559         23 AIIHRDVKPSNILV-NSGGEIKICDFGVSGQ   52 (131)
Q Consensus        23 ~~~h~~l~~~~il~-~~~~~~~l~d~g~~~~   52 (131)
                      .+.|.|+.+.||++ ..++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            58899999999999 7889999999987643

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=93.33  E-value=0.11  Score=35.55  Aligned_cols=36  Identities=28%  Similarity=0.429  Sum_probs=30.3

Q ss_pred             HHHHHHHh-cCCcEecCCCCCcEEEecCCcEEEeecc
Q psy17559         13 KGLTYLRE-KHAIIHRDVKPSNILVNSGGEIKICDFG   48 (131)
Q Consensus        13 ~~l~~lh~-~~~~~h~~l~~~~il~~~~~~~~l~d~g   48 (131)
                      .+|.-.|+ ..+.+|+|.+|+||+-|+.|.+|+.|-+
T Consensus       152 ~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~  188 (308)
T PF07387_consen  152 KDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPV  188 (308)
T ss_pred             HHHHHhhccCCCeecCCCChhheeecCCCCEEecChh
Confidence            45777785 3469999999999999999999999854

The function of this family is unknown.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=93.29  E-value=0.12  Score=36.23  Aligned_cols=30  Identities=13%  Similarity=0.214  Sum_probs=26.5

Q ss_pred             CCcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         22 HAIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        22 ~~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      .+++|+|+.++|++++.++.+.++||..+.
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            379999999999999988889999997653

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=93.19  E-value=0.099  Score=35.17  Aligned_cols=28  Identities=25%  Similarity=0.432  Sum_probs=24.7

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      .++|+|+.+.|++++.++ +.+.||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            578999999999999877 9999998754

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG2268|consensus

Probab=93.03  E-value=0.33  Score=35.14  Aligned_cols=42  Identities=26%  Similarity=0.371  Sum_probs=31.8

Q ss_pred             HHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecc
Q psy17559          6 YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFG   48 (131)
Q Consensus         6 ~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g   48 (131)
                      .+...+..-+--|-. +|+||+|.+--|++++.++.++++||.
T Consensus       206 ~ly~~lm~~Iv~la~-~GlIHgDFNEFNimv~dd~~i~vIDFP  247 (465)
T KOG2268|consen  206 TLYDDLMGLIVRLAN-HGLIHGDFNEFNIMVKDDDKIVVIDFP  247 (465)
T ss_pred             HHHHHHHHHHHHHHH-cCceecccchheeEEecCCCEEEeech
Confidence            344444444444544 499999999999999999999999985

>PRK10271 thiK thiamine kinase; Provisional

Probab=92.86  E-value=0.13  Score=33.68  Aligned_cols=30  Identities=27%  Similarity=0.551  Sum_probs=25.0

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeeccccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSGQL   53 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~   53 (131)
                      ...|+|+.+.|+++..++ ++++||+.+...
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g  107 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG  107 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence            468999999999987766 889999877543

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=91.43  E-value=0.24  Score=35.26  Aligned_cols=30  Identities=20%  Similarity=0.591  Sum_probs=26.9

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeecccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSGQ   52 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~~   52 (131)
                      .++|+|.++.|++++.++.+-|.||+.+..
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            699999999999999888899999997643

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=91.34  E-value=0.22  Score=35.58  Aligned_cols=28  Identities=36%  Similarity=0.681  Sum_probs=24.5

Q ss_pred             cEecCCCCCcEEEecCCc-EEEeeccccc
Q psy17559         24 IIHRDVKPSNILVNSGGE-IKICDFGVSG   51 (131)
Q Consensus        24 ~~h~~l~~~~il~~~~~~-~~l~d~g~~~   51 (131)
                      ++|.|+.+.||+++.+.. +.+.||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            899999999999998774 7899998653

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=91.21  E-value=0.24  Score=34.40  Aligned_cols=29  Identities=21%  Similarity=0.542  Sum_probs=24.1

Q ss_pred             CcEecCCCCCcEEEecCCc-EEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGE-IKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~-~~l~d~g~~~   51 (131)
                      .++|+|+++.|++++.++. ..+.||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            5899999999999997454 5799998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=90.71  E-value=0.31  Score=34.94  Aligned_cols=30  Identities=23%  Similarity=0.453  Sum_probs=25.5

Q ss_pred             CcEecCCCCCcEEEec-CCcEEEeecccccc
Q psy17559         23 AIIHRDVKPSNILVNS-GGEIKICDFGVSGQ   52 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~-~~~~~l~d~g~~~~   52 (131)
                      .+.|+|+++.|++++. ++.+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            5899999999999986 46799999987653

>KOG1235|consensus

Probab=90.58  E-value=0.83  Score=34.89  Aligned_cols=33  Identities=33%  Similarity=0.532  Sum_probs=27.5

Q ss_pred             CCcEecCCCCCcEEEec----CCcEEEeecccccccc
Q psy17559         22 HAIIHRDVKPSNILVNS----GGEIKICDFGVSGQLI   54 (131)
Q Consensus        22 ~~~~h~~l~~~~il~~~----~~~~~l~d~g~~~~~~   54 (131)
                      .|++|.|-+|.|+++..    +..+.+.|+|+.....
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            38999999999999984    5568999999876543

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=89.98  E-value=0.39  Score=31.50  Aligned_cols=29  Identities=24%  Similarity=0.455  Sum_probs=23.8

Q ss_pred             CcEecCCCCCcEEEecCC-----cEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSGG-----EIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~-----~~~l~d~g~~~   51 (131)
                      .++|+|+.+.|+++..++     .+.+.||..+.
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            689999999999997543     57899997654

subfamily of choline kinases

>KOG1035|consensus

Probab=89.39  E-value=0.79  Score=38.15  Aligned_cols=97  Identities=27%  Similarity=0.346  Sum_probs=57.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEE---EecCCcEEEe--eccccccccccc-ccCCCCccceeCcccccCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNIL---VNSGGEIKIC--DFGVSGQLIDSM-ANSFVGTRSYMSPERLQGT   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il---~~~~~~~~l~--d~g~~~~~~~~~-~~~~~~~~~~~~Pe~~~~~   76 (131)
                      +++.+..++.++++++|+. ...|.-+......   .+..+.+...  +++..+...... ......+..+.+++.....
T Consensus       287 ~~r~~~~~~~~GL~~~h~~-~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~  365 (1351)
T KOG1035|consen  287 TLRILHQKLLEGLAYLHSL-SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKEN  365 (1351)
T ss_pred             HHHHHHHHHhhhHHHHHHh-ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccc
Confidence            4566788899999999986 3555555444222   2223334433  666554443321 1222333445667766655


Q ss_pred             CC--CCcchHHHHHHHHHHHHhCCCC
Q psy17559         77 HY--SVQSDIWSLGLSLVEMAIGMYP  100 (131)
Q Consensus        77 ~~--~~~~d~~slg~~l~~l~~g~~p  100 (131)
                      ..  +...|+|.+|.+...+..+..+
T Consensus       366 ~~~~~r~~dL~~lgll~~~~~~~~~i  391 (1351)
T KOG1035|consen  366 TAKKSRLTDLWCLGLLLLQLSQGEDI  391 (1351)
T ss_pred             cchhhhhhHHHHHHHHHhhhhhcCcc
Confidence            44  4447999999999888766543

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=87.37  E-value=0.72  Score=32.86  Aligned_cols=30  Identities=23%  Similarity=0.484  Sum_probs=25.3

Q ss_pred             CcEecCCCCCcEEEec-CCcEEEeecccccc
Q psy17559         23 AIIHRDVKPSNILVNS-GGEIKICDFGVSGQ   52 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~-~~~~~l~d~g~~~~   52 (131)
                      .+.|.|+.+.|++++. ++.++++||..+..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            3789999999999974 57899999987754

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=86.44  E-value=0.95  Score=33.33  Aligned_cols=30  Identities=27%  Similarity=0.391  Sum_probs=24.5

Q ss_pred             cCCcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         21 KHAIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        21 ~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      ...++|+|+.+.||++..+ .+++.|+..+.
T Consensus       222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~  251 (401)
T PRK09550        222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAF  251 (401)
T ss_pred             CCceeeccCCcccEEeeCC-CcEEEeccccc
Confidence            3469999999999999765 58899987654

>KOG0576|consensus

Probab=86.35  E-value=0.28  Score=38.27  Aligned_cols=90  Identities=31%  Similarity=0.389  Sum_probs=61.2

Q ss_pred             HHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCcchHH
Q psy17559          7 SSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIW   85 (131)
Q Consensus         7 ~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~d~~   85 (131)
                      ..+.-..+++++|+.. =+|+|    |++.. ++..+..+++........ ...+..+++.+++||+...+.+....|.|
T Consensus       341 ~~r~et~~l~~l~~~~-~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~  414 (829)
T KOG0576|consen  341 PLRKETRPLAELHSSY-KVHRD----NILGS-EEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSG  414 (829)
T ss_pred             hhhhhccccccccccc-ccCcc----ccccc-ccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCcc
Confidence            3444455778888642 36666    44443 466788888876544332 34566788899999999888899999999


Q ss_pred             HHHHHHHHHHhCCCCCC
Q psy17559         86 SLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        86 slg~~l~~l~~g~~p~~  102 (131)
                      +++.-..++..|..|-.
T Consensus       415 ~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  415 SLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCcchhhcCCCCCCCC
Confidence            99875556655555543

>PRK06148 hypothetical protein; Provisional

Probab=86.34  E-value=0.75  Score=37.83  Aligned_cols=30  Identities=33%  Similarity=0.518  Sum_probs=24.5

Q ss_pred             CCcEecCCCCCcEEEecCC--c-EEEeeccccc
Q psy17559         22 HAIIHRDVKPSNILVNSGG--E-IKICDFGVSG   51 (131)
Q Consensus        22 ~~~~h~~l~~~~il~~~~~--~-~~l~d~g~~~   51 (131)
                      .+++|.|+++.||+++.++  . .-+.|||.+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            3699999999999999764  3 4699999653

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=86.23  E-value=0.99  Score=32.87  Aligned_cols=34  Identities=32%  Similarity=0.528  Sum_probs=22.5

Q ss_pred             hhHHHHHHHHHHHHH--Hh---cCCcEecCCCCCcEEEecC
Q psy17559          4 VPYSSFQVLKGLTYL--RE---KHAIIHRDVKPSNILVNSG   39 (131)
Q Consensus         4 ~~~~~~q~~~~l~~l--h~---~~~~~h~~l~~~~il~~~~   39 (131)
                      ++.+..|++-  -|+  -+   ....+|.||+|+||++-++
T Consensus       277 vkfifLQiaL--LyikIYelp~c~nF~H~DLKPdNILiFds  315 (434)
T PF05445_consen  277 VKFIFLQIAL--LYIKIYELPCCTNFLHVDLKPDNILIFDS  315 (434)
T ss_pred             HHHHHHHHHH--HHeeeecCCCcceeeecccCcCcEEEecC
Confidence            4567778743  342  11   1248999999999998543

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PRK11768 serine/threonine protein kinase; Provisional

Probab=85.88  E-value=0.64  Score=33.02  Aligned_cols=27  Identities=26%  Similarity=0.363  Sum_probs=22.9

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      +++|+|+.+.|++++ + ...+.||+.+.
T Consensus       197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        197 LRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             cceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            689999999999995 3 57889998764

>PRK12396 5-methylribose kinase; Reviewed

Probab=84.38  E-value=1.1  Score=32.97  Aligned_cols=34  Identities=21%  Similarity=0.491  Sum_probs=25.2

Q ss_pred             HHHHhcCCcEecCCCCCcEEEecCCcEEEeecccc
Q psy17559         16 TYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS   50 (131)
Q Consensus        16 ~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~   50 (131)
                      +++-+...++|+|+++.||++..+ ..++.|-..+
T Consensus       221 ~F~~~~~aLlHGDlHtGSI~v~~~-~~kvIDpEFA  254 (409)
T PRK12396        221 SFMTNAQALIHGDLHTGSVFVKND-STKVIDPEFA  254 (409)
T ss_pred             HHHhcchhhccCcCCCCCEEecCC-ceEEEccccc
Confidence            455444579999999999999865 4777785443

>PHA03111 Ser/Thr kinase; Provisional

Probab=83.86  E-value=4.9  Score=29.36  Aligned_cols=37  Identities=24%  Similarity=0.374  Sum_probs=24.1

Q ss_pred             hhHHHHHHHHHHHHHHhc---CCcEecCCCCCcEEEecCC
Q psy17559          4 VPYSSFQVLKGLTYLREK---HAIIHRDVKPSNILVNSGG   40 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~---~~~~h~~l~~~~il~~~~~   40 (131)
                      ++.+..|++--.-.+-+.   ...+|.||+|+||++-.+.
T Consensus       281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~  320 (444)
T PHA03111        281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD  320 (444)
T ss_pred             HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence            466788875533222221   2489999999999985443

>KOG1826|consensus

Probab=83.42  E-value=0.15  Score=43.76  Aligned_cols=78  Identities=14%  Similarity=0.059  Sum_probs=59.0

Q ss_pred             cEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy17559         24 IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI  101 (131)
Q Consensus        24 ~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~  101 (131)
                      .+|++++..|.++..+..+++.++|+.+...+.  ......+++.|+.|+....-.++.++|+|..++.+|..-.|..+|
T Consensus      1361 ~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1361 NVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             chhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            678999999999999999999999998722221  223445666677777777767788899999999888776665554

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=83.11  E-value=1.1  Score=32.62  Aligned_cols=34  Identities=21%  Similarity=0.436  Sum_probs=25.1

Q ss_pred             HHHHhcCCcEecCCCCCcEEEecCCcEEEeecccc
Q psy17559         16 TYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS   50 (131)
Q Consensus        16 ~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~   50 (131)
                      +++-+...++|+|+.+.||++..++ .++.|+..+
T Consensus       186 ~f~~~~~~llHGDl~~gNi~~~~~~-~~~iD~e~~  219 (370)
T TIGR01767       186 SFLASAETLLHGDLHSGSIFVSEHE-TKVIDPEFA  219 (370)
T ss_pred             hhccCcceeeeccCCcccEEEcCCC-CEEEcCccc
Confidence            3443344799999999999997654 668887654

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK06149 hypothetical protein; Provisional

Probab=82.36  E-value=1.1  Score=36.67  Aligned_cols=29  Identities=21%  Similarity=0.337  Sum_probs=23.6

Q ss_pred             CCcEecCCCCCcEEEecCC--c---EEEeecccc
Q psy17559         22 HAIIHRDVKPSNILVNSGG--E---IKICDFGVS   50 (131)
Q Consensus        22 ~~~~h~~l~~~~il~~~~~--~---~~l~d~g~~   50 (131)
                      .+++|.|++..|++++.+.  .   ..+.|||.+
T Consensus       208 ~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~  241 (972)
T PRK06149        208 LQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDL  241 (972)
T ss_pred             ccccCCCCCcccEEEcCCCCCCcceeEEEEcccc
Confidence            4799999999999998642  2   478999865

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=81.34  E-value=7.4  Score=25.81  Aligned_cols=34  Identities=32%  Similarity=0.569  Sum_probs=24.5

Q ss_pred             HHHHHHhcCCcEecCCCCCcEEEecCC----cEEEee-cc
Q psy17559         14 GLTYLREKHAIIHRDVKPSNILVNSGG----EIKICD-FG   48 (131)
Q Consensus        14 ~l~~lh~~~~~~h~~l~~~~il~~~~~----~~~l~d-~g   48 (131)
                      -.++|-+. .|+.+|+++.||++..+.    .+.++| +|
T Consensus       130 f~~~l~~~-~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G  168 (199)
T PF10707_consen  130 FKRYLLDH-HIVIRDLNPHNIVVQRRDSGEFRLVLIDGLG  168 (199)
T ss_pred             HHHHHHHc-CCeecCCCcccEEEEecCCCceEEEEEeCCC
Confidence            44566555 699999999999997432    367777 44

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	131
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-52
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-52
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-51
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-51
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-51
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-51
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-51
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-49
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-45
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-45
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-25
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-25
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-24
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-23
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-22
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-20
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-20
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-20
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-19
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-19
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-19
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-19
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-17
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-16
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-16
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-16
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-16
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-16
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-16
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-16
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-16
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-16
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-16
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-16
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-16
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-16
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-16
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-16
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-16
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		9e-16
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-16
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-16
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-16
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-15
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-15
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-15
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-15
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-15
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-15
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-15
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-15
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-15
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-15
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-15
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-15
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-15
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-15
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-15
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-15
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-15
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-15
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-15
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-15
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-15
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-15
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-15
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-15
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-15
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-15
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-15
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-15
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-15
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-15
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-15
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-15
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-15
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-15
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-15
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-15
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-15
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-15
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-14
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-14
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-14
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-14
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-14
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-14
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-14
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-14
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-14
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-13
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-13
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-13
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-13
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-13
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-13
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-12
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-12
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-12
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-12
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-12
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-12
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-12
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-12
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-12
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-12
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-12
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-12
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-12
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-12
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-12
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-12
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-12
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-12
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-12
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-12
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-12
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-12
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-12
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-12
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-12
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		7e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-12
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		9e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		9e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-11
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-11
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-11
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-11
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-11
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-11
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-11
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-11
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-11
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-11
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-11
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-11
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-11
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		7e-11
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-11
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-11
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-11
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-11
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-11
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-11
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-11
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		9e-11
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		9e-11
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		9e-11
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		9e-11
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		9e-11
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-10
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-10
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-10
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-10
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		5e-10
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		5e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-10
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		8e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-09
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-09
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-09
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-09
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-09
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-09
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-09
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-09
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-09
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		3e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-09
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		7e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		8e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		9e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-08
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-08
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-08
3soa_A	444	Full-Length Human Camkii Length = 444		6e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-08
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		8e-08
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		8e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		9e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		9e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-07
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-07
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-07
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-07
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-07
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-07
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-07
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-07
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-07
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-07
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-07
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-07
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-07
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-07
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		8e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		8e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-07
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		9e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-07
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-06
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		1e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-06
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-06
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-06
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-06
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-06
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-06
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-06
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-06
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-06
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-06
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-06
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-06
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		3e-06
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		3e-06
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		3e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-06
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-06
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-06
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		4e-06
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-06
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-06
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-06
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		5e-06
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-06
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-06
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-06
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		5e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-06
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		5e-06
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		6e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		7e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-06
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		7e-06
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		8e-06
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		8e-06
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		8e-06
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		8e-06
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		8e-06
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		8e-06
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		8e-06
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-06
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		8e-06
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-06
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		8e-06
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		8e-06
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		9e-06
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		9e-06
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		9e-06
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		9e-06

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  198 bits (503), Expect = 9e-52,   Method: Compositional matrix adjust.
 Identities = 93/107 (86%), Positives = 99/107 (92%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 172 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 231
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK L  +FG
Sbjct: 232 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 278

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  197 bits (502), Expect = 9e-52,   Method: Compositional matrix adjust.
 Identities = 93/107 (86%), Positives = 99/107 (92%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 137 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 196
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK L  +FG
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 243

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  197 bits (502), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 94/113 (83%), Positives = 101/113 (89%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  VL+GL YLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 120 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 179
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDG 120
           M+PERLQGTHYSVQSDIWS+GLSLVE+A+G YPIPPPDAK L AIFG    DG
Sbjct: 180 MAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDG 232

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  197 bits (501), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 93/107 (86%), Positives = 99/107 (92%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 169
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK L  +FG
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 216

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  197 bits (500), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 93/107 (86%), Positives = 99/107 (92%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 169
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK L  +FG
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 216

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  197 bits (500), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 93/107 (86%), Positives = 99/107 (92%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 169
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK L  +FG
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 216

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  197 bits (500), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 93/107 (86%), Positives = 99/107 (92%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 169
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK L  +FG
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 216

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  191 bits (484), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 90/100 (90%), Positives = 95/100 (95%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 169
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK 107
           MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  177 bits (450), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 84/94 (89%), Positives = 89/94 (94%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 129 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 188
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPI
Sbjct: 189 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  177 bits (449), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 83/96 (86%), Positives = 88/96 (91%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLID MAN FVGTRSY
Sbjct: 113 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSY 172
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
           MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YP PP
Sbjct: 173 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPP 208

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  110 bits (274), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 49/96 (51%), Positives = 71/96 (73%), Gaps = 6/96 (6%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-NSFVGTRSYMS 69
           ++K L YL+EKH +IHRDVKPSNIL++  G+IK+CDFG+SG+L+D  A +   G  +YM+
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMA 192
Query: 70  PERLQ-----GTHYSVQSDIWSLGLSLVEMAIGMYP 100
           PER+         Y +++D+WSLG+SLVE+A G +P
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  108 bits (270), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 50/100 (50%), Positives = 71/100 (71%), Gaps = 5/100 (5%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF-VGTRS 66
           +   +K L +L+E   IIHRD+KPSNIL++  G IK+CDFG+SGQL+DS+A +   G R 
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRP 190
Query: 67  YMSPERLQGTH----YSVQSDIWSLGLSLVEMAIGMYPIP 102
           YM+PER+  +     Y V+SD+WSLG++L E+A G +P P
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  105 bits (263), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 48/95 (50%), Positives = 72/95 (75%), Gaps = 5/95 (5%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF-VGTRSYMS 69
           ++K L +L  K ++IHRDVKPSN+L+N+ G++K+CDFG+SG L+DS+A +   G + YM+
Sbjct: 162 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMA 221
Query: 70  PER----LQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           PER    L    YSV+SDIWSLG++++E+AI  +P
Sbjct: 222 PERINPELNQKGYSVKSDIWSLGITMIELAILRFP 256

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  103 bits (258), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 47/95 (49%), Positives = 70/95 (73%), Gaps = 5/95 (5%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF-VGTRSYMS 69
           ++K L +L  K ++IHRDVKPSN+L+N+ G++K+CDFG+SG L+D +A     G + YM+
Sbjct: 118 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMA 177
Query: 70  PER----LQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           PER    L    YSV+SDIWSLG++++E+AI  +P
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 46/95 (48%), Positives = 67/95 (70%), Gaps = 5/95 (5%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF-VGTRSYMS 69
           ++K L +L  K ++IHRDVKPSN+L+N+ G++K CDFG+SG L+D +A     G + Y +
Sbjct: 145 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXA 204
Query: 70  PER----LQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           PER    L    YSV+SDIWSLG++ +E+AI  +P
Sbjct: 205 PERINPELNQKGYSVKSDIWSLGITXIELAILRFP 239

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 47/109 (43%), Positives = 72/109 (66%), Gaps = 10/109 (9%)
Query: 1   LKQVPYSSFQV-------LKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL 53
           L+  P+  FQ+       LKGL YL  +  I HRD+K +N+L++  G++K+ DFGV+GQL
Sbjct: 112 LRAGPFDEFQIATMLKEILKGLDYLHSEKKI-HRDIKAANVLLSEQGDVKLADFGVAGQL 170
Query: 54  IDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            D+    N+FVGT  +M+PE +Q + Y  ++DIWSLG++ +E+A G  P
Sbjct: 171 TDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 43/93 (46%), Positives = 67/93 (72%), Gaps = 3/93 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVGTRSY 67
           ++LKGL YL  +  I HRD+K +N+L++  GE+K+ DFGV+GQL D+    N+FVGT  +
Sbjct: 112 EILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 170
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           M+PE ++ + Y  ++DIWSLG++ +E+A G  P
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 43/93 (46%), Positives = 67/93 (72%), Gaps = 3/93 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVGTRSY 67
           ++LKGL YL  +  I HRD+K +N+L++  GE+K+ DFGV+GQL D+    N+FVGT  +
Sbjct: 132 EILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 190
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           M+PE ++ + Y  ++DIWSLG++ +E+A G  P
Sbjct: 191 MAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 43/93 (46%), Positives = 66/93 (70%), Gaps = 3/93 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVGTRSY 67
           ++LKGL YL  +  I HRD+K +N+L++  GE+K+ DFGV+GQL D+    N FVGT  +
Sbjct: 127 EILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFW 185
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           M+PE ++ + Y  ++DIWSLG++ +E+A G  P
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 43/93 (46%), Positives = 66/93 (70%), Gaps = 3/93 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVGTRSY 67
           ++LKGL YL  +  I HRD+K +N+L++  GE+K+ DFGV+GQL D+    N FVGT  +
Sbjct: 112 EILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFW 170
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           M+PE ++ + Y  ++DIWSLG++ +E+A G  P
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 42/93 (45%), Positives = 66/93 (70%), Gaps = 3/93 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVGTRSY 67
           ++LKGL YL  +  I HRD+K +N+L++  G++K+ DFGV+GQL D+    N FVGT  +
Sbjct: 124 EILKGLDYLHSERKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFW 182
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           M+PE ++ + Y  ++DIWSLG++ +E+A G  P
Sbjct: 183 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 50/104 (48%), Positives = 65/104 (62%), Gaps = 5/104 (4%)
Query: 12  LKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSYMS 69
           LKGL YL     I HRD+K  NIL+N+ G  K+ DFGV+GQL D MA  N  +GT  +M+
Sbjct: 135 LKGLEYLHFMRKI-HRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMA 193
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE +Q   Y+  +DIWSLG++ +EMA G  P    D   + AIF
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPY--ADIHPMRAIF 235

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 44/117 (37%), Positives = 72/117 (61%), Gaps = 10/117 (8%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSF 61
           + Y   ++L+GL++L + H +IHRD+K  N+L+    E+K+ DFGVS QL  ++   N+F
Sbjct: 131 IAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 189
Query: 62  VGTRSYMSPERLQGTH-----YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           +GT  +M+PE +         Y  +SD+WSLG++ +EMA G  P+   D   + A+F
Sbjct: 190 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL--CDMHPMRALF 244

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 45/104 (43%), Positives = 60/104 (57%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D MA  FV
Sbjct: 122 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-GFV 179
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 45/104 (43%), Positives = 60/104 (57%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D MA  FV
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-GFV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 45/104 (43%), Positives = 60/104 (57%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D MA  FV
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-GFV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 60/104 (57%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 155 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 212
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY++  DIWS+G  + E+  G    P  D
Sbjct: 213 ATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTD 256

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 133 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-GYV 190
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 133 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-GYV 190
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 132 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT-GYV 189
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 128 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT-GYV 185
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 43/109 (39%), Positives = 68/109 (62%), Gaps = 12/109 (11%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NS 60
           Q+     Q+L+ L +L  K  IIHRD+K  N+L+   G+I++ DFGVS + + ++   +S
Sbjct: 118 QIQVVCRQMLEALNFLHSKR-IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176
Query: 61  FVGTRSYMSP-----ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP 104
           F+GT  +M+P     E ++ T Y  ++DIWSLG++L+EMA     I PP
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA----QIEPP 221

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 133 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-GYV 190
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 43/109 (39%), Positives = 68/109 (62%), Gaps = 12/109 (11%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NS 60
           Q+     Q+L+ L +L  K  IIHRD+K  N+L+   G+I++ DFGVS + + ++   +S
Sbjct: 110 QIQVVCRQMLEALNFLHSKR-IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 168
Query: 61  FVGTRSYMSP-----ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP 104
           F+GT  +M+P     E ++ T Y  ++DIWSLG++L+EMA     I PP
Sbjct: 169 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA----QIEPP 213

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 122 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 179
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 131 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-GYV 188
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 137 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-GYV 194
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 195 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 238

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 131 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-GYV 188
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 132 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 189
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 123 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 180
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 181 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 224

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 122 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 179
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 132 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 189
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 136 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 193
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 194 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 237

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-GYV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 123 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 180
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 181 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 224

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 128 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 185
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 124 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 181
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 182 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 225

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 122 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 179
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 131 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 188
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 137 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 194
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 195 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 238

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 125 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 182
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 183 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 226

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 131 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 188
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 133 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 190
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 128 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 185
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 132 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 189
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 138 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 195
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 138 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 195
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 138 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 195
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 145 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 202
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 203 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 246

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 146 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 203
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 145 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 202
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 203 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 246

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 149 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMX-GYV 206
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 207 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 250

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 58/104 (55%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG+     D M   +V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMT-GYV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 146 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 203
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 128 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 185
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M   +V
Sbjct: 149 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYV 206
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 207 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 250

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/105 (40%), Positives = 61/105 (58%), Gaps = 3/105 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           + V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E++I DFG++ Q  + M   +
Sbjct: 131 EHVQFLVYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM-TGY 188
Query: 62  VGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           V TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSD 233

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 42/105 (40%), Positives = 61/105 (58%), Gaps = 3/105 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           + V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E++I DFG++ Q  + M   +
Sbjct: 131 EHVQFLVYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM-TGY 188
Query: 62  VGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           V TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSD 233

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 43/111 (38%), Positives = 63/111 (56%), Gaps = 3/111 (2%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ--LIDSMA 58
           L +  + + +++ GL +L  K  I++RD+K  NIL++  G IKI DFG+  +  L D+  
Sbjct: 118 LSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 176
Query: 59  NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           N F GT  Y++PE L G  Y+   D WS G+ L EM IG  P    D + L
Sbjct: 177 NEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 227

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/105 (40%), Positives = 61/105 (58%), Gaps = 3/105 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           + V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E++I DFG++ Q  + M   +
Sbjct: 123 EHVQFLVYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEM-TGY 180
Query: 62  VGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           V TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 181 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSD 225

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 43/111 (38%), Positives = 63/111 (56%), Gaps = 3/111 (2%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ--LIDSMA 58
           L +  + + +++ GL +L  K  I++RD+K  NIL++  G IKI DFG+  +  L D+  
Sbjct: 117 LSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 175
Query: 59  NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           N F GT  Y++PE L G  Y+   D WS G+ L EM IG  P    D + L
Sbjct: 176 NXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 226

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S  ++  GT  Y+ 
Sbjct: 120 ELANALSYCHSKR-VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYLP 178
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +GM   PP +A T    +
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGM---PPFEAHTYQETY 219

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 58/104 (55%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M    V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGX-V 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/104 (40%), Positives = 59/104 (56%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI D+G++    D M   +V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMT-GYV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/103 (40%), Positives = 64/103 (62%), Gaps = 6/103 (5%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQL--IDSMANS 60
           + + + Q+L+GL YL + + I+HRD+K  N+L+N+  G +KI DFG S +L  I+    +
Sbjct: 124 IGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182
Query: 61  FVGTRSYMSPERLQG--THYSVQSDIWSLGLSLVEMAIGMYPI 101
           F GT  YM+PE +      Y   +DIWSLG +++EMA G  P 
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 41/99 (41%), Positives = 60/99 (60%), Gaps = 9/99 (9%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-------DSMANSFV 62
           +VL+GL YL  K+  IHRDVK  NIL+   G ++I DFGVS  L        + +  +FV
Sbjct: 129 EVLEGLEYLH-KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 63  GTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
           GT  +M+PE ++    Y  ++DIWS G++ +E+A G  P
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 41/99 (41%), Positives = 60/99 (60%), Gaps = 9/99 (9%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-------DSMANSFV 62
           +VL+GL YL  K+  IHRDVK  NIL+   G ++I DFGVS  L        + +  +FV
Sbjct: 124 EVLEGLEYLH-KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 63  GTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
           GT  +M+PE ++    Y  ++DIWS G++ +E+A G  P
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 42/105 (40%), Positives = 65/105 (61%), Gaps = 6/105 (5%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQL--IDSMA 58
           + + + + Q+L+GL YL + + I+HRD+K  N+L+N+  G +KI DFG S +L  I+   
Sbjct: 108 QTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 166
Query: 59  NSFVGTRSYMSPERLQG--THYSVQSDIWSLGLSLVEMAIGMYPI 101
            +F GT  YM+PE +      Y   +DIWSLG +++EMA G  P 
Sbjct: 167 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 58/104 (55%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D M    V
Sbjct: 146 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGX-V 203
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S   +  GT  Y+ 
Sbjct: 120 ELANALSYCHSKR-VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLP 178
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +GM   PP +A T    +
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGM---PPFEAHTYQETY 219

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 2/91 (2%)
Query: 22  HAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMANSFVGTRSYMSPERLQGTHYS 79
           H ++HRD+KP+N+ ++    +K+ DFG++  L    S A +FVGT  YMSPE++    Y+
Sbjct: 135 HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYN 194
Query: 80  VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLA 110
            +SDIWSLG  L E+   M P      K LA
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFSQKELA 225

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 2/91 (2%)
Query: 22  HAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMANSFVGTRSYMSPERLQGTHYS 79
           H ++HRD+KP+N+ ++    +K+ DFG++  L    S A +FVGT  YMSPE++    Y+
Sbjct: 135 HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYN 194
Query: 80  VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLA 110
            +SDIWSLG  L E+   M P      K LA
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFSQKELA 225

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 56/96 (58%), Gaps = 5/96 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + ANSFVGT 
Sbjct: 140 EIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 198
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y+SPE L     S  SD+W+LG  + ++  G+ P 
Sbjct: 199 QYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 42/104 (40%), Positives = 58/104 (55%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DF ++    D M   +V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMT-GYV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 54/91 (59%), Gaps = 2/91 (2%)
Query: 22  HAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMANSFVGTRSYMSPERLQGTHYS 79
           H ++HRD+KP+N+ ++    +K+ DFG++  L   +  A  FVGT  YMSPE++    Y+
Sbjct: 135 HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMSYN 194
Query: 80  VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLA 110
            +SDIWSLG  L E+   M P      K LA
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFSQKELA 225

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S   +  GT  Y+ 
Sbjct: 121 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLP 179
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 180 PEXIEGRXHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 220

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 58/104 (55%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S  ++  GT  Y+ 
Sbjct: 117 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLP 175
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 216

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 42/104 (40%), Positives = 58/104 (55%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI  FG++    D M   +V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMT-GYV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 42/104 (40%), Positives = 58/104 (55%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI D G++    D M   +V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMT-GYV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 42/104 (40%), Positives = 58/104 (55%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI D G++    D M   +V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMT-GYV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S  +   GT  Y+ 
Sbjct: 142 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLP 200
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 201 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 241

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 43/109 (39%), Positives = 64/109 (58%), Gaps = 12/109 (11%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NS 60
           Q+     Q L  L YL + + IIHRD+K  NIL    G+IK+ DFGVS +   ++   +S
Sbjct: 136 QIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 194
Query: 61  FVGTRSYMSPERL-----QGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP 104
           F+GT  +M+PE +     +   Y  ++D+WSLG++L+EMA     I PP
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA----EIEPP 239

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S   +  GT  Y+ 
Sbjct: 142 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLP 200
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 201 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 241

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S  +   GT  Y+ 
Sbjct: 119 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLP 177
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 218

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S   +  GT  Y+ 
Sbjct: 116 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLP 174
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 215

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S   +  GT  Y+ 
Sbjct: 121 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLP 179
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 220

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S   +  GT  Y+ 
Sbjct: 115 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLP 173
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 174 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 214

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S   +  GT  Y+ 
Sbjct: 119 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLP 177
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 218

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S   +  GT  Y+ 
Sbjct: 133 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLP 191
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 192 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 232

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S   +  GT  Y+ 
Sbjct: 121 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLP 179
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 220

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 56/99 (56%), Gaps = 4/99 (4%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S   +  GT  Y+ 
Sbjct: 120 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLP 178
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT 108
           PE ++G  +  + D+WSLG+   E  +G    PP +A T
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANT 214

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S   +  GT  Y+ 
Sbjct: 119 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLP 177
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 218

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/104 (40%), Positives = 58/104 (55%), Gaps = 3/104 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI D G++    D M   +V
Sbjct: 126 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMT-GYV 183
Query: 63  GTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            TR Y +PE  L   HY+   DIWS+G  + E+  G    P  D
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 56/99 (56%), Gaps = 4/99 (4%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S   +  GT  Y+ 
Sbjct: 113 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLP 171
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT 108
           PE ++G  +  + D+WSLG+   E  +G    PP +A T
Sbjct: 172 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANT 207

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S   +  GT  Y+ 
Sbjct: 117 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLP 175
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 216

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/101 (41%), Positives = 59/101 (58%), Gaps = 8/101 (7%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN- 59
           L+ V Y  +Q+L+GL Y+     +IHRD+KPSN+LVN   E+KI DFG++  L  S A  
Sbjct: 158 LEHVRYFLYQLLRGLKYMHSAQ-VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 216
Query: 60  -----SFVGTRSYMSPERLQGTHYSVQS-DIWSLGLSLVEM 94
                 +V TR Y +PE +   H   Q+ D+WS+G    EM
Sbjct: 217 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEM 257

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S      GT  Y+ 
Sbjct: 116 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLP 174
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 215

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S      GT  Y+ 
Sbjct: 117 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLP 175
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 216

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S   +  GT  Y+ 
Sbjct: 119 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLP 177
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 218

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 43/109 (39%), Positives = 63/109 (57%), Gaps = 12/109 (11%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NS 60
           Q+     Q L  L YL + + IIHRD+K  NIL    G+IK+ DFGVS +    +   +S
Sbjct: 136 QIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS 194
Query: 61  FVGTRSYMSPERL-----QGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP 104
           F+GT  +M+PE +     +   Y  ++D+WSLG++L+EMA     I PP
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA----EIEPP 239

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 55/98 (56%), Gaps = 3/98 (3%)
Query: 24  IIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSVQ 81
           II+RD+KP NIL++  G IK+ DFG+S + ID    A SF GT  YM+PE +    ++  
Sbjct: 148 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 207
Query: 82  SDIWSLGLSLVEMAIGMYPIPPPDAK-TLAAIFGPSRG 118
           +D WS G+ + EM  G  P    D K T+  I     G
Sbjct: 208 ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG 245

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 55/98 (56%), Gaps = 3/98 (3%)
Query: 24  IIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSVQ 81
           II+RD+KP NIL++  G IK+ DFG+S + ID    A SF GT  YM+PE +    ++  
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 206
Query: 82  SDIWSLGLSLVEMAIGMYPIPPPDAK-TLAAIFGPSRG 118
           +D WS G+ + EM  G  P    D K T+  I     G
Sbjct: 207 ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG 244

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S      GT  Y+ 
Sbjct: 121 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLP 179
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 220

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S      GT  Y+ 
Sbjct: 116 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLP 174
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 215

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 40/98 (40%), Positives = 55/98 (56%), Gaps = 3/98 (3%)
Query: 24  IIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSVQ 81
           II+RD+KP NIL++  G IK+ DFG+S + ID    A SF GT  YM+PE +    ++  
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 206
Query: 82  SDIWSLGLSLVEMAIGMYPIPPPDAK-TLAAIFGPSRG 118
           +D WS G+ + EM  G  P    D K T+  I     G
Sbjct: 207 ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG 244

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S      GT  Y+ 
Sbjct: 116 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLP 174
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT 108
           PE ++G  +  + D+WSLG+   E  +G    PP +A T
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANT 210

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 56/99 (56%), Gaps = 4/99 (4%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S   +  GT  Y+ 
Sbjct: 116 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLP 174
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT 108
           PE ++G  +  + D+WSLG+   E  +G    PP +A T
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANT 210

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 56/99 (56%), Gaps = 4/99 (4%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S   +  GT  Y+ 
Sbjct: 116 ELANALSYCHSK-KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLP 174
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT 108
           PE ++G  +  + D+WSLG+   E  +G    PP +A T
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANT 210

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 39/97 (40%), Positives = 58/97 (59%), Gaps = 3/97 (3%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           +++ Y  +Q+LKGL Y+     ++HRD+KP N+ VN   E+KI DFG++    D+    +
Sbjct: 126 EKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARH-ADAEMTGY 183
Query: 62  VGTRSYMSPER-LQGTHYSVQSDIWSLGLSLVEMAIG 97
           V TR Y +PE  L   HY+   DIWS+G  + EM  G
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 42/101 (41%), Positives = 59/101 (58%), Gaps = 8/101 (7%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-- 58
           L+ V Y  +Q+L+GL Y+     +IHRD+KPSN+LVN   E+KI DFG++  L  S A  
Sbjct: 157 LEHVRYFLYQLLRGLKYMHSAQ-VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 215
Query: 59  ----NSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEM 94
                 +V TR Y +PE +   H Y+   D+WS+G    EM
Sbjct: 216 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEM 256

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 55/96 (57%), Gaps = 5/96 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + ANSFVGT 
Sbjct: 141 EIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 199
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y+SPE L        SD+W+LG  + ++  G+ P 
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 41/98 (41%), Positives = 55/98 (56%), Gaps = 3/98 (3%)
Query: 24  IIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSVQ 81
           II+RD+KP NIL++  G IK+ DFG+S + ID    A SF GT  YM+PE +    +S  
Sbjct: 151 IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHS 210
Query: 82  SDIWSLGLSLVEMAIGMYPIPPPDAK-TLAAIFGPSRG 118
           +D WS G+ + EM  G  P    D K T+  I     G
Sbjct: 211 ADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLG 248

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 39/97 (40%), Positives = 58/97 (59%), Gaps = 3/97 (3%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           +++ Y  +Q+LKGL Y+     ++HRD+KP N+ VN   E+KI DFG++    D+    +
Sbjct: 144 EKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARH-ADAEMTGY 201
Query: 62  VGTRSYMSPER-LQGTHYSVQSDIWSLGLSLVEMAIG 97
           V TR Y +PE  L   HY+   DIWS+G  + EM  G
Sbjct: 202 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 238

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S      GT  Y+ 
Sbjct: 116 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLP 174
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 215

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 55/96 (57%), Gaps = 5/96 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + ANSFVGT 
Sbjct: 137 EIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 195
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y+SPE L        SD+W+LG  + ++  G+ P 
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/87 (44%), Positives = 54/87 (62%), Gaps = 2/87 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-NSFVGTRSY 67
           FQ+L+GL +L   H ++HRD+KP NILV S G+IK+ DFG++      MA  S V T  Y
Sbjct: 127 FQLLRGLDFL-HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 185
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM 94
            +PE L  + Y+   D+WS+G    EM
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S      GT  Y+ 
Sbjct: 118 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLP 176
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 217

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/87 (44%), Positives = 54/87 (62%), Gaps = 2/87 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-NSFVGTRSY 67
           FQ+L+GL +L   H ++HRD+KP NILV S G+IK+ DFG++      MA  S V T  Y
Sbjct: 127 FQLLRGLDFL-HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 185
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM 94
            +PE L  + Y+   D+WS+G    EM
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/87 (44%), Positives = 54/87 (62%), Gaps = 2/87 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-NSFVGTRSY 67
           FQ+L+GL +L   H ++HRD+KP NILV S G+IK+ DFG++      MA  S V T  Y
Sbjct: 127 FQLLRGLDFL-HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 185
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM 94
            +PE L  + Y+   D+WS+G    EM
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S      GT  Y+ 
Sbjct: 119 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLP 177
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT 108
           PE ++G  +  + D+WSLG+   E  +G    PP +A T
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANT 213

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S      GT  Y+ 
Sbjct: 116 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLP 174
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 215

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S      GT  Y+ 
Sbjct: 121 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLP 179
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 220

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 39/106 (36%), Positives = 63/106 (59%), Gaps = 7/106 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID---SMANSFVGTRS 66
           Q+L G+ +  +   I+HRD+KP NIL++S   +KI DFG++  L +   +  N  +GT  
Sbjct: 119 QILDGIKHAHDMR-IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
           Y SPE+ +G      +DI+S+G+ L EM +G    PP + +T  +I
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGE---PPFNGETAVSI 220

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 55/96 (57%), Gaps = 5/96 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + AN+FVGT 
Sbjct: 138 EIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTA 196
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y+SPE L        SD+W+LG  + ++  G+ P 
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI +FG S     S   +  GT  Y+ 
Sbjct: 118 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLP 176
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 217

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI +FG S     S   +  GT  Y+ 
Sbjct: 119 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLP 177
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY 218

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRS 66
           Q+   L ++  +  ++HRD+KP+N+ + + G +K+ D G+ G+   S    A+S VGT  
Sbjct: 144 QLCSALEHMHSRR-VMHRDIKPANVFITATGVVKLGDLGL-GRFFSSKTTAAHSLVGTPY 201
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           YMSPER+    Y+ +SDIWSLG  L EMA    P 
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 42/99 (42%), Positives = 64/99 (64%), Gaps = 7/99 (7%)
Query: 9   FQ-VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTR 65
           FQ ++KG+ YL  +  IIHRD+KPSN+LV   G IKI DFGVS +    D++ ++ VGT 
Sbjct: 143 FQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTP 201
Query: 66  SYMSPERLQGTH--YSVQS-DIWSLGLSLVEMAIGMYPI 101
           ++M+PE L  T   +S ++ D+W++G++L     G  P 
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 42/120 (35%), Positives = 62/120 (51%), Gaps = 9/120 (7%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSP 70
           VL   +Y+  +  I HRDVKPSNIL++  G +K+ DFG S  ++D       GT  +M P
Sbjct: 160 VLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPP 219
Query: 71  ERL--QGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK-TLAAIFGPSRGDGYWHVSYP 127
           E    + ++   + DIWSLG+ L  M    Y + P   K +L  +F   R     ++ YP
Sbjct: 220 EFFSNESSYNGAKVDIWSLGICLYVM---FYNVVPFSLKISLVELFNNIRTK---NIEYP 273

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 42/109 (38%), Positives = 62/109 (56%), Gaps = 12/109 (11%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NS 60
           Q+     Q L  L YL + + IIHRD+K  NIL    G+IK+ DFGVS +    +   + 
Sbjct: 136 QIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDX 194
Query: 61  FVGTRSYMSPERL-----QGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP 104
           F+GT  +M+PE +     +   Y  ++D+WSLG++L+EMA     I PP
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA----EIEPP 239

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 43/113 (38%), Positives = 60/113 (53%), Gaps = 8/113 (7%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSF 61
           + + +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + AN F
Sbjct: 136 FYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           VGT  Y+SPE L        SD+W+LG  + ++  G+   PP  A     IF 
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL---PPFRAGNEGLIFA 244

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 43/113 (38%), Positives = 60/113 (53%), Gaps = 8/113 (7%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSF 61
           + + +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + AN F
Sbjct: 136 FYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           VGT  Y+SPE L        SD+W+LG  + ++  G+   PP  A     IF 
Sbjct: 195 VGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGL---PPFRAGNEGLIFA 244

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + AN FVGT 
Sbjct: 145 EIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 203
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y+SPE L        SD+W+LG  + ++  G+ P 
Sbjct: 204 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + AN FVGT 
Sbjct: 138 EIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y+SPE L        SD+W+LG  + ++  G+ P 
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + AN FVGT 
Sbjct: 138 EIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y+SPE L        SD+W+LG  + ++  G+ P 
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + AN FVGT 
Sbjct: 138 EIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y+SPE L        SD+W+LG  + ++  G+ P 
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + AN FVGT 
Sbjct: 140 EIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y+SPE L        SD+W+LG  + ++  G+ P 
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + AN FVGT 
Sbjct: 141 EIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 199
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y+SPE L        SD+W+LG  + ++  G+ P 
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + AN FVGT 
Sbjct: 118 EIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y+SPE L        SD+W+LG  + ++  G+ P 
Sbjct: 177 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + AN FVGT 
Sbjct: 143 EIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 201
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y+SPE L        SD+W+LG  + ++  G+ P 
Sbjct: 202 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 56/100 (56%), Gaps = 5/100 (5%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSF 61
           + + +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + AN F
Sbjct: 136 FYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           VGT  Y+SPE L        SD+W+LG  + ++  G+ P 
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + AN FVGT 
Sbjct: 140 EIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y+SPE L        SD+W+LG  + ++  G+ P 
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 43/98 (43%), Positives = 58/98 (59%), Gaps = 7/98 (7%)
Query: 3   QVPYSSFQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           ++ +  +Q+LKGL Y+   HA  IIHRD+KP N+ VN   E+KI DFG++ Q  DS    
Sbjct: 129 RIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-ADSEMXG 184
Query: 61  FVGTRSYMSPER-LQGTHYSVQSDIWSLGLSLVEMAIG 97
            V TR Y +PE  L    Y+   DIWS+G  + EM  G
Sbjct: 185 XVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 40/101 (39%), Positives = 59/101 (58%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRS 66
           FQ++ G+ +    H IIHRD+KP NILV+  G +K+CDFG +  L     + +  V TR 
Sbjct: 131 FQIINGIGFCH-SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRW 189
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE L G   Y    D+W++G  + EM +G  P+ P D+
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGDS 229

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + AN FVGT 
Sbjct: 117 EIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y+SPE L        SD+W+LG  + ++  G+ P 
Sbjct: 176 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + AN FVGT 
Sbjct: 122 EIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 180
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y+SPE L        SD+W+LG  + ++  G+ P 
Sbjct: 181 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + AN FVGT 
Sbjct: 115 EIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 173
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y+SPE L        SD+W+LG  + ++  G+ P 
Sbjct: 174 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + AN FVGT 
Sbjct: 116 EIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 174
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y+SPE L        SD+W+LG  + ++  G+ P 
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + AN FVGT 
Sbjct: 137 EIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 195
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y+SPE L        SD+W+LG  + ++  G+ P 
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 127 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTSDLKICDFGLA-RVADPDHDHTG 184
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 185 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 231

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 67/126 (53%), Gaps = 15/126 (11%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS-- 60
            + Y  +Q L+ +  L   + +IHRD+KPSN+L+NS  ++K+CDFG++  + +S A++  
Sbjct: 113 HIQYFIYQTLRAVKVLHGSN-VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 61  ----------FVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK-T 108
                     FV TR Y +PE  L    YS   D+WS G  L E+ +     P  D +  
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231
Query: 109 LAAIFG 114
           L  IFG
Sbjct: 232 LLLIFG 237

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 53/85 (62%), Gaps = 5/85 (5%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQG 75
           ++ IIHRDVKP+NIL+++   +K+ DFG++  + DS        + +GT  Y+SPE+ +G
Sbjct: 134 QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG 193
Query: 76  THYSVQSDIWSLGLSLVEMAIGMYP 100
                +SD++SLG  L E+  G  P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/118 (38%), Positives = 68/118 (57%), Gaps = 7/118 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSM 57
           L  V Y  +Q+L+GL +  E + I+HRD+KP N+L+N  G++K+ DFG++   G  +++ 
Sbjct: 107 LNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF 165
Query: 58  ANSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPIP-PPDAKTLAAIF 113
           ++  V T  Y +P+ L G+  YS   DIWS G  L EM  G    P   D + L  IF
Sbjct: 166 SSEVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF 222

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 57/101 (56%), Gaps = 3/101 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--AN 59
           +Q+      VL+ L+YL  +  +IHRD+K  +IL+ S G IK+ DFG   Q+   +    
Sbjct: 141 EQIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 199
Query: 60  SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
             VGT  +M+PE +    Y  + DIWSLG+ ++EM  G  P
Sbjct: 200 XLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 145 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTXDLKICDFGLA-RVADPDHDHTG 202
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 203 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 249

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 127 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTG 184
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 185 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 231

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 130 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTG 187
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 188 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 234

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 131 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTG 188
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 189 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 235

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 122 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTG 179
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 180 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 226

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 129 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTG 186
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 233

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 129 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTG 186
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 233

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 123 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTG 180
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 181 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 133 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTG 190
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 191 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 237

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 125 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTG 182
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 183 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 229

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 129 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTG 186
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 233

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 125 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTXDLKICDFGLA-RVADPDHDHTG 182
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 183 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 229

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 129 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTXDLKICDFGLA-RVADPDHDHTG 186
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 233

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 125 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTG 182
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 183 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 127 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTG 184
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 185 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 231

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 123 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTG 180
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 181 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 227

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 125 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTXDLKICDFGLA-RVADPDHDHTG 182
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 183 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 229

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 129 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTXDLKICDFGLA-RVADPDHDHTG 186
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 233

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 145 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTG 202
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 203 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 249

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 53/85 (62%), Gaps = 5/85 (5%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQG 75
           ++ IIHRDVKP+NI++++   +K+ DFG++  + DS        + +GT  Y+SPE+ +G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 76  THYSVQSDIWSLGLSLVEMAIGMYP 100
                +SD++SLG  L E+  G  P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 53/85 (62%), Gaps = 5/85 (5%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQG 75
           ++ IIHRDVKP+NI++++   +K+ DFG++  + DS        + +GT  Y+SPE+ +G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 76  THYSVQSDIWSLGLSLVEMAIGMYP 100
                +SD++SLG  L E+  G  P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 53/85 (62%), Gaps = 5/85 (5%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQG 75
           ++ IIHRDVKP+NI++++   +K+ DFG++  + DS        + +GT  Y+SPE+ +G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 76  THYSVQSDIWSLGLSLVEMAIGMYP 100
                +SD++SLG  L E+  G  P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 53/85 (62%), Gaps = 5/85 (5%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQG 75
           ++ IIHRDVKP+NI++++   +K+ DFG++  + DS        + +GT  Y+SPE+ +G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 76  THYSVQSDIWSLGLSLVEMAIGMYP 100
                +SD++SLG  L E+  G  P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 63/108 (58%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 145 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLINTTCDLKICDFGLA-RIADPEHDHTG 202
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
                V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 203 FLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 249

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 67/126 (53%), Gaps = 15/126 (11%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS-- 60
            + Y  +Q L+ +  L   + +IHRD+KPSN+L+NS  ++K+CDFG++  + +S A++  
Sbjct: 113 HIQYFIYQTLRAVKVLHGSN-VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 61  ----------FVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK-T 108
                     +V TR Y +PE  L    YS   D+WS G  L E+ +     P  D +  
Sbjct: 172 PTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231
Query: 109 LAAIFG 114
           L  IFG
Sbjct: 232 LLLIFG 237

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 53/85 (62%), Gaps = 5/85 (5%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQG 75
           ++ IIHRDVKP+NI++++   +K+ DFG++  + DS        + +GT  Y+SPE+ +G
Sbjct: 151 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 210
Query: 76  THYSVQSDIWSLGLSLVEMAIGMYP 100
                +SD++SLG  L E+  G  P
Sbjct: 211 DSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 42/105 (40%), Positives = 60/105 (57%), Gaps = 2/105 (1%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 126 ERMSYLLYQMLVGIKHLHSA-GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP 184
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           +V TR Y +PE + G  Y    DIWS+G+ + EM  G    P  D
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTD 229

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 42/105 (40%), Positives = 60/105 (57%), Gaps = 2/105 (1%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 126 ERMSYLLYQMLVGIKHLHSA-GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP 184
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           +V TR Y +PE + G  Y    DIWS+G+ + EM  G    P  D
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTD 229

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 60/96 (62%), Gaps = 4/96 (4%)
Query: 9   FQVLKGLTYLR--EKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMANSFVGTR 65
            Q  +G+ YL   +  A+IHRD+KP N+L+ +GG + KICDFG +  +   M N+  G+ 
Sbjct: 110 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-KGSA 168
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           ++M+PE  +G++YS + D++S G+ L E+     P 
Sbjct: 169 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 204

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 60/96 (62%), Gaps = 4/96 (4%)
Query: 9   FQVLKGLTYLR--EKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMANSFVGTR 65
            Q  +G+ YL   +  A+IHRD+KP N+L+ +GG + KICDFG +  +   M N+  G+ 
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-KGSA 167
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           ++M+PE  +G++YS + D++S G+ L E+     P 
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 63/108 (58%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 129 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTG 186
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
                V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 187 FLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 233

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 63/108 (58%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++ ++ D       
Sbjct: 130 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTG 187
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
                V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 188 FLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 234

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 44/119 (36%), Positives = 67/119 (56%), Gaps = 10/119 (8%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSP 70
            L+GL YL   H +IHRDVK  NIL++  G +K+ DFG +   I + AN FVGT  +M+P
Sbjct: 163 ALQGLAYLH-SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS--IMAPANXFVGTPYWMAP 219
Query: 71  E---RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT----LAAIFGPSRGDGYW 122
           E    +    Y  + D+WSLG++ +E+A    P+   +A +    +A    P+   G+W
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 278

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 44/118 (37%), Positives = 67/118 (56%), Gaps = 10/118 (8%)
Query: 12  LKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPE 71
           L+GL YL   H +IHRDVK  NIL++  G +K+ DFG +   I + AN FVGT  +M+PE
Sbjct: 125 LQGLAYLH-SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS--IMAPANXFVGTPYWMAPE 181
Query: 72  ---RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT----LAAIFGPSRGDGYW 122
               +    Y  + D+WSLG++ +E+A    P+   +A +    +A    P+   G+W
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 239

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 2/105 (1%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           +++  L YL  +  +++RD+K  N++++  G IKI DFG+  + I   A    F GT  Y
Sbjct: 118 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEY 177
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
           ++PE L+   Y    D W LG+ + EM  G  P    D + L  +
Sbjct: 178 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 222

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 58/97 (59%), Gaps = 2/97 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS-GQLIDSMANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     + M   
Sbjct: 126 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP 184
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIG 97
           +V TR Y +PE + G  Y+   DIWS+G  + E+  G
Sbjct: 185 YVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 2/105 (1%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           +++  L YL  +  +++RD+K  N++++  G IKI DFG+  + I   A    F GT  Y
Sbjct: 117 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEY 176
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
           ++PE L+   Y    D W LG+ + EM  G  P    D + L  +
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 221

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 2/105 (1%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           +++  L YL  +  +++RD+K  N++++  G IKI DFG+  + I   A    F GT  Y
Sbjct: 116 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEY 175
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
           ++PE L+   Y    D W LG+ + EM  G  P    D + L  +
Sbjct: 176 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 220

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/105 (40%), Positives = 59/105 (56%), Gaps = 2/105 (1%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 126 ERMSYLLYQMLVGIKHLHSA-GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP 184
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           +V TR Y +PE + G  Y    DIWS+G  + EM  G    P  D
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/98 (39%), Positives = 58/98 (59%), Gaps = 5/98 (5%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGV--SGQLIDSMANSFVGTRS 66
           FQ+L+GL Y   +  ++HRD+KP N+L+N  GE+K+ DFG+  +  +     ++ V T  
Sbjct: 107 FQLLRGLAYCH-RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLW 165
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPP 103
           Y  P+ L G T YS Q D+W +G    EMA G  P+ P
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR-PLFP 202

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 2/102 (1%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN--SFVGTRSY 67
           +++  L YL  +  +++RD+K  N++++  G IKI DFG+  + I   A   +F GT  Y
Sbjct: 256 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEY 315
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           ++PE L+   Y    D W LG+ + EM  G  P    D + L
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 357

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 2/102 (1%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN--SFVGTRSY 67
           +++  L YL  +  +++RD+K  N++++  G IKI DFG+  + I   A   +F GT  Y
Sbjct: 259 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEY 318
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           ++PE L+   Y    D W LG+ + EM  G  P    D + L
Sbjct: 319 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 360

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/105 (40%), Positives = 59/105 (56%), Gaps = 2/105 (1%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 126 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP 184
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           +V TR Y +PE + G  Y    DIWS+G  + EM  G    P  D
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 60/101 (59%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S++ +R 
Sbjct: 157 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 215
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 255

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS-- 60
            + Y  +Q L+ +  L   + +IHRD+KPSN+L+NS  ++K+CDFG++  + +S A++  
Sbjct: 113 HIQYFIYQTLRAVKVLHGSN-VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 61  ----------FVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK-T 108
                      V TR Y +PE  L    YS   D+WS G  L E+ +     P  D +  
Sbjct: 172 PTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231
Query: 109 LAAIFG 114
           L  IFG
Sbjct: 232 LLLIFG 237

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 60/101 (59%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S++ +R 
Sbjct: 163 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 261

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 60/101 (59%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S++ +R 
Sbjct: 134 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 192
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 193 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 232

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/105 (40%), Positives = 59/105 (56%), Gaps = 2/105 (1%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 126 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP 184
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           +V TR Y +PE + G  Y    DIWS+G  + EM  G    P  D
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 42/96 (43%), Positives = 58/96 (60%), Gaps = 8/96 (8%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGG---EIKICDFGVSG--QLIDSMANSFVGT 64
           QV  G+TY+  KH I+HRD+KP NIL+ S     +IKI DFG+S   Q    M +  +GT
Sbjct: 129 QVFSGITYM-HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-IGT 186
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
             Y++PE L+GT Y  + D+WS G+ L  +  G  P
Sbjct: 187 AYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 60/101 (59%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S++ +R 
Sbjct: 129 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 227

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 60/101 (59%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S++ +R 
Sbjct: 167 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 225
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 226 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 265

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 60/101 (59%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S++ +R 
Sbjct: 129 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 227

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 60/101 (59%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S++ +R 
Sbjct: 165 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 223
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 224 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 263

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 60/101 (59%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S++ +R 
Sbjct: 129 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 227

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 56/91 (61%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL++    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 110 FQLLQGLSFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 167
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 3/101 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--AN 59
           +Q+      VL+ L YL     +IHRD+K  +IL+   G +K+ DFG   Q+   +    
Sbjct: 141 EQIATVCEAVLQALAYL-HAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199
Query: 60  SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
             VGT  +M+PE +  + Y+ + DIWSLG+ ++EM  G  P
Sbjct: 200 XLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 60/101 (59%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S++ +R 
Sbjct: 142 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 200
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 240

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 60/101 (59%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S++ +R 
Sbjct: 208 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 266
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 267 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 306

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 33/77 (42%), Positives = 49/77 (63%), Gaps = 3/77 (3%)
Query: 24  IIHRDVKPSNILVNSG-GEIKICDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGT-HYSV 80
           + HRD+KP N+LVN   G +K+CDFG + +L  S  N +++ +R Y +PE + G  HY+ 
Sbjct: 152 VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTT 211
Query: 81  QSDIWSLGLSLVEMAIG 97
             DIWS+G    EM +G
Sbjct: 212 AVDIWSVGCIFAEMMLG 228

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 59/105 (56%), Gaps = 2/105 (1%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 128 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVP 186
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           FV TR Y +PE + G  Y    DIWS+G  + EM  G    P  D
Sbjct: 187 FVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 231

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/86 (43%), Positives = 52/86 (60%), Gaps = 2/86 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-NSFVGTRSYM 68
           Q L+GL +L   + I+HRD+KP NILV SGG +K+ DFG++      MA +  V T  Y 
Sbjct: 120 QFLRGLDFL-HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYR 178
Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEM 94
           +PE L  + Y+   D+WS+G    EM
Sbjct: 179 APEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 110 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 167
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 109 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 166
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/105 (40%), Positives = 59/105 (56%), Gaps = 2/105 (1%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 127 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 185
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           +V TR Y +PE + G  Y    DIWS+G  + EM  G    P  D
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 117 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 174
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 175 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 205

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 110 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 167
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 111 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 168
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 109 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 166
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 113 FQLLQGLAFC-HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 170
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 110 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 167
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 109 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 166
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/105 (40%), Positives = 59/105 (56%), Gaps = 2/105 (1%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 126 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 184
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           +V TR Y +PE + G  Y    DIWS+G  + EM  G    P  D
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 110 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 167
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 168 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMV 198

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 109 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 166
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 110 FQLLQGLAFC-HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 167
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 117 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 174
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 175 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMV 205

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 111 FQLLQGLAFC-HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 168
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/117 (37%), Positives = 66/117 (56%), Gaps = 9/117 (7%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMAN 59
           Q+    +Q+L+G+ +  + H I+HRD+KP N+L+NS G +K+ DFG++   G  + S  +
Sbjct: 120 QIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178
Query: 60  SFVGTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPIPP--PDAKTLAAIF 113
             V T  Y +P+ L G+  YS   DIWS+G    EM  G  P+ P   D   L  IF
Sbjct: 179 EVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIF 233

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 113 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 170
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/105 (40%), Positives = 59/105 (56%), Gaps = 2/105 (1%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 126 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 184
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           +V TR Y +PE + G  Y    DIWS+G  + EM  G    P  D
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 111 FQLLQGLAFC-HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 168
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 114 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 171
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 112 FQLLQGLAFC-HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 169
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 113 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 170
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 110 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 167
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 113 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 170
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 113 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 170
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 112 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 169
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 110 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 167
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 119 ERMSYLLYQMLXGIKHLHSA-GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTP 177
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           +V TR Y +PE + G  Y    DIWS+G  + EM 
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 112 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 169
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 110 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 167
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 126 ERMSYLLYQMLXGIKHLHSA-GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTP 184
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           +V TR Y +PE + G  Y    DIWS+G  + EM 
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 111 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 168
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/117 (37%), Positives = 66/117 (56%), Gaps = 9/117 (7%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMAN 59
           Q+    +Q+L+G+ +  + H I+HRD+KP N+L+NS G +K+ DFG++   G  + S  +
Sbjct: 120 QIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178
Query: 60  SFVGTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPIPP--PDAKTLAAIF 113
             V T  Y +P+ L G+  YS   DIWS+G    EM  G  P+ P   D   L  IF
Sbjct: 179 EVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIF 233

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 113 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 170
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 114 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 171
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 202

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 111 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 168
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 109 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 166
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/86 (43%), Positives = 51/86 (59%), Gaps = 2/86 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-NSFVGTRSYM 68
           Q L+GL +L   + I+HRD+KP NILV SGG +K+ DFG++      MA    V T  Y 
Sbjct: 128 QFLRGLDFL-HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR 186
Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEM 94
           +PE L  + Y+   D+WS+G    EM
Sbjct: 187 APEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 126 ERMSYLLYQMLXGIKHLHSA-GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTP 184
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           +V TR Y +PE + G  Y    DIWS+G  + EM 
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 65/109 (59%), Gaps = 14/109 (12%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           ++QV KG+ +L E  + +HRD+   N+LV  G  +KICDFG++    D M++S    R  
Sbjct: 178 AYQVAKGMEFL-EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR---DIMSDSNYVVRGN 233
Query: 66  -----SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP--PPDA 106
                 +M+PE L    Y+++SD+WS G+ L E+ ++G+ P P  P DA
Sbjct: 234 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 109 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 166
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/105 (40%), Positives = 59/105 (56%), Gaps = 2/105 (1%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 126 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 184
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           +V TR Y +PE + G  Y    DIWS+G  + EM  G    P  D
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 112 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 169
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGTR 65
           FQ+L+GL +    H ++HRD+KP N+L+N+ G IK+ DFG++   G  + +  +  V T 
Sbjct: 110 FQLLQGLAFC-HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 167
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMA 95
            Y +PE L G  +YS   DIWSLG    EM 
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 63/116 (54%), Gaps = 9/116 (7%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVG 63
           + S ++   L YL E+  II+RD+K  N+L++S G IK+ D+G+  + +      ++F G
Sbjct: 157 FYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 215
Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI------PPPDAKTLAAIF 113
           T +Y++PE L+G  Y    D W+LG+ + EM  G  P         PD  T   +F
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 271

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 1/95 (1%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L Y  E+  +IHRD+KP N+L+   GE+KI DFG S            GT  Y+ 
Sbjct: 122 ELADALHYCHER-KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLP 180
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP 104
           PE ++G  +  + D+W  G+   E  +GM P   P
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 1/95 (1%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L Y  E+  +IHRD+KP N+L+   GE+KI DFG S            GT  Y+ 
Sbjct: 123 ELADALHYCHER-KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLP 181
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP 104
           PE ++G  +  + D+W  G+   E  +GM P   P
Sbjct: 182 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 216

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 37/86 (43%), Positives = 52/86 (60%), Gaps = 2/86 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS-FVGTRSYM 68
           Q L+GL +L   + I+HRD+KP NILV SGG +K+ DFG++      MA +  V T  Y 
Sbjct: 120 QFLRGLDFL-HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYR 178
Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEM 94
           +PE L  + Y+   D+WS+G    EM
Sbjct: 179 APEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 57/97 (58%), Gaps = 2/97 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     + M   
Sbjct: 124 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTP 182
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIG 97
           +V TR Y +PE + G  Y    DIWS+G  + E+  G
Sbjct: 183 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 35/103 (33%), Positives = 60/103 (58%), Gaps = 6/103 (5%)
Query: 3   QVPYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSM 57
           Q P + F   Q++ GL +L +++ II+RD+KP N+L++  G ++I D G++ +L    + 
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRN-IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345
Query: 58  ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
              + GT  +M+PE L G  Y    D ++LG++L EM     P
Sbjct: 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 35/103 (33%), Positives = 60/103 (58%), Gaps = 6/103 (5%)
Query: 3   QVPYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSM 57
           Q P + F   Q++ GL +L +++ II+RD+KP N+L++  G ++I D G++ +L    + 
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRN-IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345
Query: 58  ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
              + GT  +M+PE L G  Y    D ++LG++L EM     P
Sbjct: 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 35/103 (33%), Positives = 60/103 (58%), Gaps = 6/103 (5%)
Query: 3   QVPYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSM 57
           Q P + F   Q++ GL +L +++ II+RD+KP N+L++  G ++I D G++ +L    + 
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRN-IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345
Query: 58  ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
              + GT  +M+PE L G  Y    D ++LG++L EM     P
Sbjct: 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 35/103 (33%), Positives = 60/103 (58%), Gaps = 6/103 (5%)
Query: 3   QVPYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSM 57
           Q P + F   Q++ GL +L +++ II+RD+KP N+L++  G ++I D G++ +L    + 
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRN-IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345
Query: 58  ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
              + GT  +M+PE L G  Y    D ++LG++L EM     P
Sbjct: 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 120 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 178
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           +V TR Y +PE + G  Y    DIWS+G  + EM 
Sbjct: 179 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 127 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 185
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           +V TR Y +PE + G  Y    DIWS+G  + EM 
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 126 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 184
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           +V TR Y +PE + G  Y    DIWS+G  + EM 
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 119 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 177
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           +V TR Y +PE + G  Y    DIWS+G  + EM 
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 56/94 (59%), Gaps = 2/94 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 164 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 222
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
           +V TR Y +PE + G  Y    DIWS+G  + EM
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 125 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 183
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           +V TR Y +PE + G  Y    DIWS+G  + EM 
Sbjct: 184 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 57/102 (55%), Gaps = 6/102 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           Q++ G+ YL   H I+HRD+  SN+L+     IKI DFG++ QL        +  GT +Y
Sbjct: 120 QIITGMLYL-HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNY 178
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           +SPE    + + ++SD+WSLG     + IG    PP D  T+
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGR---PPFDTDTV 217

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 164 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 222
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           +V TR Y +PE + G  Y    DIWS+G  + EM 
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 127 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 185
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           +V TR Y +PE + G  Y    DIWS+G  + EM 
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 120 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 178
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           +V TR Y +PE + G  Y    DIWS+G  + EM 
Sbjct: 179 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 57/96 (59%), Gaps = 6/96 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGG---EIKICDFGVSGQL-IDSMANSFVGTR 65
           QV  G+TY+  KH I+HRD+KP NIL+ S     +IKI DFG+S     ++     +GT 
Sbjct: 129 QVFSGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA 187
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y++PE L+GT Y  + D+WS G+ L  +  G  P 
Sbjct: 188 YYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPF 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 126 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 184
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           +V TR Y +PE + G  Y    DIWS+G  + EM 
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 57/96 (59%), Gaps = 6/96 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGG---EIKICDFGVSGQL-IDSMANSFVGTR 65
           QV  G+TY+  KH I+HRD+KP NIL+ S     +IKI DFG+S     ++     +GT 
Sbjct: 129 QVFSGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA 187
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            Y++PE L+GT Y  + D+WS G+ L  +  G  P 
Sbjct: 188 YYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 126 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTP 184
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           +V TR Y +PE + G  Y    DIWS+G  + EM 
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 62/116 (53%), Gaps = 9/116 (7%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVG 63
           + S ++   L YL E+  II+RD+K  N+L++S G IK+ D+G+  + +      + F G
Sbjct: 110 FYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCG 168
Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI------PPPDAKTLAAIF 113
           T +Y++PE L+G  Y    D W+LG+ + EM  G  P         PD  T   +F
Sbjct: 169 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 224

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 62/116 (53%), Gaps = 9/116 (7%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVG 63
           + S ++   L YL E+  II+RD+K  N+L++S G IK+ D+G+  + +      + F G
Sbjct: 125 FYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCG 183
Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI------PPPDAKTLAAIF 113
           T +Y++PE L+G  Y    D W+LG+ + EM  G  P         PD  T   +F
Sbjct: 184 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 239

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 59/101 (58%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S + +R 
Sbjct: 141 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 199
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 239

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 126 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTP 184
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           +V TR Y +PE + G  Y    DIWS+G  + EM 
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 59/101 (58%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S + +R 
Sbjct: 133 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 191
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 231

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 62/116 (53%), Gaps = 9/116 (7%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVG 63
           + S ++   L YL E+  II+RD+K  N+L++S G IK+ D+G+  + +      + F G
Sbjct: 114 FYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCG 172
Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI------PPPDAKTLAAIF 113
           T +Y++PE L+G  Y    D W+LG+ + EM  G  P         PD  T   +F
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 228

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/106 (36%), Positives = 61/106 (57%), Gaps = 5/106 (4%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDSMA-NSFVGTR 65
           Q+L+ + Y    + I+HR++KP N+L+ S   G  +K+ DFG++ ++ DS A + F GT 
Sbjct: 113 QILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA 111
            Y+SPE L+   YS   DIW+ G+ L  + +G  P    D   L A
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA 217

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 59/101 (58%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S + +R 
Sbjct: 163 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 221
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 261

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 59/101 (58%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S + +R 
Sbjct: 141 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 199
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 239

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 59/101 (58%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S + +R 
Sbjct: 137 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 195
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 235

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 59/101 (58%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S + +R 
Sbjct: 129 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 227

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 59/101 (58%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S + +R 
Sbjct: 129 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 227

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 59/101 (58%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S + +R 
Sbjct: 129 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 227

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 59/101 (58%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S + +R 
Sbjct: 148 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 206
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 246

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 59/101 (58%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S + +R 
Sbjct: 129 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 227

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/108 (37%), Positives = 63/108 (58%), Gaps = 10/108 (9%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------S 56
            + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KI DFG++ ++ D       
Sbjct: 125 HICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTXDLKIXDFGLA-RVADPDHDHTG 182
Query: 57  MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
               +V TR Y +PE  L    Y+   DIWS+G  L EM +   PI P
Sbjct: 183 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFP 229

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 59/101 (58%), Gaps = 5/101 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + L Y+     I HRD+KP N+L++    + K+CDFG + QL+    N S + +R 
Sbjct: 130 YQLFRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 188
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           Y +PE + G T Y+   D+WS G  L E+ +G  PI P D+
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 228

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/106 (36%), Positives = 61/106 (57%), Gaps = 5/106 (4%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDSMA-NSFVGTR 65
           Q+L+ + Y    + I+HR++KP N+L+ S   G  +K+ DFG++ ++ DS A + F GT 
Sbjct: 112 QILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 170
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA 111
            Y+SPE L+   YS   DIW+ G+ L  + +G  P    D   L A
Sbjct: 171 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA 216

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 37/86 (43%), Positives = 51/86 (59%), Gaps = 2/86 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-NSFVGTRSYM 68
           Q L+GL +L   + I+HRD+KP NILV SGG +K+ DFG++      MA    V T  Y 
Sbjct: 120 QFLRGLDFL-HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYR 178
Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEM 94
           +PE L  + Y+   D+WS+G    EM
Sbjct: 179 APEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 5/95 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRSYM 68
           +++  L YL+ +  IIHRD+KP NIL++  G + I DF ++  L  ++   +  GT+ YM
Sbjct: 123 ELVMALDYLQNQR-IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181
Query: 69  SPERL---QGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           +PE     +G  YS   D WSLG++  E+  G  P
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 55/100 (55%), Gaps = 3/100 (3%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANS 60
           Q+     + L+ L +L   + +IHRD+K  NIL+   G +K+ DFG   Q+    S  ++
Sbjct: 117 QIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            VGT  +M+PE +    Y  + DIWSLG+  +EM  G  P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/106 (36%), Positives = 61/106 (57%), Gaps = 5/106 (4%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDSMA-NSFVGTR 65
           Q+L+ + Y    + I+HR++KP N+L+ S   G  +K+ DFG++ ++ DS A + F GT 
Sbjct: 113 QILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA 111
            Y+SPE L+   YS   DIW+ G+ L  + +G  P    D   L A
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA 217

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/121 (38%), Positives = 67/121 (55%), Gaps = 11/121 (9%)
Query: 1   LKQVPYSSF--QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLID 55
           L+ V   SF  Q+L G+ Y  ++  ++HRD+KP N+L+N  GE+KI DFG++   G  + 
Sbjct: 97  LESVTAKSFLLQLLNGIAYCHDRR-VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155
Query: 56  SMANSFVGTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPIPP--PDAKTLAAI 112
              +  V T  Y +P+ L G+  YS   DIWS+G    EM  G  P+ P   +A  L  I
Sbjct: 156 KYTHEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRI 213
Query: 113 F 113
           F
Sbjct: 214 F 214

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTR 65
           ++Q L+ + +   KH  IHRDVKP NIL+     IK+CDFG +  L       +  V TR
Sbjct: 108 TWQTLQAVNFCH-KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR 166
Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMAIGM 98
            Y SPE L G T Y    D+W++G    E+  G+
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 6/95 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDSMA-NSFVGTR 65
           QVL G+TY+  K+ I+HRD+KP N+L+ S  +   I+I DFG+S     S      +GT 
Sbjct: 134 QVLSGITYM-HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTA 192
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            Y++PE L GT Y  + D+WS G+ L  +  G  P
Sbjct: 193 YYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 226

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 56/105 (53%), Gaps = 3/105 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           +++  L YL  +  +++RD+K  N++++  G IKI DFG+  + I   A   +F GT  Y
Sbjct: 116 EIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 174
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
           ++PE L+   Y    D W LG+ + EM  G  P    D + L  +
Sbjct: 175 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 219

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 56/105 (53%), Gaps = 3/105 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           +++  L YL  +  +++RD+K  N++++  G IKI DFG+  + I   A   +F GT  Y
Sbjct: 113 EIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 171
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
           ++PE L+   Y    D W LG+ + EM  G  P    D + L  +
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 39/95 (41%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQL-IDSMANSFVGTR 65
           QVL G TYL  KH I+HRD+KP N+L+ S      IKI DFG+S    +       +GT 
Sbjct: 112 QVLSGTTYL-HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTA 170
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            Y++PE L+   Y  + D+WS G+ L  +  G  P
Sbjct: 171 YYIAPEVLR-KKYDEKCDVWSCGVILYILLCGYPP 204

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 56/105 (53%), Gaps = 3/105 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           +++  L YL  +  +++RD+K  N++++  G IKI DFG+  + I   A   +F GT  Y
Sbjct: 113 EIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 171
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
           ++PE L+   Y    D W LG+ + EM  G  P    D + L  +
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 60/106 (56%), Gaps = 6/106 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSY 67
           ++   L YL   + I++RD+KP NIL++S G I + DFG+  + I+  S  ++F GT  Y
Sbjct: 147 EIASALGYLHSLN-IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEY 205
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           ++PE L    Y    D W LG  L EM   +Y +PP  ++  A ++
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEM---LYGLPPFYSRNTAEMY 248

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/121 (38%), Positives = 67/121 (55%), Gaps = 11/121 (9%)
Query: 1   LKQVPYSSF--QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLID 55
           L+ V   SF  Q+L G+ Y  ++  ++HRD+KP N+L+N  GE+KI DFG++   G  + 
Sbjct: 97  LESVTAKSFLLQLLNGIAYCHDRR-VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155
Query: 56  SMANSFVGTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPIPP--PDAKTLAAI 112
              +  V T  Y +P+ L G+  YS   DIWS+G    EM  G  P+ P   +A  L  I
Sbjct: 156 KYTHEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRI 213
Query: 113 F 113
           F
Sbjct: 214 F 214

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/121 (38%), Positives = 67/121 (55%), Gaps = 11/121 (9%)
Query: 1   LKQVPYSSF--QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLID 55
           L+ V   SF  Q+L G+ Y  ++  ++HRD+KP N+L+N  GE+KI DFG++   G  + 
Sbjct: 97  LESVTAKSFLLQLLNGIAYCHDRR-VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155
Query: 56  SMANSFVGTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPIPP--PDAKTLAAI 112
              +  V T  Y +P+ L G+  YS   DIWS+G    EM  G  P+ P   +A  L  I
Sbjct: 156 KYTHEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGA-PLFPGVSEADQLMRI 213
Query: 113 F 113
           F
Sbjct: 214 F 214

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 40/105 (38%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 120 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 178
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           +V TR Y +PE + G  Y    D+WS+G  + EM       P  D
Sbjct: 179 YVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRD 223

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 3/100 (3%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANS 60
           Q+     + L+ L +L   + +IHRD+K  NIL+   G +K+ DFG   Q+    S  + 
Sbjct: 117 QIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSE 175
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            VGT  +M+PE +    Y  + DIWSLG+  +EM  G  P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 40/105 (38%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 131 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 189
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           +V TR Y +PE + G  Y    D+WS+G  + EM       P  D
Sbjct: 190 YVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRD 234

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 60/107 (56%), Gaps = 8/107 (7%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           S+QV KG+ +L  K+ I HRD+   NIL+  G   KICDFG++  + +       G    
Sbjct: 174 SYQVAKGMAFLASKNCI-HRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARL 232
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP--PPDAK 107
              +M+PE +    Y+ +SD+WS G+ L E+ ++G  P P  P D+K
Sbjct: 233 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 279

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 39/106 (36%), Positives = 61/106 (57%), Gaps = 5/106 (4%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDSMA-NSFVGTR 65
           Q+L+ + Y    + I+HR++KP N+L+ S   G  +K+ DFG++ ++ DS A + F GT 
Sbjct: 136 QILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 194
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA 111
            Y+SPE L+   YS   DIW+ G+ L  + +G  P    D   L A
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA 240

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/105 (40%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 126 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 184
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            V TR Y +PE + G  Y    DIWS+G  + EM  G    P  D
Sbjct: 185 EVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 54/90 (60%), Gaps = 10/90 (11%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS--- 66
           Q+ KG+ Y+  K  +IHRD+KPSNI +    ++KI DFG    L+ S+ N    TRS   
Sbjct: 144 QITKGVDYIHSK-KLIHRDLKPSNIFLVDTKQVKIGDFG----LVTSLKNDGKRTRSKGT 198
Query: 67  --YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
             YMSPE++    Y  + D+++LGL L E+
Sbjct: 199 LRYMSPEQISSQDYGKEVDLYALGLILAEL 228

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 60/107 (56%), Gaps = 8/107 (7%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           S+QV KG+ +L  K+ I HRD+   NIL+  G   KICDFG++  + +       G    
Sbjct: 174 SYQVAKGMAFLASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 232
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP--PPDAK 107
              +M+PE +    Y+ +SD+WS G+ L E+ ++G  P P  P D+K
Sbjct: 233 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 279

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 60/107 (56%), Gaps = 8/107 (7%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           S+QV KG+ +L  K+ I HRD+   NIL+  G   KICDFG++  + +       G    
Sbjct: 169 SYQVAKGMAFLASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 227
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP--PPDAK 107
              +M+PE +    Y+ +SD+WS G+ L E+ ++G  P P  P D+K
Sbjct: 228 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 274

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 6/95 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDSMA-NSFVGTR 65
           QVL G+TYL  KH I+HRD+KP N+L+ S  +   IKI DFG+S    +       +GT 
Sbjct: 144 QVLSGVTYL-HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTA 202
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            Y++PE L+   Y  + D+WS+G+ L  +  G  P
Sbjct: 203 YYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 60/107 (56%), Gaps = 8/107 (7%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           S+QV KG+ +L  K+ I HRD+   NIL+  G   KICDFG++  + +       G    
Sbjct: 151 SYQVAKGMAFLASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP--PPDAK 107
              +M+PE +    Y+ +SD+WS G+ L E+ ++G  P P  P D+K
Sbjct: 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 60/107 (56%), Gaps = 8/107 (7%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           S+QV KG+ +L  K+ I HRD+   NIL+  G   KICDFG++  + +       G    
Sbjct: 167 SYQVAKGMAFLASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 225
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP--PPDAK 107
              +M+PE +    Y+ +SD+WS G+ L E+ ++G  P P  P D+K
Sbjct: 226 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 272

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 3/105 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           +++  L YL  +  +++RD+K  N++++  G IKI DFG+  + I   A    F GT  Y
Sbjct: 113 EIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEY 171
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
           ++PE L+   Y    D W LG+ + EM  G  P    D + L  +
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 3/100 (3%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANS 60
           Q+     + L+ L +L   + +IHRD+K  NIL+   G +K+ DFG   Q+    S  + 
Sbjct: 117 QIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX 175
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            VGT  +M+PE +    Y  + DIWSLG+  +EM  G  P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 3/100 (3%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANS 60
           Q+     + L+ L +L   + +IHRD+K  NIL+   G +K+ DFG   Q+    S  + 
Sbjct: 118 QIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX 176
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            VGT  +M+PE +    Y  + DIWSLG+  +EM  G  P
Sbjct: 177 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 3/105 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           +++  L YL  +  +++RD+K  N++++  G IKI DFG+  + I   A    F GT  Y
Sbjct: 118 EIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEY 176
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
           ++PE L+   Y    D W LG+ + EM  G  P    D + L  +
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 221

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 3/105 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           +++  L YL  +  +++RD+K  N++++  G IKI DFG+  + I   A    F GT  Y
Sbjct: 113 EIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEY 171
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
           ++PE L+   Y    D W LG+ + EM  G  P    D + L  +
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 3/105 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           +++  L YL  +  +++RD+K  N++++  G IKI DFG+  + I   A    F GT  Y
Sbjct: 113 EIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEY 171
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
           ++PE L+   Y    D W LG+ + EM  G  P    D + L  +
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 6/129 (4%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--AN 59
           +Q+      VL+ L+ L     +IHRD+K  +IL+   G +K+ DFG   Q+   +    
Sbjct: 127 EQIAAVCLAVLQALSVL-HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 185
Query: 60  SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI---PPPDAKTLAAIFGPS 116
             VGT  +M+PE +    Y  + DIWSLG+ ++EM  G  P    PP  A  +     P 
Sbjct: 186 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP 245
Query: 117 RGDGYWHVS 125
           R      VS
Sbjct: 246 RLKNLHKVS 254

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 6/129 (4%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--AN 59
           +Q+      VL+ L+ L  +  +IHRD+K  +IL+   G +K+ DFG   Q+   +    
Sbjct: 116 EQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174
Query: 60  SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI---PPPDAKTLAAIFGPS 116
             VGT  +M+PE +    Y  + DIWSLG+ ++EM  G  P    PP  A  +     P 
Sbjct: 175 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP 234
Query: 117 RGDGYWHVS 125
           R      VS
Sbjct: 235 RLKNLHKVS 243

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 57/102 (55%), Gaps = 3/102 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRSYM 68
           Q++  + Y  +K+ I+HRD+K  N+L++    IKI DFG S +  + +  ++F G+  Y 
Sbjct: 122 QIVSAVQYCHQKY-IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYA 180
Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           +PE  QG  Y   + D+WSLG+ L  +  G  P    + K L
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 222

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 6/129 (4%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--AN 59
           +Q+      VL+ L+ L     +IHRD+K  +IL+   G +K+ DFG   Q+   +    
Sbjct: 125 EQIAAVCLAVLQALSVL-HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 183
Query: 60  SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI---PPPDAKTLAAIFGPS 116
             VGT  +M+PE +    Y  + DIWSLG+ ++EM  G  P    PP  A  +     P 
Sbjct: 184 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP 243
Query: 117 RGDGYWHVS 125
           R      VS
Sbjct: 244 RLKNLHKVS 252

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/127 (35%), Positives = 66/127 (51%), Gaps = 13/127 (10%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNIL-VNSGGE---IKICDFGVSGQLI--DSMANSFV 62
           F + K + YL  +  ++HRD+KPSNIL V+  G    I+ICDFG + QL   + +  +  
Sbjct: 123 FTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI---PPPDAKTLAAIFGP---S 116
            T ++++PE L+   Y    DIWSLG+ L  M  G  P    P    + + A  G    S
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS 241
Query: 117 RGDGYWH 123
              GYW+
Sbjct: 242 LSGGYWN 248

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 3/101 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS- 60
           +Q+      VL+ L+ L     +IHRD+K  +IL+   G +K+ DFG   Q+   +    
Sbjct: 247 EQIAAVCLAVLQALSVL-HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 305
Query: 61  -FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
             VGT  +M+PE +    Y  + DIWSLG+ ++EM  G  P
Sbjct: 306 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 6/129 (4%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--AN 59
           +Q+      VL+ L+ L  +  +IHRD+K  +IL+   G +K+ DFG   Q+   +    
Sbjct: 120 EQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 178
Query: 60  SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI---PPPDAKTLAAIFGPS 116
             VGT  +M+PE +    Y  + DIWSLG+ ++EM  G  P    PP  A  +     P 
Sbjct: 179 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP 238
Query: 117 RGDGYWHVS 125
           R      VS
Sbjct: 239 RLKNLHKVS 247

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 39/95 (41%), Positives = 55/95 (57%), Gaps = 6/95 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDS-MANSFVGTR 65
           QVL G+TY   K+ I+HRD+KP N+L+ S  +   I+I DFG+S     S      +GT 
Sbjct: 134 QVLSGITY-XHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTA 192
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            Y++PE L GT Y  + D+WS G+ L  +  G  P
Sbjct: 193 YYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 226

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           SFQV KG+ +L  +  I HRD+   NIL++    +KICDFG++  +         G    
Sbjct: 154 SFQVAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    Y++QSD+WS G+ L E+ ++G  P P
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 3/101 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS- 60
           +Q+      VL+ L+ L     +IHRD+K  +IL+   G +K+ DFG   Q+   +    
Sbjct: 170 EQIAAVCLAVLQALSVL-HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228
Query: 61  -FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
             VGT  +M+PE +    Y  + DIWSLG+ ++EM  G  P
Sbjct: 229 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 40/109 (36%), Positives = 54/109 (49%), Gaps = 7/109 (6%)
Query: 1   LKQVPYSSF--QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI---KICDFGVSGQLID 55
           LK+ P  +    +   L YL E   IIHRD+KP NI++  G +    KI D G + +L  
Sbjct: 119 LKEGPIRTLLSDISSALRYLHENR-IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 177
Query: 56  -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
             +   FVGT  Y++PE L+   Y+V  D WS G    E   G  P  P
Sbjct: 178 GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 40/109 (36%), Positives = 54/109 (49%), Gaps = 7/109 (6%)
Query: 1   LKQVPYSSF--QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI---KICDFGVSGQLID 55
           LK+ P  +    +   L YL E   IIHRD+KP NI++  G +    KI D G + +L  
Sbjct: 118 LKEGPIRTLLSDISSALRYLHENR-IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 56  -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
             +   FVGT  Y++PE L+   Y+V  D WS G    E   G  P  P
Sbjct: 177 GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           SFQV KG+ +L  +  I HRD+   NIL++    +KICDFG++  +         G    
Sbjct: 145 SFQVAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    Y++QSD+WS G+ L E+ ++G  P P
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           SFQV KG+ +L  +  I HRD+   NIL++    +KICDFG++  +         G    
Sbjct: 145 SFQVAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    Y++QSD+WS G+ L E+ ++G  P P
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 58/100 (58%), Gaps = 3/100 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSY 67
           ++   L +L +K  II+RD+KP NI++N  G +K+ DFG+  + I   ++ ++F GT  Y
Sbjct: 129 EISMALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEY 187
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK 107
           M+PE L  + ++   D WSLG  + +M  G  P    + K
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK 227

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           SFQV KG+ +L  +  I HRD+   NIL++    +KICDFG++  +         G    
Sbjct: 154 SFQVAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    Y++QSD+WS G+ L E+ ++G  P P
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           SFQV KG+ +L  +  I HRD+   NIL++    +KICDFG++  +         G    
Sbjct: 154 SFQVAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARL 212
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    Y++QSD+WS G+ L E+ ++G  P P
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/107 (34%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L+ +   SFQV KG+ +L  +  I HRD+   NIL++    +KICDFG++  +       
Sbjct: 147 LEHLIXYSFQVAKGMEFLASRKXI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 61  FVGTR----SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
             G       +M+PE +    Y++QSD+WS G+ L E+ ++G  P P
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/105 (39%), Positives = 57/105 (54%), Gaps = 2/105 (1%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 126 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEP 184
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            V TR Y +PE + G  Y    DIWS+G  + EM       P  D
Sbjct: 185 EVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRD 229

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 56/102 (54%), Gaps = 3/102 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRSYM 68
           Q++  + Y  +K  I+HRD+K  N+L+++   IKI DFG S +  +    ++F G+  Y 
Sbjct: 119 QIVSAVQYCHQKR-IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYA 177
Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           +PE  QG  Y   + D+WSLG+ L  +  G  P    + K L
Sbjct: 178 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 219

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 3/102 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRSYM 68
           Q++  + Y  +K  I+HRD+K  N+L+++   IKI DFG S +    +  ++F G   Y 
Sbjct: 121 QIVSAVQYCHQKF-IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYA 179
Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           +PE  QG  Y   + D+WSLG+ L  +  G  P    + K L
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 3/100 (3%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANS 60
           Q+     + L+ L +L   + +IHR++K  NIL+   G +K+ DFG   Q+    S  ++
Sbjct: 118 QIAAVCRECLQALEFLH-SNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 176
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            VGT  +M+PE +    Y  + DIWSLG+  +EM  G  P
Sbjct: 177 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 39/95 (41%), Positives = 55/95 (57%), Gaps = 6/95 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILV---NSGGEIKICDFGVSGQLI-DSMANSFVGTR 65
           Q+L G+ YL  KH I+HRD+KP NIL+   NS   IKI DFG+S     D      +GT 
Sbjct: 154 QILSGICYL-HKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            Y++PE L+   Y+ + D+WS G+ +  +  G  P
Sbjct: 213 YYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/95 (42%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQL-IDSMANSFVGTR 65
           QVL G TYL  KH I+HRD+KP N+L+ S      IKI DFG+S    +       +GT 
Sbjct: 129 QVLSGTTYLH-KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTA 187
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            Y++PE L+   Y  + D+WS G+ L  +  G YP
Sbjct: 188 YYIAPEVLR-KKYDEKCDVWSCGVILYILLCG-YP 220

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           SFQV KG+ +L  +  I HRD+   NIL++    +KICDFG++  +         G    
Sbjct: 145 SFQVAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    Y++QSD+WS G+ L E+ ++G  P P
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 55/93 (59%), Gaps = 3/93 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYM 68
           Q++  + Y   +H I+HRD+KP N+L++    +KI DFG+S  + D +   +  G+ +Y 
Sbjct: 116 QIICAIEYCH-RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 174
Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYP 100
           +PE + G  Y+  + D+WS G+ L  M +G  P
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           SFQV KG+ +L  +  I HRD+   NIL++    +KICDFG++  +         G    
Sbjct: 154 SFQVAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    Y++QSD+WS G+ L E+ ++G  P P
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           SFQV KG+ +L  +  I HRD+   NIL++    +KICDFG++  +         G    
Sbjct: 145 SFQVAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    Y++QSD+WS G+ L E+ ++G  P P
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 56/102 (54%), Gaps = 3/102 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRSYM 68
           Q++  + Y  +K  I+HRD+K  N+L+++   IKI DFG S +    +  ++F G+  Y 
Sbjct: 121 QIVSAVQYCHQKF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 179
Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           +PE  QG  Y   + D+WSLG+ L  +  G  P    + K L
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           SFQV KG+ +L  +  I HRD+   NIL++    +KICDFG++  +         G    
Sbjct: 156 SFQVAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 214
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    Y++QSD+WS G+ L E+ ++G  P P
Sbjct: 215 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 254

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 56/102 (54%), Gaps = 3/102 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRSYM 68
           Q++  + Y  +K  I+HRD+K  N+L+++   IKI DFG S +    +  ++F G+  Y 
Sbjct: 114 QIVSAVQYCHQKF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 172
Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           +PE  QG  Y   + D+WSLG+ L  +  G  P    + K L
Sbjct: 173 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 214

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           SFQV KG+ +L  +  I HRD+   NIL++    +KICDFG++  +         G    
Sbjct: 206 SFQVAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 264
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    Y++QSD+WS G+ L E+ ++G  P P
Sbjct: 265 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 304

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 57/100 (57%), Gaps = 3/100 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSY 67
           ++   L +L +K  II+RD+KP NI++N  G +K+ DFG+  + I   ++ + F GT  Y
Sbjct: 129 EISMALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEY 187
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK 107
           M+PE L  + ++   D WSLG  + +M  G  P    + K
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK 227

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           SFQV KG+ +L  +  I HRD+   NIL++    +KICDFG++  +         G    
Sbjct: 204 SFQVAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 262
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    Y++QSD+WS G+ L E+ ++G  P P
Sbjct: 263 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 302

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           SFQV KG+ +L  +  I HRD+   NIL++    +KICDFG++  +         G    
Sbjct: 197 SFQVAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 255
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    Y++QSD+WS G+ L E+ ++G  P P
Sbjct: 256 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 295

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 3/102 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRSYM 68
           Q++  + Y  +K  I+HRD+K  N+L+++   IKI DFG S +  +    ++F G   Y 
Sbjct: 122 QIVSAVQYCHQKR-IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYA 180
Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           +PE  QG  Y   + D+WSLG+ L  +  G  P    + K L
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 222

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 56/102 (54%), Gaps = 3/102 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRSYM 68
           Q++  + Y  +K  I+HRD+K  N+L+++   IKI DFG S +    +  ++F G+  Y 
Sbjct: 121 QIVSAVQYCHQKF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 179
Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           +PE  QG  Y   + D+WSLG+ L  +  G  P    + K L
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           SFQV KG+ +L  +  I HRD+   NIL++    +KICDFG++  +         G    
Sbjct: 199 SFQVAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    Y++QSD+WS G+ L E+ ++G  P P
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 297

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 56/102 (54%), Gaps = 3/102 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRSYM 68
           Q++  + Y  +K  I+HRD+K  N+L+++   IKI DFG S +    +  ++F G+  Y 
Sbjct: 121 QIVSAVQYCHQKF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 179
Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           +PE  QG  Y   + D+WSLG+ L  +  G  P    + K L
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/100 (38%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS--GGEIKICDFGVS-GQLIDSMANSFVGTRS 66
           Q+L G++Y      I HRD+K  N L++      +KICDFG S   ++ S   S VGT +
Sbjct: 124 QLLSGVSYCHSMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 182
Query: 67  YMSPERLQGTHYSVQ-SDIWSLGLSLVEMAIGMYPIPPPD 105
           Y++PE L    Y  + +D+WS G++L  M +G YP   P+
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           SFQV KG+ +L  +  I HRD+   NIL++    +KICDFG++  +         G    
Sbjct: 191 SFQVAKGMEFLASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 249
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    Y++QSD+WS G+ L E+ ++G  P P
Sbjct: 250 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/86 (43%), Positives = 53/86 (61%), Gaps = 6/86 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDSMA-NSFVGTR 65
           QVL G+TY+  K+ I+HRD+KP N+L+ S  +   I+I DFG+S     S      +GT 
Sbjct: 140 QVLSGITYMH-KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTA 198
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSL 91
            Y++PE L GT Y  + D+WS G+ L
Sbjct: 199 YYIAPEVLHGT-YDEKCDVWSTGVIL 223

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/86 (43%), Positives = 52/86 (60%), Gaps = 6/86 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDSMA-NSFVGTR 65
           QVL G+TY+  K+ I+HRD+KP N+L+ S      I+I DFG+S     S      +GT 
Sbjct: 157 QVLSGITYMH-KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTA 215
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSL 91
            Y++PE L GT Y  + D+WS G+ L
Sbjct: 216 YYIAPEVLHGT-YDEKCDVWSTGVIL 240

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 50/92 (54%), Gaps = 2/92 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           +V   L YL  K  II+RD+KP NIL++  G IKI DFG +  + D +     GT  Y++
Sbjct: 114 EVCLALEYLHSKD-IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTYXLCGTPDYIA 171
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           PE +    Y+   D WS G+ + EM  G  P 
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/86 (43%), Positives = 52/86 (60%), Gaps = 6/86 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDSMA-NSFVGTR 65
           QVL G+TY+  K+ I+HRD+KP N+L+ S      I+I DFG+S     S      +GT 
Sbjct: 158 QVLSGITYMH-KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTA 216
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSL 91
            Y++PE L GT Y  + D+WS G+ L
Sbjct: 217 YYIAPEVLHGT-YDEKCDVWSTGVIL 241

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 62/115 (53%), Gaps = 6/115 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYM 68
           Q+L  + Y   +H ++HRD+KP N+L+++    KI DFG+S  + D     +  G+ +Y 
Sbjct: 119 QILSAVDYC-HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 177
Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYW 122
           +PE + G  Y+  + DIWS G+ L  +  G  P    D + +  +F   RG  ++
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPF---DDEHVPTLFKKIRGGVFY 229

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           SFQV KG+ +L  +  I HRD+   NIL++    +KICDFG++  +         G    
Sbjct: 150 SFQVAKGMEFLASRKXI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    Y++QSD+WS G+ L E+ ++G  P P
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 248

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 3/102 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRSYM 68
           Q++  + Y  +K  I+HRD+K  N+L+++   IKI DFG S +    +  + F G+  Y 
Sbjct: 121 QIVSAVQYCHQKF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYA 179
Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           +PE  QG  Y   + D+WSLG+ L  +  G  P    + K L
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/105 (38%), Positives = 57/105 (54%), Gaps = 2/105 (1%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 126 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEP 184
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            V TR Y +PE + G  Y    D+WS+G  + EM       P  D
Sbjct: 185 EVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRD 229

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 3/102 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRSYM 68
           Q++  + Y  +K  I+HRD+K  N+L+++   IKI DFG S +    +  ++F G   Y 
Sbjct: 121 QIVSAVQYCHQKF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYA 179
Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           +PE  QG  Y   + D+WSLG+ L  +  G  P    + K L
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 65/108 (60%), Gaps = 8/108 (7%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L+ + + S QV +G+ +L  K+ I HRDV   N+L+ +G   KI DFG++  +++  +N 
Sbjct: 151 LRDLLHFSSQVAQGMAFLASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMND-SNY 208
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            V   +     +M+PE +    Y+VQSD+WS G+ L E+ ++G+ P P
Sbjct: 209 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 256

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 56/91 (61%), Gaps = 10/91 (10%)
Query: 14  GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS------GQLIDSMANSFVGTRSY 67
           G+ +L E H I HRD+K +NIL++     KI DFG++       Q +  M +  VGT +Y
Sbjct: 145 GINFLHENHHI-HRDIKSANILLDEAFTAKISDFGLARASEKFAQTV--MXSRIVGTTAY 201
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGM 98
           M+PE L+G   + +SDI+S G+ L+E+  G+
Sbjct: 202 MAPEALRG-EITPKSDIYSFGVVLLEIITGL 231

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 65/108 (60%), Gaps = 8/108 (7%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L+ + + S QV +G+ +L  K+ I HRDV   N+L+ +G   KI DFG++  +++  +N 
Sbjct: 157 LRDLLHFSSQVAQGMAFLASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMND-SNY 214
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            V   +     +M+PE +    Y+VQSD+WS G+ L E+ ++G+ P P
Sbjct: 215 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 262

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 56/98 (57%), Gaps = 4/98 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ--LIDSMANSFVGTRS 66
           FQ+LKGL +   ++ ++HRD+KP N+L+N  GE+K+ DFG++    +     ++ V T  
Sbjct: 108 FQLLKGLGFCHSRN-VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLW 166
Query: 67  YMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPIPP 103
           Y  P+ L G   YS   D+WS G    E+A    P+ P
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFP 204

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 65/108 (60%), Gaps = 8/108 (7%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L+ + + S QV +G+ +L  K+ I HRDV   N+L+ +G   KI DFG++  +++  +N 
Sbjct: 159 LRDLLHFSSQVAQGMAFLASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMND-SNY 216
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            V   +     +M+PE +    Y+VQSD+WS G+ L E+ ++G+ P P
Sbjct: 217 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 264

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 33/85 (38%), Positives = 47/85 (55%), Gaps = 9/85 (10%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 75
           +  I++RD+KP NIL++  G I+I D G++     GQ I       VGT  YM+PE ++ 
Sbjct: 304 RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKN 359
Query: 76  THYSVQSDIWSLGLSLVEMAIGMYP 100
             Y+   D W+LG  L EM  G  P
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 33/85 (38%), Positives = 47/85 (55%), Gaps = 9/85 (10%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 75
           +  I++RD+KP NIL++  G I+I D G++     GQ I       VGT  YM+PE ++ 
Sbjct: 304 RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKN 359
Query: 76  THYSVQSDIWSLGLSLVEMAIGMYP 100
             Y+   D W+LG  L EM  G  P
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 117 WQVLEAVRHC-HNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 175
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 226

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/127 (33%), Positives = 65/127 (51%), Gaps = 13/127 (10%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNIL-VNSGGE---IKICDFGVSGQLI--DSMANSFV 62
           F + K + YL  +  ++HRD+KPSNIL V+  G    I+ICDFG + QL   + +  +  
Sbjct: 123 FTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPC 181
Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI---PPPDAKTLAAIFGPSR-- 117
            T ++++PE L+   Y    DIWSLG+ L     G  P    P    + + A  G  +  
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFS 241
Query: 118 -GDGYWH 123
              GYW+
Sbjct: 242 LSGGYWN 248

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 61/115 (53%), Gaps = 6/115 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYM 68
           Q+L  + Y   +H ++HRD+KP N+L+++    KI DFG+S  + D        G+ +Y 
Sbjct: 119 QILSAVDYC-HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYA 177
Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYW 122
           +PE + G  Y+  + DIWS G+ L  +  G  P    D + +  +F   RG  ++
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPF---DDEHVPTLFKKIRGGVFY 229

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 55/91 (60%), Gaps = 10/91 (10%)
Query: 14  GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS------GQLIDSMANSFVGTRSY 67
           G+ +L E H I HRD+K +NIL++     KI DFG++       Q +  M    VGT +Y
Sbjct: 139 GINFLHENHHI-HRDIKSANILLDEAFTAKISDFGLARASEKFAQXV--MXXRIVGTTAY 195
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGM 98
           M+PE L+G   + +SDI+S G+ L+E+  G+
Sbjct: 196 MAPEALRG-EITPKSDIYSFGVVLLEIITGL 225

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 55/91 (60%), Gaps = 10/91 (10%)
Query: 14  GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS------GQLIDSMANSFVGTRSY 67
           G+ +L E H I HRD+K +NIL++     KI DFG++       Q +  M    VGT +Y
Sbjct: 145 GINFLHENHHI-HRDIKSANILLDEAFTAKISDFGLARASEKFAQTV--MXXRIVGTTAY 201
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGM 98
           M+PE L+G   + +SDI+S G+ L+E+  G+
Sbjct: 202 MAPEALRG-EITPKSDIYSFGVVLLEIITGL 231

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 31/96 (32%), Positives = 57/96 (59%), Gaps = 2/96 (2%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           + + +++ GL ++  +  +++RD+KP+NIL++  G ++I D G++        ++ VGT 
Sbjct: 296 FYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 354
Query: 66  SYMSPERLQ-GTHYSVQSDIWSLGLSLVEMAIGMYP 100
            YM+PE LQ G  Y   +D +SLG  L ++  G  P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 31/96 (32%), Positives = 57/96 (59%), Gaps = 2/96 (2%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           + + +++ GL ++  +  +++RD+KP+NIL++  G ++I D G++        ++ VGT 
Sbjct: 296 FYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 354
Query: 66  SYMSPERLQ-GTHYSVQSDIWSLGLSLVEMAIGMYP 100
            YM+PE LQ G  Y   +D +SLG  L ++  G  P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 31/96 (32%), Positives = 57/96 (59%), Gaps = 2/96 (2%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           + + +++ GL ++  +  +++RD+KP+NIL++  G ++I D G++        ++ VGT 
Sbjct: 296 FYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 354
Query: 66  SYMSPERLQ-GTHYSVQSDIWSLGLSLVEMAIGMYP 100
            YM+PE LQ G  Y   +D +SLG  L ++  G  P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 31/96 (32%), Positives = 57/96 (59%), Gaps = 2/96 (2%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           + + +++ GL ++  +  +++RD+KP+NIL++  G ++I D G++        ++ VGT 
Sbjct: 295 FYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 353
Query: 66  SYMSPERLQ-GTHYSVQSDIWSLGLSLVEMAIGMYP 100
            YM+PE LQ G  Y   +D +SLG  L ++  G  P
Sbjct: 354 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 3/96 (3%)
Query: 8   SFQVLKGLTYLREKHA-IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVGT 64
           ++ V KG+ YL  ++  I+HR++K  N+LV+    +K+CDFG+S     +   + S  GT
Sbjct: 143 AYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGT 202
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
             +M+PE L+    + +SD++S G+ L E+A    P
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 61/113 (53%), Gaps = 10/113 (8%)
Query: 8   SFQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGE--------IKICDFGVSGQLIDSM 57
           + Q+ +G+ YL ++    IIHRD+K SNIL+    E        +KI DFG++ +   + 
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT 170
Query: 58  ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLA 110
             S  G  ++M+PE ++ + +S  SD+WS G+ L E+  G  P    D   +A
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA 223

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 54/98 (55%), Gaps = 11/98 (11%)
Query: 25  IHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTH---- 77
           +HRD+KP NIL++  G I++ DFG   +L++     ++  VGT  Y+SPE LQ       
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKG 256
Query: 78  -YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
            Y  + D WSLG+ + EM  G  P     A++L   +G
Sbjct: 257 RYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYG 291

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 51/85 (60%), Gaps = 7/85 (8%)
Query: 24  IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT---- 76
           +IHRDVKP N+L++  G +K+ DFG   ++ ++     ++ VGT  Y+SPE L+      
Sbjct: 195 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDG 254
Query: 77  HYSVQSDIWSLGLSLVEMAIGMYPI 101
           +Y  + D WS+G+ L EM +G  P 
Sbjct: 255 YYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 120 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 178
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 179 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 229

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ GL YL  +  I+H+D+KP N+L+ +GG +KI   GV+  L     D    +  G+ 
Sbjct: 117 QLIDGLEYLHSQ-GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 66  SYMSPERLQG--THYSVQSDIWSLGLSLVEMAIGMYPI 101
           ++  PE   G  T    + DIWS G++L  +  G+YP 
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 113 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAK 171
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 215

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 120 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAK 178
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 179 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 222

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 113 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAK 171
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 215

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 117 WQVLEAVRHC-HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 175
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 226

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 3/96 (3%)
Query: 8   SFQVLKGLTYLREKHA-IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS--FVGT 64
           ++ V KG+ YL  ++  I+HRD+K  N+LV+    +K+CDFG+S         S    GT
Sbjct: 143 AYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGT 202
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
             +M+PE L+    + +SD++S G+ L E+A    P
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 59/102 (57%), Gaps = 9/102 (8%)
Query: 10  QVLKGLTYLREKHA--IIHRDVKPSNILVNS--GGEIKICDFGVS-GQLIDSMANSFVGT 64
           Q++ G++Y    HA  + HRD+K  N L++      +KICDFG S   ++ S   S VGT
Sbjct: 122 QLISGVSYC---HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 178
Query: 65  RSYMSPERLQGTHYSVQ-SDIWSLGLSLVEMAIGMYPIPPPD 105
            +Y++PE L    Y  + +D+WS G++L  M +G YP   P+
Sbjct: 179 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 220

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 3/102 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYM 68
           Q+L G+ Y   +H ++HRD+KP N+L+++    KI DFG+S  + D        G+ +Y 
Sbjct: 124 QILSGVDYC-HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYA 182
Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           +PE + G  Y+  + DIWS G+ L  +  G  P       TL
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL 224

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 116 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAK 174
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 175 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 218

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 121 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 179
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 230

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 65/125 (52%), Gaps = 9/125 (7%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVG 63
           + + +++  L +L +K  II+RD+K  N+L++  G  K+ DFG+  + I +     +F G
Sbjct: 128 FYAAEIISALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCG 186
Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYWH 123
           T  Y++PE LQ   Y    D W++G+ L EM  G  P    +A+    +F     D    
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF---EAENEDDLFEAILND---E 240
Query: 124 VSYPT 128
           V YPT
Sbjct: 241 VVYPT 245

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 121 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 179
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 230

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 59/102 (57%), Gaps = 9/102 (8%)
Query: 10  QVLKGLTYLREKHA--IIHRDVKPSNILVNS--GGEIKICDFGVS-GQLIDSMANSFVGT 64
           Q++ G++Y    HA  + HRD+K  N L++      +KICDFG S   ++ S   S VGT
Sbjct: 123 QLISGVSYC---HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 179
Query: 65  RSYMSPERLQGTHYSVQ-SDIWSLGLSLVEMAIGMYPIPPPD 105
            +Y++PE L    Y  + +D+WS G++L  M +G YP   P+
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 221

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 122 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 180
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 231

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 137 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 195
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 246

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 137 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 195
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 246

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 122 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 180
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 231

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 136 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 194
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 195 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 245

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 122 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 180
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 231

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 136 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 194
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 195 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 245

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 137 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 195
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 246

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 164 WQVLEAVRHC-HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 222
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 223 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 273

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 144 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 202
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 203 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 253

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 149 WQVLEAVRHC-HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 207
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 258

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 164 WQVLEAVRHC-HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 222
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 223 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 273

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 120 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 179 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 222

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 115 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 174 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 156 WQVLEAVRHC-HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 214
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 265

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 115 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 174 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 113 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAK 171
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 215

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 60/109 (55%), Gaps = 5/109 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMANSFVGTRS 66
              L+GL YL + H I+HRD+KP+N+L++  G +K+ DFG++      +      V TR 
Sbjct: 119 LMTLQGLEYLHQ-HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRW 177
Query: 67  YMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPIP-PPDAKTLAAIF 113
           Y +PE L G   Y V  D+W++G  L E+ + +  +P   D   L  IF
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 226

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 120 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 179 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 222

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 169 WQVLEAVRHC-HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 227
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 228 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 278

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 117 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 175
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 176 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 219

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 119 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 221

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 117 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 175
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 176 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 219

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 115 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 174 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 59/110 (53%), Gaps = 6/110 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-DSMANS 60
           P++ F   ++  GL +L+ K  II+RD+K  N++++S G IKI DFG+  + I D +   
Sbjct: 121 PHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK 179
Query: 61  -FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
            F GT  Y++PE +    Y    D W+ G+ L EM  G  P    D   L
Sbjct: 180 XFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 120 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 179 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 222

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 120 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 179 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 222

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 115 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 174 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 32/83 (38%), Positives = 48/83 (57%), Gaps = 7/83 (8%)
Query: 25  IHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT----H 77
           IHRDVKP N+L++  G +K+ DFG   ++        ++ VGT  Y+SPE L+      +
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 254
Query: 78  YSVQSDIWSLGLSLVEMAIGMYP 100
           Y  + D WS+G+ L EM +G  P
Sbjct: 255 YGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 32/83 (38%), Positives = 48/83 (57%), Gaps = 7/83 (8%)
Query: 25  IHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT----H 77
           IHRDVKP N+L++  G +K+ DFG   ++        ++ VGT  Y+SPE L+      +
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 249
Query: 78  YSVQSDIWSLGLSLVEMAIGMYP 100
           Y  + D WS+G+ L EM +G  P
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 32/83 (38%), Positives = 48/83 (57%), Gaps = 7/83 (8%)
Query: 25  IHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT----H 77
           IHRDVKP N+L++  G +K+ DFG   ++        ++ VGT  Y+SPE L+      +
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 254
Query: 78  YSVQSDIWSLGLSLVEMAIGMYP 100
           Y  + D WS+G+ L EM +G  P
Sbjct: 255 YGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 56/98 (57%), Gaps = 3/98 (3%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-ID-SMANSFVG 63
           Y   Q ++G+ YL   + +IHRD+K  N+ +N   ++KI DFG++ ++  D     +  G
Sbjct: 146 YFMRQTIQGVQYL-HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCG 204
Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           T +Y++PE L    +S + DIWSLG  L  + +G  P 
Sbjct: 205 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 128 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 186
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 187 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 230

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 115 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 174 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 115 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 174 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 164 WQVLEAVRHC-HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 222
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 223 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 273

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           S QV +G+ +L  K+ I HRDV   N+L+ +G   KI DFG++  +++  +N  V   + 
Sbjct: 170 SSQVAQGMAFLASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMND-SNYIVKGNAR 227
Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
               +M+PE +    Y+VQSD+WS G+ L E+ ++G+ P P
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/86 (39%), Positives = 51/86 (59%), Gaps = 2/86 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-DSMANSFVGTRSYM 68
           Q+ KG+ Y+  K  +I+RD+KPSNI +    ++KI DFG+   L  D       GT  YM
Sbjct: 130 QITKGVDYIHSK-KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYM 188
Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEM 94
           SPE++    Y  + D+++LGL L E+
Sbjct: 189 SPEQISSQDYGKEVDLYALGLILAEL 214

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           S QV +G+ +L  K+ I HRDV   N+L+ +G   KI DFG++  +++  +N  V   + 
Sbjct: 170 SSQVAQGMAFLASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMND-SNYIVKGNAR 227
Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
               +M+PE +    Y+VQSD+WS G+ L E+ ++G+ P P
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 59/110 (53%), Gaps = 6/110 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-DSMANS 60
           P++ F   ++  GL +L+ K  II+RD+K  N++++S G IKI DFG+  + I D +   
Sbjct: 442 PHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK 500
Query: 61  -FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
            F GT  Y++PE +    Y    D W+ G+ L EM  G  P    D   L
Sbjct: 501 XFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 550

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 134 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAK 192
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 193 FPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID 236

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           S QV +G+ +L  K+ I HRDV   N+L+ +G   KI DFG++  +++  +N  V   + 
Sbjct: 172 SSQVAQGMAFLASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMND-SNYIVKGNAR 229
Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
               +M+PE +    Y+VQSD+WS G+ L E+ ++G+ P P
Sbjct: 230 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 270

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 3/111 (2%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 117 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 175
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y  +S  +WSLG+ L +M  G  P    +      +F   R
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 226

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 3/98 (3%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-ID-SMANSFVG 63
           Y   Q ++G+ YL   + +IHRD+K  N+ +N   ++KI DFG++ ++  D        G
Sbjct: 146 YFMRQTIQGVQYL-HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCG 204
Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           T +Y++PE L    +S + DIWSLG  L  + +G  P 
Sbjct: 205 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 56/101 (55%), Gaps = 3/101 (2%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-ID-SMANS 60
           +  Y   Q ++G+ YL   + +IHRD+K  N+ +N   ++KI DFG++ ++  D      
Sbjct: 127 EARYFMRQTIQGVQYL-HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD 185
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
             GT +Y++PE L    +S + DIWSLG  L  + +G  P 
Sbjct: 186 LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 226

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 3/95 (3%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 149 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 207
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPI 101
             PE ++   Y  +S  +WSLG+ L +M  G  P 
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 3/95 (3%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 150 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 208
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPI 101
             PE ++   Y  +S  +WSLG+ L +M  G  P 
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 3/95 (3%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 150 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 208
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPI 101
             PE ++   Y  +S  +WSLG+ L +M  G  P 
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 3/95 (3%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 150 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 208
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPI 101
             PE ++   Y  +S  +WSLG+ L +M  G  P 
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 3/95 (3%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 149 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 207
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPI 101
             PE ++   Y  +S  +WSLG+ L +M  G  P 
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 11/98 (11%)
Query: 25  IHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTH---- 77
           +HRD+KP N+L++  G I++ DFG   ++ D     ++  VGT  Y+SPE LQ       
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 256
Query: 78  -YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
            Y  + D WSLG+ + EM  G  P     A++L   +G
Sbjct: 257 KYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYG 291

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 3/95 (3%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 150 WQVLEAVRHC-HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 208
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPI 101
             PE ++   Y  +S  +WSLG+ L +M  G  P 
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 3/95 (3%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 149 WQVLEAVRHC-HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 207
Query: 68  MSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPI 101
             PE ++   Y  +S  +WSLG+ L +M  G  P 
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 58/100 (58%), Gaps = 6/100 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVG-TR- 65
           SFQV +G+ +L  +  I HRD+   NIL++    +KICDFG++  +  +      G TR 
Sbjct: 205 SFQVARGMEFLSSRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL 263
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
              +M+PE +    YS +SD+WS G+ L E+ ++G  P P
Sbjct: 264 PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYP 303

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 68/129 (52%), Gaps = 9/129 (6%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ-LIDSM-ANS 60
           Q  + + ++  GL +L  K  II+RD+K  N++++S G IKI DFG+  + ++D +    
Sbjct: 121 QAVFYAAEISIGLFFLH-KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTRE 179
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDG 120
           F GT  Y++PE +    Y    D W+ G+ L EM  G    PP D +    +F   +   
Sbjct: 180 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ---PPFDGEDEDELF---QSIM 233
Query: 121 YWHVSYPTT 129
             +VSYP +
Sbjct: 234 EHNVSYPKS 242

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 11/98 (11%)
Query: 25  IHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTH---- 77
           +HRD+KP N+L++  G I++ DFG   ++ D     ++  VGT  Y+SPE LQ       
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 272
Query: 78  -YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
            Y  + D WSLG+ + EM  G  P     A++L   +G
Sbjct: 273 KYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYG 307

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 51/89 (57%), Gaps = 4/89 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR--- 65
             V +G+ YL E+ ++IHRD+   N LV     IK+ DFG++  ++D    S  GT+   
Sbjct: 110 LDVCEGMAYL-EEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 168
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
            + SPE    + YS +SD+WS G+ + E+
Sbjct: 169 KWASPEVFSFSRYSSKSDVWSFGVLMWEV 197

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 3/98 (3%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-ID-SMANSFVG 63
           Y   Q ++G+ YL   + +IHRD+K  N+ +N   ++KI DFG++ ++  D        G
Sbjct: 146 YFMRQTIQGVQYL-HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCG 204
Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           T +Y++PE L    +S + DIWSLG  L  + +G  P 
Sbjct: 205 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 62/121 (51%), Gaps = 8/121 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILV---NSGGEIKICDFGVSGQLIDSMANSFVGTRS 66
           QVL  + YL E + I+HRD+KP N+L        +I I DFG+S    + + ++  GT  
Sbjct: 114 QVLSAVKYLHE-NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPG 172
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYWHVSY 126
           Y++PE L    YS   D WS+G+    +  G    PP   +T + +F   + +GY+    
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCGY---PPFYEETESKLFEKIK-EGYYEFES 228
Query: 127 P 127
           P
Sbjct: 229 P 229

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 4/89 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR--- 65
             V +G+ YL E+  +IHRD+   N LV     IK+ DFG++  ++D    S  GT+   
Sbjct: 113 LDVCEGMAYL-EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 171
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
            + SPE    + YS +SD+WS G+ + E+
Sbjct: 172 KWASPEVFSFSRYSSKSDVWSFGVLMWEV 200

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 4/89 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR--- 65
             V +G+ YL E+  +IHRD+   N LV     IK+ DFG++  ++D    S  GT+   
Sbjct: 111 LDVCEGMAYL-EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
            + SPE    + YS +SD+WS G+ + E+
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEV 198

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 4/89 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR--- 65
             V +G+ YL E+  +IHRD+   N LV     IK+ DFG++  ++D    S  GT+   
Sbjct: 110 LDVCEGMAYL-EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 168
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
            + SPE    + YS +SD+WS G+ + E+
Sbjct: 169 KWASPEVFSFSRYSSKSDVWSFGVLMWEV 197

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 4/89 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR--- 65
             V +G+ YL E+  +IHRD+   N LV     IK+ DFG++  ++D    S  GT+   
Sbjct: 108 LDVCEGMAYL-EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 166
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
            + SPE    + YS +SD+WS G+ + E+
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMWEV 195

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 56/102 (54%), Gaps = 3/102 (2%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSY 67
           Q+   L ++ ++  I+HRD+K  NI +   G +++ DFG++  L  +  +A + +GT  Y
Sbjct: 133 QICLALKHVHDRK-ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYY 191
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           +SPE  +   Y+ +SDIW+LG  L E+    +       K L
Sbjct: 192 LSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 15/99 (15%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFG-VSGQLIDSMANSF------- 61
           Q+ + + +L  K  ++HRD+KPSNI       +K+ DFG V+    D    +        
Sbjct: 172 QIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 62  ------VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
                 VGT+ YMSPE++ G +YS + DI+SLGL L E+
Sbjct: 231 ATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 56/107 (52%), Gaps = 18/107 (16%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFG-VSGQLIDSMANSF------ 61
            Q+ + + +L  K  ++HRD+KPSNI       +K+ DFG V+    D    +       
Sbjct: 125 LQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 62  -------VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
                  VGT+ YMSPE++ G  YS + DI+SLGL L E+   +YP 
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL---LYPF 227

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 116 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAK 174
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 175 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 218

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+ + + ++     I HRD+KP N+LVNS    +K+CDFG + +LI S  + + + +R 
Sbjct: 148 YQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRF 206
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
           Y +PE + G T Y+   D+WS+G    E+ +G
Sbjct: 207 YRAPELMLGATEYTPSIDLWSIGCVFGELILG 238

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 4/89 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR--- 65
             V +G+ YL E+  +IHRD+   N LV     IK+ DFG++  ++D    S  GT+   
Sbjct: 130 LDVCEGMAYL-EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 188
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
            + SPE    + YS +SD+WS G+ + E+
Sbjct: 189 KWASPEVFSFSRYSSKSDVWSFGVLMWEV 217

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +
Sbjct: 117 YMATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAK 175
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 176 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 219

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 4/98 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ--LIDSMANSFVGTRS 66
           FQ+LKGL +   ++ ++HRD+KP N+L+N  GE+K+ +FG++    +     ++ V T  
Sbjct: 108 FQLLKGLGFCHSRN-VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW 166
Query: 67  YMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPIPP 103
           Y  P+ L G   YS   D+WS G    E+A    P+ P
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 57/105 (54%), Gaps = 6/105 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDSMAN--SFVGT 64
           Q+L+ + ++ + H I+HRD+KP N+L+ S   G  +K+ DFG++ ++         F GT
Sbjct: 138 QILESVNHIHQ-HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGT 196
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
             Y+SPE L+   Y    DIW+ G+ L  + +G  P    D   L
Sbjct: 197 PGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKL 241

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 54/94 (57%), Gaps = 3/94 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           Q++ G  YL  ++ +IHRD+K  N+ +N   E+KI DFG++ ++        +  GT +Y
Sbjct: 129 QIVLGCQYL-HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNY 187
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           ++PE L    +S + D+WS+G  +  + +G  P 
Sbjct: 188 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 221

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 54/94 (57%), Gaps = 3/94 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           Q++ G  YL  ++ +IHRD+K  N+ +N   E+KI DFG++ ++        +  GT +Y
Sbjct: 125 QIVLGCQYL-HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNY 183
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           ++PE L    +S + D+WS+G  +  + +G  P 
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 42/99 (42%), Positives = 60/99 (60%), Gaps = 9/99 (9%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLID-SMANSFVGT 64
           +Q+L  + YL E + IIHRD+KP N+L++S  E   IKI DFG S  L + S+  +  GT
Sbjct: 260 YQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 318
Query: 65  RSYMSPERL--QGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
            +Y++PE L   GT  Y+   D WSLG+ L  + +  YP
Sbjct: 319 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYP 356

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 42/99 (42%), Positives = 60/99 (60%), Gaps = 9/99 (9%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLID-SMANSFVGT 64
           +Q+L  + YL E + IIHRD+KP N+L++S  E   IKI DFG S  L + S+  +  GT
Sbjct: 246 YQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304
Query: 65  RSYMSPERL--QGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
            +Y++PE L   GT  Y+   D WSLG+ L  + +  YP
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYP 342

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 54/94 (57%), Gaps = 3/94 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           Q++ G  YL  ++ +IHRD+K  N+ +N   E+KI DFG++ ++        +  GT +Y
Sbjct: 125 QIVLGCQYL-HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNY 183
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           ++PE L    +S + D+WS+G  +  + +G  P 
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHR++   N LV     +K+ DFG+S  +      +  G +
Sbjct: 322 YMATQISSAMEYL-EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 380
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 381 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y + Q+   + YL EK   IHR++   N LV     +K+ DFG+S  +      +  G +
Sbjct: 361 YMATQISSAMEYL-EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 419
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIPPPD 105
               + +PE L    +S++SD+W+ G+ L E+A  GM P P  D
Sbjct: 420 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 463

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 59/108 (54%), Gaps = 21/108 (19%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM------------ 57
           Q+L+ L+Y+  +  IIHRD+KP NI ++    +KI DFG++  +  S+            
Sbjct: 124 QILEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 58  ----ANSFVGTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYP 100
                 S +GT  Y++ E L GT HY+ + D++SLG+   EM   +YP
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM---IYP 227

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 59/108 (54%), Gaps = 21/108 (19%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM------------ 57
           Q+L+ L+Y+  +  IIHRD+KP NI ++    +KI DFG++  +  S+            
Sbjct: 124 QILEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 58  ----ANSFVGTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYP 100
                 S +GT  Y++ E L GT HY+ + D++SLG+   EM   +YP
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM---IYP 227

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 55/97 (56%), Gaps = 6/97 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDS--MANSFVGT 64
           Q+L+ L Y  + + IIHRDVKP N+L+ S      +K+ DFGV+ QL +S  +A   VGT
Sbjct: 138 QILEALRYCHDNN-IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGT 196
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
             +M+PE ++   Y    D+W  G+ L  +  G  P 
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 112 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 112 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 112 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 112 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 112 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 112 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 112 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 111 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 209

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 113 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 113 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 113 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMAN 59
           K +   ++QV +G+ YL  K  I HRD+   N+LV     +KI DFG++  +  ID    
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKK 208
Query: 60  SFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
           +  G     +M+PE L    Y+ QSD+WS G+ L E+  +G  P P
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 254

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 112 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 113 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 113 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 61/122 (50%), Gaps = 26/122 (21%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID---------- 55
           Y  +Q++K + YL     ++HRD+KPSNIL+N+   +K+ DFG+S   ++          
Sbjct: 113 YVVYQLIKVIKYLHSG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 56  -------------SMANSFVGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPI 101
                         +   +V TR Y +PE L G T Y+   D+WSLG  L E+  G  PI
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PI 230
Query: 102 PP 103
            P
Sbjct: 231 FP 232

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 113 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 112 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           Q+ +G+ ++ E++  IHRD++ +NILV+     KI DFG++  + D+   +  G +    
Sbjct: 117 QIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIK 175
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
           + +PE +    ++++SD+WS G+ L E+   G  P P
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 113 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 112 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---SY 67
           V + + YL  K   +HRD+   N LVN  G +K+ DFG+S  ++D    S VG++    +
Sbjct: 129 VCEAMEYLESKQ-FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRW 187
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYP 100
             PE L  + +S +SDIW+ G+ + E+ ++G  P
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 113 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 171
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 112 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 112 QLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 66  SYMSPERLQGTHYSVQS-DIWSLGLSLVEMAIGMYPIPPP 104
            Y++PE L+   +  +  D+WS G+ L  M  G  P   P
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           Q+ +G+ ++ E++  IHRD++ +NILV+     KI DFG++  + D+   +  G +    
Sbjct: 117 QIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 175
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
           + +PE +    ++++SD+WS G+ L E+   G  P P
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           Q+ +G+ ++ E++  IHRD++ +NILV+     KI DFG++  + D+   +  G +    
Sbjct: 118 QIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 176
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
           + +PE +    ++++SD+WS G+ L E+   G  P P
Sbjct: 177 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 213

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           Q+ +G+ ++ E++  IHRD++ +NILV+     KI DFG++  + D+   +  G +    
Sbjct: 119 QIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 177
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
           + +PE +    ++++SD+WS G+ L E+   G  P P
Sbjct: 178 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 214

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           Q+ +G+ ++ E++  IHRD++ +NILV+     KI DFG++  + D+   +  G +    
Sbjct: 125 QIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 183
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
           + +PE +    ++++SD+WS G+ L E+   G  P P
Sbjct: 184 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 220

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           Q+ +G+ ++ E++  IHRD++ +NILV+     KI DFG++  + D+   +  G +    
Sbjct: 123 QIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 181
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
           + +PE +    ++++SD+WS G+ L E+   G  P P
Sbjct: 182 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 218

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           Q+ +G+ ++ E++  IHRD++ +NILV+     KI DFG++  + D+   +  G +    
Sbjct: 117 QIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 175
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
           + +PE +    ++++SD+WS G+ L E+   G  P P
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           Q+ +G+ ++ E++  IHRD++ +NILV+     KI DFG++  + D+   +  G +    
Sbjct: 126 QIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK 184
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
           + +PE +    ++++SD+WS G+ L E+   G  P P
Sbjct: 185 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 221

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 54/107 (50%), Gaps = 7/107 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILV------NSGGEIKICDFGVSGQLIDSMANSF 61
           S Q+L GL Y+  +  IIH D+KP N+L+       +  +IKI D G +    +   NS 
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS- 195
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT 108
           + TR Y SPE L G  +   +DIWS    + E+  G +   P +  +
Sbjct: 196 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 54/107 (50%), Gaps = 7/107 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILV------NSGGEIKICDFGVSGQLIDSMANSF 61
           S Q+L GL Y+  +  IIH D+KP N+L+       +  +IKI D G +    +   NS 
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS- 195
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT 108
           + TR Y SPE L G  +   +DIWS    + E+  G +   P +  +
Sbjct: 196 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 58/107 (54%), Gaps = 6/107 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L+ +   SFQV KG+ +L  +  I HRD+   NIL++    +KI DFG++  +       
Sbjct: 143 LEHLIXYSFQVAKGMEFLASRKXI-HRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYV 201
Query: 61  FVGTR----SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
             G       +M+PE +    Y++QSD+WS G+ L E+ ++G  P P
Sbjct: 202 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 248

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 59/106 (55%), Gaps = 6/106 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYM 68
           Q++  + Y   +H I+HRD+KP N+L++    +KI DFG+S  + D +   +  G+ +Y 
Sbjct: 111 QIISAVEYC-HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 169
Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           +PE + G  Y+  + D+WS G+ L  M     P    D +++  +F
Sbjct: 170 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF---DDESIPVLF 212

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 59/99 (59%), Gaps = 5/99 (5%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           S Q+ +G+ ++ E+   IHRD++ +NILV++    KI DFG++  + D+   +  G +  
Sbjct: 117 SAQIAEGMAFI-EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 175
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             + +PE +    ++++SD+WS G+ L+E+   G  P P
Sbjct: 176 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 214

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 59/106 (55%), Gaps = 6/106 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYM 68
           Q++  + Y   +H I+HRD+KP N+L++    +KI DFG+S  + D +   +  G+ +Y 
Sbjct: 115 QIISAVEYC-HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 173
Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           +PE + G  Y+  + D+WS G+ L  M     P    D +++  +F
Sbjct: 174 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF---DDESIPVLF 216

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 5/97 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           QV  G+ Y+ E+   IHRD++ +NILV +G   KI DFG++  + D+   +  G +    
Sbjct: 113 QVAAGMAYI-ERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIK 171
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
           + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 172 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP 208

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 59/106 (55%), Gaps = 6/106 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYM 68
           Q++  + Y   +H I+HRD+KP N+L++    +KI DFG+S  + D +   +  G+ +Y 
Sbjct: 120 QIISAVEYC-HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 178
Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           +PE + G  Y+  + D+WS G+ L  M     P    D +++  +F
Sbjct: 179 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF---DDESIPVLF 221

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           Q++ G  YL  ++ +IHRD+K  N+ +N   E+KI DFG++ ++           GT +Y
Sbjct: 149 QIVLGCQYL-HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 207
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           ++PE L    +S + D+WS+G  +  + +G  P 
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 241

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 54/89 (60%), Gaps = 6/89 (6%)
Query: 14  GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGV---SGQLIDSMANS-FVGTRSYMS 69
           G+ +L E H I HRD+K +NIL++     KI DFG+   S +    +  S  VGT +Y +
Sbjct: 136 GINFLHENHHI-HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXA 194
Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGM 98
           PE L+G   + +SDI+S G+ L+E+  G+
Sbjct: 195 PEALRG-EITPKSDIYSFGVVLLEIITGL 222

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           Q++ G  YL  ++ +IHRD+K  N+ +N   E+KI DFG++ ++           GT +Y
Sbjct: 147 QIVLGCQYL-HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 205
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           ++PE L    +S + D+WS+G  +  + +G  P 
Sbjct: 206 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 239

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/99 (42%), Positives = 60/99 (60%), Gaps = 9/99 (9%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLID-SMANSFVGT 64
           +Q+L  + YL E + IIHRD+KP N+L++S  E   IKI DFG S  L + S+  +  GT
Sbjct: 120 YQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 178
Query: 65  RSYMSPERL--QGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
            +Y++PE L   GT  Y+   D WSLG+ L  + +  YP
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYP 216

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---SY 67
           V + + YL  K   +HRD+   N LVN  G +K+ DFG+S  ++D    S VG++    +
Sbjct: 113 VCEAMEYLESKQ-FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 171
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYP 100
             PE L  + +S +SDIW+ G+ + E+ ++G  P
Sbjct: 172 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 205

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 59/99 (59%), Gaps = 5/99 (5%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           S Q+ +G+ ++ E+   IHRD++ +NILV++    KI DFG++  + D+   +  G +  
Sbjct: 290 SAQIAEGMAFI-EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             + +PE +    ++++SD+WS G+ L+E+   G  P P
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 387

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/99 (42%), Positives = 60/99 (60%), Gaps = 9/99 (9%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLID-SMANSFVGT 64
           +Q+L  + YL E + IIHRD+KP N+L++S  E   IKI DFG S  L + S+  +  GT
Sbjct: 121 YQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 65  RSYMSPERL--QGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
            +Y++PE L   GT  Y+   D WSLG+ L  + +  YP
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYP 217

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 60/116 (51%), Gaps = 6/116 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANS 60
           P +S+   Q++  + YLR K  IIHRD+K  NI++     IK+ DFG +  L    +  +
Sbjct: 130 PLASYIFRQLVSAVGYLRLKD-IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188
Query: 61  FVGTRSYMSPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
           F GT  Y +PE L G  Y   + ++WSLG++L  +     P    +    AAI  P
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPP 244

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 59/106 (55%), Gaps = 6/106 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYM 68
           Q++  + Y   +H I+HRD+KP N+L++    +KI DFG+S  + D +   +  G+ +Y 
Sbjct: 121 QIISAVEYC-HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 179
Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           +PE + G  Y+  + D+WS G+ L  M     P    D +++  +F
Sbjct: 180 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF---DDESIPVLF 222

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 57/102 (55%), Gaps = 5/102 (4%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
           Q+    + V +G+ +L E H  IHRD+   N LV+    +K+ DFG++  ++D    S V
Sbjct: 105 QLLEMCYDVCEGMAFL-ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163
Query: 63  GTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYP 100
           GT+    + +PE      YS +SD+W+ G+ + E+ ++G  P
Sbjct: 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 60/114 (52%), Gaps = 6/114 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           Q++ G  YL  ++ +IHRD+K  N+ +N   E+KI DFG++ ++           GT +Y
Sbjct: 123 QIVLGCQYL-HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGY 121
           ++PE L    +S + D+WS+G  +  + +G    PP +   L   +   + + Y
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK---PPFETSCLKETYLRIKKNEY 232

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/99 (42%), Positives = 60/99 (60%), Gaps = 9/99 (9%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLID-SMANSFVGT 64
           +Q+L  + YL E + IIHRD+KP N+L++S  E   IKI DFG S  L + S+  +  GT
Sbjct: 121 YQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 65  RSYMSPERL--QGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
            +Y++PE L   GT  Y+   D WSLG+ L  + +  YP
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYP 217

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 58/102 (56%), Gaps = 9/102 (8%)
Query: 10  QVLKGLTYLREKHA--IIHRDVKPSNILVNS--GGEIKICDFGVS-GQLIDSMANSFVGT 64
           Q++ G++Y    HA  + HRD+K  N L++      +KIC FG S   ++ S   S VGT
Sbjct: 123 QLISGVSYC---HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGT 179
Query: 65  RSYMSPERLQGTHYSVQ-SDIWSLGLSLVEMAIGMYPIPPPD 105
            +Y++PE L    Y  + +D+WS G++L  M +G YP   P+
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 221

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---SY 67
           V + + YL  K   +HRD+   N LVN  G +K+ DFG+S  ++D    S VG++    +
Sbjct: 129 VCEAMEYLESKQ-FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 187
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYP 100
             PE L  + +S +SDIW+ G+ + E+ ++G  P
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           Q+ +G+ ++ E++  IHRD++ +NILV+     KI DFG++  + D+   +  G +    
Sbjct: 122 QIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 180
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
           + +PE +    ++++SD+WS G+ L E+   G  P P
Sbjct: 181 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 217

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           Q+ +G+ ++ E++  IHRD++ +NILV+     KI DFG++  + D+   +  G +    
Sbjct: 123 QIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 181
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
           + +PE +    ++++SD+WS G+ L E+   G  P P
Sbjct: 182 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 218

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/99 (42%), Positives = 60/99 (60%), Gaps = 9/99 (9%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLID-SMANSFVGT 64
           +Q+L  + YL E + IIHRD+KP N+L++S  E   IKI DFG S  L + S+  +  GT
Sbjct: 121 YQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 65  RSYMSPERL--QGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
            +Y++PE L   GT  Y+   D WSLG+ L  + +  YP
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYP 217

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/99 (42%), Positives = 60/99 (60%), Gaps = 9/99 (9%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLID-SMANSFVGT 64
           +Q+L  + YL E + IIHRD+KP N+L++S  E   IKI DFG S  L + S+  +  GT
Sbjct: 127 YQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 185
Query: 65  RSYMSPERL--QGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
            +Y++PE L   GT  Y+   D WSLG+ L  + +  YP
Sbjct: 186 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYP 223

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           Q+ +G+ ++ E++  IHRD++ +NILV+     KI DFG++  + D+   +  G +    
Sbjct: 117 QIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
           + +PE +    ++++SD+WS G+ L E+   G  P P
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---SY 67
           V + + YL  K   +HRD+   N LVN  G +K+ DFG+S  ++D    S VG++    +
Sbjct: 120 VCEAMEYLESKQ-FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 178
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYP 100
             PE L  + +S +SDIW+ G+ + E+ ++G  P
Sbjct: 179 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 212

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMAN 59
           K +   ++QV +G+ YL  K  I HRD+   N+LV     +KI DFG++  +  ID    
Sbjct: 135 KDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 60  SFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
           +  G     +M+PE L    Y+ QSD+WS G+ L E+  +G  P P
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMAN 59
           K +   ++QV +G+ YL  K  I HRD+   N+LV     +KI DFG++  +  ID    
Sbjct: 143 KDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 201
Query: 60  SFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
           +  G     +M+PE L    Y+ QSD+WS G+ L E+  +G  P P
Sbjct: 202 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 247

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMAN 59
           K +   ++QV +G+ YL  K  I HRD+   N+LV     +KI DFG++  +  ID    
Sbjct: 142 KDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 200
Query: 60  SFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
           +  G     +M+PE L    Y+ QSD+WS G+ L E+  +G  P P
Sbjct: 201 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 246

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMAN 59
           K +   ++QV +G+ YL  K  I HRD+   N+LV     +KI DFG++  +  ID    
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 60  SFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
           +  G     +M+PE L    Y+ QSD+WS G+ L E+  +G  P P
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 254

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 58/102 (56%), Gaps = 9/102 (8%)
Query: 10  QVLKGLTYLREKHA--IIHRDVKPSNILVNS--GGEIKICDFGVS-GQLIDSMANSFVGT 64
           Q++ G++Y    HA  + HRD+K  N L++      +KI DFG S   ++ S   S VGT
Sbjct: 123 QLISGVSY---AHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGT 179
Query: 65  RSYMSPERLQGTHYSVQ-SDIWSLGLSLVEMAIGMYPIPPPD 105
            +Y++PE L    Y  + +D+WS G++L  M +G YP   P+
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 221

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---SY 67
           V + + YL  K   +HRD+   N LVN  G +K+ DFG+S  ++D    S VG++    +
Sbjct: 109 VCEAMEYLESKQ-FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 167
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYP 100
             PE L  + +S +SDIW+ G+ + E+ ++G  P
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 201

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMAN 59
           K +   ++QV +G+ YL  K  I HRD+   N+LV     +KI DFG++  +  ID    
Sbjct: 139 KDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 197
Query: 60  SFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
           +  G     +M+PE L    Y+ QSD+WS G+ L E+  +G  P P
Sbjct: 198 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 243

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMAN 59
           K +   ++QV +G+ YL  K  I HRD+   N+LV     +KI DFG++  +  ID    
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 60  SFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
           +  G     +M+PE L    Y+ QSD+WS G+ L E+  +G  P P
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 254

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMAN 59
           K +   ++QV +G+ YL  K  I HRD+   N+LV     +KI DFG++  +  ID    
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 60  SFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
           +  G     +M+PE L    Y+ QSD+WS G+ L E+  +G  P P
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 254

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 58/107 (54%), Gaps = 6/107 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMA 58
            K +   ++Q+ +G+ YL  +  I HRD+   N+LV     +KI DFG++  +  ID   
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 59  NSFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
           N+  G     +M+PE L    Y+ QSD+WS G+ + E+  +G  P P
Sbjct: 215 NTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 4/92 (4%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMAN-SFVGTRS 66
           +Q+L+ L Y+     I HRD+KP N+L++   G +K+ DFG +  LI    N S + +R 
Sbjct: 148 YQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY 206
Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
           Y +PE + G T+Y+   DIWS G  + E+  G
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           Q+ +G+ ++ E++  IHRD++ +NILV+     KI DFG++  + D+   +  G +    
Sbjct: 127 QIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 185
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
           + +PE +    ++++SD+WS G+ L E+   G  P P
Sbjct: 186 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 222

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMAN 59
           K +   ++QV +G+ YL  K  I HRD+   N+LV     +KI DFG++  +  ID    
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 60  SFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
           +  G     +M+PE L    Y+ QSD+WS G+ L E+  +G  P P
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---SY 67
           V + + YL  K   +HRD+   N LVN  G +K+ DFG+S  ++D    S VG++    +
Sbjct: 114 VCEAMEYLESKQ-FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 172
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYP 100
             PE L  + +S +SDIW+ G+ + E+ ++G  P
Sbjct: 173 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 56/97 (57%), Gaps = 7/97 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDS--MANSFVGT 64
           Q+L+ + YL E + I+HRD+KP N+L  +      +KI DFG+S ++++   +  +  GT
Sbjct: 156 QILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLS-KIVEHQVLMKTVCGT 213
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
             Y +PE L+G  Y  + D+WS+G+    +  G  P 
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           Q+ +G+ ++ E++  IHRD++ +NILV+     KI DFG++  + D+   +  G +    
Sbjct: 112 QIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 170
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
           + +PE +    ++++SD+WS G+ L E+   G  P P
Sbjct: 171 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 207

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G IK+ DFG + + +       
Sbjct: 142 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIKVADFGFAKR-VKGRTWXL 199
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G IK+ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIKVADFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 8/107 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF---VGTR 65
            QV KG+ +L  K   +HRD+   N +++    +K+ DFG++  ++D   +S     G +
Sbjct: 141 LQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAK 199
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
               +M+ E LQ   ++ +SD+WS G+ L E+     P P PD  T 
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTF 245

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G IK+ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIKVADFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 8/105 (7%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE--IKICDFGVSGQLIDSMA 58
           +++  +S  Q L  L     K+ IIH D+KP NIL+   G   IK+ DFG S        
Sbjct: 202 VRKFAHSILQCLDAL----HKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQRV 256
Query: 59  NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
            + + +R Y +PE + G  Y +  D+WSLG  L E+  G YP+ P
Sbjct: 257 YTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLP 300

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 57/99 (57%), Gaps = 5/99 (5%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           S Q+ +G+ Y+ E+   IHRD++ +N+LV+     KI DFG++  + D+   +  G +  
Sbjct: 116 SAQIAEGMAYI-ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 174
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             + +PE +    ++++SD+WS G+ L E+   G  P P
Sbjct: 175 IKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYP 213

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G IK+ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIKVADFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/77 (46%), Positives = 45/77 (58%), Gaps = 3/77 (3%)
Query: 23  AIIHRDVKPSNILVNS--GGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 80
           +IIH D+KP NIL+ +     IKI DFG S QL   +    + +R Y SPE L G  Y +
Sbjct: 179 SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX-IQSRFYRSPEVLLGMPYDL 237
Query: 81  QSDIWSLGLSLVEMAIG 97
             D+WSLG  LVEM  G
Sbjct: 238 AIDMWSLGCILVEMHTG 254

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 8/105 (7%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE--IKICDFGVSGQLIDSMA 58
           +++  +S  Q L  L     K+ IIH D+KP NIL+   G   IK+ DFG S        
Sbjct: 202 VRKFAHSILQCLDAL----HKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQRV 256
Query: 59  NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
            + + +R Y +PE + G  Y +  D+WSLG  L E+  G YP+ P
Sbjct: 257 YTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLP 300

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           +K + Y+S Q+ KG+ YL  K   IHRD+   NILV +   +KI DFG++  L       
Sbjct: 114 IKLLQYTS-QICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKE 169
Query: 61  FVGTRS-------YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           F   +        + +PE L  + +SV SD+WS G+ L E+   +     P A+ +  I 
Sbjct: 170 FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229
Query: 114 GPSRG 118
              +G
Sbjct: 230 NDKQG 234

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 61/107 (57%), Gaps = 12/107 (11%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           ++Q+ +G+ YL E   ++HRD+   NILV  G ++KI DFG+S  + +   +S+V     
Sbjct: 156 AWQISQGMQYLAE-MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE--DSYVKRSQG 212
Query: 66  ----SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP--PPD 105
                +M+ E L    Y+ QSD+WS G+ L E+  +G  P P  PP+
Sbjct: 213 RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 60/105 (57%), Gaps = 8/105 (7%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGT- 64
           ++Q+ +G+ YL E  +++HRD+   NILV  G ++KI DFG+S  +   DS      G  
Sbjct: 156 AWQISQGMQYLAE-MSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRI 214
Query: 65  -RSYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP--PPD 105
              +M+ E L    Y+ QSD+WS G+ L E+  +G  P P  PP+
Sbjct: 215 PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/77 (46%), Positives = 45/77 (58%), Gaps = 3/77 (3%)
Query: 23  AIIHRDVKPSNILVNS--GGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 80
           +IIH D+KP NIL+ +     IKI DFG S QL   +    + +R Y SPE L G  Y +
Sbjct: 160 SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX-IQSRFYRSPEVLLGMPYDL 218
Query: 81  QSDIWSLGLSLVEMAIG 97
             D+WSLG  LVEM  G
Sbjct: 219 AIDMWSLGCILVEMHTG 235

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 48/78 (61%), Gaps = 2/78 (2%)
Query: 22  HAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF-VGTRSYMSPERLQGTHYSV 80
             ++H DVKP+NI +   G  K+ DFG+  +L  + A     G   YM+PE LQG+ Y  
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS-YGT 234
Query: 81  QSDIWSLGLSLVEMAIGM 98
            +D++SLGL+++E+A  M
Sbjct: 235 AADVFSLGLTILEVACNM 252

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/77 (46%), Positives = 45/77 (58%), Gaps = 3/77 (3%)
Query: 23  AIIHRDVKPSNILVNSGGE--IKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 80
           +IIH D+KP NIL+ +     IKI DFG S QL   +    + +R Y SPE L G  Y +
Sbjct: 179 SIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQX-IQSRFYRSPEVLLGMPYDL 237
Query: 81  QSDIWSLGLSLVEMAIG 97
             D+WSLG  LVEM  G
Sbjct: 238 AIDMWSLGCILVEMHTG 254

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N++++  G IK+ DFG++ + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLMIDQQGYIKVTDFGLAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 8/107 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF---VGTR 65
            QV KG+ YL  K   +HRD+   N +++    +K+ DFG++  + D    S     G +
Sbjct: 139 LQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAK 197
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
               +M+ E LQ   ++ +SD+WS G+ L E+     P P PD  T 
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTF 243

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 59/105 (56%), Gaps = 8/105 (7%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGT- 64
           ++Q+ +G+ YL E   ++HRD+   NILV  G ++KI DFG+S  +   DS      G  
Sbjct: 156 AWQISQGMQYLAE-MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRI 214
Query: 65  -RSYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP--PPD 105
              +M+ E L    Y+ QSD+WS G+ L E+  +G  P P  PP+
Sbjct: 215 PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 3/95 (3%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ-LIDSMANS 60
           + + Y  + +L GL  L E   ++HRD+ P NIL+    +I ICDF ++ +   D+    
Sbjct: 134 QHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192
Query: 61  FVGTRSYMSPER-LQGTHYSVQSDIWSLGLSLVEM 94
           +V  R Y +PE  +Q   ++   D+WS G  + EM
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           +K + Y+S Q+ KG+ YL  K   IHRD+   NILV +   +KI DFG++  L       
Sbjct: 119 IKLLQYTS-QICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 176
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
            V         + +PE L  + +SV SD+WS G+ L E+   +     P A+ +  I   
Sbjct: 177 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 236
Query: 116 SRG 118
            +G
Sbjct: 237 KQG 239

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 13  KGLTYLREKHAIIHRDVKPSNIL-VNSGGE---IKICDFGVSGQLI--DSMANSFVGTRS 66
           K + YL  +  ++HRD+KPSNIL V+  G    ++ICDFG + QL   + +  +   T +
Sbjct: 132 KTVEYLHSQ-GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN 190
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           +++PE L+   Y    DIWSLG+ L  M  G  P 
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 3/95 (3%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ-LIDSMANS 60
           + + Y  + +L GL  L E   ++HRD+ P NIL+    +I ICDF ++ +   D+    
Sbjct: 134 QHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192
Query: 61  FVGTRSYMSPER-LQGTHYSVQSDIWSLGLSLVEM 94
           +V  R Y +PE  +Q   ++   D+WS G  + EM
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           +K + Y+S Q+ KG+ YL  K   IHRD+   NILV +   +KI DFG++  L       
Sbjct: 117 IKLLQYTS-QICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 174
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
            V         + +PE L  + +SV SD+WS G+ L E+   +     P A+ +  I   
Sbjct: 175 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 234
Query: 116 SRG 118
            +G
Sbjct: 235 KQG 237

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           +K + Y+S Q+ KG+ YL  K   IHRD+   NILV +   +KI DFG++  L       
Sbjct: 145 IKLLQYTS-QICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 202
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
            V         + +PE L  + +SV SD+WS G+ L E+   +     P A+ +  I   
Sbjct: 203 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262
Query: 116 SRG 118
            +G
Sbjct: 263 KQG 265

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           +K + Y+S Q+ KG+ YL  K   IHRD+   NILV +   +KI DFG++  L       
Sbjct: 117 IKLLQYTS-QICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 174
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
            V         + +PE L  + +SV SD+WS G+ L E+   +     P A+ +  I   
Sbjct: 175 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 234
Query: 116 SRG 118
            +G
Sbjct: 235 KQG 237

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           +K + Y+S Q+ KG+ YL  K   IHRD+   NILV +   +KI DFG++  L       
Sbjct: 121 IKLLQYTS-QICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 178
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
            V         + +PE L  + +SV SD+WS G+ L E+   +     P A+ +  I   
Sbjct: 179 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 238
Query: 116 SRG 118
            +G
Sbjct: 239 KQG 241

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           +K + Y+S Q+ KG+ YL  K   IHRD+   NILV +   +KI DFG++  L       
Sbjct: 120 IKLLQYTS-QICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 177
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
            V         + +PE L  + +SV SD+WS G+ L E+   +     P A+ +  I   
Sbjct: 178 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 237
Query: 116 SRG 118
            +G
Sbjct: 238 KQG 240

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           +K + Y+S Q+ KG+ YL  K   IHRD+   NILV +   +KI DFG++  L       
Sbjct: 117 IKLLQYTS-QICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 174
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
            V         + +PE L  + +SV SD+WS G+ L E+   +     P A+ +  I   
Sbjct: 175 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 234
Query: 116 SRG 118
            +G
Sbjct: 235 KQG 237

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +     + 
Sbjct: 127 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWTL 184
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 185 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           +K + Y+S Q+ KG+ YL  K   IHRD+   NILV +   +KI DFG++  L       
Sbjct: 114 IKLLQYTS-QICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 171
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
            V         + +PE L  + +SV SD+WS G+ L E+   +     P A+ +  I   
Sbjct: 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231
Query: 116 SRG 118
            +G
Sbjct: 232 KQG 234

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 13  KGLTYLREKHAIIHRDVKPSNIL-VNSGGE---IKICDFGVSGQLI--DSMANSFVGTRS 66
           K + YL  +  ++HRD+KPSNIL V+  G    ++ICDFG + QL   + +  +   T +
Sbjct: 132 KTVEYLHSQ-GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN 190
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           +++PE L+   Y    DIWSLG+ L  M  G  P 
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 61/107 (57%), Gaps = 8/107 (7%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI----DS 56
           +K++   + Q  +G+ YL  K +IIHRD+K +NI ++    +KI DFG++ +        
Sbjct: 119 MKKLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177
Query: 57  MANSFVGTRSYMSPE--RLQGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
                 G+  +M+PE  R+Q ++ YS QSD+++ G+ L E+  G  P
Sbjct: 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 61/107 (57%), Gaps = 8/107 (7%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI----DS 56
           +K++   + Q  +G+ YL  K +IIHRD+K +NI ++    +KI DFG++ +        
Sbjct: 119 MKKLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177
Query: 57  MANSFVGTRSYMSPE--RLQGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
                 G+  +M+PE  R+Q ++ YS QSD+++ G+ L E+  G  P
Sbjct: 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +     + 
Sbjct: 162 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGATWTL 219
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           +K + Y+S Q+ KG+ YL  K   IHRD+   NILV +   +KI DFG++  L       
Sbjct: 132 IKLLQYTS-QICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 189
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
            V         + +PE L  + +SV SD+WS G+ L E+   +     P A+ +  I   
Sbjct: 190 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 249
Query: 116 SRG 118
            +G
Sbjct: 250 KQG 252

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           +K + Y+S Q+ KG+ YL  K   IHRD+   NILV +   +KI DFG++  L       
Sbjct: 132 IKLLQYTS-QICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 189
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
            V         + +PE L  + +SV SD+WS G+ L E+   +     P A+ +  I   
Sbjct: 190 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 249
Query: 116 SRG 118
            +G
Sbjct: 250 KQG 252

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           +K + Y+S Q+ KG+ YL  K   IHRD+   NILV +   +KI DFG++  L       
Sbjct: 118 IKLLQYTS-QICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 175
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
            V         + +PE L  + +SV SD+WS G+ L E+   +     P A+ +  I   
Sbjct: 176 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 235
Query: 116 SRG 118
            +G
Sbjct: 236 KQG 238

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           +K + Y+S Q+ KG+ YL  K   IHRD+   NILV +   +KI DFG++  L       
Sbjct: 114 IKLLQYTS-QICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 171
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
            V         + +PE L  + +SV SD+WS G+ L E+   +     P A+ +  I   
Sbjct: 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231
Query: 116 SRG 118
            +G
Sbjct: 232 KQG 234

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           +K + Y+S Q+ KG+ YL  K   IHRD+   NILV +   +KI DFG++  L       
Sbjct: 113 IKLLQYTS-QICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 170
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
            V         + +PE L  + +SV SD+WS G+ L E+   +     P A+ +  I   
Sbjct: 171 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 230
Query: 116 SRG 118
            +G
Sbjct: 231 KQG 233

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           +K + Y+S Q+ KG+ YL  K   IHRD+   NILV +   +KI DFG++  L       
Sbjct: 112 IKLLQYTS-QICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 169
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
            V         + +PE L  + +SV SD+WS G+ L E+   +     P A+ +  I   
Sbjct: 170 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 229
Query: 116 SRG 118
            +G
Sbjct: 230 KQG 232

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 54/105 (51%), Gaps = 8/105 (7%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE--IKICDFGVSGQLIDSMA 58
           +++  +S  Q L  L     K+ IIH D+KP NIL+   G   IK+ DFG S        
Sbjct: 202 VRKFAHSILQCLDAL----HKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQRV 256
Query: 59  NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
              + +R Y +PE + G  Y +  D+WSLG  L E+  G YP+ P
Sbjct: 257 YXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLP 300

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +     + 
Sbjct: 142 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWTL 199
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 57/102 (55%), Gaps = 9/102 (8%)
Query: 10  QVLKGLTYLREKHA--IIHRDVKPSNILVNS--GGEIKICDFGVS-GQLIDSMANSFVGT 64
           Q++ G++Y    HA  + HRD+K  N L++      +KIC FG S   ++ S     VGT
Sbjct: 123 QLISGVSYC---HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGT 179
Query: 65  RSYMSPERLQGTHYSVQ-SDIWSLGLSLVEMAIGMYPIPPPD 105
            +Y++PE L    Y  + +D+WS G++L  M +G YP   P+
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 221

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N++++  G IK+ DFG + + +       
Sbjct: 142 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGRTWXL 199
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N++++  G IK+ DFG + + +       
Sbjct: 142 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGRTWXL 199
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 14  GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR----SYMS 69
           G+ YL E    IHRD+   N LV     +KI DFG+S +  D +  +  G R     + +
Sbjct: 225 GMEYL-ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTA 283
Query: 70  PERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
           PE L    YS +SD+WS G+ L E  ++G  P P
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYP 317

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N++++  G IK+ DFG + + +       
Sbjct: 142 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGRTWXL 199
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N++++  G IK+ DFG + + +       
Sbjct: 142 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGRTWXL 199
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N++++  G IK+ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N++++  G IK+ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF---VGTR 65
            QV KG+ +L  K   +HRD+   N +++    +K+ DFG++  + D   +S     G +
Sbjct: 141 LQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 199
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
               +M+ E LQ   ++ +SD+WS G+ L E+     P P PD  T 
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTF 245

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 6/97 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI---DSMANSFVGTRS 66
           +++  L +L  K  II+RD+K  NIL++S G + + DFG+S + +      A  F GT  
Sbjct: 167 EIVLALEHLH-KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 67  YMSPERLQG--THYSVQSDIWSLGLSLVEMAIGMYPI 101
           YM+P+ ++G  + +    D WSLG+ + E+  G  P 
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF---VGTR 65
            QV KG+ +L  K   +HRD+   N +++    +K+ DFG++  + D   +S     G +
Sbjct: 138 LQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 196
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
               +M+ E LQ   ++ +SD+WS G+ L E+     P P PD  T 
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTF 242

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF---VGTR 65
            QV KG+ +L  K   +HRD+   N +++    +K+ DFG++  + D   +S     G +
Sbjct: 140 LQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
               +M+ E LQ   ++ +SD+WS G+ L E+     P P PD  T 
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTF 244

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF---VGTR 65
            QV KG+ +L  K   +HRD+   N +++    +K+ DFG++  + D   +S     G +
Sbjct: 140 LQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
               +M+ E LQ   ++ +SD+WS G+ L E+     P P PD  T 
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTF 244

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF---VGTR 65
            QV KG+ +L  K   +HRD+   N +++    +K+ DFG++  + D   +S     G +
Sbjct: 145 LQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 203
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
               +M+ E LQ   ++ +SD+WS G+ L E+     P P PD  T 
Sbjct: 204 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTF 249

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 AGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF---VGTR 65
            QV KG+ +L  K   +HRD+   N +++    +K+ DFG++  + D   +S     G +
Sbjct: 199 LQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
               +M+ E LQ   ++ +SD+WS G+ L E+     P P PD  T 
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTF 303

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMAN 59
           LKQ    + Q+ KG+ YL  +   +HRD+   N+LV S  ++KI DFG++  +  D    
Sbjct: 113 LKQQLKYAVQICKGMDYLGSRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXX 171
Query: 60  SFVGTRS----YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
           +    R     + +PE L  + + + SD+WS G++L E+         P A  L  I GP
Sbjct: 172 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI-GP 230
Query: 116 SRG 118
           + G
Sbjct: 231 THG 233

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 142 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 199
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTR 65
            QV KG+ YL  K   +HRD+   N +++    +K+ DFG++  + D      ++  G +
Sbjct: 138 LQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 196
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
               +M+ E LQ   ++ +SD+WS G+ L E+     P P PD  T 
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTF 242

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTR 65
            QV KG+ YL  K   +HRD+   N +++    +K+ DFG++  + D      ++  G +
Sbjct: 135 LQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
               +M+ E LQ   ++ +SD+WS G+ L E+     P P PD  T 
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTF 239

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 142 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 199
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 142 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 199
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMA 58
            K +   ++Q+ +G+ YL  +  I HRD+   N+LV     +KI DFG++  +  ID   
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 59  NSFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +  G     +M+PE L    Y+ QSD+WS G+ + E+  +G  P P
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           Q+ +G+ ++ E++  IHR+++ +NILV+     KI DFG++  + D+   +  G +    
Sbjct: 113 QIAEGMAFIEERN-YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 171
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
           + +PE +    ++++SD+WS G+ L E+   G  P P
Sbjct: 172 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 208

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 128 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDEQGYIQVTDFGFAKR-VKGRTWXL 185
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 186 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTR 65
            QV KG+ YL  K   +HRD+   N +++    +K+ DFG++  + D      ++  G +
Sbjct: 132 LQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 190
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
               +M+ E LQ   ++ +SD+WS G+ L E+     P P PD  T 
Sbjct: 191 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTF 236

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTR 65
            QV KG+ YL  K   +HRD+   N +++    +K+ DFG++  + D      ++  G +
Sbjct: 140 LQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
               +M+ E LQ   ++ +SD+WS G+ L E+     P P PD  T 
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTF 244

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTR 65
            QV KG+ YL  K   +HRD+   N +++    +K+ DFG++  + D      ++  G +
Sbjct: 139 LQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 197
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
               +M+ E LQ   ++ +SD+WS G+ L E+     P P PD  T 
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTF 243

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMAN 59
           LKQ    + Q+ KG+ YL  +   +HRD+   N+LV S  ++KI DFG++  +  D    
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXX 183
Query: 60  SFVGTRS----YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
           +    R     + +PE L  + + + SD+WS G++L E+         P A  L  I GP
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI-GP 242
Query: 116 SRG 118
           + G
Sbjct: 243 THG 245

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTR 65
            QV KG+ YL  K   +HRD+   N +++    +K+ DFG++  + D      ++  G +
Sbjct: 140 LQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
               +M+ E LQ   ++ +SD+WS G+ L E+     P P PD  T 
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTF 244

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMA 58
            K +   ++Q+ +G+ YL  +  I HRD+   N+LV     +KI DFG++  +  ID   
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 59  NSFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +  G     +M+PE L    Y+ QSD+WS G+ + E+  +G  P P
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 142 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 199
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 142 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 199
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 134 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 191
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 192 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 33/154 (21%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG-------------------E 41
           L  +   ++Q+ K + +L   + + H D+KP NIL                        +
Sbjct: 117 LDHIRKMAYQICKSVNFL-HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 42  IKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           IK+ DFG S    D   ++ V TR Y +PE +    +S   D+WS+G  L+E  +G    
Sbjct: 176 IKVVDFG-SATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234
Query: 102 PPPDAKT----LAAIFGP--------SRGDGYWH 123
           P  D+K     +  I GP        +R   Y+H
Sbjct: 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFH 268

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 134 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 191
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 192 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTR 65
            QV KG+ YL  K   +HRD+   N +++    +K+ DFG++  + D      ++  G +
Sbjct: 137 LQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 195
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
               +M+ E LQ   ++ +SD+WS G+ L E+     P P PD  T 
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTF 241

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 162 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 219
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 14  GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR----SYMS 69
           G+ YL E    IHRD+   N LV     +KI DFG+S +  D +  +  G R     + +
Sbjct: 225 GMEYL-ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA 283
Query: 70  PERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
           PE L    YS +SD+WS G+ L E  ++G  P P
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYP 317

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 162 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 219
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 142 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 199
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTR 65
            QV KG+ YL  K   +HRD+   N +++    +K+ DFG++  + D      ++  G +
Sbjct: 159 LQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 217
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
               +M+ E LQ   ++ +SD+WS G+ L E+     P P PD  T 
Sbjct: 218 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTF 263

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 XGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 136 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 193
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 194 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 57/105 (54%), Gaps = 6/105 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLI-DSMA-NSFVGT 64
           Q+L+ + +  +   ++HRD+KP N+L+ S   G  +K+ DFG++ ++  D  A   F GT
Sbjct: 111 QILEAVLHCHQM-GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGT 169
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
             Y+SPE L+   Y    DIW+ G+ L  + +G  P    D   L
Sbjct: 170 PGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKL 214

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTR 65
            QV KG+ YL  K   +HRD+   N +++    +K+ DFG++  + D      ++  G +
Sbjct: 158 LQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 216
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
               +M+ E LQ   ++ +SD+WS G+ L E+     P P PD  T 
Sbjct: 217 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTF 262

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 58/99 (58%), Gaps = 12/99 (12%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSG-------QLIDSMANSFV 62
           Q+ KG+ YL E+H ++HR++   N+L+ S  ++++ DFGV+        QL+ S A + +
Sbjct: 141 QIAKGMYYL-EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 199
Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
               +M+ E +    Y+ QSD+WS G+++ E M  G  P
Sbjct: 200 ---KWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 235

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N++++  G I++ DFG++ + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLMIDQQGYIQVTDFGLAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 11/96 (11%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           YSS Q+ KG+ YL  +  + HRD+   NILV S   +KI DFG++  L   +   +   R
Sbjct: 120 YSS-QICKGMEYLGSRRCV-HRDLAARNILVESEAHVKIADFGLAKLL--PLDKDYYVVR 175
Query: 66  S-------YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
                   + +PE L    +S QSD+WS G+ L E+
Sbjct: 176 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 11/96 (11%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           YSS Q+ KG+ YL  +  + HRD+   NILV S   +KI DFG++  L   +   +   R
Sbjct: 132 YSS-QICKGMEYLGSRRCV-HRDLAARNILVESEAHVKIADFGLAKLL--PLDKDYYVVR 187
Query: 66  S-------YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
                   + +PE L    +S QSD+WS G+ L E+
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 11/96 (11%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           YSS Q+ KG+ YL  +  + HRD+   NILV S   +KI DFG++  L   +   +   R
Sbjct: 119 YSS-QICKGMEYLGSRRCV-HRDLAARNILVESEAHVKIADFGLAKLL--PLDKDYYVVR 174
Query: 66  S-------YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
                   + +PE L    +S QSD+WS G+ L E+
Sbjct: 175 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 210

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 58/99 (58%), Gaps = 12/99 (12%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSG-------QLIDSMANSFV 62
           Q+ KG+ YL E+H ++HR++   N+L+ S  ++++ DFGV+        QL+ S A + +
Sbjct: 123 QIAKGMYYL-EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181
Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
               +M+ E +    Y+ QSD+WS G+++ E M  G  P
Sbjct: 182 ---KWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 57/99 (57%), Gaps = 5/99 (5%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           S Q+ +G+ Y+  K+  IHRD++ +N+LV+     KI DFG++  + D+   +  G +  
Sbjct: 115 SAQIAEGMAYIERKN-YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 173
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             + +PE +    ++++S++WS G+ L E+   G  P P
Sbjct: 174 IKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPYP 212

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   S Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +
Sbjct: 110 LPQLVDMSAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 168
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 169 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 214

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMA 58
            K +   ++Q+ +G+ YL  +  I HRD+   N+LV     +KI DFG++  +  ID   
Sbjct: 145 FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 203
Query: 59  NSFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +  G     +M+PE L    Y+ QSD+WS G+ + E+  +G  P P
Sbjct: 204 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 250

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   S Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +
Sbjct: 110 LPQLVDMSAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTA 168
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 169 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 214

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMA 58
            K +   ++Q+ +G+ YL  +  I HRD+   N+LV     +KI DFG++  +  ID   
Sbjct: 148 FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 206
Query: 59  NSFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +  G     +M+PE L    Y+ QSD+WS G+ + E+  +G  P P
Sbjct: 207 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 253

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMA 58
            K +   ++Q+ +G+ YL  +  I HRD+   N+LV     +KI DFG++  +  ID   
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 59  NSFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +  G     +M+PE L    Y+ QSD+WS G+ + E+  +G  P P
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMA 58
            K +   ++Q+ +G+ YL  +  I HRD+   N+LV     +KI DFG++  +  ID   
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 59  NSFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +  G     +M+PE L    Y+ QSD+WS G+ + E+  +G  P P
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMA 58
            K +   ++Q+ +G+ YL  +  I HRD+   N+LV     +KI DFG++  +  ID   
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 59  NSFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +  G     +M+PE L    Y+ QSD+WS G+ + E+  +G  P P
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---SY 67
           V + + YL  K   +HRD+   N LVN  G +K+ DFG+S  ++D    S  G++    +
Sbjct: 114 VCEAMEYLESKQ-FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRW 172
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYP 100
             PE L  + +S +SDIW+ G+ + E+ ++G  P
Sbjct: 173 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMA 58
            K +   ++Q+ +G+ YL  +  I HRD+   N+LV     +KI DFG++  +  ID   
Sbjct: 143 FKDLVSCTYQLARGMEYLASQKCI-HRDLTARNVLVTENNVMKIADFGLARDINNIDYYK 201
Query: 59  NSFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +  G     +M+PE L    Y+ QSD+WS G+ + E+  +G  P P
Sbjct: 202 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 248

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 63/111 (56%), Gaps = 16/111 (14%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS--------GQ 52
           +K++   + Q  +G+ YL  K +IIHRD+K +NI ++    +KI DFG++          
Sbjct: 107 MKKLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSH 165
Query: 53  LIDSMANSFVGTRSYMSPE--RLQGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
             + ++ S +    +M+PE  R+Q ++ YS QSD+++ G+ L E+  G  P
Sbjct: 166 QFEQLSGSIL----WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMA 58
            K +   ++Q+ +G+ YL  +  I HRD+   N+LV     +KI DFG++  +  ID   
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 59  NSFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +  G     +M+PE L    Y+ QSD+WS G+ + E+  +G  P P
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMA 58
            K +   ++Q+ +G+ YL  +  I HRD+   N+LV     +KI DFG++  +  ID   
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 59  NSFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +  G     +M+PE L    Y+ QSD+WS G+ + E+  +G  P P
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMA 58
            K +   ++Q+ +G+ YL  +  I HRD+   N+LV     +KI DFG++  +  ID   
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 59  NSFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +  G     +M+PE L    Y+ QSD+WS G+ + E+  +G  P P
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +
Sbjct: 103 LPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTA 161
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 162 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 207

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N++++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLMIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +
Sbjct: 113 LPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTA 171
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 172 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 217

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           YSS Q+ KG+ YL  +  + HRD+   NILV S   +KI DFG++  L        V   
Sbjct: 116 YSS-QICKGMEYLGSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREP 173
Query: 66  S-----YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
                 + +PE L    +S QSD+WS G+ L E+
Sbjct: 174 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 59/111 (53%), Gaps = 8/111 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNIL---VNSGGEIKICDFGVSGQLID--SMANSFVG 63
           FQVL  + YL +   I+HRD+KP N+L   ++   +I I DFG+S ++ D  S+ ++  G
Sbjct: 123 FQVLDAVKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTACG 180
Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI-PPPDAKTLAAIF 113
           T  Y++PE L    YS   D WS+G+    +  G  P     DAK    I 
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL 231

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 56/116 (48%), Gaps = 12/116 (10%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNIL--VNSGGEIKICDFGVSGQLIDSMANSF------ 61
           Q+   L YL  +  I HRD+KP N L   N   EIK+ DFG+S +        +      
Sbjct: 176 QIFSALHYLHNQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK 234
Query: 62  VGTRSYMSPERLQGTH--YSVQSDIWSLGLSLVEMAIGMYPIP-PPDAKTLAAIFG 114
            GT  +++PE L  T+  Y  + D WS G+ L  + +G  P P   DA T++ +  
Sbjct: 235 AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN 290

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 59/111 (53%), Gaps = 8/111 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNIL---VNSGGEIKICDFGVSGQLID--SMANSFVG 63
           FQVL  + YL +   I+HRD+KP N+L   ++   +I I DFG+S ++ D  S+ ++  G
Sbjct: 123 FQVLDAVKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTACG 180
Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI-PPPDAKTLAAIF 113
           T  Y++PE L    YS   D WS+G+    +  G  P     DAK    I 
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL 231

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 57/108 (52%), Gaps = 21/108 (19%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM------------ 57
           Q+L+ L+Y+  +  IIHR++KP NI ++    +KI DFG++  +  S+            
Sbjct: 124 QILEALSYIHSQ-GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 58  ----ANSFVGTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYP 100
                 S +GT  Y++ E L GT HY+ + D +SLG+   E    +YP
Sbjct: 183 SSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEX---IYP 227

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +
Sbjct: 362 LPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 466

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 59/111 (53%), Gaps = 8/111 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNIL---VNSGGEIKICDFGVSGQLID--SMANSFVG 63
           FQVL  + YL +   I+HRD+KP N+L   ++   +I I DFG+S ++ D  S+ ++  G
Sbjct: 123 FQVLDAVKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTACG 180
Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI-PPPDAKTLAAIF 113
           T  Y++PE L    YS   D WS+G+    +  G  P     DAK    I 
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL 231

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 59/111 (53%), Gaps = 8/111 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNIL---VNSGGEIKICDFGVSGQLID--SMANSFVG 63
           FQVL  + YL +   I+HRD+KP N+L   ++   +I I DFG+S ++ D  S+ ++  G
Sbjct: 123 FQVLDAVKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTACG 180
Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI-PPPDAKTLAAIF 113
           T  Y++PE L    YS   D WS+G+    +  G  P     DAK    I 
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL 231

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +
Sbjct: 279 LPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 383

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 54/84 (64%), Gaps = 5/84 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDSMA-NSFVGTR 65
           Q+L+G+ YL + + I+H D+KP NIL++S    G+IKI DFG+S ++  +      +GT 
Sbjct: 139 QILEGVYYLHQNN-IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 66  SYMSPERLQGTHYSVQSDIWSLGL 89
            Y++PE L     +  +D+W++G+
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGI 221

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSYM 68
           QV+  + +   +  ++HRD+K  NIL++   G  K+ DFG    L D     F GTR Y 
Sbjct: 147 QVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYS 205
Query: 69  SPERLQGTHY-SVQSDIWSLGLSLVEMAIGMYPI 101
            PE +    Y ++ + +WSLG+ L +M  G  P 
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPF 239

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +
Sbjct: 279 LPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 383

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +
Sbjct: 106 LPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 164
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 165 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 210

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N++++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLIIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +
Sbjct: 279 LPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 383

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++PE +    Y+   D W+LG+ + +MA G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--IDSMA 58
            K +   ++Q+ +G+ YL  +  I HRD+   N+LV     ++I DFG++  +  ID   
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNVMRIADFGLARDINNIDYYK 214
Query: 59  NSFVGTR--SYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +  G     +M+PE L    Y+ QSD+WS G+ + E+  +G  P P
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +
Sbjct: 113 LPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 172 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 217

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +
Sbjct: 113 LPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 172 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 217

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +
Sbjct: 113 LPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 172 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 217

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +
Sbjct: 113 LPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 172 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 217

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +
Sbjct: 113 LPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 172 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 217

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +
Sbjct: 102 LPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 160
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 161 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 206

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +
Sbjct: 104 LPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 162
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 163 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 208

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +
Sbjct: 113 LPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 172 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 217

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI----DSMANSFVGTR 65
           Q  +G+ YL  K +IIHRD+K +NI ++    +KI DFG++ +              G+ 
Sbjct: 112 QTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 170
Query: 66  SYMSPE--RLQGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
            +M+PE  R+Q  + YS QSD+++ G+ L E+  G  P
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLI-DSMANSFV----- 62
           Q L+GL YL  +  I+H DVK  N+L++S G    +CDFG +  L  D +  S +     
Sbjct: 158 QALEGLEYLHTRR-ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 63  -GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            GT ++M+PE + G     + DIWS    ++ M  G +P
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI----DSMANSFVGTR 65
           Q  +G+ YL  K +IIHRD+K +NI ++    +KI DFG++ +              G+ 
Sbjct: 132 QTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 190
Query: 66  SYMSPE--RLQGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
            +M+PE  R+Q  + YS QSD+++ G+ L E+  G  P
Sbjct: 191 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLI-DSMANSFV----- 62
           Q L+GL YL  +  I+H DVK  N+L++S G    +CDFG +  L  D +  S +     
Sbjct: 174 QALEGLEYLHTRR-ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 232
Query: 63  -GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            GT ++M+PE + G     + DIWS    ++ M  G +P
Sbjct: 233 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 6/97 (6%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTR-- 65
            Q+ KG++YL E   ++HRD+   N+LV S   +KI DFG++  L ID       G +  
Sbjct: 126 MQIAKGMSYL-EDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 184
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             +M+ E +    ++ QSD+WS G+++ E M  G  P
Sbjct: 185 IKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKP 221

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 3/93 (3%)
Query: 10  QVLKGLTYLREKHA-IIHRDVKPSNILVNS-GGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           Q+LKGL +L  +   IIHRD+K  NI +    G +KI D G++     S A + +GT  +
Sbjct: 137 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEF 196
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            +PE  +   Y    D+++ G   +E A   YP
Sbjct: 197 XAPEXYE-EKYDESVDVYAFGXCXLEXATSEYP 228

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI----DSMANSFVGTR 65
           Q  +G+ YL  K +IIHRD+K +NI ++    +KI DFG++ +              G+ 
Sbjct: 140 QTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 198
Query: 66  SYMSPE--RLQGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
            +M+PE  R+Q  + YS QSD+++ G+ L E+  G  P
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLI-DSMANSFV----- 62
           Q L+GL YL  +  I+H DVK  N+L++S G    +CDFG +  L  D +  S +     
Sbjct: 172 QALEGLEYLHTRR-ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 230
Query: 63  -GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            GT ++M+PE + G     + DIWS    ++ M  G +P
Sbjct: 231 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           +K + Y+S Q+ KG+ YL  K   IHR++   NILV +   +KI DFG++  L       
Sbjct: 115 IKLLQYTS-QICKGMEYLGTKR-YIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYY 172
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP 115
            V         + +PE L  + +SV SD+WS G+ L E+   +     P A+ +  I   
Sbjct: 173 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 232
Query: 116 SRG 118
            +G
Sbjct: 233 KQG 235

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 41/78 (52%), Gaps = 3/78 (3%)
Query: 26  HRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF---VGTRSYMSPERLQGTHYSVQS 82
           HRDVKP NILV++     + DFG++    D         VGT  Y +PER   +H + ++
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 83  DIWSLGLSLVEMAIGMYP 100
           DI++L   L E   G  P
Sbjct: 217 DIYALTCVLYECLTGSPP 234

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 58/102 (56%), Gaps = 16/102 (15%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS--------GQLIDSMANSF 61
           Q  +G+ YL  K+ IIHRD+K +NI ++ G  +KI DFG++         Q ++    S 
Sbjct: 140 QTAQGMDYLHAKN-IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSV 198
Query: 62  VGTRSYMSPE--RLQGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
           +    +M+PE  R+Q  + +S QSD++S G+ L E+  G  P
Sbjct: 199 L----WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLI-DSMANSFV----- 62
           Q L+GL YL  +  I+H DVK  N+L++S G    +CDFG +  L  D +  S +     
Sbjct: 193 QALEGLEYLHSRR-ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYI 251
Query: 63  -GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            GT ++M+PE + G     + D+WS    ++ M  G +P
Sbjct: 252 PGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG+   + D+   +
Sbjct: 280 LPQLVDMAAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTA 338
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 339 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 384

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 33/86 (38%), Positives = 44/86 (51%), Gaps = 10/86 (11%)
Query: 25  IHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSF--VGTRSYMSPERLQGTHYSV- 80
           +HRD+KP NIL++  G I++ DFG   +L  D    S   VGT  Y+SPE LQ       
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 81  ------QSDIWSLGLSLVEMAIGMYP 100
                 + D W+LG+   EM  G  P
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 55/105 (52%), Gaps = 6/105 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDSMAN--SFVGT 64
           Q+L+ + +  +   ++HRD+KP N+L+ S   G  +K+ DFG++ ++         F GT
Sbjct: 129 QILEAVLHCHQM-GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 187
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
             Y+SPE L+   Y    D+W+ G+ L  + +G  P    D   L
Sbjct: 188 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL 232

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT  Y++P  +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 57/105 (54%), Gaps = 6/105 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLI-DSMA-NSFVGT 64
           Q+L+ + +    + I+HRD+KP N+L+ S   G  +K+ DFG++ ++  D  A   F GT
Sbjct: 111 QILESVNHCH-LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGT 169
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
             Y+SPE L+   Y    D+W+ G+ L  + +G  P    D   L
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRL 214

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 45/90 (50%), Gaps = 12/90 (13%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGV------SGQLIDSMANSFVGTRSYMSPERLQ 74
           K AI HRD+K  NILV   G+  I D G+      S   +D   N  VGT+ YM+PE L 
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190
Query: 75  GT------HYSVQSDIWSLGLSLVEMAIGM 98
            T          + DIW+ GL L E+A  M
Sbjct: 191 ETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 63/154 (40%), Gaps = 33/154 (21%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG-------------------E 41
           L  +   ++Q+ K + +L     + H D+KP NIL                        +
Sbjct: 117 LDHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 42  IKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           IK+ DFG S    D   ++ V  R Y +PE +    +S   D+WS+G  L+E  +G    
Sbjct: 176 IKVVDFG-SATYDDEHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234
Query: 102 PPPDAKT----LAAIFGP--------SRGDGYWH 123
           P  D+K     +  I GP        +R   Y+H
Sbjct: 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFH 268

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 47/88 (53%), Gaps = 7/88 (7%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH-- 77
           K  I+HRD+KP NIL++    IK+ DFG S QL       S  GT SY++PE ++ +   
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMND 201
Query: 78  ----YSVQSDIWSLGLSLVEMAIGMYPI 101
               Y  + D+WS G+ +  +  G  P 
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+  G+ Y+ E+   +HRD+  +NILV      K+ DFG++  + D+   +
Sbjct: 113 LPQLVDMAAQIASGMAYV-ERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTA 171
Query: 61  FVGTR---SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             G +    + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 172 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 217

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 57/105 (54%), Gaps = 6/105 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLI-DSMA-NSFVGT 64
           Q+L+ + +    + I+HRD+KP N+L+ S   G  +K+ DFG++ ++  D  A   F GT
Sbjct: 111 QILESVNHCH-LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGT 169
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
             Y+SPE L+   Y    D+W+ G+ L  + +G  P    D   L
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRL 214

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 45/90 (50%), Gaps = 12/90 (13%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGV------SGQLIDSMANSFVGTRSYMSPERLQ 74
           K AI HRD+K  NILV   G+  I D G+      S   +D   N  VGT+ YM+PE L 
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190
Query: 75  GT------HYSVQSDIWSLGLSLVEMAIGM 98
            T          + DIW+ GL L E+A  M
Sbjct: 191 ETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 48/92 (52%), Gaps = 7/92 (7%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYM 68
            QV +G+ YL E+   +HRD+   N +++    +K+ DFG++  ++D    S    R   
Sbjct: 131 LQVARGMEYLAEQ-KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 69  SP------ERLQGTHYSVQSDIWSLGLSLVEM 94
            P      E LQ   ++ +SD+WS G+ L E+
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWEL 221

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 45/90 (50%), Gaps = 12/90 (13%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGV------SGQLIDSMANSFVGTRSYMSPERLQ 74
           K AI HRD+K  NILV   G+  I D G+      S   +D   N  VGT+ YM+PE L 
Sbjct: 160 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 219
Query: 75  GT------HYSVQSDIWSLGLSLVEMAIGM 98
            T          + DIW+ GL L E+A  M
Sbjct: 220 ETIQVDCFDSYKRVDIWAFGLVLWEVARRM 249

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVS------GQLIDSMANSFV 62
           Q L+GL YL  +  I+H DVK  N+L++S G    +CDFG +      G   D +   ++
Sbjct: 174 QALEGLEYLHSRR-ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYI 232
Query: 63  -GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            GT ++M+PE + G     + D+WS    ++ M  G +P
Sbjct: 233 PGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 52/96 (54%), Gaps = 3/96 (3%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V + + YL E +  +HRD+   N+LV+     K+ DFG++ +   +     +  + +
Sbjct: 295 SLDVCEAMEYL-EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-W 352
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +PE L+   +S +SD+WS G+ L E+ + G  P P
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 388

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 5/89 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-DSMANSFVGTR--- 65
           Q+ KG+ YL E+  ++HRD+   N+LV S   +KI DFG++  L  D    +  G +   
Sbjct: 125 QIAKGMMYLEERR-LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 183
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
            +M+ E +    ++ QSD+WS G+++ E+
Sbjct: 184 KWMALECIHYRKFTHQSDVWSYGVTIWEL 212

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 5/89 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-DSMANSFVGTR--- 65
           Q+ KG+ YL E+  ++HRD+   N+LV S   +KI DFG++  L  D    +  G +   
Sbjct: 148 QIAKGMMYLEERR-LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 206
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
            +M+ E +    ++ QSD+WS G+++ E+
Sbjct: 207 KWMALECIHYRKFTHQSDVWSYGVTIWEL 235

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/118 (33%), Positives = 59/118 (50%), Gaps = 19/118 (16%)
Query: 4   VPYSSF-----QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE----IKICDFGVSGQLI 54
           +P S F      V+ G+ +LRE + I+HR++KP NI+   G +     K+ DFG + +L 
Sbjct: 109 LPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167
Query: 55  D-SMANSFVGTRSYMSP---ER--LQGTH---YSVQSDIWSLGLSLVEMAIGMYPIPP 103
           D     S  GT  Y+ P   ER  L+  H   Y    D+WS+G++    A G  P  P
Sbjct: 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 16/102 (15%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS--------GQLIDSMANSF 61
           Q  +G+ YL  K +IIHRD+K +NI ++    +KI DFG++            + ++ S 
Sbjct: 112 QTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 62  VGTRSYMSPE--RLQGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
           +    +M+PE  R+Q  + YS QSD+++ G+ L E+  G  P
Sbjct: 171 L----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 56/99 (56%), Gaps = 15/99 (15%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           S Q+ +G+ ++ E+   IHRD++ +NILV++    KI DFG++           VG +  
Sbjct: 284 SAQIAEGMAFI-EQRNYIHRDLRAANILVSASLVCKIADFGLAR----------VGAKFP 332
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMAI-GMYPIP 102
             + +PE +    ++++SD+WS G+ L+E+   G  P P
Sbjct: 333 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 371

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 16/102 (15%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS--------GQLIDSMANSF 61
           Q  +G+ YL  K +IIHRD+K +NI ++    +KI DFG++            + ++ S 
Sbjct: 117 QTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 175
Query: 62  VGTRSYMSPE--RLQGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
           +    +M+PE  R+Q  + YS QSD+++ G+ L E+  G  P
Sbjct: 176 L----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 16/102 (15%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS--------GQLIDSMANSF 61
           Q  +G+ YL  K +IIHRD+K +NI ++    +KI DFG++            + ++ S 
Sbjct: 117 QTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 175
Query: 62  VGTRSYMSPE--RLQGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
           +    +M+PE  R+Q  + YS QSD+++ G+ L E+  G  P
Sbjct: 176 L----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 16/102 (15%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS--------GQLIDSMANSF 61
           Q  +G+ YL  K +IIHRD+K +NI ++    +KI DFG++            + ++ S 
Sbjct: 139 QTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 197
Query: 62  VGTRSYMSPE--RLQGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
           +    +M+PE  R+Q  + YS QSD+++ G+ L E+  G  P
Sbjct: 198 L----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 16/102 (15%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS--------GQLIDSMANSF 61
           Q  +G+ YL  K +IIHRD+K +NI ++    +KI DFG++            + ++ S 
Sbjct: 112 QTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 62  VGTRSYMSPE--RLQGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
           +    +M+PE  R+Q  + YS QSD+++ G+ L E+  G  P
Sbjct: 171 L----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 16/102 (15%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS--------GQLIDSMANSF 61
           Q  +G+ YL  K +IIHRD+K +NI ++    +KI DFG++            + ++ S 
Sbjct: 140 QTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 198
Query: 62  VGTRSYMSPE--RLQGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
           +    +M+PE  R+Q  + YS QSD+++ G+ L E+  G  P
Sbjct: 199 L----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 16/102 (15%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS--------GQLIDSMANSF 61
           Q  +G+ YL  K +IIHRD+K +NI ++    +KI DFG++            + ++ S 
Sbjct: 114 QTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 172
Query: 62  VGTRSYMSPE--RLQGTH-YSVQSDIWSLGLSLVEMAIGMYP 100
           +    +M+PE  R+Q  + YS QSD+++ G+ L E+  G  P
Sbjct: 173 L----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 55/113 (48%), Gaps = 18/113 (15%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTRSYMSPERLQGT 76
           +H I+H D+KP+N L+   G +K+ DFG++ Q+       + +S VGT +YM PE ++  
Sbjct: 126 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 77  HYSVQS-----------DIWSLGLSLVEMAIGMYPIPP--PDAKTLAAIFGPS 116
             S ++           D+WSLG  L  M  G  P          L AI  P+
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 237

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 52/96 (54%), Gaps = 3/96 (3%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V + + YL E +  +HRD+   N+LV+     K+ DFG++ +   +     +  + +
Sbjct: 108 SLDVCEAMEYL-EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-W 165
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +PE L+   +S +SD+WS G+ L E+ + G  P P
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 5/100 (5%)
Query: 5   PYSSF---QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
           P++ F   Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +       
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            GT   ++PE +    Y+   D W+LG+ + EMA G  P 
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 55/113 (48%), Gaps = 18/113 (15%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTRSYMSPERLQGT 76
           +H I+H D+KP+N L+   G +K+ DFG++ Q+       + +S VGT +YM PE ++  
Sbjct: 145 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 77  HYSVQS-----------DIWSLGLSLVEMAIGMYPIPP--PDAKTLAAIFGPS 116
             S ++           D+WSLG  L  M  G  P          L AI  P+
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 52/96 (54%), Gaps = 3/96 (3%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V + + YL E +  +HRD+   N+LV+     K+ DFG++ +   +     +  + +
Sbjct: 123 SLDVCEAMEYL-EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-W 180
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +PE L+   +S +SD+WS G+ L E+ + G  P P
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 216

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 55/113 (48%), Gaps = 18/113 (15%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTRSYMSPERLQGT 76
           +H I+H D+KP+N L+   G +K+ DFG++ Q+       + +S VGT +YM PE ++  
Sbjct: 125 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 183
Query: 77  HYSVQS-----------DIWSLGLSLVEMAIGMYPIPP--PDAKTLAAIFGPS 116
             S ++           D+WSLG  L  M  G  P          L AI  P+
Sbjct: 184 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 236

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDS--MANSFVGT 64
           Q+L+ L Y  + + IIHRDVKP  +L+ S      +K+  FGV+ QL +S  +A   VGT
Sbjct: 140 QILEALRYCHDNN-IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGT 198
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
             +M+PE ++   Y    D+W  G+ L  +  G  P 
Sbjct: 199 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 235

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 55/113 (48%), Gaps = 18/113 (15%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTRSYMSPERLQGT 76
           +H I+H D+KP+N L+   G +K+ DFG++ Q+       + +S VGT +YM PE ++  
Sbjct: 129 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 187
Query: 77  HYSVQS-----------DIWSLGLSLVEMAIGMYPIPP--PDAKTLAAIFGPS 116
             S ++           D+WSLG  L  M  G  P          L AI  P+
Sbjct: 188 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 240

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 55/113 (48%), Gaps = 18/113 (15%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTRSYMSPERLQGT 76
           +H I+H D+KP+N L+   G +K+ DFG++ Q+       + +S VGT +YM PE ++  
Sbjct: 173 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 231
Query: 77  HYSVQS-----------DIWSLGLSLVEMAIGMYPIPP--PDAKTLAAIFGPS 116
             S ++           D+WSLG  L  M  G  P          L AI  P+
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 52/96 (54%), Gaps = 3/96 (3%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V + + YL E +  +HRD+   N+LV+     K+ DFG++ +   +     +  + +
Sbjct: 114 SLDVCEAMEYL-EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-W 171
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIP 102
            +PE L+   +S +SD+WS G+ L E+ + G  P P
Sbjct: 172 TAPEALREAAFSTKSDVWSFGILLWEIYSFGRVPYP 207

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           ++Q+   L YL  K   +HRD+   N+LV+S   +K+ DFG+S  + DS        +  
Sbjct: 117 AYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLP 175
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
             +M+PE +    ++  SD+W  G+ + E  I M+ + P
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWE--ILMHGVKP 212

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 60/120 (50%), Gaps = 23/120 (19%)
Query: 4   VPYSSF-----QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE----IKICDFGVSGQLI 54
           +P S F      V+ G+ +LRE + I+HR++KP NI+   G +     K+ DFG + +L 
Sbjct: 109 LPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167
Query: 55  DSMANSFV---GTRSYMSP---ER--LQGTH---YSVQSDIWSLGLSLVEMAIGMYPIPP 103
           D     FV   GT  Y+ P   ER  L+  H   Y    D+WS+G++    A G  P  P
Sbjct: 168 DD--EQFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 55/113 (48%), Gaps = 18/113 (15%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTRSYMSPERLQGT 76
           +H I+H D+KP+N L+   G +K+ DFG++ Q+       + +S VGT +YM PE ++  
Sbjct: 145 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDM 203
Query: 77  HYSVQS-----------DIWSLGLSLVEMAIGMYPIPP--PDAKTLAAIFGPS 116
             S ++           D+WSLG  L  M  G  P          L AI  P+
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDS--MANSFVGT 64
           Q+L+ L Y  + + IIHRDVKP  +L+ S      +K+  FGV+ QL +S  +A   VGT
Sbjct: 138 QILEALRYCHDNN-IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGT 196
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
             +M+PE ++   Y    D+W  G+ L  +  G  P 
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 16/95 (16%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTRSYMSPERLQGT 76
           +H I+H D+KP+N L+   G +K+ DFG++ Q+       + +S VGT +YM PE ++  
Sbjct: 173 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 231
Query: 77  HYSVQS-----------DIWSLGLSLVEMAIGMYP 100
             S ++           D+WSLG  L  M  G  P
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH-- 77
           K  I+HRD+KP NIL++    IK+ DFG S QL          GT SY++PE ++ +   
Sbjct: 129 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 188
Query: 78  ----YSVQSDIWSLGLSLVEMAIGMYPI 101
               Y  + D+WS G+ +  +  G  P 
Sbjct: 189 NHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-DSMANSFVGTRSYMS 69
           +L+ +++L   + I+HRD+KP NIL++   +I++ DFG S  L          GT  Y++
Sbjct: 209 LLEAVSFLHANN-IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLA 267
Query: 70  PERLQ----GTH--YSVQSDIWSLGLSLVEMAIGMYPI 101
           PE L+     TH  Y  + D+W+ G+ L  +  G  P 
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH-- 77
           K  I+HRD+KP NIL++    IK+ DFG S QL          GT SY++PE ++ +   
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 201
Query: 78  ----YSVQSDIWSLGLSLVEMAIGMYPI 101
               Y  + D+WS G+ +  +  G  P 
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 58/126 (46%), Gaps = 22/126 (17%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEI---KICDFGV-SGQLIDSMANSFV---- 62
           V   L +L  K  I HRD+KP NIL  S  ++   KICDF + SG  +++          
Sbjct: 120 VAAALDFLHTK-GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPEL 178
Query: 63  ----GTRSYMSPERL-----QGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
               G+  YM+PE +     Q T Y  + D+WSLG+ L  M  G     PP      A  
Sbjct: 179 TTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGY----PPFVGHCGADC 234
Query: 114 GPSRGD 119
           G  RG+
Sbjct: 235 GWDRGE 240

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 55/105 (52%), Gaps = 6/105 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDSMAN--SFVGT 64
           Q+L+ + +  +   ++HR++KP N+L+ S   G  +K+ DFG++ ++         F GT
Sbjct: 118 QILEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 176
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
             Y+SPE L+   Y    D+W+ G+ L  + +G  P    D   L
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL 221

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 7/90 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-----IDSMANSFVGT 64
           QV  G+ YL E+   +HRD+   N LV     +KI DFG+S  +       +  N  +  
Sbjct: 182 QVAAGMAYLSERK-FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI 240
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
           R +M PE +    Y+ +SD+W+ G+ L E+
Sbjct: 241 R-WMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/87 (39%), Positives = 46/87 (52%), Gaps = 12/87 (13%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI------DSMANSFVGTRSYMSP---- 70
           K AI HRD+K  NILV   G   I D G++ + I      D   N+ VGT+ YM P    
Sbjct: 160 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD 219
Query: 71  ERLQGTHYS--VQSDIWSLGLSLVEMA 95
           E L   H+   + +D++S GL L E+A
Sbjct: 220 ESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSG---GEIKICDFGVSGQLI-DSMANSFVGTR 65
           Q++  L Y   +H ++H+D+KP NIL         IKI DFG++     D  + +  GT 
Sbjct: 132 QMMNALAYFHSQH-VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTA 190
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
            YM+PE  +    + + DIWS G+ +  +  G  P 
Sbjct: 191 LYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPF 225

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGT 64
           Q+  G+ YL   H ++H+D+   N+LV     +KI D G+  ++  +     + NS +  
Sbjct: 136 QIAAGMEYL-SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 194
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYP 100
           R +M+PE +    +S+ SDIWS G+ L E+ + G+ P
Sbjct: 195 R-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 56/121 (46%), Gaps = 25/121 (20%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNIL---------------VNSGGEIKIC 45
           ++ +     ++LK L YLR K ++ H D+KP NIL               V  G +I+I 
Sbjct: 136 IEDIKLYCIEILKALNYLR-KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 46  DFGVSG-QLIDSMANSF--------VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAI 96
               +G +LID    +F        + TR Y +PE +    + V SD+WS G  L E+  
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
Query: 97  G 97
           G
Sbjct: 255 G 255

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 5/86 (5%)
Query: 13  KGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS--GQLIDSMANSFV--GTRSYM 68
           +GL YL  + AIIHRDVK  NIL++     KI DFG+S  G  +D      V  GT  Y+
Sbjct: 150 RGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEM 94
            PE       + +SD++S G+ L E+
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEV 234

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           ++Q+   L YL  K   +HRD+   N+LV+S   +K+ DFG+S  + DS        +  
Sbjct: 119 AYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 177
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
             +M+PE +    ++  SD+W  G+ + E  I M+ + P
Sbjct: 178 IKWMAPESINFRRFTSASDVWMFGVCMWE--ILMHGVKP 214

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGT 64
           Q+  G+ YL   H ++H+D+   N+LV     +KI D G+  ++  +     + NS +  
Sbjct: 153 QIAAGMEYLSSHH-VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 211
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYP 100
           R +M+PE +    +S+ SDIWS G+ L E+ + G+ P
Sbjct: 212 R-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           ++Q+   L YL  K   +HRD+   N+LV+S   +K+ DFG+S  + DS        +  
Sbjct: 145 AYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 203
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
             +M+PE +    ++  SD+W  G+ + E  I M+ + P
Sbjct: 204 IKWMAPESINFRRFTSASDVWMFGVCMWE--ILMHGVKP 240

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           ++Q+   L YL  K   +HRD+   N+LV+S   +K+ DFG+S  + DS        +  
Sbjct: 120 AYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 178
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
             +M+PE +    ++  SD+W  G+ + E  I M+ + P
Sbjct: 179 IKWMAPESINFRRFTSASDVWMFGVCMWE--ILMHGVKP 215

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           ++Q+   L YL  K   +HRD+   N+LV+S   +K+ DFG+S  + DS        +  
Sbjct: 122 AYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 180
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
             +M+PE +    ++  SD+W  G+ + E  I M+ + P
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWE--ILMHGVKP 217

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + QV  G+ YL   H  +HRD+   N LV  G  +KI DFG+S   I S    
Sbjct: 128 LGQLLAVASQVAAGMVYLAGLH-FVHRDLATRNCLVGQGLVVKIGDFGMSRD-IYSTDYY 185
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
            VG R+     +M PE +    ++ +SD+WS G+ L E+
Sbjct: 186 RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEI 224

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 56/116 (48%), Gaps = 7/116 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           S Q+ K + YL E    +HRD+   NILV S   +K+ DFG+S  + D        TR  
Sbjct: 115 SLQICKAMAYL-ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP 173
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIFGPSRGD 119
             +MSPE +    ++  SD+W   + + E ++ G  P    + K +  +    +GD
Sbjct: 174 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL--EKGD 227

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           ++Q+   L YL  K   +HRD+   N+LV+S   +K+ DFG+S  + DS        +  
Sbjct: 117 AYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
             +M+PE +    ++  SD+W  G+ + E  I M+ + P
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWE--ILMHGVKP 212

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + QV  G+ YL   H  +HRD+   N LV  G  +KI DFG+S + I S    
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLH-FVHRDLATRNCLVGQGLVVKIGDFGMS-RDIYSTDYY 214
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
            VG R+     +M PE +    ++ +SD+WS G+ L E+
Sbjct: 215 RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEI 253

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGT 64
           ++Q+   L YL  K   +HRD+   N+LV+S   +K+ DFG+S  + DS    A+     
Sbjct: 117 AYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
             +M+PE +    ++  SD+W  G+ + E  I M+ + P
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWE--ILMHGVKP 212

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           ++Q+   L YL  K   +HRD+   N+LV+S   +K+ DFG+S  + DS        +  
Sbjct: 114 AYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
             +M+PE +    ++  SD+W  G+ + E  I M+ + P
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWE--ILMHGVKP 209

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + QV  G+ YL   H  +HRD+   N LV  G  +KI DFG+S   I S    
Sbjct: 134 LGQLLAVASQVAAGMVYLAGLH-FVHRDLATRNCLVGQGLVVKIGDFGMSRD-IYSTDYY 191
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
            VG R+     +M PE +    ++ +SD+WS G+ L E+
Sbjct: 192 RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEI 230

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 4/90 (4%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           S Q+ K + YL E    +HRD+   NILV S   +K+ DFG+S  + D        TR  
Sbjct: 131 SLQICKAMAYL-ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP 189
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
             +MSPE +    ++  SD+W   + + E+
Sbjct: 190 IKWMSPESINFRRFTTASDVWMFAVCMWEI 219

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 56/116 (48%), Gaps = 7/116 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           S Q+ K + YL E    +HRD+   NILV S   +K+ DFG+S  + D        TR  
Sbjct: 119 SLQICKAMAYL-ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP 177
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIFGPSRGD 119
             +MSPE +    ++  SD+W   + + E ++ G  P    + K +  +    +GD
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL--EKGD 231

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 45/78 (57%)
Query: 24  IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 83
           +IHRD+KP N+L+   GE+KI DFG S         +  GT  Y+ PE ++G  ++ + D
Sbjct: 144 VIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVD 203
Query: 84  IWSLGLSLVEMAIGMYPI 101
           +W +G+   E+ +G  P 
Sbjct: 204 LWCIGVLCYELLVGNPPF 221

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           ++Q+   L YL  K   +HRD+   N+LV+S   +K+ DFG+S  + DS        +  
Sbjct: 497 AYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
             +M+PE +    ++  SD+W  G+ + E  I M+ + P
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWE--ILMHGVKP 592

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 54/113 (47%), Gaps = 18/113 (15%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTRSYMSPERLQGT 76
           +H I+H D+KP+N L+   G +K+ DFG++ Q+       + +S VG  +YM PE ++  
Sbjct: 173 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 77  HYSVQS-----------DIWSLGLSLVEMAIGMYPIPP--PDAKTLAAIFGPS 116
             S ++           D+WSLG  L  M  G  P          L AI  P+
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 15/98 (15%)
Query: 9   FQVLKGLTYLREKHA--IIHRDVKPSNILVN----SGGEIKICDFGVSGQLIDSMA---- 58
           +Q+L G+ YL   HA  ++HRD+KP+NILV       G +KI D G +      +     
Sbjct: 135 YQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191
Query: 59  -NSFVGTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEM 94
            +  V T  Y +PE L G  HY+   DIW++G    E+
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 229

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 42/83 (50%), Gaps = 3/83 (3%)
Query: 22  HAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 78
           H I HRDVKP N+L  S  +   +K+ DFG + +   +   +   T  Y++PE L    Y
Sbjct: 128 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKY 187
Query: 79  SVQSDIWSLGLSLVEMAIGMYPI 101
               D+WSLG+ +  +  G  P 
Sbjct: 188 DKSCDMWSLGVIMYILLCGFPPF 210

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGT----- 64
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 119 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 176
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 62/138 (44%), Gaps = 25/138 (18%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNIL-VNSGGE------------------ 41
           + QV + +FQ+ + + +L + + + H D+KP NIL VNS  E                  
Sbjct: 136 IHQVRHMAFQLCQAVKFLHD-NKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTA 194
Query: 42  IKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           +++ DFG S        ++ V TR Y +PE +    +S   D+WS+G  + E  +G    
Sbjct: 195 VRVVDFG-SATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLF 253
Query: 102 PPPDAKT----LAAIFGP 115
              D +     +  I GP
Sbjct: 254 QTHDNREHLAMMERILGP 271

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 57/117 (48%), Gaps = 6/117 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+ +G+ YL  +H  IHRD+   N+L+++   +KI DFG++  + +     
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXY 191
Query: 61  FVGTRS-----YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
            V         + +PE L+   +   SD+WS G++L E+         P  K L  I
Sbjct: 192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---- 65
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 131 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 188
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 189 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 238

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 46/87 (52%), Gaps = 12/87 (13%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGV------SGQLIDSMANSFVGTRSYMSPERLQ 74
           K AI HRD+K  NILV   G   I D G+      +   ID   N  VGT+ YM+PE L 
Sbjct: 165 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 224
Query: 75  GT----HYSV--QSDIWSLGLSLVEMA 95
            +    H+    ++DI+++GL   E+A
Sbjct: 225 DSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 42/83 (50%), Gaps = 3/83 (3%)
Query: 22  HAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 78
           H I HRDVKP N+L  S  +   +K+ DFG + +   +   +   T  Y++PE L    Y
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKY 206
Query: 79  SVQSDIWSLGLSLVEMAIGMYPI 101
               D+WSLG+ +  +  G  P 
Sbjct: 207 DKSCDMWSLGVIMYILLCGFPPF 229

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---- 65
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 128 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 185
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 33/111 (29%), Positives = 50/111 (45%), Gaps = 26/111 (23%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--------------- 53
           + +L G  ++ E   IIHRD+KP+N L+N    +K+CDFG++  +               
Sbjct: 136 YNLLLGENFIHES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 54  ---------IDSMANSFVGTRSYMSPER-LQGTHYSVQSDIWSLGLSLVEM 94
                    +     S V TR Y +PE  L   +Y+   DIWS G    E+
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGT----- 64
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 135 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 192
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             +M+ E +    Y+ QSD+WS G+++ E M  G  P
Sbjct: 193 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 229

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGT----- 64
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 125 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 182
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---- 65
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 127 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 184
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---- 65
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 132 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 189
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGT----- 64
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 125 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 182
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---- 65
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 150 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 207
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 208 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 257

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGT----- 64
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 126 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 183
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 233

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGT----- 64
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 125 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 182
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---- 65
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 128 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 185
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---- 65
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 127 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 184
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGT----- 64
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 132 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 189
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---- 65
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 132 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 189
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---- 65
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 129 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 186
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 236

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---- 65
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 128 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 185
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/86 (37%), Positives = 47/86 (54%), Gaps = 5/86 (5%)
Query: 13  KGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTRSYM 68
           +GL YL  + AIIHRDVK  NIL++     KI DFG+S +  +     +     GT  Y+
Sbjct: 150 RGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEM 94
            PE       + +SD++S G+ L E+
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEV 234

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGT----- 64
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 125 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 182
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---- 65
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 128 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 185
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 46/87 (52%), Gaps = 12/87 (13%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGV------SGQLIDSMANSFVGTRSYMSPERLQ 74
           K AI HRD+K  NILV   G   I D G+      +   ID   N  VGT+ YM+PE L 
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 75  GT----HYS--VQSDIWSLGLSLVEMA 95
            +    H+    ++DI+++GL   E+A
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGT----- 64
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 126 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 183
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 233

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGT----- 64
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 125 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 182
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             +M+ E +    Y+ QSD+WS G+++ E M  G  P
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 46/87 (52%), Gaps = 12/87 (13%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGV------SGQLIDSMANSFVGTRSYMSPERLQ 74
           K AI HRD+K  NILV   G   I D G+      +   ID   N  VGT+ YM+PE L 
Sbjct: 127 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 186
Query: 75  GT----HYS--VQSDIWSLGLSLVEMA 95
            +    H+    ++DI+++GL   E+A
Sbjct: 187 DSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 46/87 (52%), Gaps = 12/87 (13%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGV------SGQLIDSMANSFVGTRSYMSPERLQ 74
           K AI HRD+K  NILV   G   I D G+      +   ID   N  VGT+ YM+PE L 
Sbjct: 152 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 211
Query: 75  GT----HYS--VQSDIWSLGLSLVEMA 95
            +    H+    ++DI+++GL   E+A
Sbjct: 212 DSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 46/87 (52%), Gaps = 12/87 (13%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGV------SGQLIDSMANSFVGTRSYMSPERLQ 74
           K AI HRD+K  NILV   G   I D G+      +   ID   N  VGT+ YM+PE L 
Sbjct: 129 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 188
Query: 75  GT----HYS--VQSDIWSLGLSLVEMA 95
            +    H+    ++DI+++GL   E+A
Sbjct: 189 DSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 2/94 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS-GQLIDSMANS 60
           +Q+ + +  V +G+ YL +K   IHRD+   NILV      KI DFG+S GQ +      
Sbjct: 132 QQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 190
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
                 +M+ E L  + Y+  SD+WS G+ L E+
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 224

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 2/94 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS-GQLIDSMANS 60
           +Q+ + +  V +G+ YL +K   IHRD+   NILV      KI DFG+S GQ +      
Sbjct: 142 QQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 200
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
                 +M+ E L  + Y+  SD+WS G+ L E+
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 46/87 (52%), Gaps = 12/87 (13%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGV------SGQLIDSMANSFVGTRSYMSPERLQ 74
           K AI HRD+K  NILV   G   I D G+      +   ID   N  VGT+ YM+PE L 
Sbjct: 132 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 191
Query: 75  GT----HYS--VQSDIWSLGLSLVEMA 95
            +    H+    ++DI+++GL   E+A
Sbjct: 192 DSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGT----- 64
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 159 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 216
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             +M+ E +    Y+ QSD+WS G+++ E M  G  P
Sbjct: 217 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 253

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 5/98 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+ + + Q+  G+ YL  +H  +HRD+   N LV +   +KI DFG+S  +  +    
Sbjct: 132 LSQMLHIASQIASGMVYLASQH-FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 190
Query: 61  FVGTR----SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
             G       +M PE +    ++ +SD+WS G+ L E+
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGT 64
           ++Q+   L YL  K   +HRD+   N+LV++   +K+ DFG+S  + DS    A+     
Sbjct: 117 AYQLSTALAYLESKR-FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
             +M+PE +    ++  SD+W  G+ + E  I M+ + P
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWE--ILMHGVKP 212

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 10/91 (10%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS--- 66
           QV  G+ YL EK+  +HRD+   N+L+ +    KI DFG+S  L     +S+   RS   
Sbjct: 118 QVSMGMKYLEEKN-FVHRDLAARNVLLVNRHYAKISDFGLSKAL--GADDSYYTARSAGK 174
Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVE 93
               + +PE +    +S +SD+WS G+++ E
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWE 205

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---- 65
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG   +L+ +    +        
Sbjct: 127 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFG-RAKLLGAEEKEYHAEGGKVP 184
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGT----- 64
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG   +L+ +    +        
Sbjct: 125 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFG-RAKLLGAEEKEYHAEGGKVP 182
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---- 65
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG   +L+ +    +        
Sbjct: 127 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFG-RAKLLGAEEKEYHAEGGKVP 184
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---- 65
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG   +L+ +    +        
Sbjct: 132 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFG-RAKLLGAEEKEYHAEGGKVP 189
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---- 65
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG   +L+ +    +        
Sbjct: 127 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFG-RAKLLGAEEKEYHAEGGKVP 184
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 8/97 (8%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGT----- 64
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG   +L+ +    +        
Sbjct: 129 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFG-RAKLLGAEEKEYHAEGGKVP 186
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             +M+ E +    Y+ QSD+WS G+++ E M  G  P
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN----SFVGTR- 65
           +  G+ YL + +  +HRD+   NILVNS    K+ DFG+S  L D  ++    S +G + 
Sbjct: 144 IAAGMKYLADMN-YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 202
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
              + +PE +Q   ++  SD+WS G+ + E M+ G  P
Sbjct: 203 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
           Q+ + + Q+  G+ YL  +H  +HRD+   N LV     +KI DFG+S  +  +      
Sbjct: 129 QMLHIAQQIAAGMVYLASQH-FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG 187
Query: 63  GTR----SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
           G       +M PE +    ++ +SD+WSLG+ L E+
Sbjct: 188 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 223

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 51/97 (52%), Gaps = 9/97 (9%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR----- 65
           +  G+ YL +  A+ HRD+   NIL+NS    K+ DFG+S  L D    ++  TR     
Sbjct: 156 IASGMKYLSDMGAV-HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIP 213
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             + SPE +    ++  SD+WS G+ L E M+ G  P
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           ++Q+   L YL  K   +HRD+   N+LV++   +K+ DFG+S  + DS        +  
Sbjct: 497 AYQLSTALAYLESKR-FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
             +M+PE +    ++  SD+W  G+ + E  I M+ + P
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWE--ILMHGVKP 592

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/84 (39%), Positives = 47/84 (55%), Gaps = 5/84 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSG-QLIDSMANSFVGTR 65
           QVL  + YL  +  I+HRD+KP N+L  S  E   I I DFG+S  +    + ++  GT 
Sbjct: 128 QVLDAVYYLH-RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTP 186
Query: 66  SYMSPERLQGTHYSVQSDIWSLGL 89
            Y++PE L    YS   D WS+G+
Sbjct: 187 GYVAPEVLAQKPYSKAVDCWSIGV 210

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 4/99 (4%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS--GGEIKICDFGVSGQLI-DSMANSFVGTRS 66
           Q  +GL ++ E H+I+H D+KP NI+  +     +KI DFG++ +L  D +      T  
Sbjct: 157 QACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE 215
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           + +PE +        +D+W++G+    +  G+ P    D
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 34/114 (29%), Positives = 50/114 (43%), Gaps = 29/114 (25%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL--------------- 53
           + +L G  ++ E   IIHRD+KP+N L+N    +KICDFG++  +               
Sbjct: 138 YNLLLGEKFIHES-GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEK 196
Query: 54  ------------IDSMANSFVGTRSYMSPER-LQGTHYSVQSDIWSLGLSLVEM 94
                       +     S V TR Y +PE  L   +Y+   DIWS G    E+
Sbjct: 197 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAEL 250

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 4/95 (4%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS--GGEIKICDFGVSGQLIDSMA-NSFVGTRS 66
           QV KGL ++ E +  +H D+KP NI+  +    E+K+ DFG++  L    +     GT  
Sbjct: 263 QVCKGLCHMHENN-YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 321
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           + +PE  +G      +D+WS+G+    +  G+ P 
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/119 (26%), Positives = 59/119 (49%), Gaps = 10/119 (8%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+ +G+ YL  +H  IHR++   N+L+++   +KI DFG++  + +   + 
Sbjct: 116 LAQLLLFAQQICEGMAYLHSQH-YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE--GHE 172
Query: 61  FVGTRS-------YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
           +   R        + +PE L+   +   SD+WS G++L E+         P  K L  I
Sbjct: 173 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 231

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 4/95 (4%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS--GGEIKICDFGVSGQLIDSMA-NSFVGTRS 66
           QV KGL ++ E +  +H D+KP NI+  +    E+K+ DFG++  L    +     GT  
Sbjct: 157 QVCKGLCHMHENN-YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 215
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           + +PE  +G      +D+WS+G+    +  G+ P 
Sbjct: 216 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR----- 65
           +  G+ YL +    +HRD+   NIL+NS    K+ DFG+S  L D    ++  TR     
Sbjct: 156 IASGMKYLSD-MGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIP 213
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             + SPE +    ++  SD+WS G+ L E M+ G  P
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 41/87 (47%), Gaps = 5/87 (5%)
Query: 24  IIHRDVKPSNILV---NSGGEIKICDFGVSGQL--IDSMANSFVGTRSYMSPERLQGTHY 78
           ++HRD+KP N+L    N   EIKI DFG +      +    +   T  Y +PE L    Y
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGY 186
Query: 79  SVQSDIWSLGLSLVEMAIGMYPIPPPD 105
               D+WSLG+ L  M  G  P    D
Sbjct: 187 DESCDLWSLGVILYTMLSGQVPFQSHD 213

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 59/110 (53%), Gaps = 8/110 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGT----- 64
           Q+ +G+ YL ++  ++HRD+   N+LV +   +KI DFG++ +L+ +    +        
Sbjct: 122 QIAEGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVP 179
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIPPPDAKTLAAIF 113
             +M+ E +    Y+ QSD+WS G+++ E M  G  P     A  +++I 
Sbjct: 180 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 229

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 50/104 (48%), Gaps = 25/104 (24%)
Query: 11  VLKGLTYLRE--------KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-------- 54
           V +GL YL          K AI HRD+   N+LV + G   I DFG+S +L         
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 55  --DSMANSFVGTRSYMSPERLQGT-------HYSVQSDIWSLGL 89
             D+ A S VGT  YM+PE L+G            Q D+++LGL
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/119 (26%), Positives = 59/119 (49%), Gaps = 10/119 (8%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+ +G+ YL  +H  IHR++   N+L+++   +KI DFG++  + +   + 
Sbjct: 116 LAQLLLFAQQICEGMAYLHAQH-YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE--GHE 172
Query: 61  FVGTRS-------YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
           +   R        + +PE L+   +   SD+WS G++L E+         P  K L  I
Sbjct: 173 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 231

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 18/101 (17%)
Query: 13  KGLTYLRE---------KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA----N 59
           +GL YL E         K AI HRD+K  N+L+ +     I DFG++ +     +    +
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191
Query: 60  SFVGTRSYMSPERLQGT-----HYSVQSDIWSLGLSLVEMA 95
             VGTR YM+PE L+G         ++ D++++GL L E+A
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 14  GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR------SY 67
           G+ YL +  A+ HRD+   NILVNS    K+ DFG+S  L D    ++  TR       +
Sbjct: 143 GMKYLSDMSAV-HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT-TRGGKIPIRW 200
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
            +PE +    ++  SD+WS G+ + E M+ G  P
Sbjct: 201 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 2/94 (2%)
Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS-GQLIDSMANS 60
           +Q+ + +  V +G+ YL +K   IHR++   NILV      KI DFG+S GQ +      
Sbjct: 139 QQLLHFAADVARGMDYLSQKQ-FIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 197
Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
                 +M+ E L  + Y+  SD+WS G+ L E+
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 231

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR----- 65
           +  G+ YL +    +HRD+   NIL+NS    K+ DFG+S  L D    ++  TR     
Sbjct: 154 IASGMKYLSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIP 211
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             + SPE +    ++  SD+WS G+ L E M+ G  P
Sbjct: 212 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR----- 65
           +  G+ YL +    +HRD+   NIL+NS    K+ DFG+S  L D    ++  TR     
Sbjct: 127 IASGMKYLSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIP 184
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             + SPE +    ++  SD+WS G+ L E M+ G  P
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR----- 65
           +  G+ YL +    +HRD+   NIL+NS    K+ DFG+S  L D    ++  TR     
Sbjct: 156 IASGMKYLSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIP 213
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             + SPE +    ++  SD+WS G+ L E M+ G  P
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR----- 65
           +  G+ YL +    +HRD+   NIL+NS    K+ DFG+S  L D    ++  TR     
Sbjct: 127 IASGMKYLSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIP 184
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             + SPE +    ++  SD+WS G+ L E M+ G  P
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR----- 65
           +  G+ YL +    +HRD+   NIL+NS    K+ DFG+S  L D    ++  TR     
Sbjct: 156 IASGMKYLSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIP 213
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             + SPE +    ++  SD+WS G+ L E M+ G  P
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR----- 65
           +  G+ YL +    +HRD+   NIL+NS    K+ DFG+S  L D    ++  TR     
Sbjct: 144 IASGMKYLSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIP 201
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             + SPE +    ++  SD+WS G+ L E M+ G  P
Sbjct: 202 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR----- 65
           +  G+ YL +    +HRD+   NIL+NS    K+ DFG+S  L D    ++  TR     
Sbjct: 156 IASGMKYLSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIP 213
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             + SPE +    ++  SD+WS G+ L E M+ G  P
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR----- 65
           +  G+ YL +    +HRD+   NIL+NS    K+ DFG+S  L D    ++  TR     
Sbjct: 156 IASGMKYLSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIP 213
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             + SPE +    ++  SD+WS G+ L E M+ G  P
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR----- 65
           +  G+ YL +    +HRD+   NIL+NS    K+ DFG+S  L D    ++  TR     
Sbjct: 156 IASGMKYLSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIP 213
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             + SPE +    ++  SD+WS G+ L E M+ G  P
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 42/87 (48%), Gaps = 12/87 (13%)
Query: 21  KHAIIHRDVKPSNILVNSGGEIKICDFGVS------GQLIDSMANSFVGTRSYMSPE--- 71
           K AI HRD K  N+LV S  +  I D G++         +D   N  VGT+ YM+PE   
Sbjct: 131 KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLD 190
Query: 72  ---RLQGTHYSVQSDIWSLGLSLVEMA 95
              R         +DIW+ GL L E+A
Sbjct: 191 EQIRTDCFESYKWTDIWAFGLVLWEIA 217

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 63/110 (57%), Gaps = 7/110 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNIL-VN-SGGEIKICDFGVSGQLI--DSMANSFVGTR 65
           Q+ +G+ ++ + + I+H D+KP NIL VN    +IKI DFG++ +    + +  +F GT 
Sbjct: 195 QICEGIRHMHQMY-ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTP 252
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP-IPPPDAKTLAAIFG 114
            +++PE +     S  +D+WS+G+    +  G+ P +   DA+TL  I  
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 63/120 (52%), Gaps = 9/120 (7%)
Query: 1   LKQVPYSSF--QVLKGLTYLREKHAIIHRDVKPSNILVNSGG----EIKICDFGVSGQLI 54
           L +   +SF  Q+L G+ YL  K  I H D+KP NI++         IK+ DFG++ ++ 
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 55  DSMA-NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP-IPPPDAKTLAAI 112
           D +   +  GT  +++PE +      +++D+WS+G+    +  G  P +     +TLA I
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 7/91 (7%)
Query: 13  KGLTYLRE--KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTRS 66
           +GL YL +     IIHRDVK +NIL++   E  + DFG++ +L+D     +  +  GT  
Sbjct: 150 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDXHVXXAVRGTIG 208
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIG 97
           +++PE L     S ++D++  G+ L+E+  G
Sbjct: 209 HIAPEYLSTGKSSEKTDVFGYGVMLLELITG 239

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 7/96 (7%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGT-----R 65
           +  G+ YL +    +HRD+   NILVNS    K+ DFG+S  + D     +  T      
Sbjct: 154 IAAGMRYLAD-MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPV 212
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
            + +PE +Q   ++  SD+WS G+ + E M+ G  P
Sbjct: 213 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 11/99 (11%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS--- 66
           QV  G+ YL EK+  +HR++   N+L+ +    KI DFG+S  L     +S+   RS   
Sbjct: 444 QVSMGMKYLEEKN-FVHRNLAARNVLLVNRHYAKISDFGLSKAL--GADDSYYTARSAGK 500
Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
               + +PE +    +S +SD+WS G+++ E ++ G  P
Sbjct: 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 64/124 (51%), Gaps = 9/124 (7%)
Query: 1   LKQVPYSSF--QVLKGLTYLREKHAIIHRDVKPSNILVNSGG----EIKICDFGVSGQLI 54
           L +   +SF  Q+L G+ YL  K  I H D+KP NI++         IK+ DFG++ ++ 
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 55  DSMA-NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP-IPPPDAKTLAAI 112
           D +   +  GT  +++PE +      +++D+WS+G+    +  G  P +     +TLA I
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230
Query: 113 FGPS 116
              S
Sbjct: 231 TAVS 234

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGT----R 65
           ++  G+ YL   +  +HRD+   N +V     +KI DFG++  + ++      G      
Sbjct: 140 EIADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 198
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
            +MSPE L+   ++  SD+WS G+ L E+A
Sbjct: 199 RWMSPESLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 64/124 (51%), Gaps = 9/124 (7%)
Query: 1   LKQVPYSSF--QVLKGLTYLREKHAIIHRDVKPSNILVNSGG----EIKICDFGVSGQLI 54
           L +   +SF  Q+L G+ YL  K  I H D+KP NI++         IK+ DFG++ ++ 
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 55  DSMA-NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP-IPPPDAKTLAAI 112
           D +   +  GT  +++PE +      +++D+WS+G+    +  G  P +     +TLA I
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230
Query: 113 FGPS 116
              S
Sbjct: 231 TAVS 234

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 63/120 (52%), Gaps = 9/120 (7%)
Query: 1   LKQVPYSSF--QVLKGLTYLREKHAIIHRDVKPSNILVNSGG----EIKICDFGVSGQLI 54
           L +   +SF  Q+L G+ YL  K  I H D+KP NI++         IK+ DFG++ ++ 
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 55  DSMA-NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP-IPPPDAKTLAAI 112
           D +   +  GT  +++PE +      +++D+WS+G+    +  G  P +     +TLA I
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGT----R 65
           ++  G+ YL   +  +HRD+   N +V     +KI DFG++  + ++      G      
Sbjct: 131 EIADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 189
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
            +MSPE L+   ++  SD+WS G+ L E+A
Sbjct: 190 RWMSPESLKDGVFTTYSDVWSFGVVLWEIA 219

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 64/124 (51%), Gaps = 9/124 (7%)
Query: 1   LKQVPYSSF--QVLKGLTYLREKHAIIHRDVKPSNILVNSGG----EIKICDFGVSGQLI 54
           L +   +SF  Q+L G+ YL  K  I H D+KP NI++         IK+ DFG++ ++ 
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 55  DSMA-NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP-IPPPDAKTLAAI 112
           D +   +  GT  +++PE +      +++D+WS+G+    +  G  P +     +TLA I
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230
Query: 113 FGPS 116
              S
Sbjct: 231 TAVS 234

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 58/109 (53%), Gaps = 7/109 (6%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGG----EIKICDFGVSGQLIDSMA-NSFVGT 64
           Q+L G+ YL  K  I H D+KP NI++         IK+ DFG++ ++ D +   +  GT
Sbjct: 123 QILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP-IPPPDAKTLAAI 112
             +++PE +      +++D+WS+G+    +  G  P +     +TLA I
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 55/127 (43%), Gaps = 15/127 (11%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE-----IKICDFGVSGQLID 55
           LK V   + Q+L  + Y+  K+ +I+RDVKP N L+   G      I I DFG++ + ID
Sbjct: 96  LKTVLMIAIQLLSRMEYVHSKN-LIYRDVKPENFLIGRQGNKKEHVIHIIDFGLAKEYID 154
Query: 56  SMA---------NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
                        S  GT  YMS     G   S + D+ +LG   +    G  P     A
Sbjct: 155 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 214
Query: 107 KTLAAIF 113
            TL   +
Sbjct: 215 DTLKERY 221

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 52/113 (46%), Gaps = 22/113 (19%)
Query: 3   QVPYS---SF--QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM 57
           Q P+S   SF   +  G+ YL   + IIHRD+   N LV     + + DFG++  ++D  
Sbjct: 104 QYPWSQRVSFAKDIASGMAYLHSMN-IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162
Query: 58  AN----------------SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
                             + VG   +M+PE + G  Y  + D++S G+ L E+
Sbjct: 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+ +G+ YL  +H  IHR +   N+L+++   +KI DFG++  + +   + 
Sbjct: 110 LAQLLLFAQQICEGMAYLHAQH-YIHRALAARNVLLDNDRLVKIGDFGLAKAVPE--GHE 166
Query: 61  FVGTRS-------YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
           +   R        + +PE L+   +   SD+WS G++L E+
Sbjct: 167 YYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 207

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L Q+   + Q+ +G+ YL  +H  IHR +   N+L+++   +KI DFG++  + +   + 
Sbjct: 111 LAQLLLFAQQICEGMAYLHAQH-YIHRALAARNVLLDNDRLVKIGDFGLAKAVPE--GHE 167
Query: 61  FVGTRS-------YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
           +   R        + +PE L+   +   SD+WS G++L E+
Sbjct: 168 YYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 208

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 58/127 (45%), Gaps = 22/127 (17%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILV---NSGGEIKICDFGV-SGQLIDSMANSF----- 61
           V   L +L  K  I HRD+KP NIL    N    +KICDFG+ SG  ++   +       
Sbjct: 120 VASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPEL 178
Query: 62  ---VGTRSYMSPERL-----QGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
               G+  YM+PE +     + + Y  + D+WSLG+ L  +  G     PP      +  
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY----PPFVGRCGSDC 234
Query: 114 GPSRGDG 120
           G  RG+ 
Sbjct: 235 GWDRGEA 241

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR----- 65
           +  G+ YL +    +HRD+   NIL+NS    K+ DFG++  L D    ++  TR     
Sbjct: 156 IASGMKYLSD-MGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYT-TRGGKIP 213
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             + SPE +    ++  SD+WS G+ L E M+ G  P
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 9/97 (9%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR----- 65
           +  G+ YL +    +HRD+   NIL+NS    K+ DFG+ G++++    +   TR     
Sbjct: 156 IASGMKYLSD-MGYVHRDLAARNILINSNLVCKVSDFGL-GRVLEDDPEAAYTTRGGKIP 213
Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             + SPE +    ++  SD+WS G+ L E M+ G  P
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 7/91 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGT 64
           ++  G+ YL   +  +HRD+   N +V     +KI DFG++  + ++          +  
Sbjct: 146 EIADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           R +MSPE L+   ++  SD+WS G+ L E+A
Sbjct: 205 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           + QV +G+ YL  K   IHRD+   N+L+ +   +KI DFG+   L  +  +  +     
Sbjct: 127 AVQVAEGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 185
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
              ++ +PE L+   +S  SD W  G++L EM
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 217

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 33/116 (28%), Positives = 51/116 (43%), Gaps = 31/116 (26%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS----------GQL----- 53
           + +L G+ Y+     I+HRD+KP+N LVN    +K+CDFG++           QL     
Sbjct: 163 YNLLVGVKYVHSA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 54  --------------IDSMANSFVGTRSYMSPER-LQGTHYSVQSDIWSLGLSLVEM 94
                         +       V TR Y +PE  L   +Y+   D+WS+G    E+
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           + QV +G+ YL  K   IHRD+   N+L+ +   +KI DFG+   L  +  +  +     
Sbjct: 117 AVQVAEGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 175
Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
              ++ +PE L+   +S  SD W  G++L EM
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 51/101 (50%), Gaps = 4/101 (3%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMA-NSF 61
           + +  +++LK L Y   K  I+HRDVKP N++++    ++++ D+G++     +   N  
Sbjct: 139 IRFYMYELLKALDYCHSK-GIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVR 197
Query: 62  VGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPI 101
           V +R +  PE L     Y    D+WSLG  L  M     P 
Sbjct: 198 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPF 238

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 7/91 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGT 64
           ++  G+ YL   +  +HRD+   N +V     +KI DFG++  + ++          +  
Sbjct: 146 EIADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           R +MSPE L+   ++  SD+WS G+ L E+A
Sbjct: 205 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 7/91 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGT 64
           ++  G+ YL   +  +HRD+   N +V     +KI DFG++  + ++          +  
Sbjct: 136 EIADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 194
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           R +MSPE L+   ++  SD+WS G+ L E+A
Sbjct: 195 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIA 224

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 51/101 (50%), Gaps = 4/101 (3%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMA-NSF 61
           + +  +++LK L Y   K  I+HRDVKP N++++    ++++ D+G++     +   N  
Sbjct: 134 IRFYMYELLKALDYCHSK-GIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVR 192
Query: 62  VGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPI 101
           V +R +  PE L     Y    D+WSLG  L  M     P 
Sbjct: 193 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPF 233

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 7/91 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGT 64
           ++  G+ YL   +  +HRD+   N +V     +KI DFG++  + ++          +  
Sbjct: 140 EIADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 198
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           R +MSPE L+   ++  SD+WS G+ L E+A
Sbjct: 199 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 7/91 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGT 64
           ++  G+ YL   +  +HRD+   N +V     +KI DFG++  + ++          +  
Sbjct: 137 EIADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           R +MSPE L+   ++  SD+WS G+ L E+A
Sbjct: 196 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIA 225

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 56/98 (57%), Gaps = 12/98 (12%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-KICDFGVSGQLID-------SMANS 60
           +Q+L+GL Y+   + ++HRD+KP+N+ +N+   + KI DFG++ +++D        ++  
Sbjct: 127 YQLLRGLKYIHSAN-VLHRDLKPANLFINTEDLVLKIGDFGLA-RIMDPHYSHKGHLSEG 184
Query: 61  FVGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
            V T+ Y SP  L    +Y+   D+W+ G    EM  G
Sbjct: 185 LV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 14  GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR------SY 67
           G+ YL +  + +HRD+   NILVNS    K+ DFG+S  L D    ++  TR       +
Sbjct: 122 GMKYLSD-MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT-TRGGKIPIRW 179
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
            +PE +    ++  SD+WS G+ + E M+ G  P
Sbjct: 180 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 7/91 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGT 64
           ++  G+ YL   +  +HRD+   N +V     +KI DFG++  + ++          +  
Sbjct: 133 EIADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 191
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           R +MSPE L+   ++  SD+WS G+ L E+A
Sbjct: 192 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIA 221

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 7/91 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGT 64
           ++  G+ YL   +  +HRD+   N +V     +KI DFG++  + ++          +  
Sbjct: 139 EIADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 197
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           R +MSPE L+   ++  SD+WS G+ L E+A
Sbjct: 198 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 7/91 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGT 64
           ++  G+ YL   +  +HRD+   N +V     +KI DFG++  + ++          +  
Sbjct: 139 EIADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 197
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           R +MSPE L+   ++  SD+WS G+ L E+A
Sbjct: 198 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR----- 65
           +  G+ YL   +  +HRD+   NILVNS    K+ DFG+S  L D    ++  +      
Sbjct: 156 IAAGMKYLANMN-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214
Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
            + +PE +    ++  SD+WS G+ + E M  G  P
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 14  GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR------SY 67
           G+ YL +  + +HRD+   NILVNS    K+ DFG+S  L D    ++  TR       +
Sbjct: 128 GMKYLSD-MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT-TRGGKIPIRW 185
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
            +PE +    ++  SD+WS G+ + E M+ G  P
Sbjct: 186 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 6/92 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFV 62
           + QV +G+ YL  K   IHRD+   N+L+ +   +KI DFG+   L  +     M     
Sbjct: 127 AVQVAEGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
              ++ +PE L+   +S  SD W  G++L EM
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 217

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 7/91 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGT 64
           ++  G+ YL   +  +HRD+   N +V     +KI DFG++  + ++          +  
Sbjct: 168 EIADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 226
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           R +MSPE L+   ++  SD+WS G+ L E+A
Sbjct: 227 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIA 256

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L+++   + ++  G+ YL  K   +HRD+   N +V     +KI DFG++  + ++    
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR 187
Query: 61  FVGT----RSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
             G       +M+PE L+   ++  SD+WS G+ L E+ 
Sbjct: 188 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L+++   + ++  G+ YL  K   +HRD+   N +V     +KI DFG++  + ++    
Sbjct: 126 LQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR 184
Query: 61  FVGT----RSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
             G       +M+PE L+   ++  SD+WS G+ L E+ 
Sbjct: 185 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 223

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS 60
           L+++   + ++  G+ YL  K   +HRD+   N +V     +KI DFG++  + ++    
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR 187
Query: 61  FVGT----RSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
             G       +M+PE L+   ++  SD+WS G+ L E+ 
Sbjct: 188 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 6/92 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFV 62
           + QV +G+ YL  K   IHRD+   N+L+ +   +KI DFG+   L  +     M     
Sbjct: 117 AVQVAEGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
              ++ +PE L+   +S  SD W  G++L EM
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 6/92 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFV 62
           + QV +G+ YL  K   IHRD+   N+L+ +   +KI DFG+   L  +     M     
Sbjct: 117 AVQVAEGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
              ++ +PE L+   +S  SD W  G++L EM
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 8/91 (8%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL---IDSMANSF---VGT 64
           +L GL Y+  ++ I+HRD+K +N+L+   G +K+ DFG++       +S  N +   V T
Sbjct: 134 LLNGLYYI-HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 65  RSYMSPERLQGTH-YSVQSDIWSLGLSLVEM 94
             Y  PE L G   Y    D+W  G  + EM
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 8/91 (8%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL---IDSMANSF---VGT 64
           +L GL Y+  ++ I+HRD+K +N+L+   G +K+ DFG++       +S  N +   V T
Sbjct: 133 LLNGLYYI-HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 191
Query: 65  RSYMSPERLQGTH-YSVQSDIWSLGLSLVEM 94
             Y  PE L G   Y    D+W  G  + EM
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 6/92 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFV 62
           + QV +G+ YL  K   IHRD+   N+L+ +   +KI DFG+   L  +     M     
Sbjct: 121 AVQVAEGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
              ++ +PE L+   +S  SD W  G++L EM
Sbjct: 180 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 211

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 6/92 (6%)
Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFV 62
           + QV +G+ YL  K   IHRD+   N+L+ +   +KI DFG+   L  +     M     
Sbjct: 121 AVQVAEGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
              ++ +PE L+   +S  SD W  G++L EM
Sbjct: 180 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 211

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 8/91 (8%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL---IDSMANSF---VGT 64
           +L GL Y+  ++ I+HRD+K +N+L+   G +K+ DFG++       +S  N +   V T
Sbjct: 134 LLNGLYYI-HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 65  RSYMSPERLQGTH-YSVQSDIWSLGLSLVEM 94
             Y  PE L G   Y    D+W  G  + EM
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 8/91 (8%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL---IDSMANSF---VGT 64
           +L GL Y+  ++ I+HRD+K +N+L+   G +K+ DFG++       +S  N +   V T
Sbjct: 134 LLNGLYYI-HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 65  RSYMSPERLQGTH-YSVQSDIWSLGLSLVEM 94
             Y  PE L G   Y    D+W  G  + EM
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/100 (27%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--- 57
           L+++   + ++  G+ YL  K   +HRD+   N +V     +KI DFG++  + ++    
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYR 187
Query: 58  --ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
                 +  R +M+PE L+   ++  SD+WS G+ L E+ 
Sbjct: 188 KGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 9/98 (9%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN----SFVGTR- 65
           +  G+ YL + +  +HR +   NILVNS    K+ DFG+S  L D  ++    S +G + 
Sbjct: 118 IAAGMKYLADMN-YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 176
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
              + +PE +Q   ++  SD+WS G+ + E M+ G  P
Sbjct: 177 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 12/108 (11%)
Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNIL--VNSGGE---IKICDFGVS---GQLIDSMANS 60
           +Q++ G+ +   +  + HRD+KP N+L  V+   E   +KI DFG++   G  I    + 
Sbjct: 139 YQLINGVNFCHSRRCL-HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE 197
Query: 61  FVGTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK 107
            + T  Y  PE L G+ HYS   DIWS+     EM +   P+ P D++
Sbjct: 198 II-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT-PLFPGDSE 243

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILV---NSGGEIKICDFGVSGQLI-DSMANSFVGTRS 66
           VL  + Y   K  + HRD+KP N L    +    +K+ DFG++ +     M  + VGT  
Sbjct: 115 VLSAVAYC-HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPY 173
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP 104
           Y+SP+ L+G  Y  + D WS G+ +  +  G  P   P
Sbjct: 174 YVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP 210

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 9/98 (9%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN----SFVGTR- 65
           +  G+ YL E  + +HRD+   NILVNS    K+ DFG+S  L ++ ++    S +G + 
Sbjct: 125 IASGMRYLAE-MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKI 183
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
              + +PE +    ++  SD WS G+ + E M+ G  P
Sbjct: 184 PIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 50/141 (35%), Gaps = 48/141 (34%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILV------------------NSGG----------- 40
           QVL+GL YL  K  IIH D+KP NIL+                   +G            
Sbjct: 148 QVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTA 207
Query: 41  ------------------EIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 82
                              +KI D G +   +       + TR Y S E L G  YS  +
Sbjct: 208 PAADLLVNPLDPRNADKIRVKIADLG-NACWVHKHFTEDIQTRQYRSIEVLIGAGYSTPA 266
Query: 83  DIWSLGLSLVEMAIGMYPIPP 103
           DIWS      E+A G Y   P
Sbjct: 267 DIWSTACMAFELATGDYLFEP 287

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 55/127 (43%), Gaps = 15/127 (11%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE-----IKICDFGVSGQLID 55
           LK V   + Q++  + Y+  K+ +I+RDVKP N L+   G      I I DFG++ + ID
Sbjct: 104 LKTVLMIAIQLISRMEYVHSKN-LIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYID 162
Query: 56  SMA---------NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
                        S  GT  YMS     G   S + D+ +LG   +    G  P     A
Sbjct: 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222
Query: 107 KTLAAIF 113
            TL   +
Sbjct: 223 DTLKERY 229

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 55/127 (43%), Gaps = 15/127 (11%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG-----EIKICDFGVSGQLID 55
           LK V   + Q++  + Y+  K ++I+RDVKP N LV   G      I I DFG++ + ID
Sbjct: 99  LKTVLMIAIQLITRMEYVHTK-SLIYRDVKPENFLVGRPGTKRQHAIHIIDFGLAKEYID 157
Query: 56  SMA---------NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
                        S  GT  YMS     G   S + D+ +LG   +    G  P     A
Sbjct: 158 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 217
Query: 107 KTLAAIF 113
            TL   +
Sbjct: 218 DTLKERY 224

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILV---NSGGEIKICDFGVSGQLI-DSMANSFVGTRS 66
           VL  + Y   K  + HRD+KP N L    +    +K+ DFG++ +     M  + VGT  
Sbjct: 132 VLSAVAYC-HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPY 190
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP 104
           Y+SP+ L+G  Y  + D WS G+ +  +  G  P   P
Sbjct: 191 YVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP 227

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 7/91 (7%)
Query: 13  KGLTYLRE--KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTRS 66
           +GL YL +     IIHRDVK +NIL++   E  + DFG++ +L+D     +  +  G   
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDXHVXXAVRGXIG 200
Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIG 97
           +++PE L     S ++D++  G+ L+E+  G
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITG 231

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL----IDSMANSFVGTR- 65
           +  G+ YL E  + +HRD+   NILVNS    K+ DFG+S  L     D    S +G + 
Sbjct: 127 IASGMRYLAE-MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185
Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
              + +PE +    ++  SD WS G+ + E M+ G  P
Sbjct: 186 PIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 53/143 (37%), Gaps = 50/143 (34%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVN------------------SGG----------- 40
           QVL+GL YL  K  IIH D+KP NIL++                  SG            
Sbjct: 138 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 197
Query: 41  --------------------EIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 80
                               ++KI D G +   +       + TR Y S E L G+ Y+ 
Sbjct: 198 PATAGNFLVNPLEPKNAEKLKVKIADLG-NACWVHKHFTEDIQTRQYRSLEVLIGSGYNT 256
Query: 81  QSDIWSLGLSLVEMAIGMYPIPP 103
            +DIWS      E+A G Y   P
Sbjct: 257 PADIWSTACMAFELATGDYLFEP 279

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVS-----GQLIDSM 57
           + +  +++LK L Y      I+HRDVKP N+L++    ++++ D+G++     GQ     
Sbjct: 133 IRFYMYEILKALDYCHSM-GIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQ----E 187
Query: 58  ANSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPI 101
            N  V +R +  PE L     Y    D+WSLG  L  M     P 
Sbjct: 188 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/100 (27%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--- 57
           L+++   + ++  G+ YL  K   +HRD+   N +V     +KI DFG++  + ++    
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 187
Query: 58  --ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
                 +  R +M+PE L+   ++  SD+WS G+ L E+ 
Sbjct: 188 KGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 46/87 (52%), Gaps = 8/87 (9%)
Query: 14  GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR------SY 67
           G+ YL +    +HRD+   NIL+NS    K+ DFG+S  L D    ++  TR       +
Sbjct: 136 GMKYLSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIPIRW 193
Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEM 94
            +PE +    ++  SD+WS G+ + E+
Sbjct: 194 TAPEAIAFRKFTSASDVWSYGIVMWEV 220

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 53/143 (37%), Gaps = 50/143 (34%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVN------------------SGG----------- 40
           QVL+GL YL  K  IIH D+KP NIL++                  SG            
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 41  --------------------EIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 80
                               ++KI D G +   +       + TR Y S E L G+ Y+ 
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLG-NACWVHKHFTEDIQTRQYRSLEVLIGSGYNT 272
Query: 81  QSDIWSLGLSLVEMAIGMYPIPP 103
            +DIWS      E+A G Y   P
Sbjct: 273 PADIWSTACMAFELATGDYLFEP 295

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 47/91 (51%), Gaps = 7/91 (7%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGT 64
           ++  G+ YL   +  +HRD+   N  V     +KI DFG++  + ++          +  
Sbjct: 133 EIADGMAYLN-ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 191
Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
           R +MSPE L+   ++  SD+WS G+ L E+A
Sbjct: 192 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIA 221

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 14  GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-----SYM 68
           G+ YL +    +HRD+   N+LV+S    K+ DFG+S  L D    ++  T       + 
Sbjct: 163 GMRYLSDL-GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221
Query: 69  SPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
           +PE +    +S  SD+WS G+ + E +A G  P
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/100 (27%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--- 57
           L+++   + ++  G+ YL  K   +HRD+   N +V     +KI DFG++  + ++    
Sbjct: 128 LQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 186
Query: 58  --ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
                 +  R +M+PE L+   ++  SD+WS G+ L E+ 
Sbjct: 187 KGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEIT 225

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 56/138 (40%), Gaps = 25/138 (18%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNIL-VNSGGE------------------ 41
           L  V + ++Q+   L +L E   + H D+KP NIL VNS  E                  
Sbjct: 122 LPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 42  IKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           I++ DFG S         + V TR Y  PE +    ++   D+WS+G  L E   G    
Sbjct: 181 IRVADFG-SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239
Query: 102 PPPDAKT----LAAIFGP 115
              + +     +  I GP
Sbjct: 240 QTHENREHLVMMEKILGP 257

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 10/87 (11%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGG----EIKICDFGVSGQLIDSMANSF---V 62
           Q+L G+ YL  K  I H D+KP NI++         IK+ DFG++ ++     N F    
Sbjct: 123 QILDGVHYLHSKR-IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIF 179
Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGL 89
           GT  +++PE +      +++D+WS+G+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGV 206

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 56/138 (40%), Gaps = 25/138 (18%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNIL-VNSGGE------------------ 41
           L  V + ++Q+   L +L E   + H D+KP NIL VNS  E                  
Sbjct: 131 LPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 189
Query: 42  IKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           I++ DFG S         + V TR Y  PE +    ++   D+WS+G  L E   G    
Sbjct: 190 IRVADFG-SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 248
Query: 102 PPPDAKT----LAAIFGP 115
              + +     +  I GP
Sbjct: 249 QTHENREHLVMMEKILGP 266

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 56/138 (40%), Gaps = 25/138 (18%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNIL-VNSGGE------------------ 41
           L  V + ++Q+   L +L E   + H D+KP NIL VNS  E                  
Sbjct: 154 LPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 212
Query: 42  IKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           I++ DFG S         + V TR Y  PE +    ++   D+WS+G  L E   G    
Sbjct: 213 IRVADFG-SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 271
Query: 102 PPPDAKT----LAAIFGP 115
              + +     +  I GP
Sbjct: 272 QTHENREHLVMMEKILGP 289

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 10/87 (11%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGG----EIKICDFGVSGQLIDSMANSF---V 62
           Q+L G+ YL  K  I H D+KP NI++         IK+ DFG++ ++     N F    
Sbjct: 116 QILDGVHYLHSKR-IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIF 172
Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGL 89
           GT  +++PE +      +++D+WS+G+
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGV 199

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 57/127 (44%), Gaps = 22/127 (17%)
Query: 11  VLKGLTYLREKHAIIHRDVKPSNILV---NSGGEIKICDFGV-SGQLIDSMANSF----- 61
           V   L +L  K  I HRD+KP NIL    N    +KICDF + SG  ++   +       
Sbjct: 120 VASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 62  ---VGTRSYMSPERL-----QGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
               G+  YM+PE +     + + Y  + D+WSLG+ L  +  G     PP      +  
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY----PPFVGRCGSDC 234
Query: 114 GPSRGDG 120
           G  RG+ 
Sbjct: 235 GWDRGEA 241

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 10/87 (11%)
Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGG----EIKICDFGVSGQLIDSMANSF---V 62
           Q+L G+ YL  K  I H D+KP NI++         IK+ DFG++ ++     N F    
Sbjct: 137 QILDGVHYLHSKR-IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIF 193
Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGL 89
           GT  +++PE +      +++D+WS+G+
Sbjct: 194 GTPEFVAPEIVNYEPLGLEADMWSIGV 220

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVS-----GQLIDSM 57
           + +  +++LK L Y      I+HRDVKP N++++    ++++ D+G++     GQ     
Sbjct: 131 IRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----E 185
Query: 58  ANSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPI 101
            N  V +R +  PE L     Y    D+WSLG  L  M     P 
Sbjct: 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVS-----GQLIDSM 57
           + +  +++LK L Y      I+HRDVKP N++++    ++++ D+G++     GQ     
Sbjct: 133 IRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----E 187
Query: 58  ANSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPI 101
            N  V +R +  PE L     Y    D+WSLG  L  M     P 
Sbjct: 188 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVS-----GQLIDSM 57
           + +  +++LK L Y      I+HRDVKP N++++    ++++ D+G++     GQ     
Sbjct: 133 IRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----E 187
Query: 58  ANSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPI 101
            N  V +R +  PE L     Y    D+WSLG  L  M     P 
Sbjct: 188 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVS-----GQLIDSM 57
           + +  +++LK L Y      I+HRDVKP N++++    ++++ D+G++     GQ     
Sbjct: 133 IRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----E 187
Query: 58  ANSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPI 101
            N  V +R +  PE L     Y    D+WSLG  L  M     P 
Sbjct: 188 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVS-----GQLIDSM 57
           + +  +++LK L Y      I+HRDVKP N++++    ++++ D+G++     GQ     
Sbjct: 133 IRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----E 187
Query: 58  ANSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPI 101
            N  V +R +  PE L     Y    D+WSLG  L  M     P 
Sbjct: 188 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVS-----GQLIDSM 57
           + +  +++LK L Y      I+HRDVKP N++++    ++++ D+G++     GQ     
Sbjct: 132 IRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----E 186
Query: 58  ANSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPI 101
            N  V +R +  PE L     Y    D+WSLG  L  M     P 
Sbjct: 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVS-----GQLIDSM 57
           + +  +++LK L Y      I+HRDVKP N++++    ++++ D+G++     GQ     
Sbjct: 133 IRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----E 187
Query: 58  ANSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPI 101
            N  V +R +  PE L     Y    D+WSLG  L  M     P 
Sbjct: 188 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVS-----GQLIDSM 57
           + +  +++LK L Y      I+HRDVKP N++++    ++++ D+G++     GQ     
Sbjct: 133 IRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----E 187
Query: 58  ANSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPI 101
            N  V +R +  PE L     Y    D+WSLG  L  M     P 
Sbjct: 188 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVS-----GQLIDSM 57
           + +  +++LK L Y      I+HRDVKP N++++    ++++ D+G++     GQ     
Sbjct: 132 IRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----E 186
Query: 58  ANSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPI 101
            N  V +R +  PE L     Y    D+WSLG  L  M     P 
Sbjct: 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVS-----GQLIDSM 57
           + +  +++LK L Y      I+HRDVKP N++++    ++++ D+G++     GQ     
Sbjct: 133 IRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----E 187
Query: 58  ANSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPI 101
            N  V +R +  PE L     Y    D+WSLG  L  M     P 
Sbjct: 188 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 7/93 (7%)
Query: 14  GLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTR---SYM 68
           G+ YL +    +HRD+   N+LV+S    K+ DFG+S  L D    A +  G +    + 
Sbjct: 163 GMRYLSDL-GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWT 221
Query: 69  SPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
           +PE +    +S  SD+WS G+ + E +A G  P
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVS-----GQLIDSM 57
           + +  +++LK L Y      I+HRDVKP N++++    ++++ D+G++     GQ     
Sbjct: 133 IRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----E 187
Query: 58  ANSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPI 101
            N  V +R +  PE L     Y    D+WSLG  L  M     P 
Sbjct: 188 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVS-----GQLIDSM 57
           + +  +++LK L Y      I+HRDVKP N++++    ++++ D+G++     GQ     
Sbjct: 133 IRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----E 187
Query: 58  ANSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPI 101
            N  V +R +  PE L     Y    D+WSLG  L  M     P 
Sbjct: 188 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVS-----GQLIDSM 57
           + +  +++LK L Y      I+HRDVKP N++++    ++++ D+G++     GQ     
Sbjct: 138 IRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----E 192
Query: 58  ANSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPI 101
            N  V +R +  PE L     Y    D+WSLG  L  M     P 
Sbjct: 193 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 237

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 4   VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVS-----GQLIDSM 57
           + +  +++LK L Y      I+HRDVKP N++++    ++++ D+G++     GQ     
Sbjct: 133 IRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----E 187
Query: 58  ANSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPI 101
            N  V +R +  PE L     Y    D+WSLG  L  M     P 
Sbjct: 188 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 54/120 (45%), Gaps = 13/120 (10%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILV---NSGGEIKICDFGVSGQLIDSM 57
           LK V   + Q++  + Y+  K+  IHRDVKP N L+     G  + I DFG++ +  D+ 
Sbjct: 104 LKTVLLLADQMISRIEYIHSKN-FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162
Query: 58  AN---------SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT 108
            +         +  GT  Y S     G   S + D+ SLG  L+   +G  P     A T
Sbjct: 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 54/120 (45%), Gaps = 13/120 (10%)
Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILV---NSGGEIKICDFGVSGQLIDSM 57
           LK V   + Q++  + Y+  K+  IHRDVKP N L+     G  + I DFG++ +  D+ 
Sbjct: 102 LKTVLLLADQMISRIEYIHSKN-FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160
Query: 58  AN---------SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT 108
            +         +  GT  Y S     G   S + D+ SLG  L+   +G  P     A T
Sbjct: 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	131
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-64
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-59
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-58
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-57
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-56
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-35
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	8e-35
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-34
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-34
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-34
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-34
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-33
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-33
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-32
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-31
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-31
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-30
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-30
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-29
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-28
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-26
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-26
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-26
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-25
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-25
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-25
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-25
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-25
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-25
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-25
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-25
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-25
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-25
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-25
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-24
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-24
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-24
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-24
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-24
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-24
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-24
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-24
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-24
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-24
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-24
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-23
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-23
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-23
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-23
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-23
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-23
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-23
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-23
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-23
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-23
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-23
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-23
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-23
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-22
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-22
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-22
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-22
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-22
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-22
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-22
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-22
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-22
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-22
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-22
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-22
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-22
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-22
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-22
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-22
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-21
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-21
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-21
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-21
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-21
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-20
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-20
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-20
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-20
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-20
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-20
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-20
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-20
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-20
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-20
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-20
3rp9_A	458	Mitogen-activated protein kinase; structural genom	9e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-19
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-19
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-19
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-19
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-19
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-19
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-18
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-18
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-18
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-18
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-18
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-18
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-18
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-18
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-18
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	9e-18
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-17
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-17
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-16
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-16
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-16
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-16
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-16
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-15
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-15
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-15
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-15
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-15
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-15
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-15
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-15
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-15
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	8e-15
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-14
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-14
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-14
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-14
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-14
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-14
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-14
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-14
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-14
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-14
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-14
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-14
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-14
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-14
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-14
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-14
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-14
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-14
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-14
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-13
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-13
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-13
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-13
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-13
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-13
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-13
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-13
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-13
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-13
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-13
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-13
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-13
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-13
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-12
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-11
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-11
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-07

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  198 bits (504), Expect = 5e-64
 Identities = 93/118 (78%), Positives = 99/118 (83%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSY
Sbjct: 137 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 196

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYWHVS 125
           MSPERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK L  +FG           
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  182 bits (465), Expect = 5e-59
 Identities = 47/105 (44%), Positives = 72/105 (68%), Gaps = 5/105 (4%)

Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-NSFVGT 64
             +  ++K L +L  K ++IHRDVKPSN+L+N+ G++K+CDFG+SG L+D +A +   G 
Sbjct: 113 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGC 172

Query: 65  RSYMSPER----LQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           + YM+PER    L    YSV+SDIWSLG++++E+AI  +P     
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG 217

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  178 bits (453), Expect = 8e-57
 Identities = 50/104 (48%), Positives = 73/104 (70%), Gaps = 5/104 (4%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS-FVGTRS 66
           +   +K L +L+E   IIHRD+KPSNIL++  G IK+CDFG+SGQL+DS+A +   G R 
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRP 190

Query: 67  YMSPERLQGTH----YSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
           YM+PER+  +     Y V+SD+WSLG++L E+A G +P P  ++
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  177 bits (452), Expect = 1e-56
 Identities = 49/104 (47%), Positives = 72/104 (69%), Gaps = 6/104 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-NSFVGTRS 66
           +  ++K L YL+EKH +IHRDVKPSNIL++  G+IK+CDFG+SG+L+D  A +   G  +
Sbjct: 130 TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAA 189

Query: 67  YMSPERLQ-----GTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           YM+PER+         Y +++D+WSLG+SLVE+A G +P     
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  124 bits (314), Expect = 2e-36
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 4/102 (3%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRSY 67
            Q+ KG+ Y+  K  +I+RD+KPSNI +    ++KI DFG+   L  D       GT  Y
Sbjct: 129 EQITKGVDYIHSKK-LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRY 187

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           MSPE++    Y  + D+++LGL L E+          +    
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCD--TAFETSKF 227

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  122 bits (308), Expect = 3e-35
 Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 7/106 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRSYM 68
             L  L +L  +  ++H DVKP+NI +   G  K+ DFG+  +L          G   YM
Sbjct: 165 DTLLALAHLHSQG-LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYM 223

Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP-DAKTLAAIF 113
           +PE LQG  Y   +D++SLGL+++E+A  M     P   +    + 
Sbjct: 224 APELLQG-SYGTAADVFSLGLTILEVACNM---ELPHGGEGWQQLR 265

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  121 bits (305), Expect = 8e-35
 Identities = 47/104 (45%), Positives = 65/104 (62%), Gaps = 6/104 (5%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--N 59
            ++       LKGL YL      IHRD+K  NIL+N+ G  K+ DFGV+GQL D+MA  N
Sbjct: 125 DEIATILQSTLKGLEYLHFMR-KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN 183

Query: 60  SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
           + +GT  +M+PE +Q   Y+  +DIWSLG++ +EMA G    PP
Sbjct: 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK---PP 224

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  119 bits (301), Expect = 3e-34
 Identities = 44/96 (45%), Positives = 68/96 (70%), Gaps = 6/96 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRSY 67
           ++LKGL YL  +   IHRD+K +N+L++  GE+K+ DFGV+GQL D+    N+FVGT  +
Sbjct: 127 EILKGLDYLHSEK-KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 185

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
           M+PE ++ + Y  ++DIWSLG++ +E+A G    PP
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGE---PP 218

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  119 bits (300), Expect = 4e-34
 Identities = 36/93 (38%), Positives = 55/93 (59%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           Q+   L ++  +  ++HRD+KP+N+ + + G +K+ D G+        + A+S VGT  Y
Sbjct: 144 QLCSALEHMHSRR-VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 202

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           MSPER+    Y+ +SDIWSLG  L EMA    P
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  120 bits (302), Expect = 5e-34
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 6/106 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           Q+   L ++ ++  I+HRD+K  NI +   G +++ DFG++  L     +A + +GT  Y
Sbjct: 133 QICLALKHVHDRK-ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYY 191

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           +SPE  +   Y+ +SDIW+LG  L E+          +A ++  + 
Sbjct: 192 LSPEICENKPYNNKSDIWALGCVLYELCTLK---HAFEAGSMKNLV 234

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  118 bits (298), Expect = 7e-34
 Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 6/104 (5%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--N 59
            Q+     + L+ L +L     +IHRD+K  NIL+   G +K+ DFG   Q+    +  +
Sbjct: 116 GQIAAVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174

Query: 60  SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
           + VGT  +M+PE +    Y  + DIWSLG+  +EM  G    PP
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE---PP 215

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  119 bits (299), Expect = 7e-34
 Identities = 38/104 (36%), Positives = 59/104 (56%), Gaps = 6/104 (5%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--N 59
           +Q+      VL+ L YL  +  +IHRD+K  +IL+   G +K+ DFG   Q+   +    
Sbjct: 141 EQIATVCEAVLQALAYLHAQG-VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199

Query: 60  SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
           S VGT  +M+PE +  + Y+ + DIWSLG+ ++EM  G    PP
Sbjct: 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE---PP 240

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  118 bits (298), Expect = 1e-33
 Identities = 40/106 (37%), Positives = 65/106 (61%), Gaps = 8/106 (7%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--N 59
           + + Y   ++L+GL++L +   +IHRD+K  N+L+    E+K+ DFGVS QL  ++   N
Sbjct: 129 EWIAYICREILRGLSHLHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 187

Query: 60  SFVGTRSYMSPE-----RLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           +F+GT  +M+PE           Y  +SD+WSLG++ +EMA G  P
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  116 bits (293), Expect = 4e-33
 Identities = 42/109 (38%), Positives = 67/109 (61%), Gaps = 11/109 (10%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--N 59
            Q+     Q+L+ L +L  K  IIHRD+K  N+L+   G+I++ DFGVS + + ++   +
Sbjct: 117 PQIQVVCRQMLEALNFLHSKR-IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175

Query: 60  SFVGTRSYMSPE-----RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
           SF+GT  +M+PE      ++ T Y  ++DIWSLG++L+EMA      PP
Sbjct: 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE---PP 221

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  117 bits (295), Expect = 4e-33
 Identities = 33/113 (29%), Positives = 49/113 (43%), Gaps = 13/113 (11%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLID-------SMANSF 61
           Q L+GL YL  +  I+H DVK  N+L++S G    +CDFG +  L            +  
Sbjct: 158 QALEGLEYLHTRR-ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216

Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP-PDAKTLAAIF 113
            GT ++M+PE + G     + DIWS    ++ M  G     P           
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC---HPWTQYFRGPLCL 266

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  115 bits (291), Expect = 4e-33
 Identities = 39/110 (35%), Positives = 59/110 (53%), Gaps = 9/110 (8%)

Query: 10  QVLKGLTYL----REKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVG 63
           Q+   L          H ++HRD+KP+N+ ++    +K+ DFG++  L    S A +FVG
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178

Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           T  YMSPE++    Y+ +SDIWSLG  L E+   M   PP  A +   + 
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM---PPFTAFSQKELA 225

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  115 bits (291), Expect = 6e-33
 Identities = 42/96 (43%), Positives = 59/96 (61%), Gaps = 6/96 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQL--IDSMANSFVGTRS 66
           Q+L+GL YL +   I+HRD+K  N+L+N+  G +KI DFG S +L  I+    +F GT  
Sbjct: 130 QILEGLKYLHDNQ-IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ 188

Query: 67  YMSPE--RLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           YM+PE        Y   +DIWSLG +++EMA G  P
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  113 bits (284), Expect = 9e-32
 Identities = 43/105 (40%), Positives = 59/105 (56%), Gaps = 12/105 (11%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-------NSFV 62
           +VL+GL YL +    IHRDVK  NIL+   G ++I DFGVS  L             +FV
Sbjct: 129 EVLEGLEYLHKNG-QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187

Query: 63  GTRSYMSPERL-QGTHYSVQSDIWSLGLSLVEMAIGMYP---IPP 103
           GT  +M+PE + Q   Y  ++DIWS G++ +E+A G  P    PP
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  113 bits (284), Expect = 2e-31
 Identities = 39/105 (37%), Positives = 61/105 (58%), Gaps = 9/105 (8%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
            ++   +   L+GL YL   + +IHRDVK  NIL++  G +K+ DFG +  +  + ANSF
Sbjct: 154 VEIAAVTHGALQGLAYLHSHN-MIHRDVKAGNILLSEPGLVKLGDFGSASIM--APANSF 210

Query: 62  VGTRSYMSPE---RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
           VGT  +M+PE    +    Y  + D+WSLG++ +E+A      PP
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK---PP 252

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  112 bits (281), Expect = 2e-31
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 5/106 (4%)

Query: 10  QVLKGLTYLREKH-AIIHRDVKPSNILVNSG-GEIKICDFGVSGQLIDSMANSFVGTRSY 67
           Q+LKGL +L  +   IIHRD+K  NI +    G +KI D G++     S A + +GT  +
Sbjct: 137 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEF 196

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           M+PE  +   Y    D+++ G+ ++EMA   Y  P  + +  A I+
Sbjct: 197 MAPEMYEE-KYDESVDVYAFGMCMLEMATSEY--PYSECQNAAQIY 239

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  111 bits (280), Expect = 3e-31
 Identities = 34/101 (33%), Positives = 51/101 (50%), Gaps = 15/101 (14%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM------------ 57
           Q+ + + +L  K  ++HRD+KPSNI       +K+ DFG+   +                
Sbjct: 126 QIAEAVEFLHSKG-LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184

Query: 58  --ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAI 96
                 VGT+ YMSPE++ G  YS + DI+SLGL L E+  
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  109 bits (274), Expect = 2e-30
 Identities = 29/117 (24%), Positives = 49/117 (41%), Gaps = 26/117 (22%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEI-------------------KICDFGVS 50
           QV +GL Y+     ++H D+KPSNI ++                        KI D G  
Sbjct: 123 QVGRGLRYIHSMS-LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181

Query: 51  GQLIDSMANSFVGTRSYMSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPIPPPDA 106
            ++  S      G   +++ E LQ  + +  ++DI++L L++V  A      P P  
Sbjct: 182 TRI--SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE---PLPRN 233

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  109 bits (273), Expect = 5e-30
 Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 15/103 (14%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM------------ 57
           Q+ + + +L  K  ++HRD+KPSNI       +K+ DFG+   +                
Sbjct: 172 QIAEAVEFLHSKG-LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230

Query: 58  --ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGM 98
                 VGT+ YMSPE++ G +YS + DI+SLGL L E+    
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF 273

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  107 bits (270), Expect = 1e-29
 Identities = 36/121 (29%), Positives = 56/121 (46%), Gaps = 23/121 (19%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL---------------- 53
           Q+L+ L+Y+  +  IIHRD+KP NI ++    +KI DFG++  +                
Sbjct: 124 QILEALSYIHSQG-IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 54  IDSMANSFVGTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
                 S +GT  Y++ E L GT HY+ + D++SLG+   EM       P         I
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-----YPFSTGMERVNI 237

Query: 113 F 113
            
Sbjct: 238 L 238

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  107 bits (269), Expect = 5e-29
 Identities = 31/108 (28%), Positives = 50/108 (46%), Gaps = 15/108 (13%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA---------NS 60
            VLK L Y+      +HR VK S+IL++  G++ +     +  +I               
Sbjct: 136 GVLKALDYIHHMG-YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194

Query: 61  FVGTRSYMSPERLQ--GTHYSVQSDIWSLGLSLVEMAIGMYP---IPP 103
            V    ++SPE LQ     Y  +SDI+S+G++  E+A G  P   +P 
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  106 bits (265), Expect = 5e-28
 Identities = 37/104 (35%), Positives = 49/104 (47%), Gaps = 5/104 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLID-SMANSFVGTR 65
            +   L YL E   IIHRD+KP NI++  G +    KI D G + +L    +   FVGT 
Sbjct: 129 DISSALRYLHENR-IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTL 187

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
            Y++PE L+   Y+V  D WS G    E   G  P  P      
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  102 bits (256), Expect = 8e-28
 Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 4/104 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S      GT  Y+ 
Sbjct: 117 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLP 175

Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+WSLG+   E  +G    PP +A T    +
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVG---KPPFEANTYQETY 216

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  100 bits (252), Expect = 4e-27
 Identities = 38/115 (33%), Positives = 51/115 (44%), Gaps = 19/115 (16%)

Query: 10  QVLKGLTYLRE-------KHAIIHRDVKPSNILVNSGGEIKICDFGVS------GQLIDS 56
            +  GL +L         K AI HRD+K  NILV   G+  I D G++         +D 
Sbjct: 113 SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV 172

Query: 57  MANSFVGTRSYMSPERLQGT------HYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
             N  VGT+ YM+PE L  T          + DIW+ GL L E+A  M      +
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  100 bits (251), Expect = 1e-26
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 2/93 (2%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
            VL   +Y+  +  I HRDVKPSNIL++  G +K+ DFG S  ++D       GT  +M 
Sbjct: 159 SVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMP 218

Query: 70  PERLQG--THYSVQSDIWSLGLSLVEMAIGMYP 100
           PE      ++   + DIWSLG+ L  M   + P
Sbjct: 219 PEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 99.0 bits (247), Expect = 5e-26
 Identities = 33/106 (31%), Positives = 54/106 (50%), Gaps = 17/106 (16%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTR 65
            +L+ +  + +   I+H D+KP+N L+   G +K+ DFG++ Q+       + +S VGT 
Sbjct: 116 NMLEAVHTIHQHG-IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTV 173

Query: 66  SYMSPERLQGTH-----------YSVQSDIWSLGLSLVEMAIGMYP 100
           +YM PE ++               S +SD+WSLG  L  M  G  P
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 97.8 bits (244), Expect = 7e-26
 Identities = 36/94 (38%), Positives = 60/94 (63%), Gaps = 4/94 (4%)

Query: 10  QVLKGLTYL--REKHAIIHRDVKPSNILVNSGGE-IKICDFGVSGQLIDSMANSFVGTRS 66
           Q  +G+ YL   +  A+IHRD+KP N+L+ +GG  +KICDFG +  +   M N+  G+ +
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-KGSAA 168

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           +M+PE  +G++YS + D++S G+ L E+     P
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP 202

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 98.3 bits (245), Expect = 1e-25
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 17/106 (16%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN----SFVGTR 65
            +L+ +  + +   I+H D+KP+N L+   G +K+ DFG++ Q+     +    S VG  
Sbjct: 163 NMLEAVHTIHQHG-IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220

Query: 66  SYMSPERLQGT-----------HYSVQSDIWSLGLSLVEMAIGMYP 100
           +YM PE ++               S +SD+WSLG  L  M  G  P
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 97.4 bits (243), Expect = 1e-25
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 3/94 (3%)

Query: 10  QVLKGLTYL-REKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRS 66
            V KG+ YL      I+HR++K  N+LV+    +K+CDFG+S     +   + S  GT  
Sbjct: 145 DVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPE 204

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           +M+PE L+    + +SD++S G+ L E+A    P
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 97.0 bits (242), Expect = 1e-25
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 17/103 (16%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN----SFVGTR 65
            +L+ +  + +   I+H D+KP+N L+   G +K+ DFG++ Q+     +    S VGT 
Sbjct: 135 NMLEAVHTIHQHG-IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTV 192

Query: 66  SYMSPERLQGTH-----------YSVQSDIWSLGLSLVEMAIG 97
           +YM PE ++               S +SD+WSLG  L  M  G
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 96.6 bits (241), Expect = 2e-25
 Identities = 34/108 (31%), Positives = 50/108 (46%), Gaps = 7/108 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRS 66
           Q+   L          HRDVKP NILV++     + DFG++    D       + VGT  
Sbjct: 142 QIGSALDAAHA-AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLY 200

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           YM+PER   +H + ++DI++L   L E   G    PP     L+ +  
Sbjct: 201 YMAPERFSESHATYRADIYALTCVLYECLTGS---PPYQGDQLSVMGA 245

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 95.7 bits (239), Expect = 2e-25
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 4/104 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L Y  E+  +IHRD+KP N+L+   GE+KI DFG S         +  GT  Y+ 
Sbjct: 122 ELADALHYCHERK-VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLP 180

Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           PE ++G  +  + D+W  G+   E  +GM   PP D+ +     
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGM---PPFDSPSHTETH 221

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 97.0 bits (242), Expect = 3e-25
 Identities = 38/92 (41%), Positives = 55/92 (59%), Gaps = 7/92 (7%)

Query: 9   FQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS 66
           +Q+LKGL Y+   H+  ++HRD+KP N+ VN   E+KI DFG++      M   +V TR 
Sbjct: 133 YQMLKGLKYI---HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-YVVTRW 188

Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
           Y +PE +    HY+   DIWS+G  + EM  G
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 97.1 bits (242), Expect = 3e-25
 Identities = 40/95 (42%), Positives = 56/95 (58%), Gaps = 6/95 (6%)

Query: 6   YSSFQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS-FV 62
           Y  +Q+L G+ +L   H+  IIHRD+KPSNI+V S   +KI DFG++     S   + +V
Sbjct: 131 YLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 187

Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIG 97
            TR Y +PE + G  Y    DIWS+G  + EM  G
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 96.3 bits (240), Expect = 4e-25
 Identities = 35/114 (30%), Positives = 51/114 (44%), Gaps = 19/114 (16%)

Query: 11  VLKGLTYL-------REKHAIIHRDVKPSNILVNSGGEIKICDFGVS------GQLIDSM 57
            + GL +L       + K AI HRD+K  NILV   G   I D G++         +D  
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202

Query: 58  ANSFVGTRSYMSPERLQGT------HYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            N+ VGT+ YM PE L  +         + +D++S GL L E+A         +
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 96.6 bits (241), Expect = 5e-25
 Identities = 41/92 (44%), Positives = 55/92 (59%), Gaps = 7/92 (7%)

Query: 9   FQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS 66
           +Q+LKGL Y+   HA  IIHRD+KP N+ VN   E+KI DFG++ Q    M   +V TR 
Sbjct: 135 YQMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-TGYVVTRW 190

Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
           Y +PE +     Y+   DIWS+G  + EM  G
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 95.2 bits (237), Expect = 8e-25
 Identities = 35/111 (31%), Positives = 53/111 (47%), Gaps = 20/111 (18%)

Query: 13  KGLTYL---------REKHAIIHRDVKPSNILVNSGGEIKICDFGVS-----GQLIDSMA 58
           +GL YL           K AI HRD+K  N+L+ +     I DFG++     G+      
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT- 190

Query: 59  NSFVGTRSYMSPERLQGTH-----YSVQSDIWSLGLSLVEMAIGMYPIPPP 104
           +  VGTR YM+PE L+G         ++ D++++GL L E+A        P
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 95.9 bits (239), Expect = 8e-25
 Identities = 40/92 (43%), Positives = 57/92 (61%), Gaps = 7/92 (7%)

Query: 9   FQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS 66
           +Q+L+GL Y+   H+  IIHRD+KPSN+ VN   E+KI DFG++    D M   +V TR 
Sbjct: 139 YQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-YVATRW 194

Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
           Y +PE +    HY+   DIWS+G  + E+  G
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 96.1 bits (239), Expect = 1e-24
 Identities = 33/118 (27%), Positives = 53/118 (44%), Gaps = 15/118 (12%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE----IKICDFGVSGQLID-SMANSFVGT 64
            V+ G+ +LRE   I+HR++KP NI+   G +     K+ DFG + +L D     S  GT
Sbjct: 120 DVVGGMNHLRENG-IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGT 178

Query: 65  RSYMSPERLQGT--------HYSVQSDIWSLGLSLVEMAIGMYP-IPPPDAKTLAAIF 113
             Y+ P+  +           Y    D+WS+G++    A G  P  P    +    + 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 94.8 bits (236), Expect = 1e-24
 Identities = 33/118 (27%), Positives = 53/118 (44%), Gaps = 15/118 (12%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE----IKICDFGVSGQLID-SMANSFVGT 64
            V+ G+ +LRE   I+HR++KP NI+   G +     K+ DFG + +L D     S  GT
Sbjct: 120 DVVGGMNHLRENG-IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGT 178

Query: 65  RSYMSPERLQGT--------HYSVQSDIWSLGLSLVEMAIGMYP-IPPPDAKTLAAIF 113
             Y+ P+  +           Y    D+WS+G++    A G  P  P    +    + 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 95.5 bits (237), Expect = 1e-24
 Identities = 17/93 (18%), Positives = 36/93 (38%), Gaps = 4/93 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           Q+++    L+ K  ++H    P N+ +   G + + D       + +   +     +Y  
Sbjct: 202 QLIRLAANLQSKG-LVHGHFTPDNLFIMPDGRLMLGDVSAL-WKVGTRGPASSVPVTYAP 259

Query: 70  PERLQG--THYSVQSDIWSLGLSLVEMAIGMYP 100
            E L      ++   + W LGLS+  +     P
Sbjct: 260 REFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 95.1 bits (237), Expect = 2e-24
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 7/93 (7%)

Query: 9   FQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVS-GQLIDSMANSFVGTR 65
           + +L GL  L   H   ++HRD+ P NIL+    +I ICDF ++     D+    +V  R
Sbjct: 141 YHILLGLHVL---HEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197

Query: 66  SYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIG 97
            Y +PE  +Q   ++   D+WS G  + EM   
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 94.8 bits (236), Expect = 2e-24
 Identities = 35/112 (31%), Positives = 49/112 (43%), Gaps = 19/112 (16%)

Query: 13  KGLTYLRE-------KHAIIHRDVKPSNILVNSGGEIKICDFGVS------GQLIDSMAN 59
            GL +L         K AI HRD+K  NILV   G   I D G++         ID   N
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209

Query: 60  SFVGTRSYMSPERLQGT------HYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
             VGT+ YM+PE L  +          ++DI+++GL   E+A         +
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 95.7 bits (238), Expect = 2e-24
 Identities = 39/95 (41%), Positives = 55/95 (57%), Gaps = 6/95 (6%)

Query: 6   YSSFQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS-FV 62
           Y  +Q+L G+ +L   H+  IIHRD+KPSNI+V S   +KI DFG++     S   + +V
Sbjct: 168 YLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 224

Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIG 97
            TR Y +PE + G  Y    DIWS+G  + EM   
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 94.7 bits (235), Expect = 3e-24
 Identities = 23/115 (20%), Positives = 41/115 (35%), Gaps = 14/115 (12%)

Query: 10  QVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSFVGT 64
           QV++ L  L   H   ++H  ++P +I+++  G + +  F      G    S        
Sbjct: 219 QVIRLLASL---HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAP 275

Query: 65  RSYMSPERLQG-----THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA-KTLAAIF 113
               +   L       T  +   D W+LGL++  +     P     A      IF
Sbjct: 276 PETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIF 330

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 93.2 bits (232), Expect = 3e-24
 Identities = 29/114 (25%), Positives = 53/114 (46%), Gaps = 12/114 (10%)

Query: 10  QVLKGLTYL-REKHAIIHRDVKPSNILVNSGGE-----IKICDFGVSGQLIDSMANSFVG 63
            +  G+ Y+  +   I+HRD++  NI + S  E      K+ DFG+S Q + S+ +  +G
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV-SGLLG 188

Query: 64  TRSYMSPERLQGTH--YSVQSDIWSLGLSLVEMAIGMYP---IPPPDAKTLAAI 112
              +M+PE +      Y+ ++D +S  + L  +  G  P         K +  I
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 94.3 bits (235), Expect = 3e-24
 Identities = 36/96 (37%), Positives = 57/96 (59%), Gaps = 4/96 (4%)

Query: 6   YSSFQVLKGLTYLREKHA-IIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMAN-SFV 62
              FQ+++ +  L      + HRD+KP N+LVN + G +K+CDFG + +L  S  N +++
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192

Query: 63  GTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
            +R Y +PE + G  HY+   DIWS+G    EM +G
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 93.1 bits (232), Expect = 4e-24
 Identities = 41/99 (41%), Positives = 58/99 (58%), Gaps = 6/99 (6%)

Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSF 61
           Y++ +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + ANSF
Sbjct: 135 YTA-EIVSALEYLHGKG-IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192

Query: 62  VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           VGT  Y+SPE L        SD+W+LG  + ++  G+ P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 94.9 bits (236), Expect = 5e-24
 Identities = 23/105 (21%), Positives = 55/105 (52%), Gaps = 12/105 (11%)

Query: 10  QVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           ++L  L+YL   H+  +++ D+KP NI++     +K+ D G   ++  +      GT  +
Sbjct: 190 EILPALSYL---HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI--NSFGYLYGTPGF 243

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
            +PE ++    +V +DI+++G +L  + + +   P  + + +  +
Sbjct: 244 QAPEIVRT-GPTVATDIYTVGRTLAALTLDL---PTRNGRYVDGL 284

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 94.0 bits (234), Expect = 5e-24
 Identities = 35/100 (35%), Positives = 57/100 (57%), Gaps = 4/100 (4%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG-GEIKICDFGVSGQLIDSMAN 59
           +  V    +Q+ + L Y+     I HRD+KP N+L++     +K+CDFG + QL+    N
Sbjct: 155 VIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213

Query: 60  -SFVGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
            S++ +R Y +PE + G T Y+   D+WS G  L E+ +G
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 93.6 bits (233), Expect = 6e-24
 Identities = 33/95 (34%), Positives = 57/95 (60%), Gaps = 4/95 (4%)

Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG-GEIKICDFGVSGQLIDSMAN-SFVG 63
              +Q+ + + ++     I HRD+KP N+LVNS    +K+CDFG + +LI S  + +++ 
Sbjct: 145 IYIYQLFRAVGFIH-SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC 203

Query: 64  TRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
           +R Y +PE + G T Y+   D+WS+G    E+ +G
Sbjct: 204 SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 91.8 bits (229), Expect = 8e-24
 Identities = 37/106 (34%), Positives = 56/106 (52%), Gaps = 6/106 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           Q++ G+ YL     I+HRD+  SN+L+     IKI DFG++ QL        +  GT +Y
Sbjct: 120 QIITGMLYLHSHG-ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNY 178

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           +SPE    + + ++SD+WSLG     + IG    PP D  T+    
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGR---PPFDTDTVKNTL 221

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 93.6 bits (233), Expect = 8e-24
 Identities = 35/93 (37%), Positives = 55/93 (59%), Gaps = 4/93 (4%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSG-GEIKICDFGVSGQLIDSMAN-SFVGTR 65
            +Q+L+ L Y+     I HRD+KP N+L++   G +K+ DFG +  LI    N S++ +R
Sbjct: 147 MYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR 205

Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
            Y +PE + G T+Y+   DIWS G  + E+  G
Sbjct: 206 YYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 91.6 bits (228), Expect = 9e-24
 Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 10/101 (9%)

Query: 10  QVLKGLTYL--REKHAIIHRDVKPSNILVNSGGE--------IKICDFGVSGQLIDSMAN 59
           Q+ +G+ YL       IIHRD+K SNIL+    E        +KI DFG++ +   +   
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM 172

Query: 60  SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           S  G  ++M+PE ++ + +S  SD+WS G+ L E+  G  P
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 94.1 bits (234), Expect = 1e-23
 Identities = 32/93 (34%), Positives = 54/93 (58%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           Q++ GL +L +   II+RD+KP N+L++  G ++I D G++ +L    +    + GT  +
Sbjct: 297 QIVSGLEHLHQ-RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           M+PE L G  Y    D ++LG++L EM     P
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 94.1 bits (234), Expect = 1e-23
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 2/92 (2%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYM 68
           ++  GL  L     I++RD+KP NIL++  G I+I D G++  + +       VGT  YM
Sbjct: 294 EICCGLEDLHR-ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYM 352

Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           +PE ++   Y+   D W+LG  L EM  G  P
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 93.8 bits (233), Expect = 1e-23
 Identities = 31/92 (33%), Positives = 54/92 (58%), Gaps = 2/92 (2%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           +++ GL ++     +++RD+KP+NIL++  G ++I D G++        ++ VGT  YM+
Sbjct: 300 EIILGLEHM-HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMA 358

Query: 70  PERLQ-GTHYSVQSDIWSLGLSLVEMAIGMYP 100
           PE LQ G  Y   +D +SLG  L ++  G  P
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 91.1 bits (227), Expect = 2e-23
 Identities = 36/94 (38%), Positives = 57/94 (60%), Gaps = 4/94 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRS 66
           Q+L G+ +  +   I+HRD+KP NIL++S   +KI DFG++  L ++     N  +GT  
Sbjct: 119 QILDGIKHAHDMR-IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           Y SPE+ +G      +DI+S+G+ L EM +G  P
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 92.4 bits (229), Expect = 2e-23
 Identities = 20/102 (19%), Positives = 39/102 (38%), Gaps = 14/102 (13%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           QV++ L  L     ++H  ++P +I+++  G + +  F    +  D        +R +  
Sbjct: 214 QVIRLLASLHHYG-LVHTYLRPVDIVLDQRGGVFLTGFEHLVR--DGARVVSSVSRGFEP 270

Query: 70  PERLQ-----------GTHYSVQSDIWSLGLSLVEMAIGMYP 100
           PE               T  +   D W+LGL +  +     P
Sbjct: 271 PELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 92.9 bits (231), Expect = 2e-23
 Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 2/102 (1%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           +++  L YL  +  +++RD+K  N++++  G IKI DFG+  + I   +   +F GT  Y
Sbjct: 256 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEY 315

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           ++PE L+   Y    D W LG+ + EM  G  P    D + L
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 357

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 90.8 bits (226), Expect = 2e-23
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 8/98 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ----LIDSMANSFVGTR 65
           Q  +G+ YL    +IIHRD+K +NI ++    +KI DFG++ +              G+ 
Sbjct: 128 QTARGMDYL-HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186

Query: 66  SYMSPERLQG---THYSVQSDIWSLGLSLVEMAIGMYP 100
            +M+PE ++      YS QSD+++ G+ L E+  G  P
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 92.5 bits (230), Expect = 2e-23
 Identities = 28/104 (26%), Positives = 44/104 (42%), Gaps = 14/104 (13%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE-----IKICDFGVS-----GQLIDSMAN 59
           Q   GL +L   + I+HRD+KP NIL++           I DFG+      G+   S  +
Sbjct: 126 QTTSGLAHLHSLN-IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184

Query: 60  SFVGTRSYMSPERLQGT---HYSVQSDIWSLGLSLVEMAIGMYP 100
              GT  +++PE L      + +   DI+S G     +      
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 91.6 bits (228), Expect = 3e-23
 Identities = 39/97 (40%), Positives = 57/97 (58%), Gaps = 11/97 (11%)

Query: 9   FQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVS-GQLIDSMANSF---- 61
           +Q+L+GL Y+   H+  ++HRD+KPSN+L+N+  ++KICDFG++     D     F    
Sbjct: 135 YQILRGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191

Query: 62  VGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIG 97
           V TR Y +PE  L    Y+   DIWS+G  L EM   
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 90.3 bits (225), Expect = 4e-23
 Identities = 37/93 (39%), Positives = 49/93 (52%), Gaps = 6/93 (6%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFG---VSGQLIDSMANSFVGTR 65
           +Q L+ + +   KH  IHRDVKP NIL+     IK+CDFG   +     D   +  V TR
Sbjct: 109 WQTLQAVNFC-HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD-EVATR 166

Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
            Y SPE L G T Y    D+W++G    E+  G
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 91.2 bits (227), Expect = 4e-23
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 5/108 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYM 68
           +++  L YL+ +  IIHRD+KP NIL++  G + I DF ++  L   +   +  GT+ YM
Sbjct: 123 ELVMALDYLQNQR-IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181

Query: 69  SPE---RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           +PE     +G  YS   D WSLG++  E+  G  P     + +   I 
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 90.8 bits (226), Expect = 4e-23
 Identities = 32/106 (30%), Positives = 55/106 (51%), Gaps = 6/106 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           Q++ G  YL     +IHRD+K  N+ +N   E+KI DFG++ ++           GT +Y
Sbjct: 149 QIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 207

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           ++PE L    +S + D+WS+G  +  + +G    PP +   L   +
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK---PPFETSCLKETY 250

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 89.9 bits (224), Expect = 5e-23
 Identities = 32/106 (30%), Positives = 55/106 (51%), Gaps = 6/106 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           Q++ G  YL     +IHRD+K  N+ +N   E+KI DFG++ ++           GT +Y
Sbjct: 123 QIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           ++PE L    +S + D+WS+G  +  + +G    PP +   L   +
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK---PPFETSCLKETY 224

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 89.9 bits (224), Expect = 5e-23
 Identities = 36/98 (36%), Positives = 50/98 (51%), Gaps = 18/98 (18%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF------- 61
            Q L+GL +L   + I+HRD+KP NILV SGG +K+ DFG        +A  +       
Sbjct: 127 RQFLRGLDFLHA-NCIVHRDLKPENILVTSGGTVKLADFG--------LARIYSYQMALT 177

Query: 62  --VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIG 97
             V T  Y +PE L  + Y+   D+WS+G    EM   
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 90.4 bits (225), Expect = 5e-23
 Identities = 32/137 (23%), Positives = 60/137 (43%), Gaps = 28/137 (20%)

Query: 6   YSSFQVLKGLTYLREKHA--IIHRDVKPSNILVNSGG-EIKICDFGVSGQLIDSMANS-- 60
              +Q+L+GL Y+   H+  ++HRD+KP+N+ +N+    +KI DFG++  +    ++   
Sbjct: 124 LFMYQLLRGLKYI---HSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180

Query: 61  ---FVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIG--MYP-------------- 100
               + T+ Y SP   L   +Y+   D+W+ G    EM  G  ++               
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240

Query: 101 IPPPDAKTLAAIFGPSR 117
           IP    +    +     
Sbjct: 241 IPVVHEEDRQELLSVIP 257

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 90.4 bits (225), Expect = 6e-23
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 6/93 (6%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL---IDSMANSFVGTR 65
           FQ++ G+ +    H IIHRD+KP NILV+  G +K+CDFG +  L    +   +  V TR
Sbjct: 131 FQIINGIGFC-HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD-EVATR 188

Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
            Y +PE L G   Y    D+W++G  + EM +G
Sbjct: 189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 90.0 bits (224), Expect = 7e-23
 Identities = 37/98 (37%), Positives = 52/98 (53%), Gaps = 18/98 (18%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF------- 61
           FQ+L+GL +L   H ++HRD+KP NILV S G+IK+ DFG        +A  +       
Sbjct: 127 FQLLRGLDFL-HSHRVVHRDLKPQNILVTSSGQIKLADFG--------LARIYSFQMALT 177

Query: 62  --VGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIG 97
             V T  Y +PE L  + Y+   D+WS+G    EM   
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 89.5 bits (223), Expect = 7e-23
 Identities = 37/106 (34%), Positives = 53/106 (50%), Gaps = 20/106 (18%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF------- 61
           FQ+LKGL +      ++HRD+KP N+L+N  GE+K+ +FG        +A +F       
Sbjct: 108 FQLLKGLGFC-HSRNVLHRDLKPQNLLINRNGELKLANFG--------LARAFGIPVRCY 158

Query: 62  ---VGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPP 103
              V T  Y  P+ L G   YS   D+WS G    E+A    P+ P
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 89.3 bits (222), Expect = 1e-22
 Identities = 31/105 (29%), Positives = 45/105 (42%), Gaps = 15/105 (14%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS--------- 60
            + +GL  +  K    HRD+KP+NIL+   G+  + D G   Q    +  S         
Sbjct: 142 GICRGLEAIHAKG-YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200

Query: 61  --FVGTRSYMSPERLQGTHYSV---QSDIWSLGLSLVEMAIGMYP 100
                T SY +PE      + V   ++D+WSLG  L  M  G  P
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 90.0 bits (223), Expect = 1e-22
 Identities = 20/106 (18%), Positives = 42/106 (39%), Gaps = 16/106 (15%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSG-----------GEIKICDFGVSGQLI---- 54
           ++L  +  + +   IIH D+KP N ++ +G             + + D G S  +     
Sbjct: 180 RMLYMIEQVHDCE-IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238

Query: 55  DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            ++  +   T  +   E L    ++ Q D + +  ++  M  G Y 
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 89.5 bits (222), Expect = 1e-22
 Identities = 39/118 (33%), Positives = 53/118 (44%), Gaps = 25/118 (21%)

Query: 11  VLKGLTYLRE--------KHAIIHRDVKPSNILVNSGGEIKICDFGVS----------GQ 52
           V +GL YL          K AI HRD+   N+LV + G   I DFG+S            
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179

Query: 53  LIDSMANSFVGTRSYMSPERLQGT-------HYSVQSDIWSLGLSLVEMAIGMYPIPP 103
             D+ A S VGT  YM+PE L+G            Q D+++LGL   E+ +    + P
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 88.8 bits (221), Expect = 2e-22
 Identities = 33/96 (34%), Positives = 55/96 (57%), Gaps = 6/96 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-----NSFVGT 64
              + L +  +   IIHRDVKP+NI++++   +K+ DFG++  + DS        + +GT
Sbjct: 124 DACQALNFSHQNG-IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
             Y+SPE+ +G     +SD++SLG  L E+  G  P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 89.1 bits (222), Expect = 2e-22
 Identities = 36/93 (38%), Positives = 54/93 (58%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           ++   L +L     II+RD+KP NIL++  G IK+ DFG+S + I  +  A SF GT  Y
Sbjct: 134 ELALALDHLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           M+PE +    ++  +D WS G+ + EM  G  P
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 89.2 bits (222), Expect = 2e-22
 Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 20/100 (20%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF------- 61
              L+GL YL + H I+HRD+KP+N+L++  G +K+ DFG        +A SF       
Sbjct: 119 LMTLQGLEYLHQ-HWILHRDLKPNNLLLDENGVLKLADFG--------LAKSFGSPNRAY 169

Query: 62  ---VGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
              V TR Y +PE L G   Y V  D+W++G  L E+ + 
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 89.2 bits (222), Expect = 2e-22
 Identities = 38/101 (37%), Positives = 57/101 (56%), Gaps = 18/101 (17%)

Query: 9   FQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS------ 60
           +Q L+ +  L   H   +IHRD+KPSN+L+NS  ++K+CDFG++  + +S A++      
Sbjct: 119 YQTLRAVKVL---HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175

Query: 61  ------FVGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEM 94
                 FV TR Y +PE  L    YS   D+WS G  L E+
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 89.8 bits (223), Expect = 2e-22
 Identities = 35/115 (30%), Positives = 55/115 (47%), Gaps = 14/115 (12%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI---DSMANSFVGTRS 66
           +++  +  +  +   +HRD+KP NIL++  G I++ DFG   +L       +   VGT  
Sbjct: 170 EIVMAIDSV-HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228

Query: 67  YMSPERLQG-------THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           Y+SPE LQ          Y  + D W+LG+   EM  G     P  A + A  +G
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ---TPFYADSTAETYG 280

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 88.8 bits (221), Expect = 2e-22
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           ++   L +L +   II+RD+KP NI++N  G +K+ DFG+  + I   ++ ++F GT  Y
Sbjct: 129 EISMALGHLHQ-KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEY 187

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           M+PE L  + ++   D WSLG  + +M  G  P
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 89.4 bits (222), Expect = 2e-22
 Identities = 36/112 (32%), Positives = 57/112 (50%), Gaps = 11/112 (9%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRS 66
           +V+  L  +      IHRDVKP N+L++  G +K+ DFG   ++        ++ VGT  
Sbjct: 176 EVVLALDAIHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234

Query: 67  YMSPERLQG----THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           Y+SPE L+      +Y  + D WS+G+ L EM +G     P  A +L   + 
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD---TPFYADSLVGTYS 283

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 88.0 bits (219), Expect = 3e-22
 Identities = 36/100 (36%), Positives = 50/100 (50%), Gaps = 20/100 (20%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF------- 61
            Q+L G+ Y      ++HRD+KP N+L+N  GE+KI DFG        +A +F       
Sbjct: 107 LQLLNGIAYC-HDRRVLHRDLKPQNLLINREGELKIADFG--------LARAFGIPVRKY 157

Query: 62  ---VGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
              + T  Y +P+ L G   YS   DIWS+G    EM  G
Sbjct: 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 88.4 bits (220), Expect = 3e-22
 Identities = 36/100 (36%), Positives = 53/100 (53%), Gaps = 20/100 (20%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF------- 61
           +Q+L+G+ +  +   I+HRD+KP N+L+NS G +K+ DFG        +A +F       
Sbjct: 126 YQLLRGVAHCHQHR-ILHRDLKPQNLLINSDGALKLADFG--------LARAFGIPVRSY 176

Query: 62  ---VGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
              V T  Y +P+ L G   YS   DIWS+G    EM  G
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 88.2 bits (219), Expect = 3e-22
 Identities = 28/125 (22%), Positives = 48/125 (38%), Gaps = 17/125 (13%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS----------------GQL 53
            +  G+ YL     IIHRD+   N LV     + + DFG++                 + 
Sbjct: 116 DIASGMAYL-HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174

Query: 54  IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
                 + VG   +M+PE + G  Y  + D++S G+ L E+   +   P    +T+    
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL 234

Query: 114 GPSRG 118
                
Sbjct: 235 NVRGF 239

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 88.0 bits (219), Expect = 4e-22
 Identities = 38/93 (40%), Positives = 56/93 (60%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           +++ GL +L     I++RD+K  NIL++  G IKI DFG+  + +  D+  N+F GT  Y
Sbjct: 126 EIILGLQFL-HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDY 184

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           ++PE L G  Y+   D WS G+ L EM IG  P
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 88.1 bits (219), Expect = 5e-22
 Identities = 34/93 (36%), Positives = 55/93 (59%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           ++   L YL E   II+RD+K  N+L++S G IK+ D+G+  + +      ++F GT +Y
Sbjct: 118 EISLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNY 176

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           ++PE L+G  Y    D W+LG+ + EM  G  P
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 87.7 bits (218), Expect = 5e-22
 Identities = 38/100 (38%), Positives = 52/100 (52%), Gaps = 20/100 (20%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF------- 61
           FQ+L+GL Y      ++HRD+KP N+L+N  GE+K+ DFG        +A +        
Sbjct: 107 FQLLRGLAYCHR-QKVLHRDLKPQNLLINERGELKLADFG--------LARAKSIPTKTY 157

Query: 62  ---VGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
              V T  Y  P+ L G T YS Q D+W +G    EMA G
Sbjct: 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 88.7 bits (220), Expect = 6e-22
 Identities = 36/113 (31%), Positives = 59/113 (52%), Gaps = 12/113 (10%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI---DSMANSFVGTRS 66
           +++  +  +  +   +HRD+KP NIL++  G I++ DFG   +L+      ++  VGT  
Sbjct: 183 EMVIAIDSV-HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241

Query: 67  YMSPERLQGTH-----YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           Y+SPE LQ        Y  + D WSLG+ + EM  G     P  A++L   +G
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE---TPFYAESLVETYG 291

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 87.7 bits (218), Expect = 7e-22
 Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 8/96 (8%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS---GQLIDSMANSF---V 62
             +L GL Y+  ++ I+HRD+K +N+L+   G +K+ DFG++       +S  N +   V
Sbjct: 131 QMLLNGLYYI-HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189

Query: 63  GTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
            T  Y  PE L G   Y    D+W  G  + EM   
Sbjct: 190 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 88.2 bits (219), Expect = 7e-22
 Identities = 34/93 (36%), Positives = 55/93 (59%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           ++   L YL E   II+RD+K  N+L++S G IK+ D+G+  + +      ++F GT +Y
Sbjct: 161 EISLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNY 219

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           ++PE L+G  Y    D W+LG+ + EM  G  P
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 88.9 bits (220), Expect = 7e-22
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS--GQLIDSMANSFVGTRSY 67
           ++  GL +L +   II+RD+K  N++++S G IKI DFG+            +F GT  Y
Sbjct: 450 EIAIGLFFL-QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDY 508

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           ++PE +    Y    D W+ G+ L EM  G  P
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 88.1 bits (219), Expect = 7e-22
 Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           ++   L YL     I++RD+KP NIL++S G I + DFG+  + I  +S  ++F GT  Y
Sbjct: 147 EIASALGYLHS-LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEY 205

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           ++PE L    Y    D W LG  L EM  G+ P
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 87.3 bits (217), Expect = 7e-22
 Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 6/97 (6%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGV--SGQLIDSMANSFVGTR 65
           +++LK L Y      I+HRDVKP N++++    ++++ D+G+           N  V +R
Sbjct: 137 YEILKALDYC-HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASR 194

Query: 66  SYMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPI 101
            +  PE L     Y    D+WSLG  L  M     P 
Sbjct: 195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 87.3 bits (217), Expect = 7e-22
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           +++  L YL     +++RD+K  N++++  G IKI DFG+  + I   +   +F GT  Y
Sbjct: 113 EIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 171

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           ++PE L+   Y    D W LG+ + EM  G  P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 87.3 bits (217), Expect = 9e-22
 Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           ++  GL +L +   II+RD+K  N++++S G IKI DFG+  + I       +F GT  Y
Sbjct: 129 EIAIGLFFL-QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDY 187

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           ++PE +    Y    D W+ G+ L EM  G  P
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 87.3 bits (217), Expect = 1e-21
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           +++  L +L     II+RD+K  N+L++  G  K+ DFG+  + I       +F GT  Y
Sbjct: 132 EIISALMFL-HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDY 190

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           ++PE LQ   Y    D W++G+ L EM  G  P
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 86.2 bits (214), Expect = 1e-21
 Identities = 40/96 (41%), Positives = 59/96 (61%), Gaps = 6/96 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
            ++KG+ YL     IIHRD+KPSN+LV   G IKI DFGVS +    D++ ++ VGT ++
Sbjct: 145 DLIKGIEYL-HYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAF 203

Query: 68  MSPERLQGTH--YS-VQSDIWSLGLSLVEMAIGMYP 100
           M+PE L  T   +S    D+W++G++L     G  P
Sbjct: 204 MAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 86.7 bits (215), Expect = 2e-21
 Identities = 37/117 (31%), Positives = 54/117 (46%), Gaps = 7/117 (5%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG------GEIKICDFGVSGQLI 54
           L  V   S Q+L GL Y+  +  IIH D+KP N+L+          +IKI D G +    
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACWY 188

Query: 55  DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA 111
           D    + + TR Y SPE L G  +   +DIWS    + E+  G +   P +  +   
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 86.1 bits (214), Expect = 2e-21
 Identities = 33/82 (40%), Positives = 46/82 (56%), Gaps = 4/82 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDSMANSFVGTRS 66
           QVL  + YL E   I+HRD+KP N+L  +  E   I I DFG+S    + + ++  GT  
Sbjct: 114 QVLSAVKYLHENG-IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPG 172

Query: 67  YMSPERLQGTHYSVQSDIWSLG 88
           Y++PE L    YS   D WS+G
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIG 194

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 86.1 bits (214), Expect = 2e-21
 Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 20/100 (20%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF------- 61
           +Q+L+GL +   ++ I+HRD+KP N+L+N  G++K+ DFG        +A +F       
Sbjct: 115 WQLLQGLAFC-HENKILHRDLKPQNLLINKRGQLKLGDFG--------LARAFGIPVNTF 165

Query: 62  ---VGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
              V T  Y +P+ L G   YS   DIWS G  L EM  G
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG 205

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 85.3 bits (211), Expect = 5e-21
 Identities = 34/114 (29%), Positives = 49/114 (42%), Gaps = 14/114 (12%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS--GGEIKICDFGVS------GQLIDSMANSF 61
           Q+   L YL  +  I HRD+KP N L ++    EIK+ DFG+S               + 
Sbjct: 176 QIFSALHYLHNQG-ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK 234

Query: 62  VGTRSYMSPERLQGT--HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
            GT  +++PE L  T   Y  + D WS G+ L  + +G     P      A   
Sbjct: 235 AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA---VPFPGVNDADTI 285

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 85.9 bits (213), Expect = 5e-21
 Identities = 39/108 (36%), Positives = 57/108 (52%), Gaps = 9/108 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDS-MANSFVGTR 65
           QVL G+TY+ +   I+HRD+KP N+L+ S  +   I+I DFG+S     S      +GT 
Sbjct: 134 QVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTA 192

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
            Y++PE L G  Y  + D+WS G+ L  +  G    PP +      I 
Sbjct: 193 YYIAPEVLHG-TYDEKCDVWSTGVILYILLSGC---PPFNGANEYDIL 236

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 85.5 bits (212), Expect = 5e-21
 Identities = 35/112 (31%), Positives = 51/112 (45%), Gaps = 29/112 (25%)

Query: 9   FQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFG------------------ 48
           +Q++K + YL   H+  ++HRD+KPSNIL+N+   +K+ DFG                  
Sbjct: 116 YQLIKVIKYL---HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 49  -VSGQLIDSMANSF----VGTRSYMSPER-LQGTHYSVQSDIWSLGLSLVEM 94
                             V TR Y +PE  L  T Y+   D+WSLG  L E+
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 84.7 bits (210), Expect = 6e-21
 Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSG-GEIKICDFGVSGQLIDSMANSFVGTRSYM 68
           QVL+ + +      ++HRD+K  NIL++   GE+K+ DFG    L D++   F GTR Y 
Sbjct: 157 QVLEAVRHC-HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYS 215

Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYP 100
            PE ++   Y    + +WSLG+ L +M  G  P
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 85.1 bits (211), Expect = 6e-21
 Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 4/82 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDSMANSFVGTRS 66
            +   + +L   + I HRDVKP N+L  S  +   +K+ DFG + +   +   +   T  
Sbjct: 136 DIGTAIQFLHSHN-IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY 194

Query: 67  YMSPERLQGTHYSVQSDIWSLG 88
           Y++PE L    Y    D+WSLG
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLG 216

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 85.6 bits (212), Expect = 7e-21
 Identities = 35/132 (26%), Positives = 51/132 (38%), Gaps = 31/132 (23%)

Query: 9   FQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFG------------------ 48
           + +L G  ++   H   IIHRD+KP+N L+N    +K+CDFG                  
Sbjct: 136 YNLLLGENFI---HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192

Query: 49  --VSGQLIDSMANSF----VGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
                   +          V TR Y +PE  L   +Y+   DIWS G    E+ + M   
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL-LNMLQS 251

Query: 102 PPPDAKTLAAIF 113
              D      +F
Sbjct: 252 HINDPTNRFPLF 263

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 85.1 bits (211), Expect = 7e-21
 Identities = 38/100 (38%), Positives = 52/100 (52%), Gaps = 4/100 (4%)

Query: 1   LKQVPYSSFQVLKGLTYLR-EKHAIIHRDVKPSNILVNSGG--EIKICDFGVSGQLIDSM 57
           L      + Q+   L +L   + +IIH D+KP NIL+ +     IKI DFG S   +   
Sbjct: 156 LNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQR 214

Query: 58  ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIG 97
              ++ +R Y SPE L G  Y +  D+WSLG  LVEM  G
Sbjct: 215 IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 84.3 bits (209), Expect = 1e-20
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 10/98 (10%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI---DSMANSFVGTRS 66
           +++  L +L +   II+RD+K  NIL++S G + + DFG+S + +      A  F GT  
Sbjct: 167 EIVLALEHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225

Query: 67  YMSPERLQGTHY----SVQSDIWSLGLSLVEMAIGMYP 100
           YM+P+ ++G       +V  D WSLG+ + E+  G  P
Sbjct: 226 YMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGASP 261

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 84.4 bits (209), Expect = 2e-20
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 4/99 (4%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG--EIKICDFGVSGQLIDSMA 58
           L  V   +  +L+ L  L  K+ IIH D+KP NIL+   G   IK+ DFG S        
Sbjct: 199 LPLVRKFAHSILQCLDALH-KNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQRV 256

Query: 59  NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIG 97
            +++ +R Y +PE + G  Y +  D+WSLG  L E+  G
Sbjct: 257 YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 83.5 bits (207), Expect = 2e-20
 Identities = 32/93 (34%), Positives = 47/93 (50%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSG-GEIKICDFGVSGQLIDSMANSFVGTRSYM 68
           QV+  + +      ++HRD+K  NIL++   G  K+ DFG    L D     F GTR Y 
Sbjct: 147 QVVAAIQHC-HSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYS 205

Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYP 100
            PE +    Y  + + +WSLG+ L +M  G  P
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 84.8 bits (210), Expect = 2e-20
 Identities = 40/108 (37%), Positives = 60/108 (55%), Gaps = 9/108 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDS-MANSFVGTR 65
           QVL G+TYL + + I+HRD+KP N+L+ S  +   IKI DFG+S    +       +GT 
Sbjct: 144 QVLSGVTYLHKHN-IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTA 202

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
            Y++PE L+   Y  + D+WS+G+ L  +  G    PP   +T   I 
Sbjct: 203 YYIAPEVLRK-KYDEKCDVWSIGVILFILLAGY---PPFGGQTDQEIL 246

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 83.9 bits (208), Expect = 2e-20
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 2/91 (2%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +     +  GT   ++
Sbjct: 149 QIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWTLCGTPEALA 206

Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           PE +    Y+   D W+LG+ + EMA G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 82.7 bits (205), Expect = 2e-20
 Identities = 15/95 (15%), Positives = 36/95 (37%), Gaps = 7/95 (7%)

Query: 10  QVLKGLTYL-REKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYM 68
            + +G+ +L   +  I    +   +++++     +I    V            +   +++
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK--FSFQS-PGRMYAPAWV 175

Query: 69  SPERLQG---THYSVQSDIWSLGLSLVEMAIGMYP 100
           +PE LQ          +D+WS  + L E+     P
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 84.4 bits (209), Expect = 2e-20
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLI-DSMANSFVGTR 65
           Q+L G+ YL + + I+HRD+KP NIL+ +      IKI DFG+S     D      +GT 
Sbjct: 154 QILSGICYLHKHN-IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
            Y++PE L+   Y+ + D+WS G+ +  +  G    PP   +    I 
Sbjct: 213 YYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGY---PPFGGQNDQDII 256

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 83.5 bits (207), Expect = 3e-20
 Identities = 32/84 (38%), Positives = 48/84 (57%), Gaps = 6/84 (7%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDS--MANSFVGT 64
           Q+L+ L Y  + + IIHRDVKP  +L+ S      +K+  FGV+ QL +S  +A   VGT
Sbjct: 138 QILEALRYCHDNN-IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGT 196

Query: 65  RSYMSPERLQGTHYSVQSDIWSLG 88
             +M+PE ++   Y    D+W  G
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCG 220

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 82.8 bits (205), Expect = 3e-20
 Identities = 27/125 (21%), Positives = 52/125 (41%), Gaps = 20/125 (16%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS-------GQLIDSMANSFV 62
           +++KG+ YL     I+H+D+K  N+  ++ G++ I DFG+            +       
Sbjct: 138 EIVKGMGYL-HAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQN 195

Query: 63  GTRSYMSPERLQGT---------HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           G   +++PE ++            +S  SD+++LG    E+       P       A I+
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE--WPFKTQPAEAIIW 253

Query: 114 GPSRG 118
               G
Sbjct: 254 QMGTG 258

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 82.2 bits (204), Expect = 3e-20
 Identities = 30/83 (36%), Positives = 49/83 (59%), Gaps = 5/83 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLID-SMANSFVGTR 65
           Q+L+ + Y      I+HR++KP N+L+ S  +   +K+ DFG++ ++ D    + F GT 
Sbjct: 113 QILESIAYCHSNG-IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171

Query: 66  SYMSPERLQGTHYSVQSDIWSLG 88
            Y+SPE L+   YS   DIW+ G
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACG 194

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 82.7 bits (205), Expect = 4e-20
 Identities = 31/105 (29%), Positives = 47/105 (44%), Gaps = 25/105 (23%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSG-----GEIKICDFGVSGQLIDSMANSF-- 61
           +Q++ G+ +       +HRD+KP N+L++         +KI DFG        +A +F  
Sbjct: 139 YQLINGVNFC-HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG--------LARAFGI 189

Query: 62  --------VGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
                   + T  Y  PE L G  HYS   DIWS+     EM + 
Sbjct: 190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 82.6 bits (205), Expect = 4e-20
 Identities = 37/95 (38%), Positives = 54/95 (56%), Gaps = 3/95 (3%)

Query: 6   YSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR 65
           Y++ +V   L YL  K  II+RD+KP NIL++  G IKI DFG +  + D +  +  GT 
Sbjct: 111 YAA-EVCLALEYLHSKD-IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTYTLCGTP 167

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            Y++PE +    Y+   D WS G+ + EM  G  P
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 83.6 bits (207), Expect = 4e-20
 Identities = 40/108 (37%), Positives = 58/108 (53%), Gaps = 9/108 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDS-MANSFVGTR 65
           QV  G+TY+ + + I+HRD+KP NIL+ S  +   IKI DFG+S     +      +GT 
Sbjct: 129 QVFSGITYMHKHN-IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA 187

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
            Y++PE L+G  Y  + D+WS G+ L  +  G    PP   K    I 
Sbjct: 188 YYIAPEVLRG-TYDEKCDVWSAGVILYILLSGT---PPFYGKNEYDIL 231

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 82.7 bits (205), Expect = 5e-20
 Identities = 31/85 (36%), Positives = 47/85 (55%), Gaps = 7/85 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE----IKICDFGVSGQLI--DSMANSFVG 63
            + K + YL  +  ++HRD+KPSNIL          I+ICDFG + QL   + +  +   
Sbjct: 124 TITKTVEYLHAQG-VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY 182

Query: 64  TRSYMSPERLQGTHYSVQSDIWSLG 88
           T ++++PE L+   Y    DIWSLG
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLG 207

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 83.1 bits (206), Expect = 5e-20
 Identities = 25/84 (29%), Positives = 47/84 (55%), Gaps = 6/84 (7%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLID--SMANSFVGT 64
           Q+L+ + +  +   ++HR++KP N+L+ S  +   +K+ DFG++ ++         F GT
Sbjct: 118 QILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 176

Query: 65  RSYMSPERLQGTHYSVQSDIWSLG 88
             Y+SPE L+   Y    D+W+ G
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACG 200

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 82.7 bits (205), Expect = 6e-20
 Identities = 32/83 (38%), Positives = 52/83 (62%), Gaps = 5/83 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDSMA-NSFVGTR 65
           Q+L+ + Y    + I+HR++KP N+L+ S  +   +K+ DFG++ ++ DS A + F GT 
Sbjct: 136 QILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 194

Query: 66  SYMSPERLQGTHYSVQSDIWSLG 88
            Y+SPE L+   YS   DIW+ G
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACG 217

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 82.5 bits (204), Expect = 8e-20
 Identities = 24/82 (29%), Positives = 43/82 (52%), Gaps = 4/82 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS--GGEIKICDFGVSGQLI-DSMANSFVGTRS 66
           Q  +GL ++ E   I+H D+KP NI+  +     +KI DFG++ +L  D +      T  
Sbjct: 157 QACEGLKHMHEHS-IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE 215

Query: 67  YMSPERLQGTHYSVQSDIWSLG 88
           + +PE +        +D+W++G
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIG 237

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 81.5 bits (202), Expect = 9e-20
 Identities = 27/82 (32%), Positives = 39/82 (47%), Gaps = 4/82 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS--GGEIKICDFGVSGQLI-DSMANSFVGTRS 66
           QV + L +L   + I H D++P NI+  +     IKI +FG + QL              
Sbjct: 110 QVCEALQFLHSHN-IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE 168

Query: 67  YMSPERLQGTHYSVQSDIWSLG 88
           Y +PE  Q    S  +D+WSLG
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLG 190

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 82.6 bits (204), Expect = 9e-20
 Identities = 34/137 (24%), Positives = 53/137 (38%), Gaps = 36/137 (26%)

Query: 9   FQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFG------------------ 48
           + +L G+ Y+   H+  I+HRD+KP+N LVN    +K+CDFG                  
Sbjct: 163 YNLLVGVKYV---HSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219

Query: 49  -------VSGQLIDSMANSF----VGTRSYMSPE-RLQGTHYSVQSDIWSLGLSLVEMAI 96
                  +                V TR Y +PE  L   +Y+   D+WS+G    E+ +
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL-L 278

Query: 97  GMYPIPPPDAKTLAAIF 113
            M             +F
Sbjct: 279 NMIKENVAYHADRGPLF 295

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 81.6 bits (202), Expect = 1e-19
 Identities = 37/95 (38%), Positives = 54/95 (56%), Gaps = 5/95 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILV--NSGGEIKICDFGVS-GQLIDSMANSFVGTRS 66
           Q+L G++Y      I HRD+K  N L+  +    +KICDFG S   ++ S   S VGT +
Sbjct: 124 QLLSGVSYC-HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 182

Query: 67  YMSPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYP 100
           Y++PE L    Y    +D+WS G++L  M +G YP
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 81.1 bits (201), Expect = 1e-19
 Identities = 27/84 (32%), Positives = 47/84 (55%), Gaps = 6/84 (7%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS----GGEIKICDFGVSGQLID-SMANSFVGT 64
           Q+L G+ YL  K  I H D+KP NI++         IK+ DFG++ ++ D     +  GT
Sbjct: 123 QILDGVNYLHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181

Query: 65  RSYMSPERLQGTHYSVQSDIWSLG 88
             +++PE +      +++D+WS+G
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIG 205

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 81.2 bits (201), Expect = 1e-19
 Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 6/106 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYM 68
           Q++  + Y  +K  I+HRD+K  N+L+++   IKI DFG S +       ++F G   Y 
Sbjct: 122 QIVSAVQYCHQKR-IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYA 180

Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           +PE  QG  Y   + D+WSLG+ L  +  G  P    D + L  + 
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF---DGQNLKELR 223

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 81.2 bits (201), Expect = 1e-19
 Identities = 31/83 (37%), Positives = 48/83 (57%), Gaps = 5/83 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLID-SMANSFVGTR 65
           Q+L+ + YL E   I+HRD+KP N+L  +      +KI DFG+S  +    +  +  GT 
Sbjct: 156 QILEAVAYLHENG-IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTP 214

Query: 66  SYMSPERLQGTHYSVQSDIWSLG 88
            Y +PE L+G  Y  + D+WS+G
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVG 237

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 80.4 bits (199), Expect = 2e-19
 Identities = 30/86 (34%), Positives = 46/86 (53%), Gaps = 8/86 (9%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYM 68
            +L+ +  L + + I+HRD+KP NIL++    IK+ DFG S QL          GT SY+
Sbjct: 132 ALLEVICALHKLN-IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 190

Query: 69  SPERLQG------THYSVQSDIWSLG 88
           +PE ++         Y  + D+WS G
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTG 216

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 80.8 bits (200), Expect = 2e-19
 Identities = 31/83 (37%), Positives = 53/83 (63%), Gaps = 5/83 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDSMA-NSFVGTR 65
           Q+L+G+ YL + + I+H D+KP NIL++S    G+IKI DFG+S ++  +      +GT 
Sbjct: 139 QILEGVYYLHQNN-IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197

Query: 66  SYMSPERLQGTHYSVQSDIWSLG 88
            Y++PE L     +  +D+W++G
Sbjct: 198 EYLAPEILNYDPITTATDMWNIG 220

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 80.4 bits (199), Expect = 2e-19
 Identities = 24/84 (28%), Positives = 41/84 (48%), Gaps = 6/84 (7%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDS--MANSFVGT 64
           +++  ++++ +   ++HRD+KP N+L     +   IKI DFG +           +   T
Sbjct: 114 KLVSAVSHMHDVG-VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFT 172

Query: 65  RSYMSPERLQGTHYSVQSDIWSLG 88
             Y +PE L    Y    D+WSLG
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLG 196

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 79.5 bits (197), Expect = 3e-19
 Identities = 26/84 (30%), Positives = 47/84 (55%), Gaps = 6/84 (7%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS----GGEIKICDFGVSGQLI-DSMANSFVGT 64
           Q+L G+ YL  K  I H D+KP NI++         IK+ DFG++ ++   +   +  GT
Sbjct: 116 QILDGVHYLHSKR-IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT 174

Query: 65  RSYMSPERLQGTHYSVQSDIWSLG 88
             +++PE +      +++D+WS+G
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIG 198

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 80.2 bits (198), Expect = 4e-19
 Identities = 36/129 (27%), Positives = 53/129 (41%), Gaps = 33/129 (25%)

Query: 10  QVLKGLTYL-REKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS-------- 60
           Q  + + ++ R+K  IIHRD+K  N+L+++ G IK+CDFG +  +      S        
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203

Query: 61  ------FVGTRSYMSPE---RLQGTHYSVQSDIWSLGLSLVEM-------------AI-- 96
                    T  Y +PE            + DIW+LG  L  +              I  
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263

Query: 97  GMYPIPPPD 105
           G Y IPP D
Sbjct: 264 GKYSIPPHD 272

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 80.5 bits (199), Expect = 4e-19
 Identities = 27/84 (32%), Positives = 47/84 (55%), Gaps = 6/84 (7%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS----GGEIKICDFGVSGQLID-SMANSFVGT 64
           Q+L G+ YL  K  I H D+KP NI++         IK+ DFG++ ++ D     +  GT
Sbjct: 123 QILDGVNYLHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181

Query: 65  RSYMSPERLQGTHYSVQSDIWSLG 88
             +++PE +      +++D+WS+G
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIG 205

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 80.6 bits (199), Expect = 4e-19
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 11/99 (11%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILV----NSGGEIKICDFGVS---GQLIDSMANSF 61
           +Q+L G+ YL     ++HRD+KP+NILV       G +KI D G +      +  +A+  
Sbjct: 135 YQILDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193

Query: 62  --VGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIG 97
             V T  Y +PE L G  HY+   DIW++G    E+   
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 80.5 bits (199), Expect = 4e-19
 Identities = 25/82 (30%), Positives = 46/82 (56%), Gaps = 4/82 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS--GGEIKICDFGVSGQLI-DSMANSFVGTRS 66
           Q+ +G+ ++ + + I+H D+KP NIL  +    +IKI DFG++ +           GT  
Sbjct: 195 QICEGIRHMHQMY-ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPE 253

Query: 67  YMSPERLQGTHYSVQSDIWSLG 88
           +++PE +     S  +D+WS+G
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVG 275

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 80.0 bits (198), Expect = 4e-19
 Identities = 26/84 (30%), Positives = 46/84 (54%), Gaps = 6/84 (7%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS----GGEIKICDFGVSGQLI-DSMANSFVGT 64
           Q+L G+ YL     I H D+KP NI++         IKI DFG++ ++   +   +  GT
Sbjct: 122 QILNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180

Query: 65  RSYMSPERLQGTHYSVQSDIWSLG 88
             +++PE +      +++D+WS+G
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIG 204

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 79.8 bits (197), Expect = 7e-19
 Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 5/83 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLI-DSMANSFVGTR 65
            + + + YL   + I HRDVKP N+L  S      +K+ DFG + +    +   +   T 
Sbjct: 169 SIGEAIQYLHSIN-IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 227

Query: 66  SYMSPERLQGTHYSVQSDIWSLG 88
            Y++PE L    Y    D+WSLG
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLG 250

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 79.4 bits (196), Expect = 7e-19
 Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRSYM 68
           Q++  + YLR    IIHRD+K  NI++     IK+ DFG +  L    +  +F GT  Y 
Sbjct: 138 QLVSAVGYLR-LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYC 196

Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYP 100
           +PE L G  Y   + ++WSLG++L  +     P
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 79.8 bits (197), Expect = 7e-19
 Identities = 27/86 (31%), Positives = 47/86 (54%), Gaps = 8/86 (9%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYM 68
            +L+ +++L   + I+HRD+KP NIL++   +I++ DFG S  L          GT  Y+
Sbjct: 208 SLLEAVSFLHANN-IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYL 266

Query: 69  SPERLQGT------HYSVQSDIWSLG 88
           +PE L+ +       Y  + D+W+ G
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACG 292

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 78.0 bits (193), Expect = 1e-18
 Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 9/108 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLID-SMANSFVGTR 65
            VL  + Y  +   + HRD+KP N L  +      +K+ DFG++ +     M  + VGT 
Sbjct: 114 DVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP 172

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
            Y+SP+ L+G  Y  + D WS G+ +  +  G    PP  A T + + 
Sbjct: 173 YYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGY---PPFSAPTDSEVM 216

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 78.0 bits (193), Expect = 1e-18
 Identities = 41/108 (37%), Positives = 59/108 (54%), Gaps = 9/108 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLI-DSMANSFVGTR 65
           QV  G+TY+ + H I+HRD+KP NIL+ S  +   IKI DFG+S     ++     +GT 
Sbjct: 129 QVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA 187

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
            Y++PE L+G  Y  + D+WS G+ L  +  G    PP   K    I 
Sbjct: 188 YYIAPEVLRG-TYDEKCDVWSAGVILYILLSGT---PPFYGKNEYDIL 231

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 79.0 bits (195), Expect = 2e-18
 Identities = 37/86 (43%), Positives = 51/86 (59%), Gaps = 8/86 (9%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLID-SMANSFVGTR 65
           Q+L  + YL E + IIHRD+KP N+L++S  E   IKI DFG S  L + S+  +  GT 
Sbjct: 247 QMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305

Query: 66  SYMSPERLQGTH---YSVQSDIWSLG 88
           +Y++PE L       Y+   D WSLG
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLG 331

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 77.7 bits (192), Expect = 2e-18
 Identities = 32/108 (29%), Positives = 52/108 (48%), Gaps = 9/108 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLI-DSMANSFVGTR 65
           Q++  L Y   +H ++H+D+KP NIL         IKI DFG++     D  + +  GT 
Sbjct: 132 QMMNALAYFHSQH-VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTA 190

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
            YM+PE  +    + + DIWS G+ +  +  G     P    +L  + 
Sbjct: 191 LYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGC---LPFTGTSLEEVQ 234

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 79.1 bits (195), Expect = 2e-18
 Identities = 27/82 (32%), Positives = 44/82 (53%), Gaps = 4/82 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS--GGEIKICDFGVSGQLI-DSMANSFVGTRS 66
           QV KGL ++ E +  +H D+KP NI+  +    E+K+ DFG++  L          GT  
Sbjct: 263 QVCKGLCHMHENN-YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 321

Query: 67  YMSPERLQGTHYSVQSDIWSLG 88
           + +PE  +G      +D+WS+G
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVG 343

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 78.0 bits (193), Expect = 2e-18
 Identities = 34/94 (36%), Positives = 57/94 (60%), Gaps = 8/94 (8%)

Query: 13  KGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV-----GTRSY 67
            G+ +L E H  IHRD+K +NIL++     KI DFG++ +  +  A + +     GT +Y
Sbjct: 144 NGINFLHENH-HIHRDIKSANILLDEAFTAKISDFGLA-RASEKFAQTVMTSRIVGTTAY 201

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           M+PE L+G   + +SDI+S G+ L+E+  G+  +
Sbjct: 202 MAPEALRG-EITPKSDIYSFGVVLLEIITGLPAV 234

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 78.1 bits (193), Expect = 2e-18
 Identities = 31/109 (28%), Positives = 49/109 (44%), Gaps = 21/109 (19%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG-------------------EIKICDFG 48
           ++Q+ K + +L     + H D+KP NIL                        +IK+ DFG
Sbjct: 124 AYQICKSVNFLHSNK-LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182

Query: 49  VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIG 97
            S    D   ++ V TR Y +PE +    +S   D+WS+G  L+E  +G
Sbjct: 183 -SATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 77.8 bits (192), Expect = 3e-18
 Identities = 30/116 (25%), Positives = 48/116 (41%), Gaps = 21/116 (18%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG-------------------E 41
           L  V + ++Q+   L +L  ++ + H D+KP NIL  +                      
Sbjct: 122 LPHVRHMAYQLCHALRFLH-ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180

Query: 42  IKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIG 97
           I++ DFG S         + V TR Y  PE +    ++   D+WS+G  L E   G
Sbjct: 181 IRVADFG-SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 76.9 bits (190), Expect = 3e-18
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 6/96 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS----GQLIDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 113 QLMAGVVYL-HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 66  SYMSPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYP 100
            Y++PE L+   +     D+WS G+ L  M  G  P
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 76.9 bits (190), Expect = 5e-18
 Identities = 37/86 (43%), Positives = 51/86 (59%), Gaps = 8/86 (9%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLID-SMANSFVGTR 65
           Q+L  + YL E + IIHRD+KP N+L++S  E   IKI DFG S  L + S+  +  GT 
Sbjct: 122 QMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180

Query: 66  SYMSPERLQGTH---YSVQSDIWSLG 88
           +Y++PE L       Y+   D WSLG
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLG 206

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 77.0 bits (190), Expect = 5e-18
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 6/96 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS----GQLIDSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 113 QLMAGVVYL-HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 66  SYMSPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYP 100
            Y++PE L+   +     D+WS G+ L  M  G  P
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 76.6 bits (189), Expect = 9e-18
 Identities = 33/122 (27%), Positives = 50/122 (40%), Gaps = 27/122 (22%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG-------------------- 40
           ++ +     ++LK L YLR+   + H D+KP NIL++                       
Sbjct: 136 IEDIKLYCIEILKALNYLRKMS-LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194

Query: 41  -----EIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
                 IK+ DFG           S + TR Y +PE +    + V SD+WS G  L E+ 
Sbjct: 195 RTKSTGIKLIDFG-CATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253

Query: 96  IG 97
            G
Sbjct: 254 TG 255

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 75.6 bits (186), Expect = 3e-17
 Identities = 30/105 (28%), Positives = 47/105 (44%), Gaps = 27/105 (25%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE-------------IKICDFGVSGQLID- 55
           Q+  G+ +L     IIHRD+KP NILV++                I I DFG+  +L   
Sbjct: 123 QIASGVAHLHSLK-IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 56  -----SMANSFVGTRSYMSPERLQGT-------HYSVQSDIWSLG 88
                +  N+  GT  + +PE L+ +         +   DI+S+G
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG 226

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 74.6 bits (184), Expect = 3e-17
 Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 7/97 (7%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV----GTR 65
           Q++ GL YL     I+H+D+KP N+L+ +GG +KI   GV+  L    A+       G+ 
Sbjct: 117 QLIDGLEYL-HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 66  SYMSPERLQGT-HYS-VQSDIWSLGLSLVEMAIGMYP 100
           ++  PE   G   +S  + DIWS G++L  +  G+YP
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 73.4 bits (181), Expect = 1e-16
 Identities = 36/106 (33%), Positives = 53/106 (50%), Gaps = 10/106 (9%)

Query: 13  KGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV-----GTRSY 67
           +GL YL  + AIIHRDVK  NIL++     KI DFG+S +    +  + +     GT  Y
Sbjct: 150 RGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGIS-KKGTELDQTHLSTVVKGTLGY 207

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI---PPPDAKTLA 110
           + PE       + +SD++S G+ L E+      I    P +   LA
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 72.7 bits (179), Expect = 2e-16
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSG-QLIDSMANSFVGTRSYM 68
           Q++  + Y   +H I+HRD+KP N+L++    +KI DFG+S      +   +  G+ +Y 
Sbjct: 116 QIICAIEYC-HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 174

Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYP 100
           +PE + G  Y+  + D+WS G+ L  M +G  P
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 72.3 bits (178), Expect = 2e-16
 Identities = 29/96 (30%), Positives = 43/96 (44%), Gaps = 18/96 (18%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVS---------GQLIDSM 57
            V   L +L  K  I HRD+KP NIL     +   +KICDF +            +    
Sbjct: 119 DVASALDFLHNKG-IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177

Query: 58  ANSFVGTRSYMSPERLQG-----THYSVQSDIWSLG 88
             +  G+  YM+PE ++      + Y  + D+WSLG
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 71.7 bits (176), Expect = 6e-16
 Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSG-QLIDSMANSFVGTRSYM 68
           Q+L G+ Y   +H ++HRD+KP N+L+++    KI DFG+S          +  G+ +Y 
Sbjct: 124 QILSGVDYC-HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 182

Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYP 100
           +PE + G  Y+  + DIWS G+ L  +  G  P
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 70.7 bits (174), Expect = 7e-16
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 3/93 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSG-QLIDSMANSFVGTRSYM 68
           Q+L  + Y   +H ++HRD+KP N+L+++    KI DFG+S          +  G+ +Y 
Sbjct: 119 QILSAVDYC-HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 177

Query: 69  SPERLQGTHYS-VQSDIWSLGLSLVEMAIGMYP 100
           +PE + G  Y+  + DIWS G+ L  +  G  P
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 70.3 bits (173), Expect = 8e-16
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 5/99 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
              V +G+ YL E   +IHRD+   N LV     IK+ DFG++  ++D    S  GT+  
Sbjct: 110 CLDVCEGMAYLEEAC-VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 168

Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
             + SPE    + YS +SD+WS G+ + E  + G  P  
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 207

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 70.3 bits (173), Expect = 9e-16
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 5/99 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           + Q+   + YL EK   IHRD+   N LV     +K+ DFG+S  +      +  G +  
Sbjct: 117 ATQISSAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175

Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
             + +PE L    +S++SD+W+ G+ L E    GM P P
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 214

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 71.0 bits (174), Expect = 1e-15
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 5/99 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           + Q+   + YL +K+  IHR++   N LV     +K+ DFG+S  +      +  G +  
Sbjct: 324 ATQISSAMEYLEKKN-FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 382

Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
             + +PE L    +S++SD+W+ G+ L E+A  GM P P
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 421

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 70.7 bits (173), Expect = 1e-15
 Identities = 36/102 (35%), Positives = 56/102 (54%), Gaps = 10/102 (9%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           SFQV KG+ +L  +   IHRD+   NIL++    +KICDFG++  +       +V     
Sbjct: 199 SFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKD--PDYVRKGDA 255

Query: 67  -----YMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
                +M+PE +    Y++QSD+WS G+ L E  ++G  P P
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 297

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 69.9 bits (172), Expect = 1e-15
 Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 5/99 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
            + V +G+ +L      IHRD+   N LV+    +K+ DFG++  ++D    S VGT+  
Sbjct: 110 CYDVCEGMAFLESHQ-FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP 168

Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
             + +PE      YS +SD+W+ G+ + E  ++G  P  
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 69.6 bits (171), Expect = 2e-15
 Identities = 36/102 (35%), Positives = 57/102 (55%), Gaps = 10/102 (9%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           S+QV KG+ +L  K+  IHRD+   NIL+  G   KICDFG++  + +     +V   + 
Sbjct: 151 SYQVAKGMAFLASKN-CIHRDLAARNILLTHGRITKICDFGLARDIKNDSN--YVVKGNA 207

Query: 67  -----YMSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
                +M+PE +    Y+ +SD+WS G+ L E+  +G  P P
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 69.6 bits (171), Expect = 3e-15
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 6/100 (6%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
                 G+ YL  K   IHRD+   N LV     +KI DFG+S +  D +  +  G R  
Sbjct: 219 VGDAAAGMEYLESKC-CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV 277

Query: 68  ----MSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
                +PE L    YS +SD+WS G+ L E  ++G  P P
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYP 317

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 69.9 bits (171), Expect = 3e-15
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 5/99 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           ++Q+   L YL  K   +HRD+   N+LV+S   +K+ DFG+S  + DS        +  
Sbjct: 497 AYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555

Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
             +M+PE +    ++  SD+W  G+ + E+   G+ P  
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 69.8 bits (171), Expect = 3e-15
 Identities = 28/99 (28%), Positives = 53/99 (53%), Gaps = 5/99 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           + Q+  G+ Y+   +  +HRD++ +NILV      K+ DFG++  + D+   +  G +  
Sbjct: 286 AAQIASGMAYVERMN-YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344

Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
             + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 383

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 69.3 bits (170), Expect = 4e-15
 Identities = 35/102 (34%), Positives = 59/102 (57%), Gaps = 10/102 (9%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           ++QV KG+ +L  K   +HRD+   N+LV  G  +KICDFG++  ++      +V   + 
Sbjct: 178 AYQVAKGMEFLEFKS-CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN--YVVRGNA 234

Query: 67  -----YMSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
                +M+PE L    Y+++SD+WS G+ L E+  +G+ P P
Sbjct: 235 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 68.8 bits (169), Expect = 4e-15
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 5/99 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
              V + + YL  K   +HRD+   N LVN  G +K+ DFG+S  ++D    S VG++  
Sbjct: 126 CKDVCEAMEYLESKQ-FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP 184

Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
             +  PE L  + +S +SDIW+ G+ + E  ++G  P  
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 68.0 bits (167), Expect = 7e-15
 Identities = 30/99 (30%), Positives = 58/99 (58%), Gaps = 5/99 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           + Q+ +G+ ++ E++  IHRD++ +NILV+     KI DFG++  + D+   +  G +  
Sbjct: 115 AAQIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173

Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
             + +PE +    ++++SD+WS G+ L E+   G  P P
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 68.8 bits (168), Expect = 8e-15
 Identities = 29/99 (29%), Positives = 54/99 (54%), Gaps = 5/99 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           + Q+  G+ Y+ E+   +HRD++ +NILV      K+ DFG++  + D+   +  G +  
Sbjct: 369 AAQIASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 427

Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
             + +PE      ++++SD+WS G+ L E+   G  P P
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 466

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 68.0 bits (167), Expect = 8e-15
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 7/95 (7%)

Query: 13  KGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMAN----SFVGTRS 66
           +GL YL +     IIHRDVK +NIL++   E  + DFG++ +L+D        +  GT  
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIG 200

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI 101
           +++PE L     S ++D++  G+ L+E+  G    
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 67.6 bits (166), Expect = 8e-15
 Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 4/91 (4%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           ++Q+   L YL  K   +HRD+   N+LV+S   +K+ DFG+S  + DS        +  
Sbjct: 122 AYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 180

Query: 67  --YMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
             +M+PE +    ++  SD+W  G+ + E+ 
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 68.1 bits (167), Expect = 8e-15
 Identities = 37/101 (36%), Positives = 59/101 (58%), Gaps = 8/101 (7%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           S QV +G+ +L  K+  IHRDV   N+L+ +G   KI DFG++  +++   N  V   + 
Sbjct: 170 SSQVAQGMAFLASKN-CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-NYIVKGNAR 227

Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
               +M+PE +    Y+VQSD+WS G+ L E+  +G+ P P
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 68.2 bits (167), Expect = 1e-14
 Identities = 33/101 (32%), Positives = 56/101 (55%), Gaps = 8/101 (7%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           ++Q+ +G+ YL  +   IHRD+   N+LV     +KI DFG++ + I+++      T   
Sbjct: 209 TYQLARGMEYLASQK-CIHRDLAARNVLVTENNVMKIADFGLA-RDINNIDYYKKTTNGR 266

Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
               +M+PE L    Y+ QSD+WS G+ + E+  +G  P P
Sbjct: 267 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 67.7 bits (166), Expect = 1e-14
 Identities = 30/100 (30%), Positives = 54/100 (54%), Gaps = 6/100 (6%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTRS 66
             Q+ KG+ YL E   ++HR++   N+L+ S  ++++ DFGV+  L  D     +   ++
Sbjct: 121 GVQIAKGMYYLEEHG-MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179

Query: 67  ---YMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
              +M+ E +    Y+ QSD+WS G+++ E M  G  P  
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 219

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 67.7 bits (166), Expect = 1e-14
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 7/97 (7%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS--- 66
            V  G+ YL +    +HRD+   N+LV+S    K+ DFG+S  L D    ++  T     
Sbjct: 159 GVGAGMRYLSDLG-YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217

Query: 67  --YMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             + +PE +    +S  SD+WS G+ + E +A G  P
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 67.3 bits (165), Expect = 2e-14
 Identities = 33/108 (30%), Positives = 50/108 (46%), Gaps = 22/108 (20%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           ++Q+ +G+ YL  +   IHRD+   N+LV     +KI DFG        +A        Y
Sbjct: 163 TYQLARGMEYLASQK-CIHRDLAARNVLVTENNVMKIADFG--------LARDINNIDYY 213

Query: 68  ------------MSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
                       M+PE L    Y+ QSD+WS G+ + E+  +G  P P
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 67.4 bits (165), Expect = 2e-14
 Identities = 30/99 (30%), Positives = 47/99 (47%), Gaps = 7/99 (7%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS--- 66
            +  G+ YL +    +HRD+   NIL+NS    K+ DFG+   L D    ++        
Sbjct: 155 GIASGMKYLSDMG-YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213

Query: 67  --YMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
             + SPE +    ++  SD+WS G+ L E M+ G  P  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 67.4 bits (165), Expect = 2e-14
 Identities = 30/99 (30%), Positives = 60/99 (60%), Gaps = 5/99 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           S Q+ +G+ ++ +++  IHRD++ +NILV++    KI DFG++  + D+   +  G +  
Sbjct: 290 SAQIAEGMAFIEQRN-YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 348

Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
             + +PE +    ++++SD+WS G+ L+E+   G  P P
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 387

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 67.0 bits (164), Expect = 3e-14
 Identities = 36/108 (33%), Positives = 50/108 (46%), Gaps = 22/108 (20%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           ++QV +G+ YL  K   IHRD+   N+LV     +KI DFG        +A        Y
Sbjct: 197 AYQVARGMEYLASKK-CIHRDLAARNVLVTEDNVMKIADFG--------LARDIHHIDYY 247

Query: 68  ------------MSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
                       M+PE L    Y+ QSD+WS G+ L E+  +G  P P
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 66.5 bits (163), Expect = 3e-14
 Identities = 37/108 (34%), Positives = 53/108 (49%), Gaps = 22/108 (20%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           SFQV KG+ +L  +   IHRD+   NIL++    +KICDFG        +A        Y
Sbjct: 154 SFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFG--------LARDIYKDPDY 204

Query: 68  ------------MSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
                       M+PE +    Y++QSD+WS G+ L E+  +G  P P
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 66.9 bits (164), Expect = 3e-14
 Identities = 28/91 (30%), Positives = 51/91 (56%), Gaps = 5/91 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTR- 65
             Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++  L  +       G + 
Sbjct: 123 CVQIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181

Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
              +M+ E +    Y+ QSD+WS G+++ E+
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWEL 212

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 66.5 bits (163), Expect = 3e-14
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 4/90 (4%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR-- 65
           S Q+ K + YL   +  +HRD+   NILV S   +K+ DFG+S  + D        TR  
Sbjct: 119 SLQICKAMAYLESIN-CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP 177

Query: 66  -SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
             +MSPE +    ++  SD+W   + + E+
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEI 207

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 66.5 bits (163), Expect = 3e-14
 Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 6/92 (6%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTR 65
           + Q+ KG+ YL  K   IHRD+   NILV +   +KI DFG++  L              
Sbjct: 120 TSQICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178

Query: 66  S---YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
           S   + +PE L  + +SV SD+WS G+ L E+
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 66.1 bits (162), Expect = 3e-14
 Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 3/96 (3%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V + + YL E +  +HRD+   N+LV+     K+ DFG++ +   +     +  + +
Sbjct: 123 SLDVCEAMEYL-EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-W 180

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
            +PE L+   +S +SD+WS G+ L E  + G  P P
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 216

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 66.6 bits (163), Expect = 3e-14
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 7/97 (7%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV--GTRS- 66
            +  G+ YL   +  +HRD+   NILVNS    K+ DFG+S  L D    ++   G +  
Sbjct: 155 GIAAGMKYLANMN-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213

Query: 67  --YMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYP 100
             + +PE +    ++  SD+WS G+ + E M  G  P
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 66.6 bits (163), Expect = 3e-14
 Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 6/92 (6%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTR 65
           + Q+ KG+ YL  K   IHRD+   NILV +   +KI DFG++  L              
Sbjct: 151 TSQICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209

Query: 66  S---YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
           S   + +PE L  + +SV SD+WS G+ L E+
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYEL 241

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 66.6 bits (163), Expect = 4e-14
 Identities = 28/96 (29%), Positives = 50/96 (52%), Gaps = 3/96 (3%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V + + YL   +  +HRD+   N+LV+     K+ DFG++ +   +     +  + +
Sbjct: 295 SLDVCEAMEYLEGNN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-W 352

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
            +PE L+   +S +SD+WS G+ L E+   G  P P
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 388

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 66.2 bits (162), Expect = 4e-14
 Identities = 29/101 (28%), Positives = 48/101 (47%), Gaps = 8/101 (7%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           + ++  G+ YL      +HRD+   N +V     +KI DFG++ + I        G +  
Sbjct: 144 AGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMT-RDIYETDYYRKGGKGL 201

Query: 68  -----MSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
                MSPE L+   ++  SD+WS G+ L E+A +   P  
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 66.2 bits (162), Expect = 4e-14
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 9/104 (8%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV---GT 64
           S Q+ KG+ YL  +   +HRD+   NILV S   +KI DFG++ +L+    + +V     
Sbjct: 133 SSQICKGMEYLGSRR-CVHRDLAARNILVESEAHVKIADFGLA-KLLPLDKDYYVVREPG 190

Query: 65  RS---YMSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIPPP 104
           +S   + +PE L    +S QSD+WS G+ L E+         P 
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 65.8 bits (161), Expect = 6e-14
 Identities = 31/102 (30%), Positives = 46/102 (45%), Gaps = 11/102 (10%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDSMANSFVGTRS 66
            +  G  YL E H  IHRD+   N L+   G     KI DFG++ + I   +    G  +
Sbjct: 148 DIACGCQYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRASYYRKGGCA 205

Query: 67  Y-----MSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
                 M PE      ++ ++D WS G+ L E+  +G  P P
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 247

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 65.4 bits (160), Expect = 6e-14
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 8/93 (8%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           + Q+ KG+ YL  +   +HRD+   N+LV S  ++KI DFG++ + I++    +      
Sbjct: 132 AVQICKGMDYLGSRQ-YVHRDLAARNVLVESEHQVKIGDFGLT-KAIETDKEYYTVKDDR 189

Query: 67  -----YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
                + +PE L  + + + SD+WS G++L E+
Sbjct: 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 65.5 bits (160), Expect = 8e-14
 Identities = 31/102 (30%), Positives = 45/102 (44%), Gaps = 11/102 (10%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDSMANSFVGTRS 66
            +  G  YL E H  IHRD+   N L+   G     KI DFG++ + I        G  +
Sbjct: 189 DIACGCQYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRAGYYRKGGCA 246

Query: 67  Y-----MSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
                 M PE      ++ ++D WS G+ L E+  +G  P P
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 64.9 bits (159), Expect = 9e-14
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 22/108 (20%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           ++Q+ +G+ YL E   ++HRD+   NILV  G ++KI DFG        ++       SY
Sbjct: 156 AWQISQGMQYLAEMK-LVHRDLAARNILVAEGRKMKISDFG--------LSRDVYEEDSY 206

Query: 68  ------------MSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
                       M+ E L    Y+ QSD+WS G+ L E+  +G  P P
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 64.6 bits (158), Expect = 1e-13
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 6/92 (6%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTR 65
           + QV +G+ YL  K   IHRD+   N+L+ +   +KI DFG+   L   D         +
Sbjct: 127 AVQVAEGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185

Query: 66  ---SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
              ++ +PE L+   +S  SD W  G++L EM
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 217

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 64.7 bits (158), Expect = 1e-13
 Identities = 27/92 (29%), Positives = 50/92 (54%), Gaps = 6/92 (6%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           + Q+ +G+ YL  +H  IHRD+   N+L+++   +KI DFG++  + +      V     
Sbjct: 140 AQQICEGMAYLHAQH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198

Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
               + +PE L+   +   SD+WS G++L E+
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 64.6 bits (158), Expect = 1e-13
 Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 8/102 (7%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
             QV +G+ YL E+   +HRD+   N +++    +K+ DFG++  ++D    S    R  
Sbjct: 130 GLQVARGMEYLAEQK-FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188

Query: 67  -----YMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
                + + E LQ   ++ +SD+WS G+ L E +  G  P  
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR 230

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 64.2 bits (157), Expect = 2e-13
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 6/90 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRS- 66
           QV  G+ YL EK+  +HRD+   N+L+ +    KI DFG+S  L   DS   +    +  
Sbjct: 118 QVSMGMKYLEEKN-FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 176

Query: 67  --YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
             + +PE +    +S +SD+WS G+++ E 
Sbjct: 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEA 206

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 63.8 bits (156), Expect = 2e-13
 Identities = 27/93 (29%), Positives = 47/93 (50%), Gaps = 8/93 (8%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
             QV  G+ YL E +  +HRD+   N+L+ +    KI DFG+S + + +  N +      
Sbjct: 123 VHQVSMGMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTHG 180

Query: 67  -----YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
                + +PE +    +S +SD+WS G+ + E 
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEA 213

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 63.9 bits (156), Expect = 3e-13
 Identities = 28/91 (30%), Positives = 51/91 (56%), Gaps = 5/91 (5%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL-IDSMANSFVGTR- 65
             Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++  L  +       G + 
Sbjct: 123 CVQIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181

Query: 66  --SYMSPERLQGTHYSVQSDIWSLGLSLVEM 94
              +M+ E +    Y+ QSD+WS G+++ E+
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWEL 212

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 63.8 bits (155), Expect = 3e-13
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 6/90 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRS- 66
           QV  G+ YL EK+  +HR++   N+L+ +    KI DFG+S  L   DS   +    +  
Sbjct: 444 QVSMGMKYLEEKN-FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502

Query: 67  --YMSPERLQGTHYSVQSDIWSLGLSLVEM 94
             + +PE +    +S +SD+WS G+++ E 
Sbjct: 503 LKWYAPECINFRKFSSRSDVWSYGVTMWEA 532

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 63.4 bits (155), Expect = 4e-13
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 8/102 (7%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
             QV KG+ YL  K   +HRD+   N +++    +K+ DFG++  + D    S       
Sbjct: 134 GLQVAKGMKYLASKK-FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192

Query: 67  -----YMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
                +M+ E LQ   ++ +SD+WS G+ L E M  G  P P
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 63.4 bits (155), Expect = 4e-13
 Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 7/93 (7%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           + Q+  G+ YL  +H  +HRD+   N LV +   +KI DFG+S  +  +     VG  + 
Sbjct: 139 ASQIASGMVYLASQH-FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-VGGHTM 196

Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
               +M PE +    ++ +SD+WS G+ L E+ 
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 63.4 bits (154), Expect = 4e-13
 Identities = 40/167 (23%), Positives = 56/167 (33%), Gaps = 60/167 (35%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSG---------------------------- 39
             QVL+GL YL  K  IIH D+KP NIL++                              
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 40  ---------------------GEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 78
                                 ++KI D G +   +       + TR Y S E L G+ Y
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNA-CWVHKHFTEDIQTRQYRSLEVLIGSGY 270

Query: 79  SVQSDIWSLGLSLVEMAIGMYPIPPPDAKT-------LA---AIFGP 115
           +  +DIWS      E+A G Y   P   +        +A    + G 
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK 317

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 62.9 bits (153), Expect = 7e-13
 Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 8/102 (7%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
             QV KG+ +L  K   +HRD+   N +++    +K+ DFG++  + D   +S       
Sbjct: 198 GLQVAKGMKFLASKK-FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256

Query: 67  -----YMSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
                +M+ E LQ   ++ +SD+WS G+ L E M  G  P P
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 62.7 bits (153), Expect = 8e-13
 Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 8/97 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS--- 66
           QV  G+ YL   H  +HRD+   N LV  G  +KI DFG+S + I S     VG R+   
Sbjct: 166 QVAAGMVYLAGLH-FVHRDLATRNCLVGQGLVVKIGDFGMS-RDIYSTDYYRVGGRTMLP 223

Query: 67  --YMSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYP 100
             +M PE +    ++ +SD+WS G+ L E+   G  P
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 62.3 bits (152), Expect = 9e-13
 Identities = 34/111 (30%), Positives = 48/111 (43%), Gaps = 31/111 (27%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
           +  V +G+ YL +K   IHRD+   NILV      KI DFG+S              R  
Sbjct: 148 AADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGLS--------------RGQ 192

Query: 67  --Y------------MSPERLQGTHYSVQSDIWSLGLSLVE-MAIGMYPIP 102
             Y            M+ E L  + Y+  SD+WS G+ L E +++G  P  
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 62.3 bits (152), Expect = 9e-13
 Identities = 27/101 (26%), Positives = 48/101 (47%), Gaps = 8/101 (7%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
              +  G+ YL  ++  IHRD+   N ++     + + DFG+S + I S      G  S 
Sbjct: 143 MVDIACGMEYLSSRN-FIHRDLAARNCMLAEDMTVCVADFGLS-RKIYSGDYYRQGCASK 200

Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
               +++ E L    Y+V SD+W+ G+++ E+   G  P  
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA 241

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 62.3 bits (152), Expect = 9e-13
 Identities = 32/99 (32%), Positives = 48/99 (48%), Gaps = 8/99 (8%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           + QV  G+ YL E+   +HRD+   N LV     +KI DFG+S + I S           
Sbjct: 180 ARQVAAGMAYLSERK-FVHRDLATRNCLVGENMVVKIADFGLS-RNIYSADYYKADGNDA 237

Query: 68  -----MSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYP 100
                M PE +    Y+ +SD+W+ G+ L E+   G+ P
Sbjct: 238 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 61.8 bits (151), Expect = 1e-12
 Identities = 27/93 (29%), Positives = 47/93 (50%), Gaps = 7/93 (7%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
             Q+  G+ YL   H ++H+D+   N+LV     +KI D G+  + + +     +   S 
Sbjct: 134 VAQIAAGMEYLSSHH-VVHKDLATRNVLVYDKLNVKISDLGLF-REVYAADYYKLLGNSL 191

Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVEMA 95
               +M+PE +    +S+ SDIWS G+ L E+ 
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 61.1 bits (149), Expect = 2e-12
 Identities = 27/101 (26%), Positives = 51/101 (50%), Gaps = 8/101 (7%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRS- 66
              +  G+ YL  ++  +HRD+   N ++     + + DFG+S + I S      G  + 
Sbjct: 153 MVDIALGMEYLSNRN-FLHRDLAARNCMLRDDMTVCVADFGLS-KKIYSGDYYRQGRIAK 210

Query: 67  ----YMSPERLQGTHYSVQSDIWSLGLSLVEMA-IGMYPIP 102
               +++ E L    Y+ +SD+W+ G+++ E+A  GM P P
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYP 251

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 59.3 bits (144), Expect = 1e-11
 Identities = 27/105 (25%), Positives = 43/105 (40%), Gaps = 15/105 (14%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGG-----EIKICDFGVSGQLIDSMAN----- 59
           Q+L  +  + EK  +++RD+KP N L+          I + DFG+     D +       
Sbjct: 114 QMLARVQSIHEKS-LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY 172

Query: 60  ----SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
               +  GT  YMS     G   S + D+ +LG   +    G  P
Sbjct: 173 REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 59.0 bits (143), Expect = 1e-11
 Identities = 14/103 (13%), Positives = 29/103 (28%), Gaps = 26/103 (25%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
            +            +      PS + V+  G++ +                       M 
Sbjct: 137 SLAAAADAAHR-AGVALSIDHPSRVRVSIDGDVVLAYPA------------------TMP 177

Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI 112
                    + Q DI  +G SL  + +  +P+P    ++  A 
Sbjct: 178 DA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP 213

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 59.2 bits (144), Expect = 1e-11
 Identities = 24/82 (29%), Positives = 32/82 (39%), Gaps = 24/82 (29%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDSMANSFVGTRS 66
            + + + YL     I HRDVKP N+L  S      +K+ DFG                  
Sbjct: 125 SIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFG------------------ 165

Query: 67  YMSPERLQGTHYSVQSDIWSLG 88
             + E   G  Y    D+WSLG
Sbjct: 166 -FAKE-TTGEKYDKSCDMWSLG 185

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.9 bits (143), Expect = 2e-11
 Identities = 31/105 (29%), Positives = 46/105 (43%), Gaps = 15/105 (14%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE-----IKICDFGVSGQLIDSMAN----- 59
           Q++  + Y+  K+ +I+RDVKP N L+   G      I I DF ++ + ID         
Sbjct: 113 QLISRMEYVHSKN-LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPY 171

Query: 60  ----SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
               S  GT  YMS     G   S + D+ +LG   +    G  P
Sbjct: 172 REHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.5 bits (142), Expect = 2e-11
 Identities = 31/103 (30%), Positives = 49/103 (47%), Gaps = 13/103 (12%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDSMAN------- 59
           Q++  + Y+  K+  IHRDVKP N L+  G +   + I DFG++ +  D+  +       
Sbjct: 113 QMISRIEYIHSKN-FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 171

Query: 60  --SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
             +  GT  Y S     G   S + D+ SLG  L+   +G  P
Sbjct: 172 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 58.5 bits (142), Expect = 2e-11
 Identities = 21/102 (20%), Positives = 43/102 (42%), Gaps = 24/102 (23%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE--------IKICDFGVSGQLIDSMAN 59
           + Q+   + +L E   +IH +V   NIL+    +        IK+ D G        ++ 
Sbjct: 119 AKQLAAAMHFLEENT-LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG--------ISI 169

Query: 60  SFVGTRSY------MSPERLQ-GTHYSVQSDIWSLGLSLVEM 94
           + +           + PE ++   + ++ +D WS G +L E+
Sbjct: 170 TVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEI 211

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 58.5 bits (141), Expect = 3e-11
 Identities = 28/103 (27%), Positives = 46/103 (44%), Gaps = 13/103 (12%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDSMAN------- 59
           Q++  + ++  K   +HRD+KP N L+  G     + I DFG++ +  D+  +       
Sbjct: 111 QMINRVEFVHSKS-FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169

Query: 60  --SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
             +  GT  Y S     G   S + D+ SLG  L+    G  P
Sbjct: 170 NKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.8 bits (140), Expect = 4e-11
 Identities = 22/102 (21%), Positives = 44/102 (43%), Gaps = 12/102 (11%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE--IKICDFGVSGQLIDSM---------A 58
           ++L  L +L E    +H +V   NI V+   +  + +  +G + +   S           
Sbjct: 167 RLLDALEFLHENE-YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSR 225

Query: 59  NSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
           +   G   ++S +  +G   S +SD+ SLG  +++   G  P
Sbjct: 226 SPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.8 bits (140), Expect = 5e-11
 Identities = 23/102 (22%), Positives = 45/102 (44%), Gaps = 12/102 (11%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE--IKICDFGVSGQLIDSMAN-------- 59
           ++L  L Y+ E    +H D+K +N+L+       + + D+G+S +   +  +        
Sbjct: 159 RMLDVLEYIHENE-YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPR 217

Query: 60  -SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
               GT  + S +  +G   S +SD+  LG  ++    G  P
Sbjct: 218 KGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 57.1 bits (138), Expect = 8e-11
 Identities = 23/102 (22%), Positives = 44/102 (43%), Gaps = 12/102 (11%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE--IKICDFGVSGQLIDSMAN-------- 59
           ++L  L Y+ E    +H D+K SN+L+N      + + D+G++ +      +        
Sbjct: 160 RILDILEYIHEHE-YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPK 218

Query: 60  -SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
               GT  + S +   G   S + D+  LG  +++   G  P
Sbjct: 219 RCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 47.6 bits (112), Expect = 2e-07
 Identities = 20/108 (18%), Positives = 29/108 (26%), Gaps = 18/108 (16%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICD-----------FGVSGQLID-- 55
            Q+   L          HRD+   N+L+      K+              G+   +ID  
Sbjct: 168 HQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYT 227

Query: 56  ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMY 99
                     V     M  +   G     Q DI+ L         G Y
Sbjct: 228 LSRLERDGIVVFCDVSMDEDLFTG-DGDYQFDIYRLMKKENNNRWGEY 274

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	131
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.97
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.97
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.97
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.97
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.97
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.97
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.97
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.97
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.97
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.96
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.96
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.96
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.96
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.96
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.95
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.95
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.94
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.94
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.94
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.94
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.93
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.93
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.93
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.93
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.93
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.93
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.93
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.93
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.93
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.93
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.93
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.93
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.93
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.93
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.93
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.93
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.93
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.92
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.92
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.92
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.92
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.92
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.92
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.92
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.92
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.92
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.92
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.92
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.92
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.92
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.92
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.92
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.92
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.92
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.92
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.92
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.92
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.92
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.92
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.92
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.92
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.92
3niz_A	311	Rhodanese family protein; structural genomics, str	99.92
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.92
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.92
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.92
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.92
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.92
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.91
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.91
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.91
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.91
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.91
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.91
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.91
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.91
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.91
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.91
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.91
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.91
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.91
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.91
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.91
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.91
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.91
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.91
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.91
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.91
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.91
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.91
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.91
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.91
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.91
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.91
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.91
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.91
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.91
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.91
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.91
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.91
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.91
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.91
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.91
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.91
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.91
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.91
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.91
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.91
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.91
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.91
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.91
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.91
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.9
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.9
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.9
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.9
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.9
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.9
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.9
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.9
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.9
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.9
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.9
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.9
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.9
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.9
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.9
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.9
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.9
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.9
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.9
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.9
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.9
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.9
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.9
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.9
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.9
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.9
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.9
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.9
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.9
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.9
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.9
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.9
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.9
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.9
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.9
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.9
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.9
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.9
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.9
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.9
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.9
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.9
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.9
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.9
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.9
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.9
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.9
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.9
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.9
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.9
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.9
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.9
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.9
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.9
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.9
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.9
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.9
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.9
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.9
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.9
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.9
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.9
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.9
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.89
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.89
3bhy_A	283	Death-associated protein kinase 3; death associate	99.89
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.89
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.89
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.89
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.89
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.89
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.89
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.89
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.89
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.89
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.89
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.89
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.89
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.89
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.89
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.89
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.89
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.89
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.89
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.89
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.89
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.89
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.89
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.89
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.89
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.89
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.89
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.89
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.89
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.89
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.89
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.89
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.89
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.89
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.88
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.88
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.88
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.88
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.88
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.88
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.88
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.88
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.88
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.88
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.88
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.88
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.88
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.88
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.88
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.88
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.88
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.88
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.88
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.88
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.88
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.88
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.88
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.87
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.87
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.87
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.87
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.87
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.87
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.87
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.86
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.86
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.85
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.84
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.84
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.83
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.81
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.78
3uqc_A	286	Probable conserved transmembrane protein; structur	99.75
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.56
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.22
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.08
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.61
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	97.47
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	97.32
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.06
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	96.97
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.36
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	94.65
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.23
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	94.07
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	93.37
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	92.71
3ats_A	357	Putative uncharacterized protein; hypothetical pro	92.55
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	92.13
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	92.06
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	91.95
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	91.78
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	91.27
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	90.6
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	90.37
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	89.75
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	89.46
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	88.83
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.65
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	87.87
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.05
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	85.04
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	83.25

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.97  E-value=6.5e-32  Score=188.95  Aligned_cols=110  Identities=33%  Similarity=0.578  Sum_probs=98.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||.|||++ +|+||||+|+||+++.++.+|++|||+++....  ....+..||+.|+|||++.+..|+.
T Consensus       171 ~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~  249 (346)
T 4fih_A          171 QIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGP  249 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCc
Confidence            5788999999999999997 899999999999999999999999999976543  2345678999999999999889999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+||++|||++|..||.+.+..+..+.+
T Consensus       250 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i  282 (346)
T 4fih_A          250 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI  282 (346)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence            999999999999999999999988776665544

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.97  E-value=4.7e-32  Score=187.26  Aligned_cols=110  Identities=37%  Similarity=0.615  Sum_probs=97.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc----ccccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      +++.++.|++.||.|||++ +|+||||+|+||+++.++.+|++|||+++....    ....+..||+.|+|||++.+..+
T Consensus       133 ~~~~~~~qi~~al~ylH~~-~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y  211 (311)
T 4aw0_A          133 CTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA  211 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCB
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCC
Confidence            5778999999999999997 899999999999999999999999999976532    23456789999999999999899


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      +.++|+||+||++|+|++|..||.+.+..++.+.+
T Consensus       212 ~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i  246 (311)
T 4aw0_A          212 CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI  246 (311)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999999999999999988777665544

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.97  E-value=5.9e-32  Score=186.46  Aligned_cols=110  Identities=36%  Similarity=0.586  Sum_probs=96.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||.|||++ +++||||+|.||+++.++.+|++|||+++....  ....+..||+.|+|||.+.+..++.
T Consensus       127 ~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~  205 (304)
T 3ubd_A          127 DVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ  205 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCC
Confidence            5778999999999999997 899999999999999999999999999976532  3345678999999999999999999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+||++|+|++|+.||.+.+..++.+.+
T Consensus       206 ~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i  238 (304)
T 3ubd_A          206 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI  238 (304)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH
Confidence            999999999999999999999988877666554

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.97  E-value=5.3e-32  Score=189.62  Aligned_cols=110  Identities=30%  Similarity=0.510  Sum_probs=97.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||.|||++ ||+||||||.||+++.++.+||+|||+++.....  ......||+.|+|||++.+..++.
T Consensus       126 ~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~  204 (350)
T 4b9d_A          126 QILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNN  204 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCc
Confidence            4678999999999999997 8999999999999999999999999999765432  234567999999999999989999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+||++|+|++|+.||.+.+..++...+
T Consensus       205 ~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i  237 (350)
T 4b9d_A          205 KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI  237 (350)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence            999999999999999999999988876655544

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.97  E-value=3e-31  Score=189.66  Aligned_cols=110  Identities=33%  Similarity=0.578  Sum_probs=98.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..+++|++.||.|||++ ||+||||+++|||++.++.+||+|||+++....  .......||+.|+|||++.+..|+.
T Consensus       248 ~~~~~~~qil~aL~ylH~~-~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~  326 (423)
T 4fie_A          248 QIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGP  326 (423)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCc
Confidence            5788999999999999997 899999999999999999999999999976543  2345678999999999999989999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+||++|+|++|..||.+....+..+.+
T Consensus       327 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i  359 (423)
T 4fie_A          327 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI  359 (423)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence            999999999999999999999888776665554

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.97  E-value=2.7e-31  Score=181.01  Aligned_cols=110  Identities=28%  Similarity=0.513  Sum_probs=88.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-ccccCCCCccceeCcccccCCCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHY-SV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~-~~   80 (131)
                      +++.++.|++.||+|||++ +++||||+|+||+++.++.+|++|||+++.... ....+..||+.|+|||.+.+..+ +.
T Consensus       113 ~~~~~~~qi~~al~ylH~~-~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~  191 (275)
T 3hyh_A          113 EARRFFQQIISAVEYCHRH-KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP  191 (275)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCC
Confidence            5788999999999999997 899999999999999999999999999976543 23456789999999999988775 57


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|+|++|+.||.+.+..++.+.+
T Consensus       192 ~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i  224 (275)
T 3hyh_A          192 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI  224 (275)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             hhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999988877665544

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.97  E-value=5.5e-31  Score=180.67  Aligned_cols=112  Identities=31%  Similarity=0.557  Sum_probs=94.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCC--cEecCCCCCcEEEe-cCCcEEEeecccccccccccccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHA--IIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~--~~h~~l~~~~il~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +++.++.|++.||.|||++ +  |+||||+|.||+++ .++.+|++|||+++........+..||+.|+|||++.+ .++
T Consensus       130 ~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~  207 (290)
T 3fpq_A          130 VLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYD  207 (290)
T ss_dssp             HHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCC-CCC
Confidence            4678999999999999996 6  99999999999998 47899999999997655555566789999999999865 699


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPP-DAKTLAAIFGPS  116 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~-~~~~~~~~~~~~  116 (131)
                      .++|+||+|+++|+|++|+.||... ....+.+.+...
T Consensus       208 ~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~  245 (290)
T 3fpq_A          208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG  245 (290)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC
Confidence            9999999999999999999999754 445555555443

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.97  E-value=3.8e-31  Score=184.50  Aligned_cols=104  Identities=33%  Similarity=0.502  Sum_probs=89.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC-cEEEeecccccccccc-------cccCCCCccceeCccccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG-EIKICDFGVSGQLIDS-------MANSFVGTRSYMSPERLQ   74 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~-~~~l~d~g~~~~~~~~-------~~~~~~~~~~~~~Pe~~~   74 (131)
                      +++.++.|++.||.|||++ +|+||||+|.||+++.++ .+||+|||+++.....       ......||+.|+|||++.
T Consensus       151 ~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~  229 (336)
T 4g3f_A          151 RALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM  229 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHC
Confidence            5778999999999999997 899999999999999887 5999999999765321       123357999999999999


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         75 GTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        75 ~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +..++.++|+||+||++|+|++|+.||.+....
T Consensus       230 ~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~  262 (336)
T 4g3f_A          230 GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG  262 (336)
T ss_dssp             TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH
Confidence            999999999999999999999999999765544

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.97  E-value=1e-30  Score=180.56  Aligned_cols=110  Identities=31%  Similarity=0.502  Sum_probs=89.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc----ccccCCCCccceeCcccccC---
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTRSYMSPERLQG---   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~~~~~~Pe~~~~---   75 (131)
                      ++..++.|++.||.|||++ +++||||+|.||+++.++.+|++|||+++....    .......||+.|+|||++.+   
T Consensus       133 ~~~~i~~qia~gL~yLH~~-~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~  211 (307)
T 3omv_A          133 QLIDIARQTAQGMDYLHAK-NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDN  211 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCC
Confidence            4678999999999999997 799999999999999999999999999975432    22345679999999999964   


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHh
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA-KTLAAIF  113 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~-~~~~~~~  113 (131)
                      ..++.++|+||||+++|||++|+.||...+. ..+...+
T Consensus       212 ~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~  250 (307)
T 3omv_A          212 NPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV  250 (307)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred             CCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence            3588999999999999999999999986543 3444443

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.97  E-value=8.6e-31  Score=181.15  Aligned_cols=113  Identities=24%  Similarity=0.427  Sum_probs=98.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++||||++.||++++++.+|++|||+++.....    ......+++.|+|||.+.+..+
T Consensus       146 ~~~~i~~qia~gl~yLH~~-~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~  224 (308)
T 4gt4_A          146 DFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF  224 (308)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC
Confidence            4578999999999999997 7999999999999999999999999998765332    2334578889999999999999


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  116 (131)
                      +.++|+||||+++||+++ |..||.+....++.+.+...
T Consensus       225 s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~  263 (308)
T 4gt4_A          225 SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR  263 (308)
T ss_dssp             CHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT
T ss_pred             CccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            999999999999999998 89999998888877776543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.96  E-value=8.2e-31  Score=180.59  Aligned_cols=112  Identities=27%  Similarity=0.442  Sum_probs=96.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++||||+|.||+++.++.+|++|||+++.....    ......+++.|+|||.+.+..+
T Consensus       129 ~~~~i~~qia~gl~yLH~~-~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~  207 (299)
T 4asz_A          129 QMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF  207 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCC
Confidence            4678999999999999997 7999999999999999999999999998754322    1233457889999999999999


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      +.++|+||||+++|||++ |+.||......++...+..
T Consensus       208 ~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          208 TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999999999998 8999998887777665543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.96  E-value=4.3e-30  Score=179.07  Aligned_cols=111  Identities=28%  Similarity=0.440  Sum_probs=90.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++||||++.||+++.++.+|++|||+++.....    ......+++.|+|||.+.+..+
T Consensus       159 ~~~~i~~qia~gl~yLH~~-~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~  237 (329)
T 4aoj_A          159 QLLAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF  237 (329)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHhcC-CeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCC
Confidence            4678999999999999997 7999999999999999999999999998755322    2234568899999999999999


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||||+++|||++ |+.||......++...+.
T Consensus       238 ~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  274 (329)
T 4aoj_A          238 TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT  274 (329)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred             CccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999999999998 899999888777666553

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.96  E-value=4.6e-30  Score=191.52  Aligned_cols=101  Identities=30%  Similarity=0.578  Sum_probs=92.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccC-CCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~   81 (131)
                      +++.+++|++.||.|||++ ||+||||+|.||+++.+|.+|++|||++.........+..||+.|+|||++.. ..++.+
T Consensus       293 ~a~~y~~qIl~aL~yLH~~-gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~  371 (689)
T 3v5w_A          293 DMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS  371 (689)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCchHHeEEeCCCCEEecccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcH
Confidence            5788999999999999997 89999999999999999999999999998776666677899999999999964 579999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      +|+||+||++|+|++|..||.+.
T Consensus       372 vDiWSLGvilYEmLtG~~PF~~~  394 (689)
T 3v5w_A          372 ADWFSLGCMLFKLLRGHSPFRQH  394 (689)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTCGG
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999643

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.96  E-value=3.4e-29  Score=178.37  Aligned_cols=108  Identities=36%  Similarity=0.603  Sum_probs=93.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc------ccccCCCCccceeCcccccCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------SMANSFVGTRSYMSPERLQGT   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~~~~~~Pe~~~~~   76 (131)
                      +++.+++|++.||.|||++ |++||||+|.||+++.++.+|++|||+++....      ....+..||+.|+|||++.+.
T Consensus       159 ~~~~~~~qil~al~ylH~~-~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~  237 (398)
T 4b99_A          159 HVRYFLYQLLRGLKYMHSA-QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL  237 (398)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHC-cCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCC
Confidence            5788999999999999997 899999999999999999999999999975432      223456899999999998775


Q ss_pred             -CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         77 -HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        77 -~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                       .++.++|+||+||++|+|++|+.||.+.+..+..+
T Consensus       238 ~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~  273 (398)
T 4b99_A          238 HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQ  273 (398)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH
T ss_pred             CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHH
Confidence             46899999999999999999999999877655444

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.96  E-value=6.1e-30  Score=179.71  Aligned_cols=110  Identities=32%  Similarity=0.579  Sum_probs=92.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++||||++.||+++.++.+|++|||+++.....    ......+++.|+|||.+.+..+
T Consensus       186 ~~~~~~~qia~gl~yLH~~-~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y  264 (353)
T 4ase_A          186 HLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY  264 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHhHhhC-CeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC
Confidence            4568999999999999998 7999999999999999999999999999765322    2234567889999999999999


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDA-KTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~-~~~~~~~  113 (131)
                      +.++|+||||+++|||++ |..||.+... +.+.+.+
T Consensus       265 ~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i  301 (353)
T 4ase_A          265 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  301 (353)
T ss_dssp             CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred             CCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            999999999999999998 8999987553 3344443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.95  E-value=8.8e-29  Score=174.34  Aligned_cols=102  Identities=29%  Similarity=0.517  Sum_probs=85.7

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC-CcEEEeecccccccccc------------------------
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG-GEIKICDFGVSGQLIDS------------------------   56 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~-~~~~l~d~g~~~~~~~~------------------------   56 (131)
                      ++++.+++|++.||+|||++ ||+||||||+||+++.+ +.+|++|||+++.....                        
T Consensus       117 ~~~~~~~~qll~al~ylH~~-gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (361)
T 4f9c_A          117 QEVREYMLNLFKALKRIHQF-GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSI  195 (361)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC----------------
T ss_pred             HHHHHHHHHHHHHHHHHHHC-CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccc
Confidence            35788999999999999997 89999999999999876 78999999998643221                        


Q ss_pred             ------cccCCCCccceeCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         57 ------MANSFVGTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        57 ------~~~~~~~~~~~~~Pe~~~~~-~~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                            ......||+.|+|||++.+. .++.++|+||+||++|+|++|+.||...
T Consensus       196 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          196 CLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             cccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence                  11234689999999999775 5899999999999999999999999543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.95  E-value=6.8e-29  Score=171.05  Aligned_cols=96  Identities=36%  Similarity=0.636  Sum_probs=79.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--------------cccCCCCccceeC
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--------------MANSFVGTRSYMS   69 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--------------~~~~~~~~~~~~~   69 (131)
                      ++.++.|++.||.|||++ +++||||+|.||+++.++.+|++|||+++.....              ......||+.|+|
T Consensus       120 ~~~i~~qi~~al~ylH~~-~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmA  198 (299)
T 4g31_A          120 CLHIFLQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMS  198 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSC
T ss_pred             HHHHHHHHHHHHHHHHHC-cCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccC
Confidence            567999999999999997 8999999999999999999999999998754321              1123469999999


Q ss_pred             cccccCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         70 PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        70 Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      ||.+.+..++.++|+||+||++|||++   ||..
T Consensus       199 PE~~~~~~y~~~~DiwSlGvilyell~---Pf~~  229 (299)
T 4g31_A          199 PEQIHGNSYSHKVDIFSLGLILFELLY---PFST  229 (299)
T ss_dssp             HHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             HHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence            999999899999999999999999995   7754

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.94  E-value=2e-27  Score=175.82  Aligned_cols=111  Identities=26%  Similarity=0.425  Sum_probs=96.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC--CcEEEeecccccccccc-cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG--GEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~--~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +++.+++|++.||.|||++ +++||||+|.||+++.+  +.+|++|||+++..... ......|++.|+|||++.+..++
T Consensus       256 ~~~~~~~qi~~al~ylH~~-~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~  334 (573)
T 3uto_A          256 EAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG  334 (573)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCC
Confidence            5678999999999999997 89999999999999854  78999999999766432 33456799999999999999999


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~  114 (131)
                      .++|+||+||++|+|++|..||.+.+..+....+.
T Consensus       335 ~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~  369 (573)
T 3uto_A          335 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK  369 (573)
T ss_dssp             HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence            99999999999999999999999888776665543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.94  E-value=6.5e-28  Score=166.44  Aligned_cols=99  Identities=32%  Similarity=0.437  Sum_probs=80.8

Q ss_pred             chhHHHHHHHHHHHHHHhc-------CCcEecCCCCCcEEEecCCcEEEeecccccccccc------cccCCCCccceeC
Q psy17559          3 QVPYSSFQVLKGLTYLREK-------HAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS------MANSFVGTRSYMS   69 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~-------~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~~~~~~   69 (131)
                      ++..++.|++.||+|||++       .+++||||+|.||+++.++.+|++|||+++.....      ......||+.|+|
T Consensus       101 ~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymA  180 (303)
T 3hmm_A          101 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA  180 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCC
T ss_pred             HHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccC
Confidence            4678999999999999974       27999999999999999999999999998754322      1224578999999


Q ss_pred             cccccCC------CCCCcchHHHHHHHHHHHHhCCCCC
Q psy17559         70 PERLQGT------HYSVQSDIWSLGLSLVEMAIGMYPI  101 (131)
Q Consensus        70 Pe~~~~~------~~~~~~d~~slg~~l~~l~~g~~p~  101 (131)
                      ||++.+.      .++.++|+||||+++|||++|..||
T Consensus       181 PE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~  218 (303)
T 3hmm_A          181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  218 (303)
T ss_dssp             HHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred             HHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence            9999753      3567899999999999999997655

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.94  E-value=2.5e-26  Score=160.47  Aligned_cols=110  Identities=30%  Similarity=0.619  Sum_probs=95.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||.|||++ |++||||+|.||+++.++.++++|||++....  ........|++.|+|||.+.+..++.
T Consensus       106 ~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  184 (337)
T 1o6l_A          106 RARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR  184 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCc
Confidence            4678899999999999997 89999999999999999999999999987532  22344567899999999999888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|+|++|..||...+...+.+.+
T Consensus       185 ~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i  217 (337)
T 1o6l_A          185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI  217 (337)
T ss_dssp             THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             hhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999887766555443

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.94  E-value=2.4e-26  Score=161.45  Aligned_cols=110  Identities=33%  Similarity=0.578  Sum_probs=96.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||.|||++ |++||||+|.||+++.++.++++|||++....  ........|++.|+|||.+.+..++.
T Consensus       122 ~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  200 (353)
T 2i0e_A          122 HAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK  200 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBST
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCC
Confidence            4678999999999999997 89999999999999999999999999987532  22345567899999999999888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|+|++|..||...+..++.+.+
T Consensus       201 ~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i  233 (353)
T 2i0e_A          201 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI  233 (353)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cccccchHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999988776655443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.93  E-value=7.3e-27  Score=164.08  Aligned_cols=110  Identities=31%  Similarity=0.581  Sum_probs=92.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||.|||++ |++||||+|.||+++.++.++++|||++....  ........|++.|+|||.+.+..++.
T Consensus       125 ~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  203 (353)
T 3txo_A          125 RARFYAAEIISALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGP  203 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCC
Confidence            4678999999999999997 89999999999999999999999999987532  22344567899999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|+|++|..||...+..++.+.+
T Consensus       204 ~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i  236 (353)
T 3txo_A          204 AVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI  236 (353)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999988876655544

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.93  E-value=2.9e-26  Score=160.65  Aligned_cols=110  Identities=37%  Similarity=0.679  Sum_probs=96.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||.|||++ |++||||+|.||+++.++.++++|||+++...  ........|++.|+|||.+.+..++.
T Consensus       119 ~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  197 (345)
T 1xjd_A          119 RATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNH  197 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCC
Confidence            4678999999999999997 89999999999999999999999999987542  23345667899999999999888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|+|++|..||...+..++.+.+
T Consensus       198 ~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i  230 (345)
T 1xjd_A          198 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI  230 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             hhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999888776655543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.93  E-value=4.5e-26  Score=171.30  Aligned_cols=111  Identities=32%  Similarity=0.563  Sum_probs=97.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||.|||++ +++||||+|+||+++.++.++|+|||+++...  ........|++.|+|||++.+..++.
T Consensus       443 ~~~~~~~qi~~aL~~LH~~-gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~  521 (674)
T 3pfq_A          443 HAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK  521 (674)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBST
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCc
Confidence            4678999999999999997 89999999999999999999999999987532  23345667899999999999889999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~  114 (131)
                      ++|+||||+++|||++|+.||.+.+..++.+.+.
T Consensus       522 ~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~  555 (674)
T 3pfq_A          522 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM  555 (674)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            9999999999999999999999888776665543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.93  E-value=4.7e-26  Score=161.03  Aligned_cols=109  Identities=33%  Similarity=0.595  Sum_probs=95.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||+|||++ |++||||+|.||+++.++.++++|||+++...  ........|++.|+|||.+.+..++.
T Consensus       140 ~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  218 (373)
T 2r5t_A          140 RARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDR  218 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCc
Confidence            4667899999999999997 89999999999999999999999999987532  22345667899999999999888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      ++|+||+|+++|+|++|..||...+..++.+.
T Consensus       219 ~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~  250 (373)
T 2r5t_A          219 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN  250 (373)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHH
T ss_pred             hhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            99999999999999999999988776655543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.93  E-value=4.3e-26  Score=163.00  Aligned_cols=110  Identities=31%  Similarity=0.539  Sum_probs=94.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCCC--
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTH--   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~--   77 (131)
                      .++.++.|++.||.|||+. |++||||+|.||+++.++.++++|||++......   ......|++.|+|||++....  
T Consensus       169 ~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~  247 (410)
T 3v8s_A          169 WARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD  247 (410)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCC
Confidence            4678899999999999997 8999999999999999999999999998655432   234668999999999997654  


Q ss_pred             --CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         78 --YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        78 --~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                        ++.++|+||+|+++|+|++|..||...+..+..+.+
T Consensus       248 ~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i  285 (410)
T 3v8s_A          248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI  285 (410)
T ss_dssp             CEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             cCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHH
Confidence              789999999999999999999999887766554443

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.93  E-value=3.2e-26  Score=160.93  Aligned_cols=99  Identities=20%  Similarity=0.320  Sum_probs=87.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec-----------CCcEEEeecccccccc----cccccCCCCccce
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-----------GGEIKICDFGVSGQLI----DSMANSFVGTRSY   67 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~-----------~~~~~l~d~g~~~~~~----~~~~~~~~~~~~~   67 (131)
                      ++..++.|++.||+|||+. +++||||+|.||+++.           ++.++++|||++....    ........++..|
T Consensus       173 ~~~~i~~qi~~~L~~lH~~-~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y  251 (365)
T 3e7e_A          173 LVISFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGF  251 (365)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSC
T ss_pred             HHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCC
Confidence            4778999999999999997 8999999999999998           8999999999986432    2233456789999


Q ss_pred             eCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy17559         68 MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        68 ~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      +|||.+.+..++.++|+||||+++|+|++|..||.
T Consensus       252 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  286 (365)
T 3e7e_A          252 QCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV  286 (365)
T ss_dssp             CCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred             CChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence            99999999889999999999999999999999884

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.93  E-value=1e-25  Score=156.23  Aligned_cols=107  Identities=34%  Similarity=0.582  Sum_probs=93.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .++.++.|++.||.|||++ |++||||+|.||+++.++.++++|||++..... ......+++.|+|||.+.+..++.++
T Consensus       107 ~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~  184 (318)
T 1fot_A          107 VAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTYTLCGTPDYIAPEVVSTKPYNKSI  184 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTSCEEECCCSSCEECSS-CBCCCCSCTTTCCHHHHTTCCBCTTH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCChheEEEcCCCCEEEeecCcceecCC-ccccccCCccccCHhHhcCCCCCccc
Confidence            4677899999999999997 899999999999999999999999999875543 23456789999999999988899999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      |+||+|+++|+|++|..||...+..+..+
T Consensus       185 DiwslG~il~ell~g~~pf~~~~~~~~~~  213 (318)
T 1fot_A          185 DWWSFGILIYEMLAGYTPFYDSNTMKTYE  213 (318)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             chhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999999998776654443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.93  E-value=6.2e-26  Score=164.31  Aligned_cols=104  Identities=39%  Similarity=0.597  Sum_probs=87.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      +++.++.|++.||+|||+. |++||||+|.||+++.++.++++|||+++..... ......+++.|+|||.+.+..++.+
T Consensus       165 ~~~~~~~qil~aL~~lH~~-~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  243 (464)
T 3ttj_A          165 RMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN  243 (464)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHH
Confidence            4678999999999999997 8999999999999999999999999998765443 3345678899999999999899999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +|+||+|+++++|++|+.||.+.+..
T Consensus       244 ~DiwSlG~il~ell~g~~pF~g~~~~  269 (464)
T 3ttj_A          244 VDIWSVGCIMGEMVRHKILFPGRDYI  269 (464)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999999887754

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.93  E-value=7e-26  Score=163.02  Aligned_cols=109  Identities=30%  Similarity=0.536  Sum_probs=93.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCccccc-----
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQ-----   74 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~-----   74 (131)
                      +++.++.|++.||.|||+. +++||||+|.||+++.++.++++|||++......   ......|++.|+|||++.     
T Consensus       176 ~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~  254 (437)
T 4aw2_A          176 MARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGG  254 (437)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTS
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccC
Confidence            4678999999999999997 8999999999999999999999999998654322   223457899999999986     


Q ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         75 GTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        75 ~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      ...++.++|+||+|+++|+|++|..||...+..+..+.
T Consensus       255 ~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~  292 (437)
T 4aw2_A          255 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK  292 (437)
T ss_dssp             CCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             CCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHh
Confidence            45689999999999999999999999988776655443

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.93  E-value=8.9e-26  Score=157.12  Aligned_cols=110  Identities=32%  Similarity=0.591  Sum_probs=95.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-ccccCCCCccceeCcccccCCCCC-C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYS-V   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~-~   80 (131)
                      ++..++.|++.||.|||+. +++||||+|.||+++.++.++++|||++..... .......+++.|+|||.+.+..+. .
T Consensus       115 ~~~~~~~qi~~al~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  193 (328)
T 3fe3_A          115 EARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGP  193 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCc
Confidence            4678999999999999997 899999999999999999999999999865532 234556789999999999887764 7


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|+|++|..||.+.+..++.+.+
T Consensus       194 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i  226 (328)
T 3fe3_A          194 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERV  226 (328)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             hhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            899999999999999999999988876665544

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.93  E-value=5.8e-26  Score=161.68  Aligned_cols=99  Identities=35%  Similarity=0.689  Sum_probs=89.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||.|||++ |++||||+|.||+++.++.++++|||+++...  ........|++.|+|||++.+..++.
T Consensus       154 ~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~  232 (396)
T 4dc2_A          154 HARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF  232 (396)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCCh
Confidence            4678999999999999997 89999999999999999999999999987532  23445667899999999999989999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      ++|+||+|+++|+|++|..||.
T Consensus       233 ~~DiwslGvllyell~G~~Pf~  254 (396)
T 4dc2_A          233 SVDWWALGVLMFEMMAGRSPFD  254 (396)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSST
T ss_pred             HHHHHHHHHHHHHHHhCCCCCc
Confidence            9999999999999999999995

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.93  E-value=1.4e-25  Score=153.94  Aligned_cols=107  Identities=33%  Similarity=0.581  Sum_probs=93.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.|||++ |++|+||+|.||+++.++.++++|||++......  ......+++.|+|||.+.+..++.
T Consensus       117 ~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  195 (297)
T 3fxz_A          117 QIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP  195 (297)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCc
Confidence            4678999999999999997 8999999999999999999999999998655432  234557889999999999888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLA  110 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~  110 (131)
                      ++|+||+|+++|++++|..||...+.....
T Consensus       196 ~~DiwslG~il~ell~g~~pf~~~~~~~~~  225 (297)
T 3fxz_A          196 KVDIWSLGIMAIEMIEGEPPYLNENPLRAL  225 (297)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999999999999999999877655433

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.93  E-value=5.3e-26  Score=157.86  Aligned_cols=102  Identities=31%  Similarity=0.482  Sum_probs=89.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCc-----EEEeeccccccccccc---------ccCCCCcccee
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE-----IKICDFGVSGQLIDSM---------ANSFVGTRSYM   68 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~-----~~l~d~g~~~~~~~~~---------~~~~~~~~~~~   68 (131)
                      ++..++.|++.||+|||+. +++||||+|.||+++.++.     ++++|||++.......         .....+++.|+
T Consensus       106 ~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~  184 (330)
T 2izr_A          106 TVLMIAIQLISRMEYVHSK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM  184 (330)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCcccc
Confidence            5678999999999999997 8999999999999998877     9999999987543221         23557889999


Q ss_pred             CcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         69 SPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        69 ~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      |||.+.+..++.++|+||||+++|++++|..||....
T Consensus       185 aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~  221 (330)
T 2izr_A          185 SINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK  221 (330)
T ss_dssp             CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             ChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence            9999999889999999999999999999999998644

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.93  E-value=1.1e-25  Score=157.93  Aligned_cols=109  Identities=27%  Similarity=0.502  Sum_probs=95.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      +++.++.|++.||.|||+. |++||||+|.||+++.++.++++|||++...... .....+++.|+|||.+.+..++.++
T Consensus       142 ~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~  219 (350)
T 1rdq_E          142 HARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TWTLCGTPEALAPEIILSKGYNKAV  219 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-BCCCEECGGGCCHHHHTTCCBCTHH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccccCccceEEECCCCCEEEcccccceeccCC-cccccCCccccCHHHhcCCCCCCcC
Confidence            4678999999999999997 8999999999999999999999999998765432 3455788999999999988899999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      |+||+|+++|+|++|..||...+..+..+.+
T Consensus       220 DiwslG~il~ell~g~~Pf~~~~~~~~~~~i  250 (350)
T 1rdq_E          220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKI  250 (350)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CEecccHhHhHHhhCCCCCCCCCHHHHHHHH
Confidence            9999999999999999999887766555433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.93  E-value=1.5e-25  Score=158.72  Aligned_cols=105  Identities=37%  Similarity=0.679  Sum_probs=88.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-----------------------cccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-----------------------SMAN   59 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-----------------------~~~~   59 (131)
                      .+..++.|++.||.|||+. |++||||+|.||+++.++.++++|||+++....                       ....
T Consensus       110 ~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (388)
T 3oz6_A          110 HKQYVVYQLIKVIKYLHSG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT  188 (388)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC--------------
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccccccccccccccccccccc
Confidence            3567899999999999997 899999999999999999999999999864321                       1122


Q ss_pred             CCCCccceeCcccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         60 SFVGTRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        60 ~~~~~~~~~~Pe~~~~-~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      ...+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||.+.+...
T Consensus       189 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             -CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             CCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            3468889999999976 568999999999999999999999998776543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.93  E-value=1.2e-25  Score=154.62  Aligned_cols=107  Identities=33%  Similarity=0.486  Sum_probs=93.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      +++.++.|++.||+|||++ +++|+||+|.||+++.++.++++|||.+...... ......+++.|+|||.+.+..++.+
T Consensus       121 ~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  199 (308)
T 3g33_A          121 TIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP  199 (308)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCST
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCch
Confidence            4678999999999999997 8999999999999999999999999998755432 2344567889999999988889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAKTLA  110 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~~~~  110 (131)
                      +|+||+|+++|++++|..||......+..
T Consensus       200 ~DiwslG~il~~l~~g~~pf~~~~~~~~~  228 (308)
T 3g33_A          200 VDMWSVGCIFAEMFRRKPLFCGNSEADQL  228 (308)
T ss_dssp             HHHHHHHHHHHHTTTSSCSCCCSSHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999999999877765433

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.93  E-value=1.1e-25  Score=160.90  Aligned_cols=108  Identities=30%  Similarity=0.495  Sum_probs=92.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCccccc-----
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQ-----   74 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~-----   74 (131)
                      .++.++.|++.||.|||+. +++||||+|.||+++.++.++++|||++......   ......|++.|+|||++.     
T Consensus       163 ~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~  241 (412)
T 2vd5_A          163 MARFYLAEIVMAIDSVHRL-GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG  241 (412)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccC
Confidence            4677899999999999997 8999999999999999999999999998765332   223457899999999987     


Q ss_pred             --CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         75 --GTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        75 --~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                        ...++.++|+||+|+++|+|++|..||...+..+...
T Consensus       242 ~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~  280 (412)
T 2vd5_A          242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG  280 (412)
T ss_dssp             TTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             cCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH
Confidence              3468899999999999999999999998877665443

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.92  E-value=1.4e-25  Score=161.52  Aligned_cols=111  Identities=30%  Similarity=0.608  Sum_probs=94.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.|||+..|++||||+|.||+++.++.++++|||++....  ........+++.|+|||.+.+..++.
T Consensus       249 ~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  328 (446)
T 4ejn_A          249 RARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR  328 (446)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCT
T ss_pred             HHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCC
Confidence            4678899999999999982389999999999999999999999999987532  22344567899999999999888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|+|++|..||...+...+.+.+
T Consensus       329 ~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i  361 (446)
T 4ejn_A          329 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI  361 (446)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999888776655544

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.92  E-value=2.5e-25  Score=155.83  Aligned_cols=100  Identities=35%  Similarity=0.673  Sum_probs=89.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc--cccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||.|||++ +++||||+|.||+++.++.++++|||+++...  ........+++.|+|||.+.+..++.
T Consensus       111 ~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  189 (345)
T 3a8x_A          111 HARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF  189 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCCh
Confidence            4678999999999999997 89999999999999999999999999987532  22345567899999999999888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      ++|+||+|+++|+|++|..||..
T Consensus       190 ~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          190 SVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             HHhHHHHHHHHHHHHhCCCCcCC
Confidence            99999999999999999999964

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.92  E-value=2.5e-25  Score=157.92  Aligned_cols=101  Identities=35%  Similarity=0.631  Sum_probs=88.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-ccccCCCCccceeCcccccC---CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQG---THY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~---~~~   78 (131)
                      +++.++.|++.||.|||+. |++||||+|.||+++.++.++++|||++..... .......|++.|+|||.+..   ..+
T Consensus       116 ~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~  194 (384)
T 4fr4_A          116 TVKLFICELVMALDYLQNQ-RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGY  194 (384)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCB
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCC
Confidence            4678999999999999997 899999999999999999999999999876533 33456678999999999964   458


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      +.++|+||+|+++|+|++|..||...
T Consensus       195 ~~~~DiwSlG~il~elltG~~Pf~~~  220 (384)
T 4fr4_A          195 SFAVDWWSLGVTAYELLRGRRPYHIR  220 (384)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             CccceeechHHHHHHHHhCCCCCCCC
Confidence            89999999999999999999999743

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.92  E-value=3.3e-25  Score=153.96  Aligned_cols=108  Identities=32%  Similarity=0.542  Sum_probs=90.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.|||++ |++||||+|.||+++.++.++++|||++.....  .......+++.|+|||.+.+..++.
T Consensus       122 ~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  200 (327)
T 3a62_A          122 TACFYLAEISMALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNR  200 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCC
Confidence            4677899999999999997 899999999999999999999999999865432  2234557889999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      ++|+||+|+++|+|++|..||...+..+..+
T Consensus       201 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~  231 (327)
T 3a62_A          201 AVDWWSLGALMYDMLTGAPPFTGENRKKTID  231 (327)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccchhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            9999999999999999999998777665444

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.92  E-value=4.2e-25  Score=154.72  Aligned_cols=107  Identities=33%  Similarity=0.564  Sum_probs=92.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec-------------------------CCcEEEeeccccccccccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-------------------------GGEIKICDFGVSGQLIDSM   57 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~-------------------------~~~~~l~d~g~~~~~~~~~   57 (131)
                      +++.++.|++.||.|||+. |++||||+|.||+++.                         ++.++++|||++..... .
T Consensus       138 ~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-~  215 (360)
T 3llt_A          138 DIKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-Y  215 (360)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-C
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC-C
Confidence            5678999999999999997 8999999999999975                         77899999999865433 2


Q ss_pred             ccCCCCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         58 ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        58 ~~~~~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      .....+++.|+|||.+.+..++.++|+||+|+++|++++|..||...+..+..+
T Consensus       216 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  269 (360)
T 3llt_A          216 HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLA  269 (360)
T ss_dssp             CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHH
Confidence            345578889999999999899999999999999999999999998777654443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.92  E-value=4.6e-25  Score=155.35  Aligned_cols=111  Identities=27%  Similarity=0.465  Sum_probs=95.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC----cEEEeecccccccccc-cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG----EIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~----~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||.|||+. |++|+||+|.||+++.++    .++++|||++...... ......|++.|+|||.+.+..
T Consensus       116 ~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~  194 (361)
T 2yab_A          116 EATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP  194 (361)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCC
Confidence            5678999999999999997 899999999999998776    7999999998765432 334567899999999999888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~  114 (131)
                      ++.++|+||+|+++|+|++|..||.+....+..+.+.
T Consensus       195 ~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~  231 (361)
T 2yab_A          195 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT  231 (361)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999999999999999998877766655443

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.92  E-value=3.1e-25  Score=156.49  Aligned_cols=112  Identities=29%  Similarity=0.507  Sum_probs=94.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||+|||++ +++||||++.||+++.++.++++|||++......    ......+++.|+|||.+.+..+
T Consensus       204 ~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  282 (370)
T 2psq_A          204 DLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY  282 (370)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC
Confidence            3567899999999999997 8999999999999999999999999998754332    1223345678999999998889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      +.++|+||||+++|+|++ |..||.....+++.+.+..
T Consensus       283 ~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~  320 (370)
T 2psq_A          283 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE  320 (370)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred             CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence            999999999999999998 9999988877766665543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.92  E-value=3.4e-25  Score=152.93  Aligned_cols=110  Identities=31%  Similarity=0.526  Sum_probs=87.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCC--cEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~--~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||+|||++ +  ++|+||++.||+++.++.++++|||++......  ......+++.|+|||.+.+..+
T Consensus       138 ~~~~i~~qi~~aL~~LH~~-~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  216 (309)
T 3p86_A          138 RRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS  216 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHTS-SSCCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHHcC-CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCC
Confidence            4677999999999999997 8  999999999999999999999999998654322  2334568889999999999889


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      +.++|+||+|+++|++++|..||......+....+
T Consensus       217 ~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~  251 (309)
T 3p86_A          217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV  251 (309)
T ss_dssp             CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999999999999999988877665544

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.92  E-value=6.3e-25  Score=151.83  Aligned_cols=108  Identities=37%  Similarity=0.595  Sum_probs=91.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      .++.++.|++.||.|||++ |++|+||+|.||+++.++.++++|||++......  ......+++.|+|||.+.+. .++
T Consensus       109 ~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  187 (317)
T 2pmi_A          109 LVKYFQWQLLQGLAFCHEN-KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYS  187 (317)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCC
Confidence            4567889999999999997 8999999999999999999999999998755322  23345678899999999764 589


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      .++|+||+|+++|+|++|..||...+..+..+
T Consensus       188 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  219 (317)
T 2pmi_A          188 TSIDIWSCGCILAEMITGKPLFPGTNDEEQLK  219 (317)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            99999999999999999999998777654433

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.92  E-value=5.5e-25  Score=149.33  Aligned_cols=110  Identities=32%  Similarity=0.539  Sum_probs=92.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      ++..++.|++.+|.|||+. |++|+||+|.||+++.++.++++|||++............++..|++||.+.+..++.++
T Consensus       110 ~~~~~~~qi~~~l~~LH~~-~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  188 (279)
T 3fdn_A          110 RTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV  188 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TCEECCCCGGGEEECTTSCEEECSCCEESCC--------CCCCTTCCHHHHTTCCCCTTH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecccCChHhEEEcCCCCEEEEeccccccCCcccccccCCCCCccCHhHhccCCCCccc
Confidence            4678999999999999997 899999999999999999999999998865554444556788899999999888889999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      |+||+|++++++++|..||......+..+.+
T Consensus       189 Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  219 (279)
T 3fdn_A          189 DLWSLGVLCYEFLVGKPPFEANTYQETYKRI  219 (279)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             hhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence            9999999999999999999988766555443

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.92  E-value=2.7e-25  Score=156.26  Aligned_cols=100  Identities=25%  Similarity=0.400  Sum_probs=87.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEe--cCCcEEEeeccccccccccc---------ccCCCCccceeCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN--SGGEIKICDFGVSGQLIDSM---------ANSFVGTRSYMSPE   71 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~--~~~~~~l~d~g~~~~~~~~~---------~~~~~~~~~~~~Pe   71 (131)
                      ++..++.|++.||+|||++ +++||||+|.||+++  .++.++++|||+++......         .....+++.|+|||
T Consensus       153 ~~~~i~~qi~~~l~~lH~~-~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  231 (364)
T 3op5_A          153 TVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSID  231 (364)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHH
Confidence            5678999999999999998 899999999999999  88999999999986543211         12345889999999


Q ss_pred             cccCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         72 RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        72 ~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      .+.+..++.++|+||||+++|+|++|..||..
T Consensus       232 ~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          232 AHNGVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             HhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            99988899999999999999999999999974

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.92  E-value=4.2e-25  Score=158.53  Aligned_cols=105  Identities=34%  Similarity=0.558  Sum_probs=92.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCc--EEEeecccccccccccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE--IKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||+|||+. +++||||+|.||+++.++.  ++++|||++..... ......+++.|+|||.+.+..++.
T Consensus       201 ~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~  278 (429)
T 3kvw_A          201 LVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-RVYTYIQSRFYRAPEVILGARYGM  278 (429)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC-CCCSSCSCGGGCCHHHHHTBCCCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEccCCCcceEEeecccceecCC-cccccCCCCCccChHHHhCCCCCc
Confidence            4678999999999999998 8999999999999998887  99999999865433 234557888999999999988999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      ++|+||||+++|+|++|..||...+..+.
T Consensus       279 ~~DiwSlG~il~elltG~~pf~~~~~~~~  307 (429)
T 3kvw_A          279 PIDMWSLGCILAELLTGYPLLPGEDEGDQ  307 (429)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             hHHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999999999999987775543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.92  E-value=1.8e-25  Score=157.51  Aligned_cols=99  Identities=17%  Similarity=0.277  Sum_probs=85.8

Q ss_pred             hHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccC--CCCCCcc
Q psy17559          5 PYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG--THYSVQS   82 (131)
Q Consensus         5 ~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~   82 (131)
                      ..++.|++.||+|||++ +++||||+|.||+++.++.++++|||++........ ...+++.|+|||.+.+  ..++.++
T Consensus       197 ~~i~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~~  274 (371)
T 3q60_A          197 HILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-ASSVPVTYAPREFLNASTATFTHAL  274 (371)
T ss_dssp             HHHHHHHHHHHHHHHHT-TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-GGGSCGGGCCHHHHTCSEEECCHHH
T ss_pred             HHHHHHHHHHHHHHHHC-CCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-CccCCcCCcChhhccCCCCCcCccc
Confidence            46669999999999997 899999999999999999999999999876543322 3445589999999987  6789999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      |+||+|+++|+|++|..||....
T Consensus       275 DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          275 NAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             HHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             cHHHHHHHHHHHHhCCCCCCCcC
Confidence            99999999999999999997653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.92  E-value=8.8e-25  Score=157.57  Aligned_cols=111  Identities=28%  Similarity=0.504  Sum_probs=95.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec---CCcEEEeecccccccccc--cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~---~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||.|||++ |++||||+|.||+++.   ++.++++|||++......  ......+++.|+|||.+.+..
T Consensus       111 ~~~~i~~qil~aL~~lH~~-givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~  189 (444)
T 3soa_A          111 DASHCIQQILEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP  189 (444)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCC
Confidence            4678999999999999997 8999999999999984   577999999998665432  223567899999999999888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~  114 (131)
                      ++.++|+||+|+++|+|++|..||.+.+..++.+.+.
T Consensus       190 ~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~  226 (444)
T 3soa_A          190 YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK  226 (444)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence            9999999999999999999999998888776665543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.92  E-value=8.8e-25  Score=155.31  Aligned_cols=104  Identities=33%  Similarity=0.620  Sum_probs=90.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEe-cCCcEEEeeccccccccc-ccccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~-~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      .++.++.|++.||.|||++ |++||||+|.||+++ .++.++++|||+++.... .......+++.|+|||.+.+. .++
T Consensus       142 ~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  220 (394)
T 4e7w_A          142 LIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYT  220 (394)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCC
Confidence            4678899999999999997 899999999999999 789999999999876532 233455778899999998764 589


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      .++|+||+|+++|+|++|+.||.+....
T Consensus       221 ~~~DiwSlG~il~ell~g~~pf~~~~~~  248 (394)
T 4e7w_A          221 TNIDIWSTGCVMAELMQGQPLFPGESGI  248 (394)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999999999999999999877654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.92  E-value=3.4e-25  Score=151.28  Aligned_cols=101  Identities=28%  Similarity=0.412  Sum_probs=87.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCc-----EEEeecccccccccc---------cccCCCCcccee
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE-----IKICDFGVSGQLIDS---------MANSFVGTRSYM   68 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~-----~~l~d~g~~~~~~~~---------~~~~~~~~~~~~   68 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++.     ++++|||++......         ......+++.|+
T Consensus       107 ~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  185 (298)
T 1csn_A          107 TVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM  185 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccC
Confidence            5678999999999999997 8999999999999987765     999999998654332         123456888999


Q ss_pred             CcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         69 SPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        69 ~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      |||.+.+..++.++|+||||+++|++++|..||...
T Consensus       186 aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  221 (298)
T 1csn_A          186 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  221 (298)
T ss_dssp             CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             CchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence            999999888999999999999999999999999764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.92  E-value=5.7e-25  Score=150.65  Aligned_cols=106  Identities=35%  Similarity=0.600  Sum_probs=88.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.+|.|||+. |++|+||+|.||+++.++.++++|||++......   ......+++.|+|||.+.+..++
T Consensus       112 ~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  190 (294)
T 4eqm_A          112 TAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD  190 (294)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCC
Confidence            4678999999999999997 8999999999999999999999999998755332   22345688899999999998899


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      .++|+||+|+++|++++|..||......+.
T Consensus       191 ~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  220 (294)
T 4eqm_A          191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSI  220 (294)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCSSCSSCHHHH
T ss_pred             chHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            999999999999999999999987775543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.92  E-value=9.6e-25  Score=151.28  Aligned_cols=109  Identities=34%  Similarity=0.593  Sum_probs=94.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.|||+. |++|+||+|.||+++.++.++++|||++......  ......+++.|+|||.+.+..++.
T Consensus       142 ~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  220 (321)
T 2c30_A          142 QIATVCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYAT  220 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCc
Confidence            4678999999999999997 8999999999999999999999999998654332  234557889999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      ++|+||+|+++|++++|..||......+....
T Consensus       221 ~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~  252 (321)
T 2c30_A          221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR  252 (321)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999999999987776554443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=1e-24  Score=153.77  Aligned_cols=103  Identities=38%  Similarity=0.642  Sum_probs=90.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccC-CCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~   81 (131)
                      ++..++.|++.||.|||+. |++||||+|.||+++.++.++++|||+++..... .....+++.|+|||.+.+ ..++.+
T Consensus       129 ~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~  206 (367)
T 1cm8_A          129 RIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-MTGYVVTRWYRAPEVILNWMRYTQT  206 (367)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-CCSSCSCGGGCCTHHHHTTTCCCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCcCHHHEEEcCCCCEEEEeeecccccccc-cCcCcCCCCcCCHHHHhCCCCCChh
Confidence            4678999999999999997 8999999999999999999999999998765432 334577889999999877 678999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +|+||+|+++++|++|+.||.+.+..
T Consensus       207 ~DiwslG~il~ell~g~~pf~~~~~~  232 (367)
T 1cm8_A          207 VDIWSVGCIMAEMITGKTLFKGSDHL  232 (367)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999999877654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.92  E-value=9.6e-25  Score=156.26  Aligned_cols=104  Identities=33%  Similarity=0.649  Sum_probs=88.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC-CcEEEeeccccccccc-ccccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG-GEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~-~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      .++.++.|++.||.|||+. +++||||++.||+++.+ +.++++|||+++.... .......+++.|+|||.+.+. .++
T Consensus       157 ~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  235 (420)
T 1j1b_A          157 YVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYT  235 (420)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCC
Confidence            3678899999999999997 89999999999999955 5689999999875432 223445778899999999764 689


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      .++|+||+|+++|+|++|+.||.+....
T Consensus       236 ~~~DiwSlG~il~ell~G~~pf~~~~~~  263 (420)
T 1j1b_A          236 SSIDVWSAGCVLAELLLGQPIFPGDSGV  263 (420)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             chhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999999999999999999877643

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.92  E-value=1.7e-25  Score=159.84  Aligned_cols=101  Identities=24%  Similarity=0.337  Sum_probs=87.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccc---------
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERL---------   73 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~---------   73 (131)
                      ++..++.|++.||+|||++ +++||||+|.||+++.++.++|+|||++...... .....+ +.|+|||.+         
T Consensus       212 ~~~~i~~qi~~aL~~LH~~-~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~  288 (413)
T 3dzo_A          212 ARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQ  288 (413)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGG
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCcccceEEEecCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhcccccccc
Confidence            4567789999999999997 8999999999999999999999999998765443 344566 899999999         


Q ss_pred             -cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         74 -QGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        74 -~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                       ....++.++|+||||+++|+|++|+.||.....
T Consensus       289 ~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~  322 (413)
T 3dzo_A          289 HHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA  322 (413)
T ss_dssp             GCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGG
T ss_pred             ccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence             455678899999999999999999999976543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.92  E-value=4.6e-25  Score=152.91  Aligned_cols=113  Identities=25%  Similarity=0.467  Sum_probs=93.8

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      +++..++.|++.||.|||+. |++|+||+|.||+++.++.++++|||++......    ......++..|+|||.+.+..
T Consensus       115 ~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  193 (325)
T 3kex_A          115 QLLLNWGVQIAKGMYYLEEH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK  193 (325)
T ss_dssp             THHHHHHHHHHHHHHHHHHT-TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHHHhC-CCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCC
Confidence            45778999999999999997 8999999999999999999999999998765322    123345667899999998888


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      ++.++|+||+|+++|++++ |..||......++.+.+..
T Consensus       194 ~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  232 (325)
T 3kex_A          194 YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK  232 (325)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT
T ss_pred             CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc
Confidence            9999999999999999999 9999987776666655543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.92  E-value=1.3e-24  Score=147.84  Aligned_cols=110  Identities=30%  Similarity=0.532  Sum_probs=95.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      ++..++.|++.||.|||++ |++|+||++.||+++.++.++++|||.+............++..|++||.+.+..++.++
T Consensus       115 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  193 (284)
T 2vgo_A          115 RSATFMEELADALHYCHER-KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKV  193 (284)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEEcCCCCEEEecccccccCcccccccccCCCCcCCHHHhccCCCCccc
Confidence            4678999999999999997 899999999999999999999999998865544444556788899999999988899999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      |+||+|++++++++|..||......+..+.+
T Consensus       194 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  224 (284)
T 2vgo_A          194 DLWCAGVLCYEFLVGMPPFDSPSHTETHRRI  224 (284)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             chhhHHHHHHHHHHCCCCCCCCCHhHHHHHH
Confidence            9999999999999999999877766554433

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.92  E-value=9.1e-25  Score=153.79  Aligned_cols=110  Identities=34%  Similarity=0.582  Sum_probs=93.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC---cEEEeecccccccccc-cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG---EIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~---~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++   .++++|||++...... ......+++.|+|||.+.+..+
T Consensus       129 ~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  207 (362)
T 2bdw_A          129 DASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY  207 (362)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCC
Confidence            4678999999999999997 899999999999998643   5999999998765432 2334578899999999998889


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      +.++|+||+|+++|+|++|..||...+..++...+
T Consensus       208 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i  242 (362)
T 2bdw_A          208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI  242 (362)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99999999999999999999999887776655544

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.92  E-value=6.5e-25  Score=151.47  Aligned_cols=104  Identities=35%  Similarity=0.573  Sum_probs=88.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccC-CCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQG-THYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~-~~~~   79 (131)
                      +++.++.|++.||.|||++ |++|+||+|.||+++.++.++++|||++.....  .......+++.|+|||.+.+ ..++
T Consensus       120 ~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  198 (311)
T 3niz_A          120 QIKIYLYQLLRGVAHCHQH-RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS  198 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCC
Confidence            4678999999999999997 899999999999999999999999999876532  22334567889999999876 4589


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      .++|+||+|+++|++++|..||......
T Consensus       199 ~~~DiwslG~il~~ll~g~~pf~~~~~~  226 (311)
T 3niz_A          199 TSVDIWSIGCIFAEMITGKPLFPGVTDD  226 (311)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSTT
T ss_pred             chHHhHHHHHHHHHHHhCCCCCCCCChH
Confidence            9999999999999999999999755543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.92  E-value=8.4e-25  Score=160.92  Aligned_cols=101  Identities=32%  Similarity=0.621  Sum_probs=89.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||.|||+. |++||||+|.||+++.++.++++|||++......  ......|++.|+|||.+.+..++.
T Consensus       290 ~~~~~~~qi~~aL~~LH~~-gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~  368 (543)
T 3c4z_A          290 RAIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF  368 (543)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHHHHc-CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCCh
Confidence            4567899999999999997 8999999999999999999999999998765432  233457899999999999988999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      ++|+||+|+++|+|++|..||...
T Consensus       369 ~~DiwSlGvilyelltG~~PF~~~  392 (543)
T 3c4z_A          369 SVDYFALGVTLYEMIAARGPFRAR  392 (543)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred             HHhcCcchHHHHHHHhCCCCCCCC
Confidence            999999999999999999999764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.92  E-value=6.2e-25  Score=154.87  Aligned_cols=106  Identities=40%  Similarity=0.604  Sum_probs=84.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.||.|||++ |++|+||+|.||+++.++.++++|||++...... ......+++.|+|||.+.+..++.+
T Consensus       128 ~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  206 (371)
T 2xrw_A          128 RMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN  206 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCch
Confidence            4678999999999999997 8999999999999999999999999998765432 2334577889999999998889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      +|+||+|+++|++++|..||.+.+..+.
T Consensus       207 ~DiwslG~il~el~~g~~pf~~~~~~~~  234 (371)
T 2xrw_A          207 VDIWSVGCIMGEMIKGGVLFPGTDHIDQ  234 (371)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             HhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999999999999999987775543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.92  E-value=6.8e-25  Score=156.23  Aligned_cols=102  Identities=28%  Similarity=0.459  Sum_probs=84.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec---CCcEEEeeccccccccc-ccccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~---~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      +++.++.|++.||.|||+. +++||||++.||+++.   ++.++++|||+++.... .......+++.|+|||++.+..+
T Consensus       162 ~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  240 (400)
T 1nxk_A          162 EASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY  240 (400)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCC
Confidence            4678999999999999997 8999999999999997   78899999999875543 22345567889999999988889


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      +.++|+||+|+++|+|++|..||....
T Consensus       241 ~~~~DiwslG~il~ell~g~~pf~~~~  267 (400)
T 1nxk_A          241 DKSCDMWSLGVIMYILLCGYPPFYSNH  267 (400)
T ss_dssp             SSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred             CCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence            999999999999999999999996543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.92  E-value=1.7e-24  Score=148.16  Aligned_cols=109  Identities=38%  Similarity=0.654  Sum_probs=92.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCC---
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH---   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~---   77 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++.++++|||++......  ......+++.|+|||.+.+..   
T Consensus       138 ~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  216 (298)
T 2zv2_A          138 QARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIF  216 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCE
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCC
Confidence            4678999999999999997 8999999999999999999999999998755332  234557889999999997654   


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      .+.++|+||+|+++|++++|..||...........
T Consensus       217 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  251 (298)
T 2zv2_A          217 SGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK  251 (298)
T ss_dssp             ESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHH
Confidence            36789999999999999999999987776554443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.92  E-value=3.3e-25  Score=155.34  Aligned_cols=112  Identities=83%  Similarity=1.293  Sum_probs=96.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .+..++.|++.+|.|||++.|++|+||++.||+++.++.++++|||++............+++.|+|||.+.+..++.++
T Consensus       132 ~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  211 (360)
T 3eqc_A          132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS  211 (360)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchh
Confidence            46789999999999999854799999999999999999999999999866554444556788999999999988899999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhC
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~  114 (131)
                      |+||+|+++|++++|..||...+.++....+.
T Consensus       212 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  243 (360)
T 3eqc_A          212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFG  243 (360)
T ss_dssp             HHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence            99999999999999999999888877766654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.91  E-value=7.6e-25  Score=154.45  Aligned_cols=104  Identities=39%  Similarity=0.704  Sum_probs=81.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccC-CCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~   81 (131)
                      ++..++.|++.||.|||+. |++|+||+|.||+++.++.++++|||+++..... .....++..|+|||.+.+ ..++.+
T Consensus       133 ~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~  210 (367)
T 2fst_X          133 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-MTGYVATRWYRAPEIMLNWMHYNQT  210 (367)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECC----------------CCCTTCCHHHHTTCCSCCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeCCCCHhhEEECCCCCEEEeecccccccccc-CCCcCcCcCccChHHHcCCcCCCch
Confidence            4678999999999999997 8999999999999999999999999998764432 234577889999999877 578999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      +|+||+|+++++|++|..||.+.+..+
T Consensus       211 ~DiwslG~il~ell~g~~pf~~~~~~~  237 (367)
T 2fst_X          211 VDIWSVGCIMAELLTGRTLFPGTDHID  237 (367)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999999999999999999998777543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.91  E-value=1.5e-24  Score=151.62  Aligned_cols=108  Identities=28%  Similarity=0.437  Sum_probs=91.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc------ccccCCCCccceeCcccccC-
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------SMANSFVGTRSYMSPERLQG-   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~~~~~~Pe~~~~-   75 (131)
                      +++.++.|++.||.|||++ |++|+||+|.||+++.++.++++|||++.....      .......+++.|+|||.+.+ 
T Consensus       125 ~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  203 (351)
T 3mi9_A          125 EIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE  203 (351)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCC
Confidence            5788999999999999997 899999999999999999999999999865431      12234567889999999876 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      ..++.++|+||+|++++++++|..||.+........
T Consensus       204 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  239 (351)
T 3mi9_A          204 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA  239 (351)
T ss_dssp             CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            457999999999999999999999998877654433

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.91  E-value=1.4e-24  Score=150.72  Aligned_cols=109  Identities=27%  Similarity=0.423  Sum_probs=93.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC----cEEEeeccccccccc-ccccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG----EIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~----~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||.|||+. +++|+||+|.||+++.++    .++++|||++..... .......+++.|+|||.+.+..
T Consensus       115 ~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~  193 (326)
T 2y0a_A          115 EATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP  193 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCC
Confidence            4678999999999999997 899999999999998877    799999999876532 2334557889999999998888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      ++.++|+||+|+++|++++|..||.+....+....
T Consensus       194 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  228 (326)
T 2y0a_A          194 LGLEADMWSIGVITYILLSGASPFLGDTKQETLAN  228 (326)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH
T ss_pred             CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH
Confidence            99999999999999999999999987776554443

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.91  E-value=2.8e-25  Score=154.14  Aligned_cols=113  Identities=28%  Similarity=0.468  Sum_probs=94.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++||||+|.||+++.++.++++|||++......    ......++..|+|||.+.+..+
T Consensus       118 ~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  196 (327)
T 3poz_A          118 YLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY  196 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHhhC-CeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCC
Confidence            4678999999999999997 8999999999999999999999999998654322    1123345678999999998889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  116 (131)
                      +.++|+||||+++|++++ |..||......++.+.+...
T Consensus       197 ~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  235 (327)
T 3poz_A          197 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG  235 (327)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC
Confidence            999999999999999999 99999988877776666443

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.91  E-value=8.2e-25  Score=152.79  Aligned_cols=102  Identities=30%  Similarity=0.577  Sum_probs=89.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY-SV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~-~~   80 (131)
                      +++.++.|++.||.|||+. |++||||+|.||+++.++.++++|||++...... ......+++.|+|||.+.+..+ +.
T Consensus       109 ~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  187 (336)
T 3h4j_B          109 EGRRFFQQIICAIEYCHRH-KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP  187 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCC
Confidence            5678999999999999998 8999999999999999999999999998765432 3445678899999999988765 68


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ++|+||+|+++|++++|..||....
T Consensus       188 ~~DiwslG~il~~ll~g~~Pf~~~~  212 (336)
T 3h4j_B          188 EVDVWSCGIVLYVMLVGRLPFDDEF  212 (336)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred             ccchhHHHHHHHHHHhCCCCCCCcc
Confidence            9999999999999999999997544

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.91  E-value=6.3e-25  Score=151.34  Aligned_cols=106  Identities=31%  Similarity=0.575  Sum_probs=86.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      +++.++.|++.+|.|||++ +++|+||++.||+++.++.++++|||++......     ......+++.|+|||.+.+..
T Consensus       117 ~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  195 (311)
T 3ork_A          117 RAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS  195 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCC
Confidence            4678999999999999997 8999999999999999999999999998654322     223346788999999999888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      ++.++|+||+|+++|++++|..||......+.
T Consensus       196 ~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  227 (311)
T 3ork_A          196 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV  227 (311)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             CCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            99999999999999999999999987776544

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.91  E-value=1.7e-24  Score=150.83  Aligned_cols=105  Identities=28%  Similarity=0.491  Sum_probs=91.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEE-------------------ecCCcEEEeecccccccccccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILV-------------------NSGGEIKICDFGVSGQLIDSMANSFVG   63 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~-------------------~~~~~~~l~d~g~~~~~~~~~~~~~~~   63 (131)
                      +++.++.|++.||.|||++ +++|+||+|.||++                   +.++.++++|||++...... .....+
T Consensus       124 ~~~~i~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~g  201 (355)
T 2eu9_A          124 HVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-HTTIVA  201 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-CCSSCS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-ccCCcC
Confidence            5678999999999999997 89999999999999                   56788999999998654332 344578


Q ss_pred             ccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         64 TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        64 ~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      ++.|+|||.+.+..++.++|+||+|+++|++++|..||......+.
T Consensus       202 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          202 TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             CGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             CCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            8999999999988899999999999999999999999987776543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.91  E-value=8.8e-25  Score=149.01  Aligned_cols=101  Identities=32%  Similarity=0.488  Sum_probs=88.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEE---ecCCcEEEeecccccccccc---------cccCCCCccceeCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILV---NSGGEIKICDFGVSGQLIDS---------MANSFVGTRSYMSP   70 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~---~~~~~~~l~d~g~~~~~~~~---------~~~~~~~~~~~~~P   70 (131)
                      ++..++.|++.||.|||+. +++|+||+|.||++   +.++.++++|||.+......         ......+++.|+||
T Consensus       106 ~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  184 (296)
T 4hgt_A          106 TVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI  184 (296)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccch
Confidence            5678999999999999997 89999999999999   78889999999998654332         12345678899999


Q ss_pred             ccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         71 ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        71 e~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      |.+.+..++.++|+||+|+++|++++|..||...
T Consensus       185 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  218 (296)
T 4hgt_A          185 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL  218 (296)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             HHhcCCCCCchhHHHHHHHHHHHHhcCCCCCccc
Confidence            9999888999999999999999999999999753

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.91  E-value=1.2e-24  Score=153.89  Aligned_cols=113  Identities=31%  Similarity=0.513  Sum_probs=96.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      +++.++.|++.||+|||++ +++|+||+|.||+++.++.++++|||++......    ......++..|+|||.+.+..+
T Consensus       192 ~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  270 (382)
T 3tt0_A          192 DLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY  270 (382)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC
Confidence            4678999999999999997 8999999999999999999999999998755432    2223345678999999998889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  116 (131)
                      +.++|+||||++++++++ |..||.....+++.+.+...
T Consensus       271 ~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~  309 (382)
T 3tt0_A          271 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG  309 (382)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            999999999999999998 99999988888777766544

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.91  E-value=2.3e-25  Score=157.29  Aligned_cols=99  Identities=21%  Similarity=0.287  Sum_probs=84.6

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCC-------
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGT-------   76 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-------   76 (131)
                      +..++.|++.||+|||++ +++||||+|.||+++.++.++++|||++..... ......+ +.|+|||.+.+.       
T Consensus       208 ~~~i~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~  284 (377)
T 3byv_A          208 RLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHR  284 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHH
T ss_pred             HHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccc
Confidence            456999999999999997 899999999999999999999999999875443 2334456 899999999877       


Q ss_pred             ----CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         77 ----HYSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        77 ----~~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                          .++.++|+||||+++|+|++|..||....
T Consensus       285 ~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~  317 (377)
T 3byv_A          285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDA  317 (377)
T ss_dssp             CCEEECCHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             cccccCChhhhHHHHHHHHHHHHHCCCCCcccc
Confidence                78999999999999999999999997544

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.91  E-value=9.9e-25  Score=148.87  Aligned_cols=101  Identities=32%  Similarity=0.489  Sum_probs=88.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEE---ecCCcEEEeeccccccccccc---------ccCCCCccceeCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILV---NSGGEIKICDFGVSGQLIDSM---------ANSFVGTRSYMSP   70 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~---~~~~~~~l~d~g~~~~~~~~~---------~~~~~~~~~~~~P   70 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||++   +.++.++++|||.+.......         .....+++.|+||
T Consensus       106 ~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  184 (296)
T 3uzp_A          106 TVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI  184 (296)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCCh
Confidence            5678999999999999997 89999999999999   478899999999986543321         2345688899999


Q ss_pred             ccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         71 ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        71 e~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      |.+.+..++.++|+||+|+++|++++|..||...
T Consensus       185 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  218 (296)
T 3uzp_A          185 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL  218 (296)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             hhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence            9999888999999999999999999999999753

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.91  E-value=2.2e-24  Score=149.31  Aligned_cols=107  Identities=31%  Similarity=0.559  Sum_probs=92.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec-------------------CCcEEEeecccccccccccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-------------------GGEIKICDFGVSGQLIDSMANSFVG   63 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~-------------------~~~~~l~d~g~~~~~~~~~~~~~~~   63 (131)
                      ++..++.|++.||+|||++ +++|+||+|.||+++.                   ++.++++|||.+..... ......+
T Consensus       119 ~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~g  196 (339)
T 1z57_A          119 HIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE-HHSTLVS  196 (339)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS-CCCSSCS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc-ccccccC
Confidence            4678999999999999997 8999999999999987                   56799999999865433 2344578


Q ss_pred             ccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         64 TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        64 ~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      ++.|+|||.+.+..++.++|+||+|+++|++++|..||...+..+...
T Consensus       197 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  244 (339)
T 1z57_A          197 TRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA  244 (339)
T ss_dssp             CGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred             CccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            889999999998889999999999999999999999998877654433

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=6.3e-25  Score=152.32  Aligned_cols=110  Identities=26%  Similarity=0.419  Sum_probs=93.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec--CCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS--GGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~--~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||.|||+. |++|+||+|.||+++.  ++.++++|||++...... ......+++.|+|||.+.+..++
T Consensus       103 ~~~~i~~qi~~al~~lH~~-givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  181 (321)
T 1tki_A          103 EIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS  181 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEEC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCC
Confidence            4678999999999999997 8999999999999986  788999999998765332 22345678899999999888889


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||+|+++|++++|..||......+..+.+
T Consensus       182 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  215 (321)
T 1tki_A          182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENI  215 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             chhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH
Confidence            9999999999999999999999887766555443

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.91  E-value=8.8e-25  Score=149.09  Aligned_cols=105  Identities=33%  Similarity=0.568  Sum_probs=87.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      +++.++.|++.||.|||++ |++|+||+|.||+++.++.++++|||.+.....  .......+++.|+|||.+.+. .++
T Consensus       101 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  179 (288)
T 1ob3_A          101 TAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS  179 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCC
Confidence            4678999999999999997 899999999999999999999999998865432  122344678899999999764 589


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      .++|+||+|+++|++++|..||......+
T Consensus       180 ~~~DiwslG~il~~l~~g~~pf~~~~~~~  208 (288)
T 1ob3_A          180 TTIDIWSVGCIFAEMVNGTPLFPGVSEAD  208 (288)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999999998776543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.91  E-value=1.5e-24  Score=150.34  Aligned_cols=108  Identities=36%  Similarity=0.592  Sum_probs=87.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccC-CCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQG-THYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~-~~~~   79 (131)
                      +++.++.|++.||.|||+. |++|+||+|.||+++.++.++++|||++.....  .......+++.|+|||.+.+ ..++
T Consensus       101 ~~~~~~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  179 (324)
T 3mtl_A          101 NVKLFLFQLLRGLAYCHRQ-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYS  179 (324)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEEESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCC
Confidence            4678899999999999997 899999999999999999999999999865432  22234467889999999876 4689


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      .++|+||+|+++|++++|..||.+....+...
T Consensus       180 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  211 (324)
T 3mtl_A          180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH  211 (324)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999999999998877654433

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.91  E-value=1.5e-24  Score=151.91  Aligned_cols=104  Identities=34%  Similarity=0.545  Sum_probs=89.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCc---EEEeecccccccccc--cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~---~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      .+..++.|++.||.|||++ +++||||+|.||+++.++.   ++++|||++......  ......+++.|+|||.+.+..
T Consensus       131 ~~~~i~~qi~~al~~lH~~-~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  209 (351)
T 3c0i_A          131 VASHYMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP  209 (351)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCC
Confidence            4567899999999999997 8999999999999986554   999999998765432  234457899999999999888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      ++.++|+||+|+++|++++|..||.....+
T Consensus       210 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~  239 (351)
T 3c0i_A          210 YGKPVDVWGCGVILFILLSGCLPFYGTKER  239 (351)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCSSCSSHHH
T ss_pred             CCchHhhHHHHHHHHHHHHCCCCCCCcHHH
Confidence            999999999999999999999999875443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.91  E-value=2.4e-24  Score=147.15  Aligned_cols=105  Identities=35%  Similarity=0.584  Sum_probs=88.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTH-YS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~-~~   79 (131)
                      +++.++.|++.||.|||++ |++|+||++.||+++.++.++++|||.+.....  .......+++.|+|||.+.+.. ++
T Consensus       102 ~~~~~~~ql~~~l~~lH~~-~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  180 (292)
T 3o0g_A          102 IVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS  180 (292)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcC
Confidence            4678999999999999997 899999999999999999999999999875532  2234456788999999997765 79


Q ss_pred             CcchHHHHHHHHHHHHhCCCC-CCCCCHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYP-IPPPDAKT  108 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p-~~~~~~~~  108 (131)
                      .++|+||+|++++++++|..| |...+..+
T Consensus       181 ~~~DiwslG~il~~l~~~~~p~~~~~~~~~  210 (292)
T 3o0g_A          181 TSIDMWSAGCIFAELANAGRPLFPGNDVDD  210 (292)
T ss_dssp             THHHHHHHHHHHHHHTTTSCCSCCCSSHHH
T ss_pred             chHHHHHHHHHHHHHHHcCCCCcCCCCHHH
Confidence            999999999999999988777 45555443

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.91  E-value=8.1e-25  Score=151.99  Aligned_cols=113  Identities=28%  Similarity=0.468  Sum_probs=91.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||+. +++|+||+|.||+++.++.++++|||++......    ......++..|++||.+.+..+
T Consensus       118 ~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  196 (327)
T 3lzb_A          118 YLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY  196 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHhhC-CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCC
Confidence            4678999999999999997 8999999999999999999999999998655322    1223345668999999998889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  116 (131)
                      +.++|+||+|+++|++++ |..||......++.+.+...
T Consensus       197 ~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  235 (327)
T 3lzb_A          197 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG  235 (327)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence            999999999999999999 99999988877777666443

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.91  E-value=1.5e-24  Score=160.29  Aligned_cols=101  Identities=33%  Similarity=0.599  Sum_probs=90.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      +++.++.|++.||.|||+. |++||||+|.||+++.++.++++|||++...... ......|++.|+|||++.+..++.+
T Consensus       287 ~~~~i~~qIl~aL~yLH~~-gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~  365 (576)
T 2acx_A          287 RAVFYAAEICCGLEDLHRE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS  365 (576)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeccCCchheEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCcc
Confidence            4678899999999999997 8999999999999999999999999998765432 2345678999999999998889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      +|+||+|+++|+|++|..||...
T Consensus       366 ~DiwSLGvilyeLltG~~PF~~~  388 (576)
T 2acx_A          366 PDWWALGCLLYEMIAGQSPFQQR  388 (576)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSSCS
T ss_pred             chHHHHHHHHHHHHhCCCCCccc
Confidence            99999999999999999999765

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.91  E-value=2.2e-24  Score=148.39  Aligned_cols=100  Identities=29%  Similarity=0.538  Sum_probs=86.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc----------------cCCCCccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA----------------NSFVGTRS   66 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~----------------~~~~~~~~   66 (131)
                      ++..++.|++.||+|||++ +++|+||++.||+++.++.++++|||++........                ....+++.
T Consensus       109 ~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  187 (310)
T 3s95_A          109 QRVSFAKDIASGMAYLHSM-NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY  187 (310)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGG
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcc
Confidence            4678999999999999997 899999999999999999999999999865432111                14568889


Q ss_pred             eeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         67 YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        67 ~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      |+|||.+.+..++.++|+||+|+++|++++|..||..
T Consensus       188 y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~  224 (310)
T 3s95_A          188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD  224 (310)
T ss_dssp             GCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred             eeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence            9999999998899999999999999999999998864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.91  E-value=2.4e-24  Score=152.32  Aligned_cols=106  Identities=37%  Similarity=0.512  Sum_probs=90.8

Q ss_pred             chhHHHHHHHHHHHHHHh-cCCcEecCCCCCcEEEe--cCCcEEEeecccccccccccccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLRE-KHAIIHRDVKPSNILVN--SGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~-~~~~~h~~l~~~~il~~--~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      .+..++.|++.||.|||+ ..|++||||+|.||+++  .++.++++|||++...... .....+++.|+|||.+.+..++
T Consensus       158 ~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~  236 (382)
T 2vx3_A          158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-IYQYIQSRFYRSPEVLLGMPYD  236 (382)
T ss_dssp             HHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-CCSSCSCGGGCCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc-cccccCCccccChHHHcCCCCC
Confidence            467899999999999995 34899999999999995  4678999999998765432 3456788899999999998899


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      .++|+||+|+++|+|++|..||.+.+..+.
T Consensus       237 ~~~DiwSlG~il~elltg~~pf~~~~~~~~  266 (382)
T 2vx3_A          237 LAIDMWSLGCILVEMHTGEPLFSGANEVDQ  266 (382)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999999999999999999987765543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.91  E-value=1.6e-24  Score=146.34  Aligned_cols=109  Identities=34%  Similarity=0.546  Sum_probs=86.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCC---cEecCCCCCcEEEec--------CCcEEEeecccccccccccccCCCCccceeCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHA---IIHRDVKPSNILVNS--------GGEIKICDFGVSGQLIDSMANSFVGTRSYMSPE   71 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~---~~h~~l~~~~il~~~--------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe   71 (131)
                      ++..++.|++.||.|||++ +   ++|+||+|.||+++.        ++.++++|||.+............+++.|++||
T Consensus       106 ~~~~i~~~l~~~l~~lH~~-~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE  184 (271)
T 3dtc_A          106 ILVNWAVQIARGMNYLHDE-AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPE  184 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHHS-SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-------------CCGGGSCHH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccccCCCCccceeCHH
Confidence            4678999999999999997 7   899999999999985        677999999998766554444567888999999


Q ss_pred             cccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         72 RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        72 ~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      .+.+..++.++|+||+|++++++++|..||...+.......
T Consensus       185 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  225 (271)
T 3dtc_A          185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG  225 (271)
T ss_dssp             HHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH
T ss_pred             HhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Confidence            99888899999999999999999999999988776554443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=3.3e-24  Score=151.61  Aligned_cols=105  Identities=29%  Similarity=0.608  Sum_probs=89.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEe-cCCcEEEeeccccccccc-ccccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~-~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      .++.++.|++.||.|||+. |++||||+|.||+++ .++.++++|||++..... .......+++.|+|||.+.+. .++
T Consensus       142 ~~~~i~~qi~~aL~~LH~~-gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  220 (383)
T 3eb0_A          142 LISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYT  220 (383)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCC
Confidence            4678999999999999997 899999999999998 678999999999875533 233455678899999998775 489


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      .++|+||+|+++|+|++|+.||.+....+
T Consensus       221 ~~~DiwslG~il~ell~g~~pf~~~~~~~  249 (383)
T 3eb0_A          221 PSIDLWSIGCVFGELILGKPLFSGETSID  249 (383)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             cchhhhhHHHHHHHHHhCCCCCCCCChHH
Confidence            99999999999999999999998776543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.91  E-value=1.4e-24  Score=157.92  Aligned_cols=103  Identities=28%  Similarity=0.455  Sum_probs=89.7

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEE---ecCCcEEEeeccccccccccc---------ccCCCCccceeC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILV---NSGGEIKICDFGVSGQLIDSM---------ANSFVGTRSYMS   69 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~---~~~~~~~l~d~g~~~~~~~~~---------~~~~~~~~~~~~   69 (131)
                      ++++.++.|++.||.|||++ +++|+||++.||++   +.++.++|+|||++.......         .....++..|++
T Consensus       103 ~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~a  181 (483)
T 3sv0_A          103 KTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS  181 (483)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHC-CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccC
Confidence            35788999999999999997 89999999999999   578899999999987554321         125578889999


Q ss_pred             cccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         70 PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        70 Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ||.+.+..++.++|+||||+++|+|++|..||....
T Consensus       182 PE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~  217 (483)
T 3sv0_A          182 VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK  217 (483)
T ss_dssp             HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             HHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            999999889999999999999999999999997644

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.91  E-value=2.7e-24  Score=151.12  Aligned_cols=105  Identities=35%  Similarity=0.634  Sum_probs=89.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-----ccCCCCccceeCcccccC-C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQG-T   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~Pe~~~~-~   76 (131)
                      ++..++.|++.||.|||++ |++|+||+|.||+++.++.++++|||.+.......     .....+++.|+|||.+.. .
T Consensus       129 ~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  207 (364)
T 3qyz_A          129 HICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK  207 (364)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCC
Confidence            4678999999999999997 89999999999999999999999999986554321     234578899999998755 4


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         77 HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      .++.++|+||+|+++|++++|..||.+....+
T Consensus       208 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  239 (364)
T 3qyz_A          208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD  239 (364)
T ss_dssp             SCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG
T ss_pred             CCCcchhHHHHHHHHHHHHHCCCCCCCCChHH
Confidence            58999999999999999999999998766443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.91  E-value=2.1e-24  Score=150.73  Aligned_cols=100  Identities=24%  Similarity=0.396  Sum_probs=87.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC--cEEEeecccccccccc---------cccCCCCccceeCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG--EIKICDFGVSGQLIDS---------MANSFVGTRSYMSPE   71 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~--~~~l~d~g~~~~~~~~---------~~~~~~~~~~~~~Pe   71 (131)
                      +++.++.|++.||+|||+. +++|+||+|.||+++.++  .++++|||+++.....         ......++..|+|||
T Consensus       152 ~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  230 (345)
T 2v62_A          152 TVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLD  230 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHH
Confidence            5678999999999999997 899999999999999877  8999999998654321         113456888999999


Q ss_pred             cccCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         72 RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        72 ~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      .+.+..++.++|+||||+++|++++|..||..
T Consensus       231 ~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          231 AHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             HHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             HhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            99988899999999999999999999999954

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.91  E-value=1.8e-24  Score=156.17  Aligned_cols=111  Identities=26%  Similarity=0.493  Sum_probs=94.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||.|||++ +++||||++.||+++.++.++++|||+++.....   ......++..|+|||.+....++
T Consensus       285 ~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  363 (454)
T 1qcf_A          285 KLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT  363 (454)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCC
Confidence            4667999999999999997 7999999999999999999999999998765332   12233456789999999888899


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      .++|+||||+++|++++ |..||.+....++.+.+.
T Consensus       364 ~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~  399 (454)
T 1qcf_A          364 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE  399 (454)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999999999999998 999999888776665543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.91  E-value=4.9e-24  Score=149.34  Aligned_cols=104  Identities=37%  Similarity=0.641  Sum_probs=89.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCccccc---CCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQ---GTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~   79 (131)
                      ++..++.|++.||.|||+. +++|+||+|.||+++.++.++++|||++......  ....+++.|+|||.+.   ...++
T Consensus       155 ~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~  231 (348)
T 1u5q_A          155 EIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--NSFVGTPYWMAPEVILAMDEGQYD  231 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--CCCCSCGGGCCHHHHHTTSSCCBC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--CcccCCcceeCHhhhccccCCCCC
Confidence            4678999999999999997 8999999999999999999999999998655432  3457889999999984   45688


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      .++|+||||+++|++++|..||......+.
T Consensus       232 ~~~DiwslG~il~ell~g~~p~~~~~~~~~  261 (348)
T 1u5q_A          232 GKVDVWSLGITCIELAERKPPLFNMNAMSA  261 (348)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            999999999999999999999987665433

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.91  E-value=3.8e-24  Score=151.19  Aligned_cols=108  Identities=25%  Similarity=0.409  Sum_probs=91.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEe--cCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN--SGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~--~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||+|||+. +++|+||+|.||++.  .++.++++|||++...... ......+++.|+|||.+.+..++
T Consensus       188 ~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  266 (373)
T 2x4f_A          188 DTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVS  266 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCC
Confidence            4567899999999999997 899999999999994  5678999999998765432 23445688999999999888899


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      .++|+||||+++|+|++|..||...+..+...
T Consensus       267 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~  298 (373)
T 2x4f_A          267 FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN  298 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999999999998777654443

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.91  E-value=1.3e-24  Score=153.57  Aligned_cols=112  Identities=29%  Similarity=0.424  Sum_probs=94.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccc----cCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||+|||++ +++||||+|.||+++.++.++++|||+++.......    ....++..|+|||.+.+..+
T Consensus       214 ~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  292 (377)
T 3cbl_A          214 TLLQMVGDAAAGMEYLESK-CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY  292 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEE
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCC
Confidence            4678999999999999997 899999999999999999999999999865433211    11224567999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      +.++|+||||+++||+++ |..||......+..+.+..
T Consensus       293 ~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~  330 (377)
T 3cbl_A          293 SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK  330 (377)
T ss_dssp             EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999999999998 9999998887777666544

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.91  E-value=4.8e-24  Score=147.32  Aligned_cols=105  Identities=34%  Similarity=0.529  Sum_probs=92.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-ccccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.||.|||+. |++|+||++.||+++.++.++++|||.+..... .......++..|++||.+.+..++.+
T Consensus       121 ~~~~~~~qi~~~l~~lH~~-gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  199 (326)
T 1blx_A          121 TIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP  199 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceeccCCHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcc
Confidence            4678999999999999997 899999999999999999999999999865543 23345567889999999988889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      +|+||+|+++|++++|..||......+
T Consensus       200 ~Di~slG~il~~l~~g~~pf~~~~~~~  226 (326)
T 1blx_A          200 VDLWSVGCIFAEMFRRKPLFRGSSDVD  226 (326)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             hhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence            999999999999999999998776543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.91  E-value=1.5e-24  Score=154.32  Aligned_cols=102  Identities=33%  Similarity=0.543  Sum_probs=82.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEE----ecCCcEEEeecccccccccc-----cccCCCCccceeCcccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILV----NSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERL   73 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~----~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~   73 (131)
                      +++.++.|++.||.|||++ +++||||+|.||++    +.++.++++|||++......     ......+++.|+|||.+
T Consensus       129 ~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~  207 (405)
T 3rgf_A          129 MVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL  207 (405)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhh
Confidence            4678999999999999997 89999999999999    66789999999998755321     22345678899999999


Q ss_pred             cCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         74 QGT-HYSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        74 ~~~-~~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      .+. .++.++|+||+|+++|+|++|..||....
T Consensus       208 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          208 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             TTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             cCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            874 48999999999999999999999997554

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.91  E-value=2.2e-24  Score=152.32  Aligned_cols=102  Identities=38%  Similarity=0.548  Sum_probs=88.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC------------------------------------------
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG------------------------------------------   40 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~------------------------------------------   40 (131)
                      +++.++.|++.||.|||++.|++||||+|.||+++.++                                          
T Consensus       147 ~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (397)
T 1wak_A          147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLE  226 (397)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTS
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccc
Confidence            46789999999999999853799999999999998765                                          


Q ss_pred             -------cEEEeecccccccccccccCCCCccceeCcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         41 -------EIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        41 -------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                             .++++|||.+...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus       227 ~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  297 (397)
T 1wak_A          227 PKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS  297 (397)
T ss_dssp             GGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             cccccccceEecccccccccccc-CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence                   7999999998665432 334578899999999998889999999999999999999999997544

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.91  E-value=1.7e-24  Score=149.65  Aligned_cols=110  Identities=21%  Similarity=0.416  Sum_probs=87.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||+|||++ |++|+||+|.||+++.++.++++|||++.......    .....+++.|++||.+.+..+
T Consensus       138 ~~~~i~~qi~~al~~LH~~-~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  216 (323)
T 3qup_A          138 TLVRFMVDIACGMEYLSSR-NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY  216 (323)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHHcC-CcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCC
Confidence            4678999999999999997 89999999999999999999999999986543321    123345668999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      +.++|+||+|+++|++++ |..||......+..+.+
T Consensus       217 ~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~  252 (323)
T 3qup_A          217 TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL  252 (323)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred             CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence            999999999999999999 99999887766655544

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.91  E-value=1.6e-24  Score=156.23  Aligned_cols=110  Identities=26%  Similarity=0.458  Sum_probs=91.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      ++..++.|++.||+|||++ +++||||++.||+++.++.++++|||+++...... ....++..|+|||.+.+..++.++
T Consensus       290 ~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~s  367 (450)
T 1k9a_A          290 CLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALREKKFSTKS  367 (450)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTSCEEECCCTTCEECC-------CCCTTTSCHHHHHSSCCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-cCCCCCcceeCHHHhcCCCCCcHH
Confidence            4678999999999999997 89999999999999999999999999987543321 223556789999999988899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         83 DIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        83 d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      |+||||+++|++++ |..||......++.+.+.
T Consensus       368 DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~  400 (450)
T 1k9a_A          368 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE  400 (450)
T ss_dssp             HHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999999999998 999998777665555543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.91  E-value=6e-24  Score=146.99  Aligned_cols=110  Identities=27%  Similarity=0.473  Sum_probs=94.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC----cEEEeecccccccccc-cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG----EIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~----~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||.|||+. |++|+||+|.||+++.++    .++++|||++...... ......+++.|+|||.+.+..
T Consensus       116 ~~~~i~~qi~~aL~~lH~~-~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  194 (321)
T 2a2a_A          116 EATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP  194 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCC
Confidence            4678999999999999997 899999999999999877    7999999998765432 234456888999999998888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++.++|+||+|+++|++++|..||......+....+
T Consensus       195 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i  230 (321)
T 2a2a_A          195 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANI  230 (321)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred             CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999999877766555443

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.91  E-value=2.1e-24  Score=149.84  Aligned_cols=112  Identities=27%  Similarity=0.360  Sum_probs=92.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-----ccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||.|||+. +++|+||+|.||+++.++.++++|||++.......     .....++..|+|||.+.+..
T Consensus       152 ~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  230 (325)
T 3kul_A          152 QLVGMLRGVGAGMRYLSDL-GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT  230 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCE
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCC
Confidence            5678999999999999997 89999999999999999999999999987553321     12223456799999998888


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      ++.++|+||+|+++|++++ |..||......++...+..
T Consensus       231 ~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~  269 (325)
T 3kul_A          231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE  269 (325)
T ss_dssp             ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred             CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence            9999999999999999998 9999988887766665543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.91  E-value=3.9e-24  Score=148.41  Aligned_cols=108  Identities=31%  Similarity=0.526  Sum_probs=90.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec---CCcEEEeecccccccccc-cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~---~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||+|||++ |++|+||+|.||+++.   ++.++++|||++...... ......+++.|+|||.+.+..+
T Consensus       132 ~~~~i~~ql~~~L~~LH~~-givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  210 (327)
T 3lm5_A          132 DVIRLIKQILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPI  210 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCC
Confidence            4678999999999999997 8999999999999987   788999999998765432 2344578899999999998889


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      +.++|+||+|+++|++++|..||...+..+...
T Consensus       211 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  243 (327)
T 3lm5_A          211 TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL  243 (327)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Confidence            999999999999999999999998777665443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=5.2e-24  Score=148.23  Aligned_cols=107  Identities=31%  Similarity=0.556  Sum_probs=87.9

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC--cEEEeecccccccccc------cccCCCCccceeCcccccC
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG--EIKICDFGVSGQLIDS------MANSFVGTRSYMSPERLQG   75 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~--~~~l~d~g~~~~~~~~------~~~~~~~~~~~~~Pe~~~~   75 (131)
                      ++.++.|++.||.|||++ +++|+||+|.||+++.++  .++++|||++......      ......+++.|+|||.+.+
T Consensus       170 ~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  248 (345)
T 3hko_A          170 ISNIMRQIFSALHYLHNQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT  248 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred             HHHHHHHHHHHHHHHHHC-CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence            567999999999999998 899999999999998766  7999999998654321      1234568889999999975


Q ss_pred             --CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         76 --THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        76 --~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                        ..++.++|+||||+++|++++|..||......+...
T Consensus       249 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  286 (345)
T 3hko_A          249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTIS  286 (345)
T ss_dssp             SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHH
Confidence              568899999999999999999999998777654444

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.91  E-value=3e-24  Score=152.46  Aligned_cols=109  Identities=25%  Similarity=0.434  Sum_probs=92.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec--CCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS--GGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~--~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||.|||+. |++|+||+|.||+++.  ++.++++|||++...... ......+++.|+|||.+.+..++
T Consensus       150 ~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  228 (387)
T 1kob_A          150 EVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG  228 (387)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCC
Confidence            5678999999999999997 8999999999999974  467999999998765432 22344688899999999988899


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      .++|+||+|+++|+|++|..||...+..+....
T Consensus       229 ~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~  261 (387)
T 1kob_A          229 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN  261 (387)
T ss_dssp             HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH
T ss_pred             CcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999999999999987776544443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.91  E-value=3.4e-24  Score=155.68  Aligned_cols=110  Identities=31%  Similarity=0.560  Sum_probs=93.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-ccccCCCCccceeCcccccCCCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHY-SV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~-~~   80 (131)
                      +++.++.|++.||.|||+. +++||||+|.||+++.++.++++|||++..... .......+++.|+|||.+.+..+ +.
T Consensus       117 ~~~~i~~qi~~aL~~LH~~-givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  195 (476)
T 2y94_A          117 ESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP  195 (476)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCCcccccHHHEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCC
Confidence            4678999999999999997 899999999999999999999999999876543 23345678999999999988665 68


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|+++|++++|..||.......+.+.+
T Consensus       196 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i  228 (476)
T 2y94_A          196 EVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI  228 (476)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH
T ss_pred             cceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999877655554433

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=5.6e-24  Score=148.64  Aligned_cols=106  Identities=32%  Similarity=0.569  Sum_probs=90.9

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCC-CC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGT-HY   78 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~-~~   78 (131)
                      .++..++.|++.||.|||+. |++|+||++.||+++.++.++++|||++.....  .......+++.|+|||.+.+. .+
T Consensus       112 ~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  190 (346)
T 1ua2_A          112 SHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY  190 (346)
T ss_dssp             SHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCC
T ss_pred             HHHHHHHHHHHHHHHHHHHC-CEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCC
Confidence            35788999999999999997 899999999999999999999999999876532  223445678899999999764 47


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      +.++|+||+|+++|++++|..||.+....+
T Consensus       191 ~~~~DiwslG~il~ell~g~~~~~~~~~~~  220 (346)
T 1ua2_A          191 GVGVDMWAVGCILAELLLRVPFLPGDSDLD  220 (346)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             CchhhhHhHHHHHHHHHHCCCCCCCCCHHH
Confidence            899999999999999999999998776543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.90  E-value=1.1e-23  Score=143.63  Aligned_cols=111  Identities=32%  Similarity=0.570  Sum_probs=92.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCC--cEecCCCCCcEEEe-cCCcEEEeecccccccccccccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHA--IIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~--~~h~~l~~~~il~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +++.++.|++.||.|||+. +  ++|+||+|.||+++ .++.++++|||++............+++.|+|||.+.+ .++
T Consensus       130 ~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~  207 (290)
T 1t4h_A          130 VLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYD  207 (290)
T ss_dssp             HHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCC
T ss_pred             HHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccccccccCCcCcCCHHHHhc-cCC
Confidence            4678999999999999997 7  99999999999998 78899999999986555444455678889999998864 589


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPP-PDAKTLAAIFGP  115 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~-~~~~~~~~~~~~  115 (131)
                      .++|+||+|++++++++|..||.. .......+.+..
T Consensus       208 ~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  244 (290)
T 1t4h_A          208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS  244 (290)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred             CcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc
Confidence            999999999999999999999976 344444444433

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.90  E-value=4.7e-24  Score=150.34  Aligned_cols=104  Identities=37%  Similarity=0.640  Sum_probs=87.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccC-CCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~   81 (131)
                      ++..++.|++.||+|||+. |++|+||+|.||+++.++.++++|||++...... .....+++.|+|||.+.+ ..++.+
T Consensus       145 ~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~  222 (371)
T 4exu_A          145 KIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-MTGYVVTRWYRAPEVILSWMHYNQT  222 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECSTTCC---------CTTCCCTTSCHHHHSCCSCCCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCcCCCcCHHHeEECCCCCEEEEecCcccccccC-cCCcccCccccCHHHhcCCCCCCcH
Confidence            4678999999999999997 8999999999999999999999999998755432 334567889999999877 678999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      +|+||+|++++++++|..||.+.+..+
T Consensus       223 ~DiwslG~il~el~~g~~pf~~~~~~~  249 (371)
T 4exu_A          223 VDIWSVGCIMAEMLTGKTLFKGKDYLD  249 (371)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             HhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            999999999999999999998776543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.90  E-value=2.9e-24  Score=150.31  Aligned_cols=101  Identities=23%  Similarity=0.382  Sum_probs=88.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC--cEEEeeccccccccccc---------ccCCCCccceeCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG--EIKICDFGVSGQLIDSM---------ANSFVGTRSYMSPE   71 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~--~~~l~d~g~~~~~~~~~---------~~~~~~~~~~~~Pe   71 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++  .++++|||++.......         .....+++.|+|||
T Consensus       160 ~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  238 (352)
T 2jii_A          160 SVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMD  238 (352)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHH
Confidence            5678999999999999998 899999999999999888  89999999986543221         12346888999999


Q ss_pred             cccCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         72 RLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        72 ~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      .+.+..++.++|+||||+++|++++|..||...
T Consensus       239 ~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          239 LHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             HHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            999888999999999999999999999999754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.90  E-value=2.8e-24  Score=147.70  Aligned_cols=113  Identities=31%  Similarity=0.518  Sum_probs=95.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++.++++|||++......    ......+++.|++||.+.+..+
T Consensus       151 ~~~~i~~qi~~~l~~lH~~-~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  229 (314)
T 2ivs_A          151 DLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY  229 (314)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc
Confidence            4678999999999999997 8999999999999999999999999998654321    1223345678999999988888


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  116 (131)
                      +.++|+||+|+++|++++ |..||.....+.+.+.+...
T Consensus       230 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  268 (314)
T 2ivs_A          230 TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG  268 (314)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcC
Confidence            999999999999999999 99999888777666655443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.90  E-value=7.6e-24  Score=143.83  Aligned_cols=110  Identities=34%  Similarity=0.585  Sum_probs=93.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCc---EEEeecccccccccc-cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~---~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++.   ++++|||.+...... ......+++.|+|||.+.+..+
T Consensus       106 ~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  184 (284)
T 3kk8_A          106 DASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY  184 (284)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCB
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCC
Confidence            4678999999999999997 8999999999999986555   999999998655432 2334578889999999998889


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      +.++|+||+|++++++++|..||...........+
T Consensus       185 ~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  219 (284)
T 3kk8_A          185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI  219 (284)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH
Confidence            99999999999999999999999887766655544

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.90  E-value=7.2e-24  Score=148.26  Aligned_cols=106  Identities=32%  Similarity=0.610  Sum_probs=90.2

Q ss_pred             chhHHHHHHHHHHHHHH--hcCCcEecCCCCCcEEEec-CCcEEEeecccccccccc-cccCCCCccceeCcccccCCC-
Q psy17559          3 QVPYSSFQVLKGLTYLR--EKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH-   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh--~~~~~~h~~l~~~~il~~~-~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~-   77 (131)
                      .+..++.|++.|+.|||  +. |++|+||+|.||+++. ++.++++|||++...... ......+++.|+|||.+.+.. 
T Consensus       130 ~~~~~~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  208 (360)
T 3e3p_A          130 LIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQH  208 (360)
T ss_dssp             HHHHHHHHHHHHHHHHTSTTT-CCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSS
T ss_pred             HHHHHHHHHHHHHHHHhCCCC-CeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCC
Confidence            35678999999999999  76 8999999999999996 899999999998765432 233456788999999987654 


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      ++.++|+||+|+++|++++|..||...+....
T Consensus       209 ~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  240 (360)
T 3e3p_A          209 YTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ  240 (360)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH
Confidence            89999999999999999999999987775533

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.90  E-value=2.7e-24  Score=155.11  Aligned_cols=93  Identities=32%  Similarity=0.616  Sum_probs=77.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--------------------------
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--------------------------   56 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--------------------------   56 (131)
                      +++.++.|++.||.|||+. +++||||+|.||+++.++.++++|||+++.....                          
T Consensus       157 ~~~~~~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (458)
T 3rp9_A          157 HIKTLLYNLLVGVKYVHSA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKN  235 (458)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC------------------
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCcccccccccccccccc
Confidence            4678999999999999997 8999999999999999999999999998654311                          


Q ss_pred             ---cccCCCCccceeCcccc-cCCCCCCcchHHHHHHHHHHHHh
Q psy17559         57 ---MANSFVGTRSYMSPERL-QGTHYSVQSDIWSLGLSLVEMAI   96 (131)
Q Consensus        57 ---~~~~~~~~~~~~~Pe~~-~~~~~~~~~d~~slg~~l~~l~~   96 (131)
                         ......+++.|+|||++ ....++.++|+||+||++|||++
T Consensus       236 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          236 LKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             ---------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             ccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence               11234568899999986 45668999999999999999998

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.90  E-value=5.9e-24  Score=147.49  Aligned_cols=102  Identities=32%  Similarity=0.616  Sum_probs=88.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc----ccccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      +++.++.|++.||.|||+. |++|+||++.||+++.++.++++|||++.....    .......+++.|+|||.+.+..+
T Consensus       106 ~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  184 (323)
T 3tki_A          106 DAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF  184 (323)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSB
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCC
Confidence            5678999999999999997 899999999999999999999999999865432    12335578899999999987665


Q ss_pred             -CCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         79 -SVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        79 -~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                       +.++|+||+|+++|++++|..||....
T Consensus       185 ~~~~~DiwslG~il~~ll~g~~pf~~~~  212 (323)
T 3tki_A          185 HAEPVDVWSCGIVLTAMLAGELPWDQPS  212 (323)
T ss_dssp             CHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred             CCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence             778999999999999999999997544

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.90  E-value=2.7e-24  Score=147.59  Aligned_cols=110  Identities=32%  Similarity=0.517  Sum_probs=93.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEE---ecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILV---NSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||.|||++ |++|+||++.||++   +.++.++++|||.+............+++.|+|||.+.+..++
T Consensus       107 ~~~~~~~qi~~~l~~lH~~-~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  185 (304)
T 2jam_A          107 DASLVIQQVLSAVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYS  185 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccccccCCCCccChHHhccCCCC
Confidence            4678999999999999997 89999999999999   6788899999999865444333344578899999999988899


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||+|+++|++++|..||......+..+.+
T Consensus       186 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i  219 (304)
T 2jam_A          186 KAVDCWSIGVITYILLCGYPPFYEETESKLFEKI  219 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            9999999999999999999999877766554443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.90  E-value=4.2e-24  Score=147.37  Aligned_cols=98  Identities=36%  Similarity=0.519  Sum_probs=83.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      +++.++.|++.||.|||+. +++|+||+|.||+++.++.++++|||++...... ......+++.|+|||.+.+ .++.+
T Consensus       158 ~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~  235 (311)
T 3p1a_A          158 QVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTA  235 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCch
Confidence            4678999999999999997 8999999999999999999999999998655432 3344568899999999876 68999


Q ss_pred             chHHHHHHHHHHHHhCCCCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~  102 (131)
                      +|+||+|+++|++++|..|+.
T Consensus       236 ~DiwslG~il~el~~g~~~~~  256 (311)
T 3p1a_A          236 ADVFSLGLTILEVACNMELPH  256 (311)
T ss_dssp             HHHHHHHHHHHHHHHTCCCCS
T ss_pred             hhHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999966654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.90  E-value=2.4e-24  Score=146.40  Aligned_cols=110  Identities=27%  Similarity=0.498  Sum_probs=84.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---ccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||.|||++ |++|+||+|.||+++.++.++++|||++.......   .....+++.|+|||.+....++
T Consensus       117 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  195 (281)
T 1mp8_A          117 SLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT  195 (281)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCS
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCC
Confidence            4678899999999999997 89999999999999999999999999986553321   2233456689999999888899


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||+|+++|++++ |..||......+....+
T Consensus       196 ~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i  230 (281)
T 1mp8_A          196 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI  230 (281)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred             CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH
Confidence            99999999999999996 99999877766555544

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.90  E-value=2.1e-24  Score=152.09  Aligned_cols=113  Identities=25%  Similarity=0.452  Sum_probs=94.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC---cEEEeecccccccccc----cccCCCCccceeCcccccC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG---EIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQG   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~---~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~   75 (131)
                      +++.++.|++.||.|||++ |++||||+|.||+++.++   .++++|||+++.....    ......+++.|+|||.+.+
T Consensus       182 ~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  260 (367)
T 3l9p_A          182 DLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME  260 (367)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC
Confidence            4678999999999999997 899999999999999554   4999999998654221    2233456778999999988


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCC
Q psy17559         76 THYSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  116 (131)
                      ..++.++|+||||+++|++++ |..||......++.+.+...
T Consensus       261 ~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          261 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            889999999999999999998 99999988887777665443

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.90  E-value=3.8e-24  Score=144.51  Aligned_cols=112  Identities=28%  Similarity=0.463  Sum_probs=94.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++.++++|||.+......   ......++..|+|||.+.+..++
T Consensus       107 ~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  185 (269)
T 4hcu_A          107 TLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS  185 (269)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCC
Confidence            4678999999999999997 8999999999999999999999999998655332   22334456689999999888899


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      .++|+||+|++++++++ |..||......+..+.+..
T Consensus       186 ~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~  222 (269)
T 4hcu_A          186 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST  222 (269)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred             chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Confidence            99999999999999999 9999998887766665543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.90  E-value=1.1e-23  Score=142.69  Aligned_cols=109  Identities=28%  Similarity=0.533  Sum_probs=92.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEE---ecCCcEEEeeccccccccc-ccccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILV---NSGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~---~~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||+|||++ |++|+||+|.||++   +.++.++++|||.+..... .......+++.|+|||.+.+. +
T Consensus       107 ~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~  184 (277)
T 3f3z_A          107 DAARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-Y  184 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-B
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc-C
Confidence            4678999999999999997 89999999999999   7788999999999865543 233455788899999998664 8


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      +.++|+||+|++++++++|..||......+....+
T Consensus       185 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  219 (277)
T 3f3z_A          185 GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI  219 (277)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99999999999999999999999877766554433

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.90  E-value=7.3e-24  Score=148.25  Aligned_cols=104  Identities=37%  Similarity=0.640  Sum_probs=87.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccC-CCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~   81 (131)
                      ++..++.|++.||.|||++ |++|+||+|.||+++.++.++++|||.+...... .....+++.|+|||.+.+ ..++.+
T Consensus       127 ~~~~i~~qi~~al~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~  204 (353)
T 3coi_A          127 KIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-MTGYVVTRWYRAPEVILSWMHYNQT  204 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTCCEEECSTTCTTC---------CCSBCCSCHHHHSCCSCCCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEeECCCCcEEEeecccccCCCCC-ccccccCcCcCCHHHHhCcCCCCch
Confidence            4678999999999999997 8999999999999999999999999998654332 234567889999999876 578999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      +|+||+|++++++++|..||.+.+..+
T Consensus       205 ~Di~slG~il~el~~g~~pf~~~~~~~  231 (353)
T 3coi_A          205 VDIWSVGCIMAEMLTGKTLFKGKDYLD  231 (353)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSBSSCHHH
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999999999999999999998776543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.90  E-value=3.3e-24  Score=149.43  Aligned_cols=100  Identities=35%  Similarity=0.590  Sum_probs=87.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY-SV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~-~~   80 (131)
                      .+..++.|++.||.|||++ +++|+||+|.||+++.++.++++|||++...... ......+++.|+|||.+.+..+ +.
T Consensus       131 ~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  209 (335)
T 3dls_A          131 LASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGP  209 (335)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEEeccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCC
Confidence            4678999999999999997 8999999999999999999999999998755432 2334568899999999988766 78


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      ++|+||+|+++|++++|..||..
T Consensus       210 ~~DiwslG~il~el~~g~~pf~~  232 (335)
T 3dls_A          210 ELEMWSLGVTLYTLVFEENPFCE  232 (335)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             cccchhHHHHHHHHHhCCCchhh
Confidence            89999999999999999999964

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.90  E-value=4.3e-24  Score=144.11  Aligned_cols=110  Identities=25%  Similarity=0.427  Sum_probs=92.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---ccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||.|||+. |++|+||+|.||+++.++.++++|||.+.......   .....++..|+|||.+.+..++
T Consensus       105 ~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  183 (268)
T 3sxs_A          105 QLLEMCYDVCEGMAFLESH-QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS  183 (268)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEE
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCc
Confidence            5678999999999999997 89999999999999999999999999986543321   2233445679999999888899


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||+|++++++++ |..||......+.....
T Consensus       184 ~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  218 (268)
T 3sxs_A          184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV  218 (268)
T ss_dssp             TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH
Confidence            99999999999999998 99999887776655544

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.90  E-value=7e-24  Score=145.75  Aligned_cols=107  Identities=35%  Similarity=0.574  Sum_probs=86.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccC-CCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQG-THYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~   79 (131)
                      ++..++.|++.||.|||++ |++|+||+|.||+++.++.++++|||.+......  ......++..|+|||.+.+ ..++
T Consensus       103 ~~~~i~~~l~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  181 (311)
T 4agu_A          103 LVKSITWQTLQAVNFCHKH-NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYG  181 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCC
Confidence            4678999999999999997 8999999999999999999999999998655422  2234567889999999976 5679


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLA  110 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~  110 (131)
                      .++|+||+|++++++++|..||......+..
T Consensus       182 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  212 (311)
T 4agu_A          182 PPVDVWAIGCVFAELLSGVPLWPGKSDVDQL  212 (311)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999999999999999999999877765443

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.90  E-value=6e-24  Score=144.39  Aligned_cols=112  Identities=29%  Similarity=0.435  Sum_probs=94.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.+|.|||++ +++|+||+|.||+++.++.++++|||.+......   ......+++.|++||.+.+..++
T Consensus       121 ~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  199 (283)
T 3gen_A          121 QLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS  199 (283)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCC
Confidence            4678999999999999997 8999999999999999999999999998655332   12233456789999999888899


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      .++|+||+|+++|++++ |..||......+..+.+..
T Consensus       200 ~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~  236 (283)
T 3gen_A          200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ  236 (283)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred             chhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc
Confidence            99999999999999998 9999998887766655543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.90  E-value=3.1e-24  Score=148.97  Aligned_cols=102  Identities=30%  Similarity=0.518  Sum_probs=70.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC---cEEEeeccccccccc--ccccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG---EIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~---~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++   .++++|||++.....  .......+++.|+|||.+.+..
T Consensus       107 ~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  185 (325)
T 3kn6_A          107 EASYIMRKLVSAVSHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG  185 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCC
Confidence            4678999999999999997 899999999999998665   799999999865432  2234456788999999999888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ++.++|+||+|+++|++++|..||...+
T Consensus       186 ~~~~~DiwslG~il~~ll~g~~pf~~~~  213 (325)
T 3kn6_A          186 YDESCDLWSLGVILYTMLSGQVPFQSHD  213 (325)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred             CCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence            9999999999999999999999997543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.90  E-value=2.9e-24  Score=149.32  Aligned_cols=112  Identities=27%  Similarity=0.434  Sum_probs=93.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++|+||++.||+++.++.++++|||++......    ......+++.|+|||.+.+..+
T Consensus       175 ~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  253 (343)
T 1luf_A          175 EQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY  253 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc
Confidence            4567999999999999997 8999999999999999999999999998654322    1223456778999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      +.++|+||||+++|++++ |..||......+....+..
T Consensus       254 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  291 (343)
T 1luf_A          254 TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD  291 (343)
T ss_dssp             CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred             CcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhC
Confidence            999999999999999998 9999998887766655433

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.90  E-value=7.9e-24  Score=150.27  Aligned_cols=110  Identities=32%  Similarity=0.542  Sum_probs=87.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccC---
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQG---   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~---   75 (131)
                      ++..++.|++.||.|||+. +++||||+|.||+++ ++.++++|||++......    ......+++.|+|||.+.+   
T Consensus       156 ~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  233 (390)
T 2zmd_A          156 ERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS  233 (390)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC--
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccc
Confidence            4678999999999999997 899999999999995 578999999998765432    2235578999999999865   


Q ss_pred             --------CCCCCcchHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHhC
Q psy17559         76 --------THYSVQSDIWSLGLSLVEMAIGMYPIPPPD--AKTLAAIFG  114 (131)
Q Consensus        76 --------~~~~~~~d~~slg~~l~~l~~g~~p~~~~~--~~~~~~~~~  114 (131)
                              ..++.++|+||||+++|+|++|..||....  ...+...+.
T Consensus       234 ~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~  282 (390)
T 2zmd_A          234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  282 (390)
T ss_dssp             ----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred             cccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence                    357889999999999999999999997543  234444443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.90  E-value=1.5e-23  Score=143.23  Aligned_cols=109  Identities=29%  Similarity=0.495  Sum_probs=93.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.|||++ |++|+||++.||+++.++.++++|||.+.....  .......++..|++||.+.+..++.
T Consensus       116 ~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  194 (294)
T 2rku_A          116 EARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF  194 (294)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCc
Confidence            4678999999999999997 899999999999999999999999999865432  2233456788999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAI  112 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~  112 (131)
                      ++|+||+|++++++++|..||......+....
T Consensus       195 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  226 (294)
T 2rku_A          195 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLR  226 (294)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999999999987776554443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.90  E-value=5e-24  Score=147.31  Aligned_cols=101  Identities=34%  Similarity=0.483  Sum_probs=87.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ |++|+||+|.||+++.++.++++|||++......    ......+++.|+|||.+.+..+
T Consensus       140 ~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  218 (321)
T 2qkw_B          140 QRLEICIGAARGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRL  218 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBC
T ss_pred             HHHHHHHHHHHHHHHhcCC-CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCC
Confidence            4678999999999999997 8999999999999999999999999998653321    1223457889999999988889


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      +.++|+||+|+++|++++|+.||...
T Consensus       219 ~~~~Di~slG~il~ell~g~~p~~~~  244 (321)
T 2qkw_B          219 TEKSDVYSFGVVLFEVLCARSAIVQS  244 (321)
T ss_dssp             CTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred             CcccchHhHHHHHHHHHhCCCccccc
Confidence            99999999999999999999999643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.90  E-value=5.9e-24  Score=148.34  Aligned_cols=100  Identities=33%  Similarity=0.582  Sum_probs=81.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccC---
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQG---   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~---   75 (131)
                      ++..++.|++.||.|||+. +++||||+|.||+++ ++.++++|||++......    ......+++.|+|||.+.+   
T Consensus       109 ~~~~i~~qi~~al~~lH~~-~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  186 (343)
T 3dbq_A          109 ERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS  186 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccc
Confidence            4678999999999999997 899999999999997 678999999998765432    1234578999999999864   


Q ss_pred             --------CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         76 --------THYSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        76 --------~~~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                              ..++.++|+||+|+++|+|++|..||...
T Consensus       187 ~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  223 (343)
T 3dbq_A          187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  223 (343)
T ss_dssp             ----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             cccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence                    56788999999999999999999999754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.90  E-value=1.2e-23  Score=146.38  Aligned_cols=108  Identities=30%  Similarity=0.507  Sum_probs=93.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.+|.|||++ +++|+||++.||+++.++.++++|||++.....  .......++..|++||.+.+..++.
T Consensus       142 ~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  220 (335)
T 2owb_A          142 EARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF  220 (335)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCc
Confidence            4678999999999999997 899999999999999999999999999865432  2234456788999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      ++|+||||+++|++++|..||......+...
T Consensus       221 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  251 (335)
T 2owb_A          221 EVDVWSIGCIMYTLLVGKPPFETSCLKETYL  251 (335)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             hhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH
Confidence            9999999999999999999998776554433

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.90  E-value=4.7e-24  Score=149.39  Aligned_cols=104  Identities=32%  Similarity=0.606  Sum_probs=81.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec---CCcEEEeecccccccccc-cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~---~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||+. +++|+||+|.||+++.   ++.++++|||++...... ......+++.|+|||.+.+..+
T Consensus       149 ~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  227 (349)
T 2w4o_A          149 DAADAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY  227 (349)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCC
Confidence            4678999999999999997 8999999999999975   788999999998755332 2344568889999999998889


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +.++|+||||+++|++++|..||......
T Consensus       228 ~~~~DiwslG~il~ell~g~~pf~~~~~~  256 (349)
T 2w4o_A          228 GPEVDMWSVGIITYILLCGFEPFYDERGD  256 (349)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCTTCCTTCH
T ss_pred             CcccchHHHHHHHHHHHhCCCCCCCCccc
Confidence            99999999999999999999999755543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.90  E-value=4.8e-24  Score=145.52  Aligned_cols=110  Identities=29%  Similarity=0.549  Sum_probs=83.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc----ccccCCCCccceeCccccc---C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTRSYMSPERLQ---G   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~~~~~~Pe~~~---~   75 (131)
                      ++..++.|++.+|.|||+. +++|+||++.||+++.++.++++|||++.....    .......+++.|++||.+.   .
T Consensus       121 ~~~~i~~qi~~~L~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  199 (289)
T 3og7_A          121 KLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS  199 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCC
Confidence            4678999999999999997 899999999999999999999999999864432    1223456788999999986   4


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHh
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPD-AKTLAAIF  113 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~-~~~~~~~~  113 (131)
                      ..++.++|+||+|++++++++|..||.... .+.+.+.+
T Consensus       200 ~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  238 (289)
T 3og7_A          200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV  238 (289)
T ss_dssp             CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH
T ss_pred             CCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHh
Confidence            567889999999999999999999997644 33444433

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.90  E-value=1.3e-23  Score=147.94  Aligned_cols=110  Identities=27%  Similarity=0.514  Sum_probs=92.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-ccccCCCCccceeCcccccC------
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQG------   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~------   75 (131)
                      .+..++.|++.||.|||+. |++|+||+|.||+++.++.++++|||++..... .......+++.|+|||.+.+      
T Consensus       201 ~~~~i~~qi~~~L~~LH~~-gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  279 (365)
T 2y7j_A          201 ETRSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETH  279 (365)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTS
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccC
Confidence            4678999999999999997 899999999999999999999999998865543 23345678899999999853      


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ..++.++|+||||+++|++++|..||.........+.+
T Consensus       280 ~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i  317 (365)
T 2y7j_A          280 PGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI  317 (365)
T ss_dssp             CCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            35788999999999999999999999877665554443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.90  E-value=1.8e-24  Score=151.26  Aligned_cols=102  Identities=34%  Similarity=0.618  Sum_probs=87.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++.++++|||++......    ......+++.|+|||.+.+..+
T Consensus       194 ~~~~~~~ql~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  272 (359)
T 3vhe_A          194 HLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY  272 (359)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCC
Confidence            4678999999999999997 8999999999999999999999999998654321    2234456778999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPD  105 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~  105 (131)
                      +.++|+||+|+++|++++ |..||....
T Consensus       273 ~~~~Di~slG~il~ellt~g~~p~~~~~  300 (359)
T 3vhe_A          273 TIQSDVWSFGVLLWEIFSLGASPYPGVK  300 (359)
T ss_dssp             CHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             CchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence            999999999999999998 999997655

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.90  E-value=6.4e-24  Score=146.67  Aligned_cols=100  Identities=32%  Similarity=0.626  Sum_probs=85.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEE----ecCCcEEEeecccccccccc-cccCCCCccceeCccccc---
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILV----NSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQ---   74 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~----~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~---   74 (131)
                      +++.++.|++.||+|||+. +++|+||+|.||++    +.++.++++|||++...... ......++..|+|||.+.   
T Consensus       113 ~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~  191 (319)
T 4euu_A          113 EFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV  191 (319)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhcc
Confidence            4678999999999999997 89999999999998    66677999999998765432 334456889999999985   


Q ss_pred             -----CCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         75 -----GTHYSVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        75 -----~~~~~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                           +..++.++|+||+|+++|++++|..||..
T Consensus       192 ~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  225 (319)
T 4euu_A          192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (319)
T ss_dssp             SCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             ccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                 46788999999999999999999999963

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.90  E-value=8.1e-24  Score=148.29  Aligned_cols=106  Identities=27%  Similarity=0.501  Sum_probs=84.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-ccccCCCCccceeCcccccC-CCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQG-THYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~-~~~~~   80 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++.++++|||.+..... .......+++.|+|||.+.+ ..++.
T Consensus       135 ~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  213 (362)
T 3pg1_A          135 HIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTK  213 (362)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-cCEecCCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCc
Confidence            4678999999999999997 899999999999999999999999999865432 22334567888999999876 66899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      ++|+||+|+++|++++|..||......+.
T Consensus       214 ~~DiwslG~il~~l~~g~~pf~~~~~~~~  242 (362)
T 3pg1_A          214 LVDMWSAGCVMAEMFNRKALFRGSTFYNQ  242 (362)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             HhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999999999999987765433

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.90  E-value=6.6e-24  Score=152.35  Aligned_cols=98  Identities=33%  Similarity=0.577  Sum_probs=80.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc------------------------cc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS------------------------MA   58 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~------------------------~~   58 (131)
                      +++.++.|++.||.|||+. |++||||+|.||+++.++.++++|||+++.....                        ..
T Consensus       130 ~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  208 (432)
T 3n9x_A          130 HIKTILYNLLLGENFIHES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQL  208 (432)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEEC-----------------------------
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccc
Confidence            5678999999999999998 8999999999999999999999999998754321                        12


Q ss_pred             cCCCCccceeCcccc-cCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy17559         59 NSFVGTRSYMSPERL-QGTHYSVQSDIWSLGLSLVEMAIGMYPI  101 (131)
Q Consensus        59 ~~~~~~~~~~~Pe~~-~~~~~~~~~d~~slg~~l~~l~~g~~p~  101 (131)
                      ....+++.|+|||.+ ....++.++|+||+||++|+|++|..||
T Consensus       209 ~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          209 TSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             --CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            445778899999986 4556899999999999999999854443

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.90  E-value=8.6e-24  Score=147.53  Aligned_cols=105  Identities=36%  Similarity=0.635  Sum_probs=88.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc------------cccCCCCccceeCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS------------MANSFVGTRSYMSP   70 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~------------~~~~~~~~~~~~~P   70 (131)
                      ++..++.|++.||.|||+. |++|+||++.||+++.++.++++|||++......            ......+++.|+||
T Consensus       113 ~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  191 (353)
T 2b9h_A          113 HIQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAP  191 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCC
Confidence            4678999999999999997 8999999999999999999999999998654321            11234678899999


Q ss_pred             ccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         71 ERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        71 e~~~~-~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      |.+.. ..++.++|+||+|+++|++++|..||.+.+..+
T Consensus       192 E~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  230 (353)
T 2b9h_A          192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH  230 (353)
T ss_dssp             HHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             eeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            98764 568999999999999999999999998877543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.90  E-value=3.5e-24  Score=148.29  Aligned_cols=101  Identities=34%  Similarity=0.594  Sum_probs=88.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEe-cCCcEEEeecccccccccccccCCCCccceeCcccccCCCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY-SV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~   80 (131)
                      ++..++.|++.||+|||+. +++|+||++.||+++ .++.++++|||++............+++.|+|||.+.+..+ +.
T Consensus       150 ~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  228 (320)
T 3a99_A          150 LARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR  228 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcEeCCCCHHHEEEeCCCCCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCc
Confidence            4677999999999999997 899999999999999 77899999999987665544455678899999999876655 68


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      ++|+||||+++|++++|..||...
T Consensus       229 ~~Di~slG~il~el~~g~~pf~~~  252 (320)
T 3a99_A          229 SAAVWSLGILLYDMVCGDIPFEHD  252 (320)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             cchHHhHHHHHHHHHHCCCCCCCh
Confidence            899999999999999999999643

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.90  E-value=1.5e-23  Score=143.71  Aligned_cols=110  Identities=40%  Similarity=0.721  Sum_probs=95.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.+||+. |++|+||++.||+++.++.++++|||.+......  ......++..|++||.+.+..++.
T Consensus       120 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  198 (303)
T 3a7i_A          120 QIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS  198 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCc
Confidence            4678999999999999997 8999999999999999999999999998655432  234456788999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||||++++++++|..||...........+
T Consensus       199 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  231 (303)
T 3a7i_A          199 KADIWSLGITAIELARGEPPHSELHPMKVLFLI  231 (303)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             hhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh
Confidence            999999999999999999999877766555444

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.90  E-value=7.1e-24  Score=145.92  Aligned_cols=110  Identities=22%  Similarity=0.455  Sum_probs=88.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++.++++|||++......    ......+++.|++||.+.+..+
T Consensus       148 ~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  226 (313)
T 3brb_A          148 TLLKFMVDIALGMEYLSNR-NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY  226 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCc
Confidence            5678999999999999997 8999999999999999999999999998654322    1223345678999999998889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      +.++|+||||+++|++++ |..||......+..+.+
T Consensus       227 ~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  262 (313)
T 3brb_A          227 TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL  262 (313)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence            999999999999999999 99999877766555544

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.90  E-value=2.5e-24  Score=150.00  Aligned_cols=105  Identities=27%  Similarity=0.463  Sum_probs=70.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec---CCcEEEeecccccccccccccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~---~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +++.++.|++.||.|||++ |++|+||++.||+++.   ++.++++|||++............+++.|++||.+.+..++
T Consensus       129 ~~~~i~~ql~~~l~~LH~~-~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  207 (336)
T 3fhr_A          129 EAAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYD  207 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----------------------CHHH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEEecCCCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCC
Confidence            5678999999999999998 8999999999999986   44599999999876655444556778899999999888889


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      .++|+||+|+++|++++|..||.......
T Consensus       208 ~~~Di~slG~il~~l~~g~~pf~~~~~~~  236 (336)
T 3fhr_A          208 KSCDMWSLGVIMYILLCGFPPFYSNTGQA  236 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             chhhHHHHHHHHHHHHHCCCCCCCccchh
Confidence            99999999999999999999997655443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.90  E-value=6.3e-24  Score=146.73  Aligned_cols=97  Identities=35%  Similarity=0.598  Sum_probs=84.3

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--------------cccCCCCccceeC
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--------------MANSFVGTRSYMS   69 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--------------~~~~~~~~~~~~~   69 (131)
                      ++.++.|++.||+|||++ |++|+||+|.||+++.++.++++|||++......              ......+++.|+|
T Consensus       166 ~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHHHhC-CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            678999999999999997 8999999999999999999999999998655332              1233468889999


Q ss_pred             cccccCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy17559         70 PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPI  101 (131)
Q Consensus        70 Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~  101 (131)
                      ||.+.+..++.++|+||+|+++|++++|..|+
T Consensus       245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~  276 (332)
T 3qd2_B          245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ  276 (332)
T ss_dssp             HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred             hHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence            99999888999999999999999999987765

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.90  E-value=1.2e-23  Score=146.06  Aligned_cols=105  Identities=36%  Similarity=0.653  Sum_probs=86.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      ++..++.|++.||.|||+. |++|+||+|.||+++.++.++++|||.+.....  .......++..|++||.+.+. .++
T Consensus       125 ~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  203 (331)
T 4aaa_A          125 VVQKYLFQIINGIGFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYG  203 (331)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcc
Confidence            4678999999999999997 899999999999999999999999999865432  223345678899999999775 688


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      .++|+||+|+++|++++|..||......+
T Consensus       204 ~~~Di~slG~il~~l~~g~~pf~~~~~~~  232 (331)
T 4aaa_A          204 KAVDVWAIGCLVTEMFMGEPLFPGDSDID  232 (331)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             hHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            99999999999999999999998776543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=8.2e-24  Score=144.14  Aligned_cols=112  Identities=29%  Similarity=0.415  Sum_probs=94.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||.+||+. +++|+||+|.||+++.++.++++|||++......     ......+++.|+|||.+.+..
T Consensus       111 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  189 (287)
T 1u59_A          111 NVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK  189 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCC
Confidence            4678999999999999997 8999999999999999999999999998654321     122334567899999998888


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      ++.++|+||+|+++|++++ |..||......+..+.+..
T Consensus       190 ~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~  228 (287)
T 1u59_A          190 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ  228 (287)
T ss_dssp             ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred             CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc
Confidence            8999999999999999998 9999988776666655543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.90  E-value=8.3e-24  Score=143.35  Aligned_cols=103  Identities=33%  Similarity=0.561  Sum_probs=70.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++.++++|||.+.....  .......+++.|+|||.+.+..++.
T Consensus       113 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  191 (278)
T 3cok_A          113 EARHFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGL  191 (278)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSSCCGGGEEECTTCCEEECCCTTCEECC----------------------------
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCc
Confidence            4678999999999999997 899999999999999999999999999865432  2223456788999999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      ++|+||+|++++++++|..||.....
T Consensus       192 ~~Di~slG~il~~l~~g~~p~~~~~~  217 (278)
T 3cok_A          192 ESDVWSLGCMFYTLLIGRPPFDTDTV  217 (278)
T ss_dssp             CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCChhH
Confidence            99999999999999999999976553

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.90  E-value=7.6e-24  Score=147.19  Aligned_cols=111  Identities=29%  Similarity=0.513  Sum_probs=93.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++|+||++.||+++.++.++++|||++......    ......++..|+|||.+.+..+
T Consensus       158 ~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  236 (334)
T 2pvf_A          158 DLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY  236 (334)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc
Confidence            4578899999999999997 8999999999999999999999999998654322    1223345678999999988888


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||+|+++|++++ |..||.....+++.+.+.
T Consensus       237 ~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  273 (334)
T 2pvf_A          237 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK  273 (334)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHh
Confidence            999999999999999998 999999888776665543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.90  E-value=8.9e-24  Score=145.85  Aligned_cols=111  Identities=24%  Similarity=0.430  Sum_probs=93.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ |++|+||+|.||+++.++.++++|||++......    ......+++.|+|||.+.+..+
T Consensus       139 ~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  217 (322)
T 1p4o_A          139 KMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF  217 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCC
Confidence            4567899999999999997 8999999999999999999999999998654322    1223345678999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||+|+++|++++ |..||......+..+.+.
T Consensus       218 ~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  254 (322)
T 1p4o_A          218 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  254 (322)
T ss_dssp             CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence            999999999999999999 899999888776665543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.90  E-value=6.7e-24  Score=144.10  Aligned_cols=110  Identities=28%  Similarity=0.442  Sum_probs=90.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||.|||++ |++|+||+|.||+++.++.++++|||.+......   ......++..|+|||.+.+..++
T Consensus       114 ~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  192 (281)
T 3cc6_A          114 TLVLYSLQICKAMAYLESI-NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT  192 (281)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCC
Confidence            4677899999999999997 8999999999999999999999999988655332   12234456789999999888899


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||||+++|++++ |..||......+..+.+
T Consensus       193 ~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~  227 (281)
T 3cc6_A          193 TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL  227 (281)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH
T ss_pred             chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH
Confidence            99999999999999998 99999866655554443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=5.7e-24  Score=149.22  Aligned_cols=100  Identities=33%  Similarity=0.569  Sum_probs=84.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc---ccccCCCCccceeCcccccC--CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID---SMANSFVGTRSYMSPERLQG--TH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~~~~~~Pe~~~~--~~   77 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++.++++|||+++....   .......+++.|++||.+.+  ..
T Consensus       160 ~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  238 (355)
T 1vzo_A          160 EVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG  238 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC--
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCC
Confidence            4677899999999999997 899999999999999999999999999865432   12234568899999999985  34


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      ++.++|+||||+++|++++|..||..
T Consensus       239 ~~~~~DvwslG~il~ell~g~~pf~~  264 (355)
T 1vzo_A          239 HDKAVDWWSLGVLMYELLTGASPFTV  264 (355)
T ss_dssp             -CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred             CCchhhHHHHHHHHHHHHHCCCCCcc
Confidence            78999999999999999999999963

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=4.8e-24  Score=148.48  Aligned_cols=102  Identities=33%  Similarity=0.624  Sum_probs=87.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||+. |++|+||+|.||+++.++.++++|||++.......    .....+++.|+|||.+.+..+
T Consensus       173 ~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  251 (344)
T 1rjb_A          173 DLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY  251 (344)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC
Confidence            3567999999999999997 89999999999999999999999999986553321    223345678999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPD  105 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~  105 (131)
                      +.++|+||||+++|++++ |..||....
T Consensus       252 ~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          252 TIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             CHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            999999999999999998 999997655

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.90  E-value=2.3e-23  Score=143.37  Aligned_cols=108  Identities=41%  Similarity=0.648  Sum_probs=92.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.|||+. |++|+||+|.||+++.++.++++|||.+......  ......++..|++||.+.+..++.
T Consensus       126 ~~~~i~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  204 (314)
T 3com_A          126 EIATILQSTLKGLEYLHFM-RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNC  204 (314)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCc
Confidence            4678999999999999997 8999999999999999999999999998654432  233456788999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      ++|+||+|+++|++++|..||..........
T Consensus       205 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  235 (314)
T 3com_A          205 VADIWSLGITAIEMAEGKPPYADIHPMRAIF  235 (314)
T ss_dssp             THHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            9999999999999999999998766554433

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=1.6e-23  Score=142.97  Aligned_cols=111  Identities=26%  Similarity=0.476  Sum_probs=91.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc------cccCCCCccceeCcccccCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS------MANSFVGTRSYMSPERLQGT   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~   76 (131)
                      ++..++.|++.||+|||+. |++|+||+|.||+++.++.++++|||.+......      ......++..|++||.+.+.
T Consensus       125 ~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  203 (298)
T 3pls_A          125 DLISFGLQVARGMEYLAEQ-KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY  203 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccC
Confidence            4678999999999999997 8999999999999999999999999998654321      22334567789999999988


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         77 HYSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      .++.++|+||+|+++|++++ +..||...+..+....+.
T Consensus       204 ~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~  242 (298)
T 3pls_A          204 RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA  242 (298)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH
T ss_pred             CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh
Confidence            89999999999999999999 555566666655555443

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.90  E-value=2.1e-23  Score=145.28  Aligned_cols=111  Identities=34%  Similarity=0.554  Sum_probs=94.0

Q ss_pred             chhHHHHHHHHHHHHHHh-cCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCC-CCCC
Q psy17559          3 QVPYSSFQVLKGLTYLRE-KHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGT-HYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~-~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~   80 (131)
                      +++.++.|++.||.|||+ . |++|+||++.||+++.++.++++|||.+............++..|+|||.+.+. .++.
T Consensus       152 ~~~~i~~qi~~~l~~lH~~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  230 (348)
T 2pml_X          152 VIKCIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNG  230 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHTS-CEECCCCCGGGEEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEH
T ss_pred             HHHHHHHHHHHHHHHHhccC-CEeecCCChHhEEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCc
Confidence            467899999999999998 6 899999999999999999999999999876554445566788899999999876 5555


Q ss_pred             -cchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhC
Q psy17559         81 -QSDIWSLGLSLVEMAIGMYPIPPPDA-KTLAAIFG  114 (131)
Q Consensus        81 -~~d~~slg~~l~~l~~g~~p~~~~~~-~~~~~~~~  114 (131)
                       ++|+||+|++++++++|..||..... .+..+.+.
T Consensus       231 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~  266 (348)
T 2pml_X          231 AKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR  266 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence             99999999999999999999986654 44554443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.90  E-value=4.2e-24  Score=159.76  Aligned_cols=114  Identities=26%  Similarity=0.394  Sum_probs=94.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-----ccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||.|||++ +++||||++.||+++.++.++++|||+++......     .....++..|+|||.+....
T Consensus       470 ~~~~i~~qi~~~L~yLH~~-~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~  548 (635)
T 4fl3_A          470 NIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK  548 (635)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCC
Confidence            4678999999999999997 89999999999999999999999999986543221     12223456899999998888


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPSR  117 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~  117 (131)
                      ++.++|+||||+++|++++ |..||.+....++.+.+....
T Consensus       549 ~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~  589 (635)
T 4fl3_A          549 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE  589 (635)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999999999999998 999999988887777665443

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.90  E-value=4.4e-24  Score=145.94  Aligned_cols=99  Identities=37%  Similarity=0.518  Sum_probs=83.9

Q ss_pred             chhHHHHHHHHHHHHHH--------hcCCcEecCCCCCcEEEecCCcEEEeecccccccccc------cccCCCCcccee
Q psy17559          3 QVPYSSFQVLKGLTYLR--------EKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS------MANSFVGTRSYM   68 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh--------~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~~~~~   68 (131)
                      ++..++.|++.||.|||        +. +++|+||+|.||+++.++.++++|||++......      ......+++.|+
T Consensus       106 ~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~  184 (301)
T 3q4u_A          106 SCLRIVLSIASGLAHLHIEIFGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM  184 (301)
T ss_dssp             HHHHHHHHHHHHHHHHHSCBCSTTCBC-EEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHHhhhhccCCC-CeecCCCChHhEEEcCCCCEEEeeCCCeeeccccccccccccccccccccee
Confidence            46789999999999999        76 8999999999999999999999999998654321      123347889999


Q ss_pred             CcccccCC------CCCCcchHHHHHHHHHHHHhC----------CCCCC
Q psy17559         69 SPERLQGT------HYSVQSDIWSLGLSLVEMAIG----------MYPIP  102 (131)
Q Consensus        69 ~Pe~~~~~------~~~~~~d~~slg~~l~~l~~g----------~~p~~  102 (131)
                      |||.+.+.      .++.++|+||+|+++|++++|          ..||.
T Consensus       185 aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             ChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            99999775      345789999999999999999          88884

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.90  E-value=2.5e-23  Score=143.36  Aligned_cols=112  Identities=24%  Similarity=0.414  Sum_probs=89.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-------ccccCCCCccceeCcccccC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-------SMANSFVGTRSYMSPERLQG   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-------~~~~~~~~~~~~~~Pe~~~~   75 (131)
                      ++..++.|++.||+|||++ +++|+||++.||+++ ++.++++|||++.....       .......++..|+|||.+..
T Consensus       131 ~~~~i~~qi~~al~~lH~~-~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~  208 (319)
T 2y4i_B          131 KTRQIAQEIVKGMGYLHAK-GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ  208 (319)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhh
Confidence            5678999999999999997 899999999999998 67899999998754321       12233457789999999864


Q ss_pred             ---------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCCC
Q psy17559         76 ---------THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        76 ---------~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~~  116 (131)
                               ..++.++|+||||+++|++++|..||.....+.....+...
T Consensus       209 ~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  258 (319)
T 2y4i_B          209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG  258 (319)
T ss_dssp             BSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred             ccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence                     34688999999999999999999999988877666554433

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.90  E-value=1.6e-23  Score=144.29  Aligned_cols=110  Identities=30%  Similarity=0.411  Sum_probs=84.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.+|.|||+. +++|+||++.||+++.++.++++|||++......   ......++..|++||.+.+..++
T Consensus       135 ~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  213 (309)
T 2h34_A          135 RAVAIVRQIGSALDAAHAA-GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHAT  213 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----
T ss_pred             HHHHHHHHHHHHHHHHHHC-cCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCC
Confidence            4678999999999999997 8999999999999999999999999988654332   22344678899999999888899


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||||+++|++++|..||...........+
T Consensus       214 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  247 (309)
T 2h34_A          214 YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI  247 (309)
T ss_dssp             CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH
T ss_pred             chHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh
Confidence            9999999999999999999999877766554444

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.90  E-value=1.8e-23  Score=151.97  Aligned_cols=110  Identities=33%  Similarity=0.569  Sum_probs=91.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEe---cCCcEEEeeccccccccc-ccccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN---SGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~---~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ |++||||+|.||+++   .++.++++|||++..... .......+++.|+|||.+.+ .+
T Consensus       122 ~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~  199 (486)
T 3mwu_A          122 DAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TY  199 (486)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CC
Confidence            4678999999999999997 899999999999995   455799999999875543 23345678999999999976 58


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||+|+++|++++|..||.+....+..+.+.
T Consensus       200 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  235 (486)
T 3mwu_A          200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE  235 (486)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999999999999999998887766655443

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.90  E-value=8.5e-24  Score=146.32  Aligned_cols=103  Identities=27%  Similarity=0.440  Sum_probs=72.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCC--cEecCCCCCcEEEecCCcEEEeeccccccccccc--------------ccCCCCccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--------------ANSFVGTRS   66 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~--~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~--------------~~~~~~~~~   66 (131)
                      +++.++.|++.||.|||+. +  ++|+||+|.||+++.++.++++|||++.......              .....+++.
T Consensus       137 ~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~  215 (337)
T 3ll6_A          137 TVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPM  215 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-----------------------
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCC
Confidence            5678999999999999997 7  9999999999999999999999999986543211              113457888


Q ss_pred             eeCcccc---cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         67 YMSPERL---QGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        67 ~~~Pe~~---~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      |++||.+   ....++.++|+||||+++|++++|..||.....
T Consensus       216 y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          216 YRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             --------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             cCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            9999998   455688999999999999999999999975544

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.90  E-value=9.6e-24  Score=143.67  Aligned_cols=110  Identities=29%  Similarity=0.458  Sum_probs=91.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||.+||++ +++|+||+|.||+++.++.++++|||.+......     ......++..|++||.+.+..
T Consensus       122 ~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  200 (291)
T 1u46_A          122 TLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT  200 (291)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCC
Confidence            4678999999999999997 8999999999999999999999999998654322     122345566899999998888


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      ++.++|+||+|++++++++ |..||...+..+....+
T Consensus       201 ~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  237 (291)
T 1u46_A          201 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI  237 (291)
T ss_dssp             EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH
Confidence            8999999999999999999 99999988877666554

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.90  E-value=7.3e-24  Score=146.83  Aligned_cols=112  Identities=30%  Similarity=0.362  Sum_probs=93.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      +++.++.|++.||.|||+. |++|+||+|.||+++.++.++++|||++...... ......++..|++||.+.+..++.+
T Consensus       143 ~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  221 (327)
T 1fvr_A          143 QLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN  221 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCch
Confidence            4678999999999999997 8999999999999999999999999998643322 2223345678999999988888999


Q ss_pred             chHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         82 SDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        82 ~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      +|+||+|+++|++++ |..||......+..+.+..
T Consensus       222 ~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~  256 (327)
T 1fvr_A          222 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  256 (327)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             hcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence            999999999999998 9999998887776665543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.90  E-value=1e-23  Score=142.93  Aligned_cols=111  Identities=26%  Similarity=0.493  Sum_probs=93.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||.|||+. |++|+||++.||+++.++.++++|||.+......   ......++..|+|||.+.+..++
T Consensus       110 ~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  188 (279)
T 1qpc_A          110 KLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT  188 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEEC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCC
Confidence            4678999999999999997 8999999999999999999999999998655332   12233456689999999888889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      .++|+||+|++++++++ |..||......+..+.+.
T Consensus       189 ~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  224 (279)
T 1qpc_A          189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE  224 (279)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             chhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh
Confidence            99999999999999998 999998887776665553

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.90  E-value=1.3e-23  Score=148.71  Aligned_cols=104  Identities=31%  Similarity=0.505  Sum_probs=87.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc---------ccccCCCCccceeCcccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID---------SMANSFVGTRSYMSPERL   73 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~---------~~~~~~~~~~~~~~Pe~~   73 (131)
                      +++.++.|++.||.|||++ +++||||+|.||+++.++.++++|||.+.....         .......+++.|+|||.+
T Consensus       129 ~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  207 (389)
T 3gni_B          129 AIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL  207 (389)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHH
Confidence            4678999999999999997 899999999999999999999999998754321         112234678889999999


Q ss_pred             cC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         74 QG--THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        74 ~~--~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      .+  ..++.++|+||+|+++|+|++|..||......
T Consensus       208 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  243 (389)
T 3gni_B          208 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT  243 (389)
T ss_dssp             STTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST
T ss_pred             hccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence            87  56899999999999999999999999765543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.90  E-value=1.2e-23  Score=142.69  Aligned_cols=111  Identities=26%  Similarity=0.454  Sum_probs=89.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      ++..++.|++.+|.+||++ +++|+||+|.||+++.++.++++|||.+...... .....++..|+|||.+.+..++.++
T Consensus       118 ~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~  195 (278)
T 1byg_A          118 CLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-QDTGKLPVKWTAPEALREKKFSTKS  195 (278)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC-------------CCTTTSCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccccCCCcceEEEeCCCcEEEeecccccccccc-ccCCCccccccCHHHhCCCCCCchh
Confidence            4678999999999999997 8999999999999999999999999988654432 2233556789999999888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         83 DIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        83 d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      |+||+|++++++++ |..||......+....+..
T Consensus       196 Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~  229 (278)
T 1byg_A          196 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK  229 (278)
T ss_dssp             HHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence            99999999999998 9999988777766665544

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.90  E-value=1.7e-23  Score=144.59  Aligned_cols=108  Identities=37%  Similarity=0.671  Sum_probs=85.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCccccc-----C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQ-----G   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~-----~   75 (131)
                      .+..++.|++.||.|||+. |++|+||++.||+++.++.++++|||++......  ......++..|+|||.+.     .
T Consensus       130 ~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  208 (326)
T 2x7f_A          130 WIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD  208 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC------
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccC
Confidence            3678999999999999997 8999999999999999999999999988654322  233456788999999986     4


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      ..++.++|+||||+++|++++|..||..........
T Consensus       209 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  244 (326)
T 2x7f_A          209 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF  244 (326)
T ss_dssp             --CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             cCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence            568899999999999999999999998776554443

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.89  E-value=6.1e-24  Score=153.32  Aligned_cols=111  Identities=25%  Similarity=0.445  Sum_probs=90.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---ccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||+|||++ +++||||++.||+++.++.++++|||+++......   .....++..|+|||.+....++
T Consensus       281 ~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  359 (452)
T 1fmk_A          281 QLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT  359 (452)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCC
Confidence            4678999999999999997 89999999999999999999999999987554321   1223456789999999888899


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      .++|+||||+++|++++ |..||.+....++.+.+.
T Consensus       360 ~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~  395 (452)
T 1fmk_A          360 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE  395 (452)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999999999999999 999999888776666553

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.89  E-value=7.2e-24  Score=157.95  Aligned_cols=112  Identities=28%  Similarity=0.401  Sum_probs=92.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-----ccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||+|||++ +++||||++.||+++.++.++++|||+++......     .....+++.|+|||.+.+..
T Consensus       437 ~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~  515 (613)
T 2ozo_A          437 NVAELLHQVSMGMKYLEEK-NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK  515 (613)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCC
Confidence            4678999999999999997 89999999999999999999999999987653221     11223456899999998888


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      ++.++|+||||+++||+++ |..||......++.+.+..
T Consensus       516 ~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~  554 (613)
T 2ozo_A          516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ  554 (613)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence            9999999999999999998 9999998877776666544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.89  E-value=2.6e-23  Score=141.13  Aligned_cols=110  Identities=25%  Similarity=0.454  Sum_probs=91.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC----cEEEeecccccccccc-cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG----EIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~----~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||.|||+. +++|+||+|.||+++.++    .++++|||.+...... ......+++.|++||.+.+..
T Consensus       109 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  187 (283)
T 3bhy_A          109 EATQFLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP  187 (283)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCC
Confidence            4678999999999999997 899999999999998776    7999999998655332 233456788999999998888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++.++|+||+|++++++++|..||......+....+
T Consensus       188 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  223 (283)
T 3bhy_A          188 LGLEADMWSIGVITYILLSGASPFLGETKQETLTNI  223 (283)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh
Confidence            999999999999999999999999887766555444

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.89  E-value=9.6e-24  Score=146.57  Aligned_cols=105  Identities=29%  Similarity=0.460  Sum_probs=83.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEe-----cCCcEEEeecccccccccc--cccCCCCccceeCcccccC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-----SGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQG   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~-----~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~   75 (131)
                      +++.++.|++.||.|||++ +++|+||++.||+++     .++.++++|||++......  ......++..|+|||.+.+
T Consensus       133 ~~~~i~~ql~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~  211 (329)
T 3gbz_A          133 VIKSFLYQLINGVNFCHSR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG  211 (329)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcC
Confidence            4678999999999999997 899999999999995     4445999999998654322  2234466889999999987


Q ss_pred             C-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         76 T-HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        76 ~-~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      . .++.++|+||+|+++|++++|..||......+
T Consensus       212 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  245 (329)
T 3gbz_A          212 SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID  245 (329)
T ss_dssp             CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH
Confidence            4 47999999999999999999999998776543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.89  E-value=1.4e-23  Score=141.38  Aligned_cols=111  Identities=28%  Similarity=0.467  Sum_probs=93.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||.+||++ +++|+||+|.||+++.++.++++|||.+......   ......++..|+|||.+.+..++
T Consensus       105 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  183 (267)
T 3t9t_A          105 TLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS  183 (267)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCcc
Confidence            4678999999999999997 8999999999999999999999999998654322   12234456789999999888889


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      .++|+||+|+++|++++ |..||......+..+.+.
T Consensus       184 ~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~  219 (267)
T 3t9t_A          184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS  219 (267)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh
Confidence            99999999999999999 899999887776665543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.89  E-value=1.9e-23  Score=144.58  Aligned_cols=99  Identities=29%  Similarity=0.554  Sum_probs=86.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC-cEEEeeccccccccc-ccccCCCCccceeCcccccC-CCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG-EIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQG-THYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~-~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~-~~~~   79 (131)
                      +++.++.|++.||+|||++ |++|+||+|.||+++.++ .++++|||++..... .......++..|++||.+.+ ..++
T Consensus       131 ~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  209 (330)
T 3nsz_A          131 DIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD  209 (330)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCC
Confidence            4678999999999999997 899999999999999766 799999999875443 23345567889999999977 5689


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      .++|+||+|++++++++|..||.
T Consensus       210 ~~~DiwslG~il~~ll~g~~p~~  232 (330)
T 3nsz_A          210 YSLDMWSLGCMLASMIFRKEPFF  232 (330)
T ss_dssp             THHHHHHHHHHHHHHHHTCSSSS
T ss_pred             chhhHHHHHHHHHHHHhCCCCcc
Confidence            99999999999999999999994

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.89  E-value=6.8e-24  Score=154.66  Aligned_cols=112  Identities=29%  Similarity=0.506  Sum_probs=94.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---ccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      .+..++.|++.||+|||++ +++||||++.||+++.++.++++|||+++......   .....++..|+|||.+....++
T Consensus       319 ~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  397 (495)
T 1opk_A          319 VLLYMATQISSAMEYLEKK-NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS  397 (495)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEEC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCC
Confidence            4567899999999999997 89999999999999999999999999987553321   1223345689999999888899


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      .++|+||||+++|+|++ |..||...+..++.+.+..
T Consensus       398 ~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~  434 (495)
T 1opk_A          398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK  434 (495)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred             cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            99999999999999998 9999998887776666543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.89  E-value=1.5e-23  Score=142.73  Aligned_cols=102  Identities=26%  Similarity=0.497  Sum_probs=86.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCC--cEecCCCCCcEEEecCCc-----EEEeecccccccccccccCCCCccceeCccccc-
Q psy17559          3 QVPYSSFQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGE-----IKICDFGVSGQLIDSMANSFVGTRSYMSPERLQ-   74 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~--~~h~~l~~~~il~~~~~~-----~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~-   74 (131)
                      ++..++.|++.||+|||+. +  ++|+||+|.||+++.++.     ++++|||++...... .....+++.|+|||.+. 
T Consensus       123 ~~~~~~~~l~~~l~~lH~~-~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~g~~~y~aPE~~~~  200 (287)
T 4f0f_A          123 VKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-VSGLLGNFQWMAPETIGA  200 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHTS-SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC-EECCCCCCTTSCGGGSSC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc-ccccCCCccccCchhhcc
Confidence            4678999999999999997 8  999999999999987776     999999998654432 33456888999999984 


Q ss_pred             -CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         75 -GTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        75 -~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                       ...++.++|+||+|+++|++++|..||.....
T Consensus       201 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  233 (287)
T 4f0f_A          201 EEESYTEKADTYSFAMILYTILTGEGPFDEYSY  233 (287)
T ss_dssp             SSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             CCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence             34578899999999999999999999976553

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.89  E-value=8.7e-24  Score=144.28  Aligned_cols=113  Identities=27%  Similarity=0.397  Sum_probs=94.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-----ccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||.|||+. +++|+||++.||+++.++.++++|||++.......     .....++..|+|||.+.+..
T Consensus       118 ~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  196 (291)
T 1xbb_A          118 NIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK  196 (291)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCC
Confidence            4678999999999999997 89999999999999999999999999986543221     12223457899999998888


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  116 (131)
                      ++.++|+||+|+++|++++ |..||......++.+.+...
T Consensus       197 ~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~  236 (291)
T 1xbb_A          197 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG  236 (291)
T ss_dssp             EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred             CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            8999999999999999998 99999988877777665443

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=2.2e-23  Score=145.04  Aligned_cols=112  Identities=27%  Similarity=0.383  Sum_probs=89.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-----ccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||.|||++ |++|+||++.||+++.++.++++|||.+.......     .....++..|+|||.+.+..
T Consensus       148 ~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  226 (333)
T 1mqb_A          148 QLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK  226 (333)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCC
Confidence            4678999999999999997 89999999999999999999999999986553321     11223456799999998888


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      ++.++|+||+|+++|++++ |..||......++.+.+..
T Consensus       227 ~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~  265 (333)
T 1mqb_A          227 FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND  265 (333)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred             CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC
Confidence            9999999999999999998 9999988777766665533

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.89  E-value=1.2e-23  Score=148.67  Aligned_cols=112  Identities=27%  Similarity=0.381  Sum_probs=85.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-----ccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++.++++|||++.......     .....++..|+|||.+.+..
T Consensus       148 ~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  226 (373)
T 2qol_A          148 QLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK  226 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCC
Confidence            4678999999999999997 89999999999999999999999999986553221     11122356799999998888


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      ++.++|+||||+++|++++ |..||......++.+.+..
T Consensus       227 ~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~  265 (373)
T 2qol_A          227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE  265 (373)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT
T ss_pred             cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            9999999999999999997 9999988877766665543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.89  E-value=4.3e-24  Score=149.40  Aligned_cols=100  Identities=36%  Similarity=0.636  Sum_probs=85.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC----CcEEEeeccccccccc--ccccCCCCccceeCcccccCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG----GEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGT   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~----~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~   76 (131)
                      ++..++.|++.||.|||++ |++||||+|+||++..+    +.++++|||++.....  .......+++.|+|||.+.+.
T Consensus       117 ~~~~~~~qi~~al~~lH~~-givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~  195 (342)
T 2qr7_A          117 EASAVLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ  195 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCC
Confidence            4678999999999999997 89999999999998532    3499999999875533  233456778999999999877


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         77 HYSVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      .++.++|+||+|+++|+|++|..||..
T Consensus       196 ~~~~~~DiwslG~il~ell~g~~Pf~~  222 (342)
T 2qr7_A          196 GYDAACDIWSLGVLLYTMLTGYTPFAN  222 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             CCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence            788999999999999999999999975

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.89  E-value=3.6e-23  Score=150.63  Aligned_cols=110  Identities=34%  Similarity=0.580  Sum_probs=92.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC---CcEEEeeccccccccc-ccccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG---GEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~---~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ |++||||+|.||+++..   +.++++|||++..... .......+++.|+|||.+.. .+
T Consensus       137 ~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~  214 (494)
T 3lij_A          137 DAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KY  214 (494)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CB
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc-cC
Confidence            4678999999999999997 89999999999999764   4599999999876543 23345678999999999864 68


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||+|+++|++++|..||......++.+.+.
T Consensus       215 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  250 (494)
T 3lij_A          215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE  250 (494)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999999999999999999888776665543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.89  E-value=2.4e-23  Score=141.87  Aligned_cols=109  Identities=28%  Similarity=0.504  Sum_probs=87.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEe---cCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN---SGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~---~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++   .++.++++|||++...... ......+++.|+|||.+. ..+
T Consensus       125 ~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~  202 (285)
T 3is5_A          125 YVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDV  202 (285)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCC
Confidence            4678999999999999997 899999999999994   4578999999998654332 234456788999999985 468


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      +.++|+||+|++++++++|..||.....++..+..
T Consensus       203 ~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~  237 (285)
T 3is5_A          203 TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA  237 (285)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh
Confidence            89999999999999999999999888776655543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.89  E-value=3.7e-23  Score=141.68  Aligned_cols=110  Identities=31%  Similarity=0.596  Sum_probs=92.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc----ccccCCCCccceeCcccccCCC-
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTRSYMSPERLQGTH-   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~~-   77 (131)
                      ++..++.|++.||.|||++ +++|+||++.||+++.++.++++|||.+.....    .......++..|++||.+.+.. 
T Consensus       110 ~~~~~~~qi~~al~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  188 (305)
T 2wtk_C          110 QAHGYFCQLIDGLEYLHSQ-GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDT  188 (305)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCccc
Confidence            4678999999999999997 899999999999999999999999999865432    1223456888999999997643 


Q ss_pred             -CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         78 -YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        78 -~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                       .+.++|+||+|+++|++++|..||......+..+.+
T Consensus       189 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i  225 (305)
T 2wtk_C          189 FSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI  225 (305)
T ss_dssp             EESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH
Confidence             377999999999999999999999987766655544

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.89  E-value=7.9e-24  Score=148.89  Aligned_cols=102  Identities=37%  Similarity=0.690  Sum_probs=78.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCc--EEEeecccccccc-cccccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE--IKICDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~--~~l~d~g~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +++.++.|++.||+|||++ |++||||+|.||+++.++.  ++++|||+++... ........+++.|+|||.+.+..++
T Consensus       117 ~~~~i~~ql~~~L~~LH~~-~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  195 (361)
T 3uc3_A          117 EARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD  195 (361)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCC
Confidence            5678999999999999997 8999999999999987665  9999999986432 2233455788999999999887766


Q ss_pred             Cc-chHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         80 VQ-SDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        80 ~~-~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      .+ +|+||+|+++|++++|..||....
T Consensus       196 ~~~~DiwslG~il~ell~g~~Pf~~~~  222 (361)
T 3uc3_A          196 GKIADVWSCGVTLYVMLVGAYPFEDPE  222 (361)
T ss_dssp             HHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred             CCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence            55 899999999999999999997543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.89  E-value=9.2e-24  Score=153.27  Aligned_cols=110  Identities=33%  Similarity=0.587  Sum_probs=92.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEe---cCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN---SGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~---~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++||||+|.||+++   .++.++++|||++...... ......+++.|+|||.+.+ .+
T Consensus       127 ~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~  204 (484)
T 3nyv_A          127 DAARIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TY  204 (484)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CC
Confidence            4678999999999999997 899999999999994   5678999999988654332 2234568899999999876 68


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||+|+++|++++|..||......+..+.+.
T Consensus       205 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  240 (484)
T 3nyv_A          205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE  240 (484)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            999999999999999999999999888776665543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.89  E-value=3.1e-23  Score=140.24  Aligned_cols=102  Identities=32%  Similarity=0.616  Sum_probs=87.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc----ccccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.+|.|||+. |++|+||++.||+++.++.++++|||.+.....    .......++..|++||.+.+..+
T Consensus       106 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  184 (276)
T 2yex_A          106 DAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF  184 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSB
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCC
Confidence            4678999999999999997 899999999999999999999999999865432    12334567889999999987664


Q ss_pred             -CCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         79 -SVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        79 -~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                       +.++|+||+|++++++++|..||....
T Consensus       185 ~~~~~Di~slG~il~~l~~g~~p~~~~~  212 (276)
T 2yex_A          185 HAEPVDVWSCGIVLTAMLAGELPWDQPS  212 (276)
T ss_dssp             CHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence             778999999999999999999997554

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.89  E-value=1.2e-23  Score=154.60  Aligned_cols=111  Identities=25%  Similarity=0.449  Sum_probs=94.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||.|||++ +++||||++.||+++.++.++|+|||+++.....   ......++..|+|||.+....++
T Consensus       364 ~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  442 (535)
T 2h8h_A          364 QLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT  442 (535)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCC
Confidence            5678999999999999997 7999999999999999999999999998765432   12233456789999999888899


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      .++|+||||+++|+|++ |..||......++.+.+.
T Consensus       443 ~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~  478 (535)
T 2h8h_A          443 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE  478 (535)
T ss_dssp             HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999999999999999 999999888776666553

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.89  E-value=1.3e-23  Score=147.51  Aligned_cols=102  Identities=34%  Similarity=0.539  Sum_probs=84.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC------CcEEEeecccccccccccccCCCCccceeCcccccCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG------GEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGT   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~------~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~   76 (131)
                      ++..++.|++.||+|||++.|++|+||+|.||+++.+      +.++++|||++...... .....+++.|+|||.+.+.
T Consensus       132 ~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~  210 (373)
T 1q8y_A          132 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGA  210 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTC
T ss_pred             HHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-CCCCCCCccccCcHHHhCC
Confidence            4678999999999999985379999999999999543      36899999998655432 3345778899999999988


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         77 HYSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      .++.++|+||+|+++|++++|..||....
T Consensus       211 ~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          211 PWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             CCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence            89999999999999999999999997554

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=7.4e-24  Score=149.72  Aligned_cols=108  Identities=27%  Similarity=0.492  Sum_probs=82.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc------ccCCCCccceeCcccccCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM------ANSFVGTRSYMSPERLQGT   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~~~~~~Pe~~~~~   76 (131)
                      ++..++.|++.||.|||++ +++||||+|.||+++.++.++++|||+++......      .....++..|+|||.+.+.
T Consensus       193 ~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  271 (373)
T 3c1x_A          193 DLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ  271 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCC
Confidence            4678899999999999997 89999999999999999999999999986543211      1223456689999999888


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy17559         77 HYSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAA  111 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~  111 (131)
                      .++.++|+||||+++|++++ |..||...+..+...
T Consensus       272 ~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~  307 (373)
T 3c1x_A          272 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV  307 (373)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH
Confidence            89999999999999999999 788887655444433

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.89  E-value=1.4e-23  Score=144.23  Aligned_cols=103  Identities=34%  Similarity=0.585  Sum_probs=88.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++.++++|||++.......    .....+++.|+|||.+.+..+
T Consensus       146 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  224 (313)
T 1t46_A          146 DLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY  224 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC
Confidence            4678999999999999997 89999999999999999999999999986554321    223345678999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDA  106 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~  106 (131)
                      +.++|+||+|++++++++ |..||.....
T Consensus       225 ~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          225 TFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             CHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            999999999999999998 9999976553

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.89  E-value=1.1e-23  Score=145.88  Aligned_cols=101  Identities=33%  Similarity=0.501  Sum_probs=84.9

Q ss_pred             chhHHHHHHHHHHHHHHhc---------CCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeC
Q psy17559          3 QVPYSSFQVLKGLTYLREK---------HAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMS   69 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~---------~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~   69 (131)
                      ++..++.|++.||+|||+.         .+++|+||+|.||+++.++.++++|||++......    ......+++.|+|
T Consensus       122 ~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~a  201 (322)
T 3soc_A          122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA  201 (322)
T ss_dssp             HHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCC
T ss_pred             HHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccC
Confidence            4678999999999999985         16999999999999999999999999998654322    1233568899999


Q ss_pred             cccccCC-----CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         70 PERLQGT-----HYSVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        70 Pe~~~~~-----~~~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      ||.+.+.     .++.++|+||||+++|++++|..||.+
T Consensus       202 PE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~  240 (322)
T 3soc_A          202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG  240 (322)
T ss_dssp             HHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred             HhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence            9999763     456788999999999999999999864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.89  E-value=1.3e-23  Score=142.90  Aligned_cols=101  Identities=45%  Similarity=0.831  Sum_probs=78.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccc----cCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERL----QGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~----~~~~   77 (131)
                      +++.++.|++.||.|||++.|++|+||+|.||+++.++.++++|||.+...... ......+++.|+|||.+    ....
T Consensus       110 ~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  189 (290)
T 3fme_A          110 ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKG  189 (290)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--
T ss_pred             HHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcC
Confidence            467899999999999998637999999999999999999999999998655432 23344688899999996    4456


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      ++.++|+||+|++++++++|..||..
T Consensus       190 ~~~~~Di~slG~il~~l~~g~~p~~~  215 (290)
T 3fme_A          190 YSVKSDIWSLGITMIELAILRFPYDS  215 (290)
T ss_dssp             CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCccc
Confidence            88999999999999999999999975

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.89  E-value=4.4e-23  Score=150.50  Aligned_cols=110  Identities=31%  Similarity=0.569  Sum_probs=93.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC---cEEEeecccccccccc-cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG---EIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~---~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||+. +++|+||+|.||+++.++   .++++|||++...... ......+++.|+|||.+.+ .+
T Consensus       147 ~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~  224 (504)
T 3q5i_A          147 DAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KY  224 (504)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CB
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CC
Confidence            4678999999999999997 899999999999998765   5999999998765432 3445678999999999874 68


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhC
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~  114 (131)
                      +.++|+||+|+++|++++|..||.+....++.+.+.
T Consensus       225 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  260 (504)
T 3q5i_A          225 NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE  260 (504)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999999999999999999888776655543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.89  E-value=8e-23  Score=146.89  Aligned_cols=111  Identities=27%  Similarity=0.381  Sum_probs=86.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec---C--CcEEEeecccccccccc-----cccCCCCccceeCccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS---G--GEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPER   72 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~---~--~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~   72 (131)
                      ++..++.|++.||.|||+. +++||||+|.||+++.   +  ..++++|||++......     ......+++.|+|||.
T Consensus       119 ~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~  197 (432)
T 3p23_A          119 EPITLLQQTTSGLAHLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM  197 (432)
T ss_dssp             CHHHHHHHHHHHHHHHHHT-TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGG
T ss_pred             hHHHHHHHHHHHHHHHHHC-cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhh
Confidence            4678999999999999997 8999999999999953   2  35789999998655322     2234568999999999


Q ss_pred             ccC---CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         73 LQG---THYSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        73 ~~~---~~~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      +..   ..++.++|+||+|+++|++++ |..||.............
T Consensus       198 l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~  243 (432)
T 3p23_A          198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG  243 (432)
T ss_dssp             TSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTT
T ss_pred             hhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhc
Confidence            973   467789999999999999999 999997665554444443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.89  E-value=1.5e-23  Score=143.30  Aligned_cols=101  Identities=33%  Similarity=0.525  Sum_probs=84.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||.|||+. +++|+||+|.||+++.++.++++|||++......     ......++..|+|||.+.+..
T Consensus       115 ~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  193 (295)
T 3ugc_A          115 KLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK  193 (295)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHhcC-CcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCC
Confidence            4678999999999999997 8999999999999999999999999998755332     122334566799999998888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      ++.++|+||+|+++|++++|..||...
T Consensus       194 ~~~~~Di~slG~~l~~l~~g~~~~~~~  220 (295)
T 3ugc_A          194 FSVASDVWSFGVVLYELFTYIEKSKSP  220 (295)
T ss_dssp             CCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred             CChHHHHHHHHHHHHHHHhcccccCCC
Confidence            999999999999999999999988644

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.89  E-value=1.7e-23  Score=143.12  Aligned_cols=108  Identities=28%  Similarity=0.500  Sum_probs=88.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc------cccCCCCccceeCcccccCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS------MANSFVGTRSYMSPERLQGT   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~   76 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++.++++|||.+......      ......+++.|++||.+.+.
T Consensus       129 ~~~~i~~ql~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  207 (298)
T 3f66_A          129 DLIGFGLQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ  207 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCC
Confidence            4678899999999999997 8999999999999999999999999998654322      12233456789999999888


Q ss_pred             CCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy17559         77 HYSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAA  111 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~  111 (131)
                      .++.++|+||+|++++++++ +..||...+..+...
T Consensus       208 ~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~  243 (298)
T 3f66_A          208 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV  243 (298)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH
T ss_pred             CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence            89999999999999999999 666776655444443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.89  E-value=1.5e-23  Score=142.65  Aligned_cols=113  Identities=29%  Similarity=0.511  Sum_probs=94.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---ccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      .+..++.|++.+|.|||+. +++|+||+|.||+++.++.++++|||.+.......   .....++..|+|||.+.+..++
T Consensus       112 ~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  190 (288)
T 3kfa_A          112 VLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS  190 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCC
Confidence            4568899999999999998 89999999999999999999999999986544321   2223445679999999888899


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  116 (131)
                      .++|+||+|++++++++ |..||...+.....+.+...
T Consensus       191 ~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~  228 (288)
T 3kfa_A          191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD  228 (288)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc
Confidence            99999999999999999 99999888777666655443

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.89  E-value=6e-23  Score=147.52  Aligned_cols=103  Identities=31%  Similarity=0.414  Sum_probs=82.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC-------------CcEEEeeccccccccccc------ccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG-------------GEIKICDFGVSGQLIDSM------ANSFVG   63 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~-------------~~~~l~d~g~~~~~~~~~------~~~~~~   63 (131)
                      ++..++.|++.||.|||+. +++||||+|.||+++.+             +.++++|||++.......      .....+
T Consensus       116 ~~~~i~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~g  194 (434)
T 2rio_A          116 NPISLLRQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG  194 (434)
T ss_dssp             CHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------
T ss_pred             hHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCC
Confidence            3467999999999999997 89999999999999754             379999999987654321      224468


Q ss_pred             ccceeCcccccC-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy17559         64 TRSYMSPERLQG-------THYSVQSDIWSLGLSLVEMAI-GMYPIPPPDA  106 (131)
Q Consensus        64 ~~~~~~Pe~~~~-------~~~~~~~d~~slg~~l~~l~~-g~~p~~~~~~  106 (131)
                      ++.|+|||.+.+       ..++.++|+||+|+++|++++ |..||.....
T Consensus       195 t~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             CCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            899999999965       468899999999999999998 9999975543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.89  E-value=3.9e-23  Score=139.84  Aligned_cols=110  Identities=30%  Similarity=0.548  Sum_probs=85.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY-SV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~-~~   80 (131)
                      ++..++.|++.||.|||++ +++|+||++.||+++.++.++++|||.+...... ......+++.|++||.+.+..+ +.
T Consensus       112 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  190 (276)
T 2h6d_A          112 EARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP  190 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCccCCCChhhEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCc
Confidence            4678999999999999998 8999999999999999999999999988655432 2234567889999999987654 68


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+|++++++++|..||.........+.+
T Consensus       191 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  223 (276)
T 2h6d_A          191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI  223 (276)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence            999999999999999999999877766555543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=8.3e-23  Score=141.57  Aligned_cols=101  Identities=35%  Similarity=0.529  Sum_probs=83.3

Q ss_pred             chhHHHHHHHHHHHHHHhcC-------CcEecCCCCCcEEEecCCcEEEeeccccccccccc------ccCCCCccceeC
Q psy17559          3 QVPYSSFQVLKGLTYLREKH-------AIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM------ANSFVGTRSYMS   69 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~-------~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~~~~~~   69 (131)
                      ++..++.|++.||.|||++.       +++|+||+|.||+++.++.++++|||++.......      .....+++.|+|
T Consensus       135 ~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a  214 (337)
T 3mdy_A          135 SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP  214 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCC
T ss_pred             HHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeC
Confidence            46789999999999999751       69999999999999999999999999986543221      224578899999


Q ss_pred             cccccCCCCCCc------chHHHHHHHHHHHHhC----------CCCCCC
Q psy17559         70 PERLQGTHYSVQ------SDIWSLGLSLVEMAIG----------MYPIPP  103 (131)
Q Consensus        70 Pe~~~~~~~~~~------~d~~slg~~l~~l~~g----------~~p~~~  103 (131)
                      ||.+.+......      +|+||||+++|+|++|          +.||..
T Consensus       215 PE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             HHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             hhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            999987655554      8999999999999999          777753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.89  E-value=8e-23  Score=139.63  Aligned_cols=110  Identities=29%  Similarity=0.467  Sum_probs=92.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-ccccCCCCccceeCccccc------C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQ------G   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~------~   75 (131)
                      ++..++.|++.||.|||+. |++|+||++.||+++.++.++++|||.+..... .......++..|++||.+.      .
T Consensus       125 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  203 (298)
T 1phk_A          125 ETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNH  203 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhcccccccc
Confidence            5678999999999999997 899999999999999999999999998865433 2334456788999999885      3


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ..++.++|+||+|++++++++|..||.........+.+
T Consensus       204 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  241 (298)
T 1phk_A          204 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI  241 (298)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH
Confidence            45789999999999999999999999877766555543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.89  E-value=3.7e-23  Score=142.43  Aligned_cols=100  Identities=35%  Similarity=0.656  Sum_probs=80.9

Q ss_pred             chhHHHHHHHHHHHHHHh---cCCcEecCCCCCcEEEecCCc-EEEeecccccccccccccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLRE---KHAIIHRDVKPSNILVNSGGE-IKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~---~~~~~h~~l~~~~il~~~~~~-~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||+   + +++|+||++.||+++.++. ++++|||++...... .....++..|+|||.+.+..+
T Consensus       103 ~~~~~~~qi~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~  180 (307)
T 2eva_A          103 HAMSWCLQCSQGVAYLHSMQPK-ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-MTNNKGSAAWMAPEVFEGSNY  180 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHTCSSS-CCCCCCCSGGGEEEETTTTEEEECCCCC-------------CCTTSSCHHHHTCCCC
T ss_pred             HHHHHHHHHHHHHHHHHhCCCC-CeecCCCChhHEEEeCCCCEEEEcccccccccccc-cccCCCCCceEChhhhCCCCC
Confidence            356788999999999999   5 7999999999999998876 799999998654332 223467889999999998889


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      +.++|+||||+++|++++|..||...
T Consensus       181 ~~~~Di~slG~il~el~~g~~p~~~~  206 (307)
T 2eva_A          181 SEKCDVFSWGIILWEVITRRKPFDEI  206 (307)
T ss_dssp             CTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCchhh
Confidence            99999999999999999999999744

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.89  E-value=4.8e-23  Score=141.63  Aligned_cols=106  Identities=27%  Similarity=0.476  Sum_probs=87.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEe-cCCcEEEeecccccccccc-----cccCCCCccceeCcccccC-
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQG-   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~-~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~-   75 (131)
                      +++.++.|++.||+|||+. |++|+||+|.||+++ .++.++++|||.+......     ......++..|++||.+.. 
T Consensus       121 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  199 (320)
T 2i6l_A          121 HARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP  199 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCc
Confidence            4678999999999999997 899999999999998 5678999999998754321     1223355778999998865 


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      ..++.++|+||||+++|++++|..||......+.
T Consensus       200 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  233 (320)
T 2i6l_A          200 NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ  233 (320)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            5688999999999999999999999987765443

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.88  E-value=1.4e-23  Score=149.06  Aligned_cols=99  Identities=31%  Similarity=0.607  Sum_probs=84.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEE----ecCCcEEEeecccccccccc-cccCCCCccceeCcccccC--
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILV----NSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~----~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~--   75 (131)
                      +++.++.|++.||+|||++ +++|+||+|.||++    +.++.++++|||++...... ......++..|+|||.+..  
T Consensus       113 ~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~  191 (396)
T 4eut_A          113 EFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV  191 (396)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccc
Confidence            4678999999999999997 89999999999998    66677999999998765432 3345568899999999864  


Q ss_pred             ------CCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy17559         76 ------THYSVQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        76 ------~~~~~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                            ..++.++|+||+|+++|++++|..||.
T Consensus       192 ~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~  224 (396)
T 4eut_A          192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR  224 (396)
T ss_dssp             C--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEE
T ss_pred             cccccccCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence                  456789999999999999999999996

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.88  E-value=1.1e-23  Score=142.77  Aligned_cols=110  Identities=35%  Similarity=0.569  Sum_probs=91.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCC-----cEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHA-----IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQG   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~-----~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~   75 (131)
                      ++..++.|++.||.|||+. +     ++|+||++.||+++.++.++++|||.+......  ......++..|+|||.+.+
T Consensus       112 ~~~~i~~~i~~~l~~lH~~-~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  190 (279)
T 2w5a_A          112 FVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR  190 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-C------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHhcc-cCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhcc
Confidence            4678999999999999997 7     999999999999999999999999987654322  1223457788999999988


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ..++.++|+||+|+++|++++|..||......++.+.+
T Consensus       191 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i  228 (279)
T 2w5a_A          191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI  228 (279)
T ss_dssp             C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH
Confidence            88999999999999999999999999988776655544

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.88  E-value=1.4e-23  Score=144.35  Aligned_cols=102  Identities=34%  Similarity=0.618  Sum_probs=87.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||+. +++|+||+|.||+++.++.++++|||++......    ......+++.|+|||.+.+..+
T Consensus       149 ~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  227 (316)
T 2xir_A          149 HLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY  227 (316)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc
Confidence            4678899999999999997 8999999999999999999999999998654322    1223445678999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPD  105 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~  105 (131)
                      +.++|+||+|+++|++++ |..||....
T Consensus       228 ~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          228 TIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            999999999999999998 999997654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.88  E-value=2.9e-23  Score=148.56  Aligned_cols=102  Identities=37%  Similarity=0.607  Sum_probs=80.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC---cEEEeecccccccccc-cccCCCCccceeCcccccC---
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG---EIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQG---   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~---~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~---   75 (131)
                      +++.++.|++.||+|||++ +++||||+|.||+++.++   .++++|||++...... ......+++.|+|||.+..   
T Consensus       240 ~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  318 (419)
T 3i6u_A          240 TCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGT  318 (419)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCC
Confidence            4678999999999999997 899999999999997544   4999999998765432 2345678899999999853   


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ..++.++|+||+|+++|++++|..||....
T Consensus       319 ~~~~~~~DiwslG~il~~lltg~~pf~~~~  348 (419)
T 3i6u_A          319 AGYNRAVDCWSLGVILFICLSGYPPFSEHR  348 (419)
T ss_dssp             CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred             CCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence            467889999999999999999999997543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.88  E-value=2.1e-23  Score=144.29  Aligned_cols=100  Identities=29%  Similarity=0.466  Sum_probs=87.2

Q ss_pred             chhHHHHHHHHHHHHHHhcC--CcEecCCCCCcEEEecCCcEEEeeccccccccc---ccccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKH--AIIHRDVKPSNILVNSGGEIKICDFGVSGQLID---SMANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~--~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||.|||+..  |++|+||+|.||+++.++.++++|||++.....   .......+++.|+|||.+.+..
T Consensus       132 ~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  211 (326)
T 3uim_A          132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK  211 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSE
T ss_pred             HHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCC
Confidence            46789999999999999852  699999999999999999999999999865432   1233445889999999998888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      ++.++|+||+|+++|++++|..||.
T Consensus       212 ~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          212 SSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             ECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             CCccccchhHHHHHHHHHhCCCccc
Confidence            9999999999999999999999995

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.88  E-value=2.8e-23  Score=143.80  Aligned_cols=103  Identities=48%  Similarity=0.867  Sum_probs=70.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccc----cCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERL----QGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~----~~~~   77 (131)
                      .+..++.|++.||.|||+..|++|+||++.||+++.++.++++|||++...... ......++..|+|||.+    .+..
T Consensus       126 ~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  205 (327)
T 3aln_A          126 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQG  205 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC------------------------------
T ss_pred             HHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCC
Confidence            456899999999999998536999999999999999999999999998665432 22334678899999998    4456


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ++.++|+||||+++|++++|..||....
T Consensus       206 ~~~~~Di~slG~il~~l~~g~~pf~~~~  233 (327)
T 3aln_A          206 YDVRSDVWSLGITLYELATGRFPYPKWN  233 (327)
T ss_dssp             CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred             CCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence            8899999999999999999999997644

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.88  E-value=3.8e-23  Score=140.18  Aligned_cols=99  Identities=33%  Similarity=0.497  Sum_probs=87.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      .+..++.|++.||.|||++ +++|+||+|.||+++.++.++++|||.+...... ......+++.|+|||.+.+..++.+
T Consensus       123 ~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  201 (284)
T 2a19_B          123 LALELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKE  201 (284)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcch
Confidence            4678999999999999997 8999999999999999999999999998655432 2344567889999999988889999


Q ss_pred             chHHHHHHHHHHHHhCCCCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~  102 (131)
                      +|+||+|+++|++++|..|+.
T Consensus       202 ~Di~slG~il~~l~~~~~~~~  222 (284)
T 2a19_B          202 VDLYALGLILAELLHVCDTAF  222 (284)
T ss_dssp             HHHHHHHHHHHHHHSCCSSHH
T ss_pred             hhhHHHHHHHHHHHhcCCcch
Confidence            999999999999999988874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.88  E-value=3.5e-23  Score=142.40  Aligned_cols=100  Identities=32%  Similarity=0.554  Sum_probs=87.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEe-cCCcEEEeecccccccccccccCCCCccceeCcccccCCCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY-SV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~   80 (131)
                      +++.++.|++.||.|||+. +++|+||++.||+++ .++.++++|||++............++..|++||.+.+..+ +.
T Consensus       140 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  218 (312)
T 2iwi_A          140 PSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHAL  218 (312)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-TEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCc
Confidence            4678999999999999998 899999999999999 78999999999987665544556678889999999876655 45


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      ++|+||+|+++|++++|..||..
T Consensus       219 ~~Di~slG~il~~l~~g~~pf~~  241 (312)
T 2iwi_A          219 PATVWSLGILLYDMVCGDIPFER  241 (312)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             cchHHHHHHHHHHHHHCCCCCCC
Confidence            89999999999999999999964

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.88  E-value=6.4e-23  Score=140.73  Aligned_cols=101  Identities=34%  Similarity=0.552  Sum_probs=86.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||+. +++|+||+|.||+++.++.++++|||.+......    ......+++.|+|||.+.+ .+
T Consensus       134 ~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~  211 (307)
T 2nru_A          134 MRCKIAQGAANGINFLHEN-HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EI  211 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EE
T ss_pred             HHHHHHHHHHHHHHHHhcC-CeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CC
Confidence            4567899999999999997 8999999999999999999999999988654321    2234567889999998865 47


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      +.++|+||+|+++|++++|..||....
T Consensus       212 ~~~~Dv~slG~il~~l~~g~~p~~~~~  238 (307)
T 2nru_A          212 TPKSDIYSFGVVLLEIITGLPAVDEHR  238 (307)
T ss_dssp             CTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred             CccchhHHHHHHHHHHHHCCCCcccCc
Confidence            899999999999999999999997543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.88  E-value=2.7e-23  Score=143.13  Aligned_cols=102  Identities=31%  Similarity=0.549  Sum_probs=82.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCc---EEEeecccccccccc---------cccCCCCccceeCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDS---------MANSFVGTRSYMSP   70 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~---~~l~d~g~~~~~~~~---------~~~~~~~~~~~~~P   70 (131)
                      +++.++.|++.||.|||++ +++|+||+|.||+++.++.   ++++|||++......         ......+++.|+||
T Consensus       112 ~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  190 (316)
T 2ac3_A          112 EASVVVQDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP  190 (316)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccCh
Confidence            4678999999999999997 8999999999999987765   999999987644211         11234588899999


Q ss_pred             ccccC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         71 ERLQG-----THYSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        71 e~~~~-----~~~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      |.+..     ..++.++|+||+|+++|++++|..||....
T Consensus       191 E~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  230 (316)
T 2ac3_A          191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC  230 (316)
T ss_dssp             HHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             HHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence            99864     457899999999999999999999997543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.88  E-value=2e-23  Score=144.72  Aligned_cols=102  Identities=34%  Similarity=0.554  Sum_probs=87.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||+. +++|+||+|.||+++.++.++++|||++.......    .....++..|+|||.+.+..+
T Consensus       165 ~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  243 (333)
T 2i1m_A          165 DLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY  243 (333)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHhcC-CcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCC
Confidence            4577899999999999997 89999999999999999999999999987543221    223345668999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPD  105 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~  105 (131)
                      +.++|+||||+++|++++ |..||....
T Consensus       244 ~~~~Di~slG~il~el~t~g~~p~~~~~  271 (333)
T 2i1m_A          244 TVQSDVWSYGILLWEIFSLGLNPYPGIL  271 (333)
T ss_dssp             CHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence            999999999999999998 999997654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.88  E-value=8.4e-23  Score=137.55  Aligned_cols=105  Identities=15%  Similarity=0.278  Sum_probs=87.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCC--cEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHA--IIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~--~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||+|||+. +  ++|+||+|.||+++.++.+++.|+++.....   .....+++.|+|||.+.+...+.
T Consensus       112 ~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~  187 (271)
T 3kmu_A          112 QAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ---SPGRMYAPAWVAPEALQKKPEDT  187 (271)
T ss_dssp             HHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS---CTTCBSCGGGSCHHHHHSCGGGS
T ss_pred             HHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeeec---ccCccCCccccChhhhccCCCCC
Confidence            5678999999999999986 7  9999999999999999999999888754322   23346788999999998755443


Q ss_pred             ---cchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         81 ---QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        81 ---~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                         ++|+||+|+++|++++|..||......+...
T Consensus       188 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  221 (271)
T 3kmu_A          188 NRRSADMWSFAVLLWELVTREVPFADLSNMEIGM  221 (271)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCccccChHHHHH
Confidence               7999999999999999999998777665433

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.88  E-value=5.8e-23  Score=140.54  Aligned_cols=107  Identities=38%  Similarity=0.657  Sum_probs=87.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCccccc-----C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQ-----G   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~-----~   75 (131)
                      ++..++.|++.||.|||+. |++|+||+|.||+++.++.++++|||++.....  .......++..|++||.+.     .
T Consensus       118 ~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  196 (302)
T 2j7t_A          118 QIQVVCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD  196 (302)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTS
T ss_pred             HHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCC
Confidence            4678999999999999997 899999999999999999999999998654321  1233456788999999983     5


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLA  110 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~  110 (131)
                      ..++.++|+||+|+++|++++|..||...+.....
T Consensus       197 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  231 (302)
T 2j7t_A          197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL  231 (302)
T ss_dssp             TTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             CCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence            66889999999999999999999999877655443

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.88  E-value=3.8e-23  Score=140.70  Aligned_cols=108  Identities=23%  Similarity=0.415  Sum_probs=87.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCc--------EEEeecccccccccccccCCCCccceeCccccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE--------IKICDFGVSGQLIDSMANSFVGTRSYMSPERLQ   74 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~--------~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~   74 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++.        ++++|||.+......  ....++..|+|||.+.
T Consensus       114 ~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~y~aPE~~~  190 (289)
T 4fvq_A          114 WKLEVAKQLAAAMHFLEEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--DILQERIPWVPPECIE  190 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH--HHHHHTTTTSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhhC-CeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc--cccCCcCcccCHHHhC
Confidence            4678999999999999997 8999999999999998877        999999988654332  1234567899999998


Q ss_pred             C-CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         75 G-THYSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        75 ~-~~~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      + ..++.++|+||+|+++|++++ +..||...+.....+..
T Consensus       191 ~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~  231 (289)
T 4fvq_A          191 NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY  231 (289)
T ss_dssp             CGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             CCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence            7 668999999999999999999 56666666655544443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.88  E-value=6.6e-23  Score=153.79  Aligned_cols=110  Identities=27%  Similarity=0.498  Sum_probs=90.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---ccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||.|||++ +++||||+|.||+++.++.++++|||++.......   .....+++.|+|||.+.+..++
T Consensus       492 ~~~~i~~qi~~aL~~LH~~-givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  570 (656)
T 2j0j_A          492 SLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT  570 (656)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCC
Confidence            4567899999999999997 89999999999999999999999999987653321   1223456789999999888899


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||+|+++|++++ |..||.+....+....+
T Consensus       571 ~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i  605 (656)
T 2j0j_A          571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI  605 (656)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            99999999999999996 99999988776665544

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.88  E-value=3.9e-23  Score=141.28  Aligned_cols=106  Identities=38%  Similarity=0.686  Sum_probs=86.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-------cccCCCCccceeCcccccC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-------MANSFVGTRSYMSPERLQG   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~   75 (131)
                      ++..++.|++.||.|||++ |++|+||++.||+++.++.++++|||.+......       ......+++.|+|||.+..
T Consensus       122 ~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  200 (303)
T 2vwi_A          122 TIATILREVLEGLEYLHKN-GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ  200 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcc
Confidence            4678999999999999997 8999999999999999999999999987543221       1233467889999999865


Q ss_pred             -CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         76 -THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        76 -~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                       ..++.++|+||+|+++|++++|..||........
T Consensus       201 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  235 (303)
T 2vwi_A          201 VRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV  235 (303)
T ss_dssp             HHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred             ccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH
Confidence             4678999999999999999999999987665433

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.88  E-value=3.1e-23  Score=141.93  Aligned_cols=99  Identities=28%  Similarity=0.485  Sum_probs=85.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||.|||++ +++|+||+|.||+++.++.++++|||.+......     ......++..|+|||.+.+..
T Consensus       127 ~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  205 (302)
T 4e5w_A          127 QQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK  205 (302)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE
T ss_pred             HHHHHHHHHHHHHHHhhcC-CcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCC
Confidence            4678999999999999997 8999999999999999999999999998654322     223445677899999998888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      ++.++|+||+|+++|++++|..|+.
T Consensus       206 ~~~~~Di~slG~il~~l~~g~~p~~  230 (302)
T 4e5w_A          206 FYIASDVWSFGVTLHELLTYCDSDS  230 (302)
T ss_dssp             EEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             CCcchhHHHHHHHHHHHHHccCCCc
Confidence            8999999999999999999988764

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.88  E-value=9.2e-23  Score=140.34  Aligned_cols=102  Identities=47%  Similarity=0.920  Sum_probs=79.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCccccc-----CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQ-----GT   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~-----~~   76 (131)
                      ++..++.|++.||.|||++.|++|+||++.||+++.++.++++|||.+...... ......+++.|++||.+.     ..
T Consensus       125 ~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  204 (318)
T 2dyl_A          125 ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKP  204 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCTTCCHHHHC-------
T ss_pred             HHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhccccccccc
Confidence            467899999999999998437999999999999999999999999998654332 233456788999999995     34


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         77 HYSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      .++.++|+||+|+++|++++|..||...
T Consensus       205 ~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (318)
T 2dyl_A          205 DYDIRADVWSLGISLVELATGQFPYKNC  232 (318)
T ss_dssp             -CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CCccccchhhHHHHHHHHHhCCCCCCCC
Confidence            5788999999999999999999999763

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.88  E-value=2.5e-23  Score=144.33  Aligned_cols=99  Identities=37%  Similarity=0.529  Sum_probs=82.1

Q ss_pred             chhHHHHHHHHHHHHHHhcC--------CcEecCCCCCcEEEecCCcEEEeecccccccccc----------cccCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKH--------AIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----------MANSFVGT   64 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~--------~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----------~~~~~~~~   64 (131)
                      ++..++.|++.||+|||+..        +++|+||+|.||+++.++.++++|||++......          ......++
T Consensus       112 ~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt  191 (336)
T 3g2f_A          112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT  191 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSC
T ss_pred             HHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCc
Confidence            45679999999999999851        6999999999999999999999999998654321          12244688


Q ss_pred             cceeCcccccC-------CCCCCcchHHHHHHHHHHHHhCCCCC
Q psy17559         65 RSYMSPERLQG-------THYSVQSDIWSLGLSLVEMAIGMYPI  101 (131)
Q Consensus        65 ~~~~~Pe~~~~-------~~~~~~~d~~slg~~l~~l~~g~~p~  101 (131)
                      +.|+|||.+.+       ..++.++|+||||+++|++++|..||
T Consensus       192 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             GGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             cceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence            99999999976       34567899999999999999997765

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.88  E-value=1.6e-22  Score=138.96  Aligned_cols=101  Identities=37%  Similarity=0.588  Sum_probs=78.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++..++.|++.||.|||++ +++|+||++.||+++.++.++++|||++......  ......++..|++||.+.+..++.
T Consensus       137 ~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  215 (310)
T 2wqm_A          137 TVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF  215 (310)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHHTTCCCCH
T ss_pred             HHHHHHHHHHHHHHHHhhC-CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCc
Confidence            4678999999999999997 8999999999999999999999999988654322  223446788999999998888999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      ++|+||||+++|++++|..||...
T Consensus       216 ~~Dv~slG~il~~l~~g~~p~~~~  239 (310)
T 2wqm_A          216 KSDIWSLGCLLYEMAALQSPFYGD  239 (310)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             hhhHHHHHHHHHHHHhCCCCCccc
Confidence            999999999999999999999643

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.88  E-value=9.7e-23  Score=141.57  Aligned_cols=101  Identities=33%  Similarity=0.469  Sum_probs=84.6

Q ss_pred             chhHHHHHHHHHHHHHH--------hcCCcEecCCCCCcEEEecCCcEEEeecccccccccc------cccCCCCcccee
Q psy17559          3 QVPYSSFQVLKGLTYLR--------EKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS------MANSFVGTRSYM   68 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh--------~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~~~~~   68 (131)
                      ++..++.|++.||.|||        +. +++|+||+|.||+++.++.++++|||++......      ......+++.|+
T Consensus       140 ~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~  218 (342)
T 1b6c_B          140 GMIKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM  218 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHCCBCSTTCBC-EEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhhcccC-CeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccC
Confidence            46789999999999999        65 8999999999999999999999999998654332      224457888999


Q ss_pred             CcccccCC------CCCCcchHHHHHHHHHHHHhC----------CCCCCCC
Q psy17559         69 SPERLQGT------HYSVQSDIWSLGLSLVEMAIG----------MYPIPPP  104 (131)
Q Consensus        69 ~Pe~~~~~------~~~~~~d~~slg~~l~~l~~g----------~~p~~~~  104 (131)
                      |||.+.+.      .++.++|+||||+++|++++|          ..||...
T Consensus       219 aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             CHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            99999765      233689999999999999999          7888643

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.88  E-value=3e-23  Score=143.39  Aligned_cols=101  Identities=27%  Similarity=0.482  Sum_probs=86.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.+|++||+. +++|+||++.||+++.++.++++|||.+......     ......++..|++||.+.+..
T Consensus       135 ~~~~i~~~l~~~l~~LH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  213 (318)
T 3lxp_A          135 QLLLFAQQICEGMAYLHAQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK  213 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCC
Confidence            5678999999999999997 8999999999999999999999999998655332     123345667799999998888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      ++.++|+||+|++++++++|..||...
T Consensus       214 ~~~~~Di~slG~il~~ll~g~~p~~~~  240 (318)
T 3lxp_A          214 FYYASDVWSFGVTLYELLTHCDSSQSP  240 (318)
T ss_dssp             EEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCccccc
Confidence            899999999999999999999998754

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.88  E-value=8.1e-23  Score=139.31  Aligned_cols=101  Identities=41%  Similarity=0.756  Sum_probs=85.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec-CCcEEEeeccccccccc--ccccCCCCccceeCcccccCCC--
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTH--   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~-~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~--   77 (131)
                      .+..++.|++.||.|||++ +++|+||++.||+++. ++.++++|||.+.....  .......++..|++||.+....  
T Consensus       123 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  201 (295)
T 2clq_A          123 TIGFYTKQILEGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG  201 (295)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGG
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCC
Confidence            3566899999999999997 8999999999999997 88999999999865432  2234456788999999987643  


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      ++.++|+||||+++|++++|..||...
T Consensus       202 ~~~~~Di~slG~il~~l~~g~~pf~~~  228 (295)
T 2clq_A          202 YGKAADIWSLGCTIIEMATGKPPFYEL  228 (295)
T ss_dssp             CSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence            789999999999999999999999643

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.87  E-value=8.9e-23  Score=141.36  Aligned_cols=111  Identities=25%  Similarity=0.460  Sum_probs=91.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec---CCcEEEeecccccccccc----cccCCCCccceeCcccccC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQG   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~---~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~   75 (131)
                      ++..++.|++.||.|||+. +++|+||+|.||+++.   +..++++|||++......    ......+++.|+|||.+.+
T Consensus       141 ~~~~i~~qi~~al~~LH~~-~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  219 (327)
T 2yfx_A          141 DLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME  219 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhhC-CeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC
Confidence            4678999999999999997 8999999999999984   445999999987643221    1223456778999999988


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         76 THYSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      ..++.++|+||||+++|++++ |..||......+..+.+.
T Consensus       220 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  259 (327)
T 2yfx_A          220 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  259 (327)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence            889999999999999999998 999999888776665543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.87  E-value=3e-23  Score=143.76  Aligned_cols=102  Identities=32%  Similarity=0.484  Sum_probs=87.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||+|||++ +++|+||+|.||+++.++.++++|||.+......     ......++..|++||.+.+..
T Consensus       128 ~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  206 (327)
T 3lxl_A          128 RLLLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI  206 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCC
Confidence            4678999999999999997 8999999999999999999999999998654322     223345677799999998888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ++.++|+||+|++++++++|..||....
T Consensus       207 ~~~~~Di~slG~il~~ll~g~~p~~~~~  234 (327)
T 3lxl_A          207 FSRQSDVWSFGVVLYELFTYCDKSCSPS  234 (327)
T ss_dssp             EEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred             CChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence            8999999999999999999999986443

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.87  E-value=3.5e-22  Score=137.54  Aligned_cols=100  Identities=33%  Similarity=0.582  Sum_probs=80.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccC---
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQG---   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~---   75 (131)
                      ++..++.|++.||.|||++ +++|+||++.||+++ ++.++++|||++......    ......++..|+|||.+..   
T Consensus       128 ~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  205 (313)
T 3cek_A          128 ERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS  205 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC-
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhccc
Confidence            4678999999999999997 899999999999996 488999999998755332    1234467889999999865   


Q ss_pred             --------CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         76 --------THYSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        76 --------~~~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                              ..++.++|+||||+++|++++|..||...
T Consensus       206 ~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (313)
T 3cek_A          206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  242 (313)
T ss_dssp             ---------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence                    35788999999999999999999999754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.87  E-value=1e-22  Score=140.74  Aligned_cols=102  Identities=38%  Similarity=0.623  Sum_probs=84.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCc---EEEeecccccccccc-cccCCCCccceeCccccc---C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQ---G   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~---~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~---~   75 (131)
                      +++.++.|++.||.|||++ +++|+||++.||+++.++.   ++++|||.+...... ......+++.|+|||.+.   .
T Consensus       115 ~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  193 (322)
T 2ycf_A          115 TCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGT  193 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCC
Confidence            4677899999999999997 8999999999999987654   999999998655332 122345788999999974   4


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ..++.++|+||+|+++|++++|..||....
T Consensus       194 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~  223 (322)
T 2ycf_A          194 AGYNRAVDCWSLGVILFICLSGYPPFSEHR  223 (322)
T ss_dssp             TTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            568899999999999999999999996543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.87  E-value=2e-22  Score=138.85  Aligned_cols=99  Identities=30%  Similarity=0.460  Sum_probs=83.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-----------ccCCCCccceeCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----------ANSFVGTRSYMSPE   71 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-----------~~~~~~~~~~~~Pe   71 (131)
                      ++..++.|++.||.|||+. +++|+||+|.||+++.++.++++|||.+.......           .....+++.|+|||
T Consensus       135 ~~~~i~~qi~~~L~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  213 (317)
T 2buj_A          135 QILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE  213 (317)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGG
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHh
Confidence            4678999999999999997 89999999999999999999999999875432110           11234578899999


Q ss_pred             cccCCC---CCCcchHHHHHHHHHHHHhCCCCCC
Q psy17559         72 RLQGTH---YSVQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        72 ~~~~~~---~~~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      .+....   ++.++|+||||+++|++++|..||.
T Consensus       214 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  247 (317)
T 2buj_A          214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD  247 (317)
T ss_dssp             GSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred             HhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence            987543   6889999999999999999999995

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.87  E-value=3.4e-22  Score=135.46  Aligned_cols=99  Identities=26%  Similarity=0.348  Sum_probs=81.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC-------------------CcEEEeecccccccccccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG-------------------GEIKICDFGVSGQLIDSMANSFVG   63 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~-------------------~~~~l~d~g~~~~~~~~~~~~~~~   63 (131)
                      +++.++.|++.||.|||++ +++|+||+|.||+++.+                   ..++++|||.+......  ....+
T Consensus       116 ~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~g  192 (289)
T 1x8b_A          116 ELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--QVEEG  192 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS--CCCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc--cccCC
Confidence            4678999999999999997 89999999999999844                   36899999988655432  23458


Q ss_pred             ccceeCcccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         64 TRSYMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        64 ~~~~~~Pe~~~~~-~~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      +..|+|||.+.+. .++.++|+||+|++++++++|..++...
T Consensus       193 t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          193 DSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             CGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred             CccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence            8899999999765 5668999999999999999998776543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.87  E-value=3.2e-22  Score=136.28  Aligned_cols=109  Identities=34%  Similarity=0.578  Sum_probs=90.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC---CcEEEeecccccccccc-cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG---GEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~---~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.+||++ |++|+||++.||+++.+   +.++++|||++...... ......++..|++||.+.+ .+
T Consensus       122 ~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~  199 (287)
T 2wei_A          122 DAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TY  199 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CC
Confidence            4678999999999999997 89999999999999754   36999999988654332 2233456778999999876 48


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      +.++|+||+|++++++++|..||......+..+.+
T Consensus       200 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  234 (287)
T 2wei_A          200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV  234 (287)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            89999999999999999999999888776665544

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.86  E-value=1.7e-22  Score=139.91  Aligned_cols=101  Identities=33%  Similarity=0.515  Sum_probs=86.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-----ccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||.+||+. +++|+||+|.||+++.++.++++|||++.......     .....++..|+|||.+.+..
T Consensus       146 ~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  224 (326)
T 2w1i_A          146 KLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK  224 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCC
Confidence            4678899999999999997 89999999999999999999999999986543221     22334566799999998888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      ++.++|+||||++++++++|..||...
T Consensus       225 ~~~~~Di~slG~il~el~tg~~~~~~~  251 (326)
T 2w1i_A          225 FSVASDVWSFGVVLYELFTYIEKSKSP  251 (326)
T ss_dssp             EEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred             CCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence            899999999999999999999888643

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.86  E-value=2.6e-21  Score=144.95  Aligned_cols=103  Identities=36%  Similarity=0.611  Sum_probs=89.3

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCc---EEEeecccccccccc-cccCCCCccceeCcccccCCC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE---IKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~---~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      .+++.++.|++.||.|||+. |++|+||+|.||+++.++.   ++++|||.+...... ......++..|+|||.+.+..
T Consensus       121 ~~i~~I~~QLl~aL~yLHs~-gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~  199 (676)
T 3qa8_A          121 GPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKK  199 (676)
T ss_dssp             SHHHHHHHHHHHHHHHHHHT-TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSC
T ss_pred             HHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCC
Confidence            35778999999999999997 8999999999999997664   899999998765432 234457888999999999888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ++.++|+||+|+++|++++|..||....
T Consensus       200 ~s~ksDIwSLGviLyeLltG~~Pf~~~~  227 (676)
T 3qa8_A          200 YTVTVDYWSFGTLAFECITGFRPFLPNW  227 (676)
T ss_dssp             CSTTHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred             CCchhHHHHHHHHHHHHHHCCCCCCccc
Confidence            9999999999999999999999997643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.85  E-value=9.6e-22  Score=134.13  Aligned_cols=93  Identities=38%  Similarity=0.633  Sum_probs=75.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----------------cccCCCCccc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----------------MANSFVGTRS   66 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----------------~~~~~~~~~~   66 (131)
                      ++..++.|++.||+|||++ +++|+||++.||+++.++.++++|||.+......                ......++..
T Consensus       117 ~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (303)
T 1zy4_A          117 EYWRLFRQILEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAM  195 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCccc
Confidence            4567999999999999997 8999999999999999999999999988654311                1233457788


Q ss_pred             eeCcccccCC-CCCCcchHHHHHHHHHHHHh
Q psy17559         67 YMSPERLQGT-HYSVQSDIWSLGLSLVEMAI   96 (131)
Q Consensus        67 ~~~Pe~~~~~-~~~~~~d~~slg~~l~~l~~   96 (131)
                      |+|||.+.+. .++.++|+||+|+++|++++
T Consensus       196 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          196 YVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             TSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             ccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            9999999764 68899999999999999997

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.84  E-value=1.4e-21  Score=147.10  Aligned_cols=95  Identities=22%  Similarity=0.459  Sum_probs=83.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      +++.++.|++.+|.|||++ |++||||+|.||+++.+ .++++|||++......  ....+++.|++||.+.+. ++.++
T Consensus       183 ~~~~~~~qi~~aL~~lH~~-giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~s  257 (681)
T 2pzi_A          183 EAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF--GYLYGTPGFQAPEIVRTG-PTVAT  257 (681)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC--SCCCCCTTTSCTTHHHHC-SCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCeecccChHHeEEeCC-cEEEEecccchhcccC--CccCCCccccCHHHHcCC-CCCce
Confidence            5678999999999999997 89999999999999875 8999999998765433  445688999999998764 48899


Q ss_pred             hHHHHHHHHHHHHhCCCCCC
Q psy17559         83 DIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~  102 (131)
                      |+||||++++++++|..||.
T Consensus       258 Di~slG~~l~~l~~g~~~~~  277 (681)
T 2pzi_A          258 DIYTVGRTLAALTLDLPTRN  277 (681)
T ss_dssp             HHHHHHHHHHHHHSCCCEET
T ss_pred             ehhhhHHHHHHHHhCCCCCc
Confidence            99999999999999988875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.83  E-value=1.4e-21  Score=135.86  Aligned_cols=96  Identities=20%  Similarity=0.153  Sum_probs=81.9

Q ss_pred             chhHHHHHHHHHHHHHH-hcCCcEecCCCCCcEEEecCC--------------------cEEEeecccccccccccccCC
Q psy17559          3 QVPYSSFQVLKGLTYLR-EKHAIIHRDVKPSNILVNSGG--------------------EIKICDFGVSGQLIDSMANSF   61 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh-~~~~~~h~~l~~~~il~~~~~--------------------~~~l~d~g~~~~~~~~~~~~~   61 (131)
                      +++.++.|++.||.||| +. +++||||+|.||+++.++                    .++++|||+++.....   ..
T Consensus       162 ~~~~i~~qi~~aL~~lH~~~-~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~  237 (336)
T 2vuw_A          162 TAKSILHQLTASLAVAEASL-RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IV  237 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHHH-CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EE
T ss_pred             HHHHHHHHHHHHHHHHHHhC-CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cE
Confidence            57889999999999999 77 899999999999999887                    8999999999765432   34


Q ss_pred             CCccceeCcccccCCCCCCcchHHHHHHH-HHHHHhCCCCCCC
Q psy17559         62 VGTRSYMSPERLQGTHYSVQSDIWSLGLS-LVEMAIGMYPIPP  103 (131)
Q Consensus        62 ~~~~~~~~Pe~~~~~~~~~~~d~~slg~~-l~~l~~g~~p~~~  103 (131)
                      .+++.|+|||.+.+.. +.++|+||++.. .+++++|..||..
T Consensus       238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence            6888999999998766 889999998666 6667788888853

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.81  E-value=5.6e-20  Score=125.96  Aligned_cols=84  Identities=30%  Similarity=0.522  Sum_probs=70.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec---CCcEEEeecccccccccccccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~---~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||.|||+. +++|+||+|.||+++.   ++.++++|||++....                    +..++
T Consensus       118 ~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--------------------~~~~~  176 (299)
T 3m2w_A          118 EASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--------------------GEKYD  176 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--------------------TCGGG
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEecCCCCCcEEEeccccccccc--------------------cccCC
Confidence            4678999999999999997 8999999999999997   7889999999874322                    23467


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      .++|+||+|+++|++++|..||......
T Consensus       177 ~~~DiwslG~il~el~tg~~pf~~~~~~  204 (299)
T 3m2w_A          177 KSCDMWSLGVIMYILLCGYPPFYSNHGL  204 (299)
T ss_dssp             GHHHHHHHHHHHHHHHHSSCSCCC----
T ss_pred             chhhHHHHHHHHHHHHHCCCCCCCCcch
Confidence            8899999999999999999999765543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.78  E-value=1.1e-20  Score=139.91  Aligned_cols=90  Identities=18%  Similarity=0.186  Sum_probs=61.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCCCCCc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ...++.|++.||.|+|++ ||+||||||.||+++.++.+||+|||+++.....  ...+..|++.|++||.+.+ .+...
T Consensus       341 ~~~I~~QIl~AL~ylH~~-GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~  418 (569)
T 4azs_A          341 REKILGSLLRSLAALEKQ-GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWN  418 (569)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC--------
T ss_pred             HHHHHHHHHHHHHHHHHC-CceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCc
Confidence            456899999999999997 8999999999999999999999999998765432  2334578999999999976 45678


Q ss_pred             chHHHHHHHHHHHH
Q psy17559         82 SDIWSLGLSLVEMA   95 (131)
Q Consensus        82 ~d~~slg~~l~~l~   95 (131)
                      +|+|++|+..+++.
T Consensus       419 ~d~~s~g~~~~~l~  432 (569)
T 4azs_A          419 GFWRSAPVHPFNLP  432 (569)
T ss_dssp             ----------CCCC
T ss_pred             ccccccccchhhhc
Confidence            89999998866543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.75  E-value=1.4e-18  Score=118.64  Aligned_cols=78  Identities=17%  Similarity=0.242  Sum_probs=67.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      ++..++.|++.||+|||++ |++|+||++.||+++.++.+++++.+.                  ++       .++.++
T Consensus       130 ~~~~i~~ql~~aL~~lH~~-givH~Dikp~NIll~~~g~~kl~~~~~------------------~~-------~~~~~~  183 (286)
T 3uqc_A          130 GAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSIDGDVVLAYPAT------------------MP-------DANPQD  183 (286)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEETTSCEEECSCCC------------------CT-------TCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCccCCCCcccEEEcCCCCEEEEeccc------------------cC-------CCCchh
Confidence            4677899999999999997 899999999999999999999874432                  11       367899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      |+||||+++|++++|..||...+.
T Consensus       184 Di~slG~il~elltg~~Pf~~~~~  207 (286)
T 3uqc_A          184 DIRGIGASLYALLVNRWPLPEAGV  207 (286)
T ss_dssp             HHHHHHHHHHHHHHSEECSCCCSB
T ss_pred             HHHHHHHHHHHHHHCCCCCCcCCc
Confidence            999999999999999999986543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.56  E-value=6.8e-16  Score=113.68  Aligned_cols=95  Identities=18%  Similarity=0.215  Sum_probs=77.9

Q ss_pred             hhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---------ccCCCCccceeCccccc
Q psy17559          4 VPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---------ANSFVGTRSYMSPERLQ   74 (131)
Q Consensus         4 ~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---------~~~~~~~~~~~~Pe~~~   74 (131)
                      +..++.|++.+|+|||++ +++||||+|.||+++.  .++++|||+++......         .....+++.|++||++.
T Consensus       433 ~~~i~~qi~~aL~~LH~~-gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~  509 (540)
T 3en9_A          433 NLDIAYKIGEIVGKLHKN-DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWE  509 (540)
T ss_dssp             CTHHHHHHHHHHHHHHHT-TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHC-cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHH
Confidence            468999999999999997 8999999999999998  99999999997654321         13457889999999997


Q ss_pred             C--CCCCCcchHHHHHHHHHHHHhCCCCC
Q psy17559         75 G--THYSVQSDIWSLGLSLVEMAIGMYPI  101 (131)
Q Consensus        75 ~--~~~~~~~d~~slg~~l~~l~~g~~p~  101 (131)
                      .  ..|+...|.|+..+-..+-+.++.+|
T Consensus       510 ~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          510 RFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             HHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            6  56777889999877766666666555

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.22  E-value=2.1e-11  Score=83.15  Aligned_cols=49  Identities=24%  Similarity=0.285  Sum_probs=44.8

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccc
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQ   52 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~   52 (131)
                      ++...++.|++.||++||+. |++|+||+|.||+++ ++.++++|||++..
T Consensus       193 ~~~~~i~~qi~~~l~~lH~~-giiHrDlkp~NILl~-~~~vkl~DFG~a~~  241 (282)
T 1zar_A          193 ENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE  241 (282)
T ss_dssp             SCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHHHHHHHHC-CCEeCCCCHHHEEEE-CCcEEEEECCCCeE
Confidence            45678999999999999997 899999999999999 99999999998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.08  E-value=1.8e-10  Score=77.46  Aligned_cols=48  Identities=23%  Similarity=0.302  Sum_probs=43.5

Q ss_pred             chhHHHHHHHHHHHHHH-hcCCcEecCCCCCcEEEecCCcEEEeeccccccc
Q psy17559          3 QVPYSSFQVLKGLTYLR-EKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL   53 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh-~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~   53 (131)
                      ++..++.|++.++.+|| +. |++|+||+|.||+++.  .++++|||++...
T Consensus       171 ~~~~i~~qi~~~l~~lH~~~-givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          171 DVEGIFNDVVENVKRLYQEA-ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CHHHHHHHHHHHHHHHHHTS-CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            57789999999999999 76 8999999999999988  8999999998543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.61  E-value=4.4e-08  Score=69.64  Aligned_cols=48  Identities=19%  Similarity=0.178  Sum_probs=41.4

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC----------cEEEeecccc
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG----------EIKICDFGVS   50 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~----------~~~l~d~g~~   50 (131)
                      ++...+..|++.++.+||+. |++||||+|.||+++.++          .+.++||+=+
T Consensus       205 ~~~~~l~~qll~~l~~lH~~-gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~  262 (397)
T 4gyi_A          205 PDPASLYADLIALILRLAKH-GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQM  262 (397)
T ss_dssp             SCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCc
Confidence            35678899999999999987 899999999999998776          3789998744

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=97.47  E-value=0.00019  Score=47.66  Aligned_cols=29  Identities=38%  Similarity=0.534  Sum_probs=24.3

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      +++|+|+++.||+++.++.+.++||+.+.
T Consensus       184 ~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             eEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence            58999999999999876556799998653

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=97.32  E-value=0.0003  Score=46.33  Aligned_cols=28  Identities=32%  Similarity=0.419  Sum_probs=24.4

Q ss_pred             cEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         24 IIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        24 ~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      ++|+|+++.||+++.++.+.++||+.+.
T Consensus       186 l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             EECCCCCCCcEEEECCcEEEEEcchhcc
Confidence            9999999999999876666799998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.06  E-value=0.00063  Score=47.33  Aligned_cols=31  Identities=19%  Similarity=0.419  Sum_probs=25.5

Q ss_pred             CCcEecCCCCCcEEEecCCc--EEEeecccccc
Q psy17559         22 HAIIHRDVKPSNILVNSGGE--IKICDFGVSGQ   52 (131)
Q Consensus        22 ~~~~h~~l~~~~il~~~~~~--~~l~d~g~~~~   52 (131)
                      .+++|+|+++.||+++.++.  +.+.||+.+..
T Consensus       216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            36999999999999987653  68999997653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=96.97  E-value=0.00025  Score=48.25  Aligned_cols=79  Identities=19%  Similarity=0.264  Sum_probs=46.5

Q ss_pred             CcEecCCCCCcEEEec--CCcEEEeeccccccccccc--ccCCCCccceeCcccc----cCC-C---------CCCcchH
Q psy17559         23 AIIHRDVKPSNILVNS--GGEIKICDFGVSGQLIDSM--ANSFVGTRSYMSPERL----QGT-H---------YSVQSDI   84 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~--~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~Pe~~----~~~-~---------~~~~~d~   84 (131)
                      +++|+|+++.|++++.  +..+.+.||+.+.......  ......... ..|+..    ... .         .....+.
T Consensus       192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~-~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~  270 (304)
T 3sg8_A          192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEE-YGMEFVSKILNHYKHKDIPTVLEKYRMKEKY  270 (304)
T ss_dssp             EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTS-CCHHHHHHHHHHHTCSCHHHHHHHHHHHHHH
T ss_pred             eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccc-cCHHHHHHHHHHcCCCCcHHHHHHHHHHHHH
Confidence            5899999999999997  4557899998765432110  000000000 111111    000 0         0122578


Q ss_pred             HHHHHHHHHHHhCCCCCC
Q psy17559         85 WSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        85 ~slg~~l~~l~~g~~p~~  102 (131)
                      |+++.++|.+.+|..+|-
T Consensus       271 ~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          271 WSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHHHHHHHcCCHHHH
Confidence            999999999999987763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.36  E-value=0.0044  Score=42.36  Aligned_cols=30  Identities=20%  Similarity=0.339  Sum_probs=26.6

Q ss_pred             CCcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         22 HAIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        22 ~~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      .+++|+|+++.|++++.++.+.+.||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            479999999999999877889999998764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.23  E-value=0.045  Score=38.90  Aligned_cols=30  Identities=23%  Similarity=0.366  Sum_probs=25.9

Q ss_pred             CCcEecCCCCCcEEEecCCcEEEeecccccc
Q psy17559         22 HAIIHRDVKPSNILVNSGGEIKICDFGVSGQ   52 (131)
Q Consensus        22 ~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~   52 (131)
                      .+++|+|+.+.||+++.++ +.+.||+.+..
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            4799999999999998766 99999987654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=94.07  E-value=0.032  Score=36.88  Aligned_cols=29  Identities=28%  Similarity=0.472  Sum_probs=24.9

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      .++|+|+.+.|++++.++.+.+.||+.+.
T Consensus       194 ~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          194 VVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence            38999999999999987767899998764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=93.37  E-value=0.03  Score=38.03  Aligned_cols=29  Identities=21%  Similarity=0.290  Sum_probs=24.9

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      +++|+|+++.|++++.++.+.+.||+.+.
T Consensus       188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          188 GVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            69999999999999876656899998664

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=92.71  E-value=0.64  Score=30.55  Aligned_cols=87  Identities=15%  Similarity=0.063  Sum_probs=50.2

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCc
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++++-++.|.+.+|.-.-.+..-..+-..+..+++..+|++.+.+- .+.          .....+.+||... ...+.+
T Consensus        49 EqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~~-~s~----------~~~~~~~~pe~~~-~~~te~  116 (229)
T 2yle_A           49 EQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAPA-ADD----------AGEPPPVAGKLGY-SQCMET  116 (229)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECCC-----------------------CCSS-SSSCHH
T ss_pred             HHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceecccc-ccc----------ccccCCCChhhcc-ccchHH
Confidence            4688899999888776622111112334457888888888877641 110          1122455777663 234566


Q ss_pred             chHHHHHHHHHHHHhCCCC
Q psy17559         82 SDIWSLGLSLVEMAIGMYP  100 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p  100 (131)
                      .-|+|||.++|.-+--..|
T Consensus       117 ~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A          117 EVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             HHHHHHHHHHHHHHTTTCC
T ss_pred             HHHHHHHHHHHHHhhcCCC
Confidence            7799999999988764444

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=92.55  E-value=0.045  Score=37.76  Aligned_cols=30  Identities=13%  Similarity=0.287  Sum_probs=24.9

Q ss_pred             CCcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         22 HAIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        22 ~~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      .+++|+|+++.||+++.+..+.++||+.+.
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~  251 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA  251 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence            369999999999999964457899998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=92.13  E-value=0.074  Score=35.90  Aligned_cols=29  Identities=34%  Similarity=0.439  Sum_probs=24.3

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeecccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSGQ   52 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~~   52 (131)
                      .++|+|+.+.|++ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            5899999999999 5667789999987643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=92.06  E-value=0.063  Score=36.74  Aligned_cols=31  Identities=23%  Similarity=0.380  Sum_probs=25.9

Q ss_pred             CCcEecCCCCCcEEEecC----CcEEEeecccccc
Q psy17559         22 HAIIHRDVKPSNILVNSG----GEIKICDFGVSGQ   52 (131)
Q Consensus        22 ~~~~h~~l~~~~il~~~~----~~~~l~d~g~~~~   52 (131)
                      .+++|+|+++.|++++.+    +.+.+.||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            369999999999999864    6789999987643

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=91.78  E-value=0.034  Score=38.50  Aligned_cols=31  Identities=26%  Similarity=0.381  Sum_probs=26.6

Q ss_pred             CCcEecCCCCCcEEEecCCcEEEeecccccc
Q psy17559         22 HAIIHRDVKPSNILVNSGGEIKICDFGVSGQ   52 (131)
Q Consensus        22 ~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~   52 (131)
                      .+++|+|+.+.|++++.++.+.+.||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3699999999999999877899999976643

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=91.27  E-value=0.096  Score=35.59  Aligned_cols=30  Identities=33%  Similarity=0.529  Sum_probs=24.6

Q ss_pred             CcEecCCCCCcEEEec---CCc-EEEeecccccc
Q psy17559         23 AIIHRDVKPSNILVNS---GGE-IKICDFGVSGQ   52 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~---~~~-~~l~d~g~~~~   52 (131)
                      +++|+|+++.|++++.   ++. +.+.||+.+..
T Consensus       191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            5899999999999987   355 58999987643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=90.60  E-value=0.26  Score=33.46  Aligned_cols=27  Identities=22%  Similarity=0.249  Sum_probs=23.4

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      +++|+|+++.||+++ + .+.+.||+.+.
T Consensus       196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          196 LRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             EECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             eeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            588999999999998 4 78999997654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=90.37  E-value=0.18  Score=36.53  Aligned_cols=15  Identities=33%  Similarity=0.479  Sum_probs=14.1

Q ss_pred             CcEecCCCCCcEEEe
Q psy17559         23 AIIHRDVKPSNILVN   37 (131)
Q Consensus        23 ~~~h~~l~~~~il~~   37 (131)
                      .++|+|+.+.||+++
T Consensus       291 v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          291 VLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEECSCCCGGGEEEC
T ss_pred             eEEecCCCCCcEEee
Confidence            589999999999998

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=89.75  E-value=0.15  Score=35.41  Aligned_cols=28  Identities=29%  Similarity=0.563  Sum_probs=23.2

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      +++|+|+.+.|++++.++ +.++||..+.
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            699999999999997554 8999998664

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=89.46  E-value=0.24  Score=35.02  Aligned_cols=30  Identities=30%  Similarity=0.475  Sum_probs=25.9

Q ss_pred             CcEecCCCCCcEEEecC----CcEEEeecccccc
Q psy17559         23 AIIHRDVKPSNILVNSG----GEIKICDFGVSGQ   52 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~----~~~~l~d~g~~~~   52 (131)
                      +++|+|+.+.|++++.+    +.+.++||..+..
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            59999999999999876    6789999987643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=88.83  E-value=0.14  Score=36.70  Aligned_cols=29  Identities=24%  Similarity=0.471  Sum_probs=23.7

Q ss_pred             CcEecCCCCCcEEEecC----------------------------CcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSG----------------------------GEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~----------------------------~~~~l~d~g~~~   51 (131)
                      +++|+|+.+.||+++.+                            +.+.++||..+.
T Consensus       250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~  306 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS  306 (429)
T ss_dssp             EEECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred             EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCC
Confidence            58999999999999875                            568999998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=87.87  E-value=0.25  Score=34.58  Aligned_cols=29  Identities=24%  Similarity=0.362  Sum_probs=24.1

Q ss_pred             CCcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         22 HAIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        22 ~~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      .+++|+|+.+.|++++.+ .+.+.||..+.
T Consensus       227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~  255 (397)
T 2olc_A          227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAF  255 (397)
T ss_dssp             CEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence            479999999999999765 48899987654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=85.05  E-value=0.62  Score=32.89  Aligned_cols=30  Identities=27%  Similarity=0.402  Sum_probs=24.4

Q ss_pred             CcEecCCCCCcEEEe------cCCcEEEeecccccc
Q psy17559         23 AIIHRDVKPSNILVN------SGGEIKICDFGVSGQ   52 (131)
Q Consensus        23 ~~~h~~l~~~~il~~------~~~~~~l~d~g~~~~   52 (131)
                      .+.|+|+.+.||++.      .+..+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            367999999999993      456689999988753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=83.25  E-value=0.61  Score=31.98  Aligned_cols=26  Identities=19%  Similarity=0.327  Sum_probs=22.6

Q ss_pred             CCcEecCCCCCcEEEecCCcEEEeecc
Q psy17559         22 HAIIHRDVKPSNILVNSGGEIKICDFG   48 (131)
Q Consensus        22 ~~~~h~~l~~~~il~~~~~~~~l~d~g   48 (131)
                      .+++|+|+.+.|++++.++ ..+.|+.
T Consensus       207 ~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          207 PSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             CEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             ceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            4699999999999999877 8888974

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	131
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-43
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-33
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-29
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-29
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-28
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-28
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-27
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-27
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-27
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-26
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-25
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-25
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-25
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-25
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-25
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-24
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-24
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-24
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-23
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-23
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-23
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-23
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-23
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-23
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-22
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-22
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-22
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-22
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-22
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-22
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-22
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-22
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-22
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-22
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-21
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-21
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-21
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-21
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-21
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-21
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-21
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-21
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-21
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-20
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-20
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-19
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-19
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-19
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-19
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-19
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-19
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-19
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-19
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-19
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-19
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-18
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-18
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-18
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-17
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-17
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-17
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-15
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-14

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 1e-43
 Identities = 92/105 (87%), Positives = 98/105 (93%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
            V+KGLTYLREKH I+HRDVKPSNILVNS GEIK+CDFGVSGQLIDSMANSFVGTRSYMS
Sbjct: 112 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMS 171

Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           PERLQGTHYSVQSDIWS+GLSLVEMA+G YPIPPPDAK L  +FG
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 216

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 4e-33
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 1/100 (1%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           ++   L+Y   K  +IHRD+KP N+L+ S GE+KI DFG S     S   +  GT  Y+ 
Sbjct: 114 ELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLP 172

Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           PE ++G  +  + D+WSLG+   E  +G  P      +  
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 212

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 3e-29
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 3/95 (3%)

Query: 10  QVLKGLTYL-REKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           Q+LKGL +L      IIHRD+K  NI +    G +KI D G++     S A + +GT  +
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEF 179

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIP 102
           M+PE  +   Y    D+++ G+ ++EMA   YP  
Sbjct: 180 MAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 213

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 3e-29
 Identities = 40/107 (37%), Positives = 59/107 (55%), Gaps = 6/107 (5%)

Query: 10  QVLKGLTYLREK----HAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVG 63
           Q+   L     +    H ++HRD+KP+N+ ++    +K+ DFG++  L    S A +FVG
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG 176

Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLA 110
           T  YMSPE++    Y+ +SDIWSLG  L E+   M P      K LA
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA 223

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 2e-28
 Identities = 40/98 (40%), Positives = 58/98 (59%), Gaps = 8/98 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM--ANSFVGTRSY 67
           Q L  L YL +   IIHRD+K  NIL    G+IK+ DFGVS +   ++   +SF+GT  +
Sbjct: 118 QTLDALNYLHDNK-IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW 176

Query: 68  MSPERLQGT-----HYSVQSDIWSLGLSLVEMAIGMYP 100
           M+PE +         Y  ++D+WSLG++L+EMA    P
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 7e-28
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 3/98 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           + L+ L +L     +IHRD+K  NIL+   G +K+ DFG   Q+    S  ++ VGT  +
Sbjct: 124 ECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           M+PE +    Y  + DIWSLG+  +EM  G  P    +
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  101 bits (252), Expect = 1e-27
 Identities = 38/99 (38%), Positives = 59/99 (59%), Gaps = 6/99 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
             L+GL YL   + +IHRDVK  NIL++  G +K+ DFG +  +  + ANSFVGT  +M+
Sbjct: 123 GALQGLAYLHSHN-MIHRDVKAGNILLSEPGLVKLGDFGSASIM--APANSFVGTPYWMA 179

Query: 70  PERLQGT---HYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           PE +       Y  + D+WSLG++ +E+A    P+   +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.7 bits (248), Expect = 3e-27
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 8/100 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTR 65
           Q  +G+ YL  K  IIHRD+K +NI ++    +KI DFG++                G+ 
Sbjct: 112 QTAQGMDYLHAKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170

Query: 66  SYMSPERLQG---THYSVQSDIWSLGLSLVEMAIGMYPIP 102
            +M+PE ++      YS QSD+++ G+ L E+  G  P  
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.9 bits (246), Expect = 6e-27
 Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 6/101 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI----DSMANSFVGTR 65
           Q++ G+ YL     I HRD+KP N+L++    +KI DFG++        + + N   GT 
Sbjct: 111 QLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169

Query: 66  SYMSPERLQGTHY-SVQSDIWSLGLSLVEMAIGMYPIPPPD 105
            Y++PE L+   + +   D+WS G+ L  M  G  P   P 
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.9 bits (243), Expect = 3e-26
 Identities = 41/102 (40%), Positives = 60/102 (58%), Gaps = 3/102 (2%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMANSFVGTRSY 67
           +++ GL +L  K  I++RD+K  NIL++  G IKI DFG+  + +  D+  N+F GT  Y
Sbjct: 111 EIILGLQFLHSKG-IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDY 169

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           ++PE L G  Y+   D WS G+ L EM IG  P    D + L
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 211

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 95.5 bits (237), Expect = 3e-25
 Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 5/108 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS--GGEIKICDFGVSGQLIDS-MANSFVGTRS 66
           QV KGL ++ E +  +H D+KP NI+  +    E+K+ DFG++  L          GT  
Sbjct: 132 QVCKGLCHMHENN-YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 190

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIP-PPDAKTLAAIF 113
           + +PE  +G      +D+WS+G+    +  G+ P     D +TL  + 
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.3 bits (234), Expect = 4e-25
 Identities = 40/95 (42%), Positives = 55/95 (57%), Gaps = 5/95 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTR 65
           +++  L YL  K  IIHRD+KP NIL+N    I+I DFG +  L      + ANSFVGT 
Sbjct: 116 EIVSALEYLHGKG-IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            Y+SPE L        SD+W+LG  + ++  G+ P
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 95.2 bits (236), Expect = 5e-25
 Identities = 33/113 (29%), Positives = 60/113 (53%), Gaps = 2/113 (1%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF 61
             + + + +++ GL ++  +  +++RD+KP+NIL++  G ++I D G++        ++ 
Sbjct: 107 ADMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 165

Query: 62  VGTRSYMSPERLQ-GTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           VGT  YM+PE LQ G  Y   +D +SLG  L ++  G  P      K    I 
Sbjct: 166 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.2 bits (231), Expect = 6e-25
 Identities = 28/106 (26%), Positives = 51/106 (48%), Gaps = 4/106 (3%)

Query: 8   SFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           S  V + + YL   +  +HRD+   N+LV+     K+ DFG++ +   S  ++      +
Sbjct: 109 SLDVCEAMEYLEGNN-FVHRDLAARNVLVSEDNVAKVSDFGLT-KEASSTQDTGKLPVKW 166

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
            +PE L+   +S +SD+WS G+ L E+    +   P     L  + 
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIY--SFGRVPYPRIPLKDVV 210

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 94.4 bits (234), Expect = 7e-25
 Identities = 35/100 (35%), Positives = 52/100 (52%), Gaps = 2/100 (2%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           +V   L YL  K  II+RD+KP NIL++  G IKI DFG + + +  +  +  GT  Y++
Sbjct: 112 EVCLALEYLHSKD-IIYRDLKPENILLDKNGHIKITDFGFA-KYVPDVTYTLCGTPDYIA 169

Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           PE +    Y+   D WS G+ + EM  G  P    +    
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 209

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.0 bits (230), Expect = 1e-24
 Identities = 41/107 (38%), Positives = 56/107 (52%), Gaps = 3/107 (2%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA-NSFVGTRSY 67
           FQ+L+GL +L     ++HRD+KP NILV S G+IK+ DFG++      MA  S V T  Y
Sbjct: 123 FQLLRGLDFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 181

Query: 68  MSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP-DAKTLAAIF 113
            +PE L  + Y+   D+WS+G    EM           D   L  I 
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.1 bits (228), Expect = 2e-24
 Identities = 36/111 (32%), Positives = 58/111 (52%), Gaps = 3/111 (2%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSY 67
           +QVL+ + +      ++HRD+K  NIL++ + GE+K+ DFG    L D++   F GTR Y
Sbjct: 117 WQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 175

Query: 68  MSPERLQGTHY-SVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSR 117
             PE ++   Y    + +WSLG+ L +M  G  P    +      +F   R
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 226

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 90.9 bits (225), Expect = 7e-24
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 8/100 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-DSMANSFVGTRSYM 68
            +L+ +  L + + I+HRD+KP NIL++    IK+ DFG S QL          GT SY+
Sbjct: 118 ALLEVICALHKLN-IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176

Query: 69  SPERLQGTH------YSVQSDIWSLGLSLVEMAIGMYPIP 102
           +PE ++ +       Y  + D+WS G+ +  +  G  P  
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 216

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 91.3 bits (226), Expect = 1e-23
 Identities = 29/108 (26%), Positives = 53/108 (49%), Gaps = 5/108 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS--GGEIKICDFGVSGQLI-DSMANSFVGTRS 66
           Q  +GL ++ E   I+H D+KP NI+  +     +KI DFG++ +L  D +      T  
Sbjct: 135 QACEGLKHMHEHS-IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE 193

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIP-PPDAKTLAAIF 113
           + +PE +        +D+W++G+    +  G+ P     D +TL  + 
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 241

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 89.9 bits (222), Expect = 2e-23
 Identities = 29/118 (24%), Positives = 45/118 (38%), Gaps = 15/118 (12%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS-----GGEIKICDFGVSGQLIDS-------- 56
           Q+L  +  + EK  +++RD+KP N L+          I + DFG+     D         
Sbjct: 109 QMLARVQSIHEKS-LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY 167

Query: 57  -MANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
               +  GT  YMS     G   S + D+ +LG   +    G  P     A T    +
Sbjct: 168 REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.8 bits (222), Expect = 2e-23
 Identities = 27/106 (25%), Positives = 51/106 (48%), Gaps = 4/106 (3%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---M 57
           L Q+   + Q+  G+ Y+   +  +HRD++ +NILV      K+ DFG++  + D+    
Sbjct: 112 LPQLVDMAAQIASGMAYVERMN-YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170

Query: 58  ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
                    + +PE      ++++SD+WS G+ L E+        P
Sbjct: 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.8 bits (222), Expect = 3e-23
 Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 7/108 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTR 65
           Q+ KG+ YL ++  ++HRD+   N+LV +   +KI DFG++  L        A       
Sbjct: 119 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
            +M+ E +    Y+ QSD+WS G+++ E+        P D    + I 
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS--KPYDGIPASEIS 223

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.8 bits (217), Expect = 7e-23
 Identities = 30/108 (27%), Positives = 53/108 (49%), Gaps = 6/108 (5%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID---SMANSFVGTR 65
             V +G+ YL E   +IHRD+   N LV     IK+ DFG++  ++D   + +       
Sbjct: 108 LDVCEGMAYLEEAC-VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 166

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
            + SPE    + YS +SD+WS G+ + E+        P + ++ + + 
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK--IPYENRSNSEVV 212

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.8 bits (217), Expect = 9e-23
 Identities = 27/97 (27%), Positives = 52/97 (53%), Gaps = 4/97 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRS 66
           Q+ +G+ ++ E++  IHRD++ +NILV+     KI DFG++  + D+             
Sbjct: 117 QIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
           + +PE +    ++++SD+WS G+ L E+        P
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.7 bits (219), Expect = 1e-22
 Identities = 32/114 (28%), Positives = 58/114 (50%), Gaps = 6/114 (5%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI--DSMAN 59
           ++  +   +++  L YL  +  +++RD+K  N++++  G IKI DFG+  + I   +   
Sbjct: 105 ERARFYGAEIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163

Query: 60  SFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           +F GT  Y++PE L+   Y    D W LG+ + EM  G     P   +    +F
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR---LPFYNQDHERLF 214

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.0 bits (217), Expect = 1e-22
 Identities = 30/111 (27%), Positives = 48/111 (43%), Gaps = 8/111 (7%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQL------IDSMANSFVG 63
            +L GL Y+     I+HRD+K +N+L+   G +K+ DFG++           +   + V 
Sbjct: 125 MLLNGLYYIHRNK-ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 64  TRSYMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           T  Y  PE L G   Y    D+W  G  + EM      +     +   A+ 
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 87.8 bits (217), Expect = 1e-22
 Identities = 39/117 (33%), Positives = 56/117 (47%), Gaps = 6/117 (5%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILV---NSGGEIKICDFGVSGQLI-DSM 57
           +      FQVL  + YL +   I+HRD+KP N+L    +   +I I DFG+S      S+
Sbjct: 107 RDASRLIFQVLDAVKYLHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165

Query: 58  ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIP-PPDAKTLAAIF 113
            ++  GT  Y++PE L    YS   D WS+G+    +  G  P     DAK    I 
Sbjct: 166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL 222

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 88.0 bits (217), Expect = 1e-22
 Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 5/95 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTR 65
           QV  G+ YL E+   +HRD+   N LV     +KI DFG+S  +  +       +     
Sbjct: 148 QVAAGMAYLSERK-FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI 206

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYP 100
            +M PE +    Y+ +SD+W+ G+ L E+      
Sbjct: 207 RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.9 bits (217), Expect = 1e-22
 Identities = 35/105 (33%), Positives = 50/105 (47%), Gaps = 4/105 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVS-GQLIDSMANSFVGTRSYM 68
            V +G+ YL +K   IHRD+   NILV      KI DFG+S GQ +            +M
Sbjct: 135 DVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 193

Query: 69  SPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           + E L  + Y+  SD+WS G+ L E+        P    T A ++
Sbjct: 194 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--TPYCGMTCAELY 236

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.5 bits (216), Expect = 2e-22
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 6/108 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTR 65
           QV KG+ +L  K   +HRD+   N+LV  G  +KICDFG++  ++      +  +     
Sbjct: 172 QVAKGMEFLEFKS-CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
            +M+PE L    Y+++SD+WS G+ L E+       P P     A  +
Sbjct: 231 KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-PYPGIPVDANFY 277

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.5 bits (211), Expect = 6e-22
 Identities = 30/109 (27%), Positives = 49/109 (44%), Gaps = 7/109 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-----ANSFVGT 64
           QV  G+ YL E +  +HRD+   N+L+ +    KI DFG+S  L                
Sbjct: 115 QVSMGMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173

Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIPPPDAKTLAAI 112
             + +PE +    +S +SD+WS G+ + E  + G  P        + A+
Sbjct: 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 222

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.1 bits (212), Expect = 7e-22
 Identities = 38/109 (34%), Positives = 58/109 (53%), Gaps = 5/109 (4%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMA--NSFVGTRS 66
              L+GL YL +   I+HRD+KP+N+L++  G +K+ DFG++             V TR 
Sbjct: 107 LMTLQGLEYLHQHW-ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRW 165

Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPP-DAKTLAAIF 113
           Y +PE L G   Y V  D+W++G  L E+ + +  +P   D   L  IF
Sbjct: 166 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 85.7 bits (211), Expect = 8e-22
 Identities = 33/116 (28%), Positives = 50/116 (43%), Gaps = 13/116 (11%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGG---EIKICDFGVSGQLIDS---------M 57
           Q++  + Y+  K+  IHRDVKP N L+  G     + I DFG++ +  D+          
Sbjct: 111 QMISRIEYIHSKN-FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 169

Query: 58  ANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
             +  GT  Y S     G   S + D+ SLG  L+   +G  P     A T    +
Sbjct: 170 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.3 bits (213), Expect = 8e-22
 Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 5/97 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLI-DSMANSFVGTR 65
            + + + YL   + I HRDVKP N+L  S      +K+ DFG + +    +   +   T 
Sbjct: 119 SIGEAIQYLHSIN-IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 177

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIP 102
            Y++PE L    Y    D+WSLG+ +  +  G  P  
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 214

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.3 bits (210), Expect = 1e-21
 Identities = 35/112 (31%), Positives = 49/112 (43%), Gaps = 19/112 (16%)

Query: 8   SFQVLKGLTYL-------REKHAIIHRDVKPSNILVNSGGEIKICDFGV------SGQLI 54
           +     GL +L       + K AI HRD+K  NILV   G   I D G+      +   I
Sbjct: 106 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 165

Query: 55  DSMANSFVGTRSYMSPERLQG------THYSVQSDIWSLGLSLVEMAIGMYP 100
           D   N  VGT+ YM+PE L             ++DI+++GL   E+A     
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 84.4 bits (208), Expect = 2e-21
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 6/106 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGT 64
              + L +  +   IIHRDVKP+NI++++   +K+ DFG++  + DS        + +GT
Sbjct: 119 DACQALNFSHQNG-IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177

Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLA 110
             Y+SPE+ +G     +SD++SLG  L E+  G  P       ++A
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 223

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.1 bits (210), Expect = 2e-21
 Identities = 29/103 (28%), Positives = 46/103 (44%), Gaps = 4/103 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGE--IKICDFGVSGQL-IDSMANSFVGTRS 66
           QV + L +L   + I H D++P NI+  +     IKI +FG + QL              
Sbjct: 110 QVCEALQFLHSHN-IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE 168

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL 109
           Y +PE  Q    S  +D+WSLG  +  +  G+ P      + +
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI 211

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 84.8 bits (209), Expect = 2e-21
 Identities = 30/107 (28%), Positives = 53/107 (49%), Gaps = 6/107 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTR---S 66
           Q+   + YL +K+  IHRD+   N LV     +K+ DFG+S  +      +  G +    
Sbjct: 123 QISSAMEYLEKKN-FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 181

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           + +PE L    +S++SD+W+ G+ L E+A       P     L+ ++
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM--SPYPGIDLSQVY 226

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 84.9 bits (209), Expect = 3e-21
 Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 2/116 (1%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
           Q++    YL     +I+RD+KP N+L++  G I++ DFG + + +     +  GT   ++
Sbjct: 149 QIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFA-KRVKGRTWTLCGTPEALA 206

Query: 70  PERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGPSRGDGYWHVS 125
           PE +    Y+   D W+LG+ + EMA G  P        +       +     H S
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFS 262

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.8 bits (204), Expect = 5e-21
 Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 6/107 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS---FVGTRS 66
            V + + YL  K   +HRD+   N LVN  G +K+ DFG+S  ++D    S         
Sbjct: 108 DVCEAMEYLESKQ-FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 166

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
           +  PE L  + +S +SDIW+ G+ + E+        P +  T +   
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIY--SLGKMPYERFTNSETA 211

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.4 bits (205), Expect = 6e-21
 Identities = 40/109 (36%), Positives = 53/109 (48%), Gaps = 5/109 (4%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRS 66
           FQ+L+GL +      ++HRD+KP N+L+N+ G IK+ DFG++             V T  
Sbjct: 109 FQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 167

Query: 67  YMSPERLQGTHY-SVQSDIWSLGLSLVEMAIGMYPIPPPDAK-TLAAIF 113
           Y +PE L G  Y S   DIWSLG    EM       P       L  IF
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 83.3 bits (205), Expect = 7e-21
 Identities = 30/108 (27%), Positives = 52/108 (48%), Gaps = 9/108 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS-------FV 62
            +  G+ YL + +  +HRD+   NILVNS    K+ DFG+S  L D  ++          
Sbjct: 136 GIAAGMKYLADMN-YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194

Query: 63  GTRSYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIPPPDAKTL 109
               + +PE +Q   ++  SD+WS G+ + E+ + G  P      + +
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.5 bits (203), Expect = 9e-21
 Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 6/108 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRS 66
           Q+   L YL  K   +HRD+   N+LV+S   +K+ DFG+S  + DS    A+       
Sbjct: 116 QLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174

Query: 67  YMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG 114
           +M+PE +    ++  SD+W  G+ + E+   M+ + P        + G
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEIL--MHGVKPFQGVKNNDVIG 220

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.2 bits (202), Expect = 1e-20
 Identities = 27/99 (27%), Positives = 45/99 (45%), Gaps = 6/99 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSF-----VGT 64
            +  G+ YL   +  +HRD+   NILVNS    K+ DFG+S  L D    ++        
Sbjct: 118 GIAAGMKYLANMN-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
             + +PE +    ++  SD+WS G+ + E+         
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.9 bits (199), Expect = 4e-20
 Identities = 30/108 (27%), Positives = 52/108 (48%), Gaps = 7/108 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-----SMANSFVGT 64
           QV  G+ YL E+   +HRD+   N+L+ +    KI DFG+S  L       +  ++    
Sbjct: 117 QVSMGMKYL-EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEM-AIGMYPIPPPDAKTLAA 111
             + +PE +    +S +SD+WS G+++ E  + G  P        + A
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 223

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.9 bits (196), Expect = 1e-19
 Identities = 33/109 (30%), Positives = 51/109 (46%), Gaps = 7/109 (6%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGT 64
           +QV +G+ YL  K   IHRD+   N+LV     +KI DFG++  +          +    
Sbjct: 142 YQVARGMEYLASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 200

Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
             +M+PE L    Y+ QSD+WS G+ L E+        P     +  +F
Sbjct: 201 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEELF 247

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.6 bits (195), Expect = 1e-19
 Identities = 35/100 (35%), Positives = 56/100 (56%), Gaps = 4/100 (4%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRS 66
           FQ+LKGL +   ++ ++HRD+KP N+L+N  GE+K+ +FG++          ++ V T  
Sbjct: 108 FQLLKGLGFCHSRN-VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW 166

Query: 67  YMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           Y  P+ L G   YS   D+WS G    E+A    P+ P +
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 80.5 bits (197), Expect = 2e-19
 Identities = 38/114 (33%), Positives = 54/114 (47%), Gaps = 7/114 (6%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG------EIKICDFGVSGQLI 54
           L  V   S Q+L GL Y+  +  IIH D+KP N+L+          +IKI D G +    
Sbjct: 124 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183

Query: 55  DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKT 108
           +   NS   TR Y SPE L G  +   +DIWS    + E+  G +   P +  +
Sbjct: 184 EHYTNSI-QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.5 bits (195), Expect = 2e-19
 Identities = 36/117 (30%), Positives = 56/117 (47%), Gaps = 6/117 (5%)

Query: 1   LKQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---- 56
           L+ +   SFQV KG+ +L  +   IHRD+   NIL++    +KICDFG++  +       
Sbjct: 133 LEHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 57  MANSFVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
                     +M+PE +    Y++QSD+WS G+ L E+       P P  K      
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-PYPGVKIDEEFC 247

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.6 bits (193), Expect = 3e-19
 Identities = 33/109 (30%), Positives = 50/109 (45%), Gaps = 8/109 (7%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGT 64
           QV +G+ YL  K   IHRD+   N+L+ +   +KI DFG+   L  +     M       
Sbjct: 119 QVAEGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

Query: 65  RSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
            ++ +PE L+   +S  SD W  G++L EM    Y   P      + I 
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMF--TYGQEPWIGLNGSQIL 224

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.4 bits (195), Expect = 3e-19
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 4/96 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLID-SMANSFVGTRSY 67
           Q+ + L Y+     I HRD+KP N+L++     +K+CDFG + QL+      S++ +R Y
Sbjct: 130 QLFRSLAYIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188

Query: 68  MSPERLQGTH-YSVQSDIWSLGLSLVEMAIGMYPIP 102
            +PE + G   Y+   D+WS G  L E+ +G    P
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 78.8 bits (193), Expect = 3e-19
 Identities = 39/108 (36%), Positives = 57/108 (52%), Gaps = 5/108 (4%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSY 67
           Q+L G+ Y  ++  ++HRD+KP N+L+N  GE+KI DFG++             + T  Y
Sbjct: 108 QLLNGIAYCHDRR-VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWY 166

Query: 68  MSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPIP-PPDAKTLAAIF 113
            +P+ L G+  YS   DIWS+G    EM  G    P   +A  L  IF
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.5 bits (195), Expect = 3e-19
 Identities = 36/105 (34%), Positives = 57/105 (54%), Gaps = 7/105 (6%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----- 56
             + Y  +Q+L+GL Y+   + ++HRD+KPSN+L+N+  ++KICDFG++           
Sbjct: 109 DHICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 167

Query: 57  MANSFVGTRSYMSPERL-QGTHYSVQSDIWSLGLSLVEMAIGMYP 100
               +V TR Y +PE +     Y+   DIWS+G  L EM      
Sbjct: 168 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 79.1 bits (194), Expect = 3e-19
 Identities = 29/100 (29%), Positives = 47/100 (47%), Gaps = 4/100 (4%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQL-IDSMANSFVGTRS 66
           +++LK L Y      I+HRDVKP N++++    ++++ D+G++         N  V +R 
Sbjct: 136 YEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 194

Query: 67  YMSPERLQG-THYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           +  PE L     Y    D+WSLG  L  M     P     
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.6 bits (193), Expect = 4e-19
 Identities = 26/99 (26%), Positives = 48/99 (48%), Gaps = 6/99 (6%)

Query: 21  KHAIIHRDVKPSNILVNSGGE----IKICDFGVSGQL-IDSMANSFVGTRSYMSPERLQG 75
              I H D+KP NI++         IKI DFG++ ++   +   +  GT  +++PE +  
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 190

Query: 76  THYSVQSDIWSLGLSLVEMAIGMYPIP-PPDAKTLAAIF 113
               +++D+WS+G+    +  G  P       +TLA + 
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.2 bits (189), Expect = 2e-18
 Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 5/98 (5%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTR 65
           QV KG+ +L  K+  IHRD+   NIL+  G   KICDFG++  + +     +  +     
Sbjct: 153 QVAKGMAFLASKN-CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPP 103
            +M+PE +    Y+ +SD+WS G+ L E+        P
Sbjct: 212 KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.4 bits (187), Expect = 3e-18
 Identities = 30/110 (27%), Positives = 51/110 (46%), Gaps = 9/110 (8%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANS------FVG 63
           QV KG+ +L  K   +HRD+   N +++    +K+ DFG++  + D   +S         
Sbjct: 138 QVAKGMKFLASKK-FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196

Query: 64  TRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
              +M+ E LQ   ++ +SD+WS G+ L E+       PP        I 
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA--PPYPDVNTFDIT 244

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.1 bits (186), Expect = 3e-18
 Identities = 27/108 (25%), Positives = 49/108 (45%), Gaps = 7/108 (6%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTR 65
           ++  G+ YL      +HRD+   N +V     +KI DFG++  + ++         +   
Sbjct: 141 EIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199

Query: 66  SYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF 113
            +MSPE L+   ++  SD+WS G+ L E+A       P    +   + 
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--QPYQGLSNEQVL 245

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.5 bits (182), Expect = 1e-17
 Identities = 35/118 (29%), Positives = 61/118 (51%), Gaps = 7/118 (5%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID---SMA 58
            +V     +++  L +L +   II+RD+K  NIL++S G + + DFG+S + +      A
Sbjct: 129 HEVQIYVGEIVLALEHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 187

Query: 59  NSFVGTRSYMSPERLQG--THYSVQSDIWSLGLSLVEMAIGMYPIP-PPDAKTLAAIF 113
             F GT  YM+P+ ++G  + +    D WSLG+ + E+  G  P     +  + A I 
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 245

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.9 bits (178), Expect = 6e-17
 Identities = 41/98 (41%), Positives = 55/98 (56%), Gaps = 3/98 (3%)

Query: 9   FQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYM 68
           +Q+LKGL Y+     IIHRD+KP N+ VN   E+KI DFG++ Q  DS    +V TR Y 
Sbjct: 128 YQMLKGLRYIHAAG-IIHRDLKPGNLAVNEDCELKILDFGLARQ-ADSEMTGYVVTRWYR 185

Query: 69  SPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           +PE +     Y+   DIWS+G  + EM  G       D
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.7 bits (177), Expect = 8e-17
 Identities = 41/105 (39%), Positives = 58/105 (55%), Gaps = 2/105 (1%)

Query: 2   KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANS 60
           +++ Y  +Q+L G+ +L     IIHRD+KPSNI+V S   +KI DFG++     S M   
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 177

Query: 61  FVGTRSYMSPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPD 105
           +V TR Y +PE + G  Y    DIWS+G  + EM       P  D
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.5 bits (169), Expect = 1e-15
 Identities = 43/113 (38%), Positives = 60/113 (53%), Gaps = 4/113 (3%)

Query: 3   QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFV 62
            V +  +Q+L+GL Y+     IIHRD+KPSN+ VN   E+KI DFG++    D     +V
Sbjct: 122 HVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEMTGYV 179

Query: 63  GTRSYMSPERLQGT-HYSVQSDIWSLGLSLVEMAIGMYPIPPPDA-KTLAAIF 113
            TR Y +PE +    HY+   DIWS+G  + E+  G    P  D    L  I 
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 62.9 bits (152), Expect = 8e-14
 Identities = 18/84 (21%), Positives = 35/84 (41%), Gaps = 3/84 (3%)

Query: 10  QVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMS 69
            +L+ +     +  I+H D+   N+LV+  G I I DF  S ++ +      +  R   +
Sbjct: 111 MILEEVAKFYHRG-IVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREIL-ERDVRN 167

Query: 70  PERLQGTHYSVQSDIWSLGLSLVE 93
                   Y  + DI S    +++
Sbjct: 168 IITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	131
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.97
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.97
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.96
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.96
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.96
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.96
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.96
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.96
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.96
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.96
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.96
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.96
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.96
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.96
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.95
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.95
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.95
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.95
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.95
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.95
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.95
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.95
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.95
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.95
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.95
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.95
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.95
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.95
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.95
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.95
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.95
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.95
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.94
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.94
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.94
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.94
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.94
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.94
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.94
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.94
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.93
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.93
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.93
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.93
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.93
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.93
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.93
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.93
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.93
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.93
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.92
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.92
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.92
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.92
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.92
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.91
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.91
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.91
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.91
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.91
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.9
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.89
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.35
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.23
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	93.82
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	92.84
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	89.58
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	85.77

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1e-31  Score=180.56  Aligned_cols=111  Identities=32%  Similarity=0.538  Sum_probs=99.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      +++.++.|++.||.|||++ +++||||+|.||+++.++.+|++|||++............|++.|+|||.+.+..++.++
T Consensus       107 ~~~~i~~qi~~al~~lH~~-~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~  185 (263)
T d2j4za1         107 RTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV  185 (263)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeeeeccccceecCCCCEeecccceeeecCCCcccccCCCCcccCHHHHcCCCCCchh
Confidence            5778999999999999997 899999999999999999999999999977665555567899999999999998899999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhC
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~  114 (131)
                      |+||+|+++|+|++|+.||......+..+.+.
T Consensus       186 DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~  217 (263)
T d2j4za1         186 DLWSLGVLCYEFLVGKPPFEANTYQETYKRIS  217 (263)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             hhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            99999999999999999999888776666543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-31  Score=184.95  Aligned_cols=107  Identities=85%  Similarity=1.307  Sum_probs=93.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      +++.++.|++.||.|||+++|++||||+|+||+++.++.+|++|||++............|++.|+|||++.+..++.++
T Consensus       105 ~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~  184 (322)
T d1s9ja_         105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS  184 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTH
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCccccccCCccccCchHHcCCCCCcHH
Confidence            46789999999999999854799999999999999999999999999987665555677899999999999999999999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      |+||+||++|||++|+.||.+.+..+.
T Consensus       185 DiWSlGvil~ell~G~~Pf~~~~~~~~  211 (322)
T d1s9ja_         185 DIWSMGLSLVEMAVGRYPIPPPDAKEL  211 (322)
T ss_dssp             HHHHHHHHHHHHHHSSCCSSCCCTTHH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            999999999999999999987665444

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.1e-30  Score=176.55  Aligned_cols=107  Identities=34%  Similarity=0.587  Sum_probs=94.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||.|||++ |++||||+|.||+++.++.++++|||+++....  .......|++.|+|||.+.+..++.
T Consensus       117 ~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  195 (293)
T d1yhwa1         117 QIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP  195 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCc
Confidence            5788999999999999997 899999999999999999999999999976533  2345567999999999999988999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLA  110 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~  110 (131)
                      ++|+||+|+++|+|++|..||.+.+..+..
T Consensus       196 ~~DiwSlGvilyemltG~~Pf~~~~~~~~~  225 (293)
T d1yhwa1         196 KVDIWSLGIMAIEMIEGEPPYLNENPLRAL  225 (293)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             hhceehHhHHHHHHhhCCCCCCCCCHHHHH
Confidence            999999999999999999999877755433

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.5e-30  Score=177.80  Aligned_cols=110  Identities=30%  Similarity=0.620  Sum_probs=98.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.+++|++.||.|||++ |++||||+|+||+++.+|.++++|||+++....  .......||+.|+|||++.+..++.
T Consensus       106 ~~~~~~~qil~al~ylH~~-~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~  184 (337)
T d1o6la_         106 RARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR  184 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCT
T ss_pred             HHHHHHHHHhhhhhhhhhc-CccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCCh
Confidence            4788999999999999997 899999999999999999999999999976532  2345567899999999999999999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+||++|+|++|+.||.+.+..++.+..
T Consensus       185 ~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i  217 (337)
T d1o6la_         185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI  217 (337)
T ss_dssp             THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             hhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH
Confidence            999999999999999999999988877666644

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=5.7e-30  Score=175.96  Aligned_cols=109  Identities=33%  Similarity=0.561  Sum_probs=96.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      +++.++.|++.||.|||++ +++||||+|.||+++.++.+|++|||+++..... .....|++.|+|||.+.+..++.++
T Consensus       105 ~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-~~~~~Gt~~Y~APE~l~~~~y~~~~  182 (316)
T d1fota_         105 VAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-TYTLCGTPDYIAPEVVSTKPYNKSI  182 (316)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-BCCCCSCTTTCCHHHHTTCCBCTTH
T ss_pred             HHHHHHHHHHHhhhhhccC-cEEccccCchheeEcCCCCEEEecCccceEeccc-cccccCcccccCHHHHcCCCCCchh
Confidence            4567899999999999997 8999999999999999999999999998765443 3456899999999999988899999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      |+||+|+++|+|++|+.||.+.+..++.+.+
T Consensus       183 DiwSlGvilyemltG~~Pf~~~~~~~~~~~i  213 (316)
T d1fota_         183 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKI  213 (316)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             hccccchhHHHHHhCCCCCCCcCHHHHHHHH
Confidence            9999999999999999999888776665544

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.4e-30  Score=174.12  Aligned_cols=110  Identities=36%  Similarity=0.604  Sum_probs=94.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc----ccccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      +++.++.|++.||.|||+. +++||||+|+||+++.++.++++|||+++....    .......||+.|+|||++.+..+
T Consensus       109 ~~~~~~~qi~~al~ylH~~-~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~  187 (288)
T d1uu3a_         109 CTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA  187 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCC
T ss_pred             HHHHHHHHHHHHHHhhccc-cEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCC
Confidence            5678999999999999997 899999999999999999999999999876532    12334578999999999999899


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      +.++|+||+|+++|+|++|..||...+..++.+.+
T Consensus       188 ~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i  222 (288)
T d1uu3a_         188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI  222 (288)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH
Confidence            99999999999999999999999988776665544

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.96  E-value=6.2e-30  Score=177.92  Aligned_cols=109  Identities=27%  Similarity=0.502  Sum_probs=96.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      +++.++.|++.||.|||++ +++||||+|.||+++.++.++|+|||+++..... .....|++.|+|||++.+..++.++
T Consensus       142 ~~~~i~~qi~~aL~yLH~~-~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-~~~~~Gt~~Y~APE~~~~~~~~~~~  219 (350)
T d1rdqe_         142 HARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TWTLCGTPEALAPEIILSKGYNKAV  219 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-BCCCEECGGGCCHHHHTTCCBCTHH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-cccccCccccCCHHHHcCCCCCccc
Confidence            5778999999999999997 7999999999999999999999999999766443 3456789999999999998999999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         83 DIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        83 d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      |+||+||++|+|++|+.||.+.+.....+.+
T Consensus       220 DiwSlGvilyemltG~~Pf~~~~~~~~~~~i  250 (350)
T d1rdqe_         220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKI  250 (350)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cccchhHHHHHHHhCCCCCCCcCHHHHHHHH
Confidence            9999999999999999999887766555543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.5e-30  Score=173.58  Aligned_cols=111  Identities=35%  Similarity=0.560  Sum_probs=87.4

Q ss_pred             chhHHHHHHHHHHHHHHhcC----CcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKH----AIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~----~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~   76 (131)
                      +++.++.|++.||.|||++.    +++||||+|+||+++.++.++++|||+++.....  ......+++.|+|||.+.+.
T Consensus       110 ~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~  189 (269)
T d2java1         110 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM  189 (269)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCC
Confidence            47889999999999999862    3999999999999999999999999998765432  23456789999999999988


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         77 HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      .++.++|+||+|+++|+|++|+.||......++.+.+
T Consensus       190 ~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i  226 (269)
T d2java1         190 SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI  226 (269)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence            8999999999999999999999999988877766554

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.7e-29  Score=169.27  Aligned_cols=112  Identities=31%  Similarity=0.557  Sum_probs=94.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCC--cEecCCCCCcEEEe-cCCcEEEeecccccccccccccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHA--IIHRDVKPSNILVN-SGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~--~~h~~l~~~~il~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +++.++.|++.||+|||++ +  ++||||+|.||+++ .++.+|++|||+++...........||+.|+|||.+.+ .++
T Consensus       113 ~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~  190 (270)
T d1t4ha_         113 VLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYD  190 (270)
T ss_dssp             HHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCccCCcccCccccCHHHhCC-CCC
Confidence            4678999999999999986 6  99999999999996 57899999999997655544556789999999999865 589


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPP-DAKTLAAIFGPS  116 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~-~~~~~~~~~~~~  116 (131)
                      .++|+||+|+++|+|++|+.||... +...+.+.+...
T Consensus       191 ~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~  228 (270)
T d1t4ha_         191 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG  228 (270)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred             CcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC
Confidence            9999999999999999999999754 445555555443

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=8.5e-30  Score=178.03  Aligned_cols=104  Identities=30%  Similarity=0.575  Sum_probs=93.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccC-CCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~   81 (131)
                      +++.++.|++.||+|||++ +++||||+|.||+++.++.+|++|||++............|++.|+|||.+.. ..++.+
T Consensus       108 ~~~~~~~qi~~aL~ylH~~-~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~  186 (364)
T d1omwa3         108 DMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS  186 (364)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccceeeccceeEEcCCCcEEEeeeceeeecCCCcccccccccccchhHHhhcCCCCCcc
Confidence            5778999999999999997 89999999999999999999999999998776666667789999999999864 568999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      +|+||+||++|+|++|+.||......
T Consensus       187 ~DiwSlGvilyemltG~~Pf~~~~~~  212 (364)
T d1omwa3         187 ADWFSLGCMLFKLLRGHSPFRQHKTK  212 (364)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred             cchhHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999999765433

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.3e-29  Score=171.24  Aligned_cols=110  Identities=29%  Similarity=0.503  Sum_probs=88.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc----ccccCCCCccceeCcccccC---
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTRSYMSPERLQG---   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~~~~~~Pe~~~~---   75 (131)
                      ++..++.|++.||+|||++ +++||||+|.||+++.++.+|++|||+++....    .......+++.|+|||.+.+   
T Consensus       105 ~~~~i~~qi~~gl~yLH~~-~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~  183 (276)
T d1uwha_         105 KLIDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK  183 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSS
T ss_pred             HHHHHHHHHHHHHHHHhcC-CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccC
Confidence            4678999999999999997 799999999999999999999999999865432    12345578999999999864   


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHh
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDA-KTLAAIF  113 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~-~~~~~~~  113 (131)
                      ..++.++|+||||+++|||++|+.||.+... +.+...+
T Consensus       184 ~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~  222 (276)
T d1uwha_         184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV  222 (276)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred             CCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence            3478999999999999999999999986553 3343333

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=8.1e-30  Score=171.93  Aligned_cols=102  Identities=32%  Similarity=0.616  Sum_probs=88.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc----ccccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      +++.++.|++.||+|||++ +++||||+|+||+++.++.+|++|||+++....    .......||+.|+|||.+.+..+
T Consensus       104 ~~~~i~~qi~~al~ylH~~-~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~  182 (271)
T d1nvra_         104 DAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF  182 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSB
T ss_pred             HHHHHHHHHHHHHHHHHHc-CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCC
Confidence            5678999999999999997 899999999999999999999999999976532    22345679999999999988765


Q ss_pred             -CCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         79 -SVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        79 -~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                       +.++|+||+|+++|+|++|+.||....
T Consensus       183 ~~~~~DiwSlGvilyeml~G~~pf~~~~  210 (271)
T d1nvra_         183 HAEPVDVWSCGIVLTAMLAGELPWDQPS  210 (271)
T ss_dssp             CHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred             CCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence             578999999999999999999996443

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.5e-29  Score=171.94  Aligned_cols=108  Identities=38%  Similarity=0.624  Sum_probs=92.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCccccc-----C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQ-----G   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~-----~   75 (131)
                      ++..++.|++.||.|||++ |++||||+|+||+++.++.+|++|||++.....  .......|++.|+|||++.     .
T Consensus       111 ~~~~i~~qi~~gL~ylH~~-~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~  189 (288)
T d2jfla1         111 QIQVVCKQTLDALNYLHDN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD  189 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCC
Confidence            5788999999999999997 899999999999999999999999999865533  2334678899999999984     3


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      ..++.++|+||+|+++|+|++|..||......+...
T Consensus       190 ~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~  225 (288)
T d2jfla1         190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL  225 (288)
T ss_dssp             SSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH
T ss_pred             CCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH
Confidence            457899999999999999999999998776654443

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=3.3e-29  Score=171.65  Aligned_cols=106  Identities=36%  Similarity=0.623  Sum_probs=91.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccC---CCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQG---THYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~---~~~~   79 (131)
                      ++..++.|++.||.|||++ |++||||+|.||+++.++.++++|||++......  ....||+.|+|||++.+   ..++
T Consensus       116 ~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--~~~~GT~~Y~APE~~~~~~~~~y~  192 (309)
T d1u5ra_         116 EIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--NSFVGTPYWMAPEVILAMDEGQYD  192 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--CCCCSCGGGCCHHHHTTTTSCCBC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEECCCCCEEEeecccccccCCC--CccccCccccCHHHHhccCCCCcC
Confidence            5678999999999999997 8999999999999999999999999998765432  45679999999999864   3578


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      .++|+||+|+++|+|++|..||.+....+...
T Consensus       193 ~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~  224 (309)
T d1u5ra_         193 GKVDVWSLGITCIELAERKPPLFNMNAMSALY  224 (309)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             chhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            99999999999999999999998776554433

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3e-29  Score=172.88  Aligned_cols=110  Identities=31%  Similarity=0.589  Sum_probs=92.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc----ccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      +++.++.|++.||+|||++ +++||||+|.||+++.++.+|++|||+++......    .....+++.|+|||.+.+..+
T Consensus       165 ~~~~i~~qi~~gl~yLH~~-~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~  243 (325)
T d1rjba_         165 DLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY  243 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC
Confidence            4677999999999999997 79999999999999999999999999987654322    223456889999999998899


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDA-KTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~-~~~~~~~  113 (131)
                      +.++|+||||+++|||++ |..||.+... +.+.+++
T Consensus       244 ~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~  280 (325)
T d1rjba_         244 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI  280 (325)
T ss_dssp             CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred             CcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            999999999999999997 8999986544 3444444

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.2e-28  Score=168.28  Aligned_cols=106  Identities=34%  Similarity=0.536  Sum_probs=94.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccc-cccccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      +++.++.|++.||+|||++ +++||||+|+||+++.++.++++|||.+.... ........||+.|+|||.+.+..++.+
T Consensus       117 ~~~~~~~qi~~aL~yLH~~-~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~  195 (305)
T d1blxa_         117 TIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP  195 (305)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEEecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChh
Confidence            4678999999999999997 89999999999999999999999999986543 234456788999999999999999999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      +|+||+||++|+|++|+.||.+.+..+.
T Consensus       196 ~DiwSlG~il~ell~g~~pf~~~~~~~~  223 (305)
T d1blxa_         196 VDLWSVGCIFAEMFRRKPLFRGSSDVDQ  223 (305)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ehhhchHHHHHHHHHCCCCCCCCCHHHH
Confidence            9999999999999999999987775543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5.4e-29  Score=168.91  Aligned_cols=112  Identities=29%  Similarity=0.415  Sum_probs=96.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||+|||++ +++||||+|.||+++.++.+|++|||+++.....     ......+++.|+|||.+....
T Consensus       110 ~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  188 (285)
T d1u59a_         110 NVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK  188 (285)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCC
Confidence            5678999999999999997 7999999999999999999999999998755321     123345778999999998888


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      ++.++|+||||+++||+++ |..||......++.+.+..
T Consensus       189 ~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~  227 (285)
T d1u59a_         189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ  227 (285)
T ss_dssp             ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred             CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            9999999999999999997 8999988777766666544

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=4.3e-29  Score=168.79  Aligned_cols=113  Identities=27%  Similarity=0.401  Sum_probs=96.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||+|||++ +++||||+|.||+++.++.++++|||+++.....     ......+++.|+|||.+....
T Consensus       108 ~~~~i~~qi~~gl~ylH~~-~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~  186 (277)
T d1xbba_         108 NIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK  186 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE
T ss_pred             HHHHHHHHHHHHHhhHHhC-CcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCC
Confidence            5678999999999999997 7999999999999999999999999998754321     223446788999999998888


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  116 (131)
                      ++.++|+||||+++||+++ |+.||.+....++...+...
T Consensus       187 ~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~  226 (277)
T d1xbba_         187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG  226 (277)
T ss_dssp             EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred             CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999999999999997 89999988888777766543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.95  E-value=6e-29  Score=170.23  Aligned_cols=112  Identities=32%  Similarity=0.489  Sum_probs=85.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEe---cCCcEEEeeccccccccc-ccccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN---SGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~---~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++||||+|.||++.   .++.++++|||+++.... .......||+.|+|||.+.+..+
T Consensus       108 ~~~~~~~qi~~al~ylH~~-~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~  186 (307)
T d1a06a_         108 DASRLIFQVLDAVKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY  186 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHhhhhc-eeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCC
Confidence            5678999999999999997 899999999999995   468899999999876543 23445679999999999999889


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhCC
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~~~  115 (131)
                      +.++|+||+|+++|+|++|..||.+....+....+..
T Consensus       187 ~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~  223 (307)
T d1a06a_         187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK  223 (307)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT
T ss_pred             CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence            9999999999999999999999998877666555433

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.3e-28  Score=169.49  Aligned_cols=110  Identities=36%  Similarity=0.652  Sum_probs=97.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      +++.++.|++.||.|||++ +++||||+|.||+++.++.++++|||+++....  .......|++.|+|||++.+..++.
T Consensus       104 ~~~~~~~qi~~al~ylH~~-~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  182 (320)
T d1xjda_         104 RATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNH  182 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCc
Confidence            5788999999999999998 799999999999999999999999999875432  2334567899999999999999999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++|+||+||++|+|++|+.||.+....++.+.+
T Consensus       183 ~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i  215 (320)
T d1xjda_         183 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI  215 (320)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             hhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999988877666544

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.95  E-value=7.7e-29  Score=169.14  Aligned_cols=113  Identities=28%  Similarity=0.379  Sum_probs=88.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc-------ccCCCCccceeCcccccC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM-------ANSFVGTRSYMSPERLQG   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~-------~~~~~~~~~~~~Pe~~~~   75 (131)
                      ++..++.|++.||.|||++ +++||||+|.||+++.++.+|++|||+++......       .....+++.|+|||.+.+
T Consensus       129 ~~~~i~~qia~gl~yLH~~-~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  207 (299)
T d1jpaa_         129 QLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY  207 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHS
T ss_pred             HHHHHHHHHHHHHHHHhhC-CCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc
Confidence            4678999999999999997 79999999999999999999999999987543221       112346788999999998


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCC
Q psy17559         76 THYSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  116 (131)
                      ..++.++|+||||+++|||++ |..||......++.+.+...
T Consensus       208 ~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~  249 (299)
T d1jpaa_         208 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD  249 (299)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred             CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            889999999999999999997 89999988887777666443

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.95  E-value=1.1e-28  Score=171.59  Aligned_cols=110  Identities=25%  Similarity=0.427  Sum_probs=95.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEe--cCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVN--SGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~--~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +++.++.|++.||.|||++ |++||||+|.||+++  .++.++|+|||++...... ......+++.|+|||++.+..++
T Consensus       128 ~~~~i~~qi~~aL~ylH~~-~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  206 (352)
T d1koba_         128 EVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG  206 (352)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCC
Confidence            5788999999999999997 899999999999998  5688999999999766433 33456788999999999998999


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||+||++|+|++|+.||.+....+..+.+
T Consensus       207 ~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i  240 (352)
T d1koba_         207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV  240 (352)
T ss_dssp             HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred             CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9999999999999999999999988776655443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.95  E-value=1.1e-28  Score=171.57  Aligned_cols=110  Identities=26%  Similarity=0.437  Sum_probs=95.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec--CCcEEEeeccccccccc-ccccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS--GGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~--~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||.|||++ |++||||+|.||+++.  ++.++++|||++..... .......|++.|+|||++.+..++
T Consensus       125 ~~~~i~~qi~~aL~ylH~~-~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~  203 (350)
T d1koaa2         125 EAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG  203 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBC
T ss_pred             HHHHHHHHHHHHHHHHHhc-CCeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCC
Confidence            5788999999999999997 8999999999999964  57899999999876543 233456789999999999998899


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||+|+++|+|++|..||.+.+..+..+.+
T Consensus       204 ~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i  237 (350)
T d1koaa2         204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV  237 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9999999999999999999999988776655543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1e-28  Score=166.52  Aligned_cols=101  Identities=34%  Similarity=0.584  Sum_probs=88.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec-CCcEEEeecccccccccccccCCCCccceeCcccccCCCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-GGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY-SV   80 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~   80 (131)
                      +++.++.|++.||.|||++ +++||||+|.||+++. ++.++++|||++............||+.|+|||.+.+..+ +.
T Consensus       111 ~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~  189 (273)
T d1xwsa_         111 LARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR  189 (273)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCccccCcccceEEecCCCeEEECccccceecccccccccccCCCcCCHHHHcCCCCCCc
Confidence            5778999999999999997 8999999999999985 4789999999997665555566789999999999987654 67


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      ++|+||+|+++|+|++|+.||...
T Consensus       190 ~~DiwSlGvilyell~g~~Pf~~~  213 (273)
T d1xwsa_         190 SAAVWSLGILLYDMVCGDIPFEHD  213 (273)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             ccccccceeeehhHhhCCCCCCCc
Confidence            799999999999999999999753

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.4e-28  Score=164.68  Aligned_cols=112  Identities=25%  Similarity=0.462  Sum_probs=94.2

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||.|||++ +++||||+|.||+++.++.+|++|||+++.....   ......+++.|+|||.+....++
T Consensus       110 ~~~~i~~qi~~gl~~lH~~-~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~  188 (272)
T d1qpca_         110 KLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT  188 (272)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEEC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCC
Confidence            4678999999999999997 7999999999999999999999999999765432   23345678899999999888899


Q ss_pred             CcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhCC
Q psy17559         80 VQSDIWSLGLSLVEMAIG-MYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g-~~p~~~~~~~~~~~~~~~  115 (131)
                      .++|+||||+++|||++| ..|+......++.+.+..
T Consensus       189 ~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~  225 (272)
T d1qpca_         189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER  225 (272)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred             chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            999999999999999985 556677776666665543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5.8e-28  Score=164.57  Aligned_cols=107  Identities=32%  Similarity=0.561  Sum_probs=92.2

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCC-CC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT-HY   78 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~-~~   78 (131)
                      .+++.+++|++.||+|||++ |++||||+|+||+++.++.+|++|||.++.....  ......+++.|+|||.+... .+
T Consensus       100 ~~~~~~~~qil~aL~~lH~~-~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  178 (299)
T d1ua2a_         100 SHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY  178 (299)
T ss_dssp             SHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCC
T ss_pred             HHHHHHHHHHHHHHHHhhcc-ceecccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCC
Confidence            46788999999999999997 8999999999999999999999999998765432  23445788999999998754 57


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      +.++|+||+||++|+|++|..||.+....+.
T Consensus       179 ~~~~DiwSlGvil~el~~g~~pf~~~~~~~~  209 (299)
T d1ua2a_         179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQ  209 (299)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ChhhhhhhcchHHHHHHhCcCCCCCCCHHHH
Confidence            9999999999999999999999987765543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.5e-28  Score=163.92  Aligned_cols=112  Identities=28%  Similarity=0.463  Sum_probs=86.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||.|||++ +++||||+|.||+++.++.+|++|||+++.....   ......++..|+|||.+.+..++
T Consensus       102 ~~~~i~~qia~gl~~lH~~-~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~  180 (263)
T d1sm2a_         102 TLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS  180 (263)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHHhhhcc-ceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCC
Confidence            4577999999999999997 7999999999999999999999999998755432   22234678899999999998999


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      .++|+||||+++||+++ |..||......++.+.+..
T Consensus       181 ~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~  217 (263)
T d1sm2a_         181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST  217 (263)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH
T ss_pred             chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh
Confidence            99999999999999998 5777777777666665533

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.95  E-value=2.1e-28  Score=166.09  Aligned_cols=113  Identities=27%  Similarity=0.461  Sum_probs=93.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccccc---ccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      .+..++.|++.||.|||++ +++||||+|.||+++.++.+|++|||+++......   .....+++.|+|||.+.+..++
T Consensus       116 ~~~~i~~qi~~gL~yLH~~-~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~  194 (287)
T d1opja_         116 VLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS  194 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCC
Confidence            4678899999999999997 89999999999999999999999999987654321   2233467789999999988999


Q ss_pred             CcchHHHHHHHHHHHHhCCC-CCCCCCHHHHHHHhCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMY-PIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~-p~~~~~~~~~~~~~~~~  116 (131)
                      .++|+||+|+++|||++|.. ||...+...+.+.+...
T Consensus       195 ~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~  232 (287)
T d1opja_         195 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD  232 (287)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC
Confidence            99999999999999998655 55677777776666443

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.8e-28  Score=167.98  Aligned_cols=103  Identities=28%  Similarity=0.456  Sum_probs=90.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec---CCcEEEeeccccccccc-ccccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~---~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      +++.++.|++.||.|||+. |++||||+|.||+++.   .+.++++|||+++.... .......|++.|+|||++.+..+
T Consensus       112 ~~~~i~~qi~~al~ylH~~-~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y  190 (335)
T d2ozaa1         112 EASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY  190 (335)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGG
T ss_pred             HHHHHHHHHHHHHHHHHHc-CCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCC
Confidence            5788999999999999997 8999999999999985   45699999999876543 33456679999999999998889


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         79 SVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      +.++|+||+|+++|+|++|+.||.+...
T Consensus       191 ~~~~DiwSlGvily~lltg~~Pf~~~~~  218 (335)
T d2ozaa1         191 DKSCDMWSLGVIMYILLCGYPPFYSNHG  218 (335)
T ss_dssp             SHHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred             CHHHHHHhhchhHHHHhhCCCCCCCCCH
Confidence            9999999999999999999999975543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=7e-28  Score=163.20  Aligned_cols=113  Identities=26%  Similarity=0.355  Sum_probs=88.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      ++..++.|++.||.|||++ +++||||+|.||+++.++.+|++|||+++.....     ......+++.|+|||.+....
T Consensus       111 ~~~~i~~~i~~gl~~lH~~-~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~  189 (283)
T d1mqba_         111 QLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK  189 (283)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCC
T ss_pred             HHHHHHHHHHHhhhhcccc-ccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCC
Confidence            4678999999999999997 7999999999999999999999999998754322     122345678999999999989


Q ss_pred             CCCcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIG-MYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g-~~p~~~~~~~~~~~~~~~~  116 (131)
                      ++.++|+||||+++|||+++ ..|+......++.+.+...
T Consensus       190 ~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~  229 (283)
T d1mqba_         190 FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG  229 (283)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred             CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc
Confidence            99999999999999999985 5556666666666655443

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.1e-28  Score=166.80  Aligned_cols=102  Identities=33%  Similarity=0.582  Sum_probs=83.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      +++.++.|++.||.|||++ +++||||+|.||+++.++.+||+|||+++.....    ......|++.|+|||.+.+..+
T Consensus       135 ~~~~~~~qi~~gl~ylH~~-~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~  213 (299)
T d1ywna1         135 HLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY  213 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC
Confidence            4678999999999999997 7999999999999999999999999998754322    2234568899999999999889


Q ss_pred             CCcchHHHHHHHHHHHHhC-CCCCCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAIG-MYPIPPPD  105 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g-~~p~~~~~  105 (131)
                      +.++|+||+|+++|||+++ ..||....
T Consensus       214 ~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         214 TIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999986 56787554

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.7e-28  Score=168.59  Aligned_cols=112  Identities=29%  Similarity=0.471  Sum_probs=93.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++||||+|.||+++.++.+|++|||+++.....    ......+++.|+|||.+.+..+
T Consensus       112 ~~~~i~~qi~~gl~yLH~~-~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~  190 (317)
T d1xkka_         112 YLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY  190 (317)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHHHc-CcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCC
Confidence            4678999999999999997 7999999999999999999999999998654322    1233457889999999998899


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      +.++|+||||+++|||++ |..||......++.+.+..
T Consensus       191 ~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~  228 (317)
T d1xkka_         191 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK  228 (317)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH
T ss_pred             ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence            999999999999999998 8999998877777666643

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.2e-27  Score=160.20  Aligned_cols=113  Identities=28%  Similarity=0.433  Sum_probs=97.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      .+..++.|++.||+|||++ |++||||++.||+++.++.++++|||+++.....   ......++..|+|||.+....++
T Consensus       101 ~~~~i~~qi~~gl~~LH~~-~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  179 (258)
T d1k2pa_         101 QLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS  179 (258)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHHhhc-CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCC
Confidence            4678999999999999997 8999999999999999999999999998754332   22234577889999999988899


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  116 (131)
                      .++|+||||+++|||++ |..||.....+++.+.+...
T Consensus       180 ~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~  217 (258)
T d1k2pa_         180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG  217 (258)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred             cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC
Confidence            99999999999999998 89999998888887766544

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.4e-27  Score=162.34  Aligned_cols=110  Identities=26%  Similarity=0.420  Sum_probs=95.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC----cEEEeeccccccccc-ccccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG----EIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~----~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      +++.++.|++.||+|||+. +++||||+|.||+++.++    .++++|||++..... .......+++.|+|||.+.+..
T Consensus       114 ~~~~~~~qi~~al~yLH~~-~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~  192 (293)
T d1jksa_         114 EATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP  192 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHhhhhc-ceeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCC
Confidence            4688999999999999997 899999999999998766    489999999876543 3345567889999999999888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ++.++|+||+|+++|+|++|..||.+.+..+..+.+
T Consensus       193 ~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i  228 (293)
T d1jksa_         193 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANV  228 (293)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            999999999999999999999999988776665544

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.94  E-value=9.3e-28  Score=162.04  Aligned_cols=107  Identities=31%  Similarity=0.575  Sum_probs=87.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-----ccccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-----~~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      +++.++.|++.||.|||++ |++||||+|.||+++.++..+++|||.+.....     .......|++.|+|||.+.+..
T Consensus       112 ~~~~i~~qi~~al~~lH~~-~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~  190 (277)
T d1o6ya_         112 RAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS  190 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCC
Confidence            5788999999999999997 899999999999999999999999998754322     1234557899999999999888


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLA  110 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~  110 (131)
                      ++.++|+||+|+++|+|++|+.||......+..
T Consensus       191 ~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~  223 (277)
T d1o6ya_         191 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA  223 (277)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             CCcceecccchHHHHHHHhCCCCCCCcCHHHHH
Confidence            999999999999999999999999877765443

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=5.2e-28  Score=163.01  Aligned_cols=112  Identities=27%  Similarity=0.482  Sum_probs=87.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||.|||++ +++||||+|.||+++.++.+|++|||+++.....   ......+++.|+|||.+....++
T Consensus       109 ~~~~~~~qi~~gl~ylH~~-~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~  187 (273)
T d1mp8a_         109 SLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT  187 (273)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCS
T ss_pred             HHHHHHHHHHHHhhhhccc-CeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCC
Confidence            4678999999999999997 7999999999999999999999999998754322   22344567899999999988899


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCC
Q psy17559         80 VQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~  115 (131)
                      .++|+||||+++|||++ |..||......++.+.+..
T Consensus       188 ~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~  224 (273)
T d1mp8a_         188 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN  224 (273)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred             CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            99999999999999987 8999998887777665543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=7.5e-28  Score=162.36  Aligned_cols=111  Identities=29%  Similarity=0.454  Sum_probs=93.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cccCCCCccceeCcccccCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~   77 (131)
                      .++.++.|++.||.|||++ +++||||+|.||+++.++.++++|||+++.....     ......++..|+|||.+....
T Consensus       112 ~~~~~~~qi~~gl~ylH~~-~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  190 (273)
T d1u46a_         112 TLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT  190 (273)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE
T ss_pred             HHHHHHHHHHHHHHHhhhC-CEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCC
Confidence            4678999999999999997 7999999999999999999999999998754322     223345677899999999888


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhC
Q psy17559         78 YSVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFG  114 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~  114 (131)
                      ++.++|+||||+++|||++ |..||.+.+..+..+.+.
T Consensus       191 ~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~  228 (273)
T d1u46a_         191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID  228 (273)
T ss_dssp             EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHH
Confidence            9999999999999999997 899999888887766553

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.94  E-value=1.6e-27  Score=162.55  Aligned_cols=114  Identities=25%  Similarity=0.380  Sum_probs=95.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||+|||+. +++||||+|.||+++.++.+|++|||+++.....    ......+++.|+|||.+.+..+
T Consensus       141 ~~~~i~~qi~~gl~ylH~~-~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  219 (301)
T d1lufa_         141 EQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY  219 (301)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHhhhcccC-CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC
Confidence            4678999999999999997 7999999999999999999999999998644322    2234567789999999999899


Q ss_pred             CCcchHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHhCCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAIGM-YPIPPPDAKTLAAIFGPSR  117 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~  117 (131)
                      +.++|+||||+++|||+++. .||......++.+.+....
T Consensus       220 t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~  259 (301)
T d1lufa_         220 TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN  259 (301)
T ss_dssp             CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC
T ss_pred             ChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC
Confidence            99999999999999999885 6788888777777665443

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.94  E-value=5.3e-27  Score=158.47  Aligned_cols=110  Identities=29%  Similarity=0.466  Sum_probs=94.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-ccccCCCCccceeCcccccC------
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQG------   75 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~------   75 (131)
                      +++.++.|++.||+|||++ +++||||+|+||+++.++.++++|||++..... .......|+..|.+||.+.+      
T Consensus       111 ~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~  189 (277)
T d1phka_         111 ETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNH  189 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTS
T ss_pred             HHHHHHHHHHHHHHHHHHc-CCcccccccceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccC
Confidence            5788999999999999997 899999999999999999999999999976543 23455678999999999853      


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         76 THYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        76 ~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      ..++.++|+||+|+++|+|++|+.||.........+.+
T Consensus       190 ~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i  227 (277)
T d1phka_         190 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI  227 (277)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH
Confidence            34688999999999999999999999988877665544

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=5.2e-27  Score=159.96  Aligned_cols=113  Identities=31%  Similarity=0.513  Sum_probs=98.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      +++.++.|++.||+|||+. +++||||+|+||+++.++.+|++|||++......    ......+++.|+|||.+....+
T Consensus       136 ~~~~~~~qi~~al~ylH~~-~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y  214 (299)
T d1fgka_         136 DLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY  214 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHhhhC-CEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC
Confidence            4678999999999999998 7999999999999999999999999998755432    2334567889999999988899


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCC
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~  116 (131)
                      +.++|+||||+++|||++ |..||.....+++.+.+...
T Consensus       215 ~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~  253 (299)
T d1fgka_         215 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG  253 (299)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             CchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcC
Confidence            999999999999999997 79999988888777766443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.93  E-value=6.9e-27  Score=158.95  Aligned_cols=101  Identities=28%  Similarity=0.412  Sum_probs=87.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec-----CCcEEEeecccccccccc---------cccCCCCcccee
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS-----GGEIKICDFGVSGQLIDS---------MANSFVGTRSYM   68 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~-----~~~~~l~d~g~~~~~~~~---------~~~~~~~~~~~~   68 (131)
                      ++..++.|++.+|.|||+. |++||||+|.||+++.     ++.++++|||+++.....         ......||+.|+
T Consensus       102 ~~~~i~~q~~~~l~~lH~~-giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~  180 (293)
T d1csna_         102 TVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM  180 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhc
Confidence            4678999999999999997 8999999999999974     567999999998754321         123457899999


Q ss_pred             CcccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy17559         69 SPERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPP  104 (131)
Q Consensus        69 ~Pe~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~  104 (131)
                      |||.+.+..++.++|+||+|+++|+|++|..||.+.
T Consensus       181 aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~  216 (293)
T d1csna_         181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  216 (293)
T ss_dssp             CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             CHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence            999999988999999999999999999999999744

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=4.9e-27  Score=159.20  Aligned_cols=113  Identities=24%  Similarity=0.417  Sum_probs=89.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc---cccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      ++..++.|++.||+|||+. +++||||+|.||+++.++.++|+|||+++.....   ......+++.|+|||.+....++
T Consensus       114 ~~~~i~~~i~~gl~~LH~~-~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  192 (285)
T d1fmka3         114 QLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT  192 (285)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHHhhh-heecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCC
Confidence            5688999999999999997 8999999999999999999999999998754322   22335678899999999988999


Q ss_pred             CcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIG-MYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g-~~p~~~~~~~~~~~~~~~~  116 (131)
                      .++|+||||+++|||++| ..|+......++...+...
T Consensus       193 ~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~  230 (285)
T d1fmka3         193 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG  230 (285)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred             cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence            999999999999999985 5556666666666655433

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.93  E-value=6.6e-27  Score=159.24  Aligned_cols=103  Identities=32%  Similarity=0.480  Sum_probs=87.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEec---CCcEEEeecccccccccc---------cccCCCCccceeCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNS---GGEIKICDFGVSGQLIDS---------MANSFVGTRSYMSP   70 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~---~~~~~l~d~g~~~~~~~~---------~~~~~~~~~~~~~P   70 (131)
                      ++..++.|++.||+|||++ +++||||+|.||+++.   +..++++|||+++.....         ......|++.|+||
T Consensus       104 ~~~~~~~qi~~~l~~lH~~-~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  182 (299)
T d1ckia_         104 TVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI  182 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCH
Confidence            5778999999999999997 8999999999999863   456999999998755321         12345789999999


Q ss_pred             ccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy17559         71 ERLQGTHYSVQSDIWSLGLSLVEMAIGMYPIPPPDA  106 (131)
Q Consensus        71 e~~~~~~~~~~~d~~slg~~l~~l~~g~~p~~~~~~  106 (131)
                      |.+.+..++.++|+||||+++|||++|..||.....
T Consensus       183 E~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~  218 (299)
T d1ckia_         183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA  218 (299)
T ss_dssp             HHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred             HHHhCCCCCChhhEEecCHHHHHHHhCCCcccccch
Confidence            999998899999999999999999999999975543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.8e-26  Score=158.99  Aligned_cols=104  Identities=36%  Similarity=0.649  Sum_probs=89.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-----cccCCCCccceeCcccccC-C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-----MANSFVGTRSYMSPERLQG-T   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~-~   76 (131)
                      +++.++.|++.||+|||++ |++||||+|.||+++.++.++++|||++......     ......+++.|+|||.+.. .
T Consensus       110 ~i~~i~~qil~al~yLH~~-~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~  188 (345)
T d1pmea_         110 HICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK  188 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCC
Confidence            5688999999999999997 8999999999999999999999999998654322     2344568889999999854 4


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy17559         77 HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAK  107 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~  107 (131)
                      .++.++|+||+|+++++|++|+.||......
T Consensus       189 ~~~~~~DiwSlG~il~eml~g~~pf~~~~~~  219 (345)
T d1pmea_         189 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYL  219 (345)
T ss_dssp             SCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             CCCchhhhhccCceehHHhhCCCCCCCCCHH
Confidence            5789999999999999999999999877654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=8.9e-27  Score=158.66  Aligned_cols=105  Identities=35%  Similarity=0.557  Sum_probs=90.8

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc--ccccCCCCccceeCcccccCCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID--SMANSFVGTRSYMSPERLQGTH-YS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~-~~   79 (131)
                      ++..++.|++.||+|||++ +++||||+|.||+++.++.++++|||.++....  .......+++.|+|||...... ++
T Consensus       103 ~~~~~~~qil~~L~yLH~~-~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~  181 (298)
T d1gz8a_         103 LIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS  181 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCC
T ss_pred             HHHHHHHHHHHHHHHhhcC-CEEccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCC
Confidence            5788999999999999997 899999999999999999999999999865533  2344557889999999877654 57


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      .++|+||+|+++|+|++|+.||...+..+
T Consensus       182 ~~~DiwSlGvily~m~~G~~Pf~~~~~~~  210 (298)
T d1gz8a_         182 TAVDIWSLGCIFAEMVTRRALFPGDSEID  210 (298)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccchhhhHHhhCCCCCCCCCHHH
Confidence            89999999999999999999998776543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.4e-26  Score=157.59  Aligned_cols=108  Identities=28%  Similarity=0.438  Sum_probs=91.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc------ccccCCCCccceeCcccccCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID------SMANSFVGTRSYMSPERLQGT   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~~~~~~Pe~~~~~   76 (131)
                      +++.++.|++.||.|||+. |++||||+|+||+++.++.++++|||++.....      .......+++.|+|||.+.+.
T Consensus       118 ~~~~i~~qil~~l~~lH~~-~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~  196 (318)
T d3blha1         118 EIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE  196 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHhccC-CEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCC
Confidence            5678999999999999997 899999999999999999999999999865432      122345688999999998764


Q ss_pred             -CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         77 -HYSVQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        77 -~~~~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                       .++.++|+||+|+++++|++|+.||.+.......+
T Consensus       197 ~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~  232 (318)
T d3blha1         197 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA  232 (318)
T ss_dssp             SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHH
Confidence             68899999999999999999999998776554433

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.2e-26  Score=159.84  Aligned_cols=105  Identities=33%  Similarity=0.643  Sum_probs=90.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC-cEEEeeccccccccc-ccccCCCCccceeCcccccC-CCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG-EIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQG-THYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~-~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~-~~~~   79 (131)
                      +++.++.|++.||+|||++ |++||||+|+||+++.++ .++++|||++..... .......++..|++||.+.+ ..++
T Consensus       123 ~~~~i~~qil~aL~yLH~~-~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  201 (350)
T d1q5ka_         123 YVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYT  201 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCC
T ss_pred             HHHHHHHHHHHHHHHHHhc-CCcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCC
Confidence            5678999999999999997 899999999999999765 799999999876543 33445678899999998875 4689


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      .++|+||+||++|||++|..||......+
T Consensus       202 ~~~DIwSlG~il~el~~g~~pf~~~~~~~  230 (350)
T d1q5ka_         202 SSIDVWSAGCVLAELLLGQPIFPGDSGVD  230 (350)
T ss_dssp             THHHHHHHHHHHHHHHHTSCSSCCSSHHH
T ss_pred             cceeecccceEEEehhhCCCCCCCCCHHH
Confidence            99999999999999999999998766543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.3e-26  Score=155.37  Aligned_cols=114  Identities=25%  Similarity=0.435  Sum_probs=92.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCCCCCCcc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS   82 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~   82 (131)
                      .+..++.|++.||.|||++ +++||||+|.||+++.++.++++|||+++..... .....++..|+|||.+.+..++.++
T Consensus       104 ~~~~i~~~i~~al~ylH~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-~~~~~~~~~y~aPE~l~~~~~t~~s  181 (262)
T d1byga_         104 CLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-QDTGKLPVKWTAPEALREKKFSTKS  181 (262)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC-------------CCTTTSCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHhhccccccC-ceeccccchHhheecCCCCEeecccccceecCCC-CccccccccCCChHHHhCCCCChHH
Confidence            4678999999999999997 7999999999999999999999999998765432 2334567789999999888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhCCCCC
Q psy17559         83 DIWSLGLSLVEMAI-GMYPIPPPDAKTLAAIFGPSRG  118 (131)
Q Consensus        83 d~~slg~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~  118 (131)
                      |+||||+++|||++ |..||......++...+....+
T Consensus       182 DIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~  218 (262)
T d1byga_         182 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK  218 (262)
T ss_dssp             HHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC
T ss_pred             HHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999999999997 7999988888888777755433

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.2e-26  Score=159.57  Aligned_cols=110  Identities=26%  Similarity=0.415  Sum_probs=93.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecC--CcEEEeeccccccccc-ccccCCCCccceeCcccccCCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSG--GEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~--~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~   79 (131)
                      +++.++.|++.||+|||+. |++||||+|.||+++.+  ..++++|||++..... .......+++.|++||...+..++
T Consensus       103 ~~~~i~~qi~~al~yLH~~-~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~  181 (321)
T d1tkia_         103 EIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS  181 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEEC
T ss_pred             HHHHHHHHHHHHHHHHHHc-CCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCCCCC
Confidence            5778999999999999997 89999999999999854  4789999999876543 233445678899999999988899


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKTLAAIF  113 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~~~~~~  113 (131)
                      .++|+||+|+++|+|++|..||......++...+
T Consensus       182 ~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i  215 (321)
T d1tkia_         182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENI  215 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9999999999999999999999988876655543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=8.9e-26  Score=156.36  Aligned_cols=105  Identities=37%  Similarity=0.616  Sum_probs=91.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCC-CCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGT-HYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~   81 (131)
                      +++.++.|++.||.|||++ |++||||+|.||+++.++.++++|||.+...... .....+++.|+|||.+.+. .++.+
T Consensus       122 ~~~~~~~qi~~aL~~LH~~-~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~  199 (346)
T d1cm8a_         122 RIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-MTGYVVTRWYRAPEVILNWMRYTQT  199 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-CCSSCSCGGGCCTHHHHTTTCCCTT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCcccccCcchhhcccccccccccccceeccCCc-cccccccccccCHHHHcCCCCCCcc
Confidence            5788999999999999997 8999999999999999999999999998765443 3456788999999998764 56899


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      +|+||+|+++++|++|..||.+.+..+.
T Consensus       200 ~DiwSlGvil~ell~g~~pf~~~~~~~~  227 (346)
T d1cm8a_         200 VDIWSVGCIMAEMITGKTLFKGSDHLDQ  227 (346)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             chhhcchHHHHHHHHCcCCCCCCChHHH
Confidence            9999999999999999999987765433

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.92  E-value=4.7e-26  Score=154.11  Aligned_cols=105  Identities=33%  Similarity=0.570  Sum_probs=87.1

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      ++..++.|++.||+|||+. +++||||+|.||+++.++.++++|||.+......  ......+++.|.+||.+... .++
T Consensus       101 ~~~~i~~qi~~~L~~LH~~-~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~  179 (286)
T d1ob3a_         101 TAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS  179 (286)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCC
T ss_pred             hhHHHHHHHHHHHHHhccC-cEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCC
Confidence            5678999999999999997 8999999999999999999999999998654322  23344678899999998764 468


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPDAKT  108 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~~~~  108 (131)
                      .++|+||+|+++++|++|+.||.+.+..+
T Consensus       180 ~~~DiwslGv~l~el~~G~~pf~~~~~~~  208 (286)
T d1ob3a_         180 TTIDIWSVGCIFAEMVNGTPLFPGVSEAD  208 (286)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cceeehhcCcHHHHHHHCCCCCCCCCHHH
Confidence            99999999999999999999998766443

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=5.2e-26  Score=155.58  Aligned_cols=113  Identities=29%  Similarity=0.328  Sum_probs=94.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc-cccCCCCccceeCcccccCCCCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~   81 (131)
                      ++..++.|++.||.|+|++ +++||||+|.||+++.++.+|++|||+++..... ......++..|++||.+....++.+
T Consensus       128 ~~~~~~~qia~gl~~lH~~-~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~  206 (309)
T d1fvra_         128 QLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN  206 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH
T ss_pred             HHHHHHHHHHHHHHhhhcC-CccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCcc
Confidence            4678999999999999997 7999999999999999999999999998655433 2234467889999999998889999


Q ss_pred             chHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhCCC
Q psy17559         82 SDIWSLGLSLVEMAIG-MYPIPPPDAKTLAAIFGPS  116 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g-~~p~~~~~~~~~~~~~~~~  116 (131)
                      +|+||||+++|||++| ..||...+..++.+.+...
T Consensus       207 sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~  242 (309)
T d1fvra_         207 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  242 (309)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             ceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence            9999999999999986 5678888888887776543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.5e-25  Score=153.32  Aligned_cols=112  Identities=24%  Similarity=0.410  Sum_probs=95.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.||.|||++ +++||||++.||+++.++.+||+|||+++.....    ......+++.|++||.+.+..+
T Consensus       134 ~~~~i~~~ia~gl~~LH~~-~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~  212 (308)
T d1p4oa_         134 KMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF  212 (308)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHhhC-CeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCC
Confidence            3577999999999999997 7999999999999999999999999998755332    2234467889999999998889


Q ss_pred             CCcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhCC
Q psy17559         79 SVQSDIWSLGLSLVEMAIG-MYPIPPPDAKTLAAIFGP  115 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~g-~~p~~~~~~~~~~~~~~~  115 (131)
                      +.++|+||||+++|||++| ..||......+..+.+..
T Consensus       213 ~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~  250 (308)
T d1p4oa_         213 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  250 (308)
T ss_dssp             CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             CcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            9999999999999999987 588988888777766543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=9.3e-26  Score=155.17  Aligned_cols=102  Identities=32%  Similarity=0.547  Sum_probs=86.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc---ccccCCCCccceeCcccccCC--C
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID---SMANSFVGTRSYMSPERLQGT--H   77 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~--~   77 (131)
                      ++..++.|++.|+.|+|+. +++||||+|.||+++.++.++++|||+++....   .......+++.|++||.+.+.  .
T Consensus       130 ~~~~~~~Qi~~al~~lH~~-~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~  208 (322)
T d1vzoa_         130 EVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG  208 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC--
T ss_pred             HHHHHHHHHHHHHHHhhcC-CEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcC
Confidence            4677899999999999997 799999999999999999999999999865432   223455788899999999764  4


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         78 YSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        78 ~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      ++.++|+||+||++|+|++|..||....
T Consensus       209 ~~~ksDIWSlG~iLyelltG~~PF~~~~  236 (322)
T d1vzoa_         209 HDKAVDWWSLGVLMYELLTGASPFTVDG  236 (322)
T ss_dssp             -CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred             CCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            6789999999999999999999997554

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.4e-25  Score=153.59  Aligned_cols=100  Identities=28%  Similarity=0.481  Sum_probs=86.3

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc------cccCCCCccceeCcccccCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS------MANSFVGTRSYMSPERLQGT   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~   76 (131)
                      ++..++.|++.||.|+|+. +++||||++.||++++++.++++|||+++.....      ......++..|++||.+...
T Consensus       131 ~~~~i~~qia~gL~~lH~~-~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  209 (311)
T d1r0pa_         131 DLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ  209 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC
T ss_pred             HHHHHHHHHHHhhhhhccc-CcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcC
Confidence            4568999999999999997 7999999999999999999999999998765322      11234577899999999888


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy17559         77 HYSVQSDIWSLGLSLVEMAIGMYPIPP  103 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~g~~p~~~  103 (131)
                      .++.++|+||||+++||+++|..||..
T Consensus       210 ~~~~ksDI~SfGivl~El~t~~~p~~~  236 (311)
T d1r0pa_         210 KFTTKSDVWSFGVLLWELMTRGAPPYP  236 (311)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred             CCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence            899999999999999999998777753

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.91  E-value=7.7e-25  Score=150.61  Aligned_cols=102  Identities=28%  Similarity=0.524  Sum_probs=87.6

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCC-cEEEeeccccccccc-ccccCCCCccceeCcccccCC-CCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGG-EIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGT-HYS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~-~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~-~~~   79 (131)
                      +++.++.|++.||.|||++ |++||||+|+||+++.++ .++++|||.+..... .......+++.|+|||.+.+. .++
T Consensus       130 ~i~~i~~qil~aL~~LH~~-gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  208 (328)
T d3bqca1         130 DIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD  208 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCC
T ss_pred             HHHHHHHHHHHHHHHHhhc-ccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCC
Confidence            5788999999999999997 899999999999999655 689999999876543 234556788899999998765 479


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      .++|+||+|++++++++|..||....
T Consensus       209 ~~~DiwslG~~l~e~~~g~~pf~~~~  234 (328)
T d3bqca1         209 YSLDMWSLGCMLASMIFRKEPFFHGH  234 (328)
T ss_dssp             THHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccchhhhhhhhHHhccCCCCCCCCc
Confidence            99999999999999999999997544

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=7.9e-25  Score=152.15  Aligned_cols=107  Identities=37%  Similarity=0.564  Sum_probs=86.1

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeeccccccccc-ccccCCCCccceeCcccccCCCCCC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSV   80 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~   80 (131)
                      ++++.+++|++.||.|||+. |++||||+|.||+++.++.++++|||.+..... .......+++.|+|||.+.+..++.
T Consensus       119 ~~i~~~~~qil~gl~~LH~~-giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~  197 (355)
T d2b1pa1         119 ERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE  197 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCT
T ss_pred             HHHHHHHHHHHHHHHHhhhc-ccccccCCccccccccccceeeechhhhhccccccccccccccccccChhhhcCCCCCC
Confidence            35788999999999999997 899999999999999999999999998765443 2334456788999999999989999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy17559         81 QSDIWSLGLSLVEMAIGMYPIPPPDAKTL  109 (131)
Q Consensus        81 ~~d~~slg~~l~~l~~g~~p~~~~~~~~~  109 (131)
                      ++|+||+||+++++++|+.||.+.+....
T Consensus       198 ~~DiwSlG~~l~ell~g~~pF~~~~~~~~  226 (355)
T d2b1pa1         198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQ  226 (355)
T ss_dssp             THHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CcccccccchHHHHhhCCCCCCCCCHHHH
Confidence            99999999999999999999987765533

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=2.2e-25  Score=152.17  Aligned_cols=100  Identities=32%  Similarity=0.419  Sum_probs=82.1

Q ss_pred             chhHHHHHHHHHHHHHHhc-------CCcEecCCCCCcEEEecCCcEEEeecccccccccc------cccCCCCccceeC
Q psy17559          3 QVPYSSFQVLKGLTYLREK-------HAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS------MANSFVGTRSYMS   69 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~-------~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~~~~~~   69 (131)
                      +...++.|++.||.|+|+.       ++++||||+|.||+++.++.+|++|||++......      ......|++.|+|
T Consensus       101 ~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~a  180 (303)
T d1vjya_         101 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA  180 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCC
T ss_pred             HHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCC
Confidence            4568999999999999962       47999999999999999999999999998655321      2234578999999


Q ss_pred             cccccCCC------CCCcchHHHHHHHHHHHHhCCCCCC
Q psy17559         70 PERLQGTH------YSVQSDIWSLGLSLVEMAIGMYPIP  102 (131)
Q Consensus        70 Pe~~~~~~------~~~~~d~~slg~~l~~l~~g~~p~~  102 (131)
                      ||.+....      ++.++|+||||+++||+++|..||.
T Consensus       181 PE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~  219 (303)
T d1vjya_         181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             HHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             hhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence            99986532      5678999999999999999987763

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=4.4e-25  Score=151.08  Aligned_cols=110  Identities=32%  Similarity=0.566  Sum_probs=90.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc----cccCCCCccceeCcccccCCCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHY   78 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~   78 (131)
                      ++..++.|++.|++|||++ +++||||+|.||+++.++.++++|||.++.....    ......+++.|+|||.+....+
T Consensus       146 ~~~~~~~qi~~gl~~LH~~-~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  224 (311)
T d1t46a_         146 DLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY  224 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC
Confidence            4678999999999999997 7999999999999999999999999998755322    2234567889999999988889


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHh
Q psy17559         79 SVQSDIWSLGLSLVEMAI-GMYPIPPPDA-KTLAAIF  113 (131)
Q Consensus        79 ~~~~d~~slg~~l~~l~~-g~~p~~~~~~-~~~~~~~  113 (131)
                      +.++|+||||+++|||++ |..||..... +.+.+++
T Consensus       225 ~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i  261 (311)
T d1t46a_         225 TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI  261 (311)
T ss_dssp             CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred             CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            999999999999999998 6666665444 3344444

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=7.4e-25  Score=151.66  Aligned_cols=107  Identities=38%  Similarity=0.649  Sum_probs=88.4

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcccccCC-CCCCc
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGT-HYSVQ   81 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~   81 (131)
                      +++.++.|++.||.|||++ |++||||+|.||+++.++.++++|||.+..... ......++..|++||..... .++.+
T Consensus       122 ~~~~i~~qil~aL~~LH~~-giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-~~~~~~g~~~y~apE~~~~~~~~~~~  199 (348)
T d2gfsa1         122 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-EMTGYVATRWYRAPEIMLNWMHYNQT  199 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCC----CCTG-GGSSSCHHHHTSCHHHHTTCSCCCTT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCcccccCCccccccccccccccccchhcccCc-ccccccccccccCchhhcCCccCCcc
Confidence            5788999999999999997 899999999999999999999999999865443 23456778899999987665 46899


Q ss_pred             chHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy17559         82 SDIWSLGLSLVEMAIGMYPIPPPDAKTLAA  111 (131)
Q Consensus        82 ~d~~slg~~l~~l~~g~~p~~~~~~~~~~~  111 (131)
                      +|+||+|+++|+|++|+.||.+.+......
T Consensus       200 ~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~  229 (348)
T d2gfsa1         200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLK  229 (348)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cchhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999999999998777554433

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=6.1e-24  Score=143.72  Aligned_cols=104  Identities=35%  Similarity=0.561  Sum_probs=86.5

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccc--cccCCCCccceeCcccccCCC-CC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH-YS   79 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~-~~   79 (131)
                      .++.++.|++.||+|||++ +++||||+|.||+++.++.++++|||.+......  ......++..|.+||.+.... ++
T Consensus       102 ~~~~~~~q~~~aL~~lH~~-~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~  180 (292)
T d1unla_         102 IVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS  180 (292)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCC
T ss_pred             HHHHHHHHHHHHHHHhhcC-CEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCC
Confidence            4678999999999999997 8999999999999999999999999998765432  223345667889999887654 68


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCC-CCCHH
Q psy17559         80 VQSDIWSLGLSLVEMAIGMYPIP-PPDAK  107 (131)
Q Consensus        80 ~~~d~~slg~~l~~l~~g~~p~~-~~~~~  107 (131)
                      .++|+||+|+++++|++|..||. +.+..
T Consensus       181 ~~~DiwSlG~il~ell~g~~p~~~~~~~~  209 (292)
T d1unla_         181 TSIDMWSAGCIFAELANAGRPLFPGNDVD  209 (292)
T ss_dssp             THHHHHHHHHHHHHHTTTSCCSCCCSSHH
T ss_pred             chhhccccchHHHHHhhCCCCCCCCCCHH
Confidence            99999999999999999999864 44433

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.89  E-value=7.5e-24  Score=147.02  Aligned_cols=102  Identities=34%  Similarity=0.545  Sum_probs=85.9

Q ss_pred             chhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCc------EEEeecccccccccccccCCCCccceeCcccccCC
Q psy17559          3 QVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGE------IKICDFGVSGQLIDSMANSFVGTRSYMSPERLQGT   76 (131)
Q Consensus         3 ~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~------~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~   76 (131)
                      .++.++.|++.||+|||+..|++||||+|.||+++.++.      ++++|||.+..... ......+++.|+|||.+...
T Consensus       126 ~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-~~~~~~gt~~y~aPE~~~~~  204 (362)
T d1q8ya_         126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVLLGA  204 (362)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-CCCSCCSCGGGCCHHHHHTC
T ss_pred             HHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc-ccccccccccccChhhcccc
Confidence            568899999999999998558999999999999986543      89999999865543 23456788999999999988


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy17559         77 HYSVQSDIWSLGLSLVEMAIGMYPIPPPD  105 (131)
Q Consensus        77 ~~~~~~d~~slg~~l~~l~~g~~p~~~~~  105 (131)
                      .++.++|+||+|++++++++|+.||...+
T Consensus       205 ~~~~~~DiwSlG~il~el~~g~~pF~~~~  233 (362)
T d1q8ya_         205 PWGCGADIWSTACLIFELITGDFLFEPDE  233 (362)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             CCCccccccchHHHHHHHHHCCCCCCCCc
Confidence            89999999999999999999999997543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.35  E-value=6.7e-14  Score=88.78  Aligned_cols=79  Identities=20%  Similarity=0.207  Sum_probs=56.4

Q ss_pred             CchhHHHHHHHHHHHHHHhcCCcEecCCCCCcEEEecCCcEEEeecccccccccccccCCCCccceeCcc-----cccCC
Q psy17559          2 KQVPYSSFQVLKGLTYLREKHAIIHRDVKPSNILVNSGGEIKICDFGVSGQLIDSMANSFVGTRSYMSPE-----RLQGT   76 (131)
Q Consensus         2 ~~~~~~~~q~~~~l~~lh~~~~~~h~~l~~~~il~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~Pe-----~~~~~   76 (131)
                      +++..++.|++.++++||+. |++|+||+|.||+++.+ .++++|||.+....+....      .|....     .....
T Consensus       103 ~~~~~i~~ql~~~l~~lH~~-giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~------~~l~rd~~~~~~~f~r  174 (191)
T d1zara2         103 ENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR------EILERDVRNIITYFSR  174 (191)
T ss_dssp             SCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHH------HHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhhC-CEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcH------HHHHHHHHHHHHHHcC
Confidence            45678999999999999997 89999999999999865 4889999988654322111      111100     01124


Q ss_pred             CCCCcchHHHHH
Q psy17559         77 HYSVQSDIWSLG   88 (131)
Q Consensus        77 ~~~~~~d~~slg   88 (131)
                      .++..+|+||+.
T Consensus       175 ~y~~~~d~~s~~  186 (191)
T d1zara2         175 TYRTEKDINSAI  186 (191)
T ss_dssp             HHCCCCCHHHHH
T ss_pred             CCCCcccHHHHH
Confidence            577888999964

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.23  E-value=0.0032  Score=41.31  Aligned_cols=29  Identities=21%  Similarity=0.290  Sum_probs=26.1

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      |++|+|+.++|++++.+....+.||+.+.
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcccccceeEecccccc
Confidence            79999999999999988777899999764

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=93.82  E-value=0.018  Score=36.30  Aligned_cols=29  Identities=38%  Similarity=0.534  Sum_probs=24.7

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      .++|+|+.+.|++++.++...+.||+.+.
T Consensus       184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEEEeeccCcceeecCCceEEEeechhcc
Confidence            48999999999999977667799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=92.84  E-value=0.023  Score=35.59  Aligned_cols=29  Identities=31%  Similarity=0.406  Sum_probs=24.5

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      .++|+|+.+.|++++.+..+.++||+.+.
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            48999999999999877667899998654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=89.58  E-value=0.091  Score=35.43  Aligned_cols=28  Identities=21%  Similarity=0.318  Sum_probs=23.9

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      .++|+|+.+.||+++.++ +++.||..+.
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~  251 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF  251 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence            699999999999998654 7999997664

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=85.77  E-value=0.14  Score=33.45  Aligned_cols=27  Identities=26%  Similarity=0.345  Sum_probs=22.0

Q ss_pred             CcEecCCCCCcEEEecCCcEEEeeccccc
Q psy17559         23 AIIHRDVKPSNILVNSGGEIKICDFGVSG   51 (131)
Q Consensus        23 ~~~h~~l~~~~il~~~~~~~~l~d~g~~~   51 (131)
                      +++|+|+++.|++++. + ..+.||+-+.
T Consensus       193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~  219 (325)
T d1zyla1         193 LRLHGDCHAGNILWRD-G-PMFVDLDDAR  219 (325)
T ss_dssp             EECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred             eeecCCCCcccEEEeC-C-ceEEechhcc
Confidence            6899999999999964 3 4578998764